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Introduction
Background
The National Report on Biochemical Indicators of Diet and Nutrition in the U.S. Population 
is a series of publications that provide ongoing assessment of the U.S. population’s nutritional 
status by measuring blood or urine concentrations of diet-and-nutrition biochemical indicators. 
The Centers for Disease Control and Prevention’s (CDC) Division of Laboratory Sciences at the 
National Center for Environmental Health (NCEH/DLS) conducted the laboratory analyses 
for 58 biochemical indicators presented in this 2012 report, which is the second in this series. 
CDC measured these indicators in specimens from a representative sample of the U.S. population 
during all or part of the four-year period from 2003 through 2006. Where available, data are also 
presented on changes of biochemical indicator concentrations over time since 1999. Similarly, 
data are also presented on the prevalence of low or high biochemical indicator concentrations 
during 2003–2006, and on changes in the prevalence over time since 1999. The first report of this 
series was published in July 2008 and contains information on 27 biochemical indicators from 
all or part of the four-year period from 1999 through 2002. Both reports can be accessed online: 
http://www.cdc.gov/nutritionreport.
Characteristic First report, 2008 Second report, 2012
Years of NHANES covered 1999–2002 2003–2006
Number of indicators covered 27 58
Concentrations by race/ethnic group Yes Yes
Central 95% reference intervals No Yes
Graphic representation of age patterns No Yes
Concentrations over time No Yes (1999-2006)
Prevalence estimates No Yes
Prevalence estimates over time No Yes (1999-2006)
CDC’s National Health and Nutrition Examination Survey (NHANES), conducted by the 
National Center for Health Statistics (NCHS), collected the specimens for this report. NHANES 
is a series of surveys designed to collect data on the health and nutritional status of the U.S. 
population. This report covers biochemical measurements—one important facet in the assessment 
of the U.S. population’s nutritional status. Other nutrition-related aspects from NHANES, 
such as dietary intake, supplement usage, hematologic measurements, and anthropometric body 
measurements are not covered.
In this report, a biochemical indicator means a nutrient (e.g., vitamin, fatty acid, trace element), 
a metabolite (e.g., homocysteine, methylmalonic acid), or a dietary indicator with potential 
health relevance (e.g., isoflavone, lignan) measured in blood or urine. Although most biochemical 
indicators presented in this report enter the human body from foods or supplements, the body 
itself produces some indicators in response to dietary intake or environmental exposure. Blood 
and urine concentrations reflect the amount of nutrients and dietary compounds actually in the 
body or passing through the body from all these sources.
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The biochemical indicator sections and new biochemical indicators covered in this report are:
Biochemical indicator sections New biochemical indicators
•	 Water-soluble vitamins •	 Vitamin B6
•	 Fat-soluble vitamins and nutrients •	 Vitamin C
•	 Trace elements (iron indicators and iodine) •	 Fatty acids
•	 Isoflavones and lignans •	 Iron status: Transferrin receptor and body iron
•	 Acrylamide hemoglobin adducts •	 Acrylamide hemoglobin adducts
Addressing Data Needs
This report is the second CDC product containing reference information on NCEH/DLS 
measurement data for a wide range of biochemical indicators of diet and nutrition from the most 
recent continuous NHANES survey, starting in 1999. In this comprehensive report, information 
on changes in concentrations of a large number of biochemical indicators during 1999–2006 
is presented for the first time. Prevalence information on low or high biochemical indicator 
concentrations is also presented for the first time.
NCHS has historically released or commissioned a variety of products presenting NHANES 
results. Among these are Data Briefs, Data Tables, Advance Data, Series Reports, and Reports 
through the Life Sciences Research Office (LSRO). NHANES Series Reports (mainly Series 
11) and LSRO Reports from surveys prior to the continuous NHANES have been of particular 
value to the nutrition community (see Appendix A). The NHANES Web site provides current 
information on results and products from this survey: http://www.cdc.gov/nchs/about/major/
nhanes/survey_results_and_products.htm. 
Public Health Uses
This report’s primary objective is to inform public health scientists and policy makers about the 
concentrations of biochemical indicators of diet and nutrition in the general U.S. population and 
in selected subpopulations. These data will help physicians, scientists, and public health offcials 
assess inadequate or excess intake and will inform analyses on the relation between biochemical 
indicators and health outcomes. Other objectives and potential public health uses of the 
information include
•	 Establishing and improving on existing population reference levels that can be used to 
determine whether an individual or a group has an unusually high or low concentration 
of a diet-and-nutrition biochemical indicator.
•	 Determining whether the nutritional status of special population groups, such as 
minorities, children, women of childbearing age, or the elderly, is different from that of 
other groups, or whether such nutritional status needs improvement.
•	 Tracking trends over time in the population’s biochemical indicator concentrations.
•	 Assessing the effectiveness of public health efforts to improve the diet and nutritional 
status of the U.S. population.
•	 Guide research to perform more in-depth analyses of the NHANES data and to 
generate hypotheses for future nutrition and human health studies.
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Data Presented for Each Biochemical Indicator
This report contains tables and figures of descriptive statistics on the distribution of blood and 
urine concentrations during all or part of the four-year period from 2003 through 2006 for 
each diet-and-nutrition biochemical indicator. Statistics include unadjusted geometric means 
and selected percentiles with confidence intervals. For some biochemical indicators, additional 
information is included, as available, in the form of
•	 Tables and figures describing biochemical indicator concentrations across survey cycles 
during all or part of the eight-year period from 1999 through 2006. Statistics include 
unadjusted geometric means and selected percentiles with confidence intervals. 
•	 Tables describing the prevalence of low or high concentrations of selected biochemical 
indicators during all or part of the four-year period from 2003 through 2006 and tables 
describing the prevalence across survey cycles during all or part of the eight-year period 
from 1999 through 2006. Statistics include unadjusted percentages with confidence 
intervals and estimated total number of persons affected.
See Appendix B for an overview of the type of information presented for each biochemical 
indicator. The data are grouped by age, gender, and race/ethnicity. The majority of the 
biochemical indicators reviewed in this report, with the exception of vitamin C and body iron, 
have a long upper tail (skewed right). For these biochemical indicators, a geometric mean provides 
a better estimate of central tendency because it is less influenced by high values than is the 
arithmetic mean. However, the arithmetic mean is presented for vitamin C and body iron as the 
distributions for these biochemical indicators were reasonably symmetric. Scientists can use the 
presented percentile levels to determine those serum, blood, or urine indicator concentrations 
common to people in the U.S. population and those that are unusual. Frequently, the central 
95% reference interval (2.5th to 97.5th percentile) is used to describe normal concentrations in 
a population. Concentrations outside the reference interval are considered unusual. For urine 
measurements, data are shown for both the concentration and for the concentration corrected for 
the urinary creatinine level. 
We present the following information for each biochemical indicator during all or part of 2003–
2006:
•	 A table that presents the geometric mean and selected percentile (2.5th–97.5th, so called 
central 95% reference interval) concentrations by age, gender, or race/ethnicity (1-level 
stratified).
•	 A figure that presents the geometric mean concentrations by age and gender or by age 
and race/ethnicity (2-level stratified). 
•	 Four detailed tables that present the geometric mean and selected percentile (5th or 10th, 
50th, 90th or 95th) concentrations by age, gender, and race/ethnicity (3-level stratified). 
The first table is for the overall U.S. population stratified by age and gender, while the 
next three tables present data for each racial/ethnic group (Mexican American, non-
Hispanic black, and non-Hispanic white) stratified by age and gender.
If data are available for multiple two-year survey cycles from 1999–2006, we present tables with 
geometric mean and selected percentile (5th–95th) concentrations by age, gender, or race/ethnicity 
for each available two-year survey cycle, as well as corresponding figures for selected percentiles 
(1-level stratified).
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For biochemical indicators that have accepted cutoff values for low or high concentrations or 
for both (e.g., folate, vitamins A, B6, B12, C, D, E, ferritin, iodine)—suggesting deficiency or 
excess of certain micronutrients—we present tables with prevalence estimates by age, gender, or 
race/ethnicity during all or part of 2003–2006 (1-level stratified). We also present tables with 
prevalence estimates by age, gender, or race/ethnicity for each available two-year survey cycle from 
1999–2006 to allow evaluation of changes in prevalence estimates over time (1-level stratified). 
See Appendix C for a complete listing of the cutoff values and populations described in this 
report.
Background text provides general information for each indicator to aid with interpreting the data. 
To address sources of these nutrients, biochemical pathways in the body, and known health 
effects, the text contains a brief overview about each indicator.
Each chapter contains highlights followed by detailed observations that are derived from this report’s 
data tables and figures. 
The highlights are presented directly after the background text. They summarize important 
observations and discuss them in a public health context. For example, we present figures 
highlighting prevalence information by demographic subgroups. Where long-term trending 
information beyond the continuous NHANES is available and of public health interest, we 
present figures showing changes in biochemical indicator concentrations from NHANES III 
(1988–1994) to NHANES 1999–2002 and NHANES 2003–2006. The detailed observations 
describe selected categorical differences between demographic subgroups derived from the data 
tables and figures that follow next. Each chapter is concluded by a list of pertinent references.
Interpreting the Data
Blood or urine concentrations of biochemical indicators can help in assessing the adequacy of 
intake for the U.S. population. These measurements indicate cumulative intakes from foods, some 
fortified with micronutrients (e.g., iron, thiamin, riboflavin, niacin, folate, vitamin A, vitamin 
D), and from dietary supplements that contain vitamins, minerals, or both. However, blood or 
urine concentrations of biochemical indicators can also be influenced by factors other than diet, 
such as various diseases or exposures. For those nutrients without defined adequate intakes (e.g., 
carotenoids, isoflavones), biochemical indicators are useful for assessing intake without regard to 
adequacy.
Dietary deficiencies are well documented, and they have characteristic signs and symptoms. In 
addition, recent findings have determined that less than optimal biochemical concentrations 
(representing suboptimal status) have been associated with risks of adverse health effects. These 
health effects include cardiovascular disease, stroke, impaired cognitive function, cancer, eye 
diseases, poor bone health, and other conditions. Adverse health effects, including toxicity, are also 
possible from consuming excess amounts of certain nutrients and data to assist in the assessment 
of excessive intake is a feature of this report. Determining the concentrations of a biochemical 
indicator that may indicate risk for disease and the concentrations that are of negligible health 
concern requires future research studies that are separate from this report. In collaboration with 
other agencies and institutions, CDC encourages, and itself conducts research on the relationship 
between biochemical indicators and health effects.
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This report contains unadjusted geometric means, 
selected percentiles, and prevalence estimates of low or 
high concentrations of diet-and-nutrition biochemical 
indicators for the civilian, noninstitutionalized U.S. 
population. A limited interpretation of relative 
differences between population groups is possible by 
identifying groups with nonoverlapping confidence 
intervals. However, one should be careful about 
interpreting the observed differences as causal. 
The intent is to describe the characteristics of the 
population and of selected subgroups, not to explain 
why the groups display certain characteristics or why 
they differ from each other. Furthermore, differences 
in biochemical indicator concentrations of selected 
subgroups do not necessarily imply health status problems. And for several reasons, one should use 
caution when drawing temporal conclusions from comparisons of serial cross-sectional NHANES 
survey cycles. One of these reasons is that different or improved methods of measurement may 
be employed across the NHANES survey cycles. Another reason is that there are demographic 
changes to the U.S. population over time. Finally, sampling differences could explain some of the 
observed changes from one cycle to the next. More in-depth statistical analyses, such as developing 
models to adjust simultaneously for many covariates and taking into consideration interactions 
between two or more variables, are beyond the scope of this report. Nonetheless, unadjusted 
geometric means, selected percentiles, and prevalence estimates provided in this report are useful 
to summarize reference information for blood or urine concentrations of diet-and-nutrition 
biochemical indicators for the civilian, noninstitutionalized population in the United States and 
selected subgroups. We hope that the report will stimulate scientists to examine the data further 
through analyzing the raw data available at: http://www.cdc.gov/nchs/nhanes.htm.
Laboratories may use different methods for measuring the indicators reported here. However, 
different methods may result in different method-specific reference intervals. Consequently, to 
apply these results, health science professionals should check with their particular laboratory to be 
sure that their methods compare closely to those used in this report (see Appendix D).
Sources of Information on Nutrition Monitoring to Help Interpret  
the Data
Information about dietary intake is critical to research examining the reasons for nutritional 
inadequacies. Such information is also critical to programs seeking to improve diet and nutritional 
status. Selected NCHS Advance Data Reports provide useful overviews (see Appendix A). Also of value 
are the U.S. Department of Agriculture’s (USDA) databases on food surveys and food composition: 
What We Eat in America (WWEIA) is the dietary intake interview section of NHANES (http://
www.ars.usda.gov/foodsurvey).
The Food and Nutrient Database for Dietary Studies (FNDDS) (http://www.ars.usda.gov/
Services/docs.htm?docid=12089) is a database of foods, their nutrient values, and weights for 
typical food portions. This database is used to generate data for the WWEIA survey through 
application of the nutrient values from the National Nutrient Database for Standard Reference 
(http://www.ars.usda.gov/Services/docs.htm?docid=8964).
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The National Health and Nutrition Examination Survey (NHANES)
CDC laboratory scientists used biological specimens obtained from NHANES participants to 
measure biochemical indicators of diet and nutrition for this publication. NHANES is a series of 
NCHS-conducted surveys designed to collect data on the health and nutritional status of the U.S. 
population. This is the only national survey that collects biological samples. The NHANES surveys 
began in 1960 with the first Health Examination Survey (HES 1). The nutritional component was 
added in the early 1970s in NHANES I. In 1999, NHANES became a continuous survey, sampling 
the U.S. population annually and releasing the data in two-year cycles. 
NHANES collects information on a wide range of health-related behaviors, conducts physical 
examinations, and collects samples for laboratory tests. Because of physical examination and 
biological measures, NHANES is unique in its ability to examine public health issues in the U.S. 
population, such as risk factors for cardiovascular disease. To select a representative sample of the 
civilian, noninstitutionalized population in the United States, the survey sampling plan follows 
a complex, stratified, multistage, probability-cluster design. The civilian, noninstitutionalized 
population consists of persons who are neither in the military nor institutionalized (e.g., they are 
not residents of nursing homes, college dormitories, or prisons). 
The NHANES protocol includes a home interview followed by a standardized physical 
examination at a mobile examination center. As part of the examination, for participants aged 1 
year and older, blood is obtained by venipuncture. Urine specimens are collected from participants 
aged 6 years and older. By design, approximately half of the participants are evaluated after an 
overnight fast; for the other half of the participants, there is approximately an equal distribution 
between those who fasted less than 3 hours and those who fasted between 3 and 8 hours before 
providing a biological sample. Because weather can adversely affect the mobile examination 
centers, data are collected in northern latitudes in summer and in southern latitudes in winter. 
This seasonal-latitude structure might indirectly affect biochemical indicators.
Additional detailed information about the design and conduct of the NHANES survey is available 
at http://www.cdc.gov/nchs/nhanes.htm. Information about how biological specimens are 
collected is available at (http://www.cdc.gov/nchs/data/nhanes/blood.pdf ) and included in the 
Laboratory Procedures Manual at http://www.cdc.gov/nchs/data/nhanes/lab1-6.pdf and at http://
www.cdc.gov/nchs/data/nhanes/lab7-11.pdf.
Data Analysis
NCHS has developed a comprehensive Web-based tutorial (http://www.cdc.gov/nchs/tutorials/
Nhanes/index.htm) to help users better understand the complex survey design and to help them 
analyze NHANES data.
Because the NHANES sample design is a complex, multistage probability sample, officials 
use sample weights when estimating the mean or other descriptive metrics. These weights are 
post-stratified to the U.S. Census Bureau estimates of the U.S. population to adjust for the 
unequal probability of selection into the survey and possible bias resulting from nonresponse. 
Demographic data files released by NCHS for each NHANES two-year survey cycle include a 
two-year interview weight and a medical examination weight. All estimates in this report use the 
appropriate medical examination weight. The selected medical examination weight depends on 
whether the specimens tested constitute a random subsample of all the eligible participants and 
how many survey cycles are combined to produce the estimate. 
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Combining data over multiple survey cycles can produce estimates with increased statistical 
reliability. In cases of combined estimates, new weights were constructed. For example, a four-year 
estimate for the years 2003–2006 was based on a four-year weight, which was created by assigning 
half the two-year weight for 2003–2004 or half the two-year weight for 2005–2006, depending 
when the person was sampled. 
Results are shown for the total population and by age group, gender, and race/ethnicity, as defined 
in NHANES. For these analyses, race/ethnicity is presented as Mexican American, non-Hispanic 
black, and non-Hispanic white. Other racial or ethnic groups are sampled, but the proportion 
of the total population represented by these other groups is not large enough to produce valid 
estimates. Thus, this report does not include separate estimates for other racial subcategories. The 
other racial/ethnic groups, however, are included in the overall estimates.
Data were analyzed by use of the statistical software package Statistical Analysis System (SAS, 
Version 9.2) and SUDAAN (Release 10.0). SUDAAN uses sample weights and calculates variance 
estimates that account for the complex survey design. Guidelines for the analysis of NHANES 
data are provided by NCHS at: http://www.cdc.gov/nchs/nhanes/nhanes2003-2004/analytical_
guidelines.htm.
Standard error estimates were calculated by use of the Taylor series (linearization) method within 
SUDAAN. The degrees of freedom for variance estimation are generated by subtracting the 
number of strata from the number of primary sampling units (PSUs). 
Geometric means were calculated by taking the log of each concentration, calculating the mean 
of those log values, then taking the antilog of that mean (the calculation can be done by use of 
any log base, such as 10 or e). The confidence interval uses the standard error and mean on the 
log scale and the appropriate critical value from the t-distribution to calculate upper and lower 
confidence limits on the log scale. The confidence intervals of geometric means in this report are 
based on taking the antilog of those upper and lower confidence intervals.
Percentile estimates were calculated by use of linear interpolation. Confidence intervals for 
percentiles were calculated by the Woodruff method (1952). This method uses the standard error 
of the empirical distribution function at the selected percentile and constructs a 95% confidence 
interval, followed by back-transforming by use of the inverse of the empirical distribution (see 
Appendix E for more details). We used the unweighted sample size and assumed an average 
design effect of 1.4 as the criteria to estimate percentiles of sufficient precision (U.S. Centers for 
Disease for Control and Prevention 1996; Table 1 in Appendix B). In order for percentiles to be 
considered reliable, at least 112 persons had to be represented to allow estimation of the 10th and 
90th percentiles, 224 persons for the 5th and 95th percentiles, and 448 persons for the 2.5th and 
97.5th percentiles. We flagged and footnoted percentiles where these requirements were not met.
Prevalence estimates for low or high concentrations of biochemical indicators are the weighted 
percentage of persons who fall below or above a predefined cutoff value (see Appendix C). The 
confidence intervals for prevalence estimates are based on a logit transformation that ensures 
the confidence interval limits cannot fall outside of 0 and 1. We used the relative standard error 
(RSE) as a criterion for prevalence estimates of sufficient precision. The RSE is calculated as a 
percentage by dividing the standard error of the estimate by the estimate value and multiplying by 
100. Prevalence estimates associated with a RSE between 30% and less than 40% are flagged and 
footnoted in this report. Estimates are not provided if they are associated with an RSE equal to or 
greater than 40%.
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Estimates of the total number of persons who met the definition of having low or high 
concentrations of biochemical indicators were generated by multiplying the weighted prevalence 
estimate by the population size of interest, derived from the current population survey (CPS) at 
the midpoint of the available two-year cycle. Confidence intervals for the estimated total, while 
not presented, are calculated by multiplying the population size of interest by the upper and 
lower limits of the 95% confidence interval for the weighted prevalence. CPS-based population 
tables for NHANES by age, gender, and race/ethnicity are on the NHANES Web page for a 
given survey cycle, available at http://www.cdc.gov/nchs/nhanes/response_rates_CPS.htm. When 
estimates of the total count are based on combined survey cycles (2003–2006), the 2003–2004 
CPS-based population table at the above link was used. 
Figures in the highlight section that present age-adjusted geometric mean concentrations from 
NHANES III (1988–1994), NHANES 1999–2002, and NHANES 2003–2006 or age-adjusted 
prevalence estimates by demographic subgroups have been generated in SUDAAN by use of age-
standardizing proportions from the 2000 U.S. Census population (using direct standardization). 
Statistically significant differences between age-adjusted geometric means and age-adjusted 
prevalences were assessed through pairwise comparisons. A reader should take care when 
interpreting these age-adjusted figures in isolation. The magnitude of an age-adjusted geometric 
mean or age-adjusted prevalence is completely arbitrary, and it depends upon the chosen standard 
population. Additionally, age-adjusted geometric means or age-adjusted prevalences can mask 
important information about trends if age-specific rates do not have a consistent relationship. 
It is worth noting that while NHANES 1999–2004 provided a race/ethnicity variable that was 
an analytic link to the NHANES III race/ethnicity variable called RIDRETH2, this variable is 
not included in the NHANES 2005–2006 demographics file. Therefore, the codes of the race/
ethnicity variable called RIDRETH1 were used in displaying age-adjusted geometric means by 
race/ethnicity for NHANES 1999–2002 and NHANES 2003–2006. RIDRETH1 includes 
all multi-racial responses in the Other category; whereas, RIDRETH2 includes multi-racial 
responses for Non-Hispanics with primary race White or Black in the Non-Hispanic White or 
Non-Hispanic Black categories. This means that there are slightly fewer people coded as non-
Hispanic white and non-Hispanic black through RIDRETH1 than for RIDRETH2; however, 
this difference does not affect the Mexican American category.
The limit of detection (LOD) is the level at which the measurement has a 95% probability of 
being greater than zero (Taylor 1987). For calculation of geometric means, concentrations less 
than the LOD were assigned a value equal to the LOD divided by the square root of 2. If the 
proportion of results less than the LOD (< LOD) was greater than 40%, geometric means were 
not calculated. Percentile estimates less than the LOD were reported as “< LOD”. Most of the 
indicators had very few results below the LOD value, so that the choice of statistical analysis to 
handle these results makes little practical difference. There were a few exceptions, however (e.g., 
serum cis-beta-carotene, retinyl palmitate and retinyl stearate; urinary O-desmethylangolensin and 
equol), where a larger proportion of results were < LOD. Appendix F contains a table of LOD 
values for each biochemical indicator, as well as the unweighted percent of data values that were < 
LOD for each survey cycle. LOD values may change over the time period of the report as a result 
of changes in analytical methods. We used the higher of the two LOD values for the analysis of 
the combined four-year data for 2003–2006.
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Due to changes to analytical methods for plasma total homocysteine, serum 25-hydroxyvitamin 






For biochemical indicators measured in urine, we present separate tables for the concentration 
of the indicator expressed as “per volume of urine” (uncorrected table) and the concentration of 
the indicator expressed as “per gram of creatinine” (creatinine-corrected table). Comparison of 
an individual participant’s result to population data in the tables requires correction for urinary 
dilution; thus, an individual creatinine-corrected result is needed and should be compared 
to the creatinine-corrected data tables. Otherwise, health scientists may compare means and 
percentiles from other studies to the tables having either of the corresponding units. We used the 
uncorrected tables to compare urine concentrations across groups. Because instrument responses 
are measured in units of weight per volume, LOD calculations were performed by use of the 
concentration of the indicator expressed as per volume of urine. For this reason, LOD results for 
urine measurements in Appendix F are in weight per volume of urine. In the creatinine-corrected 
tables, a result for a geometric mean or a percentile was reported as < LOD if the corresponding 
geometric mean or percentile was < LOD in the uncorrected table. Thus, for example, if the 
5th percentile for males was < LOD in the uncorrected table, it would also be < LOD in the 
creatinine-corrected table.
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B Vitamins and Related Biochemical Compounds
Background Information
Sources and Physiological Functions. Folate, vitamins B6, and B12 belong to the group of 
water-soluble B vitamins that occur naturally in food. Leafy green vegetables (such as spinach and 
turnip greens), fruits (such as citrus fruits and juices), and dried beans and peas are all natural 
sources of folate. Folic acid is the synthetic form of folate found in supplements and added 
to fortified foods. Because of wide consumption of fortified foods in the United States, these 
products have become an important contributor of folic acid to the U.S. diet. Folate functions as 
a coenzyme in single-carbon transfers in the metabolism of nucleic and amino acids. It is therefore 
especially important during periods of rapid cell division and growth, such as occurs during 
pregnancy and infancy.
The most abundant dietary sources of vitamin B6 are meats, whole grains (with the highest 
concentrations of B6 in the germ and aleuronic layer), vegetables, and nuts. Vitamin B6 is used as 
a cofactor for nearly 200 biochemical reactions in the human body, mostly related to amino acid 
metabolism. Its three major forms are pyridoxine (the major form in plants) and pyridoxal and 
pyridoxamine (the two most abundant forms in humans and animals); pyridoxal-5’-phosphate 
(PLP) is the most biologically active coenzyme form. 4-Pyridoxic acid (4PA) is the end product of 
vitamin B6 catabolism.
Vitamin B12 (cobalamin) is found naturally in animal foods, including fish, meat, poultry, eggs, 
milk, and milk products. For vegetarians, fortified breakfast cereals are a particularly valuable 
source of vitamin B12. The current Dietary Guidelines for Americans list vitamin B12 as a 
nutrient of concern for specific population groups. The guidelines recommend that persons 
50 years and older consume foods fortified with vitamin B12 or dietary supplements (U.S. 
Department of Agriculture and U.S. Department of Health and Human Services 2010). Vitamin 
B12 functions as a coenzyme for a critical methyl transfer reaction that converts homocysteine to 
methionine and for a separate reaction that converts L-methylmalonyl-coenzyme A to succinyl-
coenzyme A.
Homocysteine (Hcy) is an amino acid naturally found in the blood. Plasma Hcy concentrations 
are strongly influenced by diet as well as by genetic factors. Elevated concentrations of total 
Hcy (tHcy; the sum of free, protein-bound, and disulfides) are found in people whose folate, 
vitamin B12, or vitamin B6 status is suboptimal (Selhub 1993) and in people with impaired renal 
function (Wollensen 1999).
Methylmalonic acid (MMA) is a dicarboxylic acid naturally found in the blood. Plasma MMA 
concentrations are elevated when serum vitamin B12 concentrations are low or intermediate; such 
concentrations are therefore a useful diagnostic test for confirming vitamin B12 deficiency (Baik 
1999). As with plasma tHcy, MMA concentrations are also elevated in people with impaired renal 
function (Rasmussen 1990).
Health Effects. A chronic dietary deficiency of either folate or vitamin B12 causes macrocytic 
anemia, although strict dietary deficiencies are rare. Due to the wide abundance of vitamin B6 
in foods, dietary deficiencies of vitamin B6 are also rare. Signs of vitamin B6 deficiency include 
dermatitis, glossitis (inflammation of the tongue), depression, confusion, convulsions, and 
anemia. Symptoms do not appear immediately, however, for ~80% of the vitamin B6 in the 
body is stored in muscle tissue and will remain stable until intake has been low for several weeks 
(Coburn 1990). Certain drugs (e.g., alcohol, methotrexate, anticonvulsants, sulfa drugs) may 
interfere with the absorption or utilization of folate, and disorders of the small bowel that limit 
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absorption (e.g., Crohn’s disease, jejunal bypass surgery) can cause folate deficiency (Halsted 
1990). Drugs that react with carbonyl groups have the potential to interact with PLP. Isoniazid—
used in the treatment of tuberculosis—and L-DOPA have been shown to reduce plasma PLP 
concentrations, and a small decrease in vitamin B6 status has been seen in women taking high-
dose oral contraceptives (Institute of Medicine 1998). Most people who develop a vitamin 
B12 deficiency have an underlying stomach or intestinal disorder that limits the absorption of 
vitamin B12. Subtly reduced cognitive function resulting from early vitamin B12 deficiency is 
sometimes the only symptom of these intestinal disorders. Severe vitamin B12 deficiency can 
cause permanent nerve damage and dementia. Hematologic signs, however, are not always present 
in vitamin B12 deficiency, and hematologic signs and neurologic abnormalities can be inversely 
correlated (Baik 1999).
Clinical trials have shown that folic acid supplementation effectively reduces the number of neural 
tube birth defects (NTDs) (Czeizel 1992; MRC Vitamin Study Research Group 1991). Thus, 
the U.S. Public Health Service recommended that every woman who could become pregnant 
consume at least 400 micrograms (µg) of folic acid each day (U.S. Centers for Disease Control 
and Prevention 1992). This recommendation has also been incorporated into the current Dietary 
Guidelines for Americans, which list folate as a nutrient of concern for specific population groups 
(U.S. Department of Agriculture 2010). Since 1998, the U.S. Food and Drug Administration 
(FDA) has required the addition of folic acid to enriched breads, cereals, flours, corn meals, 
pastas, rice, and other grain products (U.S. Food and Drug Administration 1996). After the 
introduction of fortification, NTD rates have decreased by 36% (U.S. Centers for Disease 
Control and Prevention 2010); nevertheless, in the era of folic acid fortification, NTD rates are 
still highest among Hispanic women (Williams 2005). The higher prevalence in Hispanics could 
be due to their lower consumption of total folic acid, which is specifically true for less acculturated 
populations (Hamner 2011). This suggests that there may be factors in addition to folate status, 
such as genetic or environmental factors, that modulate NTD prevalence and possibly lead to 
higher folate requirements for some population groups. Recent observational studies have also 
suggested other potential benefits of the U.S. folic acid fortification, such as decreased prevalence 
of inadequate serum and RBC folate concentrations (Pfeiffer 2007), and declines in the 
incidence of stroke (Yang 2006) and neuroblastoma (French 2003). Potential roles of B vitamins 
in modulating the risk for diseases (e.g., heart disease, cancer, and cognitive impairment) are 
currently being studied. Two national health objectives that relate to folate and maternal, infant, 
and child health are part of the objectives for Healthy People 2020: Objective MICH HP2020-14 
(increase the proportion of women of childbearing potential with intake of at least 400 µg of folic 
acid from fortified foods or dietary supplements) and Objective MICH HP2020-15 (reduce the 
proportion of women of childbearing potential who have low red blood cell folate concentrations) 
(http://www.healthypeople.gov/HP2020/).
Intake Recommendations. The recommended dietary allowance (RDA) for both men and 
women is 400 µg per day of dietary folate equivalents (DFEs). DFEs adjust for the nearly 50% 
lower bioavailability of dietary folate compared to the bioavailability of folic acid: 1 mg of dietary 
folate equivalent equals 0.6 mg of folic acid from fortified food or from a supplement taken on an 
empty stomach (Institute of Medicine 1998). The RDA for vitamin B6 is 1.3 mg for both men and 
women (19–50 years), 1.7 mg for men and 1.5 mg for women aged 51 years and older, and 1.9 
mg for pregnant women (2.0 mg if lactating) (Institute of Medicine 1998). The RDA for vitamin 
B12 for adults is 2.4 µg per day. Because as many as 10 to 30% of older people may be unable to 
absorb naturally occurring vitamin B12, it is advisable for people older than 50 years to meet their 
RDA mainly by consuming foods fortified with vitamin B12 or by taking a supplement containing 
vitamin B12. People with vitamin B12 deficiency caused by a lack of intrinsic factor or intestinal 
malabsorption require parenteral B12 treatment (Institute of Medicine 1998).
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Prolonged consumption of very high daily intakes of folic acid has the potential to delay the 
diagnosis of anemia among adults with vitamin B12 deficiency. This may result in increased 
risk of progressive, unrecognized neurological damage from untreated vitamin B12 deficiency. 
Consequently, the Institute of Medicine (1998) set the Tolerable Upper Intake Level (UL) for 
folic acid intake for adults (aged 19 years and older) at 1000 µg per day. The UL is defined as 
the “maximum daily intake levels at which no risk of adverse health effects is expected for almost 
all individuals in the general population—including sensitive individuals—when the nutrient is 
consumed over long periods of time” (Institute of Medicine 2000). Because no data were available 
for children, the Institute of Medicine used the UL for adults adjusted by weight: 300–800 mg 
per day, depending on the age group. Folate intake from food 
is not associated with any health risk. The UL for vitamin B6 
for adults is 100 mg per day (Institute of Medicine 1998). If 
more is ingested through supplements, sensory neuropathy, 
dermatological lesions, and reversible nerve damage to the 
arms and legs can occur. No adverse effects have been seen, 
however, from getting large amounts of vitamin B6 through 
food sources (Institute of Medicine 1998). No adverse effects 
have been associated with excess vitamin B12 intake from food 
or supplements in healthy individuals, and no UL has been set 
(Institute of Medicine 1998).
Biochemical Indicators and Methods. Folate status can be 
assessed by measuring serum or plasma folate, which provides 
information on recent intake, and red blood cell (RBC) folate, 
indicative of body folate stores and long-term nutritional status. 
Vitamin B6 status is typically assessed by measuring the level of 
one or more of the B6 vitamers in serum or plasma. Serum PLP 
is generally viewed as the best single indicator of status. Serum 
or urinary 4PA, the end product of vitamin B6 catabolism, is an 
indicator of recent intake. Vitamin B12 status can be assessed by measuring serum or plasma total 
cobalamins or serum holo-transcobalamin II, the transport protein of absorbed cobalamin. Urinary 
or serum MMA is a specific functional indicator of vitamin B12 status. Plasma tHcy is a functional 
indicator of folate, vitamin B6, and/or B12 status, but it is not specific for either vitamin. As B 
vitamin concentrations decrease, plasma tHcy concentrations increase. 
Clinical laboratories typically use conventional units for measuring concentrations of folate 
(nanograms per milliliter [ng/mL]) and vitamin B12 (picograms [pg]/mL) and international 
system (SI) units for vitamin B6 (nanomole per liter [nmol/L]), tHcy (micromole [mmol]/L), and 
MMA (nmol/L). Conversion factors to SI units are as follows: 1 ng/mL = 2.266 nmol/L for folate 
and 1 pg/mL = 0.738 picomol (pmol)/L for vitamin B12.
Traditionally, folate has been measured by microbiologic assay; however, in clinical settings, 
radioprotein-binding assays or commercial non-radio-protein-binding assays on automated 
clinical analyzers offering high throughput are used (Shane 2011). In research settings, 
chromatography-based methods, nowadays coupled to tandem mass spectrometry (LC-MS/MS), 
are often used to measure individual forms of folate in serum or whole blood (Pfeiffer 2010). 
International reference materials for serum folate from the U.S. National Institute of Standards 
and Technology (NIST) and the United Kingdom National Institute for Biological Standards and 
Control (NIBSC), with certified or reference values by higher-order reference methods (LC-MS/
MS), have been available only for the last few years: NIST SRM 1955 and 1950, and NIBSC 
03/178. A reference material for whole blood folate has been available from the NIBSC (95/528) 
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for several years; however, the value assignment for this material was by consensus of various 
protein-binding and microbiological assays. Because of observed method differences in measuring 
folate concentrations (Gunter 1996, Pfeiffer 2010), caution should be used in comparing other 
datasets to the tables in this report. Method-specific cutoff values and reference intervals for use in 
medical diagnostics have been suggested previously (Life Sciences Research Office 1994, Gunter 
1996) and may be required until clinical assays have been standardized. 
Vitamin B6 forms in serum are most commonly measured by high performance liquid 
chromatography (HPLC) with fluorometric detection; chemical derivatization (sample, online, 
or post-column) is almost always used to enhance PLP fluorescence (Rybak 2004). Enzymatic 
(radioactive or nonradioactive) and microbiological methods have also been employed (Coburn 
2000). LC-MS/MS methods are emerging (Midttun 2005). The comparability of methods could 
be improved (Rybak 2005); such improvement is expected to occur in the future due to the new 
availability of NIST SRM 1950 and 3950 (certified concentrations for serum PLP by LC-MS/MS). 
Serum vitamin B12 is commonly measured by competitive protein-binding assay (Carmel 2011). 
Research methods for tHcy determination are HPLC with fluorescence detection or coupled to 
tandem mass spectrometry; clinical methods are based on immunoassay or enzymatic principle 
(Refsum 2004). MMA is measured by gas chromatography coupled to mass spectrometry (GC-
MS) or by LC-MS/MS (Pedersen 2011). The comparability among methods for serum vitamin 
B12, plasma Hcy, and MMA is superior to that for folate. The following international reference 
materials are available: NIBSC 03/178 for serum vitamin B12 (consensus value); and NIST SRM 
1955 and 1950 for plasma tHcy (certified concentration by LC-MS/MS or GC-MS).
Data in NHANES. Folate and vitamin B12 data presented in this report were generated by 
use of the commercial BioRad Quantaphase II radio-protein-binding assay kit. This is the same 
method used during the first four years of the continuous NHANES survey (1999-2002) and 
during NHANES III (1988-1994) (Yetley 2011). The BioRad assay measures approximately 
35% lower than the traditional microbiologic assay (Life Sciences Research Office 1994). As a 
result, the conventional cutoff values of less than 3 ng/mL for low serum folate concentrations, 
representing a negative folate balance at the time the blood sample was drawn, and less than 
140 ng/mL for low RBC folate concentrations (Life Sciences Research Office 1984) should 
be adjusted to less than 2 ng/mL and less than 95 ng/mL, respectively (Wright 1998). A 2005 
WHO Technical Consultation on folate and vitamin B12 deficiencies estimated blood folate and 
vitamin B12 concentrations below which plasma metabolite concentrations (tHcy for folate and 
MMA for vitamin B12) became elevated. It arrived at the following consensus cutoff values: 4 
ng/mL (10 nmol/L) for serum folate, 151 ng/mL (340 nmol/L) for RBC folate, and 203 pg/mL 
(150 pmol/L) for serum vitamin B12 (de Benoist 2008). Because the folate data used to derive 
these cutoff values were generated with the microbiologic assay, the cutoff values are not directly 
applicable to data generated with the BioRad radio-protein-binding assay. For this report, we used 
cutoff values of 2 ng/mL and 95 ng/mL, respectively, to estimate the prevalence of low serum and 
RBC folate concentrations. To estimate the prevalence of low serum vitamin B12 concentrations, 
we used a cutoff value of 200 pg/mL. This cutoff value is very close to the WHO consensus cutoff 
value and has been widely used in previous studies (Carmel 2011).
Vitamin B6 data presented in this report include serum PLP and 4PA. They were generated by use 
of HPLC with post-column derivatization and fluorometric detection (Rybak 2004; Rybak 2009). 
We used a cutoff value of 20 nmol/L to indicate low serum PLP concentrations. This cutoff value 
was used by the Institute of Medicine as the basis for the Estimated Average Requirement (EAR) 
(1998); it may overestimate the vitamin B6 requirement for health maintenance of more than half 
the group.
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tHcy data presented in this report were generated by use of 
the commercial Abbott fluorescence polarization immunoassay 
kit. MMA data were generated through a GC-MS method. 
Frequently used cutoff values for elevated concentrations of 
plasma tHcy and MMA are 13 µmol/L (Jacques 1999) and 271 
nmol/L (Allen 1990), respectively.
Monitoring the folate status of the U.S. population over time 
has been a priority (Yetley 2011). It has been so first because 
serum and RBC folate results from NHANES II (1976–1980) 
(Senti 1985) and NHANES III (1988–1994) (Wright 1998) 
suggested that the folate status of some population groups might 
be of public health concern; a second reason was to assess the 
impact of folic acid fortification (Pfeiffer 2007). Vitamin B12 
status of the U.S. population has been monitored during the 
second phase of NHANES III (1991–1994) (Wright 1998) 
and during eight years of the continuous survey (1999–2006). 
Plasma metabolite concentrations have also been monitored 
during several years of the continuous survey (tHcy 1999–2006; 
MMA 1999–2004). 
Pfeiffer et al. (2007) showed that the introduction of folic acid 
fortification has substantially increased serum and RBC folate 
concentrations in each age group. Serum vitamin B12 concentrations, however, did not change 
appreciably. Circulating tHcy concentrations from prefortification to postfortification decreased 
by approximately 10% in a national sample of the U.S. population (Pfeiffer 2008).
For more information on B vitamins and related biochemical indicators, see the Institute of 
Medicine’s Dietary Reference Intake reports (Institute of Medicine 1998) and fact sheets from 
the National Institutes of Health (NIH), Office of Dietary Supplements (http://ods.od.nih.gov/
Health_Information/Information_About_Individual_Dietary_Supplements.aspx).
Highlights
Blood concentrations of water-soluble B vitamins (folate, vitamins B6 and B12) in the U.S. 
population showed the following demographic patterns and characteristics:
•	 The highest concentrations were generally found in the youngest age group, except 
for RBC folate and the vitamin B6 catabolite 4-pyridoxic acid where the highest 
concentrations were found in the oldest age group.
•	 No consistent pattern was observed with regard to gender.
•	 A specific race/ethnic pattern was observed: non-Hispanic blacks had the lowest folate 
and the highest vitamin B12 status, non-Hispanic whites had the highest folate and the 
lowest vitamin B12 status, and Mexican Americans had intermediate folate and vitamin 
B12 status.
•	 In the era of folic acid fortification, the prevalence of folate deficiency was very low 
throughout the population.
•	 The likelihood of being vitamin B6 and B12 deficient was higher in persons 40 years 
and older compared to younger persons.
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Monitoring the continued effect of the U.S. folic acid fortification program of enriched grains 
and cereal products on serum and RBC folate concentrations is of great public health interest. 
Serum folate concentrations more than doubled and RBC folate concentrations increased by 
approximately 50% after the introduction of fortification in 1998. Regardless of gender or race/
ethnicity, we observed small decreases (< 10%) in serum and RBC folate concentrations from the 
earlier (1999–2002) to the later (2003–2006) post-fortification period (Figures H.1.a and H.1.b). 
However, during the first eight years post-fortification covered in this report (1999–2006), the 
prevalence of low serum (< 2 ng/mL) and RBC folate (< 95 ng/mL) concentrations was less than 
1% in the U.S. population, including women of childbearing age, regardless of race/ethnicity 
(data not shown). Folate deficiency was virtually non-existent in the general population, and it 
may be limited to persons with malabsorption, alcohol abusers, or consumers of certain drugs.












































1988-1994 1999-2002 2003-2006 
Figure H.1.a. Age-adjusted geometric mean concentrations of serum 
folate in the U.S. population aged 4 years and older by gender or 
race/ethnicity, National Health and Nutrition Examination Survey, 
1988–2006. 
Error bars represent 95% confidence intervals. Within a demographic group, bars 
not sharing a common letter differ (p < 0.05). Age adjustment was done using 
direct standardization.












































1988-1994 1999-2002 2003-2006 
Figure H.1.b. Age-adjusted geometric mean concentrations of RBC folate 
in the U.S. population aged 4 years and older by gender or race/ethnicity, 
National Health and Nutrition Examination Survey, 1988–2006. 
Error bars represent 95% confidence intervals. Within a demographic group, bars 
not sharing a common letter differ (p < 0.05). Age-adjustment was done using 
direct standardization.
Because of the close relationship of folate and vitamin B12 in one-carbon metabolism, it is of 
interest to see whether serum vitamin B12 concentrations changed since the introduction of folic 
acid fortification and whether there are differences among race/ethnic groups. We observed a small 
increase in serum vitamin B12 concentrations from pre- (1991–1994) to post-fortification (1999–
2002). We then found similar concentrations during 2003–2006 for the total population and for 
males and females (Figure H.1.c). The increase from pre- to post-fortification was observed for 
non-Hispanic whites, but not for non-Hispanic blacks and Mexican Americans; the latter two 
groups had higher serum vitamin B12 concentrations than non-Hispanic whites during both pre- 
and post-fortification. 
Assessing the extent of inadequate vitamin B12 status in the older U.S. population is challenging 
because serum vitamin B12 is not sensitive enough, plasma tHcy is not specific, and both plasma 
MMA and tHcy are artificially elevated when renal function is impaired, which is common in older 
persons. As expected, we found a higher prevalence of elevated plasma MMA (17%) or tHcy (19%) 
concentrations, potentially indicating suboptimal vitamin B12 status, than we found in the prevalence 
of low serum vitamin B12 concentrations (4%) in older persons (Figure H.1.d). Defining better 
cutoff values for vitamin B12 status biomarkers remains a continued area of research (Bailey 2011).
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1991-1994 1999-2002 2003-2006 
Figure H.1.c. Age-adjusted geometric mean concentrations of serum 
vitamin B12 in the U.S. population aged 4 years and older by gender 
or race/ethnicity, National Health and Nutrition Examination Survey, 
1991–2006. 
Error bars represent 95% confidence intervals. Within a demographic group, bars 
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Figure H.1.d. Prevalence estimates of low serum vitamin B12 (B12), 
high plasma methylmalonic acid (MMA), and high plasma total 
homocysteine (tHcy) concentrations in U.S. persons 60 years and older, 
National Health and Nutrition Examination Survey, 2003–2006. 
Data shown for plasma MMA are from NHANES 2003–2004 only. Error bars 
represent 95% confidence intervals.
Detailed Observations
The selected observations mentioned below are derived from the tables and figures presented next. 
Statements about categorical differences between demographic groups noted below are based on 
non-overlapping confidence limits from univariate analysis without adjusting for demographic 
variables (e.g., age, gender, race/ethnicity) or other blood concentration determinants (e.g., dietary 
intake, supplement usage, smoking, BMI). A multivariate analysis may alter the size and statistical 
significance of these categorical differences. Furthermore, additional significant differences of 
smaller magnitude may be present despite their lack of mention here (e.g., if confidence limits 
slightly overlap or if differences are not statistically significant before covariate adjustment has 
occurred). For a selection of citations of descriptive NHANES papers related to these biochemical 
indicators of diet and nutrition, see Appendix G.
Geometric mean concentrations (NHANES 2003–2006):
•	 Serum and RBC folate concentrations followed a U-shaped age pattern, with the lowest 
concentrations seen in adolescents and young adults, respectively (Tables 1.1.a.1 and 
1.2.a.1; Figures 1.1.a and 1.2.a).
•	 Serum PLP concentrations declined from childhood to adolescence, then stabilized 
in older age groups (Table 1.3.a.1 and Figure 1.3.a). Serum 4PA concentrations were 
lowest in adolescence and increased steadily through the oldest age group (Table 1.4.a.1 
and Figure 1.4.a).
•	 Serum vitamin B12 concentrations declined from childhood to adolescence and then 
stabilized in older age groups (Table 1.5.a.1), while plasma MMA concentrations were 
relatively stable through young adulthood, and then increased with age (Table 1.7.a.1 
and Figure 1.7.a).
•	 Plasma tHcy concentrations in adults increased with age (Table 1.6.a.1 and Figure 1.6.a).
•	 Females had higher serum and RBC folate concentrations than males (Tables 1.1.a.1 
and 1.2.a.1); males had higher serum PLP and plasma tHcy concentrations than females 
(Tables 1.3.a.1 and 1.6.a.1); males and females had similar serum 4PA (Table 1.4.a.1), 
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vitamin B12 (Table 1.5.a.1) and plasma MMA (Table 1.7.a.1) concentrations.
•	 Non-Hispanic whites had the highest concentrations of serum and RBC folate (Tables 
1.1.a.1 and 1.2.a.1), serum 4PA (Table 1.4.a.1), and plasma MMA (Table 1.7.a.1). 
They also had the lowest concentrations of serum vitamin B12 (Table 1.5.a.1). Non-
Hispanic blacks had the lowest concentrations of RBC folate (Table 1.2.a.1) and serum 
PLP (Table 1.3.a.1). Mexican Americans had the lowest concentrations of plasma tHcy 
(Table 1.6.a.1).
Changes in geometric mean concentrations across survey cycles:
•	 Serum folate concentrations decreased slightly (< 10%) between the 1999–2000 and 
2001–2002 survey cycles; however, concentrations stabilized over the next two survey 
cycles (Table 1.1.b). 
•	 RBC folate concentrations were similar across all survey cycles except for a < 10% 
decrease between the 2001–2002 and 2003–2004 survey cycles (Table 1.2.b). 
•	 We observed no changes in serum vitamin B12 (Table 1.5.b), plasma tHcy (Table 
1.6.b), or plasma MMA (Table 1.7.b) concentrations over time.
Prevalence estimates of low or high biochemical indicator concentrations:
•	 In 2003–2006, less than 1% of the population aged 1 year and older had RBC folate 
concentrations < 95 ng/mL (Table 1.2.c). Similarly, less than 1% of the population had 
low serum folate concentrations < 2 ng/mL; however, the estimates had large variances 
and we do not present a prevalence table for this indicator. 
•	 Of the population aged 1 year and older, approximately 11% had serum PLP 
concentrations < 20 nmol/L in 2005–2006 (Table 1.3.c). Compared to the prevalence 
of low PLP concentrations in persons 20–39 years of age, the prevalence of low PLP 
concentrations was lower in all younger age groups and higher in all older age groups.
•	 Approximately 2% of the population aged 1 year and older and 4% of persons 60 years and 
older had serum vitamin B12 concentrations < 200 pg/mL in 2003-2006 (Table 1.5.c). 
•	 We found elevated plasma tHcy concentrations (> 13 µmol/L) in 2003–2006 in 
approximately 8% of the population aged 20 years and older and in 19% of persons 60 
years and older (Table 1.6.c).
•	 Approximately 7% of the population aged 3 years and older and 17% of persons 60 years 
and older had plasma MMA concentrations > 271 nmol/L in 2003-2004 (Table 1.7.c).
•	 Between 1999 and 2006 (2004 for MMA), we did not observe any change in the 
prevalence of low RBC folate (Table 1.2.d), low serum vitamin B12 (Table 1.5.d), high 
plasma tHcy (Table 1.6.d), and high plasma MMA (Table 1.7.d) concentrations.



























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































1−5 6−11 12−19 20−39 40−59 60+ 1−5 6−11 12−19 20−39 40−59 60+ 


























 Non−Hispanic Blacks Non−Hispanic Whites 
Figure 1.1.a. Serum folate: Concentrations by age group 
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Table 1.1.a.2. Serum folate: Total population
Geometric mean and selected percentiles of serum concentrations (in ng/mL) for the total U.S. population aged 
1 year and older, National Health and Nutrition Examination Survey, 2003–2006.
Geometric mean 
(95% conf. interval)
Selected percentiles (95% conf. interval) Sample 
size5th 50th 95th
Males and Females
Total, 1 year and older 12.3 (12.0 – 12.6) 5.46 (5.26 – 5.66) 12.2 (11.9 – 12.5) 28.5 (27.5 – 29.5) 16,411
1–5 years 16.2 (15.5 – 16.9) 7.61 (6.92 – 8.24) 16.0 (15.5 – 16.5) 36.0 (32.0 – 41.9) 1,690
6–11 years 16.1 (15.6 – 16.6) 9.04 (8.63 – 9.58) 15.7 (15.3 – 16.2) 29.9 (27.5 – 35.0) 1,749
12–19 years 11.2 (11.0 – 11.5) 5.62 (5.45 – 5.83) 11.3 (10.9 – 11.6) 20.9 (19.9 – 21.8) 4,028
20–39 years 10.4 (10.1 – 10.7) 4.93 (4.75 – 5.09) 10.5 (10.1 – 10.9) 20.5 (19.5 – 22.9) 3,242
40–59 years 11.6 (11.2 – 12.0) 5.09 (4.57 – 5.42) 11.6 (11.3 – 11.9) 25.2 (24.1 – 28.1) 2,649
60 years and older 15.6 (15.0 – 16.1) 6.32 (5.95 – 6.61) 15.8 (15.2 – 16.3) 35.7 (34.2 – 37.7) 3,053
Males
Total, 1 year and older 11.7 (11.4 – 12.0) 5.32 (5.00 – 5.55) 11.6 (11.3 – 11.9) 26.4 (25.6 – 27.8) 8,050
1–5 years 16.2 (15.3 – 17.1) 7.56 (6.40 – 8.53) 15.8 (15.2 – 16.3) 36.2 (32.0 – 46.5) 854
6–11 years 15.8 (15.2 – 16.4) 9.10 (8.37 – 9.77) 15.3 (14.8 – 16.0) 29.1 (26.2 – 34.9) 854
12–19 years 11.2 (10.9 – 11.5) 5.45 (4.94 – 5.82) 11.3 (10.9 – 11.6) 20.5 (19.8 – 21.9) 2,041
20–39 years 9.83 (9.51 – 10.2) 4.84 (4.66 – 5.03) 9.89 (9.53 – 10.3) 18.3 (17.6 – 20.0) 1,462
40–59 years 10.8 (10.4 – 11.3) 4.84 (4.39 – 5.26) 11.0 (10.4 – 11.4) 22.7 (20.5 – 25.8) 1,305
60 years and older 14.7 (14.0 – 15.6) 6.12 (5.81 – 6.42) 14.7 (13.7 – 15.7) 34.9 (32.5 – 41.9) 1,534
Females
Total, 1 year and older 12.9 (12.5 – 13.3) 5.61 (5.33 – 5.91) 12.9 (12.5 – 13.2) 29.7 (28.8 – 31.2) 8,361
1–5 years 16.3 (15.6 – 17.0) 7.65 (6.80 – 8.30) 16.3 (15.8 – 17.0) 34.6 (30.2 – 46.5) 836
6–11 years 16.5 (15.8 – 17.2) 9.01 (8.62 – 9.59) 16.2 (15.5 – 16.9) 30.8 (28.2 – 36.6) 895
12–19 years 11.3 (10.9 – 11.7) 5.76 (5.57 – 6.04) 11.2 (10.9 – 11.7) 21.3 (19.6 – 23.4) 1,987
20–39 years 11.0 (10.6 – 11.5) 5.05 (4.63 – 5.27) 11.1 (10.7 – 11.6) 23.1 (21.1 – 26.1) 1,780
40–59 years 12.3 (11.9 – 12.8) 5.37 (4.56 – 5.96) 12.4 (11.9 – 12.9) 27.6 (25.2 – 32.1) 1,344
60 years and older 16.2 (15.7 – 16.8) 6.57 (6.05 – 6.92) 16.5 (15.9 – 17.2) 36.1 (34.4 – 38.5) 1,519
Table 1.1.a.3. Serum folate: Mexican Americans
Geometric mean and selected percentiles of serum concentrations (in ng/mL) for Mexican Americans in the U.S. 
population aged 1 year and older, National Health and Nutrition Examination Survey, 2003–2006.
Geometric mean 
(95% conf. interval)
Selected percentiles (95% conf. interval) Sample 
size5th 50th 95th
Males and Females
Total, 1 year and older 11.1 (10.7 – 11.4) 5.49 (5.17 – 5.68) 11.1 (10.8 – 11.4) 22.2 (20.8 – 23.4) 4,212
1–5 years 14.1 (13.4 – 14.7) 7.56 (6.85 – 8.17) 14.0 (13.3 – 14.8) 26.2 (23.8 – 29.4) 542
6–11 years 15.4 (14.7 – 16.2) 9.03 (8.32 – 9.67) 15.2 (14.2 – 16.0) 28.2 (26.2 – 32.2) 586
12–19 years 10.9 (10.6 – 11.2) 5.89 (5.43 – 6.28) 11.1 (10.8 – 11.5) 19.1 (18.2 – 19.8) 1,281
20–39 years 9.60 (9.24 – 9.96) 5.04 (4.70 – 5.19) 9.62 (9.07 – 10.2) 18.1 (16.8 – 19.6) 781
40–59 years 10.4 (9.76 – 11.1) 5.13 (4.59 – 5.67) 10.1 (9.51 – 11.0) 21.0 (18.7 – 23.7) 469
60 years and older 12.4 (11.6 – 13.2) 5.36 (4.61 – 6.41) 12.1 (11.6 – 12.6) 27.1 (24.6 – 37.1) 553
Males
Total, 1 year and older 10.6 (10.3 – 11.0) 5.35 (4.99 – 5.65) 10.7 (10.3 – 11.0) 20.2 (19.5 – 22.4) 2,042
1–5 years 13.7 (13.1 – 14.5) 8.03 (6.22 – 8.33) 13.5 (12.7 – 14.5) 23.9 (21.2 – 31.4) 263
6–11 years 15.1 (14.3 – 16.0) 8.68 (7.46 – 9.86) 14.9 (13.7 – 16.0) 28.3 (25.4 – 32.3) 285
12–19 years 10.9 (10.5 – 11.3) 5.62 (4.99 – 5.94) 11.1 (10.6 – 11.4) 19.1 (17.7 – 20.6) 638
20–39 years 9.11 (8.67 – 9.57) 4.90 (4.47 – 5.37) 9.09 (8.68 – 9.70) 15.6 (14.7 – 18.7) 347
40–59 years 10.1 (9.43 – 10.8) 5.11 (4.48 – 5.91) 10.0 (9.19 – 10.7) 19.1 (18.1 – 22.5) 237
60 years and older 11.4 (10.7 – 12.1) 5.27 (4.61 – 6.23) 10.5 (9.85 – 12.1) 26.0 (22.9 – 36.9) 272
Females
Total, 1 year and older 11.5 (11.1 – 12.0) 5.64 (5.15 – 5.87) 11.6 (11.3 – 11.8) 23.3 (21.8 – 25.6) 2,170
1–5 years 14.4 (13.6 – 15.2) 7.34 (6.41 – 8.10) 14.4 (13.7 – 15.9) 26.5 (24.5 – 31.9) 279
6–11 years 15.7 (14.9 – 16.5) 9.13 (8.01 – 10.2) 15.5 (14.8 – 16.3) 27.8 (25.9 – 34.2) 301
12–19 years 11.0 (10.7 – 11.3) 6.23 (5.78 – 6.54) 11.2 (10.8 – 11.6) 19.0 (18.2 – 21.0) 643
20–39 years 10.2 (9.62 – 10.8) 5.11 (4.74 – 5.38) 10.4 (9.53 – 11.0) 19.3 (18.1 – 21.8) 434
40–59 years 10.7 (10.0 – 11.5) 5.16 (3.80 – 5.85) 10.4 (9.57 – 11.4) 22.4 (19.1 – 40.0) 232
60 years and older 13.3 (12.0 – 14.7) 5.62 (4.00 – 6.65) 13.0 (12.1 – 13.7) 29.7 (25.3 – 64.8) 281
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Table 1.1.a.4. Serum folate: Non-Hispanic blacks
Geometric mean and selected percentiles of serum concentrations (in ng/mL) for non-Hispanic blacks in the 
U.S.population aged 1 year and older, National Health and Nutrition Examination Survey, 2003–2006.
Geometric mean 
(95% conf. interval)
Selected percentiles (95% conf. interval) Sample 
size5th 50th 95th
Males and Females
Total, 1 year and older 10.4 (10.1 – 10.7) 4.83 (4.56 – 5.07) 10.3 (9.94 – 10.8) 22.6 (21.4 – 23.5) 4,297
1–5 years 15.0 (14.0 – 16.0) 7.08 (5.99 – 7.80) 14.9 (14.3 – 15.6) 32.9 (28.0 – 40.7) 481
6–11 years 14.8 (14.2 – 15.3) 8.62 (7.91 – 9.03) 14.6 (14.0 – 15.2) 25.3 (23.9 – 29.4) 554
12–19 years 9.98 (9.63 – 10.4) 5.19 (4.98 – 5.39) 9.91 (9.59 – 10.3) 18.3 (17.7 – 19.1) 1,417
20–39 years 8.92 (8.56 – 9.29) 4.56 (4.26 – 4.81) 8.73 (8.34 – 9.23) 17.7 (16.7 – 19.1) 711
40–59 years 9.81 (9.28 – 10.4) 4.34 (3.93 – 4.99) 9.75 (9.04 – 10.3) 20.0 (18.8 – 26.0) 621
60 years and older 11.5 (10.8 – 12.3) 4.88 (4.48 – 5.29) 11.3 (10.7 – 11.9) 27.2 (24.5 – 36.0) 513
Males
Total, 1 year and older 10.1 (9.84 – 10.4) 4.67 (4.34 – 4.94) 10.1 (9.76 – 10.5) 21.1 (19.7 – 23.2) 2,141
1–5 years 14.9 (13.7 – 16.2) 6.69 (5.91 – 7.81) 14.7 (13.9 – 15.5) 36.5 (29.0 – 51.9) 238
6–11 years 14.4 (13.8 – 15.1) 8.87 (8.20 – 9.55) 14.3 (13.6 – 14.9) 24.3 (21.2 – 30.8) 273
12–19 years 10.2 (9.85 – 10.6) 5.02 (4.75 – 5.19) 10.3 (9.82 – 10.8) 19.0 (17.9 – 19.8) 742
20–39 years 8.48 (8.07 – 8.91) 4.33 (4.01 – 4.81) 8.35 (7.82 – 8.89) 15.4 (14.5 – 17.7) 339
40–59 years 9.41 (8.82 – 10.0) 4.11 (3.42 – 4.99) 9.38 (8.49 – 10.1) 18.7 (17.3 – 32.9) 291
60 years and older 11.1 (10.4 – 11.8) 4.73 (3.87 – 5.82) 10.7 (9.77 – 11.3) 29.0 (23.9 – 32.7) 258
Females
Total, 1 year and older 10.6 (10.2 – 11.0) 5.00 (4.62 – 5.23) 10.5 (10.0 – 11.1) 23.3 (22.0 – 24.9) 2,156
1–5 years 15.1 (14.0 – 16.4) 7.33 (5.00 – 8.42) 15.1 (14.2 – 16.3) 28.8 (26.7 – 40.8) 243
6–11 years 15.1 (14.1 – 16.1) 8.03 (7.24 – 8.98) 14.9 (14.0 – 15.9) 26.0 (24.3 – 33.6) 281
12–19 years 9.76 (9.35 – 10.2) 5.42 (4.98 – 5.57) 9.67 (9.21 – 10.0) 17.7 (16.9 – 18.4) 675
20–39 years 9.30 (8.78 – 9.86) 4.68 (4.44 – 5.01) 9.00 (8.52 – 9.59) 19.1 (17.8 – 20.8) 372
40–59 years 10.2 (9.56 – 10.8) 4.48 (4.07 – 5.18) 10.1 (9.24 – 10.7) 22.1 (19.2 – 27.7) 330
60 years and older 11.8 (10.8 – 12.9) 4.95 (4.26 – 5.65) 11.6 (11.0 – 12.8) 26.8 (23.9 – 45.8) 255
Table 1.1.a.5. Serum folate: Non-Hispanic whites
Geometric mean and selected percentiles of serum concentrations (in ng/mL) for non-Hispanic whites in the 
U.S.population aged 1 year and older, National Health and Nutrition Examination Survey, 2003–2006.
Geometric mean 
(95% conf. interval)
Selected percentiles (95% conf. interval) Sample 
size5th 50th 95th
Males and Females
Total, 1 year and older 13.0 (12.5 – 13.4) 5.72 (5.36 – 5.98) 12.9 (12.5 – 13.3) 30.1 (29.2 – 31.5) 6,633
1–5 years 17.4 (16.2 – 18.6) 7.94 (6.77 – 8.99) 17.0 (16.0 – 17.8) 37.9 (34.7 – 56.0) 478
6–11 years 16.8 (16.1 – 17.5) 9.54 (8.59 – 10.0) 16.5 (15.9 – 17.2) 31.7 (28.0 – 37.6) 449
12–19 years 11.7 (11.3 – 12.1) 5.83 (5.57 – 6.19) 11.6 (11.3 – 12.2) 22.1 (21.2 – 23.4) 1,048
20–39 years 11.0 (10.6 – 11.5) 5.22 (4.82 – 5.54) 11.1 (10.7 – 11.5) 22.9 (20.6 – 26.2) 1,453
40–59 years 12.0 (11.5 – 12.6) 5.14 (4.55 – 5.61) 12.1 (11.7 – 12.6) 26.1 (24.3 – 31.7) 1,357
60 years and older 16.3 (15.7 – 17.0) 6.55 (6.19 – 6.92) 16.7 (16.1 – 17.2) 36.8 (34.9 – 39.4) 1,848
Males
Total, 1 year and older 12.3 (11.8 – 12.7) 5.56 (5.04 – 5.93) 12.1 (11.7 – 12.6) 28.0 (26.4 – 29.8) 3,268
1–5 years 17.3 (16.0 – 18.8) 8.02 (5.84 – 9.82) 16.5 (15.7 – 17.9) 36.3 (32.6 – 55.8) 259
6–11 years 16.4 (15.5 – 17.5) 8.91† (7.81 – 10.0) 16.2 (15.1 – 16.9) 30.4† (26.1 – 52.6) 216
12–19 years 11.6 (11.2 – 12.0) 5.58 (4.93 – 6.17) 11.6 (11.2 – 12.1) 21.8 (20.4 – 23.3) 528
20–39 years 10.4 (9.94 – 10.9) 5.30 (4.75 – 5.82) 10.5 (9.93 – 11.0) 19.5 (18.1 – 22.9) 638
40–59 years 11.2 (10.6 – 11.9) 4.95 (4.36 – 5.35) 11.5 (10.9 – 12.1) 22.9 (20.9 – 26.8) 689
60 years and older 15.5 (14.5 – 16.5) 6.35 (5.91 – 6.72) 15.6 (14.5 – 16.6) 37.0 (32.7 – 45.3) 938
Females
Total, 1 year and older 13.7 (13.2 – 14.1) 5.88 (5.45 – 6.20) 13.7 (13.2 – 14.2) 31.6 (30.3 – 32.9) 3,365
1–5 years 17.4 (16.0 – 18.9) 7.79† (6.32 – 8.79) 17.1 (15.9 – 18.0) 42.7† (30.9 – 73.2) 219
6–11 years 17.2 (16.4 – 18.1) 9.71 (8.72 – 10.2) 17.0 (15.9 – 17.7) 31.7 (28.3 – 38.2) 233
12–19 years 11.8 (11.3 – 12.4) 5.90 (5.64 – 6.67) 11.8 (11.1 – 12.5) 22.2 (20.5 – 25.1) 520
20–39 years 11.7 (11.1 – 12.4) 5.19 (4.54 – 5.60) 11.8 (11.1 – 12.5) 25.7 (22.8 – 30.7) 815
40–59 years 12.9 (12.3 – 13.5) 5.40 (4.54 – 6.22) 13.1 (12.3 – 13.7) 30.9 (25.5 – 34.0) 668
60 years and older 17.1 (16.5 – 17.7) 6.85 (6.21 – 7.22) 17.6 (16.8 – 18.4) 36.6 (34.9 – 39.7) 910
† Estimate is subject to greater uncertainty due to small cell size.
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Table 1.1.b. Serum folate: Concentrations by survey cycle
Geometric mean and selected percentiles of serum concentrations (in ng/mL) for the U.S. population, National 
Health and Nutrition Examination Survey, 1999–2006.
Geometric mean 
(95% conf. interval)
Selected percentiles (95% conf. interval) Sample 
size5th 50th 95th
Total, 3 years and older
 1999–2000 14.0 (13.4 – 14.8) 5.74 (5.35 – 6.10) 14.2 (13.4 – 15.0) 33.1 (31.6 – 34.9) 7,526
 2001–2002 12.9 (12.5 – 13.3) 5.73 (5.36 – 6.05) 13.0 (12.7 – 13.4) 27.2 (26.4 – 28.5) 8,386
 2003–2004 12.1 (11.7 – 12.6) 5.40 (5.12 – 5.69) 11.9 (11.5 – 12.4) 28.2 (27.1 – 29.7) 7,836
 2005–2006 12.4 (11.9 – 12.9) 5.47 (5.10 – 5.80) 12.3 (11.9 – 12.7) 28.5 (26.5 – 30.2) 7,774
Age group
3-5 years
 1999–2000 20.1 (18.8 – 21.4) 10.5 (7.89 – 12.2) 19.1 (17.9 – 21.6) 38.2 (34.0 – 45.1) 361
 2001–2002 17.3 (16.3 – 18.4) 9.44 (7.08 – 10.6) 17.1 (16.1 – 18.3) 31.9 (29.5 – 38.5) 438
 2003–2004 16.6 (15.1 – 18.2) 8.59 (5.22 – 9.61) 16.2 (15.2 – 17.0) 34.5 (29.4 – 57.9) 448
 2005–2006 17.6 (16.5 – 18.8) 9.56 (8.34 – 10.3) 16.7 (16.1 – 17.9) 37.6 (31.3 – 77.2) 441
6–11 years
 1999–2000 19.3 (18.4 – 20.3) 11.0 (10.6 – 11.4) 19.3 (18.4 – 19.9) 33.4 (31.6 – 36.3) 885
 2001–2002 17.2 (16.6 – 17.9) 9.31 (8.75 – 9.78) 17.1 (16.3 – 17.8) 32.7 (29.9 – 37.9) 1,023
 2003–2004 15.6 (14.9 – 16.3) 9.39 (8.66 – 9.85) 15.2 (14.7 – 16.0) 27.4 (24.4 – 34.0) 843
 2005–2006 16.7 (15.9 – 17.5) 8.77 (8.26 – 9.60) 16.3 (15.5 – 17.1) 32.4 (29.5 – 36.9) 906
12–19 years
 1999–2000 13.3 (12.6 – 14.0) 6.26 (5.72 – 6.61) 13.3 (12.7 – 14.0) 27.6 (25.6 – 31.3) 2,124
 2001–2002 12.2 (11.6 – 12.8) 5.91 (5.29 – 6.28) 12.5 (11.9 – 13.3) 22.1 (21.2 – 23.4) 2,208
 2003–2004 11.0 (10.5 – 11.5) 5.56 (5.20 – 6.02) 11.0 (10.5 – 11.4) 19.7 (19.1 – 22.1) 2,058
 2005–2006 11.5 (11.2 – 11.8) 5.65 (5.39 – 5.90) 11.6 (11.1 – 12.1) 21.8 (21.1 – 22.6) 1,970
20–39 years
 1999–2000 11.8 (11.0 – 12.7) 5.15 (4.40 – 5.55) 11.6 (10.6 – 12.8) 28.6 (25.6 – 30.8) 1,470
 2001–2002 11.1 (10.6 – 11.6) 5.27 (4.78 – 5.59) 11.1 (10.6 – 11.6) 22.6 (20.6 – 24.3) 1,714
 2003–2004 10.2 (9.78 – 10.6) 4.83 (4.62 – 5.01) 10.2 (9.59 – 10.8) 20.0 (19.1 – 22.9) 1,555
 2005–2006 10.6 (10.2 – 11.1) 5.07 (4.76 – 5.33) 10.8 (10.3 – 11.2) 21.1 (19.2 – 25.9) 1,687
40–59 years
 1999–2000 13.6 (12.7 – 14.5) 5.37 (4.37 – 6.08) 13.6 (12.7 – 14.7) 31.6 (30.0 – 35.4) 1,199
 2001–2002 12.2 (11.7 – 12.7) 5.63 (4.86 – 6.06) 12.5 (11.9 – 13.1) 24.0 (22.4 – 25.3) 1,475
 2003–2004 11.6 (11.0 – 12.3) 5.20 (4.57 – 5.60) 11.6 (11.1 – 11.9) 26.0 (23.8 – 32.8) 1,276
 2005–2006 11.6 (11.0 – 12.2) 4.85 (4.39 – 5.57) 11.7 (11.1 – 12.1) 24.4 (22.8 – 29.0) 1,373
60 years and older
 1999–2000 17.4 (16.7 – 18.1) 7.09 (6.48 – 7.51) 17.4 (16.5 – 18.2) 42.3 (39.2 – 44.8) 1,487
 2001–2002 16.1 (15.4 – 16.8) 6.50 (5.75 – 7.09) 16.6 (15.4 – 17.5) 37.3 (34.2 – 40.7) 1,528
 2003–2004 15.7 (15.1 – 16.4) 6.53 (6.13 – 7.00) 15.6 (14.8 – 16.4) 34.9 (32.9 – 37.7) 1,656
 2005–2006 15.4 (14.5 – 16.4) 6.06 (5.40 – 6.58) 15.8 (15.0 – 16.8) 36.4 (34.4 – 41.9) 1,397
Gender
Males
 1999–2000 13.3 (12.7 – 14.0) 5.53 (4.73 – 6.13) 13.4 (12.7 – 14.2) 30.6 (29.0 – 32.2) 3,684
 2001–2002 12.3 (11.8 – 12.8) 5.64 (5.17 – 6.00) 12.5 (12.1 – 13.0) 25.0 (23.7 – 27.0) 4,063
 2003–2004 11.6 (11.1 – 12.1) 5.31 (4.93 – 5.69) 11.5 (11.1 – 11.9) 26.2 (24.7 – 28.1) 3,871
 2005–2006 11.7 (11.2 – 12.1) 5.24 (4.74 – 5.59) 11.6 (11.2 – 12.0) 26.2 (25.2 – 28.5) 3,780
Females
 1999–2000 14.8 (14.0 – 15.6) 5.94 (5.60 – 6.18) 14.8 (14.1 – 16.0) 35.3 (33.7 – 37.5) 3,842
 2001–2002 13.5 (13.1 – 13.9) 5.80 (5.39 – 6.35) 13.6 (13.2 – 14.0) 29.3 (27.3 – 31.6) 4,323
 2003–2004 12.6 (12.1 – 13.1) 5.51 (5.12 – 5.84) 12.5 (12.0 – 13.0) 29.5 (28.3 – 31.6) 3,965
 2005–2006 13.1 (12.5 – 13.7) 5.66 (5.25 – 6.14) 13.2 (12.6 – 13.8) 29.9 (28.2 – 32.2) 3,994
Race/ethnicity
Mexican Americans
 1999–2000 13.2 (12.8 – 13.7) 6.10 (5.49 – 6.51) 13.5 (12.9 – 14.0) 28.4 (27.1 – 30.2) 2,571
 2001–2002 11.6 (10.9 – 12.4) 5.48 (4.66 – 6.08) 11.8 (11.1 – 12.5) 22.5 (20.0 – 26.1) 2,124
 2003–2004 10.9 (10.4 – 11.5) 5.20 (5.09 – 5.50) 11.1 (10.7 – 11.6) 20.9 (19.2 – 23.4) 1,919
 2005–2006 11.1 (10.7 – 11.5) 5.56 (5.18 – 5.79) 11.0 (10.6 – 11.5) 23.1 (21.6 – 25.0) 2,012
Non-Hispanic Blacks
 1999–2000 11.7 (11.1 – 12.4) 5.15 (4.67 – 5.42) 11.6 (10.9 – 12.4) 27.3 (24.9 – 31.5) 1,712
 2001–2002 10.9 (10.2 – 11.6) 5.06 (4.47 – 5.39) 10.7 (10.1 – 11.4) 23.6 (21.7 – 25.2) 2,004
 2003–2004 10.1 (9.66 – 10.6) 4.65 (4.28 – 5.11) 10.1 (9.37 – 10.8) 21.9 (19.9 – 23.7) 2,057
 2005–2006 10.6 (10.1 – 11.1) 4.95 (4.68 – 5.15) 10.5 (9.92 – 11.2) 22.9 (21.4 – 24.0) 2,040
Non-Hispanic Whites
 1999–2000 14.8 (13.8 – 15.8) 6.11 (5.52 – 6.55) 15.0 (13.9 – 16.2) 34.2 (32.6 – 36.0) 2,557
 2001–2002 13.4 (13.0 – 13.9) 5.90 (5.62 – 6.21) 13.6 (13.2 – 14.1) 28.4 (27.2 – 29.9) 3,590
 2003–2004 12.9 (12.2 – 13.5) 5.76 (5.31 – 6.08) 12.7 (12.1 – 13.3) 30.0 (28.5 – 32.1) 3,272
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Figure 1.1.b. Serum folate: Concentrations by survey cycle 
Selected percentiles in ng/mL (95% confidence intervals), National Health and 
Nutrition Examination Survey, 1999–2006 
1. Water -Soluble Vitamins 27



























































































































































































































































































































































































































































































































































































































































































































































































































































































































































0 Non−Hispanic Blacks Non−Hispanic Whites 
Figure 1.2.a. Red blood cell folate: Concentrations by age group 
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Table 1.2.a.2. Red blood cell folate: Total population
Geometric mean and selected percentiles of red blood cell concentrations (in ng/mL) for the total U.S. 
population aged 1 year and older, National Health and Nutrition Examination Survey, 2003–2006.
Geometric mean 
(95% conf. interval)
Selected percentiles (95% conf. interval) Sample 
size5th 50th 95th
Males and Females
Total, 1 year and older 265 (261 – 270) 149 (146 – 152) 261 (256 – 265) 501 (487 – 515) 16,670
1–5 years 272 (265 – 279) 174 (169 – 178) 266 (261 – 272) 483 (436 – 531) 1,861
6–11 years 263 (258 – 268) 180 (172 – 184) 259 (254 – 264) 430 (400 – 456) 1,779
12–19 years 229 (225 – 234) 140 (134 – 146) 229 (224 – 233) 370 (355 – 390) 4,050
20–39 years 244 (238 – 250) 140 (136 – 144) 241 (235 – 247) 449 (421 – 480) 3,262
40–59 years 270 (264 – 276) 149 (143 – 154) 273 (266 – 279) 481 (461 – 510) 2,649
60 years and older 324 (317 – 332) 161 (157 – 166) 327 (315 – 338) 656 (622 – 705) 3,069
Males
Total, 1 year and older 259 (253 – 264) 149 (144 – 153) 255 (250 – 259) 469 (453 – 489) 8,172
1–5 years 281 (271 – 290) 176 (170 – 185) 271 (264 – 281) 507 (460 – 560) 941
6–11 years 265 (259 – 271) 182 (173 – 188) 257 (251 – 264) 439 (414 – 468) 867
12–19 years 229 (225 – 234) 142 (135 – 148) 229 (223 – 233) 361 (353 – 385) 2,051
20–39 years 235 (228 – 242) 140 (131 – 148) 235 (226 – 244) 397 (379 – 429) 1,467
40–59 years 263 (256 – 271) 149 (140 – 154) 265 (256 – 275) 463 (431 – 513) 1,309
60 years and older 313 (302 – 324) 159 (154 – 163) 311 (297 – 328) 651 (595 – 709) 1,537
Females
Total, 1 year and older 272 (267 – 277) 149 (146 – 153) 268 (262 – 273) 522 (508 – 535) 8,498
1–5 years 263 (255 – 270) 173 (161 – 177) 262 (254 – 267) 436 (395 – 531) 920
6–11 years 261 (254 – 269) 176 (162 – 183) 260 (253 – 267) 402 (379 – 459) 912
12–19 years 229 (223 – 234) 138 (130 – 146) 229 (223 – 234) 373 (354 – 398) 1,999
20–39 years 253 (246 – 261) 139 (134 – 145) 248 (239 – 258) 486 (461 – 529) 1,795
40–59 years 276 (269 – 284) 149 (139 – 157) 278 (271 – 288) 501 (467 – 536) 1,340
60 years and older 334 (324 – 344) 162 (157 – 172) 338 (325 – 352) 661 (616 – 744) 1,532
Table 1.2.a.3. Red blood cell folate: Mexican Americans
Geometric mean and selected percentiles of red blood cell concentrations (in ng/mL) for Mexican Americans in 
the U.S. population aged 1 year and older, National Health and Nutrition Examination Survey, 2003–2006.
Geometric mean 
(95% conf. interval)
Selected percentiles (95% conf. interval) Sample 
size5th 50th 95th
Males and Females
Total, 1 year and older 247 (242 – 252) 149 (138 – 155) 241 (237 – 246) 452 (434 – 465) 4,304
1–5 years 266 (257 – 275) 170 (152 – 177) 258 (249 – 266) 477 (441 – 507) 610
6–11 years 259 (252 – 266) 170 (156 – 183) 256 (249 – 262) 443 (396 – 483) 595
12–19 years 231 (225 – 237) 144 (136 – 154) 225 (221 – 232) 402 (386 – 423) 1,288
20–39 years 237 (228 – 246) 139 (125 – 154) 232 (223 – 241) 437 (402 – 463) 787
40–59 years 254 (245 – 264) 149 (132 – 157) 249 (235 – 264) 451 (415 – 520) 471
60 years and older 277 (263 – 292) 147 (130 – 156) 271 (258 – 290) 565 (483 – 646) 553
Males
Total, 1 year and older 238 (231 – 245) 146 (133 – 153) 234 (230 – 239) 413 (388 – 445) 2,087
1–5 years 276 (263 – 289) 171 (151 – 189) 267 (260 – 275) 481 (445 – 553) 298
6–11 years 263 (253 – 274) 171 (151 – 189) 258 (249 – 265) 466 (422 – 523) 289
12–19 years 226 (219 – 233) 139 (134 – 147) 223 (214 – 230) 378 (340 – 455) 639
20–39 years 221 (211 – 231) 136 (106 – 153) 220 (211 – 231) 367 (333 – 406) 350
40–59 years 245 (235 – 255) 149 (122 – 158) 234 (226 – 250) 429 (373 – 538) 238
60 years and older 257 (243 – 271) 146 (121 – 150) 248 (234 – 268) 478 (438 – 542) 273
Females
Total, 1 year and older 257 (252 – 263) 154 (140 – 161) 250 (246 – 256) 477 (460 – 505) 2,217
1–5 years 255 (245 – 265) 165 (139 – 177) 248 (240 – 258) 445 (398 – 506) 312
6–11 years 254 (245 – 263) 170 (153 – 180) 253 (246 – 261) 405 (358 – 477) 306
12–19 years 237 (230 – 243) 153 (135 – 158) 230 (224 – 237) 420 (398 – 450) 649
20–39 years 256 (247 – 267) 149 (135 – 161) 250 (236 – 267) 490 (458 – 587) 437
40–59 years 264 (249 – 281) 144 (110 – 159) 263 (244 – 287) 486 (424 – 746) 233
60 years and older 295 (269 – 322) 148 (91.6 – 168) 306 (267 – 329) 587 (550 – 682) 280
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Table 1.2.a.4. Red blood cell folate: Non–Hispanic blacks
Geometric mean and selected percentiles of red blood cell concentrations (in ng/mL) for non–Hispanic blacks 
in the U.S. population aged 1 year and older, National Health and Nutrition Examination Survey, 2003–2006.
Geometric mean 
(95% conf. interval)
Selected percentiles (95% conf. interval) Sample 
size5th 50th 95th
Males and Females
Total, 1 year and older 214 (210 – 218) 125 (120 – 130) 213 (210 – 216) 382 (367 – 398) 4,404
1–5 years 225 (218 – 232) 143 (132 – 152) 226 (221 – 231) 350 (330 – 371) 525
6–11 years 230 (225 – 235) 156 (146 – 165) 231 (224 – 238) 336 (321 – 370) 572
12–19 years 194 (190 – 199) 118 (111 – 124) 195 (191 – 200) 312 (299 – 319) 1,432
20–39 years 204 (199 – 210) 119 (115 – 122) 203 (193 – 209) 370 (350 – 406) 717
40–59 years 216 (208 – 225) 124 (107 – 132) 215 (209 – 221) 386 (359 – 436) 630
60 years and older 242 (231 – 254) 131 (125 – 137) 237 (221 – 252) 449 (423 – 508) 528
Males
Total, 1 year and older 209 (205 – 213) 122 (119 – 129) 208 (204 – 213) 355 (344 – 375) 2,189
1–5 years 228 (219 – 238) 143 (122 – 152) 227 (220 – 235) 359 (333 – 418) 259
6–11 years 231 (225 – 237) 164 (146 – 170) 231 (222 – 239) 337 (319 – 386) 282
12–19 years 195 (190 – 201) 123 (110 – 131) 198 (190 – 204) 305 (289 – 320) 750
20–39 years 195 (188 – 201) 116 (113 – 121) 192 (184 – 204) 309 (298 – 337) 339
40–59 years 211 (202 – 220) 120 (95.7 – 133) 209 (201 – 218) 375 (355 – 435) 295
60 years and older 233 (222 – 245) 128 (123 – 134) 224 (211 – 240) 461 (413 – 541) 264
Females
Total, 1 year and older 219 (214 – 224) 127 (119 – 131) 216 (212 – 221) 397 (374 – 416) 2,215
1–5 years 221 (214 – 228) 146 (124 – 158) 224 (218 – 232) 334 (301 – 361) 266
6–11 years 230 (221 – 239) 149 (142 – 161) 230 (219 – 242) 334 (314 – 388) 290
12–19 years 193 (188 – 200) 113 (109 – 119) 194 (190 – 200) 314 (299 – 341) 682
20–39 years 213 (204 – 221) 121 (108 – 132) 210 (199 – 219) 406 (371 – 428) 378
40–59 years 221 (210 – 233) 128 (99.8 – 133) 219 (211 – 232) 389 (353 – 494) 335
60 years and older 248 (232 – 267) 135 (104 – 150) 245 (220 – 275) 445 (421 – 521) 264
Table 1.2.a.5. Red blood cell folate: Non–Hispanic whites
Geometric mean and selected percentiles of red blood cell concentrations (in ng/mL) for non–Hispanic whites 
in the U.S. population aged 1 year and older, National Health and Nutrition Examination Survey, 2003–2006.
Geometric mean 
(95% conf. interval)
Selected percentiles (95% conf. interval) Sample 
size5th 50th 95th
Males and Females
Total, 1 year and older 281 (274 – 288) 160 (154 – 165) 276 (269 – 282) 529 (510 – 537) 6,675
1–5 years 290 (277 – 304) 191 (179 – 201) 278 (267 – 293) 528 (484 – 598) 523
6–11 years 274 (267 – 281) 191 (187 – 197) 268 (261 – 275) 439 (411 – 464) 454
12–19 years 239 (233 – 246) 152 (145 – 158) 238 (231 – 246) 376 (356 – 407) 1,046
20–39 years 258 (250 – 267) 152 (143 – 159) 254 (246 – 262) 464 (435 – 504) 1,460
40–59 years 281 (273 – 290) 159 (150 – 165) 285 (275 – 293) 494 (466 – 532) 1,346
60 years and older 339 (330 – 348) 173 (162 – 183) 340 (328 – 350) 673 (645 – 732) 1,846
Males
Total, 1 year and older 274 (267 – 281) 161 (153 – 167) 269 (262 – 278) 493 (473 – 524) 3,294
1–5 years 299 (284 – 316) 200 (173 – 208) 283 (268 – 312) 537 (498 – 659) 286
6–11 years 277 (268 – 286) 193† (188 – 202) 269 (258 – 278) 447† (425 – 517) 218
12–19 years 241 (234 – 248) 152 (139 – 158) 238 (231 – 249) 374 (355 – 437) 527
20–39 years 250 (240 – 260) 154 (141 – 165) 248 (238 – 258) 414 (395 – 447) 641
40–59 years 275 (265 – 286) 160 (148 – 165) 280 (266 – 292) 474 (433 – 534) 688
60 years and older 326 (314 – 338) 170 (161 – 184) 322 (306 – 340) 660 (609 – 716) 934
Females
Total, 1 year and older 288 (280 – 296) 158 (153 – 164) 282 (273 – 290) 546 (531 – 569) 3,381
1–5 years 280 (264 – 296) 183 (152 – 196) 272 (263 – 286) 486 (428 – 584) 237
6–11 years 270 (261 – 280) 188 (170 – 198) 267 (259 – 276) 390 (373 – 456) 236
12–19 years 238 (231 – 245) 149 (136 – 160) 237 (230 – 244) 381 (350 – 447) 519
20–39 years 267 (257 – 278) 149 (139 – 155) 263 (251 – 272) 502 (473 – 557) 819
40–59 years 287 (277 – 298) 158 (148 – 167) 289 (276 – 302) 506 (477 – 545) 658
60 years and older 350 (337 – 362) 177 (158 – 186) 352 (338 – 370) 689 (630 – 796) 912
† Estimate is subject to greater uncertainty due to small cell size.
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Table 1.2.b. Red blood cell folate: Concentrations by survey cycle
Geometric mean and selected percentiles of red blood cell concentrations (in ng/mL) for the U.S. population, 
National Health and Nutrition Examination Survey, 1999–2006.
Geometric mean 
(95% conf. interval)
Selected percentiles (95% conf. interval) Sample 
size5th 50th 95th
Total, 3 years and older
 1999–2000 281 (269 – 293) 153 (144 – 162) 277 (266 – 288) 522 (499 – 556) 7,614
 2001–2002 277 (269 – 285) 155 (148 – 160) 274 (265 – 282) 519 (500 – 540) 8,488
 2003–2004 258 (251 – 266) 146 (139 – 151) 254 (246 – 262) 483 (464 – 506) 7,849
 2005–2006 272 (267 – 277) 152 (148 – 155) 267 (263 – 270) 517 (497 – 534) 7,906
Age group
3–5 years
 1999–2000 293 (282 – 306) 198 (182 – 206) 290 (283 – 301) 446 (397 – 608) 380
 2001–2002 284 (273 – 296) 188 (163 – 201) 283 (270 – 296) 468 (394 – 522) 460
 2003–2004 263 (253 – 273) 181 (172 – 187) 258 (245 – 268) 385 (364 – 583) 453
 2005–2006 282 (269 – 295) 191 (181 – 197) 271 (265 – 281) 463 (432 – 598) 493
6–11 years
 1999–2000 284 (275 – 293) 190 (177 – 202) 282 (274 – 292) 423 (389 – 502) 898
 2001–2002 276 (266 – 287) 183 (171 – 189) 272 (260 – 283) 444 (422 – 512) 1,040
 2003–2004 258 (251 – 265) 176 (170 – 183) 255 (246 – 264) 414 (372 – 447) 849
 2005–2006 269 (260 – 277) 182 (173 – 189) 263 (257 – 271) 434 (396 – 494) 930
12–19 years
 1999–2000 247 (237 – 256) 152 (146 – 158) 244 (238 – 255) 415 (391 – 456) 2,136
 2001–2002 242 (231 – 253) 148 (138 – 157) 238 (228 – 249) 406 (381 – 446) 2,226
 2003–2004 223 (217 – 230) 137 (129 – 145) 223 (215 – 230) 356 (338 – 386) 2,063
 2005–2006 235 (229 – 241) 145 (133 – 151) 234 (228 – 240) 380 (358 – 414) 1,987
20–39 years
 1999–2000 256 (244 – 268) 141 (130 – 150) 254 (237 – 270) 460 (439 – 515) 1,474
 2001–2002 254 (246 – 263) 144 (134 – 152) 251 (240 – 262) 448 (432 – 471) 1,721
 2003–2004 236 (228 – 245) 138 (131 – 143) 234 (221 – 245) 426 (403 – 461) 1,555
 2005–2006 252 (244 – 261) 143 (138 – 150) 249 (242 – 256) 462 (428 – 525) 1,707
40–59 years
 1999–2000 294 (279 – 311) 156 (144 – 167) 292 (274 – 309) 538 (502 – 613) 1,213
 2001–2002 289 (280 – 298) 163 (155 – 170) 287 (281 – 295) 526 (484 – 585) 1,496
 2003–2004 264 (253 – 275) 148 (137 – 156) 270 (258 – 279) 465 (430 – 514) 1,273
 2005–2006 276 (270 – 282) 150 (145 – 155) 277 (270 – 284) 495 (465 – 544) 1,376
60 years and older
 1999–2000 340 (328 – 352) 169 (154 – 182) 343 (323 – 363) 667 (629 – 701) 1,513
 2001–2002 334 (323 – 345) 167 (158 – 178) 336 (325 – 349) 654 (608 – 721) 1,545
 2003–2004 320 (310 – 329) 162 (154 – 171) 321 (310 – 337) 642 (589 – 725) 1,656
 2005–2006 329 (316 – 342) 161 (155 – 168) 332 (312 – 347) 662 (618 – 733) 1,413
Gender
Males
 1999–2000 274 (262 – 286) 153 (144 – 161) 270 (259 – 280) 499 (478 – 526) 3,721
 2001–2002 269 (259 – 278) 155 (147 – 160) 265 (254 – 276) 485 (465 – 520) 4,106
 2003–2004 252 (244 – 260) 147 (138 – 153) 248 (239 – 257) 452 (431 – 485) 3,874
 2005–2006 264 (257 – 271) 151 (144 – 157) 259 (255 – 264) 481 (459 – 508) 3,845
Females
 1999–2000 288 (275 – 301) 154 (142 – 164) 286 (272 – 298) 549 (515 – 590) 3,893
 2001–2002 285 (276 – 294) 155 (148 – 159) 282 (274 – 291) 540 (518 – 575) 4,382
 2003–2004 264 (256 – 273) 146 (138 – 151) 261 (251 – 271) 502 (483 – 530) 3,975
 2005–2006 280 (273 – 287) 153 (148 – 157) 274 (267 – 282) 538 (528 – 557) 4,061
Race/ethnicity
Mexican Americans
 1999–2000 261 (253 – 268) 159 (151 – 166) 256 (251 – 262) 452 (429 – 465) 2,592
 2001–2002 256 (244 – 268) 146 (132 – 161) 252 (241 – 265) 458 (434 – 497) 2,134
 2003–2004 242 (234 – 251) 149 (136 – 157) 236 (231 – 244) 414 (398 – 462) 1,919
 2005–2006 250 (244 – 256) 148 (129 – 158) 244 (239 – 249) 461 (452 – 482) 2,057
Non-Hispanic Blacks
 1999–2000 225 (218 – 233) 125 (113 – 135) 226 (221 – 234) 386 (366 – 427) 1,738
 2001–2002 216 (210 – 222) 122 (119 – 124) 214 (208 – 220) 376 (355 – 412) 2,045
 2003–2004 209 (203 – 214) 119 (114 – 127) 209 (204 – 214) 366 (349 – 389) 2,091
 2005–2006 220 (215 – 224) 131 (124 – 136) 217 (212 – 221) 402 (376 – 422) 2,084
Non-Hispanic Whites
 1999–2000 298 (281 – 315) 165 (147 – 175) 293 (275 – 309) 555 (527 – 592) 2,585
 2001–2002 293 (286 – 300) 166 (160 – 172) 289 (283 – 295) 542 (524 – 566) 3,625
 2003–2004 273 (262 – 285) 158 (146 – 166) 269 (258 – 280) 504 (485 – 531) 3,256
 2005–2006 288 (281 – 295) 162 (155 – 167) 282 (276 – 289) 539 (527 – 567) 3,149
-
Figure 1.2.b. Red blood cell folate: Concentrations by survey cycle 
Selected percentiles in ng/mL (95% confidence intervals), National Health and 
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Table 1.2.c. Red blood cell folate: Prevalence
Prevalence (in percent) of low red blood cell folate concentration (< 95 ng/mL) for the U.S. population 





Estimated total  
number of persons
Total, 1 year and older 16,670 0.2 (0.2 – 0.4) 704,000
Age group
1–5 years 1,861 § §
6–11 years 1,779 § §
12–19 years 4,050 0.2 (0.1 – 0.4) 76,000
20–39 years 3,262 § §
40–59 years 2,649 0.4 (0.2 – 0.7) 331,000
60 years and older 3,069 § §
Gender
Males 8,172 0.2 (0.1 – 0.4) 301,000
Females 8,498 0.3 (0.2 – 0.5) 404,000
Race/ethnicity
Mexican Americans 4,304 0.3‡ (0.1 – 0.6) 72,000‡
Non-Hispanic Blacks 4,404 0.9 (0.6 – 1.5) 313,000
Non-Hispanic Whites 6,675 § §
‡ Estimate flagged: 30% ≤ RSE < 40% for the prevalence estimate. 
§ Estimate suppressed: RSE ≥ 40% for the prevalence estimate.
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Table 1.2.d. Red blood cell folate: Prevalence by survey cycle
Prevalence (in percent) of low red blood cell folate concentration (< 95 ng/mL) for the U.S. population, 
National Health and Nutrition Examination Survey, 1999–2006.
Sample size Prevalence (95% conf. interval) Estimated total number of persons
Total, 3 years and older
 1999–2000 7,614 § §
 2001–2002 8,488 0.2‡ (0.1 – 0.4) 562,000‡
 2003–2004 7,849 0.3 (0.2 – 0.6) 947,000
 2005–2006 7,906 0.2 (0.1 – 0.3) 434,000
Age group
3–5 years
 1999–2000 380 § §
 2001–2002 460 § §
 2003–2004 453 § §
 2005–2006 493 § §
6–11 years
 1999–2000 898 § §
 2001–2002 1,040 § §
 2003–2004 849 § §
 2005–2006 930 § §
12–19 years
 1999–2000 2,136 § §
 2001–2002 2,226 § §
 2003–2004 2,063 0.3‡ (0.1 – 0.5) 88,000‡
 2005–2006 1,987 0.2‡ (0.1 – 0.4) 64,000‡
20–39 years
 1999–2000 1,474 § §
 2001–2002 1,721 § §
 2003–2004 1,555 § §
 2005–2006 1,707 § §
40–59 years
 1999–2000 1,213 § §
 2001–2002 1,496 § §
 2003–2004 1,273 0.7‡ (0.3 – 1.5) 555,000‡
 2005–2006 1,376 0.1‡ (0.1 – 0.3) 118,000‡
60 years and older
 1999–2000 1,513 § §
 2001–2002 1,545 0.3‡ (0.1 – 0.7) 147,000‡
 2003–2004 1,656 § §
 2005–2006 1,413 § §
Gender
Males
 1999–2000 3,721 0.2‡ (0.1 – 0.4) 217,000‡
 2001–2002 4,106 § §
 2003–2004 3,874 0.3‡ (0.1 – 0.6) 378,000‡
 2005–2006 3,845 0.1 (0.1 – 0.2) 201,000
Females
 1999–2000 3,893 § §
 2001–2002 4,382 0.1‡ (0.1 – 0.3) 161,000‡
 2003–2004 3,975 0.4‡ (0.2 – 0.9) 570,000‡
 2005–2006 4,061 § §
Race/ethnicity
Mexican Americans
 1999–2000 2,592 § §
 2001–2002 2,134 § §
 2003–2004 1,919 § §
 2005–2006 2,057 § §
Non-Hispanic Blacks
 1999–2000 1,738 1.0 (0.5 – 1.7) 318,000
 2001–2002 2,045 0.7‡ (0.3 – 1.5) 238,000‡
 2003–2004 2,091 1.0 (0.5 – 1.9) 333,000
 2005–2006 2,084 0.8‡ (0.3 – 1.8) 261,000‡
Non-Hispanic Whites
 1999–2000 2,585 § §
 2001–2002 3,625 § §
 2003–2004 3,256 § §
 2005–2006 3,149 0.0 (0.0 – 0.1) 85,000
‡ Estimate flagged: 30% ≤ RSE < 40% for the prevalence estimate. 
§ Estimate suppressed: RSE ≥ 40% for the prevalence estimate.
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Figure 1.3.a. Serum pyridoxal−5'−phosphate: Concentrations by age group 
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Table 1.3.a.2. Serum pyridoxal-5’-phosphate: Total population
Geometric mean and selected percentiles of serum concentrations (in nmol/L) for the total U.S. population 
aged 1 year and older, National Health and Nutrition Examination Survey, 2005–2006.
Geometric mean 
(95% conf. interval)
Selected percentiles (95% conf. interval) Sample 
size10th 50th 90th
Males and Females
Total, 1 year and older 51.4 (49.1 – 53.8) 19.5 (18.2 – 20.6) 49.3 (46.9 – 51.2) 154 (139 – 162) 8,311
1–5 years 65.0 (61.2 – 69.0) 31.7 (29.2 – 35.0) 66.1 (63.1 – 70.4) 126 (116 – 140) 915
6–11 years 60.5 (56.9 – 64.4) 30.7 (28.0 – 33.5) 60.0 (55.3 – 65.5) 126 (110 – 138) 922
12–19 years 49.4 (46.7 – 52.3) 24.8 (23.3 – 26.3) 47.8 (44.9 – 51.0) 105 (92.9 – 114) 1,985
20–39 years 51.0 (47.7 – 54.6) 20.0 (18.0 – 21.6) 47.3 (43.9 – 50.5) 153 (130 – 183) 1,699
40–59 years 49.0 (45.1 – 53.3) 16.5 (14.3 – 19.0) 45.6 (41.5 – 50.3) 166 (147 – 192) 1,381
60 years and older 50.4 (46.7 – 54.5) 15.1 (13.0 – 17.5) 46.9 (41.9 – 53.5) 187 (173 – 209) 1,409
Males
Total, 1 year and older 56.0 (53.6 – 58.5) 22.6 (20.3 – 24.6) 53.9 (52.0 – 56.0) 149 (136 – 162) 4,055
1–5 years 65.3 (61.2 – 69.6) 31.6 (26.3 – 35.2) 66.8 (63.2 – 71.9) 127 (117 – 135) 455
6–11 years 62.0 (57.4 – 66.9) 31.6 (30.5 – 33.4) 60.8 (54.8 – 68.4) 130 (113 – 143) 454
12–19 years 55.4 (52.4 – 58.6) 28.9 (27.0 – 30.6) 54.8 (51.3 – 57.9) 110 (101 – 122) 991
20–39 years 61.6 (58.0 – 65.4) 26.8 (24.8 – 28.8) 55.3 (52.7 – 58.3) 165 (139 – 202) 741
40–59 years 52.1 (46.4 – 58.5) 19.1 (14.8 – 22.6) 51.0 (43.7 – 56.9) 158 (125 – 188) 680
60 years and older 49.3 (44.7 – 54.3) 16.1 (13.5 – 19.3) 45.9 (40.0 – 54.4) 171 (156 – 196) 734
Females
Total, 1 year and older 47.4 (44.7 – 50.3) 17.2 (15.2 – 18.8) 44.1 (40.8 – 47.0) 156 (141 – 165) 4,256
1–5 years 64.6 (59.3 – 70.5) 32.1 (28.5 – 36.1) 65.2 (60.9 – 71.1) 124 (106 – 156) 460
6–11 years 59.1 (54.9 – 63.6) 29.7 (25.3 – 33.6) 58.3 (52.0 – 64.0) 118 (104 – 156) 468
12–19 years 43.7 (40.5 – 47.2) 21.8 (21.0 – 22.8) 41.4 (39.0 – 45.1) 90.6 (78.4 – 111) 994
20–39 years 42.4 (38.8 – 46.3) 16.5 (14.6 – 18.4) 37.6 (35.1 – 41.8) 132 (111 – 166) 958
40–59 years 46.4 (42.5 – 50.6) 14.4 (13.0 – 17.6) 41.6 (36.3 – 46.6) 172 (161 – 207) 701
60 years and older 51.4 (46.6 – 56.7) 14.1 (12.7 – 16.2) 47.6 (39.8 – 57.1) 206 (176 – 246) 675
Table 1.3.a.3. Serum pyridoxal-5’-phosphate: Mexican Americans
Geometric mean and selected percentiles of serum concentrations (in nmol/L) for Mexican Americans in the 
U.S. population aged 1 year and older, National Health and Nutrition Examination Survey, 2005–2006.
Geometric mean 
(95% conf. interval)
Selected percentiles (95% conf. interval) Sample 
size10th 50th 90th
Males and Females
Total, 1 year and older 49.3 (47.2 – 51.4) 22.3 (19.8 – 23.9) 46.4 (44.9 – 48.3) 121 (105 – 136) 2,212
1–5 years 64.2 (60.1 – 68.7) 32.4 (28.0 – 34.2) 65.0 (59.0 – 71.1) 126 (115 – 142) 322
6–11 years 58.3 (52.5 – 64.6) 30.3 (24.0 – 34.9) 56.4 (50.8 – 65.8) 116 (98.9 – 137) 321
12–19 years 46.0 (44.4 – 47.6) 24.7 (23.0 – 26.6) 44.4 (42.5 – 47.6) 91.1 (83.7 – 100) 657
20–39 years 47.1 (44.1 – 50.4) 20.4 (15.7 – 24.8) 42.9 (40.1 – 45.6) 127 (97.0 – 143) 453
40–59 years 47.9 (42.4 – 54.1) 20.2 (14.5 – 23.3) 42.2 (38.5 – 49.4) 141 (115 – 170) 249
60 years and older 42.0 (34.9 – 50.5) 15.0 (13.1 – 17.2) 38.6 (30.2 – 50.1) 142 (101 – 184) 210
Males
Total, 1 year and older 56.4 (53.7 – 59.1) 27.9 (23.5 – 30.6) 53.7 (51.2 – 55.8) 124 (108 – 140) 1,056
1–5 years 67.0 (61.3 – 73.3) 30.4 (22.2 – 38.5) 67.7 (60.0 – 76.3) 129 (108 – 180) 153
6–11 years 61.4 (55.5 – 67.9) 32.0 (27.9 – 35.2) 57.5 (52.4 – 65.7) 126 (97.0 – 151) 157
12–19 years 53.0 (50.2 – 55.9) 28.2 (26.7 – 32.3) 51.6 (47.7 – 55.8) 104 (87.7 – 113) 318
20–39 years 57.2 (51.9 – 63.1) 29.4 (22.0 – 32.5) 51.9 (46.1 – 60.9) 135 (108 – 152) 200
40–59 years 56.7 (46.6 – 68.9) 24.0 (16.0 – 34.1) 53.3 (45.1 – 59.2) 122 (91.1 – 478) 123
60 years and older 37.8 (30.0 – 47.6) 14.7† (10.7 – 18.6) 35.6 (26.8 – 50.9) 95.5† (71.3 – 209) 105
Females
Total, 1 year and older 42.6 (40.8 – 44.6) 19.1 (16.4 – 20.8) 39.4 (38.2 – 40.3) 111 (96.5 – 130) 1,156
1–5 years 61.5 (55.9 – 67.7) 33.2 (28.9 – 34.9) 61.2 (55.2 – 68.8) 120 (97.3 – 176) 169
6–11 years 55.1 (47.2 – 64.3) 27.6 (17.6 – 34.7) 54.3 (44.6 – 68.7) 105 (87.9 – 133) 164
12–19 years 39.6 (37.6 – 41.7) 20.7 (19.0 – 22.6) 38.8 (37.2 – 39.7) 76.8 (69.9 – 87.9) 339
20–39 years 37.3 (34.3 – 40.4) 17.7 (11.8 – 19.6) 34.1 (31.7 – 36.1) 89.7 (71.6 – 134) 253
40–59 years 40.2 (35.0 – 46.3) 14.9 (10.3 – 18.9) 33.2 (29.7 – 39.1) 155 (110 – 199) 126
60 years and older 45.7 (36.9 – 56.6) 16.6† (12.6 – 19.8) 39.3 (30.7 – 53.3) 160† (106 – 212) 105
† Estimate is subject to greater uncertainty due to small cell size.
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Table 1.3.a.4. Serum pyridoxal-5’-phosphate: Non-Hispanic blacks
Geometric mean and selected percentiles of serum concentrations (in nmol/L) for non-Hispanic blacks in the 
U.S. population aged 1 year and older, National Health and Nutrition Examination Survey, 2005–2006.
Geometric mean 
(95% conf. interval)
Selected percentiles (95% conf. interval) Sample 
size10th 50th 90th
Males and Females
Total, 1 year and older 40.5 (37.4 – 44.0) 16.3 (15.4 – 17.2) 39.0 (35.9 – 41.7) 104 (90.5 – 132) 2,157
1–5 years 54.0 (49.4 – 58.9) 25.2 (22.3 – 29.5) 51.2 (46.4 – 58.8) 115 (99.1 – 138) 226
6–11 years 50.6 (45.4 – 56.4) 27.2 (25.0 – 29.8) 46.4 (41.9 – 55.9) 97.1 (90.0 – 123) 254
12–19 years 41.0 (38.1 – 44.1) 21.6 (19.8 – 22.7) 39.5 (37.1 – 43.2) 82.8 (73.6 – 90.9) 676
20–39 years 40.5 (36.8 – 44.5) 16.3 (13.2 – 18.1) 38.5 (35.3 – 43.5) 105 (94.0 – 142) 371
40–59 years 39.9 (33.5 – 47.5) 14.9 (13.2 – 17.4) 36.3 (31.1 – 41.7) 132 (82.8 – 204) 339
60 years and older 31.3 (26.8 – 36.6) 10.7 (8.73 – 12.6) 29.1 (24.5 – 35.7) 104 (79.0 – 152) 291
Males
Total, 1 year and older 44.3 (40.5 – 48.6) 19.0 (17.3 – 20.1) 43.7 (39.3 – 47.3) 104 (92.0 – 137) 1,071
1–5 years 55.4 (49.5 – 61.9) 24.6† (19.3 – 32.2) 53.6 (46.6 – 60.4) 120† (103 – 147) 109
6–11 years 53.5 (47.2 – 60.7) 29.6 (26.0 – 31.8) 52.5 (41.9 – 61.7) 100 (92.0 – 124) 133
12–19 years 44.6 (40.6 – 48.9) 22.9 (21.1 – 25.1) 44.5 (38.8 – 49.5) 89.2 (74.9 – 103) 348
20–39 years 47.5 (41.2 – 54.8) 19.7 (14.5 – 23.5) 45.2 (37.7 – 53.5) 130 (95.2 – 185) 170
40–59 years 41.2 (34.9 – 48.7) 16.0 (9.17 – 20.7) 40.7 (31.6 – 46.6) 102 (79.6 – 203) 157
60 years and older 33.0 (27.9 – 39.1) 12.4 (10.2 – 13.4) 27.9 (24.1 – 38.1) 103 (79.1 – 194) 154
Females
Total, 1 year and older 37.5 (34.2 – 41.1) 14.8 (13.4 – 16.1) 35.6 (32.3 – 39.2) 103 (85.9 – 128) 1,086
1–5 years 52.5 (46.3 – 59.4) 26.0 (11.1 – 30.5) 51.1 (42.8 – 59.8) 109 (88.7 – 149) 117
6–11 years 47.9 (42.4 – 54.2) 25.0 (22.9 – 29.8) 42.9 (38.0 – 52.0) 93.0 (84.6 – 128) 121
12–19 years 37.7 (35.2 – 40.3) 20.7 (18.7 – 21.6) 36.8 (33.7 – 39.1) 73.6 (68.9 – 85.6) 328
20–39 years 35.4 (32.2 – 38.9) 14.4 (9.31 – 16.8) 33.8 (28.4 – 37.9) 99.7 (80.0 – 141) 201
40–59 years 38.8 (30.8 – 48.9) 14.4 (13.0 – 16.1) 33.8 (26.5 – 41.0) 145 (81.3 – 261) 182
60 years and older 30.2 (24.5 – 37.2) 9.48 (8.20 – 11.2) 29.9 (22.4 – 37.0) 95.0 (74.2 – 157) 137
† Estimate is subject to greater uncertainty due to small cell size
Table 1.3.a.5. Serum pyridoxal-5’-phosphate: Non-Hispanic whites
Geometric mean and selected percentiles of serum concentrations (in nmol/L) for non-Hispanic whites in the 
U.S. population aged 1 year and older, National Health and Nutrition Examination Survey, 2005–2006.
Geometric mean 
(95% conf. interval)
Selected percentiles (95% conf. interval) Sample 
size10th 50th 90th
Males and Females
Total, 1 year and older 53.8 (50.8 – 57.0) 19.2 (17.7 – 20.7) 51.7 (49.5 – 54.6) 167 (156 – 181) 3,285
1–5 years 68.5 (63.0 – 74.4) 34.0 (30.5 – 37.3) 68.4 (63.3 – 77.5) 130 (114 – 157) 263
6–11 years 63.9 (58.7 – 69.5) 31.6 (29.2 – 34.2) 63.3 (54.9 – 72.7) 133 (117 – 170) 251
12–19 years 52.7 (48.7 – 57.1) 25.7 (23.8 – 27.2) 51.5 (47.4 – 56.8) 109 (96.0 – 127) 505
20–39 years 54.3 (48.9 – 60.3) 20.9 (17.7 – 22.7) 50.6 (44.9 – 55.8) 168 (133 – 211) 718
40–59 years 50.6 (45.6 – 56.1) 16.2 (13.7 – 19.0) 47.9 (42.7 – 52.8) 173 (153 – 199) 691
60 years and older 53.2 (49.0 – 57.9) 15.7 (13.3 – 18.2) 50.6 (44.0 – 57.5) 196 (177 – 215) 857
Males
Total, 1 year and older 58.8 (55.1 – 62.7) 22.8 (20.2 – 25.5) 57.4 (53.8 – 60.6) 166 (147 – 183) 1,636
1–5 years 68.7 (62.9 – 74.9) 34.9 (30.2 – 37.2) 70.8 (65.3 – 78.3) 126 (115 – 137) 146
6–11 years 63.9 (57.3 – 71.4) 31.6 (29.3 – 33.7) 64.7 (50.1 – 75.8) 135 (106 – 190) 121
12–19 years 60.3 (55.5 – 65.5) 29.5 (27.3 – 33.8) 59.7 (54.7 – 65.2) 117 (105 – 148) 255
20–39 years 65.9 (60.4 – 72.0) 27.9 (25.3 – 30.8) 58.4 (53.9 – 66.8) 183 (152 – 228) 310
40–59 years 54.7 (47.4 – 63.2) 19.1 (14.6 – 22.8) 53.1 (43.6 – 61.7) 173 (140 – 194) 356
60 years and older 52.0 (46.4 – 58.2) 16.7 (13.7 – 20.5) 50.4 (42.2 – 59.3) 174 (157 – 204) 448
Females
Total, 1 year and older 49.4 (45.8 – 53.2) 16.4 (14.4 – 18.7) 46.4 (42.5 – 50.4) 170 (161 – 182) 1,649
1–5 years 68.3 (59.0 – 79.0) 32.6 (26.5 – 40.3) 66.6 (59.0 – 79.5) 141 (105 – 183) 117
6–11 years 63.8 (56.8 – 71.8) 31.3 (23.7 – 35.9) 62.7 (51.7 – 74.6) 126 (108 – 175) 130
12–19 years 45.6 (41.0 – 50.8) 21.8 (19.7 – 23.9) 42.1 (39.0 – 47.8) 94.0 (80.0 – 126) 250
20–39 years 44.6 (39.3 – 50.7) 16.5 (14.4 – 18.8) 38.4 (34.5 – 45.7) 156 (112 – 216) 408
40–59 years 46.8 (42.2 – 52.0) 13.9 (12.6 – 16.4) 44.4 (35.8 – 48.3) 174 (155 – 221) 335
60 years and older 54.3 (48.6 – 60.6) 14.6 (12.5 – 17.0) 50.6 (41.6 – 62.5) 213 (184 – 254) 409
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Table 1.3.c. Serum pyridoxal-5’-phosphate: Prevalence
Prevalence (in percent) of low serum pyridoxal-5’-phosphate concentration (< 20 nmol/L) for the U.S. 







Total, 1 year and older 8,311 10.5 (9.1 – 12.0) 30,146,000
Age group
1–5 years 915 2.1‡ (1.1 – 4.2) 435,000‡
6–11 years 922 1.2‡ (0.5 – 2.7) 280,000‡
12–19 years 1,985 4.6 (3.6 – 5.7) 1,529,000
20–39 years 1,699 9.9 (7.7 – 12.6) 7,877,000
40–59 years 1,381 13.9 (11.2 – 17.1) 11,371,000
60 years and older 1,409 16.0 (13.1 – 19.5) 7,741,000
Gender
Males 4,055 7.3 (5.7 – 9.4) 10,305,000
Females 4,256 13.5 (11.7 – 15.5) 19,830,000
Race/ethnicity
Mexican Americans 2,212 7.5 (5.3 – 10.4) 2,031,000
Non-Hispanic Blacks 2,157 15.7 (13.6 – 18.0) 5,459,000
Non-Hispanic Whites 3,285 10.7 (9.1 – 12.5) 20,588,000
‡ Estimate flagged: 30% ≤ RSE < 40% for the prevalence estimate.
411. Water-Soluble Vitamins











































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Non−Hispanic Blacks Non−Hispanic Whites 
Figure 1.4.a. Serum 4−pyridoxic acid: Concentrations by age group 
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Table 1.4.a.2. Serum 4-pyridoxic acid: Total population
Geometric mean and selected percentiles of serum concentrations (in nmol/L) for the total U.S. population 
aged 1 year and older, National Health and Nutrition Examination Survey, 2005–2006. 
Geometric mean 
(95% conf. interval)
Selected percentiles (95% conf. interval) Sample 
size10th 50th 90th
Males and Females
Total, 1 year and older 31.9 (30.3 – 33.7) 11.7 (11.4 – 12.2) 25.5 (24.6 – 26.5) 116 (105 – 128) 8,312
1–5 years 25.9 (23.8 – 28.2) 12.5 (11.4 – 13.3) 24.2 (22.2 – 25.8) 59.8 (49.8 – 79.6) 917
6–11 years 23.5 (21.8 – 25.5) 11.2 (10.2 – 12.0) 21.6 (19.8 – 23.9) 56.7 (48.4 – 71.5) 922
12–19 years 20.9 (19.9 – 22.0) 10.2 (9.88 – 10.6) 19.0 (18.2 – 20.1) 48.1 (44.1 – 54.5) 1,985
20–39 years 26.8 (24.3 – 29.5) 10.7 (10.0 – 11.1) 22.2 (20.4 – 23.9) 90.9 (73.2 – 115) 1,698
40–59 years 34.7 (31.9 – 37.7) 12.6 (11.8 – 13.6) 27.3 (25.8 – 29.1) 117 (105 – 138) 1,381
60 years and older 58.6 (54.7 – 62.9) 16.4 (14.9 – 18.3) 47.6 (45.0 – 52.3) 248 (208 – 321) 1,409
Males
Total, 1 year and older 32.1 (30.0 – 34.2) 12.9 (12.1 – 13.6) 26.0 (24.9 – 27.4) 103 (92.2 – 118) 4,055
1–5 years 26.7 (23.7 – 30.0) 11.9 (10.5 – 14.1) 25.2 (22.8 – 27.0) 63.6 (48.5 – 111) 456
6–11 years 24.0 (22.1 – 26.1) 11.6 (9.92 – 12.4) 21.9 (20.2 – 24.1) 56.4 (46.0 – 83.0) 454
12–19 years 23.3 (21.9 – 24.7) 11.9 (10.9 – 12.6) 20.8 (19.7 – 21.9) 55.0 (46.8 – 67.0) 991
20–39 years 29.0 (26.1 – 32.2) 12.0 (10.9 – 13.2) 24.3 (22.5 – 26.0) 89.5 (65.9 – 124) 740
40–59 years 33.0 (29.3 – 37.2) 13.8 (11.8 – 15.2) 26.5 (24.4 – 30.2) 101 (76.3 – 124) 680
60 years and older 56.7 (50.7 – 63.5) 17.2 (15.1 – 18.9) 46.8 (41.8 – 53.3) 220 (178 – 292) 734
Females
Total, 1 year and older 31.8 (30.2 – 33.5) 11.1 (10.9 – 11.3) 24.7 (23.4 – 26.1) 133 (116 – 151) 4,257
1–5 years 25.1 (23.3 – 27.1) 12.6 (11.9 – 13.0) 22.7 (20.8 – 25.4) 59.2 (48.3 – 76.4) 461
6–11 years 23.0 (20.5 – 25.8) 10.7 (9.57 – 11.5) 20.8 (18.6 – 24.2) 54.9 (44.7 – 90.5) 468
12–19 years 18.7 (17.7 – 19.8) 9.59 (9.31 – 9.88) 17.1 (16.3 – 18.0) 42.9 (35.5 – 52.2) 994
20–39 years 24.8 (22.3 – 27.5) 9.74 (9.31 – 10.4) 19.2 (17.3 – 22.1) 92.5 (77.5 – 118) 958
40–59 years 36.4 (33.3 – 39.8) 12.1 (11.3 – 12.7) 28.1 (25.2 – 31.1) 145 (116 – 192) 701
60 years and older 60.2 (56.1 – 64.8) 15.6 (14.0 – 17.9) 48.7 (43.5 – 56.9) 257 (219 – 328) 675
Table 1.4.a.3. Serum 4-pyridoxic acid: Mexican Americans
Geometric mean and selected percentiles of serum concentrations (in nmol/L) for Mexican Americans in the 
U.S. population aged 1 year and older, National Health and Nutrition Examination Survey, 2005–2006. 
Geometric mean 
(95% conf. interval)
Selected percentiles (95% conf. interval) Sample 
size10th 50th 90th
Males and Females
Total, 1 year and older 22.5 (21.0 – 24.1) 10.7 (10.0 – 11.2) 19.0 (18.1 – 20.1) 57.9 (48.0 – 66.1) 2,213
1–5 years 22.7 (20.7 – 24.8) 11.9 (10.7 – 12.8) 20.3 (19.1 – 22.2) 52.3 (41.3 – 62.3) 324
6–11 years 19.6 (17.7 – 21.7) 9.67 (8.75 – 10.7) 18.5 (16.0 – 20.3) 44.2 (36.3 – 58.1) 321
12–19 years 17.1 (16.4 – 17.8) 9.29 (8.70 – 9.81) 15.8 (14.8 – 16.8) 34.6 (31.5 – 42.8) 657
20–39 years 21.6 (19.3 – 24.1) 10.7 (9.33 – 11.4) 18.3 (16.8 – 19.9) 53.3 (43.8 – 76.4) 452
40–59 years 27.9 (24.6 – 31.6) 11.7 (10.1 – 12.7) 22.4 (20.5 – 24.6) 71.1 (60.0 – 114) 249
60 years and older 33.8 (27.9 – 41.0) 12.5 (11.0 – 14.7) 27.3 (23.6 – 31.2) 117 (75.3 – 311) 210
Males
Total, 1 year and older 23.6 (21.9 – 25.6) 11.5 (10.8 – 12.0) 20.7 (19.4 – 21.7) 58.1 (45.6 – 68.9) 1,057
1–5 years 23.3 (20.4 – 26.5) 11.8 (10.7 – 13.7) 20.9 (18.9 – 22.9) 48.8 (38.0 – 78.1) 155
6–11 years 20.7 (18.2 – 23.6) 10.3 (8.64 – 11.4) 18.9 (16.5 – 20.9) 47.4 (39.5 – 59.3) 157
12–19 years 19.4 (18.2 – 20.6) 10.3 (9.71 – 10.8) 17.3 (16.8 – 18.4) 41.6 (34.1 – 59.2) 318
20–39 years 23.0 (20.1 – 26.2) 11.2 (9.36 – 12.7) 19.5 (17.6 – 22.2) 55.0 (42.2 – 85.5) 199
40–59 years 29.7 (24.2 – 36.4) 12.9 (12.5 – 13.9) 24.2 (21.2 – 28.4) 65.1 (45.1 – 230) 123
60 years and older 28.2 (22.0 – 36.1) 11.6† (5.00 – 14.6) 26.0 (19.9 – 33.3) 72.5† (50.8 – 193) 105
Females
Total, 1 year and older 21.4 (20.1 – 22.7) 9.91 (9.35 – 10.6) 17.3 (16.4 – 18.3) 57.0 (49.5 – 70.1) 1,156
1–5 years 22.0 (19.9 – 24.4) 11.9 (9.70 – 12.5) 20.2 (17.5 – 22.6) 52.3 (38.6 – 64.8) 169
6–11 years 18.5 (16.3 – 21.1) 9.60 (7.35 – 10.7) 17.3 (15.1 – 20.4) 41.2 (31.1 – 53.4) 164
12–19 years 15.0 (14.3 – 15.8) 8.55 (7.66 – 9.16) 14.1 (13.2 – 15.1) 28.2 (25.2 – 33.6) 339
20–39 years 20.0 (17.6 – 22.8) 9.73 (7.90 – 11.1) 16.3 (14.7 – 18.6) 49.5 (41.4 – 81.1) 253
40–59 years 26.1 (22.4 – 30.3) 10.9 (9.79 – 11.6) 19.1 (14.7 – 25.2) 90.5 (54.6 – 289) 126
60 years and older 39.2 (30.0 – 51.4) 13.9† (11.1 – 15.7) 28.0 (23.3 – 35.2) 162† (78.4 – 3,380) 105
† Estimate is subject to greater uncertainty due to small cell size.
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Table 1.4.a.4. Serum 4-pyridoxic acid: Non-Hispanic blacks
Geometric mean and selected percentiles of serum concentrations (in nmol/L) for non-Hispanic blacks in the 
U.S. population aged 1 year and older, National Health and Nutrition Examination Survey, 2005–2006.
Geometric mean 
(95% conf. interval)
Selected percentiles (95% conf. interval) Sample 
size10th 50th 90th
Males and Females
Total, 1 year and older 21.6 (19.4 – 24.0) 9.28 (8.85 – 9.59) 17.8 (16.3 – 19.3) 60.5 (51.3 – 81.9) 2,157
1–5 years 22.2 (19.2 – 25.8) 10.1 (8.17 – 11.2) 19.5 (17.6 – 22.5) 61.7 (44.0 – 96.8) 226
6–11 years 17.8 (16.0 – 19.8) 9.03 (8.25 – 9.53) 15.3 (14.3 – 17.4) 43.9 (32.5 – 67.1) 254
12–19 years 14.8 (14.0 – 15.7) 8.28 (7.64 – 8.65) 13.9 (13.1 – 14.6) 28.9 (25.7 – 34.0) 676
20–39 years 19.3 (18.1 – 20.7) 8.89 (8.39 – 9.47) 15.4 (14.2 – 17.6) 51.4 (45.3 – 60.6) 371
40–59 years 25.3 (21.3 – 30.0) 9.62 (8.24 – 10.8) 19.2 (17.6 – 21.2) 103 (57.1 – 164) 339
60 years and older 33.8 (26.3 – 43.4) 12.2 (9.71 – 14.1) 27.4 (23.1 – 30.6) 113 (81.9 – 246) 291
Males
Total, 1 year and older 21.8 (19.7 – 24.3) 9.68 (9.16 – 10.3) 18.5 (17.3 – 20.0) 55.7 (44.4 – 82.8) 1,070
1–5 years 24.5 (20.6 – 29.1) 10.3† (6.27 – 12.2) 20.9 (17.7 – 24.4) 83.7† (48.8 – 152) 108
6–11 years 18.4 (16.2 – 21.0) 9.50 (8.53 – 10.3) 15.9 (14.5 – 18.5) 44.1 (33.3 – 66.5) 133
12–19 years 16.2 (15.0 – 17.5) 9.11 (8.59 – 9.35) 15.5 (14.1 – 16.5) 30.9 (26.8 – 39.1) 348
20–39 years 19.7 (17.6 – 22.2) 9.68 (8.96 – 10.9) 17.4 (14.3 – 20.4) 44.3 (32.7 – 68.2) 170
40–59 years 25.1 (21.7 – 29.0) 9.58 (7.97 – 10.6) 19.3 (17.7 – 20.8) 71.2 (52.9 – 134) 157
60 years and older 33.2 (27.1 – 40.7) 12.5 (11.8 – 13.4) 24.3 (22.7 – 30.2) 109 (80.8 – 246) 154
Females
Total, 1 year and older 21.3 (18.7 – 24.3) 8.88 (8.38 – 9.44) 17.1 (15.0 – 19.1) 64.9 (52.5 – 94.0) 1,087
1–5 years 20.1 (16.7 – 24.2) 8.59 (7.62 – 11.1) 19.0 (16.1 – 22.5) 42.6 (34.5 – 65.2) 118
6–11 years 17.2 (15.1 – 19.7) 8.50 (7.72 – 9.43) 14.8 (13.1 – 17.4) 40.6 (31.1 – 86.4) 121
12–19 years 13.5 (12.6 – 14.4) 7.56 (6.46 – 8.33) 12.7 (11.8 – 13.4) 25.6 (22.0 – 32.8) 328
20–39 years 19.0 (16.9 – 21.5) 8.42 (7.62 – 8.98) 14.3 (12.7 – 16.9) 57.7 (45.3 – 85.7) 201
40–59 years 25.4 (19.2 – 33.7) 9.64 (7.95 – 11.0) 18.8 (15.5 – 25.8) 107 (53.1 – 217) 182
60 years and older 34.2 (24.3 – 48.1) 11.6 (8.02 – 15.3) 28.0 (21.9 – 33.8) 116 (75.1 – 431) 137
† Estimate is subject to greater uncertainty due to small cell size.
Table 1.4.a.5. Serum 4-pyridoxic acid: Non-Hispanic whites
Geometric mean and selected percentiles of serum concentrations (in nmol/L) for non-Hispanic whites in the 
U.S. population aged 1 year and older, National Health and Nutrition Examination Survey, 2005–2006.
Geometric mean 
(95% conf. interval)
Selected percentiles (95% conf. interval) Sample 
size10th 50th 90th
Males and Females
Total, 1 year and older 37.1 (35.1 – 39.1) 13.2 (12.6 – 13.8) 29.3 (27.8 – 30.6) 138 (120 – 154) 3,285
1–5 years 28.4 (25.2 – 31.8) 13.6 (11.9 – 15.1) 26.7 (24.2 – 29.2) 59.9 (49.8 – 104) 263
6–11 years 26.7 (24.1 – 29.5) 12.6 (11.8 – 13.3) 24.5 (22.4 – 26.0) 63.5 (50.7 – 96.3) 251
12–19 years 24.1 (22.4 – 26.0) 11.5 (10.6 – 12.8) 21.5 (21.0 – 22.2) 55.9 (47.7 – 74.7) 505
20–39 years 31.2 (27.5 – 35.4) 11.5 (10.7 – 12.6) 25.2 (22.6 – 28.1) 113 (89.1 – 155) 718
40–59 years 37.7 (34.1 – 41.6) 13.7 (12.5 – 14.8) 30.2 (27.9 – 32.2) 130 (111 – 148) 691
60 years and older 64.4 (58.5 – 70.9) 18.2 (15.3 – 20.2) 53.7 (48.7 – 57.9) 257 (220 – 328) 857
Males
Total, 1 year and older 36.8 (34.1 – 39.6) 14.9 (13.7 – 15.7) 29.5 (27.7 – 31.3) 116 (105 – 136) 1,636
1–5 years 29.0 (24.9 – 33.7) 14.0 (9.91 – 16.0) 27.2 (24.5 – 31.1) 59.8 (47.3 – 130) 146
6–11 years 26.4 (23.7 – 29.5) 12.5 (11.7 – 13.9) 24.9 (21.6 – 26.0) 66.7 (45.2 – 92.9) 121
12–19 years 27.1 (25.0 – 29.4) 14.2 (13.4 – 15.5) 23.5 (21.4 – 26.1) 64.0 (54.7 – 80.3) 255
20–39 years 33.6 (29.4 – 38.4) 14.4 (12.0 – 15.6) 26.9 (24.2 – 29.4) 105 (71.2 – 187) 310
40–59 years 35.5 (30.7 – 41.1) 14.9 (12.5 – 17.5) 29.3 (26.0 – 33.1) 102 (81.5 – 141) 356
60 years and older 62.6 (54.1 – 72.5) 18.8 (15.9 – 21.2) 52.3 (44.8 – 60.1) 232 (195 – 344) 448
Females
Total, 1 year and older 37.3 (35.4 – 39.4) 12.4 (11.6 – 12.7) 29.2 (26.8 – 31.4) 155 (136 – 176) 1,649
1–5 years 27.7 (24.5 – 31.3) 13.1 (11.1 – 15.1) 25.4 (20.8 – 29.9) 59.9 (49.8 – 99.2) 117
6–11 years 26.9 (22.4 – 32.3) 12.5 (10.7 – 13.7) 24.3 (20.7 – 29.2) 62.1 (47.7 – 189) 130
12–19 years 21.2 (19.2 – 23.5) 10.2 (9.58 – 11.0) 19.8 (18.0 – 21.1) 47.3 (40.3 – 69.4) 250
20–39 years 29.0 (25.5 – 33.0) 10.6 (9.87 – 11.0) 23.1 (19.3 – 26.9) 117 (90.2 – 161) 408
40–59 years 39.9 (35.9 – 44.5) 12.8 (12.1 – 13.6) 30.5 (26.6 – 34.8) 155 (128 – 223) 335
60 years and older 65.9 (60.1 – 72.4) 17.6 (14.1 – 20.4) 54.9 (47.4 – 63.8) 270 (242 – 343) 409
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Figure 1.5.a. Serum vitamin B12: Concentrations by age group
Geometric mean (95% condence interval), National Health and Nutrition Examination Survey, 2003–2006
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 Table 1.5.a.2. Serum vitamin B12: Total population
Geometric mean and selected percentiles of serum concentrations (in pg/mL) for the total U.S. population aged 
1 year and older, National Health and Nutrition Examination Survey, 2003–2006.
Geometric mean 
(95% conf. interval)
Selected percentiles (95% conf. interval) Sample 
size5th 50th 95th
Males and Females
Total, 1 year and older 500 (489 – 511) 236 (227 – 244) 495 (483 – 505) 1,090 (1,050 – 1,110) 16,316
1–5 years 804 (776 – 833) 397 (344 – 432) 814 (783 – 858) 1,520 (1,470 – 1,630) 1,678
6–11 years 728 (713 – 743) 396 (367 – 431) 724 (707 – 747) 1,280 (1,240 – 1,350) 1,747
12–19 years 510 (499 – 521) 271 (264 – 277) 509 (495 – 526) 938 (901 – 975) 4,013
20–39 years 454 (443 – 465) 231 (223 – 243) 451 (441 – 462) 884 (859 – 904) 3,214
40–59 years 466 (451 – 482) 226 (214 – 237) 460 (446 – 475) 1,020 (934 – 1,100) 2,629
60 years and older 482 (468 – 496) 210 (202 – 217) 481 (466 – 499) 1,070 (1,020 – 1,190) 3,035
Males
Total, 1 year and older 500 (490 – 509) 249 (238 – 259) 494 (484 – 505) 1,030 (994 – 1,060) 7,999
1–5 years 796 (761 – 832) 379 (302 – 423) 816 (775 – 862) 1,470 (1,430 – 1,520) 844
6–11 years 722 (701 – 744) 411 (363 – 439) 735 (713 – 761) 1,220 (1,140 – 1,270) 853
12–19 years 513 (500 – 526) 292 (272 – 309) 510 (494 – 534) 904 (866 – 951) 2,031
20–39 years 469 (456 – 483) 258 (242 – 270) 469 (454 – 485) 856 (820 – 893) 1,451
40–59 years 456 (440 – 472) 226 (212 – 246) 456 (442 – 469) 896 (825 – 985) 1,296
60 years and older 461 (447 – 475) 210 (193 – 223) 458 (442 – 480) 990 (937 – 1,100) 1,524
Females
Total, 1 year and older 500 (487 – 514) 227 (216 – 236) 495 (480 – 508) 1,140 (1,100 – 1,180) 8,317
1–5 years 813 (781 – 847) 401 (343 – 444) 810 (772 – 863) 1,560 (1,470 – 1,740) 834
6–11 years 734 (710 – 758) 393 (362 – 421) 714 (687 – 748) 1,360 (1,290 – 1,460) 894
12–19 years 506 (492 – 520) 254 (243 – 266) 507 (487 – 526) 973 (928 – 1,050) 1,982
20–39 years 439 (425 – 453) 217 (206 – 227) 431 (420 – 446) 909 (868 – 980) 1,763
40–59 years 476 (455 – 499) 223 (200 – 241) 467 (444 – 489) 1,090 (1,020 – 1,160) 1,333
60 years and older 499 (479 – 521) 210 (200 – 218) 504 (477 – 530) 1,140 (1,050 – 1,310) 1,511
Table 1.5.a.3. Serum vitamin B12: Mexican Americans
Geometric mean and selected percentiles of serum concentrations (in pg/mL) for Mexican Americans in the U.S. 
population aged 1 year and older, National Health and Nutrition Examination Survey, 2003–2006.
Geometric mean 
(95% conf. interval)
Selected percentiles (95% conf. interval) Sample 
size5th 50th 95th
Males and Females
Total, 1 year and older 549 (530 – 569) 260 (248 – 274) 527 (513 – 547) 1,170 (1,110 – 1,240) 4,205
1–5 years 833 (802 – 866) 450 (417 – 468) 842 (811 – 880) 1,480 (1,390 – 1,670) 540
6–11 years 730 (708 – 753) 409 (367 – 441) 729 (704 – 762) 1,210 (1,150 – 1,290) 587
12–19 years 508 (493 – 524) 270 (250 – 295) 505 (486 – 525) 909 (873 – 951) 1,280
20–39 years 483 (463 – 503) 249 (225 – 260) 467 (449 – 493) 955 (883 – 1,150) 778
40–59 years 535 (491 – 582) 248 (207 – 274) 483 (457 – 515) 1,310 (996 – 3,160) 468
60 years and older 496 (465 – 528) 220 (193 – 239) 458 (435 – 489) 1,240 (1,070 – 2,490) 552
Males
Total, 1 year and older 526 (510 – 543) 258 (251 – 267) 513 (492 – 533) 1,060 (1,010 – 1,110) 2,036
1–5 years 801 (766 – 838) 423 (364 – 467) 805 (776 – 844) 1,450 (1,330 – 1,630) 261
6–11 years 724 (696 – 752) 386 (345 – 462) 735 (705 – 771) 1,150 (1,080 – 1,250) 285
12–19 years 498 (478 – 519) 271 (239 – 305) 494 (476 – 516) 866 (810 – 920) 637
20–39 years 467 (443 – 492) 252 (217 – 264) 459 (431 – 494) 855 (794 – 978) 345
40–59 years 493 (460 – 529) 249 (191 – 263) 463 (446 – 494) 1,050 (915 – 2,230) 236
60 years and older 456 (412 – 505) 224 (195 – 237) 404 (376 – 448) 1,210 (929 – 5,710) 272
Females
Total, 1 year and older 574 (548 – 602) 263 (241 – 288) 550 (522 – 573) 1,290 (1,180 – 1,630) 2,169
1–5 years 869 (824 – 916) 456 (420 – 500) 887 (834 – 910) 1,590 (1,400 – 1,890) 279
6–11 years 738 (704 – 772) 413 (370 – 441) 716 (690 – 762) 1,280 (1,160 – 1,620) 302
12–19 years 519 (502 – 536) 269 (255 – 291) 518 (495 – 549) 951 (892 – 1,060) 643
20–39 years 501 (476 – 528) 248 (220 – 271) 476 (452 – 509) 1,190 (984 – 2,080) 433
40–59 years 582 (500 – 678) 243 (182 – 306) 520 (464 – 574) 1,950 (1,010 – 6,830) 232
60 years and older 531 (475 – 594) 210 (169 – 258) 494 (459 – 537) 1,370 (1,110 – 2,950) 280
491. Water-Soluble Vitamins
Table 1.5.a.4. Serum vitamin B12: Non-Hispanic blacks
Geometric mean and selected percentiles of serum concentrations (in pg/mL) for non-Hispanic blacks in the 
U.S. population aged 1 year and older, National Health and Nutrition Examination Survey, 2003–2006.
Geometric mean 
(95% conf. interval)
Selected percentiles (95% conf. interval) Sample 
size5th 50th 95th
Males and Females
Total, 1 year and older 565 (550 – 580) 266 (258 – 276) 556 (537 – 576) 1,240 (1,200 – 1,320) 4,285
1–5 years 885 (835 – 938) 431 (340 – 479) 899 (827 – 965) 1,770 (1,550 – 2,020) 476
6–11 years 827 (800 – 854) 448 (398 – 470) 817 (800 – 842) 1,560 (1,440 – 1,670) 553
12–19 years 570 (557 – 584) 284 (270 – 297) 571 (551 – 585) 1,110 (1,050 – 1,160) 1,415
20–39 years 499 (483 – 516) 259 (227 – 277) 497 (480 – 512) 941 (894 – 1,050) 706
40–59 years 524 (506 – 543) 264 (220 – 286) 515 (494 – 544) 1,120 (1,070 – 1,200) 622
60 years and older 530 (504 – 558) 225 (199 – 252) 531 (505 – 565) 1,240 (1,100 – 1,510) 513
Males
Total, 1 year and older 564 (549 – 580) 267 (257 – 282) 546 (533 – 571) 1,230 (1,140 – 1,320) 2,136
1–5 years 896 (821 – 977) 418 (293 – 494) 910 (822 – 1,010) 1,800 (1,570 – 2,150) 236
6–11 years 799 (762 – 837) 428 (350 – 466) 811 (743 – 840) 1,540 (1,370 – 1,780) 272
12–19 years 567 (550 – 585) 294 (268 – 322) 567 (541 – 585) 1,040 (993 – 1,140) 742
20–39 years 512 (488 – 536) 277 (256 – 290) 507 (482 – 527) 950 (872 – 1,160) 337
40–59 years 510 (482 – 539) 241 (204 – 269) 509 (488 – 541) 988 (863 – 1,250) 292
60 years and older 502 (472 – 533) 211 (142 – 241) 494 (459 – 521) 1,220 (998 – 1,770) 257
Females
Total, 1 year and older 565 (545 – 587) 265 (233 – 282) 563 (531 – 597) 1,250 (1,200 – 1,340) 2,149
1–5 years 874 (829 – 922) 431 (257 – 489) 880 (798 – 957) 1,650 (1,470 – 2,050) 240
6–11 years 856 (815 – 899) 468 (383 – 501) 834 (801 – 887) 1,570 (1,430 – 1,710) 281
12–19 years 574 (558 – 590) 272 (259 – 288) 576 (551 – 595) 1,160 (1,110 – 1,210) 673
20–39 years 489 (464 – 515) 231 (207 – 271) 487 (460 – 518) 938 (880 – 1,080) 369
40–59 years 536 (507 – 566) 273 (219 – 295) 527 (492 – 568) 1,170 (1,100 – 1,400) 330
60 years and older 551 (514 – 590) 232 (187 – 265) 576 (524 – 613) 1,280 (1,110 – 1,620) 256
Table 1.5.a.5. Serum vitamin B12: Non-Hispanic whites
Geometric mean and selected percentiles of serum concentrations (in pg/mL) for non-Hispanic whites in the 
U.S. population aged 1 year and older, National Health and Nutrition Examination Survey, 2003–2006.
Geometric mean 
(95% conf. interval)
Selected percentiles (95% conf. interval) Sample 
size5th 50th 95th
Males and Females
Total, 1 year and older 482 (470 – 495) 229 (222 – 239) 478 (465 – 491) 1,040 (999 – 1,080) 6,571
1–5 years 769 (730 – 810) 375 (298 – 411) 777 (730 – 830) 1,470 (1,410 – 1,560) 476
6–11 years 707 (686 – 729) 392 (345 – 435) 703 (674 – 734) 1,230 (1,170 – 1,350) 448
12–19 years 496 (484 – 509) 269 (253 – 276) 498 (481 – 517) 887 (833 – 952) 1,042
20–39 years 440 (426 – 455) 226 (215 – 238) 438 (424 – 452) 853 (814 – 889) 1,434
40–59 years 453 (435 – 471) 225 (208 – 236) 448 (434 – 465) 980 (867 – 1,090) 1,340
60 years and older 476 (461 – 492) 209 (200 – 217) 477 (460 – 499) 1,050 (990 – 1,170) 1,831
Males
Total, 1 year and older 487 (475 – 498) 244 (228 – 256) 483 (471 – 496) 981 (946 – 1,030) 3,235
1–5 years 764 (720 – 811) 353 (261 – 416) 799 (739 – 861) 1,380 (1,320 – 1,500) 254
6–11 years 708 (678 – 740) 405† (343 – 441) 715 (680 – 753) 1,160† (1,080 – 1,250) 216
12–19 years 507 (492 – 522) 293 (271 – 316) 505 (486 – 535) 847 (803 – 941) 523
20–39 years 468 (448 – 488) 263 (230 – 275) 469 (448 – 493) 826 (786 – 900) 631
40–59 years 447 (430 – 465) 226 (199 – 248) 448 (435 – 464) 879 (781 – 984) 682
60 years and older 454 (439 – 469) 208 (181 – 221) 455 (434 – 481) 952 (887 – 1,050) 929
Females
Total, 1 year and older 478 (462 – 494) 220 (210 – 230) 471 (454 – 488) 1,080 (1,040 – 1,140) 3,336
1–5 years 774 (721 – 831) 381† (325 – 431) 763 (700 – 835) 1,530† (1,450 – 1,760) 222
6–11 years 706 (671 – 743) 377 (316 – 421) 679 (648 – 742) 1,340 (1,180 – 1,490) 232
12–19 years 485 (470 – 501) 246 (226 – 259) 486 (468 – 508) 913 (842 – 1,030) 519
20–39 years 414 (398 – 431) 211 (197 – 223) 405 (387 – 427) 874 (797 – 936) 803
40–59 years 458 (432 – 485) 220 (199 – 236) 447 (419 – 483) 1,040 (900 – 1,180) 658
60 years and older 494 (471 – 519) 210 (199 – 217) 500 (470 – 523) 1,090 (1,030 – 1,320) 902
† Estimate is subject to greater uncertainty due to small cell size.
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Table 1.5.b. Serum vitamin B12: Concentrations by survey cycle
Geometric mean and selected percentiles of serum concentrations (in pg/mL) for the U.S. population, National 
Health and Nutrition Examination Survey, 1999–2006.
Geometric mean 
(95% conf. interval)
Selected percentiles (95% conf. interval) Sample 
size5th 50th 95th
Total, 3 years and older
 1999–2000 487 (481 – 494) 240 (234 – 245) 483 (474 – 494) 993 (970 – 1,040) 7,524
 2001–2002 488 (479 – 497) 236 (232 – 241) 485 (474 – 494) 1,000 (971 – 1,040) 8,390
 2003–2004 489 (472 – 507) 238 (225 – 252) 486 (467 – 500) 1,020 (979 – 1,080) 7,837
 2005–2006 502 (489 – 516) 231 (221 – 242) 497 (482 – 511) 1,100 (1,060 – 1,130) 7,694
Age group
3–5 years
 1999–2000 757 (682 – 839) 441 (321 – 459) 735 (663 – 827) 1,380 (1,300 – 1,730) 361
 2001–2002 804 (773 – 837) 471 (426 – 518) 815 (783 – 836) 1,380 (1,250 – 1,560) 439
 2003–2004 768 (716 – 824) 393 (285 – 422) 775 (716 – 852) 1,550 (1,310 – 1,800) 449
 2005–2006 877 (841 – 913) 482 (437 – 507) 894 (826 – 950) 1,470 (1,430 – 1,660) 444
6–11 years
 1999–2000 695 (659 – 733) 362 (330 – 401) 704 (676 – 738) 1,250 (1,170 – 1,340) 885
 2001–2002 691 (669 – 714) 386 (340 – 412) 696 (672 – 724) 1,270 (1,190 – 1,330) 1,022
 2003–2004 711 (689 – 733) 375 (344 – 419) 714 (679 – 736) 1,240 (1,190 – 1,360) 843
 2005–2006 745 (721 – 769) 418 (381 – 442) 741 (710 – 768) 1,290 (1,230 – 1,370) 904
12–19 years
 1999–2000 501 (491 – 511) 263 (235 – 280) 506 (494 – 518) 954 (905 – 1,010) 2,123
 2001–2002 511 (495 – 528) 269 (256 – 289) 516 (496 – 536) 934 (899 – 983) 2,208
 2003–2004 500 (483 – 518) 267 (255 – 282) 504 (481 – 528) 911 (871 – 949) 2,059
 2005–2006 519 (505 – 534) 273 (269 – 281) 519 (496 – 544) 966 (907 – 1,040) 1,954
20–39 years
 1999–2000 445 (438 – 451) 234 (219 – 240) 448 (432 – 459) 807 (791 – 824) 1,470
 2001–2002 445 (432 – 458) 230 (217 – 239) 445 (432 – 457) 822 (776 – 893) 1,715
 2003–2004 451 (434 – 468) 240 (225 – 253) 449 (431 – 465) 826 (787 – 888) 1,555
 2005–2006 457 (443 – 472) 227 (214 – 239) 452 (440 – 468) 913 (889 – 964) 1,659
40–59 years
 1999–2000 460 (447 – 474) 234 (208 – 256) 447 (432 – 466) 909 (861 – 952) 1,198
 2001–2002 460 (450 – 471) 232 (221 – 238) 456 (443 – 465) 942 (879 – 1,020) 1,478
 2003–2004 460 (435 – 486) 226 (215 – 243) 456 (438 – 479) 957 (833 – 1,110) 1,276
 2005–2006 472 (452 – 493) 223 (195 – 244) 464 (444 – 485) 1,060 (984 – 1,130) 1,353
60 years and older
 1999–2000 482 (467 – 496) 228 (212 – 243) 470 (460 – 483) 1,030 (950 – 1,130) 1,487
 2001–2002 473 (455 – 491) 220 (204 – 231) 479 (465 – 493) 1,000 (962 – 1,030) 1,528
 2003–2004 477 (459 – 496) 208 (198 – 221) 477 (454 – 494) 1,060 (967 – 1,310) 1,655
 2005–2006 487 (466 – 508) 211 (197 – 219) 495 (464 – 511) 1,070 (1,030 – 1,220) 1,380
Gender
Males
 1999–2000 487 (479 – 495) 255 (235 – 264) 488 (478 – 498) 956 (901 – 1,020) 3,682
 2001–2002 490 (476 – 505) 247 (235 – 257) 485 (468 – 497) 963 (919 – 1,010) 4,059
 2003–2004 490 (476 – 505) 250 (229 – 266) 486 (469 – 499) 971 (944 – 1,020) 3,871
 2005–2006 500 (487 – 514) 247 (226 – 259) 497 (482 – 512) 1,040 (987 – 1,110) 3,740
Females
 1999–2000 488 (481 – 495) 233 (222 – 241) 478 (465 – 495) 1,030 (981 – 1,090) 3,842
 2001–2002 486 (476 – 496) 230 (219 – 237) 485 (474 – 495) 1,040 (998 – 1,090) 4,331
 2003–2004 488 (467 – 509) 228 (212 – 245) 486 (463 – 504) 1,080 (1,010 – 1,160) 3,966
 2005–2006 504 (486 – 523) 224 (208 – 236) 497 (476 – 516) 1,150 (1,110 – 1,190) 3,954
Race/ethnicity
Mexican Americans
 1999–2000 551 (523 – 581) 268 (259 – 281) 527 (509 – 542) 1,200 (1,140 – 1,310) 2,571
 2001–2002 516 (491 – 543) 249 (227 – 271) 496 (468 – 535) 1,050 (1,010 – 1,120) 2,124
 2003–2004 543 (513 – 575) 285 (264 – 304) 520 (504 – 538) 1,080 (994 – 1,210) 1,919
 2005–2006 536 (512 – 561) 245 (223 – 257) 515 (487 – 554) 1,180 (1,110 – 1,280) 2,009
Non-Hispanic Blacks
 1999–2000 582 (565 – 599) 286 (261 – 304) 583 (569 – 603) 1,220 (1,150 – 1,270) 1,712
 2001–2002 556 (542 – 570) 269 (250 – 282) 554 (544 – 568) 1,160 (1,100 – 1,220) 2,000
 2003–2004 561 (538 – 585) 281 (262 – 294) 553 (523 – 584) 1,150 (1,090 – 1,310) 2,058
 2005–2006 559 (540 – 579) 256 (231 – 270) 546 (528 – 575) 1,250 (1,200 – 1,340) 2,032
Non-Hispanic Whites
 1999–2000 468 (460 – 476) 235 (231 – 240) 467 (454 – 478) 916 (890 – 951) 2,556
 2001–2002 474 (462 – 485) 233 (227 – 237) 473 (460 – 486) 959 (899 – 1,020) 3,594
 2003–2004 470 (452 – 489) 228 (216 – 244) 469 (449 – 488) 966 (920 – 1,050) 3,272







































































































































































Figure 1.5.b. Serum vitamin B12: Concentrations by survey cycle
Selected percentiles in pg/mL (95% conence intervals), National Health and 
Nutrition Examination Survey, 1999–2006
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Table 1.5.c. Serum vitamin B12: Prevalence
Prevalence (in percent) of low serum vitamin B12 concentration (< 200 pg/mL) for the U.S. population 





Estimated total  
number of persons
Total, 1 year and older 16,316 2.0 (1.6 – 2.4) 5,563,000
Age group
1–5 years 1,678 § §
6–11 years 1,747 § §
12–19 years 4,013 0.6 (0.4 – 1.0) 210,000
20–39 years 3,214 1.5 (1.2 – 2.0) 1,211,000
40–59 years 2,629 2.6 (1.8 – 3.7) 2,057,000
60 years and older 3,035 3.9 (3.1 – 4.9) 1,815,000
Gender
Males 7,999 1.6 (1.3 – 2.0) 2,165,000
Females 8,317 2.3 (1.9 – 2.9) 3,402,000
Race/ethnicity
Mexican Americans 4,205 1.0 (0.7 – 1.5) 265,000
Non-Hispanic Blacks 4,285 1.2 (0.8 – 1.8) 398,000
Non-Hispanic Whites 6,571 2.2 (1.8 – 2.7) 4,289,000
§ Estimate suppressed: RSE ≥ 40% for the prevalence estimate.
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Table 1.5.d. Serum vitamin B12: Prevalence by survey cycle
Prevalence (in percent) of low serum vitamin B12 concentration (< 200 pg/mL) for the U.S. population, 
National Health and Nutrition Examination Survey, 1999–2006. 
Sample size Prevalence (95% conf. interval) Estimated total number of persons
Total, 3 years and older
 1999–2000 7,524 1.9 (1.5 – 2.3) 4,933,000
 2001–2002 8,390 1.8 (1.5 – 2.2) 4,762,000
 2003–2004 7,837 1.6 (1.2 – 2.2) 4,506,000
 2005–2006 7,694 2.4 (1.9 – 3.0) 6,642,000
Age group
3–5 years
 1999–2000 361 § §
 2001–2002 439 § §
 2003–2004 449 § §
 2005–2006 444 § §
6–11 years
 1999–2000 885 § §
 2001–2002 1,022 § §
 2003–2004 843 § §
 2005–2006 904 § §
12–19 years
 1999–2000 2,123 0.8‡ (0.4 – 1.7) 251,000‡
 2001–2002 2,208 0.9 (0.5 – 1.6) 276,000
 2003–2004 2,059 0.6‡ (0.3 – 1.3) 214,000‡
 2005–2006 1,954 0.6‡ (0.3 – 1.2) 209,000‡
20–39 years
 1999–2000 1,470 2.2 (1.4 – 3.3) 1,683,000
 2001–2002 1,715 1.8 (1.2 – 2.8) 1,436,000
 2003–2004 1,555 1.0‡ (0.5 – 2.0) 805,000‡
 2005–2006 1,659 2.0 (1.6 – 2.7) 1,636,000
40–59 years
 1999–2000 1,198 2.4 (1.5 – 4.0) 1,708,000
 2001–2002 1,478 1.8 (1.1 – 3.1) 1,399,000
 2003–2004 1,276 1.9 (1.3 – 2.9) 1,508,000
 2005–2006 1,353 3.3 (1.9 – 5.5) 2,695,000
60 years and older
 1999–2000 1,487 2.7 (1.9 – 3.8) 1,159,000
 2001–2002 1,528 3.6 (2.7 – 4.6) 1,590,000
 2003–2004 1,655 3.9 (2.9 – 5.3) 1,806,000
 2005–2006 1,380 3.9 (2.8 – 5.5) 1,895,000
Gender
Males
 1999–2000 3,682 1.7 (1.2 – 2.4) 2,113,000
 2001–2002 4,059 1.3 (1.0 – 1.8) 1,699,000
 2003–2004 3,871 1.3 (0.9 – 1.9) 1,727,000
 2005–2006 3,740 1.9 (1.4 – 2.5) 2,615,000
Females
 1999–2000 3,842 2.1 (1.7 – 2.6) 2,824,000
 2001–2002 4,331 2.2 (1.7 – 3.0) 3,063,000
 2003–2004 3,966 2.0 (1.4 – 2.8) 2,787,000
 2005–2006 3,954 2.8 (2.0 – 3.9) 4,024,000
Race/ethnicity
Mexican Americans
 1999–2000 2,571 0.8‡ (0.4 – 1.5) 154,000‡
 2001–2002 2,124 1.8 (1.0 – 3.3) 419,000
 2003–2004 1,919 0.7‡ (0.3 – 1.4) 166,000‡
 2005–2006 2,009 1.5 (0.8 – 2.5) 376,000
Non-Hispanic Blacks
 1999–2000 1,712 § §
 2001–2002 2,000 § §
 2003–2004 2,058 0.7‡ (0.3 – 1.6) 239,000‡
 2005–2006 2,032 1.6 (1.0 – 2.6) 551,000
Non-Hispanic Whites
 1999–2000 2,556 2.1 (1.6 – 2.7) 3,858,000
 2001–2002 3,594 2.0 (1.6 – 2.5) 3,733,000
 2003–2004 3,272 1.9 (1.3 – 2.7) 3,572,000
 2005–2006 3,062 2.6 (2.0 – 3.5) 4,978,000
‡ Estimate flagged: 30% ≤ RSE < 40% for the prevalence estimate. 
§ Estimate suppressed: RSE ≥ 40% for the prevalence estimate.









































































































































































































































































































































































































































































































































































































































































































































































































































Non−Hispanic Blacks Non−Hispanic Whites 
Figure 1.6.a. Plasma total homocysteine: Concentrations by age group 
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Table 1.6.a.2. Plasma total homocysteine: Total population
Geometric mean and selected percentiles of plasma concentrations (in µmol/L) for the total U.S. population 
aged 20 years and older, National Health and Nutrition Examination Survey, 2003–2006.
Geometric mean 
(95% conf. interval)
Selected percentiles (95% conf. interval) Sample 
size5th 50th 95th
Males and Females
Total, 20 years and older 8.21 (8.06 – 8.37) 5.00 (4.85 – 5.12) 8.04 (7.91 – 8.17) 14.3 (13.9 – 15.0) 8,999
20–39 years 7.14 (7.04 – 7.24) 4.44 (4.30 – 4.52) 7.09 (6.99 – 7.22) 11.2 (10.9 – 11.6) 3,267
40–59 years 8.33 (8.17 – 8.50) 5.25 (5.15 – 5.36) 8.13 (8.02 – 8.29) 13.9 (13.3 – 14.5) 2,651
60 years and older 10.1 (9.85 – 10.4) 6.37 (6.07 – 6.50) 9.79 (9.57 – 10.1) 17.9 (17.1 – 18.9) 3,081
Males
Total, 20 years and older 9.00 (8.83 – 9.18) 5.96 (5.86 – 6.08) 8.68 (8.56 – 8.84) 14.8 (14.2 – 15.6) 4,329
20–39 years 8.05 (7.90 – 8.20) 5.65 (5.47 – 5.76) 7.94 (7.80 – 8.05) 11.9 (11.5 – 12.5) 1,473
40–59 years 9.21 (8.96 – 9.47) 6.28 (6.15 – 6.43) 8.86 (8.61 – 9.08) 14.3 (13.6 – 15.9) 1,306
60 years and older 10.6 (10.3 – 10.9) 6.89 (6.52 – 7.10) 10.4 (10.0 – 10.8) 18.0 (16.9 – 19.0) 1,550
Females
Total, 20 years and older 7.55 (7.36 – 7.74) 4.52 (4.40 – 4.69) 7.30 (7.13 – 7.47) 13.8 (13.1 – 14.8) 4,670
20–39 years 6.33 (6.21 – 6.46) 3.96 (3.79 – 4.11) 6.31 (6.17 – 6.46) 9.87 (9.47 – 10.5) 1,794
40–59 years 7.58 (7.38 – 7.78) 4.90 (4.67 – 5.07) 7.30 (7.11 – 7.53) 13.0 (12.1 – 15.1) 1,345
60 years and older 9.72 (9.40 – 10.1) 6.02 (5.75 – 6.27) 9.43 (9.05 – 9.69) 17.8 (16.7 – 19.2) 1,531
Table 1.6.a.3. Plasma total homocysteine: Mexican Americans
Geometric mean and selected percentiles of plasma concentrations (in µmol/L) for Mexican Americans in the 
U.S. population aged 20 years and older, National Health and Nutrition Examination Survey, 2003–2006.
Geometric mean 
(95% conf. interval)
Selected percentiles (95% conf. interval) Sample 
size5th 50th 95th
Males and Females
Total, 20 years and older 7.09 (6.95 – 7.23) 4.35 (4.20 – 4.50) 7.02 (6.87 – 7.18) 11.7 (11.2 – 12.2) 1,814
20–39 years 6.61 (6.48 – 6.74) 4.05 (3.88 – 4.31) 6.61 (6.47 – 6.73) 10.6 (9.97 – 11.1) 789
40–59 years 7.36 (7.21 – 7.52) 4.77 (4.38 – 4.92) 7.33 (7.20 – 7.47) 10.9 (10.5 – 12.3) 470
60 years and older 9.55 (9.14 – 9.98) 6.07 (5.48 – 6.41) 9.32 (8.82 – 9.88) 16.0 (15.2 – 18.0) 555
Males
Total, 20 years and older 7.85 (7.70 – 8.01) 5.50 (5.33 – 5.69) 7.74 (7.56 – 7.90) 12.2 (11.6 – 12.6) 866
20–39 years 7.47 (7.30 – 7.64) 5.38 (5.05 – 5.59) 7.38 (7.15 – 7.68) 11.3 (10.9 – 11.9) 353
40–59 years 8.03 (7.80 – 8.26) 5.71 (4.81 – 6.08) 7.91 (7.67 – 8.25) 11.8 (10.7 – 13.4) 239
60 years and older 10.3 (9.78 – 10.8) 6.79 (5.75 – 7.27) 10.0 (9.44 – 10.5) 16.0 (15.1 – 18.4) 274
Females
Total, 20 years and older 6.34 (6.17 – 6.51) 3.91 (3.76 – 4.02) 6.28 (6.10 – 6.50) 10.6 (10.1 – 11.5) 948
20–39 years 5.73 (5.57 – 5.91) 3.67 (3.41 – 3.82) 5.77 (5.57 – 5.99) 8.52 (8.11 – 9.49) 436
40–59 years 6.71 (6.49 – 6.94) 4.39 (3.91 – 4.78) 6.68 (6.36 – 6.86) 10.1 (9.32 – 12.2) 231
60 years and older 8.98 (8.49 – 9.49) 5.67 (4.83 – 6.08) 8.50 (8.07 – 9.07) 15.9 (14.2 – 19.8) 281
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Table 1.6.a.4. Plasma total homocysteine: Non-Hispanic blacks
Geometric mean and selected percentiles of plasma concentrations (in µmol/L) for non-Hispanic blacks in the 
U.S. population aged 20 years and older, National Health and Nutrition Examination Survey, 2003–2006.
Geometric mean 
(95% conf. interval)
Selected percentiles (95% conf. interval) Sample 
size5th 50th 95th
Males and Females
Total, 20 years and older 8.22 (8.03 – 8.42) 4.89 (4.61 – 5.05) 8.00 (7.82 – 8.22) 14.8 (14.4 – 15.7) 1,871
20–39 years 7.14 (6.95 – 7.34) 4.46 (4.20 – 4.61) 7.14 (6.98 – 7.36) 11.2 (10.8 – 11.8) 720
40–59 years 8.55 (8.31 – 8.79) 5.28 (5.10 – 5.39) 8.42 (8.14 – 8.70) 14.7 (13.9 – 17.1) 626
60 years and older 10.7 (10.4 – 11.0) 6.45 (6.00 – 6.95) 10.3 (10.1 – 10.7) 20.7 (18.8 – 23.6) 525
Males
Total, 20 years and older 9.09 (8.91 – 9.27) 5.93 (5.73 – 6.16) 8.78 (8.58 – 8.96) 15.3 (14.5 – 16.4) 896
20–39 years 8.19 (7.95 – 8.44) 5.72 (5.42 – 5.88) 8.04 (7.80 – 8.25) 12.1 (11.6 – 13.1) 340
40–59 years 9.40 (9.12 – 9.70) 6.17 (5.70 – 6.41) 9.11 (8.82 – 9.41) 15.3 (14.2 – 18.2) 292
60 years and older 11.1 (10.7 – 11.6) 6.76 (6.39 – 7.30) 10.9 (10.3 – 11.3) 21.1 (17.5 – 24.9) 264
Females
Total, 20 years and older 7.59 (7.34 – 7.85) 4.52 (4.23 – 4.74) 7.23 (7.07 – 7.53) 14.7 (13.5 – 15.9) 975
20–39 years 6.38 (6.19 – 6.58) 4.19 (3.80 – 4.38) 6.43 (6.25 – 6.72) 9.79 (9.22 – 10.6) 380
40–59 years 7.90 (7.56 – 8.25) 4.98 (4.46 – 5.23) 7.73 (7.22 – 8.08) 13.7 (11.9 – 16.1) 334
60 years and older 10.4 (9.98 – 10.9) 6.15 (5.74 – 6.83) 9.93 (9.50 – 10.5) 20.7 (18.7 – 24.7) 261
Table 1.6.a.5. Plasma total homocysteine: Non-Hispanic whites
Geometric mean and selected percentiles of plasma concentrations (in µmol/L) for non-Hispanic whites in the 
U.S. population aged 20 years and older, National Health and Nutrition Examination Survey, 2003–2006.
Geometric mean 
(95% conf. interval)
Selected percentiles (95% conf. interval) Sample 
size5th 50th 95th
Males and Females
Total, 20 years and older 8.39 (8.22 – 8.57) 5.18 (5.03 – 5.34) 8.21 (8.07 – 8.37) 14.5 (14.0 – 15.2) 4,670
20–39 years 7.26 (7.13 – 7.40) 4.51 (4.33 – 4.79) 7.26 (7.07 – 7.39) 11.2 (10.9 – 11.9) 1,458
40–59 years 8.40 (8.21 – 8.60) 5.36 (5.19 – 5.51) 8.24 (8.09 – 8.44) 13.6 (13.1 – 14.9) 1,353
60 years and older 10.1 (9.82 – 10.4) 6.38 (6.09 – 6.59) 9.82 (9.57 – 10.1) 17.6 (16.7 – 18.4) 1,859
Males
Total, 20 years and older 9.15 (8.94 – 9.36) 6.13 (5.95 – 6.24) 8.80 (8.61 – 8.99) 14.9 (14.2 – 16.0) 2,274
20–39 years 8.11 (7.91 – 8.32) 5.69 (5.47 – 5.85) 8.00 (7.85 – 8.14) 11.8 (11.2 – 12.7) 641
40–59 years 9.28 (8.98 – 9.59) 6.35 (6.21 – 6.55) 8.89 (8.61 – 9.16) 14.2 (13.4 – 16.0) 687
60 years and older 10.6 (10.3 – 10.9) 6.95 (6.65 – 7.15) 10.4 (10.0 – 10.8) 17.8 (16.6 – 19.0) 946
Females
Total, 20 years and older 7.75 (7.54 – 7.96) 4.72 (4.49 – 4.93) 7.53 (7.34 – 7.70) 14.0 (13.3 – 15.2) 2,396
20–39 years 6.50 (6.35 – 6.65) 3.98 (3.77 – 4.13) 6.46 (6.29 – 6.59) 10.2 (9.55 – 11.0) 817
40–59 years 7.63 (7.40 – 7.87) 4.99 (4.70 – 5.18) 7.38 (7.16 – 7.62) 13.0 (11.8 – 15.8) 666
60 years and older 9.69 (9.34 – 10.0) 6.03 (5.71 – 6.28) 9.48 (9.05 – 9.73) 17.1 (16.3 – 18.7) 913
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Table 1.6.b. Plasma total homocysteine: Concentrations by survey cycle
Geometric mean and selected percentiles of plasma concentrations (in µmol/L) for the U.S. population, National 
Health and Nutrition Examination Survey, 1999–2006. 
Geometric mean 
(95% conf. interval)
Selected percentiles (95% conf. interval) Sample 
size5th 50th 95th
Total, 20 years and older
 1999–2000 8.07 (7.95 – 8.18) 4.82 (4.65 – 5.02) 7.94 (7.82 – 8.04) 14.3 (13.5 – 15.0) 4,192
 2001–2002 8.21 (8.04 – 8.38) 5.01 (4.86 – 5.15) 8.01 (7.84 – 8.17) 14.4 (13.9 – 15.1) 4,759
 2003–2004 8.56 (8.32 – 8.81) 5.31 (5.15 – 5.40) 8.33 (8.14 – 8.55) 14.9 (14.2 – 15.9) 4,509
 2005–2006 7.88 (7.73 – 8.04) 4.78 (4.60 – 4.94) 7.76 (7.60 – 7.90) 13.7 (13.1 – 14.5) 4,490
Age group
3–5 years
 1999–2000 4.21 (4.05 – 4.39) 2.81 (2.56 – 2.98) 4.19 (4.02 – 4.42) 6.31 (5.75 – 7.70) 376
 2001–2002 4.31 (4.16 – 4.46) 2.95 (2.65 – 3.21) 4.28 (4.20 – 4.44) 6.15 (5.89 – 6.50) 454
 2003–2004 4.36 (4.18 – 4.55) 3.10 (2.87 – 3.19) 4.42 (4.14 – 4.65) 6.28 (5.72 – 6.66) 454
6–11 years
 1999–2000 4.35 (4.18 – 4.54) 2.91 (2.55 – 3.09) 4.36 (4.20 – 4.50) 6.49 (6.21 – 6.78) 899
 2001–2002 4.67 (4.58 – 4.77) 3.27 (3.04 – 3.44) 4.61 (4.53 – 4.73) 6.94 (6.60 – 7.21) 1,034
 2003–2004 4.65 (4.53 – 4.78) 3.22 (2.99 – 3.37) 4.68 (4.51 – 4.82) 6.62 (6.44 – 6.77) 852
12–19 years
 1999–2000 5.87 (5.70 – 6.05) 3.65 (3.37 – 3.81) 5.83 (5.70 – 6.01) 9.58 (9.23 – 10.6) 2,132
 2001–2002 6.03 (5.88 – 6.19) 3.96 (3.64 – 4.14) 5.90 (5.73 – 6.11) 9.48 (9.30 – 10.1) 2,225
 2003–2004 6.30 (6.14 – 6.47) 4.26 (4.08 – 4.36) 6.21 (6.02 – 6.43) 10.0 (9.43 – 10.7) 2,073
20–39 years
 1999–2000 7.19 (7.04 – 7.35) 4.23 (4.06 – 4.42) 7.26 (7.03 – 7.43) 11.9 (11.3 – 12.5) 1,474
 2001–2002 7.27 (7.12 – 7.42) 4.42 (4.21 – 4.67) 7.16 (7.08 – 7.25) 12.0 (11.6 – 12.8) 1,720
 2003–2004 7.47 (7.33 – 7.62) 4.71 (4.47 – 4.99) 7.42 (7.30 – 7.58) 11.3 (11.0 – 12.0) 1,561
 2005–2006 6.81 (6.67 – 6.95) 4.21 (3.99 – 4.42) 6.72 (6.61 – 6.84) 11.0 (10.4 – 11.5) 1,706
40–59 years
 1999–2000 8.27 (8.07 – 8.48) 5.18 (5.05 – 5.27) 8.08 (7.94 – 8.26) 13.5 (12.4 – 15.6) 1,209
 2001–2002 8.30 (8.17 – 8.43) 5.35 (5.16 – 5.48) 8.17 (8.02 – 8.31) 13.4 (12.7 – 14.1) 1,494
 2003–2004 8.67 (8.42 – 8.93) 5.60 (5.33 – 5.74) 8.44 (8.20 – 8.61) 14.4 (13.6 – 16.2) 1,280
 2005–2006 8.01 (7.84 – 8.18) 5.13 (4.82 – 5.25) 7.90 (7.70 – 8.07) 12.8 (12.5 – 14.1) 1,371
60 years and older
 1999–2000 9.78 (9.53 – 10.0) 6.10 (6.03 – 6.17) 9.45 (9.23 – 9.75) 17.6 (16.9 – 18.7) 1,509
 2001–2002 10.2 (9.76 – 10.6) 6.36 (6.12 – 6.64) 9.79 (9.33 – 10.2) 18.6 (17.7 – 19.6) 1,545
 2003–2004 10.6 (10.2 – 10.9) 6.62 (6.33 – 6.99) 10.3 (9.93 – 10.6) 19.0 (17.6 – 20.2) 1,668
 2005–2006 9.69 (9.36 – 10.0) 6.01 (5.75 – 6.29) 9.40 (9.05 – 9.75) 17.5 (16.2 – 18.5) 1,413
Gender
(20 years and older)
Males
 1999–2000 8.90 (8.69 – 9.11) 5.77 (5.57 – 5.92) 8.65 (8.42 – 8.92) 15.0 (14.2 – 16.6) 1,959
 2001–2002 9.06 (8.89 – 9.23) 6.08 (5.86 – 6.24) 8.74 (8.53 – 8.96) 14.9 (14.3 – 15.8) 2,255
 2003–2004 9.35 (9.06 – 9.65) 6.28 (6.09 – 6.42) 8.92 (8.67 – 9.17) 15.3 (14.5 – 16.7) 2,177
 2005–2006 8.67 (8.49 – 8.84) 5.82 (5.70 – 5.92) 8.42 (8.25 – 8.59) 14.2 (13.2 – 15.2) 2,152
Females
 1999–2000 7.37 (7.23 – 7.52) 4.31 (4.07 – 4.53) 7.30 (7.14 – 7.42) 13.1 (12.7 – 14.3) 2,233
 2001–2002 7.50 (7.32 – 7.68) 4.53 (4.32 – 4.73) 7.23 (7.06 – 7.36) 13.6 (12.9 – 14.8) 2,504
 2003–2004 7.89 (7.61 – 8.18) 4.86 (4.51 – 5.03) 7.60 (7.39 – 7.87) 14.3 (13.4 – 15.8) 2,332
 2005–2006 7.22 (7.00 – 7.45) 4.40 (4.19 – 4.51) 6.98 (6.80 – 7.15) 13.1 (12.1 – 14.9) 2,338
Race/ethnicity
(20 years and older)
Mexican Americans
 1999–2000 7.28 (7.06 – 7.50) 4.22 (3.96 – 4.58) 7.08 (6.88 – 7.36) 12.5 (11.8 – 13.9) 1,146
 2001–2002 7.18 (6.85 – 7.53) 4.27 (4.00 – 4.47) 7.10 (6.80 – 7.34) 12.4 (11.8 – 13.7) 1,009
 2003–2004 7.30 (7.11 – 7.49) 4.49 (4.25 – 4.57) 7.31 (7.17 – 7.42) 11.9 (11.3 – 12.7) 904
 2005–2006 6.90 (6.74 – 7.05) 4.31 (3.99 – 4.44) 6.75 (6.62 – 6.94) 11.2 (10.8 – 12.2) 910
Non-Hispanic Blacks
 1999–2000 8.14 (7.87 – 8.41) 4.71 (4.25 – 4.87) 7.91 (7.51 – 8.34) 15.3 (14.7 – 16.6) 773
 2001–2002 8.29 (8.03 – 8.55) 4.64 (4.40 – 5.08) 7.93 (7.72 – 8.17) 15.4 (14.4 – 17.9) 872
 2003–2004 8.53 (8.24 – 8.83) 5.04 (4.84 – 5.24) 8.29 (7.99 – 8.59) 14.9 (14.4 – 16.6) 869
 2005–2006 7.94 (7.72 – 8.17) 4.73 (4.50 – 4.90) 7.74 (7.50 – 7.95) 14.7 (14.0 – 15.5) 1,002
Non-Hispanic Whites
 1999–2000 8.19 (8.07 – 8.30) 5.09 (4.82 – 5.19) 8.03 (7.93 – 8.22) 14.3 (13.5 – 14.8) 1,874
 2001–2002 8.37 (8.21 – 8.54) 5.18 (5.04 – 5.26) 8.14 (7.98 – 8.28) 14.6 (14.0 – 15.7) 2,514
 2003–2004 8.74 (8.50 – 8.99) 5.46 (5.37 – 5.57) 8.53 (8.29 – 8.72) 15.1 (14.2 – 16.1) 2,406













































































































































































Figure 1.6.b. Plasma total homocysteine: Concentrations by survey cycle
Selected percentiles in µmol/L (95% con dence intervals), National Health and 
Nutrition Examination Survey, 1999–2006
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Table 1.6.c. Plasma total homocysteine: Prevalence
Prevalence (in percent) of high Plasma total homocysteine concentration (> 13 µmol/L) for the U.S. 





Estimated total  
number of persons
Total, 20 years and older 8,999 7.7 (6.8 – 8.8) 15,825,000
Age group
20–39 years 3,267 1.9 (1.4 – 2.4) 1,482,000
40–59 years 2,651 7.0 (5.6 – 8.7) 5,553,000
60 years and older 3,081 18.5 (16.3 – 21.0) 8,620,000
Gender
Males 4,329 9.2 (7.9 – 10.6) 9,021,000
Females 4,670 6.4 (5.2 – 7.7) 6,796,000
Race/ethnicity
Mexican Americans 1,814 2.1 (1.5 – 2.9) 336,000
Non-Hispanic Blacks 1,871 8.9 (7.7 – 10.2) 2,005,000





Table 1.6.d. Plasma total homocysteine: Prevalence by survey cycle
Prevalence (in percent) of high Plasma total homocysteine concentration (> 13 µmol/L) for the U.S. population, 
National Health and Nutrition Examination Survey, 1999–2006.
Sample size Prevalence (95% conf. interval) Estimated total number of persons
Total, 20 years and older
 1999–2000 4,192 6.9 (6.0 – 8.1) 13,319,000
 2001–2002 4,759 7.8 (6.5 – 9.2) 15,479,000
 2003–2004 4,509 9.5 (7.9 – 11.3) 19,421,000
 2005–2006 4,490 6.0 (5.1 – 6.9) 12,553,000
Age group
3–5 years
 1999–2000 376 § §
 2001–2002 454 § §
 2003–2004 454 § §
6–11 years
 1999–2000 899 § §
 2001–2002 1,034 § §
 2003–2004 852 § §
12–19 years
 1999–2000 2,132 1.5‡ (0.8 – 2.8) 466,000‡
 2001–2002 2,225 0.9 (0.5 – 1.6) 294,000
 2003–2004 2,073 1.1‡ (0.5 – 2.1) 358,000‡
20–39 years
 1999–2000 1,474 2.6 (1.6 – 4.3) 2,058,000
 2001–2002 1,720 3.2 (2.2 – 4.6) 2,505,000
 2003–2004 1,561 2.4 (1.7 – 3.4) 1,923,000
 2005–2006 1,706 1.3 (0.8 – 2.2) 1,034,000
40–59 years
 1999–2000 1,209 5.9 (4.3 – 8.1) 4,188,000
 2001–2002 1,494 5.8 (4.4 – 7.5) 4,378,000
 2003–2004 1,280 9.4 (7.0 – 12.4) 7,396,000
 2005–2006 1,371 4.7 (3.6 – 6.2) 3,894,000
60 years and older
 1999–2000 1,509 17.3 (14.8 – 20.3) 7,441,000
 2001–2002 1,545 20.5 (17.1 – 24.5) 9,180,000
 2003–2004 1,668 21.6 (19.2 – 24.2) 10,039,000
 2005–2006 1,413 15.6 (12.3 – 19.5) 7,527,000
Gender
(20 years and older)
Males
 1999–2000 1,959 8.6 (7.0 – 10.4) 7,854,000
 2001–2002 2,255 9.6 (7.8 – 11.7) 9,136,000
 2003–2004 2,177 11.4 (9.4 – 13.7) 11,197,000
 2005–2006 2,152 7.0 (5.6 – 8.7) 7,036,000
Females
 1999–2000 2,233 5.4 (4.5 – 6.6) 5,459,000
 2001–2002 2,504 6.1 (4.9 – 7.5) 6,342,000
 2003–2004 2,332 7.7 (6.0 – 9.8) 8,202,000
 2005–2006 2,338 5.1 (3.8 – 6.8) 5,525,000
Race/ethnicity
(20 years and older)
Mexican Americans
 1999–2000 1,146 4.4 (3.3 – 5.9) 542,000
 2001–2002 1,009 3.8 (2.5 – 5.5) 542,000
 2003–2004 904 2.7 (1.8 – 4.0) 426,000
 2005–2006 910 1.6 (1.0 – 2.5) 263,000
Non-Hispanic Blacks
 1999–2000 773 8.6 (6.7 – 10.8) 1,872,000
 2001–2002 872 9.6 (7.8 – 11.8) 2,120,000
 2003–2004 869 10.8 (8.7 – 13.2) 2,435,000
 2005–2006 1,002 7.0 (6.0 – 8.2) 1,640,000
Non-Hispanic Whites
 1999–2000 1,874 7.0 (6.0 – 8.1) 9,938,000
 2001–2002 2,514 8.4 (6.9 – 10.3) 12,142,000
 2003–2004 2,406 10.1 (8.3 – 12.2) 14,718,000
 2005–2006 2,264 6.5 (5.4 – 7.7) 9,541,000
‡ Estimate flagged: 30% ≤ RSE < 40% for the prevalence estimate. 
§ Estimate suppressed: RSE ≥ 40% for the prevalence estimate.
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Figure 1.7.a. Plasma methylmalonic acid: Concentrations by age group 
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Table 1.7.a.2. Plasma methylmalonic acid: Total population
Geometric mean and selected percentiles of plasma concentrations (in nmol/L) for the total U.S. population 
aged 3 years and older, National Health and Nutrition Examination Survey, 2003–2004. 
Geometric mean 
(95% conf. interval)
Selected percentiles (95% conf. interval) Sample 
size10th 50th 90th
Males and Females
Total, 3 years and older 134 (128 – 140) 79.6 (76.4 – 82.4) 127 (122 – 132) 231 (218 – 249) 7,544
3–5 years 120 (110 – 130) 74.5 (67.8 – 79.0) 117 (109 – 124) 198 (169 – 269) 421
6–11 years 117 (111 – 123) 77.6 (72.5 – 79.9) 113 (109 – 118) 184 (168 – 205) 806
12–19 years 118 (115 – 122) 75.1 (72.5 – 78.2) 115 (110 – 118) 189 (179 – 201) 1,979
20–39 years 122 (116 – 127) 75.5 (71.7 – 79.2) 116 (110 – 123) 201 (188 – 219) 1,496
40–59 years 137 (129 – 144) 82.3 (77.2 – 86.3) 130 (124 – 138) 223 (209 – 238) 1,230
60 years and older 177 (169 – 186) 102 (96.8 – 106) 163 (156 – 170) 328 (312 – 358) 1,612
Males
Total, 3 years and older 136 (130 – 142) 82.8 (79.4 – 85.3) 127 (123 – 132) 231 (217 – 253) 3,719
3–5 years 122 (110 – 135) 71.6 (65.1 – 78.7) 118 (103 – 129) 239 (180 – 272) 223
6–11 years 117 (109 – 126) 75.9 (69.5 – 79.4) 112 (107 – 119) 191 (167 – 223) 385
12–19 years 123 (118 – 129) 79.2 (76.7 – 81.4) 119 (112 – 125) 197 (179 – 210) 1,016
20–39 years 126 (120 – 133) 78.7 (72.6 – 85.9) 119 (111 – 125) 209 (194 – 223) 705
40–59 years 141 (132 – 151) 86.2 (79.9 – 93.2) 134 (128 – 141) 224 (206 – 266) 608
60 years and older 178 (168 – 189) 99.0 (93.0 – 103) 162 (155 – 174) 351 (328 – 373) 782
Females
Total, 3 years and older 131 (125 – 138) 77.5 (73.7 – 81.0) 126 (120 – 132) 231 (217 – 250) 3,825
3–5 years 117 (107 – 127) 75.5 (65.7 – 79.7) 117 (109 – 122) 169 (155 – 276) 198
6–11 years 116 (111 – 122) 78.7 (73.9 – 81.4) 115 (109 – 119) 177 (164 – 207) 421
12–19 years 113 (110 – 116) 71.4 (67.8 – 74.1) 109 (106 – 113) 181 (171 – 203) 963
20–39 years 117 (112 – 123) 73.0 (68.4 – 76.5) 113 (106 – 120) 197 (180 – 218) 791
40–59 years 132 (123 – 142) 79.0 (71.2 – 85.3) 126 (119 – 136) 222 (208 – 236) 622
60 years and older 177 (165 – 189) 106 (97.3 – 111) 164 (155 – 170) 315 (291 – 357) 830
Table 1.7.a.3. Plasma methylmalonic acid: Mexican Americans
Geometric mean and selected percentiles of plasma concentrations (in nmol/L) for Mexican Americans in the 
U.S. population aged 3 years and older, National Health and Nutrition Examination Survey, 2003–2004. 
Geometric mean 
(95% conf. interval)
Selected percentiles (95% conf. interval) Sample 
size10th 50th 90th
Males and Females
Total, 3 years and older 111 (108 – 114) 69.4 (67.1 – 72.4) 106 (100 – 112) 186 (174 – 201) 1,834
3–5 years 107 (94.2 – 122) 74.1† (65.1 – 76.9) 106 (87.8 – 118) 150† (133 – 279) 111
6–11 years 105 (96.7 – 113) 70.8 (61.5 – 77.1) 101 (92.6 – 112) 152 (142 – 192) 258
12–19 years 107 (102 – 112) 65.8 (62.4 – 69.8) 104 (98.3 – 109) 167 (160 – 184) 599
20–39 years 108 (99.2 – 117) 67.7 (65.0 – 70.6) 103 (92.6 – 116) 181 (156 – 242) 322
40–59 years 115 (110 – 119) 71.7 (65.4 – 75.8) 108 (102 – 115) 201 (178 – 220) 216
60 years and older 152 (138 – 168) 87.6 (81.1 – 92.8) 138 (125 – 159) 272 (245 – 368) 328
Males
Total, 3 years and older 116 (114 – 119) 74.3 (69.8 – 77.3) 109 (106 – 114) 199 (185 – 217) 911
3–5 years 108 (93.9 – 124) 72.6† (57.0 – 81.5) 105 (87.6 – 119) 145† (131 – 307) 59
6–11 years 104 (96.1 – 113) 70.2 (50.9 – 79.4) 105 (90.5 – 113) 148 (138 – 232) 124
12–19 years 118 (111 – 126) 72.9 (67.6 – 78.7) 111 (104 – 119) 198 (171 – 242) 306
20–39 years 113 (104 – 124) 75.6 (64.0 – 81.1) 106 (99.5 – 113) 189 (157 – 363) 149
40–59 years 123 (114 – 133) 73.4 (65.2 – 76.6) 116 (103 – 131) 218 (173 – 330) 113
60 years and older 153 (130 – 181) 89.1 (80.1 – 95.3) 137 (119 – 158) 268 (234 – 411) 160
Females
Total, 3 years and older 105 (99.3 – 112) 67.0 (61.7 – 68.7) 102 (92.6 – 110) 176 (157 – 201) 923
3–5 years 106 (87.6 – 128) 74.1† (57.0 – 81.0) 105 (80.4 – 127) 152† (124 – 228) 52
6–11 years 105 (94.3 – 117) 72.4 (58.9 – 77.7) 99.7 (89.6 – 115) 160 (145 – 218) 134
12–19 years 96.2 (91.3 – 101) 61.6 (55.1 – 66.5) 95.5 (90.0 – 102) 150 (142 – 156) 293
20–39 years 102 (91.2 – 113) 65.4 (56.5 – 68.0) 99.5 (81.5 – 119) 170 (147 – 208) 173
40–59 years 106 (95.2 – 117) 69.8† (58.0 – 75.4) 101 (95.6 – 109) 181† (137 – 247) 103
60 years and older 151 (135 – 170) 83.4 (77.3 – 96.5) 140 (120 – 171) 279 (243 – 333) 168
† Estimate is subject to greater uncertainty due to small cell size.
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Table 1.7.a.4. Plasma methylmalonic acid: Non-Hispanic blacks
Geometric mean and selected percentiles of plasma concentrations (in nmol/L) for non-Hispanic blacks in the 
U.S. population aged 3 years and older, National Health and Nutrition Examination Survey, 2003–2004. 
Geometric mean 
(95% conf. interval)
Selected percentiles (95% conf. interval) Sample 
size10th 50th 90th
Males and Females
Total, 3 years and older 109 (104 – 114) 68.4 (65.1 – 71.0) 105 (99.3 – 111) 177 (167 – 188) 1,993
3–5 years 95.4 (87.4 – 104) 62.7 (54.6 – 72.2) 99.4 (86.5 – 106) 139 (125 – 159) 146
6–11 years 98.7 (92.9 – 105) 65.9 (56.1 – 71.0) 96.6 (92.1 – 103) 147 (139 – 159) 290
12–19 years 96.0 (90.6 – 102) 63.9 (60.0 – 66.4) 93.2 (89.7 – 97.7) 147 (135 – 160) 721
20–39 years 102 (96.5 – 108) 66.7 (56.2 – 70.0) 99.3 (91.3 – 107) 161 (151 – 177) 328
40–59 years 117 (108 – 126) 74.1 (63.5 – 78.1) 114 (99.8 – 122) 193 (161 – 246) 275
60 years and older 148 (137 – 159) 91.8 (76.6 – 105) 142 (131 – 147) 245 (217 – 299) 233
Males
Total, 3 years and older 112 (107 – 117) 69.6 (67.8 – 72.6) 108 (101 – 113) 184 (171 – 199) 992
3–5 years 95.4 (87.4 – 104) 65.2† (< LOD – 73.4) 101 (87.6 – 107) 125† (121 – 140) 76
6–11 years 99.0 (90.5 – 108) 64.3 (50.7 – 69.3) 97.4 (86.2 – 109) 150 (138 – 177) 135
12–19 years 102 (95.5 – 109) 69.5 (64.4 – 72.8) 97.9 (92.3 – 103) 154 (143 – 179) 381
20–39 years 107 (99.9 – 114) 69.3 (64.1 – 72.9) 102 (97.0 – 114) 157 (149 – 182) 161
40–59 years 122 (110 – 136) 71.5 (61.4 – 77.4) 117 (104 – 124) 226 (179 – 280) 130
60 years and older 145 (133 – 158) 85.0† (77.2 – 98.7) 138 (125 – 150) 237† (212 – 322) 109
Females
Total, 3 years and older 107 (100 – 114) 66.9 (62.2 – 70.8) 104 (95.7 – 110) 172 (161 – 187) 1,001
3–5 years 95.4 (84.0 – 108) 59.3† (< LOD – 71.8) 95.6 (80.0 – 108) 141† (126 – 268) 70
6–11 years 98.4 (92.6 – 105) 68.7 (57.1 – 74.3) 95.9 (89.5 – 105) 145 (135 – 155) 155
12–19 years 90.3 (84.7 – 96.2) 59.4 (56.1 – 64.1) 89.6 (85.8 – 94.5) 139 (128 – 151) 340
20–39 years 98.5 (91.3 – 106) 64.5 (52.6 – 68.2) 92.9 (85.7 – 101) 162 (142 – 197) 167
40–59 years 113 (104 – 123) 75.0 (62.0 – 82.2) 110 (97.7 – 120) 169 (151 – 211) 145
60 years and older 150 (137 – 163) 96.5 (72.9 – 107) 143 (129 – 152) 247 (216 – 334) 124
< LOD means less than the limit of detection, which may vary for some compounds by year. See Appendix D for LOD. 
† Estimate is subject to greater uncertainty due to small cell size.
Table 1.7.a.5. Plasma methylmalonic acid: Non-Hispanic whites
Geometric mean and selected percentiles of plasma concentrations (in nmol/L) for non-Hispanic whites in the 
U.S. population aged 3 years and older, National Health and Nutrition Examination Survey, 2003–2004. 
Geometric mean 
(95% conf. interval)
Selected percentiles (95% conf. interval) Sample 
size10th 50th 90th
Males and Females
Total, 3 years and older 143 (136 – 150) 86.7 (82.8 – 89.9) 135 (129 – 141) 242 (229 – 266) 3,152
3–5 years 133 (123 – 145) 80.5 (64.1 – 94.6) 128 (119 – 140) 246 (200 – 274) 115
6–11 years 130 (122 – 139) 87.3 (77.5 – 95.7) 122 (114 – 135) 213 (189 – 232) 196
12–19 years 128 (122 – 133) 79.9 (77.7 – 83.3) 122 (119 – 127) 203 (188 – 217) 525
20–39 years 128 (121 – 136) 82.7 (76.3 – 87.1) 123 (115 – 132) 204 (194 – 228) 708
40–59 years 142 (134 – 152) 86.6 (80.6 – 92.9) 136 (128 – 145) 227 (210 – 258) 642
60 years and older 182 (173 – 192) 105 (99.1 – 109) 167 (161 – 176) 341 (316 – 365) 966
Males
Total, 3 years and older 144 (137 – 152) 91.0 (85.8 – 94.2) 134 (127 – 142) 240 (224 – 274) 1,535
3–5 years 139 (121 – 160) 73.7† (63.0 – 99.4) 130 (118 – 155) 267† (242 – 279) 62
6–11 years 132 (120 – 146) 91.6† (72.1 – 101) 120 (111 – 141) 207† (184 – 266) 91
12–19 years 131 (122 – 141) 83.4 (78.2 – 89.6) 125 (119 – 133) 204 (179 – 256) 266
20–39 years 130 (120 – 141) 88.1 (69.7 – 93.3) 123 (113 – 137) 205 (186 – 231) 319
40–59 years 145 (135 – 157) 95.7 (82.6 – 99.6) 138 (130 – 145) 224 (203 – 275) 321
60 years and older 182 (171 – 195) 101 (95.8 – 104) 168 (159 – 187) 364 (330 – 390) 476
Females
Total, 3 years and older 141 (135 – 148) 84.1 (79.2 – 88.1) 135 (129 – 141) 246 (231 – 261) 1,617
3–5 years 126 (113 – 141) 80.7† (54.0 – 103) 122 (113 – 140) 168† (151 – 311) 53
6–11 years 128 (121 – 136) 86.5† (71.3 – 92.4) 122 (116 – 129) 209† (170 – 251) 105
12–19 years 124 (119 – 129) 77.6 (73.9 – 80.2) 119 (115 – 127) 202 (179 – 231) 259
20–39 years 126 (119 – 133) 80.0 (75.3 – 84.5) 121 (114 – 132) 203 (187 – 239) 389
40–59 years 140 (128 – 152) 82.8 (71.4 – 90.2) 135 (122 – 147) 231 (219 – 259) 321
60 years and older 183 (170 – 196) 109 (103 – 116) 166 (161 – 175) 318 (299 – 360) 490
† Estimate is subject to greater uncertainty due to small cell size.
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Table 1.7.b. Plasma methylmalonic acid: Concentrations by survey cycle
Geometric mean and selected percentiles of plasma concentrations (in nmol/L) for the U.S. population, National 
Health and Nutrition Examination Survey, 1999–2004. 
Geometric mean 
(95% conf. interval)
Selected percentiles (95% conf. interval) Sample 
size5th 50th 95th
Total, 3 years and older
 1999–2000 132 (129 – 136) 64.9 (62.8 – 67.0) 123 (119 – 126) 280 (266 – 298) 7,597
 2001–2002 130 (126 – 133) 63.8 (61.3 – 66.4) 119 (116 – 123) 276 (263 – 293) 8,451
 2003–2004 134 (128 – 140) 70.0 (67.3 – 72.8) 127 (122 – 132) 293 (277 – 320) 7,544
Age group
3–5 years
 1999–2000 124 (118 – 131) 67.4 (61.8 – 71.6) 116 (111 – 122) 237 (197 – 332) 376
 2001–2002 116 (112 – 121) 63.9 (61.8 – 66.0) 108 (104 – 113) 219 (195 – 244) 453
 2003–2004 120 (110 – 130) 65.2 (56.6 – 72.1) 117 (109 – 124) 269 (235 – 307) 421
6–11 years
 1999–2000 125 (117 – 134) 66.9 (63.5 – 70.3) 117 (107 – 130) 210 (191 – 319) 898
 2001–2002 118 (114 – 122) 62.6 (57.7 – 66.8) 113 (109 – 118) 200 (187 – 224) 1,031
 2003–2004 117 (111 – 123) 67.5 (61.0 – 72.6) 113 (109 – 118) 228 (204 – 253) 806
12–19 years
 1999–2000 118 (112 – 125) 60.2 (55.1 – 63.5) 109 (103 – 117) 231 (206 – 291) 2,132
 2001–2002 115 (112 – 119) 56.9 (54.6 – 59.1) 107 (104 – 110) 228 (216 – 264) 2,220
 2003–2004 118 (115 – 122) 67.3 (64.8 – 70.0) 115 (110 – 118) 222 (210 – 263) 1,979
20–39 years
 1999–2000 124 (119 – 129) 62.4 (59.7 – 64.9) 116 (110 – 121) 259 (235 – 295) 1,474
 2001–2002 121 (116 – 125) 59.5 (55.9 – 61.8) 112 (107 – 117) 239 (226 – 268) 1,715
 2003–2004 122 (116 – 127) 67.3 (64.2 – 69.6) 116 (110 – 123) 246 (231 – 275) 1,496
40–59 years
 1999–2000 133 (130 – 137) 65.4 (62.6 – 68.1) 124 (122 – 127) 251 (239 – 277) 1,210
 2001–2002 131 (127 – 135) 71.2 (66.4 – 73.4) 120 (117 – 124) 264 (231 – 302) 1,491
 2003–2004 137 (129 – 144) 70.9 (66.6 – 75.0) 130 (124 – 138) 275 (252 – 338) 1,230
60 years and older
 1999–2000 168 (163 – 174) 80.3 (67.7 – 89.1) 149 (145 – 155) 423 (392 – 458) 1,507
 2001–2002 172 (164 – 180) 76.9 (74.1 – 79.8) 156 (150 – 162) 487 (413 – 604) 1,541
 2003–2004 177 (169 – 186) 89.9 (83.6 – 94.5) 163 (156 – 170) 429 (392 – 482) 1,612
Gender
Males
 1999–2000 136 (132 – 141) 67.2 (64.5 – 70.0) 127 (123 – 131) 288 (265 – 309) 3,708
 2001–2002 133 (129 – 138) 66.4 (62.7 – 70.1) 123 (120 – 127) 273 (258 – 294) 4,091
 2003–2004 136 (130 – 142) 72.4 (69.4 – 75.4) 127 (123 – 132) 299 (277 – 339) 3,719
Females
 1999–2000 128 (124 – 132) 63.3 (61.1 – 65.5) 118 (114 – 122) 276 (262 – 294) 3,889
 2001–2002 126 (123 – 130) 62.3 (59.9 – 64.7) 115 (111 – 119) 277 (261 – 301) 4,360
 2003–2004 131 (125 – 138) 68.1 (65.2 – 71.3) 126 (120 – 132) 287 (272 – 315) 3,825
Race/ethnicity
Mexican Americans
 1999–2000 110 (106 – 114) 56.2 (54.9 – 57.5) 100 (97.3 – 103) 225 (198 – 270) 2,595
 2001–2002 111 (107 – 115) 53.7 (51.0 – 56.5) 103 (99.0 – 108) 225 (218 – 235) 2,131
 2003–2004 111 (108 – 114) 61.9 (58.6 – 64.4) 106 (100 – 112) 230 (209 – 254) 1,834
Non-Hispanic Blacks
 1999–2000 108 (103 – 113) 57.5 (52.6 – 60.7) 98.3 (91.5 – 105) 217 (192 – 250) 1,732
 2001–2002 112 (108 – 116) 55.6 (53.0 – 58.2) 102 (98.3 – 107) 220 (200 – 258) 2,036
 2003–2004 109 (104 – 114) 61.1 (57.7 – 64.1) 105 (99.3 – 111) 224 (206 – 246) 1,993
Non-Hispanic Whites
 1999–2000 140 (136 – 144) 72.0 (69.8 – 74.2) 131 (126 – 135) 290 (272 – 311) 2,573
 2001–2002 137 (133 – 141) 70.6 (66.8 – 72.7) 126 (122 – 130) 288 (272 – 304) 3,605










































































































































Figure 1.7.b. Plasma methylmalonic acid: Concentrations by survey cycle
Selected percentiles in nmol/L (95% condence intervals), National Health and 
Nutrition Examination Survey, 1999–2004
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Table 1.7.c. Plasma methylmalonic acid: Prevalence
Prevalence (in percent) of high plasma methylmalonic acid concentration (> 271 nmol/L) for the U.S. 




 (95% conf. interval)
Estimated total  
number of persons
Total, 3 years and older 7,544 6.5 (5.3 – 7.9) 18,411,000
Age group
3–5 years 421 4.5‡ (2.0 – 9.7) 916,000‡
6–11 years 806 § §
12–19 years 1,979 3.2 (2.2 – 4.6) 1,054,000
20–39 years 1,496 3.8 (2.9 – 5.1) 3,066,000
40–59 years 1,230 5.8 (4.1 – 8.1) 4,557,000
60 years and older 1,612 16.7 (13.7 – 20.1) 7,748,000
Gender
Males 3,719 6.8 (5.4 – 8.6) 9,439,000
Females 3,825 6.2 (5.0 – 7.7) 8,965,000
Race/ethnicity
Mexican Americans 1,834 2.8 (1.7 – 4.4) 722,000
Non-Hispanic Blacks 1,993 2.5 (1.8 – 3.4) 846,000
Non-Hispanic Whites 3,152 7.6 (6.1 – 9.4) 14,546,000
‡ Estimate flagged: 30% ≤ RSE < 40% for the prevalence estimate. 
§ Estimate suppressed: RSE ≥ 40% for the prevalence estimate.
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Table 1.7.d. Plasma methylmalonic acid: Prevalence by survey cycle
Prevalence (in percent) of high plasma methylmalonic acid concentration (> 271 nmol/L) for the U.S. 
population, National Health and Nutrition Examination Survey, 1999–2004. 
Sample size Prevalence (95% conf. interval) Estimated total number of persons
Total, 3 years and older
 1999–2000 7,597 5.5 (4.8 – 6.3) 14,367,000
 2001–2002 8,451 5.3 (4.6 – 6.0) 14,218,000
 2003–2004 7,544 6.5 (5.3 – 7.9) 17,887,000
Age group
3–5 years
 1999–2000 376 § §
 2001–2002 453 § §
 2003–2004 421 4.5‡ (2.0 – 9.7) 553,000‡
6–11 years
 1999–2000 898 2.5‡ (1.1 – 5.6) 623,000‡
 2001–2002 1,031 1.5‡ (0.7 – 3.0) 372,000‡
 2003–2004 806 § §
12–19 years
 1999–2000 2,132 3.3 (2.1 – 5.3) 1,061,000
 2001–2002 2,220 3.3 (2.1 – 5.3) 1,079,000
 2003–2004 1,979 3.2 (2.2 – 4.6) 1,054,000
20–39 years
 1999–2000 1,474 4.5 (3.2 – 6.1) 3,496,000
 2001–2002 1,715 3.7 (2.6 – 5.0) 2,888,000
 2003–2004 1,496 3.8 (2.9 – 5.1) 3,066,000
40–59 years
 1999–2000 1,210 4.0 (3.0 – 5.2) 2,803,000
 2001–2002 1,491 4.7 (3.6 – 6.1) 3,557,000
 2003–2004 1,230 5.8 (4.1 – 8.1) 4,557,000
60 years and older
 1999–2000 1,507 13.9 (11.7 – 16.6) 5,986,000
 2001–2002 1,541 13.9 (12.0 – 16.1) 6,225,000
 2003–2004 1,612 16.7 (13.7 – 20.1) 7,748,000
Gender
Males
 1999–2000 3,708 5.7 (4.7 – 6.9) 7,231,000
 2001–2002 4,091 5.1 (4.3 – 6.0) 6,671,000
 2003–2004 3,719 6.8 (5.4 – 8.6) 9,157,000
Females
 1999–2000 3,889 5.3 (4.5 – 6.3) 7,133,000
 2001–2002 4,360 5.5 (4.6 – 6.5) 7,546,000
 2003–2004 3,825 6.2 (5.0 – 7.7) 8,723,000
Race/ethnicity
Mexican Americans
 1999–2000 2,595 3.2 (2.0 – 5.0) 632,000
 2001–2002 2,131 2.9 (2.2 – 3.8) 656,000
 2003–2004 1,834 2.8 (1.7 – 4.4) 687,000
Non-Hispanic Blacks
 1999–2000 1,732 2.5 (1.6 – 3.7) 803,000
 2001–2002 2,036 2.6 (1.7 – 3.9) 842,000
 2003–2004 1,993 2.5 (1.8 – 3.4) 817,000
Non-Hispanic Whites
 1999–2000 2,573 6.1 (5.3 – 7.1) 11,346,000
 2001–2002 3,605 5.9 (5.2 – 6.8) 11,036,000
 2003–2004 3,152 7.6 (6.1 – 9.4) 14,198,000
‡ Estimate flagged: 30% ≤ RSE < 40% for the prevalence estimate. 
§ Estimate suppressed: RSE ≥ 40% for the prevalence estimate. 
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Vitamin C (Ascorbic Acid)
Background Information
Sources and Physiological Functions. Vitamin C, a water-soluble vitamin, is a collective term 
used to refer to L-ascorbic acid (the functional form of the vitamin), dehydro-L-ascorbic acid (the 
oxidized form, DHA), and monodehydro-L-ascorbic acid (the free radical form). Greater than 
95% of vitamin C in human plasma exists as ascorbic acid (Jacob 1990). The most abundant 
dietary sources of vitamin C are orange juice, grapefruit juice, peaches, sweet red peppers, and 
papayas, followed by a variety of other fruits, vegetables, and fortified cereals. Vitamin C is a 
powerful antioxidant and a cofactor in various reduction reactions; it is a known electron donor 
for at least eight human enzymes involved in the hydroxylation of collagen and the biosynthesis 
of carnitine, hormones, and amino acids. Humans and a few other mammals, such as monkeys 
and guinea pigs, are unable to biosynthesize vitamin C from glucose and must obtain the vitamin 
from outside sources.
Approximately 70–90% of the ascorbic acid consumed is absorbed by the human body at 
usual intakes of 30–180 milligrams per day (mg/d). Bioavailability of vitamin C from food or 
supplemental sources is equivalent. Vitamin C administered after the plasma has reached a point 
of saturation (approximately 70 µmol/L) will likely be excreted as unmetabolized ascorbic acid in 
the urine (Institute of Medicine 2000).
Health Effects. The clinical manifestation of vitamin C deficiency is scurvy. Scurvy can occur if 
intake is below 10 mg/d for many weeks. Important signs and symptoms of scurvy include coiled 
hairs, follicular hyperkeratosis, fatigue, bleeding gums, and delayed wound-healing (Institute of 
Medicine 2000). Too much vitamin C can cause gastrointestinal upset, but such upset is generally 
seen only at an intake exceeding 2 gram/d, and it usually disappears within one to two weeks of 
discontinuation. High intakes of vitamin C supplements have the potential to increase urinary 
oxalate excretion, which is a risk factor for the formation of calcium oxalate kidney stones, but 
evidence is conflicting.
Vitamin C, in combination with other supplements, including vitamin E, zinc, and beta-
carotene, has been shown to slow the progression of age-related macular degeneration (AREDS 
Research Group 2001). There is conflicting evidence for the reduction of risk of cardiovascular 
disease mortality by vitamin C supplementation and its effect on cardiovascular health in general 
(Shekelle 2003). More research is also needed to determine the role vitamin C plays in cancer 
prevention and treatment. 
Intake Recommendations. The recommended daily allowance (RDA) of vitamin C for adults 
is 120% of the EAR (estimated average requirement), which was determined by the maximally 
protective neutrophil vitamin C concentration. For men, this equates to 90 mg/d, with 75 mg 
being the appropriate daily amount for women (Institute of Medicine 2000). RDAs range from 
15–25 mg/d for children one to eight years of age, 45–75 mg/d for boys aged nine to 18 years, 
and 45–65 mg/d for girls aged nine to 18 years. For infants aged 0 to 12 months, the RDA is set 
at the amount of vitamin C commonly received through regular breastfeeding and the additional 
amount obtained through solid foods during the seven to 12 month period (an average of 45 
mg/d). A number of factors, such as bioavailability, interactions with other nutrients, smoking 
status, age, and gender, affect the amount of vitamin C required by humans. For example, people 
who smoke require an additional 35 mg/d of vitamin C due to the increased ascorbic acid needed 
to repair oxidant damage (Institute of Medicine 2000).
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Biochemical Indicators and Methods. 
Vitamin C status can be assessed by 
measuring total ascorbic acid (oxidized 
and reduced) in serum or plasma, buffy-
coat, or leucocytes. Ascorbic acid in plasma 
is considered an index of the circulating 
vitamin available to tissues, and in leucocytes 
(particularly polymorphonuclear) it is 
believed to be a good indicator of tissue 
stores. Vitamin C deficiency is generally 
defined as plasma or serum concentrations 
less than 11.4 micromoles per liter (µmol/L), 
or the level at which signs and symptoms 
of scurvy may appear. Serum ascorbic acid 
concentrations between 11.4–23 µmol/L are 
considered low (Gibson 2005).
Clinical laboratories generally use international system (SI) units for vitamin C (µmol/L); 
however, some use conventional units (mg per deciliter [mg/dL]). The conversion factor to 
conventional units is: 1 µmol/L = 0.0176 mg/dL. 
High-performance liquid chromatography (HPLC) methods with electrochemical detection, 
which provide necessary sensitivity and specificity, are generally used to quantitate serum vitamin 
C concentrations. Older spectrophotometric assays were susceptible to interferences from a 
number of substances, such as riboflavin and aspirin. A multi-level standard reference material 
(SRM 970) is available from the National Institute of Standards and Technology (NIST) for 
human serum with certified values for ascorbic acid. The Micronutrients Measurement Quality 
Assurance Program (MMQAP) sponsored by NIST hosts inter-laboratory comparison studies 
directed at assuring high quality measurements of serum vitamin C.
Data in NHANES. An HPLC method with electrochemical detection was used to determine 
serum vitamin C concentrations in NHANES 2003–2006 (McCoy 2005). Because of the 
incorporation of an internal standard, improved accuracy and precision was achieved with this 
method compared to the previous method used during NHANES III (1988–1994). 
An analysis of NHANES 2003–2004 data showed that the highest serum concentrations of 
vitamin C were found in children and older persons. Mean concentrations among adult smokers 
were one-third lower than those of nonsmokers. In NHANES 2003–2004, the prevalence of 
vitamin C deficiency was significantly lower than that during NHANES III, but smokers and 
low-income persons were among those at increased risk of deficiency (Schleicher 2009). 
For more information about vitamin C, see the Institute of Medicine’s Dietary Reference Intake 
reports (Institute of Medicine, Food and Nutrition Board 2000) and fact sheets from the National 
Institutes of Health, Office of Dietary Supplements (http://ods.od.nih.gov/factsheets/VitaminC_
pf.asp).
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Highlights
Serum vitamin C concentrations in the U.S. population showed the following demographic 
patterns and characteristics:
•	 The highest concentrations were generally found in the youngest age group and higher 
concentrations were found in females compared to males.
•	 The likelihood of being vitamin C deficient or having low serum vitamin C 
concentrations varied by demographic subgroup.
Serum vitamin C concentrations less than 11.4 µmol/L may indicate vitamin C deficiency. 
Compared to non-Hispanic whites, Mexican Americans and non-Hispanic blacks had a lower 
risk of deficiency; compared to females, males had a higher risk of deficiency (Figure H.1.e). A 
number of important variables that impact vitamin C status are not addressed in this analysis, 
including smoking, overweight/obesity, socioeconomic status, and supplement use (Schleicher 
2009). Considering that manifest vitamin C deficiency is rare in the United States (Olmedo 
2006), persons categorized as vitamin C deficient may more likely experience latent scurvy, which 
is characterized by fatigue, irritability, vague, dull aching pains and weight loss (Prinzo 1999). 
Serum vitamin C concentrations between 11.4–23 µmol/L are considered low. The prevalence 
of deficient (< 11.4 µmol/L) and of low (11.4–23 µmol/L) serum vitamin C concentrations was 




























Figure H.1.e. Age-adjusted prevalence estimates of vitamin C deficiency 
(serum concentrations less than 11.4 µmol/L) in the U.S. population 
aged 6 years and older by race/ethnicity or gender, National Health and 
Nutrition Examination Survey, 2003–2006. 
Error bars represent 95% confidence intervals. Bars not sharing a common letter 


















Age in years 
< 11.4 µmol/L 11.4–23 µmol/L
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*
Figure H.1.f. Prevalence estimates of vitamin C deficiency (serum 
concentrations less than 11.4 µmol/L) and of low vitamin C 
concentrations (11.4–23 µmol/L) in the U.S. population aged 6 years 
and older by age group, National Health and Nutrition Examination 
Survey, 2003–2006. 
Error bars represent 95% confidence intervals. *Prevalence in children is 
significantly lower than prevalence in persons 20 years and older (p < 0.05).
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Detailed Observations
The selected observations mentioned below are derived from the tables and figures presented next. 
Statements about categorical differences between demographic groups noted below are based on 
non-overlapping confidence limits from univariate analysis without adjusting for demographic 
variables (e.g., age, sex, race/ethnicity) or other blood concentration determinants (e.g., dietary 
intake, supplement usage, smoking, BMI). A multivariate analysis may alter the size and statistical 
significance of these categorical differences. Furthermore, additional significant differences of 
smaller magnitude may be present despite their lack of mention here (e.g., if confidence limits 
slightly overlap or if differences are not statistically significant before covariate adjustment has 
occurred). For a selection of citations of descriptive NHANES papers related to these biochemical 
indicators of diet and nutrition, see Appendix G.
Arithmetic mean concentrations (NHANES 2003–2006):
•	 The distribution of serum vitamin C concentrations was reasonably symmetric and for 
that reason we present arithmetic means.
•	 Serum vitamin C concentrations followed a U-shaped pattern, with the lowest 
concentrations seen in 20–59 year old persons (Table 1.8.a.1 and Figure 1.8.a).
•	 Females had higher serum vitamin C concentrations than males (Table 1.8.a.1).
•	 We observed no differences in serum vitamin C concentrations among race/ethnic 
groups (Table 1.8.a.1).
Changes in arithmetic mean concentrations across survey cycles:
•	 No changes in the serum vitamin C concentrations (Table 1.8.b) were observed between 
2003–2004 and 2005–2006.
Prevalence estimates of low or high biochemical indicator concentrations:
•	 Six percent of the population aged 6 years and older had serum vitamin C 
concentrations < 11.4 µmol/L (Table 1.8.c). 
•	 Children (<1%) and adolescents (3%) had a lower prevalence of low serum vitamin C 
concentrations than older age groups (5–8%). 
•	 Non-Hispanic whites (7%) had a higher prevalence of low serum vitamin C 
concentrations than non-Hispanic blacks (4%) and Mexican Americans (3%).
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Figure 1.8.a. Serum vitamin C: Concentrations by age group
Arithmetic mean (95% confidence interval), National Health and Nutrition Examination Survey, 2003–2006
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Table 1.8.a.2. Serum vitamin C: Total population
Arithmetic mean and selected percentiles of serum concentrations (in µmol/L) for the total U.S. population 
aged 6 years and older, National Health and Nutrition Examination Survey, 2003–2006.
Arithmetic mean 
(95% conf. interval)
Selected percentiles (95% conf. interval) Sample 
size5th 50th 95th
Males and Females
Total, 6 years and older 56.1 (54.6 – 57.6) 9.61 (8.17 – 10.9) 56.3 (54.9 – 57.6) 103 (101 – 105) 14,579
6–11 years 75.1 (73.0 – 77.2) 29.0 (25.0 – 33.7) 74.5 (72.6 – 76.5) 123 (115 – 131) 1,703
12–19 years 58.0 (55.9 – 60.2) 15.2 (11.9 – 17.0) 58.6 (55.9 – 60.7) 98.9 (94.5 – 103) 3,984
20–39 years 51.0 (48.8 – 53.2) 9.00 (7.48 – 10.3) 51.4 (49.2 – 53.9) 92.9 (89.4 – 96.9) 3,233
40–59 years 51.6 (49.7 – 53.4) 7.41 (5.91 – 8.77) 52.4 (50.6 – 53.9) 97.2 (94.3 – 101) 2,635
60 years and older 63.0 (61.5 – 64.6) 10.7 (8.16 – 13.6) 62.5 (61.1 – 63.9) 117 (112 – 121) 3,024
Males
Total, 6 years and older 52.4 (50.9 – 54.0) 8.38 (7.09 – 9.70) 52.6 (51.2 – 54.0) 98.9 (96.4 – 102) 7,155
6–11 years 76.3 (73.1 – 79.5) 30.4 (21.7 – 37.7) 76.2 (72.5 – 78.7) 123 (113 – 138) 837
12–19 years 55.8 (53.6 – 58.1) 14.7 (11.2 – 16.5) 56.0 (53.4 – 58.5) 94.0 (91.2 – 100) 2,022
20–39 years 47.9 (45.3 – 50.4) 8.58 (6.68 – 9.87) 48.4 (45.2 – 50.8) 87.5 (82.8 – 95.4) 1,463
40–59 years 46.7 (44.5 – 48.9) 6.38 (4.89 – 7.94) 48.2 (46.1 – 50.2) 88.4 (84.8 – 96.3) 1,305
60 years and older 57.2 (54.9 – 59.4) 7.92 (6.72 – 10.1) 57.2 (54.7 – 59.4) 110 (105 – 118) 1,528
Females
Total, 6 years and older 59.7 (57.9 – 61.4) 11.2 (9.61 – 12.9) 59.6 (58.1 – 61.2) 106 (103 – 111) 7,424
6–11 years 73.8 (71.1 – 76.6) 28.5 (20.3 – 35.9) 72.4 (69.2 – 75.9) 123 (115 – 131) 866
12–19 years 60.4 (57.8 – 62.9) 15.7 (11.0 – 18.8) 61.4 (58.6 – 63.9) 102 (98.2 – 110) 1,962
20–39 years 54.1 (51.5 – 56.7) 9.90 (7.73 – 11.5) 55.3 (51.9 – 58.6) 96.1 (91.9 – 101) 1,770
40–59 years 56.2 (53.7 – 58.7) 9.34 (6.29 – 12.0) 56.4 (53.6 – 58.2) 103 (97.4 – 110) 1,330
60 years and older 67.8 (65.9 – 69.7) 14.3 (10.9 – 16.4) 67.0 (65.1 – 69.0) 121 (116 – 129) 1,496
Table 1.8.a.3. Serum vitamin C: Mexican Americans
Arithmetic mean and selected percentiles of serum concentrations (in µmol/L) for Mexican Americans in the 
U.S. population aged 6 years and older, National Health and Nutrition Examination Survey, 2003–2006.
Arithmetic mean 
(95% conf. interval)
Selected percentiles (95% conf. interval) Sample 
size5th 50th 95th
Males and Females
Total, 6 years and older 55.2 (52.7 – 57.7) 15.1 (11.6 – 18.7) 55.1 (52.8 – 57.7) 93.7 (90.7 – 96.0) 3,628
6–11 years 73.4 (69.4 – 77.4) 28.3 (20.7 – 37.8) 74.2 (71.7 – 76.4) 113 (107 – 130) 563
12–19 years 58.5 (56.4 – 60.5) 20.3 (14.9 – 23.9) 59.0 (57.4 – 60.7) 92.7 (90.6 – 95.2) 1,266
20–39 years 52.2 (49.4 – 54.9) 15.9 (12.2 – 20.6) 52.4 (49.9 – 54.5) 85.7 (80.9 – 90.6) 782
40–59 years 49.5 (46.9 – 52.1) 9.55 (7.54 – 14.0) 51.0 (47.5 – 54.7) 83.6 (80.0 – 85.2) 470
60 years and older 51.8 (47.8 – 55.8) 9.48 (2.78 – 14.5) 50.5 (46.0 – 55.9) 93.6 (88.9 – 103) 547
Males
Total, 6 years and older 52.7 (50.0 – 55.5) 13.6 (8.67 – 17.5) 53.3 (50.4 – 55.7) 90.8 (87.6 – 94.5) 1,762
6–11 years 73.4 (69.0 – 77.8) 28.2 (20.8 – 37.5) 74.6 (71.4 – 77.2) 113 (108 – 134) 275
12–19 years 56.7 (54.3 – 59.1) 18.9 (10.6 – 23.3) 57.4 (55.2 – 59.5) 90.1 (86.9 – 93.0) 628
20–39 years 49.6 (46.2 – 53.1) 14.2 (7.50 – 22.1) 50.8 (47.7 – 54.4) 79.5 (73.6 – 86.6) 351
40–59 years 46.2 (42.8 – 49.7) 8.27 (4.43 – 13.6) 46.3 (43.5 – 53.5) 76.5 (73.9 – 87.2) 239
60 years and older 44.8 (41.6 – 47.9) 7.27 (1.70 – 10.0) 44.0 (38.1 – 48.9) 86.3 (78.5 – 94.2) 269
Females
Total, 6 years and older 58.0 (55.4 – 60.6) 18.6 (14.1 – 21.5) 58.1 (54.8 – 60.8) 95.1 (92.4 – 99.2) 1,866
6–11 years 73.4 (69.1 – 77.7) 26.5 (18.0 – 41.2) 73.3 (70.7 – 76.2) 113 (103 – 129) 288
12–19 years 60.3 (57.8 – 62.8) 22.4 (18.8 – 24.7) 60.7 (58.4 – 62.7) 95.1 (90.9 – 104) 638
20–39 years 55.1 (51.7 – 58.6) 18.5 (12.8 – 22.6) 54.0 (50.6 – 58.0) 90.0 (84.3 – 102) 431
40–59 years 53.1 (49.9 – 56.3) 10.6 (7.49 – 18.2) 54.5 (50.0 – 58.9) 85.2 (83.9 – 92.9) 231




Table 1.8.a.4. Serum vitamin C: Non-Hispanic blacks
Arithmetic mean and selected percentiles of serum concentrations (in µmol/L) for non-Hispanic blacks in the 
U.S. population aged 6 years and older, National Health and Nutrition Examination Survey, 2003–2006. 
Arithmetic mean 
(95% conf. interval)
Selected percentiles (95% conf. interval) Sample 
size5th 50th 95th
Males and Females
Total, 6 years and older 54.3 (52.7 – 56.0) 11.9 (10.0 – 14.0) 54.0 (52.2 – 55.9) 95.2 (92.7 – 97.5) 3,784
6–11 years 73.4 (70.8 – 75.9) 39.7 (34.0 – 43.0) 72.8 (69.0 – 75.9) 107 (103 – 118) 544
12–19 years 61.5 (59.7 – 63.2) 28.1 (25.9 – 30.3) 61.3 (59.1 – 63.2) 95.0 (91.7 – 98.3) 1,400
20–39 years 51.5 (49.4 – 53.5) 14.7 (11.2 – 16.9) 50.4 (48.1 – 53.2) 87.3 (83.4 – 91.3) 711
40–59 years 49.2 (46.3 – 52.1) 8.58 (4.80 – 11.2) 48.9 (45.3 – 52.7) 93.1 (83.9 – 101) 619
60 years and older 49.8 (46.8 – 52.8) 6.69 (4.99 – 8.42) 50.8 (47.0 – 54.1) 95.9 (90.8 – 101) 510
Males
Total, 6 years and older 52.6 (51.0 – 54.1) 10.2 (7.77 – 12.6) 52.1 (50.4 – 54.2) 92.8 (90.2 – 97.3) 1,895
6–11 years 75.3 (71.0 – 79.6) 42.4 (34.1 – 44.3) 75.8 (69.8 – 79.9) 108 (104 – 118) 272
12–19 years 59.6 (58.0 – 61.2) 28.6 (24.2 – 30.2) 58.8 (56.4 – 61.0) 91.6 (89.5 – 96.1) 735
20–39 years 48.7 (46.3 – 51.2) 12.4 (6.93 – 16.2) 48.0 (44.0 – 50.9) 81.5 (76.6 – 91.0) 337
40–59 years 46.7 (43.3 – 50.1) 7.24 (4.00 – 10.4) 46.6 (42.2 – 51.3) 82.8 (77.1 – 97.4) 291
60 years and older 45.6 (41.0 – 50.3) 5.02 (2.96 – 6.19) 45.6 (38.6 – 50.9) 93.0 (89.0 – 106) 260
Females
Total, 6 years and older 55.8 (53.7 – 58.0) 13.5 (11.3 – 15.8) 55.8 (53.5 – 58.1) 95.9 (94.1 – 99.8) 1,889
6–11 years 71.3 (68.9 – 73.7) 36.8 (30.8 – 41.4) 68.8 (67.0 – 73.1) 106 (102 – 114) 272
12–19 years 63.4 (60.7 – 66.1) 27.6 (25.9 – 30.8) 63.8 (60.6 – 67.0) 96.0 (92.8 – 102) 665
20–39 years 53.7 (50.9 – 56.6) 15.7 (11.5 – 21.5) 52.7 (49.4 – 56.3) 90.5 (86.6 – 95.8) 374
40–59 years 51.3 (47.8 – 54.8) 9.84 (4.02 – 14.5) 50.4 (47.2 – 55.2) 95.9 (86.6 – 106) 328
60 years and older 52.7 (48.8 – 56.7) 9.64 (4.66 – 11.2) 54.0 (50.1 – 58.2) 96.5 (90.0 – 108) 250
Table 1.8.a.5. Serum vitamin C: Non-Hispanic whites
Arithmetic mean and selected percentiles of serum concentrations (in µmol/L) for non-Hispanic whites in the 
U.S. population aged 6 years and older, National Health and Nutrition Examination Survey, 2003–2006. 
Arithmetic mean 
(95% conf. interval)
Selected percentiles (95% conf. interval) Sample 
size5th 50th 95th
Males and Females
Total, 6 years and older 56.5 (54.6 – 58.4) 8.56 (7.26 – 9.92) 56.9 (54.9 – 58.7) 105 (103 – 108) 6,089
6–11 years 75.6 (72.5 – 78.8) 25.7 (18.7 – 31.8) 74.8 (70.9 – 77.7) 128 (118 – 144) 436
12–19 years 57.2 (54.0 – 60.4) 12.3 (9.88 – 15.7) 58.0 (53.2 – 61.5) 101 (95.4 – 107) 1,037
20–39 years 50.6 (47.8 – 53.3) 7.99 (6.39 – 8.99) 51.2 (47.7 – 55.1) 96.2 (91.2 – 102) 1,442
40–59 years 52.0 (49.7 – 54.3) 6.80 (5.56 – 8.33) 52.8 (51.2 – 55.2) 99.8 (96.0 – 103) 1,346
60 years and older 64.8 (63.0 – 66.7) 11.7 (8.22 – 14.7) 63.9 (62.4 – 65.3) 118 (114 – 123) 1,828
Males
Total, 6 years and older 52.3 (50.4 – 54.1) 7.71 (6.50 – 8.82) 52.4 (50.5 – 54.5) 101 (98.2 – 104) 2,990
6–11 years 76.5 (71.7 – 81.4) 25.4† (14.0 – 34.1) 75.8 (69.2 – 80.6) 127† (117 – 155) 210
12–19 years 54.9 (51.7 – 58.1) 12.6 (9.73 – 16.2) 54.8 (51.4 – 59.1) 94.4 (91.6 – 104) 524
20–39 years 47.2 (44.2 – 50.3) 7.92 (6.52 – 8.79) 47.5 (44.1 – 50.7) 93.8 (85.8 – 98.7) 636
40–59 years 47.0 (44.3 – 49.8) 6.19 (4.90 – 7.44) 48.5 (46.4 – 51.0) 90.2 (86.4 – 101) 687
60 years and older 58.5 (56.0 – 61.1) 8.15 (6.84 – 11.5) 58.4 (55.6 – 60.7) 112 (106 – 119) 933
Females
Total, 6 years and older 60.5 (58.2 – 62.8) 9.92 (8.18 – 11.7) 60.7 (58.5 – 62.8) 110 (106 – 114) 3,099
6–11 years 74.7 (70.3 – 79.0) 25.2 (9.65 – 36.1) 72.8 (68.7 – 78.2) 129 (115 – 145) 226
12–19 years 59.6 (55.8 – 63.5) 12.0 (8.98 – 15.7) 61.1 (56.9 – 64.7) 104 (98.6 – 120) 513
20–39 years 53.9 (50.4 – 57.4) 8.06 (5.40 – 9.86) 56.0 (50.2 – 60.7) 99.0 (93.1 – 106) 806
40–59 years 57.0 (53.9 – 60.0) 8.63 (5.81 – 11.1) 57.4 (53.5 – 59.8) 105 (98.0 – 113) 659
60 years and older 70.0 (67.7 – 72.3) 15.0 (10.9 – 17.9) 69.1 (66.5 – 72.6) 123 (117 – 131) 895
† Estimate is subject to greater uncertainty due to small cell size. 
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Table 1.8.b. Serum vitamin C: Concentrations by survey cycle
Arithmetic mean and selected percentiles of serum concentrations (in µmol/L) for the U.S. population, National 
Health and Nutrition Examination Survey, 2003–2006. 
Arithmetic mean 
(95% conf. interval)
Selected percentiles (95% conf. interval) Sample 
size5th 50th 95th
Total, 6 years and older
 2003–2004 55.8 (53.1 – 58.5) 8.55 (6.57 – 10.2) 56.3 (53.4 – 58.8) 103 (101 – 108) 7,277
 2005–2006 56.4 (54.8 – 58.0) 11.1 (9.22 – 12.4) 56.3 (55.0 – 57.6) 102 (99.2 – 105) 7,302
Age group
6–11 years
 2003–2004 74.3 (70.9 – 77.8) 27.8 (16.6 – 35.5) 73.7 (70.8 – 76.8) 126 (112 – 139) 823
 2005–2006 75.9 (73.1 – 78.7) 32.0 (26.2 – 36.6) 75.0 (72.4 – 78.1) 121 (114 – 130) 880
12–19 years
 2003–2004 56.3 (52.9 – 59.8) 13.6 (10.2 – 16.2) 56.2 (52.1 – 60.0) 98.4 (93.6 – 106) 2,016
 2005–2006 59.7 (57.0 – 62.4) 17.0 (13.4 – 20.8) 60.3 (57.3 – 63.5) 99.3 (93.0 – 107) 1,968
20–39 years
 2003–2004 49.7 (46.0 – 53.5) 7.34 (5.42 – 9.22) 50.0 (45.7 – 54.1) 95.0 (87.9 – 102) 1,540
 2005–2006 52.2 (49.7 – 54.8) 11.3 (9.71 – 12.5) 52.8 (49.7 – 55.7) 91.9 (87.8 – 97.1) 1,693
40–59 years
 2003–2004 52.6 (49.4 – 55.8) 6.71 (5.02 – 8.71) 53.5 (51.2 – 56.6) 100 (95.5 – 105) 1,266
 2005–2006 50.6 (48.3 – 52.9) 7.92 (5.51 – 10.9) 51.3 (48.9 – 53.4) 94.4 (90.1 – 100) 1,369
60 years and older
 2003–2004 63.2 (60.8 – 65.6) 10.3 (7.88 – 13.3) 62.5 (60.2 – 64.7) 119 (114 – 124) 1,632
 2005–2006 62.9 (60.7 – 65.1) 11.8 (6.99 – 15.1) 62.6 (60.7 – 64.5) 113 (108 – 119) 1,392
Gender
Males
 2003–2004 52.2 (49.4 – 54.9) 7.32 (5.74 – 9.08) 52.7 (50.1 – 55.2) 100 (97.7 – 103) 3,590
 2005–2006 52.7 (51.0 – 54.3) 9.74 (7.88 – 11.0) 52.4 (50.9 – 53.9) 97.3 (93.7 – 102) 3,565
Females
 2003–2004 59.3 (56.4 – 62.3) 9.76 (7.89 – 11.4) 59.8 (56.7 – 62.5) 108 (102 – 115) 3,687
 2005–2006 60.0 (57.9 – 62.1) 13.1 (11.1 – 15.6) 59.4 (57.7 – 61.4) 105 (101 – 111) 3,737
Race/ethnicity
Mexican Americans
 2003–2004 55.4 (50.6 – 60.2) 14.0 (7.30 – 20.1) 55.6 (51.7 – 60.0) 93.1 (89.3 – 97.1) 1,766
 2005–2006 55.1 (52.8 – 57.5) 17.1 (10.8 – 20.6) 54.6 (51.7 – 57.5) 94.2 (90.8 – 97.3) 1,862
Non-Hispanic Blacks
 2003–2004 52.9 (50.3 – 55.4) 11.1 (7.65 – 13.5) 52.0 (49.7 – 55.5) 93.7 (90.5 – 99.1) 1,880
 2005–2006 55.7 (53.6 – 57.9) 13.0 (9.49 – 16.8) 55.4 (53.5 – 57.6) 95.6 (94.0 – 99.2) 1,904
Non-Hispanic Whites
 2003–2004 56.7 (53.1 – 60.3) 7.82 (6.24 – 9.09) 57.4 (53.1 – 60.6) 108 (103 – 115) 3,103














































































































Figure 1.8.b. Serum vitamin C: Concentrations by survey cycle
Selected percentiles in µmol/L (95% condence intervals), National Health and 
Nutrition Examination Survey, 2003–2006
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Table 1.8.c. Serum vitamin C: Prevalence
Prevalence (in percent) of low serum vitamin C concentration (< 11.4 µmol/L) for the U.S. population 




 (95% conf. interval)
Estimated total 
number of persons
Total, 6 years and older 14,579 6.0 (4.9 – 7.3) 15,757,000
Age group
 6–11 years 1,703 0.8‡ (0.4 – 1.7) 191,000‡
 12–19 years 3,984 2.8 (1.9 – 4.2) 931,000
 20–39 years 3,233 6.9 (5.4 – 8.9) 5,533,000
 40–59 years 2,635 8.1 (6.3 – 10.5) 6,435,000
 60 years and older 3,024 5.1 (3.8 – 6.8) 2,362,000
Gender
 Males 7,155 7.3 (5.9 – 9.0) 9,258,000
 Females 7,424 4.8 (3.8 – 6.0) 6,476,000
Race/ethnicity
 Mexican Americans 3,628 3.1 (2.1 – 4.6) 715,000
 Non-Hispanic Blacks 3,784 4.3 (3.2 – 5.7) 1,341,000
 Non-Hispanic Whites 6,089 7.1 (5.8 – 8.7) 12,807,000




Table 1.8.d. Serum vitamin C: Prevalence by survey cycle
Prevalence (in percent) of low serum vitamin C concentration (< 11.4 µmol/L) for the U.S. population, National 
Health and Nutrition Examination Survey, 2003–2006. 
Sample size Prevalence (95% conf. interval) Estimated total number of persons
Total, 6 years and older
 2003–2004 7,277 7.3 (5.5 – 9.6) 19,054,000
 2005–2006 7,302 4.8 (3.7 – 6.1) 12,746,000
Age group
6–11 years
 2003–2004 823 1.5‡ (0.7 – 3.6) 372,000‡
 2005–2006 880 § §
12–19 years
 2003–2004 2,016 3.3 (1.9 – 5.7) 1,090,000
 2005–2006 1,968 2.3‡ (1.2 – 4.5) 783,000‡
20–39 years
 2003–2004 1,540 9.3 (6.7 – 12.8) 7,437,000
 2005–2006 1,693 4.5 (3.2 – 6.4) 3,618,000
40–59 years
 2003–2004 1,266 9.2 (6.5 – 13.0) 7,294,000
 2005–2006 1,369 7.1 (4.7 – 10.5) 5,815,000
60 years and older
 2003–2004 1,632 5.5 (3.9 – 7.5) 2,543,000
 2005–2006 1,392 4.7 (2.8 – 7.8) 2,272,000
Gender
Males
 2003–2004 3,590 8.4 (6.0 – 11.8) 10,772,000
 2005–2006 3,565 6.1 (4.8 – 7.7) 7,914,000
Females
 2003–2004 3,687 6.1 (4.6 – 8.0) 8,247,000
 2005–2006 3,737 3.5 (2.4 – 5.1) 4,827,000
Race/ethnicity
Mexican Americans
 2003–2004 1,766 3.7 (2.0 – 6.7) 840,000
 2005–2006 1,862 2.6 (1.6 – 4.2) 627,000
Non-Hispanic Blacks
 2003–2004 1,880 4.8 (3.4 – 6.8) 1,510,000
 2005–2006 1,904 3.8 (2.3 – 6.2) 1,199,000
Non-Hispanic Whites
 2003–2004 3,103 8.6 (6.4 – 11.5) 15,534,000
 2005–2006 2,986 5.6 (4.2 – 7.4) 10,186,000
‡ Estimate flagged: 30% ≤ RSE < 40% for the prevalence estimate. 
§ Estimate suppressed: RSE ≥ 40% for the prevalence estimate. 
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Non−Hispanic Blacks Non−Hispanic Whites 
Figure 2.1.a. Serum vitamin A: Concentrations by age group 
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Table 2.1.a.2. Serum vitamin A: Total population
Geometric mean and selected percentiles of serum concentrations (in µg/dL) for the total U.S. population aged 
6 years and older, National Health and Nutrition Examination Survey, 2005–2006.
Geometric mean 
(95% conf. interval)
Selected percentiles (95% conf. interval) Sample 
size10th 50th 90th
Males and Females
Total, 6 years and older 54.7 (53.8 – 55.6) 36.6 (35.8 – 37.4) 55.2 (54.2 – 56.1) 80.0 (78.1 – 82.2) 7,254
6–11 years 36.4 (35.6 – 37.2) 28.0 (27.5 – 29.1) 36.6 (35.9 – 37.3) 47.5 (45.7 – 50.1) 860
12–19 years 46.5 (45.4 – 47.7) 35.2 (33.9 – 35.9) 46.0 (44.6 – 47.5) 63.2 (60.7 – 66.9) 1,954
20–39 years 54.3 (53.3 – 55.3) 38.1 (36.5 – 39.2) 54.7 (53.5 – 55.6) 77.7 (74.1 – 81.6) 1,688
40–59 years 58.7 (57.7 – 59.7) 41.2 (39.5 – 43.0) 59.5 (58.1 – 60.4) 81.0 (79.0 – 85.2) 1,365
60 years and older 64.4 (62.8 – 66.1) 46.4 (44.7 – 47.9) 64.9 (63.1 – 67.0) 88.4 (86.0 – 91.7) 1,387
Males
Total, 6 years and older 57.2 (56.3 – 58.2) 38.5 (37.8 – 39.2) 58.0 (57.1 – 59.0) 81.8 (79.7 – 85.0) 3,547
6–11 years 36.4 (35.4 – 37.3) 28.1 (26.4 – 29.1) 36.3 (35.0 – 37.2) 47.5 (45.7 – 51.6) 427
12–19 years 48.2 (46.9 – 49.6) 36.4 (35.3 – 37.7) 48.1 (46.3 – 49.8) 64.5 (62.9 – 67.4) 980
20–39 years 59.1 (57.7 – 60.5) 44.4 (42.3 – 46.0) 58.4 (56.8 – 60.2) 80.9 (76.8 – 84.5) 738
40–59 years 61.8 (60.7 – 63.0) 44.2 (41.6 – 47.1) 63.2 (62.4 – 64.2) 84.5 (80.1 – 92.0) 673
60 years and older 66.0 (63.9 – 68.1) 48.4 (46.0 – 50.0) 66.4 (63.7 – 68.7) 90.4 (86.3 – 97.2) 729
Females
Total, 6 years and older 52.4 (51.3 – 53.5) 35.6 (34.3 – 36.4) 52.4 (50.8 – 53.8) 77.5 (75.0 – 79.0) 3,707
6–11 years 36.5 (35.3 – 37.8) 28.0 (27.5 – 29.4) 36.9 (35.9 – 38.0) 47.0 (45.1 – 52.3) 433
12–19 years 44.7 (43.5 – 45.9) 33.7 (33.3 – 35.0) 43.8 (42.7 – 45.1) 60.7 (57.0 – 66.6) 974
20–39 years 50.0 (48.7 – 51.3) 34.5 (32.7 – 36.1) 49.3 (48.3 – 50.9) 72.6 (69.5 – 75.9) 950
40–59 years 55.9 (54.1 – 57.7) 39.9 (36.9 – 41.2) 55.8 (53.8 – 58.5) 78.4 (74.2 – 82.8) 692
60 years and older 63.2 (61.3 – 65.2) 45.1 (43.0 – 47.2) 63.9 (62.5 – 65.7) 87.7 (84.0 – 91.2) 658
Table 2.1.a.3. Serum vitamin A: Mexican Americans
Geometric mean and selected percentiles of serum concentrations (in µg/dL) for Mexican Americans in the U.S. 
population aged 6 years and older, National Health and Nutrition Examination Survey, 2005–2006. 
Geometric mean 
(95% conf. interval)
Selected percentiles (95% conf. interval) Sample 
size10th 50th 90th
Males and Females
Total, 6 years and older 48.4 (47.3 – 49.5) 33.4 (32.6 – 34.2) 48.8 (46.8 – 50.2) 68.6 (66.7 – 70.3) 1,844
6–11 years 35.6 (34.4 – 37.0) 27.6 (24.8 – 28.9) 35.8 (33.8 – 37.6) 46.2 (45.0 – 48.2) 295
12–19 years 44.9 (43.3 – 46.4) 34.1 (33.4 – 35.0) 44.4 (43.2 – 46.1) 58.8 (55.6 – 64.7) 646
20–39 years 50.1 (49.1 – 51.2) 36.0 (33.3 – 37.3) 50.3 (48.7 – 53.3) 69.1 (66.8 – 72.7) 449
40–59 years 53.6 (52.4 – 54.8) 39.0 (36.6 – 41.0) 52.6 (50.7 – 55.6) 71.7 (67.2 – 85.3) 246
60 years and older 55.5 (52.8 – 58.3) 40.8 (37.3 – 42.8) 57.0 (54.7 – 58.4) 78.1 (72.9 – 85.4) 208
Males
Total, 6 years and older 51.9 (50.0 – 53.9) 36.5 (33.7 – 38.5) 53.3 (50.2 – 55.9) 70.7 (68.8 – 73.3) 883
6–11 years 35.6 (33.9 – 37.4) 27.2 (24.0 – 28.8) 35.4 (33.0 – 38.7) 46.8 (45.6 – 49.1) 145
12–19 years 47.4 (45.6 – 49.3) 36.1 (33.8 – 38.0) 47.0 (45.0 – 48.6) 60.9 (58.7 – 65.7) 313
20–39 years 54.8 (52.4 – 57.3) 41.3 (36.6 – 43.9) 56.0 (54.0 – 59.0) 70.6 (68.0 – 74.3) 198
40–59 years 59.1 (56.0 – 62.3) 45.8 (42.9 – 47.4) 57.9 (53.9 – 63.1) 77.7 (70.5 – 110) 122
60 years and older 57.6 (53.3 – 62.3) 42.6† (19.8 – 47.4) 57.6 (55.1 – 62.0) 79.5† (70.6 – 93.0) 105
Females
Total, 6 years and older 44.7 (44.0 – 45.5) 32.1 (31.3 – 32.7) 43.7 (42.7 – 45.2) 64.2 (62.1 – 67.0) 961
6–11 years 35.7 (34.6 – 36.8) 28.0 (24.0 – 29.4) 36.0 (34.3 – 37.6) 45.7 (42.2 – 52.7) 150
12–19 years 42.3 (41.0 – 43.7) 33.3 (32.2 – 33.8) 41.6 (40.2 – 43.0) 55.9 (52.3 – 61.5) 333
20–39 years 45.0 (43.9 – 46.2) 31.9 (29.8 – 33.8) 43.2 (41.7 – 46.6) 66.6 (61.2 – 69.5) 251
40–59 years 48.4 (47.1 – 49.7) 35.6 (32.4 – 37.4) 49.1 (46.5 – 50.2) 63.9 (57.7 – 81.3) 124
60 years and older 53.8 (50.9 – 56.9) 39.4† (32.9 – 42.3) 53.5 (51.4 – 58.9) 75.9† (72.9 – 83.0) 103
† Estimate is subject to greater uncertainty due to small cell size. 
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Table 2.1.a.4. Serum vitamin A: Non-Hispanic blacks
Geometric mean and selected percentiles of serum concentrations (in µg/dL) for non-Hispanic blacks in the U.S. 
population aged 6 years and older, National Health and Nutrition Examination Survey, 2005–2006. 
Geometric mean 
(95% conf. interval)
Selected percentiles (95% conf. interval) Sample 
size10th 50th 90th
Males and Females
Total, 6 years and older 48.3 (47.3 – 49.3) 32.0 (31.2 – 32.8) 48.1 (47.0 – 49.5) 72.1 (70.0 – 75.1) 1,891
6–11 years 35.6 (34.0 – 37.3) 26.6 (24.0 – 28.5) 35.7 (34.5 – 36.8) 47.3 (44.6 – 51.8) 240
12–19 years 41.1 (40.0 – 42.2) 30.5 (29.4 – 31.3) 40.9 (39.7 – 42.6) 54.2 (52.8 – 57.5) 665
20–39 years 47.3 (45.8 – 48.9) 32.3 (29.8 – 35.3) 47.9 (44.9 – 50.5) 67.7 (63.6 – 71.6) 368
40–59 years 53.2 (51.4 – 55.0) 35.4 (33.3 – 37.2) 53.7 (50.3 – 57.2) 77.1 (72.8 – 85.7) 335
60 years and older 59.9 (56.3 – 63.7) 40.1 (36.2 – 45.6) 60.7 (56.6 – 64.5) 85.1 (78.8 – 91.4) 283
Males
Total, 6 years and older 51.2 (49.9 – 52.5) 34.0 (32.9 – 35.2) 51.9 (50.2 – 53.6) 74.8 (70.9 – 79.0) 949
6–11 years 35.4 (34.1 – 36.8) 26.2 (23.2 – 28.7) 35.3 (33.5 – 36.6) 46.2 (43.7 – 51.9) 128
12–19 years 42.2 (40.8 – 43.7) 30.6 (28.8 – 32.0) 42.0 (39.7 – 44.7) 58.1 (55.1 – 60.7) 343
20–39 years 53.3 (52.1 – 54.5) 38.9 (35.7 – 40.4) 54.1 (52.3 – 55.5) 71.2 (65.9 – 77.7) 170
40–59 years 57.3 (54.9 – 59.8) 39.0 (35.8 – 42.6) 58.4 (54.0 – 62.9) 84.8 (74.8 – 92.7) 156
60 years and older 60.8 (57.0 – 64.9) 40.0 (33.9 – 46.7) 62.5 (59.9 – 64.7) 86.0 (78.4 – 110) 152
Females
Total, 6 years and older 45.9 (44.7 – 47.1) 31.1 (29.4 – 32.1) 44.9 (43.5 – 46.7) 70.1 (65.9 – 74.6) 942
6–11 years 35.8 (33.0 – 39.0) 26.7 (19.8 – 28.8) 36.1 (33.0 – 38.8) 47.6 (44.2 – 54.2) 112
12–19 years 39.9 (38.7 – 41.2) 30.1 (29.4 – 30.8) 40.2 (38.7 – 41.7) 51.1 (49.9 – 53.1) 322
20–39 years 42.7 (41.1 – 44.3) 29.2 (24.3 – 32.0) 42.4 (40.4 – 44.5) 60.4 (57.4 – 63.5) 198
40–59 years 49.9 (46.8 – 53.3) 33.4 (31.9 – 34.3) 48.8 (45.9 – 53.5) 73.3 (68.1 – 84.7) 179
60 years and older 59.3 (55.4 – 63.4) 39.8 (36.7 – 43.8) 60.3 (54.6 – 64.5) 84.9 (77.9 – 90.2) 131
Table 2.1.a.5. Serum vitamin A: Non-Hispanic whites
Geometric mean and selected percentiles of serum concentrations (in µg/dL) for non-Hispanic whites in the 
U.S. population aged 6 years and older, National Health and Nutrition Examination Survey, 2005–2006. 
Geometric mean 
(95% conf. interval)
Selected percentiles (95% conf. interval) Sample 
size10th 50th 90th
Males and Females
Total, 6 years and older 57.4 (56.4 – 58.4) 39.0 (37.8 – 40.0) 57.9 (56.8 – 59.0) 82.0 (79.8 – 85.3) 2,973
6–11 years 36.8 (35.5 – 38.2) 28.6 (26.6 – 30.1) 37.1 (35.4 – 38.2) 47.6 (45.3 – 53.0) 231
12–19 years 48.5 (46.8 – 50.2) 37.0 (35.5 – 38.4) 48.3 (45.9 – 50.0) 66.2 (63.1 – 69.3) 499
20–39 years 57.5 (55.9 – 59.1) 41.4 (39.1 – 43.0) 57.1 (56.0 – 58.6) 81.4 (77.1 – 85.6) 714
40–59 years 60.4 (59.2 – 61.6) 43.3 (41.2 – 45.6) 60.5 (59.3 – 62.6) 81.9 (79.2 – 88.0) 683
60 years and older 65.4 (63.8 – 67.0) 47.1 (45.3 – 48.8) 66.0 (63.8 – 67.9) 89.5 (86.7 – 92.6) 846
Males
Total, 6 years and older 59.7 (58.5 – 60.9) 40.9 (39.4 – 41.9) 60.4 (58.9 – 62.1) 84.1 (80.7 – 87.8) 1,472
6–11 years 37.0 (35.6 – 38.6) 28.6 (25.1 – 30.3) 37.0 (35.1 – 38.4) 47.4 (45.3 – 53.2) 112
12–19 years 50.2 (48.3 – 52.2) 38.5 (35.2 – 40.4) 49.8 (47.5 – 52.0) 66.8 (64.3 – 69.7) 254
20–39 years 61.8 (59.9 – 63.8) 47.1 (45.1 – 48.4) 60.8 (58.3 – 63.5) 83.8 (79.8 – 87.8) 309
40–59 years 63.3 (61.5 – 65.2) 45.3 (40.1 – 49.9) 64.0 (62.7 – 66.1) 85.0 (80.0 – 101) 351
60 years and older 66.8 (64.6 – 69.0) 49.7 (46.1 – 50.4) 67.1 (63.8 – 70.2) 90.6 (87.3 – 99.0) 446
Females
Total, 6 years and older 55.3 (54.1 – 56.4) 37.6 (36.2 – 39.2) 55.6 (54.4 – 56.6) 79.8 (78.2 – 82.4) 1,501
6–11 years 36.6 (34.5 – 38.9) 28.2 (26.0 – 30.5) 37.1 (34.9 – 38.9) 48.1 (44.3 – 54.7) 119
12–19 years 46.6 (44.6 – 48.8) 35.9 (33.4 – 37.4) 45.5 (43.1 – 48.5) 63.7 (59.5 – 70.1) 245
20–39 years 53.5 (51.6 – 55.3) 36.7 (34.2 – 39.7) 53.1 (51.2 – 54.9) 76.1 (72.8 – 83.1) 405
40–59 years 57.7 (56.0 – 59.4) 41.6 (40.2 – 43.5) 57.7 (55.6 – 59.6) 79.1 (75.6 – 83.9) 332
60 years and older 64.3 (62.2 – 66.5) 46.4 (44.5 – 48.3) 64.8 (62.7 – 67.4) 87.9 (84.1 – 95.0) 400
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Table 2.1.b. Serum vitamin A: Concentrations by survey cycle
Geometric mean and selected percentiles of serum concentrations (in µg/dL) for the U.S. population, National 
Health and Nutrition Examination Survey, 1999–2002 and 2005–2006.
Geometric mean 
(95% conf. interval)
Selected percentiles (95% conf. interval) Sample 
size5th 50th 95th
Total, 6 years and older
 1999–2000 52.8 (51.8 – 53.8) 30.7 (29.8 – 31.6) 53.5 (52.2 – 54.9) 85.6 (83.9 – 87.2) 7,102
 2001–2002 55.2 (54.1 – 56.4) 32.6 (31.8 – 33.5) 56.0 (54.7 – 57.3) 88.4 (86.6 – 91.6) 7,935
 2005–2006 54.7 (53.8 – 55.6) 32.5 (31.8 – 33.2) 55.2 (54.2 – 56.1) 87.8 (85.6 – 90.5) 7,254
Age group
3–5 years
 1999–2000 32.3 (31.6 – 33.1) 22.0 (19.0 – 23.1) 33.1 (31.5 – 34.6) 46.2 (41.1 – 66.3) 352
 2001–2002 33.8 (33.1 – 34.6) 24.3 (16.5 – 25.5) 34.0 (33.1 – 35.2) 47.1 (44.3 – 50.3) 430
6–11 years
 1999–2000 35.1 (34.5 – 35.6) 25.3 (23.6 – 26.1) 35.4 (35.0 – 35.8) 48.5 (46.1 – 52.3) 866
 2001–2002 37.3 (36.2 – 38.5) 26.5 (25.8 – 27.4) 37.3 (36.2 – 39.0) 51.6 (50.1 – 54.0) 1,014
 2005–2006 36.4 (35.6 – 37.2) 25.6 (24.3 – 26.9) 36.6 (35.9 – 37.3) 52.4 (49.1 – 54.3) 860
12–19 years
 1999–2000 45.7 (44.7 – 46.6) 30.1 (29.1 – 30.9) 45.8 (45.0 – 46.9) 69.4 (66.9 – 71.8) 2,111
 2001–2002 48.0 (47.1 – 48.9) 31.8 (30.4 – 33.3) 48.5 (47.6 – 49.3) 71.2 (69.0 – 74.2) 2,206
 2005–2006 46.5 (45.4 – 47.7) 32.0 (30.6 – 33.0) 46.0 (44.6 – 47.5) 69.6 (66.9 – 73.1) 1,954
20–39 years
 1999–2000 52.1 (50.8 – 53.4) 33.0 (31.1 – 34.3) 52.8 (51.2 – 54.5) 80.3 (77.9 – 83.0) 1,461
 2001–2002 54.8 (53.3 – 56.3) 34.2 (32.6 – 35.3) 55.8 (54.4 – 57.5) 83.4 (80.9 – 86.6) 1,716
 2005–2006 54.3 (53.3 – 55.3) 33.9 (32.2 – 35.1) 54.7 (53.5 – 55.6) 84.4 (81.9 – 87.9) 1,688
40–59 years
 1999–2000 59.0 (57.6 – 60.6) 35.9 (34.2 – 38.1) 59.8 (57.9 – 61.5) 90.4 (86.4 – 96.8) 1,191
 2001–2002 60.3 (59.2 – 61.5) 37.5 (34.8 – 39.9) 61.2 (59.8 – 62.7) 94.6 (90.3 – 97.8) 1,474
 2005–2006 58.7 (57.7 – 59.7) 36.8 (36.0 – 38.0) 59.5 (58.1 – 60.4) 90.3 (87.2 – 94.3) 1,365
60 years and older
 1999–2000 62.5 (61.1 – 64.0) 39.7 (36.3 – 41.9) 63.0 (61.3 – 65.0) 94.3 (90.1 – 99.5) 1,473
 2001–2002 65.0 (63.6 – 66.5) 40.3 (38.0 – 41.4) 65.4 (64.1 – 67.4) 102 (98.6 – 108) 1,525
 2005–2006 64.4 (62.8 – 66.1) 40.2 (38.2 – 43.0) 64.9 (63.1 – 67.0) 99.8 (96.2 – 102) 1,387
Gender
(6 years and older)
Males
 1999–2000 55.8 (54.4 – 57.3) 31.9 (30.1 – 33.8) 57.5 (55.8 – 58.8) 86.3 (84.6 – 90.6) 3,450
 2001–2002 58.5 (57.2 – 59.8) 34.4 (33.4 – 35.5) 59.8 (58.0 – 61.7) 91.5 (88.7 – 93.7) 3,841
 2005–2006 57.2 (56.3 – 58.2) 33.6 (32.7 – 34.8) 58.0 (57.1 – 59.0) 89.0 (86.5 – 93.0) 3,547
Females
 1999–2000 50.1 (49.1 – 51.1) 30.2 (28.7 – 31.2) 50.0 (48.8 – 51.0) 84.1 (81.2 – 87.0) 3,652
 2001–2002 52.3 (51.1 – 53.5) 31.7 (30.9 – 32.4) 52.5 (51.0 – 53.9) 86.6 (84.0 – 88.3) 4,094
 2005–2006 52.4 (51.3 – 53.5) 31.9 (31.2 – 32.6) 52.4 (50.8 – 53.8) 85.9 (83.3 – 88.7) 3,707
Race/ethnicity
(6 years and older)
Mexican Americans
 1999–2000 47.0 (46.1 – 47.8) 29.0 (28.0 – 29.7) 46.9 (45.5 – 48.3) 75.6 (73.6 – 79.0) 2,410
 2001–2002 48.6 (47.2 – 50.0) 29.8 (28.8 – 30.7) 48.8 (47.4 – 50.4) 76.6 (73.4 – 82.1) 1,991
 2005–2006 48.4 (47.3 – 49.5) 30.3 (29.3 – 31.2) 48.8 (46.8 – 50.2) 73.7 (71.9 – 77.0) 1,844
Non-Hispanic Blacks
 1999–2000 45.8 (44.2 – 47.4) 27.8 (26.4 – 28.3) 45.4 (43.1 – 47.6) 75.7 (72.5 – 81.1) 1,590
 2001–2002 47.2 (46.1 – 48.3) 28.2 (27.4 – 28.9) 47.0 (45.3 – 48.6) 80.2 (77.3 – 85.7) 1,864
 2005–2006 48.3 (47.3 – 49.3) 28.8 (27.6 – 29.8) 48.1 (47.0 – 49.5) 82.0 (78.4 – 85.5) 1,891
Non-Hispanic Whites
 1999–2000 55.6 (54.2 – 57.1) 33.4 (31.2 – 34.7) 56.8 (55.0 – 58.2) 87.3 (85.4 – 90.5) 2,456
 2001–2002 57.9 (56.4 – 59.5) 34.7 (33.1 – 36.2) 58.9 (56.8 – 60.7) 91.3 (88.9 – 93.5) 3,455















































































Figure 2.1.b. Serum vitamin A: Concentrations by survey cycle 
Selected percentiles in μg/dL (95% confidence intervals), National Health and 
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Table 2.1.c.1. Serum vitamin A: Prevalence
Prevalence (in percent) of low serum vitamin A concentration (< 20 µg/dL) for the U.S. population aged 





Estimated total  
number of persons
Total, 6 years and older 7,254 0.3 (0.1 – 0.5) 711,000
Age group
 6–11 years 860 1.0 (0.6 – 1.5) 231,000
 12–19 years 1,954 § §
 20–39 years 1,688 § §
 40–59 years 1,365 § §
 60 years and older 1,387 § §
Gender
 Males 3,547 § §
 Females 3,707 0.2‡ (0.1 – 0.4) 317,000‡
Race/ethnicity
 Mexican Americans 1,844 § §
 Non-Hispanic Blacks 1,891 0.5 (0.3 – 0.7) 145,000
 Non-Hispanic Whites 2,973 0.2‡ (0.1 – 0.5) 386,000‡
‡ Estimate flagged: 30% ≤ RSE < 40% for the prevalence estimate. 
§ Estimate suppressed: RSE ≥ 40% for the prevalence estimate. 
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Table 2.1.c.2. Serum vitamin A: Prevalence
Prevalence (in percent) of high serum vitamin A concentration (> 100 µg/dL) for the U.S. population 




 (95% conf. interval)
Estimated total  
number of persons
Total, 6 years and older 7,254 2.1 (1.6 – 2.7) 5,573,000
Age group
 6–11 years 860 § §
 12–19 years 1,954 § §
 20–39 years 1,688 1.1‡ (0.5 – 2.3) 847,000‡
 40–59 years 1,365 2.7 (1.8 – 3.9) 2,182,000
 60 years and older 1,387 4.8 (3.8 – 6.0) 2,301,000
Gender
 Males 3,547 2.5 (1.8 – 3.4) 3,265,000
 Females 3,707 1.7 (1.0 – 2.9) 2,306,000
Race/ethnicity
 Mexican Americans 1,844 0.5‡ (0.3 – 1.1) 129,000‡
 Non-Hispanic Blacks 1,891 1.1 (0.6 – 2.0) 348,000
 Non-Hispanic Whites 2,973 2.6 (2.0 – 3.5) 4,752,000
‡ Estimate flagged: 30% ≤ RSE < 40% for the prevalence estimate. 
§ Estimate suppressed: RSE ≥ 40% for the prevalence estimate. 
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Table 2.1.d.1. Serum vitamin A: Prevalence by survey cycle
Prevalence (in percent) of low serum vitamin A concentration (< 20 µg/dL) for the U.S. population, National 
Health and Nutrition Examination Survey, 1999–2002 and 2005–2006. 
Sample size Prevalence (95% conf. interval) Estimated total number of persons
Total, 6 years and older
 1999–2000 7,102 0.1 (0.1 – 0.2) 360,000
 2001–2002 7,935 0.3 (0.2 – 0.4) 698,000
 2005–2006 7,254 0.3 (0.1 – 0.5) 711,000
Age group
3–5 years
 1999–2000 352 § §
 2001–2002 430 § §
6–11 years
 1999–2000 866 1.0 (0.6 – 1.6) 243,000
 2001–2002 1,014 § §
 2005–2006 860 1.0 (0.6 – 1.5) 231,000
12–19 years
 1999–2000 2,111 § §
 2001–2002 2,206 § §
 2005–2006 1,954 § §
20–39 years
 1999–2000 1,461 § §
 2001–2002 1,716 § §
 2005–2006 1,688 § §
40–59 years
 1999–2000 1,191 § §
 2001–2002 1,474 § §
 2005–2006 1,365 § §
60 years and older
 1999–2000 1,473 § §
 2001–2002 1,525 § §
 2005–2006 1,387 § §
Gender
(6 years and older)
Males
 1999–2000 3,450 0.1‡ (0.1 – 0.3) 179,000‡
 2001–2002 3,841 0.4 (0.2 – 0.7) 456,000
 2005–2006 3,547 § §
Females
 1999–2000 3,652 0.1 (0.1 – 0.2) 181,000
 2001–2002 4,094 0.2‡ (0.1 – 0.4) 242,000‡
 2005–2006 3,707 0.2‡ (0.1 – 0.4) 317,000‡
Race/ethnicity
(6 years and older)
Mexican Americans
 1999–2000 2,410 0.4‡ (0.2 – 0.8) 75,000‡
 2001–2002 1,991 § §
 2005–2006 1,844 § §
Non-Hispanic Blacks
 1999–2000 1,590 0.5 (0.3 – 0.8) 153,000
 2001–2002 1,864 0.7 (0.3 – 1.2) 201,000
 2005–2006 1,891 0.5 (0.3 – 0.7) 145,000
Non-Hispanic Whites
 1999–2000 2,456 § §
 2001–2002 3,455 0.2‡ (0.1 – 0.5) 398,000‡
 2005–2006 2,973 0.2‡ (0.1 – 0.5) 386,000‡
‡ Estimate flagged: 30% ≤ RSE < 40% for the prevalence estimate. 
§ Estimate suppressed: RSE ≥ 40% for the prevalence estimate. 
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Table 2.1.d.2. Serum vitamin A: Prevalence by survey cycle
Prevalence (in percent) of high serum vitamin A concentration (> 100 µg/dL) for the U.S. population, National 
Health and Nutrition Examination Survey, 1999–2002 and 2005–2006. 
Sample size Prevalence (95% conf. interval) Estimated total number of persons
Total, 6 years and older
 1999–2000 7,102 1.3 (1.0 – 1.8) 3,312,000
 2001–2002 7,935 2.0 (1.6 – 2.5) 5,242,000
 2005–2006 7,254 2.1 (1.6 – 2.7) 5,573,000
Age group
3–5 years
 1999–2000 352 § §
 2001–2002 430 § §
6–11 years
 1999–2000 866 § §
 2001–2002 1,014 § §
 2005–2006 860 § §
12–19 years
 1999–2000 2,111 § §
 2001–2002 2,206 § §
 2005–2006 1,954 § §
20–39 years
 1999–2000 1,461 § §
 2001–2002 1,716 0.6‡ (0.2 – 1.3) 437,000‡
 2005–2006 1,688 1.1‡ (0.5 – 2.3) 847,000‡
40–59 years
 1999–2000 1,191 2.4 (1.4 – 4.0) 1,688,000
 2001–2002 1,474 2.9 (2.0 – 4.4) 2,222,000
 2005–2006 1,365 2.7 (1.8 – 3.9) 2,182,000
60 years and older
 1999–2000 1,473 3.2 (2.1 – 4.8) 1,381,000
 2001–2002 1,525 5.9 (4.3 – 8.0) 2,628,000
 2005–2006 1,387 4.8 (3.8 – 6.0) 2,301,000
Gender
(6 years and older)
Males
 1999–2000 3,450 1.4 (0.9 – 2.4) 1,741,000
 2001–2002 3,841 2.4 (1.9 – 3.0) 3,013,000
 2005–2006 3,547 2.5 (1.8 – 3.4) 3,265,000
Females
 1999–2000 3,652 1.2 (0.7 – 2.0) 1,570,000
 2001–2002 4,094 1.7 (1.2 – 2.4) 2,226,000
 2005–2006 3,707 1.7 (1.0 – 2.9) 2,306,000
Race/ethnicity
(6 years and older)
Mexican Americans
 1999–2000 2,410 § §
 2001–2002 1,991 § §
 2005–2006 1,844 0.5‡ (0.3 – 1.1) 129,000‡
Non-Hispanic Blacks
 1999–2000 1,590 1.2 (0.7 – 2.2) 376,000
 2001–2002 1,864 1.7‡ (0.8 – 3.7) 519,000‡
 2005–2006 1,891 1.1 (0.6 – 2.0) 348,000
Non-Hispanic Whites
 1999–2000 2,456 1.7 (1.2 – 2.4) 2,962,000
 2001–2002 3,455 2.4 (1.9 – 2.9) 4,296,000
 2005–2006 2,973 2.6 (2.0 – 3.5) 4,752,000
‡ Estimate flagged: 30% ≤ RSE < 40% for the prevalence estimate. 
§ Estimate suppressed: RSE ≥ 40% for the prevalence estimate. 
















































































































































































































































































































































































































































































































































































































































































































































































































































































Non−Hispanic Blacks Non−Hispanic Whites 
Figure 2.2.a. Serum retinyl palmitate: Concentrations by age group 
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Table 2.2.a.2. Serum retinyl palmitate: Total population
Geometric mean and selected percentiles of serum concentrations (in µg/dL) for the total U.S. population aged 
6 years and older, National Health and Nutrition Examination Survey, 2005–2006. 
Geometric mean 
(95% conf. interval)
Selected percentiles (95% conf. interval) Sample 
size10th 50th 90th
Males and Females
Total, 6 years and older 2.11 (2.05 – 2.17) < LOD 2.08 (1.99 – 2.17) 4.40 (4.28 – 4.54) 6,946
6–11 years 2.15 (2.01 – 2.29) < LOD 2.14 (1.93 – 2.27) 4.19 (4.02 – 4.62) 827
12–19 years 1.90 (1.84 – 1.97) < LOD 1.83 (1.74 – 1.94) 3.79 (3.60 – 4.10) 1,865
20–39 years 2.13 (2.04 – 2.23) < LOD 2.18 (2.03 – 2.29) 4.16 (3.86 – 4.43) 1,620
40–59 years 2.14 (2.04 – 2.25) < LOD 2.12 (2.00 – 2.24) 4.57 (4.23 – 5.15) 1,315
60 years and older 2.14 (2.01 – 2.28) < LOD 2.04 (1.88 – 2.23) 4.99 (4.54 – 5.60) 1,319
Males
Total, 6 years and older 2.15 (2.08 – 2.23) < LOD 2.14 (2.04 – 2.24) 4.52 (4.39 – 4.69) 3,397
6–11 years 2.26 (2.05 – 2.48) < LOD 2.22 (2.02 – 2.36) 4.56 (4.13 – 5.45) 411
12–19 years 1.93 (1.82 – 2.05) < LOD 1.85 (1.72 – 2.02) 3.84 (3.55 – 4.26) 935
20–39 years 2.24 (2.09 – 2.39) < LOD 2.30 (2.14 – 2.43) 4.42 (4.04 – 4.69) 714
40–59 years 2.15 (2.01 – 2.30) < LOD 2.14 (2.01 – 2.27) 4.66 (4.29 – 5.53) 650
60 years and older 2.14 (2.01 – 2.28) < LOD 2.03 (1.87 – 2.25) 5.04 (4.47 – 5.60) 687
Females
Total, 6 years and older 2.07 (2.01 – 2.12) < LOD 2.01 (1.94 – 2.11) 4.29 (4.13 – 4.44) 3,549
6–11 years 2.05 (1.86 – 2.25) < LOD 2.03 (1.81 – 2.25) 4.02 (3.76 – 4.41) 416
12–19 years 1.88 (1.80 – 1.95) < LOD 1.82 (1.69 – 1.92) 3.69 (3.44 – 4.31) 930
20–39 years 2.02 (1.94 – 2.11) < LOD 2.03 (1.91 – 2.18) 3.87 (3.65 – 4.31) 906
40–59 years 2.13 (2.03 – 2.24) < LOD 2.10 (1.97 – 2.24) 4.48 (4.00 – 5.50) 665
60 years and older 2.14 (1.97 – 2.33) < LOD 2.05 (1.78 – 2.31) 4.95 (4.36 – 6.43) 632
< LOD means less than the limit of detection, which may vary for some compounds by year. See Appendix D for LOD.
Table 2.2.a.3. Serum retinyl palmitate: Mexican Americans
Geometric mean and selected percentiles of serum concentrations (in µg/dL) for Mexican Americans in the U.S. 
population aged 6 years and older, National Health and Nutrition Examination Survey, 2005–2006. 
Geometric mean 
(95% conf. interval)
Selected percentiles (95% conf. interval) Sample 
size10th 50th 90th
Males and Females
Total, 6 years and older 1.85 (1.78 – 1.91) < LOD 1.78 (1.69 – 1.88) 3.84 (3.60 – 4.09) 1,746
6–11 years 1.79 (1.67 – 1.91) < LOD 1.68 (1.58 – 1.80) 3.66 (3.09 – 4.25) 275
12–19 years 1.65 (1.56 – 1.74) < LOD 1.62 (1.57 – 1.67) 3.11 (2.87 – 3.51) 614
20–39 years 1.90 (1.77 – 2.04) < LOD 1.87 (1.68 – 2.04) 3.94 (3.68 – 4.49) 432
40–59 years 1.89 (1.78 – 2.02) < LOD 1.81 (1.67 – 2.00) 4.08 (3.50 – 4.79) 233
60 years and older 1.95 (1.78 – 2.14) < LOD 1.79 (1.63 – 2.06) 4.57 (3.78 – 5.89) 192
Males
Total, 6 years and older 1.91 (1.80 – 2.03) < LOD 1.84 (1.69 – 2.00) 3.99 (3.70 – 4.70) 832
6–11 years 1.73 (1.56 – 1.91) < LOD 1.60 (1.51 – 1.79) 3.68 (2.85 – 5.04) 136
12–19 years 1.69 (1.56 – 1.83) < LOD 1.64 (1.56 – 1.75) 3.12 (2.70 – 3.94) 294
20–39 years 1.99 (1.74 – 2.27) < LOD 1.95 (1.67 – 2.27) 4.21 (3.82 – 5.31) 193
40–59 years 2.05 (1.86 – 2.26) < LOD 1.98 (1.55 – 2.44) 4.35 (3.76 – 5.44) 114
60 years and older 1.86 (1.56 – 2.22) < LOD† 1.76 (1.35 – 2.41) 4.45† (3.55 – 5.43) 95
Females
Total, 6 years and older 1.78 (1.70 – 1.85) < LOD 1.72 (1.63 – 1.83) 3.56 (3.44 – 3.71) 914
6–11 years 1.85 (1.70 – 2.02) < LOD 1.76 (1.63 – 1.94) 3.64 (3.14 – 4.87) 139
12–19 years 1.61 (1.52 – 1.70) < LOD 1.60 (1.47 – 1.69) 3.09 (2.79 – 3.66) 320
20–39 years 1.79 (1.63 – 1.98) < LOD 1.77 (1.53 – 2.03) 3.56 (3.32 – 3.89) 239
40–59 years 1.75 (1.63 – 1.88) < LOD 1.72 (1.52 – 1.95) 3.52 (3.24 – 4.47) 119
60 years and older 2.02 (1.77 – 2.32) < LOD† 1.79 (1.58 – 2.24) 4.59† (3.30 – 8.50) 97
< LOD means less than the limit of detection, which may vary for some compounds by year. See Appendix D for LOD. 
† Estimate is subject to greater uncertainty due to small cell size. 
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Table 2.2.a.4. Serum retinyl palmitate: Non-Hispanic blacks
Geometric mean and selected percentiles of serum concentrations (in µg/dL) for non-Hispanic blacks in the U.S. 
population aged 6 years and older, National Health and Nutrition Examination Survey, 2005–2006. 
Geometric mean 
(95% conf. interval)
Selected percentiles (95% conf. interval) Sample 
size10th 50th 90th
Males and Females
Total, 6 years and older 2.04 (1.90 – 2.19) < LOD 2.03 (1.84 – 2.20) 4.13 (3.85 – 4.48) 1,842
6–11 years 2.49 (2.19 – 2.82) < LOD 2.49 (2.13 – 3.01) 4.82 (4.58 – 5.44) 238
12–19 years 2.03 (1.88 – 2.21) < LOD 1.99 (1.84 – 2.23) 4.05 (3.58 – 4.59) 643
20–39 years 2.12 (1.92 – 2.35) < LOD 2.10 (1.91 – 2.27) 4.23 (3.81 – 4.67) 363
40–59 years 1.96 (1.82 – 2.12) < LOD 1.94 (1.73 – 2.21) 3.88 (3.59 – 4.61) 326
60 years and older 1.77 (1.60 – 1.96) < LOD 1.65 (1.44 – 1.89) 3.95 (3.26 – 4.67) 272
Males
Total, 6 years and older 2.15 (1.99 – 2.32) < LOD 2.16 (2.00 – 2.30) 4.45 (3.88 – 5.02) 921
6–11 years 2.66 (2.34 – 3.03) < LOD 2.71 (2.35 – 2.96) 5.34 (4.54 – 6.33) 127
12–19 years 2.17 (1.98 – 2.38) < LOD 2.13 (1.88 – 2.36) 4.49 (3.67 – 5.39) 330
20–39 years 2.29 (2.05 – 2.56) < LOD 2.28 (2.05 – 2.56) 4.45 (3.73 – 5.85) 168
40–59 years 1.99 (1.80 – 2.21) < LOD 2.12 (1.69 – 2.30) 3.84 (3.42 – 7.34) 153
60 years and older 1.79 (1.59 – 2.01) < LOD 1.62 (1.32 – 1.99) 4.64 (3.40 – 5.35) 143
Females
Total, 6 years and older 1.95 (1.79 – 2.12) < LOD 1.92 (1.74 – 2.14) 3.93 (3.80 – 4.22) 921
6–11 years 2.32 (1.94 – 2.77) < LOD† 2.37 (1.87 – 2.87) 4.60† (4.24 – 5.12) 111
12–19 years 1.90 (1.71 – 2.12) < LOD 1.91 (1.65 – 2.19) 3.55 (3.39 – 4.26) 313
20–39 years 1.99 (1.75 – 2.25) < LOD 2.01 (1.73 – 2.24) 3.92 (3.70 – 4.67) 195
40–59 years 1.94 (1.76 – 2.14) < LOD 1.88 (1.69 – 2.11) 3.92 (3.61 – 4.47) 173
60 years and older 1.76 (1.52 – 2.03) < LOD 1.66 (1.43 – 2.02) 3.54 (3.07 – 4.22) 129
< LOD means less than the limit of detection, which may vary for some compounds by year. See Appendix D for LOD. 
† Estimate is subject to greater uncertainty due to small cell size.
Table 2.2.a.5. Serum retinyl palmitate: Non-Hispanic whites
Geometric mean and selected percentiles of serum concentrations (in µg/dL) for non-Hispanic whites in the 
U.S. population aged 6 years and older, National Health and Nutrition Examination Survey, 2005–2006. 
Geometric mean 
(95% conf. interval)
Selected percentiles (95% conf. interval) Sample 
size10th 50th 90th
Males and Females
Total, 6 years and older 2.17 (2.10 – 2.25) < LOD 2.17 (2.04 – 2.27) 4.54 (4.39 – 4.71) 2,838
6–11 years 2.18 (1.97 – 2.41) < LOD 2.16 (1.87 – 2.30) 4.19 (3.82 – 4.82) 224
12–19 years 1.93 (1.84 – 2.03) < LOD 1.85 (1.70 – 2.01) 3.92 (3.56 – 4.47) 475
20–39 years 2.21 (2.07 – 2.36) < LOD 2.30 (2.12 – 2.44) 4.32 (3.85 – 4.66) 676
40–59 years 2.20 (2.08 – 2.33) < LOD 2.21 (2.02 – 2.34) 4.66 (4.33 – 5.45) 658
60 years and older 2.20 (2.05 – 2.37) < LOD 2.12 (1.91 – 2.35) 5.16 (4.63 – 5.86) 805
Males
Total, 6 years and older 2.22 (2.12 – 2.32) < LOD 2.21 (2.08 – 2.30) 4.66 (4.45 – 4.99) 1,407
6–11 years 2.28 (1.97 – 2.63) < LOD† 2.22 (1.95 – 2.61) 4.52† (3.80 – 5.92) 107
12–19 years 1.94 (1.79 – 2.10) < LOD 1.87 (1.68 – 2.10) 3.80 (3.40 – 4.67) 245
20–39 years 2.35 (2.14 – 2.57) < LOD 2.40 (2.22 – 2.59) 4.49 (4.09 – 5.04) 293
40–59 years 2.21 (2.06 – 2.36) < LOD 2.20 (2.02 – 2.35) 4.77 (4.35 – 6.02) 339
60 years and older 2.20 (2.04 – 2.38) < LOD 2.10 (1.89 – 2.36) 5.16 (4.50 – 5.79) 423
Females
Total, 6 years and older 2.13 (2.05 – 2.21) < LOD 2.13 (1.96 – 2.26) 4.41 (4.25 – 4.65) 1,431
6–11 years 2.07 (1.77 – 2.43) < LOD 2.10 (1.75 – 2.39) 4.05 (3.50 – 4.51) 117
12–19 years 1.92 (1.81 – 2.04) < LOD 1.81 (1.67 – 1.98) 3.98 (3.30 – 4.57) 230
20–39 years 2.08 (1.94 – 2.23) < LOD 2.21 (1.91 – 2.36) 4.07 (3.57 – 4.65) 383
40–59 years 2.20 (2.06 – 2.34) < LOD 2.21 (1.97 – 2.40) 4.54 (4.05 – 5.85) 319
60 years and older 2.20 (1.99 – 2.42) < LOD 2.15 (1.80 – 2.41) 5.15 (4.45 – 6.71) 382
< LOD means less than the limit of detection, which may vary for some compounds by year. See Appendix D for LOD. 
† Estimate is subject to greater uncertainty due to small cell size. 
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Table 2.2.b. Serum retinyl palmitate: Concentrations by survey cycle
Geometric mean and selected percentiles of serum concentrations (in µg/dL) for the U.S. population, National 
Health and Nutrition Examination Survey, 1999–2002 and 2005–2006.
Geometric mean 
(95% conf. interval)
Selected percentiles (95% conf. interval) Sample 
size5th 50th 95th
Total, 6 years and older
 1999–2000 1.23 (1.04 – 1.46) < LOD 1.47 (1.27 – 1.70) 4.95 (4.58 – 5.83) 5,589
 2001–2002 1.92 (1.83 – 2.02) .690 (.537 – .696) 1.93 (1.85 – 2.01) 5.49 (5.16 – 5.86) 7,641
 2005–2006 2.11 (2.05 – 2.17) < LOD 2.08 (1.99 – 2.17) 5.67 (5.35 – 6.03) 6,946
Age group
3–5 years
 1999–2000 1.46 (1.16 – 1.84) < LOD 1.67 (1.33 – 1.97) 5.39 (4.82 – 8.78) 278
 2001–2002 1.88 (1.71 – 2.06) .482 (< LOD – .710) 1.82 (1.69 – 2.02) 5.62 (4.79 – 8.77) 412
6–11 years
 1999–2000 1.33 (1.07 – 1.67) < LOD 1.64 (1.29 – 2.02) 5.75 (4.55 – 8.88) 651
 2001–2002 2.02 (1.90 – 2.15) .700 (.462 – .801) 2.15 (2.03 – 2.25) 5.32 (4.79 – 5.85) 967
 2005–2006 2.15 (2.01 – 2.29) < LOD 2.14 (1.93 – 2.27) 5.01 (4.70 – 5.81) 827
12–19 years
 1999–2000 1.17 (.963 – 1.41) < LOD 1.41 (1.12 – 1.68) 4.11 (3.71 – 4.77) 1,620
 2001–2002 1.71 (1.61 – 1.80) .560 (.500 – .692) 1.77 (1.66 – 1.87) 4.21 (3.98 – 4.47) 2,122
 2005–2006 1.90 (1.84 – 1.97) < LOD 1.83 (1.74 – 1.94) 4.78 (4.51 – 5.37) 1,865
20–39 years
 1999–2000 1.14 (.928 – 1.39) < LOD 1.40 (1.21 – 1.62) 4.58 (4.14 – 5.67) 1,201
 2001–2002 1.91 (1.77 – 2.06) .643 (.543 – .720) 1.91 (1.79 – 2.03) 5.14 (4.65 – 5.79) 1,655
 2005–2006 2.13 (2.04 – 2.23) < LOD 2.18 (2.03 – 2.29) 5.00 (4.67 – 5.36) 1,620
40–59 years
 1999–2000 1.30 (1.06 – 1.59) < LOD 1.55 (1.30 – 1.84) 5.49 (4.61 – 6.83) 959
 2001–2002 1.99 (1.87 – 2.11) .623 (.529 – .698) 1.96 (1.89 – 2.06) 5.70 (5.19 – 6.53) 1,429
 2005–2006 2.14 (2.04 – 2.25) < LOD 2.12 (2.00 – 2.24) 6.15 (5.46 – 6.80) 1,315
60 years and older
 1999–2000 1.34 (1.11 – 1.62) < LOD 1.54 (1.29 – 1.89) 5.78 (4.87 – 6.47) 1,158
 2001–2002 1.96 (1.82 – 2.11) .522 (.453 – .580) 1.91 (1.75 – 2.13) 6.79 (6.11 – 7.83) 1,468
 2005–2006 2.14 (2.01 – 2.28) < LOD 2.04 (1.88 – 2.23) 6.87 (6.04 – 8.01) 1,319
Gender
(6 years and older)
Males
 1999–2000 1.38 (1.17 – 1.63) < LOD 1.61 (1.40 – 1.82) 5.22 (4.65 – 5.94) 2,676
 2001–2002 2.01 (1.90 – 2.12) .636 (.544 – .687) 2.01 (1.91 – 2.12) 5.71 (5.31 – 6.20) 3,698
 2005–2006 2.15 (2.08 – 2.23) < LOD 2.14 (2.04 – 2.24) 5.89 (5.50 – 6.32) 3,397
Females
 1999–2000 1.11 (.922 – 1.33) < LOD 1.36 (1.16 – 1.61) 4.79 (4.47 – 5.80) 2,913
 2001–2002 1.85 (1.76 – 1.95) .582 (.515 – .695) 1.84 (1.75 – 1.92) 5.11 (4.78 – 5.68) 3,943
 2005–2006 2.07 (2.01 – 2.12) < LOD 2.01 (1.94 – 2.11) 5.51 (4.96 – 6.12) 3,549
Race/ethnicity
(6 years and older)
Mexican Americans
 1999–2000 .759 (.635 – .906) < LOD .945 (.808 – 1.14) 3.69 (3.32 – 4.35) 1,463
 2001–2002 1.62 (1.47 – 1.78) .503 (.398 – .575) 1.65 (1.50 – 1.85) 4.28 (3.95 – 4.80) 1,980
 2005–2006 1.85 (1.78 – 1.91) < LOD 1.78 (1.69 – 1.88) 4.77 (4.40 – 5.18) 1,746
Non-Hispanic Blacks
 1999–2000 1.18 (.848 – 1.64) < LOD 1.48 (1.07 – 1.99) 5.06 (4.41 – 5.81) 1,422
 2001–2002 1.92 (1.82 – 2.02) .628 (.390 – .709) 1.96 (1.88 – 2.06) 5.44 (4.71 – 6.44) 1,734
 2005–2006 2.04 (1.90 – 2.19) < LOD 2.03 (1.84 – 2.20) 5.00 (4.65 – 5.76) 1,842
Non-Hispanic Whites
 1999–2000 1.32 (1.08 – 1.60) < LOD 1.57 (1.33 – 1.84) 5.12 (4.60 – 6.48) 2,121
 2001–2002 1.97 (1.87 – 2.08) .636 (.584 – .684) 1.95 (1.86 – 2.06) 5.57 (5.14 – 5.99) 3,318
 2005–2006 2.17 (2.10 – 2.25) < LOD 2.17 (2.04 – 2.27) 6.02 (5.60 – 6.49) 2,838
< LOD means less than the limit of detection, which may vary for some compounds by year. See Appendix D for LOD. 
 
Figure 2.2.b. Serum retinyl palmitate: Concentrations by survey cycle 
Selected percentiles in μg/dL (95% confidence intervals), National Health and 

























































































































































































Total 3−5y 6−11y 12−19y 20+y Males Females MA NHB NHW 
(6+y) (6+y) (6+y) (6+y) (6+y) (6+y) 
Values in the graph are suppressed if either the point estimate or the lower 95% confidence limit is noted as “< LOD” in the accompanying table. 
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Table 2.3.a.2. Serum retinyl stearate: Total population
Geometric mean and selected percentiles of serum concentrations (in µg/dL) for the total U.S. population aged 
6 years and older, National Health and Nutrition Examination Survey, 2005–2006. 
Geometric mean 
(95% conf. interval)
Selected percentiles (95% conf. interval) Sample 
size10th 50th 90th
Males and Females
Total, 6 years and older * < LOD < LOD .894 (.794 – 1.02) 6,698
6–11 years * < LOD < LOD .972 (.730 – 1.21) 792
12–19 years * < LOD < LOD < LOD 1,801
20–39 years * < LOD < LOD < LOD 1,555
40–59 years * < LOD < LOD .944 (.810 – 1.16) 1,262
60 years and older * < LOD < LOD 1.32 (1.13 – 1.58) 1,288
Males
Total, 6 years and older * < LOD < LOD .964 (.871 – 1.08) 3,276
6–11 years * < LOD < LOD 1.03 (< LOD – 1.76) 394
12–19 years * < LOD < LOD < LOD 898
20–39 years * < LOD < LOD .813 (.709 – .968) 682
40–59 years * < LOD < LOD .993 (.842 – 1.17) 624
60 years and older * < LOD < LOD 1.33 (1.16 – 1.53) 678
Females
Total, 6 years and older * < LOD < LOD .839 (.741 – .960) 3,422
6–11 years * < LOD < LOD .896 (< LOD – 1.17) 398
12–19 years * < LOD < LOD < LOD 903
20–39 years * < LOD < LOD < LOD 873
40–59 years * < LOD < LOD .903 (.764 – 1.21) 638
60 years and older * < LOD < LOD 1.32 (1.06 – 1.74) 610
< LOD means less than the limit of detection, which may vary for some compounds by year. See Appendix D for LOD. 
* Not calculated. Proportion of results below limit of detection was too high to provide a valid result.
Table 2.3.a.3. Serum retinyl stearate: Mexican Americans
Geometric mean and selected percentiles of serum concentrations (in µg/dL) for Mexican Americans in the U.S. 
population aged 6 years and older, National Health and Nutrition Examination Survey, 2005–2006. 
Geometric mean 
(95% conf. interval)
Selected percentiles (95% conf. interval) Sample 
size10th 50th 90th
Males and Females
Total, 6 years and older * < LOD < LOD < LOD 1,739
6–11 years * < LOD < LOD < LOD 272
12–19 years * < LOD < LOD < LOD 604
20–39 years * < LOD < LOD < LOD 428
40–59 years * < LOD < LOD .766 (< LOD – 1.23) 238
60 years and older * < LOD < LOD .902 (.707 – 1.32) 197
Males
Total, 6 years and older * < LOD < LOD .736 (< LOD – .877) 832
6–11 years * < LOD < LOD < LOD 135
12–19 years * < LOD < LOD < LOD 290
20–39 years * < LOD < LOD .700 (< LOD – .965) 190
40–59 years * < LOD < LOD .851 (< LOD – 1.95) 118
60 years and older * < LOD† < LOD .780† (< LOD – 3.26) 99
Females
Total, 6 years and older * < LOD < LOD < LOD 907
6–11 years * < LOD < LOD < LOD 137
12–19 years * < LOD < LOD < LOD 314
20–39 years * < LOD < LOD < LOD 238
40–59 years * < LOD < LOD < LOD 120
60 years and older * < LOD† < LOD 1.02† (< LOD – 1.97) 98
< LOD means less than the limit of detection, which may vary for some compounds by year. See Appendix D for LOD. 
* Not calculated. Proportion of results below limit of detection was too high to provide a valid result. 
† Estimate is subject to greater uncertainty due to small cell size.
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Table 2.3.a.4. Serum retinyl stearate: Non-Hispanic blacks
Geometric mean and selected percentiles of serum concentrations (in µg/dL) for non-Hispanic blacks in the U.S. 
population aged 6 years and older, National Health and Nutrition Examination Survey, 2005–2006. 
Geometric mean 
(95% conf. interval)
Selected percentiles (95% conf. interval) Sample 
size10th 50th 90th
Males and Females
Total, 6 years and older * < LOD < LOD < LOD 1,699
6–11 years * < LOD < LOD < LOD 219
12–19 years * < LOD < LOD < LOD 597
20–39 years * < LOD < LOD < LOD 322
40–59 years * < LOD < LOD .781 (< LOD – .931) 301
60 years and older * < LOD < LOD .770 (< LOD – 1.39) 260
Males
Total, 6 years and older * < LOD < LOD .746 (< LOD – .868) 849
6–11 years * < LOD < LOD < LOD 118
12–19 years * < LOD < LOD < LOD 300
20–39 years * < LOD < LOD < LOD 152
40–59 years * < LOD < LOD .813 (< LOD – 1.06) 141
60 years and older * < LOD < LOD 1.06 (< LOD – 1.55) 138
Females
Total, 6 years and older * < LOD < LOD < LOD 850
6–11 years * < LOD† < LOD < LOD† 101
12–19 years * < LOD < LOD < LOD 297
20–39 years * < LOD < LOD < LOD 170
40–59 years * < LOD < LOD .701 (< LOD – .962) 160
60 years and older * < LOD < LOD < LOD 122
< LOD means less than the limit of detection, which may vary for some compounds by year. See Appendix D for LOD. 
* Not calculated. Proportion of results below limit of detection was too high to provide a valid result. 
† Estimate is subject to greater uncertainty due to small cell size.
Table 2.3.a.5. Serum retinyl stearate: Non-Hispanic whites
Geometric mean and selected percentiles of serum concentrations (in µg/dL) for non-Hispanic whites in the 
U.S. population aged 6 years and older, National Health and Nutrition Examination Survey, 2005–2006. 
Geometric mean 
(95% conf. interval)
Selected percentiles (95% conf. interval) Sample 
size10th 50th 90th
Males and Females
Total, 6 years and older * < LOD < LOD 1.01 (.932 – 1.10) 2,747
6–11 years * < LOD < LOD 1.06 (.756 – 1.99) 212
12–19 years * < LOD < LOD < LOD 465
20–39 years * < LOD < LOD .727 (< LOD – .878) 660
40–59 years * < LOD < LOD 1.00 (.869 – 1.20) 627
60 years and older * < LOD < LOD 1.40 (1.17 – 1.73) 783
Males
Total, 6 years and older * < LOD < LOD 1.09 (.967 – 1.18) 1,370
6–11 years * < LOD† < LOD 1.09† (< LOD – 7.58) 103
12–19 years * < LOD < LOD .740 (< LOD – 1.05) 244
20–39 years * < LOD < LOD .927 (.740 – 1.16) 283
40–59 years * < LOD < LOD 1.07 (.862 – 1.24) 324
60 years and older * < LOD < LOD 1.39 (1.19 – 1.65) 416
Females
Total, 6 years and older * < LOD < LOD .948 (.855 – 1.07) 1,377
6–11 years * < LOD† < LOD 1.04† (.755 – 2.95) 109
12–19 years * < LOD < LOD < LOD 221
20–39 years * < LOD < LOD < LOD 377
40–59 years * < LOD < LOD .953 (.798 – 1.31) 303
60 years and older * < LOD < LOD 1.41 (1.08 – 2.01) 367
< LOD means less than the limit of detection, which may vary for some compounds by year. See Appendix D for LOD. 
* Not calculated. Proportion of results below limit of detection was too high to provide a valid result. 
† Estimate is subject to greater uncertainty due to small cell size.
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Table 2.3.b. Serum retinyl stearate: Concentrations by survey cycle
Geometric mean and selected percentiles of serum concentrations (in µg/dL) for the U.S. population, National 
Health and Nutrition Examination Survey, 1999–2002 and 2005–2006. 
Geometric mean 
(95% conf. interval)
Selected percentiles (95% conf. interval) Sample 
size5th 50th 95th
Total, 6 years and older
 1999–2000 * < LOD < LOD 1.12 (.983 – 1.44) 4,148
 2001–2002 * < LOD < LOD 1.08 (.988 – 1.19) 7,690
 2005–2006 * < LOD < LOD 1.31 (1.23 – 1.48) 6,698
Age group
3–5 years
 1999–2000 * < LOD† < LOD 2.43† (1.72 – 3.65) 212
 2001–2002 * < LOD < LOD 1.75 (1.37 – 3.49) 416
6–11 years
 1999–2000 * < LOD < LOD 1.74 (1.09 – 10.3) 434
 2001–2002 * < LOD < LOD 1.14 (.964 – 1.34) 981
 2005–2006 * < LOD < LOD 1.33 (1.08 – 1.97) 792
12–19 years
 1999–2000 * < LOD < LOD .829 (< LOD – 1.30) 1,194
 2001–2002 * < LOD < LOD < LOD 2,145
 2005–2006 * < LOD < LOD .911 (.743 – 1.14) 1,801
20–39 years
 1999–2000 * < LOD < LOD .928 (.651 – 1.36) 872
 2001–2002 * < LOD < LOD .721 (.693 – .893) 1,658
 2005–2006 * < LOD < LOD .947 (.850 – 1.09) 1,555
40–59 years
 1999–2000 * < LOD < LOD 1.32 (.944 – 2.40) 716
 2001–2002 * < LOD < LOD 1.15 (1.04 – 1.46) 1,422
 2005–2006 * < LOD < LOD 1.35 (1.23 – 1.63) 1,262
60 years and older
 1999–2000 * < LOD < LOD 1.83 (1.39 – 2.90) 932
 2001–2002 * < LOD < LOD 1.77 (1.52 – 2.08) 1,484
 2005–2006 * < LOD < LOD 1.93 (1.59 – 2.58) 1,288
Gender
(6 years and older)
Males
 1999–2000 * < LOD < LOD 1.13 (.987 – 1.66) 2,008
 2001–2002 * < LOD < LOD 1.19 (1.09 – 1.42) 3,710
 2005–2006 * < LOD < LOD 1.40 (1.29 – 1.54) 3,276
Females
 1999–2000 * < LOD < LOD 1.10 (.951 – 1.42) 2,140
 2001–2002 * < LOD < LOD .953 (.856 – 1.09) 3,980
 2005–2006 * < LOD < LOD 1.25 (1.09 – 1.48) 3,422
Race/ethnicity
(6 years and older)
Mexican Americans
 1999–2000 * < LOD < LOD .695 (< LOD – 2.14) 1,002
 2001–2002 * < LOD < LOD .587 (< LOD – .880) 1,921
 2005–2006 * < LOD < LOD .933 (.792 – 1.19) 1,739
Non-Hispanic Blacks
 1999–2000 * < LOD < LOD .962 (.590 – 15.0) 1,060
 2001–2002 * < LOD < LOD .733 (.619 – .963) 1,827
 2005–2006 * < LOD < LOD .896 (.829 – 1.10) 1,699
Non-Hispanic Whites
 1999–2000 * < LOD < LOD 1.27 (1.00 – 1.81) 1,608
 2001–2002 * < LOD < LOD 1.13 (1.02 – 1.30) 3,331
 2005–2006 * < LOD < LOD 1.50 (1.36 – 1.64) 2,747
< LOD means less than the limit of detection, which may vary for some compounds by year. See Appendix D for LOD. 
* Not calculated. Proportion of results below limit of detection was too high to provide a valid result. 
† Estimate is subject to greater uncertainty due to cell size.














































































































































Figure 2.3.b. Serum retinyl stearate: Concentrations by survey cycle
Selected percentiles in µg/dL (95% confidence intervals), National Health and 
Nutrition Examination Survey, 1999–2002 and 2005–2006
Values in the graph are suppressed if either the point estimate or the lower 95% confidence limit is noted as “< LOD” in the accompanying table.
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Figure 2.4.a. Serum vitamin E: Concentrations by age group
Geometric mean (95% confidence interval), National Health and Nutrition Examination Survey, 2005–2006
118 2nd National Report on Biochemical Indicators of Diet and Nutrition in the U.S. Population118
Table 2.4.a.2. Serum vitamin E: Total population
Geometric mean and selected percentiles of serum concentrations (in µg/dL) for the total U.S. population aged 
6 years and older, National Health and Nutrition Examination Survey, 2005–2006. 
Geometric mean 
(95% conf. interval)
Selected percentiles (95% conf. interval) Sample 
size10th 50th 90th
Males and Females
Total, 6 years and older 1,090 (1,070 – 1,120) 702 (686 – 716) 1,060 (1,030 – 1,080) 1,790 (1,730 – 1,840) 7,254
6–11 years 820 (800 – 841) 629 (621 – 638) 806 (788 – 826) 1,070 (1,040 – 1,180) 860
12–19 years 770 (757 – 783) 578 (557 – 587) 759 (749 – 767) 1,050 (1,000 – 1,070) 1,954
20–39 years 1,020 (998 – 1,040) 710 (683 – 727) 1,000 (980 – 1,020) 1,520 (1,410 – 1,610) 1,688
40–59 years 1,230 (1,190 – 1,260) 824 (799 – 848) 1,200 (1,160 – 1,240) 1,870 (1,790 – 2,040) 1,365
60 years and older 1,400 (1,360 – 1,440) 897 (828 – 949) 1,390 (1,330 – 1,430) 2,190 (2,130 – 2,270) 1,387
Males
Total, 6 years and older 1,060 (1,040 – 1,090) 682 (664 – 704) 1,030 (1,010 – 1,070) 1,730 (1,640 – 1,770) 3,547
6–11 years 817 (789 – 847) 629 (593 – 642) 807 (766 – 843) 1,070 (1,030 – 1,180) 427
12–19 years 753 (739 – 768) 553 (527 – 580) 747 (733 – 759) 1,030 (986 – 1,070) 980
20–39 years 1,030 (1,010 – 1,050) 699 (671 – 728) 1,010 (984 – 1,030) 1,570 (1,440 – 1,730) 738
40–59 years 1,210 (1,180 – 1,250) 798 (767 – 848) 1,190 (1,160 – 1,240) 1,820 (1,740 – 1,950) 673
60 years and older 1,300 (1,230 – 1,370) 827 (762 – 887) 1,290 (1,220 – 1,330) 2,070 (1,950 – 2,310) 729
Females
Total, 6 years and older 1,120 (1,090 – 1,140) 717 (705 – 723) 1,080 (1,050 – 1,100) 1,840 (1,790 – 1,910) 3,707
6–11 years 823 (792 – 856) 628 (608 – 647) 805 (784 – 837) 1,090 (1,020 – 1,230) 433
12–19 years 788 (772 – 804) 594 (570 – 611) 771 (755 – 788) 1,050 (991 – 1,120) 974
20–39 years 1,010 (981 – 1,040) 717 (679 – 738) 997 (956 – 1,030) 1,470 (1,360 – 1,580) 950
40–59 years 1,240 (1,200 – 1,290) 841 (818 – 860) 1,210 (1,160 – 1,240) 1,920 (1,820 – 2,120) 692
60 years and older 1,490 (1,440 – 1,540) 966 (926 – 987) 1,500 (1,430 – 1,540) 2,260 (2,190 – 2,470) 658
Table 2.4.a.3. Serum vitamin E: Mexican Americans
Geometric mean and selected percentiles of serum concentrations (in µg/dL) for Mexican Americans in the U.S. 
population aged 6 years and older, National Health and Nutrition Examination Survey, 2005–2006. 
Geometric mean 
(95% conf. interval)
Selected percentiles (95% conf. interval) Sample 
size10th 50th 90th
Males and Females
Total, 6 years and older 1,010 (980 – 1,040) 671 (656 – 695) 976 (945 – 1,000) 1,580 (1,530 – 1,630) 1,844
6–11 years 793 (770 – 816) 623 (599 – 644) 779 (755 – 800) 1,010 (977 – 1,110) 295
12–19 years 760 (740 – 781) 587 (578 – 597) 750 (723 – 773) 991 (970 – 1,050) 646
20–39 years 1,020 (991 – 1,060) 727 (676 – 755) 997 (968 – 1,020) 1,520 (1,420 – 1,640) 449
40–59 years 1,240 (1,200 – 1,280) 836 (808 – 861) 1,220 (1,160 – 1,270) 1,790 (1,730 – 1,950) 246
60 years and older 1,360 (1,250 – 1,470) 913 (816 – 996) 1,300 (1,240 – 1,370) 2,000 (1,720 – 3,120) 208
Males
Total, 6 years and older 1,010 (970 – 1,050) 671 (640 – 701) 972 (925 – 999) 1,570 (1,510 – 1,610) 883
6–11 years 786 (762 – 811) 622 (598 – 643) 763 (745 – 802) 989 (962 – 1,060) 145
12–19 years 748 (718 – 778) 591 (573 – 603) 733 (690 – 775) 978 (930 – 1,060) 313
20–39 years 1,040 (1,010 – 1,080) 753 (703 – 772) 990 (967 – 1,020) 1,590 (1,460 – 1,700) 198
40–59 years 1,270 (1,190 – 1,350) 863 (814 – 908) 1,260 (1,140 – 1,350) 1,670 (1,610 – 2,030) 122
60 years and older 1,260 (1,140 – 1,390) 845† (650 – 931) 1,240 (1,100 – 1,340) 1,970† (1,570 – 3,130) 105
Females
Total, 6 years and older 1,010 (984 – 1,030) 670 (649 – 696) 985 (949 – 1,020) 1,610 (1,530 – 1,670) 961
6–11 years 800 (763 – 838) 625 (514 – 658) 787 (760 – 799) 1,050 (958 – 1,240) 150
12–19 years 774 (750 – 798) 583 (570 – 597) 763 (748 – 784) 1,020 (960 – 1,090) 333
20–39 years 1,000 (955 – 1,050) 700 (634 – 742) 1,000 (947 – 1,060) 1,490 (1,340 – 1,650) 251
40–59 years 1,210 (1,170 – 1,260) 808 (778 – 859) 1,200 (1,110 – 1,240) 1,840 (1,710 – 2,100) 124
60 years and older 1,450 (1,300 – 1,610) 1,000† (872 – 1,090) 1,410 (1,240 – 1,540) 2,040† (1,720 – 4,610) 103
† Estimate is subject to greater uncertainty due to small cell size. 
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Table 2.4.a.4. Serum vitamin E: Non-Hispanic blacks
Geometric mean and selected percentiles of serum concentrations (in µg/dL) for non-Hispanic blacks in the U.S. 
population aged 6 years and older, National Health and Nutrition Examination Survey, 2005–2006. 
Geometric mean 
(95% conf. interval)
Selected percentiles (95% conf. interval) Sample 
size10th 50th 90th
Males and Females
Total, 6 years and older 933 (915 – 951) 644 (630 – 656) 903 (884 – 918) 1,400 (1,360 – 1,470) 1,891
6–11 years 771 (743 – 801) 587 (550 – 634) 762 (735 – 800) 1,010 (941 – 1,090) 240
12–19 years 731 (715 – 748) 575 (551 – 591) 727 (717 – 736) 945 (913 – 990) 665
20–39 years 926 (896 – 957) 665 (620 – 686) 893 (865 – 933) 1,340 (1,250 – 1,450) 368
40–59 years 1,040 (1,010 – 1,070) 736 (688 – 779) 1,010 (998 – 1,050) 1,540 (1,420 – 1,670) 335
60 years and older 1,110 (1,060 – 1,160) 752 (709 – 791) 1,080 (993 – 1,150) 1,680 (1,560 – 1,780) 283
Males
Total, 6 years and older 915 (897 – 933) 636 (618 – 651) 882 (870 – 895) 1,390 (1,310 – 1,460) 949
6–11 years 768 (740 – 799) 588 (558 – 634) 752 (726 – 799) 1,030 (928 – 1,110) 128
12–19 years 732 (714 – 751) 582 (558 – 606) 727 (712 – 737) 940 (904 – 981) 343
20–39 years 937 (888 – 989) 650 (603 – 687) 896 (862 – 939) 1,400 (1,240 – 1,670) 170
40–59 years 1,010 (972 – 1,050) 718 (632 – 743) 988 (960 – 1,020) 1,520 (1,390 – 1,640) 156
60 years and older 1,050 (1,000 – 1,100) 726 (580 – 770) 980 (894 – 1,080) 1,680 (1,410 – 2,250) 152
Females
Total, 6 years and older 949 (923 – 976) 651 (638 – 673) 916 (897 – 944) 1,450 (1,350 – 1,560) 942
6–11 years 775 (735 – 817) 579 (400 – 643) 776 (746 – 803) 1,000 (931 – 1,140) 112
12–19 years 731 (706 – 757) 567 (517 – 596) 726 (712 – 750) 957 (906 – 1,050) 322
20–39 years 917 (893 – 941) 677 (613 – 704) 892 (862 – 925) 1,270 (1,190 – 1,490) 198
40–59 years 1,070 (1,030 – 1,110) 761 (707 – 808) 1,040 (1,000 – 1,110) 1,540 (1,400 – 1,740) 179
60 years and older 1,150 (1,080 – 1,230) 774 (650 – 848) 1,130 (1,040 – 1,230) 1,670 (1,560 – 1,770) 131
Table 2.4.a.5. Serum vitamin E: Non-Hispanic whites
Geometric mean and selected percentiles of serum concentrations (in µg/dL) for non-Hispanic whites in the 
U.S. population aged 6 years and older, National Health and Nutrition Examination Survey, 2005–2006. 
Geometric mean 
(95% conf. interval)
Selected percentiles (95% conf. interval) Sample 
size10th 50th 90th
Males and Females
Total, 6 years and older 1,140 (1,110 – 1,160) 718 (706 – 729) 1,110 (1,080 – 1,140) 1,870 (1,810 – 1,940) 2,973
6–11 years 840 (815 – 866) 627 (612 – 642) 826 (805 – 854) 1,120 (1,060 – 1,260) 231
12–19 years 779 (761 – 797) 579 (544 – 589) 765 (751 – 784) 1,060 (1,010 – 1,140) 499
20–39 years 1,040 (1,010 – 1,070) 711 (671 – 741) 1,030 (1,000 – 1,060) 1,550 (1,410 – 1,710) 714
40–59 years 1,260 (1,220 – 1,300) 846 (817 – 866) 1,230 (1,190 – 1,260) 1,910 (1,800 – 2,100) 683
60 years and older 1,430 (1,390 – 1,480) 919 (856 – 976) 1,430 (1,390 – 1,480) 2,230 (2,170 – 2,330) 846
Males
Total, 6 years and older 1,100 (1,070 – 1,130) 703 (671 – 725) 1,080 (1,050 – 1,120) 1,770 (1,740 – 1,850) 1,472
6–11 years 839 (801 – 879) 629 (562 – 680) 830 (791 – 880) 1,080 (1,030 – 1,300) 112
12–19 years 757 (737 – 778) 542 (523 – 572) 754 (730 – 783) 1,060 (1,000 – 1,110) 254
20–39 years 1,040 (1,020 – 1,070) 687 (640 – 735) 1,030 (1,020 – 1,060) 1,590 (1,430 – 1,770) 309
40–59 years 1,240 (1,200 – 1,270) 818 (769 – 865) 1,230 (1,180 – 1,260) 1,840 (1,750 – 2,040) 351
60 years and older 1,330 (1,240 – 1,420) 862 (733 – 930) 1,300 (1,250 – 1,360) 2,100 (1,970 – 2,460) 446
Females
Total, 6 years and older 1,170 (1,150 – 1,200) 727 (718 – 746) 1,140 (1,100 – 1,170) 1,930 (1,870 – 2,050) 1,501
6–11 years 841 (792 – 892) 624 (597 – 656) 819 (774 – 878) 1,160 (1,050 – 1,470) 119
12–19 years 803 (780 – 827) 601 (562 – 641) 779 (750 – 805) 1,060 (985 – 1,200) 245
20–39 years 1,040 (1,000 – 1,080) 720 (699 – 754) 1,020 (978 – 1,060) 1,510 (1,360 – 1,630) 405
40–59 years 1,270 (1,230 – 1,320) 862 (842 – 894) 1,240 (1,190 – 1,280) 2,000 (1,850 – 2,190) 332
60 years and older 1,530 (1,480 – 1,590) 985 (964 – 1,020) 1,530 (1,470 – 1,590) 2,320 (2,240 – 2,500) 400
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Table 2.4.b. Serum vitamin E: Concentrations by survey cycle
Geometric mean and selected percentiles of serum concentrations (in µg/dL) for the U.S. population, National 
Health and Nutrition Examination Survey, 1999–2002 and 2005–2006. 
Geometric mean 
(95% conf. interval)
Selected percentiles (95% conf. interval) Sample 
size5th 50th 95th
Total, 6 years and older
 1999–2000 1,070 (1,040 – 1,110) 597 (575 – 612) 1,010 (986 – 1,040) 2,350 (2,280 – 2,500) 7,054
 2001–2002 1,110 (1,090 – 1,140) 637 (623 – 649) 1,050 (1,010 – 1,090) 2,380 (2,260 – 2,520) 7,935
 2005–2006 1,090 (1,070 – 1,120) 631 (620 – 642) 1,060 (1,030 – 1,080) 2,090 (2,010 – 2,180) 7,254
Age group
3–5 years
 1999–2000 785 (752 – 820) 559 (514 – 585) 772 (734 – 829) 1,160 (1,120 – 1,400) 347
 2001–2002 814 (780 – 850) 577 (553 – 601) 796 (760 – 824) 1,200 (1,090 – 1,670) 430
6–11 years
 1999–2000 783 (754 – 814) 545 (519 – 557) 781 (749 – 824) 1,130 (1,090 – 1,210) 859
 2001–2002 804 (788 – 821) 576 (560 – 591) 798 (780 – 819) 1,140 (1,090 – 1,220) 1,014
 2005–2006 820 (800 – 841) 583 (563 – 601) 806 (788 – 826) 1,200 (1,120 – 1,370) 860
12–19 years
 1999–2000 736 (717 – 756) 513 (491 – 530) 729 (712 – 744) 1,100 (1,020 – 1,240) 2,108
 2001–2002 782 (768 – 796) 550 (540 – 559) 771 (761 – 786) 1,170 (1,110 – 1,280) 2,206
 2005–2006 770 (757 – 783) 527 (516 – 541) 759 (749 – 767) 1,160 (1,130 – 1,200) 1,954
20–39 years
 1999–2000 973 (952 – 995) 615 (590 – 630) 938 (911 – 972) 1,750 (1,640 – 1,860) 1,452
 2001–2002 1,010 (987 – 1,030) 646 (627 – 661) 979 (960 – 1,000) 1,720 (1,620 – 1,880) 1,716
 2005–2006 1,020 (998 – 1,040) 645 (621 – 668) 1,000 (980 – 1,020) 1,730 (1,620 – 1,900) 1,688
40–59 years
 1999–2000 1,300 (1,250 – 1,360) 753 (716 – 791) 1,230 (1,200 – 1,280) 2,670 (2,470 – 2,940) 1,181
 2001–2002 1,310 (1,270 – 1,340) 776 (751 – 793) 1,260 (1,220 – 1,300) 2,530 (2,380 – 3,030) 1,474
 2005–2006 1,230 (1,190 – 1,260) 749 (724 – 769) 1,200 (1,160 – 1,240) 2,210 (2,080 – 2,400) 1,365
60 years and older
 1999–2000 1,510 (1,470 – 1,560) 788 (749 – 825) 1,450 (1,390 – 1,510) 3,020 (2,920 – 3,290) 1,454
 2001–2002 1,540 (1,490 – 1,590) 830 (763 – 869) 1,500 (1,440 – 1,550) 3,290 (3,030 – 3,540) 1,525
 2005–2006 1,400 (1,360 – 1,440) 783 (733 – 835) 1,390 (1,330 – 1,430) 2,600 (2,510 – 2,660) 1,387
Gender
(6 years and older)
Males
 1999–2000 1,050 (1,010 – 1,090) 580 (557 – 604) 993 (976 – 1,020) 2,280 (2,130 – 2,470) 3,426
 2001–2002 1,090 (1,060 – 1,130) 623 (607 – 646) 1,030 (986 – 1,080) 2,300 (2,160 – 2,470) 3,841
 2005–2006 1,060 (1,040 – 1,090) 610 (594 – 625) 1,030 (1,010 – 1,070) 2,010 (1,930 – 2,090) 3,547
Females
 1999–2000 1,100 (1,070 – 1,140) 605 (580 – 627) 1,030 (990 – 1,070) 2,450 (2,300 – 2,690) 3,628
 2001–2002 1,130 (1,110 – 1,150) 646 (629 – 660) 1,060 (1,040 – 1,100) 2,480 (2,280 – 2,700) 4,094
 2005–2006 1,120 (1,090 – 1,140) 653 (639 – 664) 1,080 (1,050 – 1,100) 2,170 (2,080 – 2,260) 3,707
Race/ethnicity
(6 years and older)
Mexican Americans
 1999–2000 962 (932 – 994) 572 (558 – 587) 918 (895 – 947) 1,810 (1,740 – 2,010) 2,410
 2001–2002 994 (954 – 1,040) 606 (584 – 625) 949 (917 – 979) 1,810 (1,690 – 2,080) 1,991
 2005–2006 1,010 (980 – 1,040) 623 (602 – 637) 976 (945 – 1,000) 1,790 (1,750 – 1,870) 1,844
Non-Hispanic Blacks
 1999–2000 904 (869 – 941) 566 (539 – 580) 869 (835 – 910) 1,700 (1,620 – 1,910) 1,584
 2001–2002 930 (907 – 953) 601 (573 – 617) 897 (883 – 915) 1,690 (1,540 – 1,940) 1,864
 2005–2006 933 (915 – 951) 588 (581 – 601) 903 (884 – 918) 1,660 (1,560 – 1,750) 1,891
Non-Hispanic Whites
 1999–2000 1,130 (1,100 – 1,170) 618 (600 – 634) 1,060 (1,040 – 1,100) 2,540 (2,380 – 2,720) 2,414
 2001–2002 1,160 (1,130 – 1,200) 653 (626 – 674) 1,110 (1,060 – 1,150) 2,510 (2,380 – 2,690) 3,455
 2005–2006 1,140 (1,110 – 1,160) 643 (624 – 658) 1,110 (1,080 – 1,140) 2,170 (2,090 – 2,270) 2,973
 
 














































































































































Figure 2.4.b. Serum vitamin E: Concentrations by survey cycle
Selected percentiles in µg/dL (95% confidence intervals), National Health and 
Nutrition Examination Survey, 1999–2002 and 2005–2006
122 2nd National Report on Biochemical Indicators of Diet and Nutrition in the U.S. Population122
Table 2.4.c. Serum vitamin E: Prevalence
Prevalence (in percent) of low serum vitamin E concentration (< 500 µg/dL) for the U.S. population 







Total, 6 years and older 7,254 0.7 (0.5 – 0.9) 1,835,000
Age group
6–11 years 860 0.9‡ (0.4 – 2.0) 221,000‡
12–19 years 1,954 2.6 (1.6 – 4.3) 885,000
20–39 years 1,688 § §
40–59 years 1,365 0.3‡ (0.1 – 0.6) 237,000‡
60 years and older 1,387 0.4 (0.3 – 0.7) 209,000
Gender
Males 3,547 0.9 (0.6 – 1.2) 1,110,000
Females 3,707 0.5 (0.3 – 0.8) 725,000
Race/ethnicity
Mexican Americans 1,844 § §
Non-Hispanic Blacks 1,891 1.2 (0.9 – 1.7) 396,000
Non-Hispanic Whites 2,973 0.6 (0.4 – 0.8) 1,059,000
‡ Estimate flagged: 30% ≤ RSE < 40% for the prevalence estimate. 
§ Estimate suppressed: RSE ≥ 40% for the prevalence estimate. 
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Table 2.4.d. Serum vitamin E: Prevalence by survey cycle
Prevalence (in percent) of low serum vitamin E concentration (< 500 µg/dL) for the U.S. population, National 
Health and Nutrition Examination Survey, 1999–2002 and 2005–2006. 
Sample size Prevalence (95% conf. interval) Estimated total number of persons
Total, 6 years and older
 1999–2000 7,054 1.0 (0.7 – 1.6) 2,558,000
 2001–2002 7,935 0.4 (0.3 – 0.6) 1,108,000
 2005–2006 7,254 0.7 (0.5 – 0.9) 1,835,000
Age group
3–5 years
 1999–2000 347 § §
 2001–2002 430 § §
6–11 years
 1999–2000 859 2.0‡ (1.0 – 4.1) 492,000‡
 2001–2002 1,014 § §
 2005–2006 860 0.9‡ (0.4 – 2.0) 221,000‡
12–19 years
 1999–2000 2,108 3.8 (2.1 – 6.8) 1,202,000
 2001–2002 2,206 1.6 (1.0 – 2.6) 509,000
 2005–2006 1,954 2.6 (1.6 – 4.3) 885,000
20–39 years
 1999–2000 1,452 0.9‡ (0.5 – 1.8) 730,000‡
 2001–2002 1,716 § §
 2005–2006 1,688 § §
40–59 years
 1999–2000 1,181 0.1‡ (0.1 – 0.2) 80,000‡
 2001–2002 1,474 § §
 2005–2006 1,365 0.3‡ (0.1 – 0.6) 237,000‡
60 years and older
 1999–2000 1,454 § §
 2001–2002 1,525 § §
 2005–2006 1,387 0.4 (0.3 – 0.7) 209,000
Gender
(6 years and older)
Males
 1999–2000 3,426 1.4 (0.8 – 2.3) 1,660,000
 2001–2002 3,841 0.6 (0.4 – 1.0) 781,000
 2005–2006 3,547 0.9 (0.6 – 1.2) 1,110,000
Females
 1999–2000 3,628 0.7 (0.4 – 1.1) 895,000
 2001–2002 4,094 0.2 (0.1 – 0.5) 325,000
 2005–2006 3,707 0.5 (0.3 – 0.8) 725,000
Race/ethnicity
(6 years and older)
Mexican Americans
 1999–2000 2,410 1.3 (0.9 – 1.8) 227,000
 2001–2002 1,991 0.7‡ (0.4 – 1.5) 156,000‡
 2005–2006 1,844 § §
Non-Hispanic Blacks
 1999–2000 1,584 1.7 (0.9 – 3.2) 520,000
 2001–2002 1,864 0.7 (0.4 – 1.1) 207,000
 2005–2006 1,891 1.2 (0.9 – 1.7) 396,000
Non-Hispanic Whites
 1999–2000 2,414 0.8 (0.5 – 1.3) 1,491,000
 2001–2002 3,455 0.3 (0.2 – 0.5) 556,000
 2005–2006 2,973 0.6 (0.4 – 0.8) 1,059,000
‡ Estimate flagged: 30% ≤ RSE < 40% for the prevalence estimate. 
§ Estimate suppressed: RSE ≥ 40% for the prevalence estimate. 
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Figure 2.5.a. Serum gamma−tocopherol: Concentrations by age group
Geometric mean (95% confidence interval), National Health and Nutrition Examination Survey, 2005–2006
126 2nd National Report on Biochemical Indicators of Diet and Nutrition in the U.S. Population126
Table 2.5.a.2. Serum gamma-tocopherol: Total population
Geometric mean and selected percentiles of serum concentrations (in µg/dL) for the total U.S. population aged 
6 years and older, National Health and Nutrition Examination Survey, 2005–2006.
Geometric mean 
(95% conf. interval)
Selected percentiles (95% conf. interval) Sample 
size10th 50th 90th
Males and Females
Total, 6 years and older 188 (180 – 196) 93.2 (86.8 – 98.0) 196 (187 – 204) 361 (347 – 385) 7,217
6–11 years 182 (171 – 193) 106 (102 – 111) 179 (169 – 193) 311 (298 – 341) 858
12–19 years 179 (171 – 188) 106 (98.1 – 114) 184 (175 – 194) 288 (276 – 304) 1,942
20–39 years 194 (184 – 205) 106 (94.7 – 114) 200 (192 – 209) 353 (330 – 393) 1,675
40–59 years 201 (192 – 212) 95.2 (84.4 – 102) 213 (203 – 221) 400 (376 – 423) 1,358
60 years and older 165 (154 – 177) 68.6 (60.9 – 73.4) 176 (161 – 192) 358 (340 – 397) 1,384
Males
Total, 6 years and older 192 (184 – 200) 98.7 (89.3 – 107) 198 (189 – 206) 359 (349 – 389) 3,528
6–11 years 177 (166 – 189) 105 (94.0 – 109) 176 (163 – 189) 304 (276 – 349) 425
12–19 years 173 (162 – 184) 103 (89.6 – 114) 177 (168 – 188) 284 (266 – 306) 974
20–39 years 202 (193 – 211) 113 (105 – 119) 203 (194 – 215) 386 (349 – 414) 732
40–59 years 207 (194 – 221) 99.0 (86.0 – 113) 215 (202 – 230) 403 (365 – 442) 669
60 years and older 171 (157 – 185) 73.7 (66.9 – 77.2) 184 (159 – 204) 354 (336 – 396) 728
Females
Total, 6 years and older 184 (175 – 194) 88.2 (80.0 – 93.8) 194 (183 – 203) 362 (338 – 388) 3,689
6–11 years 187 (174 – 201) 110 (93.6 – 122) 183 (169 – 199) 323 (299 – 346) 433
12–19 years 187 (177 – 197) 110 (101 – 119) 191 (184 – 201) 292 (274 – 313) 968
20–39 years 187 (173 – 202) 97.2 (79.9 – 110) 196 (180 – 207) 331 (312 – 383) 943
40–59 years 197 (186 – 208) 90.5 (75.5 – 99.0) 207 (195 – 223) 398 (377 – 423) 689
60 years and older 161 (148 – 175) 63.9 (53.9 – 72.6) 168 (155 – 188) 375 (328 – 405) 656
Table 2.5.a.3. Serum gamma-tocopherol: Mexican Americans
Geometric mean and selected percentiles of serum concentrations (in µg/dL) for Mexican Americans in the U.S. 
population aged 6 years and older, National Health and Nutrition Examination Survey, 2005–2006. 
Geometric mean 
(95% conf. interval)
Selected percentiles (95% conf. interval) Sample 
size10th 50th 90th
Males and Females
Total, 6 years and older 204 (192 – 217) 113 (106 – 117) 209 (195 – 222) 363 (343 – 403) 1,841
6–11 years 199 (178 – 221) 114 (91.6 – 122) 202 (181 – 234) 323 (303 – 388) 293
12–19 years 189 (179 – 200) 115 (106 – 124) 197 (183 – 207) 292 (279 – 316) 645
20–39 years 203 (190 – 217) 111 (107 – 116) 209 (190 – 223) 366 (333 – 429) 449
40–59 years 218 (202 – 237) 114 (91.7 – 125) 226 (213 – 240) 410 (357 – 478) 246
60 years and older 210 (196 – 225) 99.7 (90.1 – 117) 211 (194 – 224) 406 (365 – 464) 208
Males
Total, 6 years and older 206 (196 – 216) 114 (109 – 118) 210 (193 – 224) 363 (339 – 417) 881
6–11 years 196 (175 – 219) 116 (90.6 – 128) 189 (171 – 221) 329 (290 – 448) 143
12–19 years 180 (169 – 191) 109 (97.9 – 115) 187 (166 – 208) 282 (264 – 310) 313
20–39 years 207 (195 – 221) 112 (107 – 118) 216 (191 – 228) 375 (316 – 522) 198
40–59 years 226 (199 – 256) 118 (96.4 – 141) 227 (201 – 265) 376 (345 – 582) 122
60 years and older 213 (187 – 242) 100† (83.3 – 119) 205 (182 – 266) 412† (353 – 496) 105
Females
Total, 6 years and older 202 (185 – 220) 112 (96.2 – 120) 207 (194 – 221) 363 (334 – 407) 960
6–11 years 201 (171 – 237) 113 (80.8 – 128) 219 (172 – 262) 322 (303 – 373) 150
12–19 years 199 (187 – 213) 128 (113 – 137) 202 (191 – 212) 308 (286 – 375) 332
20–39 years 197 (177 – 219) 109 (93.8 – 118) 202 (180 – 219) 362 (315 – 443) 251
40–59 years 211 (187 – 237) 103 (61.5 – 121) 223 (184 – 259) 423 (351 – 515) 124
60 years and older 208 (188 – 229) 98.8† (85.1 – 120) 213 (192 – 224) 398† (315 – 506) 103
† Estimate is subject to greater uncertainty due to small cell size. 
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Table 2.5.a.4. Serum gamma-tocopherol: Non-Hispanic blacks
Geometric mean and selected percentiles of serum concentrations (in µg/dL) for non-Hispanic blacks in the U.S. 
population aged 6 years and older, National Health and Nutrition Examination Survey, 2005–2006. 
Geometric mean 
(95% conf. interval)
Selected percentiles (95% conf. interval) Sample 
size10th 50th 90th
Males and Females
Total, 6 years and older 214 (198 – 231) 119 (98.4 – 135) 219 (204 – 235) 383 (357 – 407) 1,865
6–11 years 198 (183 – 214) 128 (96.7 – 141) 198 (189 – 210) 317 (291 – 360) 240
12–19 years 197 (180 – 215) 126 (105 – 142) 198 (180 – 215) 308 (279 – 338) 654
20–39 years 213 (196 – 231) 114 (93.5 – 137) 216 (202 – 231) 379 (334 – 420) 359
40–59 years 221 (198 – 247) 115 (72.3 – 140) 233 (208 – 254) 404 (378 – 476) 331
60 years and older 231 (204 – 261) 109 (60.6 – 139) 255 (216 – 286) 413 (392 – 466) 281
Males
Total, 6 years and older 209 (192 – 227) 120 (102 – 136) 210 (195 – 225) 362 (335 – 402) 935
6–11 years 191 (171 – 213) 116 (69.0 – 142) 193 (182 – 205) 297 (263 – 360) 128
12–19 years 192 (176 – 210) 127 (111 – 141) 187 (170 – 208) 302 (278 – 335) 337
20–39 years 218 (197 – 241) 119 (101 – 136) 220 (195 – 240) 386 (326 – 500) 166
40–59 years 209 (182 – 241) 109 (71.2 – 141) 213 (187 – 239) 401 (311 – 526) 153
60 years and older 223 (193 – 259) 122 (53.9 – 147) 234 (202 – 276) 393 (341 – 498) 151
Females
Total, 6 years and older 218 (203 – 234) 116 (93.3 – 134) 228 (213 – 242) 396 (375 – 410) 930
6–11 years 205 (191 – 221) 131 (99.5 – 143) 204 (189 – 229) 327 (292 – 433) 112
12–19 years 202 (183 – 223) 123 (98.5 – 147) 205 (195 – 218) 314 (279 – 354) 317
20–39 years 209 (188 – 231) 110 (81.8 – 141) 213 (195 – 236) 377 (329 – 426) 193
40–59 years 231 (210 – 255) 116 (72.3 – 134) 249 (217 – 285) 404 (399 – 443) 178
60 years and older 236 (207 – 270) 103 (54.5 – 145) 261 (219 – 299) 448 (393 – 505) 130
Table 2.5.a.5. Serum gamma-tocopherol: Non-Hispanic whites
Geometric mean and selected percentiles of serum concentrations (in µg/dL) for non-Hispanic whites in the 
U.S. population aged 6 years and older, National Health and Nutrition Examination Survey, 2005–2006. 
Geometric mean 
(95% conf. interval)
Selected percentiles (95% conf. interval) Sample 
size10th 50th 90th
Males and Females
Total, 6 years and older 182 (173 – 191) 86.4 (79.6 – 92.0) 190 (179 – 200) 356 (340 – 387) 2,965
6–11 years 175 (159 – 192) 105 (99.7 – 109) 170 (157 – 191) 304 (272 – 349) 231
12–19 years 174 (165 – 184) 102 (90.8 – 108) 179 (171 – 188) 284 (274 – 301) 499
20–39 years 191 (178 – 205) 105 (83.6 – 116) 196 (183 – 207) 349 (320 – 401) 710
40–59 years 196 (184 – 207) 91.6 (80.3 – 97.8) 207 (195 – 220) 396 (368 – 424) 680
60 years and older 158 (148 – 169) 65.9 (59.4 – 72.1) 168 (154 – 183) 353 (326 – 392) 845
Males
Total, 6 years and older 187 (178 – 197) 94.7 (81.7 – 104) 194 (184 – 204) 355 (344 – 388) 1,469
6–11 years 174 (153 – 197) 105 (82.6 – 111) 170 (150 – 192) 307 (269 – 378) 112
12–19 years 167 (155 – 180) 95.0 (76.7 – 113) 173 (163 – 181) 280 (250 – 314) 254
20–39 years 200 (190 – 210) 117 (105 – 126) 201 (188 – 212) 370 (346 – 414) 307
40–59 years 201 (185 – 218) 95.5 (80.3 – 106) 214 (195 – 230) 398 (350 – 448) 350
60 years and older 165 (151 – 180) 71.6 (62.2 – 76.5) 177 (150 – 199) 351 (331 – 380) 446
Females
Total, 6 years and older 177 (167 – 188) 79.9 (73.8 – 87.5) 186 (173 – 197) 359 (324 – 391) 1,496
6–11 years 177 (160 – 195) 104 (86.4 – 114) 171 (155 – 197) 300 (260 – 349) 119
12–19 years 182 (171 – 195) 103 (89.6 – 118) 187 (175 – 200) 289 (270 – 312) 245
20–39 years 183 (163 – 204) 92.8 (71.4 – 110) 191 (169 – 210) 323 (296 – 403) 403
40–59 years 190 (178 – 204) 83.6 (68.1 – 98.3) 203 (186 – 217) 392 (373 – 427) 330
60 years and older 153 (141 – 165) 61.1 (53.5 – 69.6) 161 (148 – 174) 357 (319 – 400) 399
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Table 2.5.b. Serum gamma-tocopherol: Concentrations by survey cycle
Geometric mean and selected percentiles of serum concentrations (in µg/dL) for the U.S. population, National 
Health and Nutrition Examination Survey, 1999–2002 and 2005–2006. 
Geometric mean 
(95% conf. interval)
Selected percentiles (95% conf. interval) Sample 
size5th 50th 95th
Total, 6 years and older
 1999–2000 199 (184 – 216) 65.1 (58.2 – 71.7) 215 (197 – 230) 464 (432 – 529) 6,129
 2001–2002 199 (191 – 207) 67.1 (59.4 – 73.8) 212 (204 – 220) 461 (436 – 485) 7,879
 2005–2006 188 (180 – 196) 70.4 (62.9 – 75.4) 196 (187 – 204) 424 (408 – 446) 7,217
Age group
3–5 years
 1999–2000 170 (140 – 206) 50.0 (16.2 – 90.8) 180 (158 – 200) 363 (308 – 455) 301
 2001–2002 181 (170 – 193) 63.3 (52.2 – 82.2) 194 (178 – 205) 365 (342 – 430) 429
6–11 years
 1999–2000 202 (183 – 223) 93.3 (72.3 – 107) 213 (184 – 231) 407 (356 – 569) 725
 2001–2002 211 (203 – 219) 102 (95.4 – 109) 218 (211 – 227) 380 (361 – 414) 1,005
 2005–2006 182 (171 – 193) 91.5 (71.3 – 99.2) 179 (169 – 193) 353 (333 – 390) 858
12–19 years
 1999–2000 197 (183 – 211) 99.0 (80.4 – 112) 198 (186 – 214) 372 (363 – 389) 1,821
 2001–2002 197 (190 – 205) 99.4 (90.2 – 107) 201 (191 – 209) 368 (346 – 391) 2,188
 2005–2006 179 (171 – 188) 89.0 (79.8 – 93.8) 184 (175 – 194) 324 (311 – 343) 1,942
20–39 years
 1999–2000 205 (189 – 222) 75.6 (60.5 – 87.3) 220 (199 – 237) 438 (414 – 477) 1,299
 2001–2002 206 (197 – 216) 85.6 (73.5 – 95.3) 217 (205 – 227) 445 (425 – 474) 1,706
 2005–2006 194 (184 – 205) 81.9 (75.3 – 93.8) 200 (192 – 209) 423 (401 – 460) 1,675
40–59 years
 1999–2000 208 (185 – 232) 59.8 (51.9 – 70.0) 231 (204 – 253) 549 (507 – 631) 1,028
 2001–2002 204 (192 – 217) 60.4 (52.2 – 68.3) 221 (208 – 238) 507 (463 – 576) 1,463
 2005–2006 201 (192 – 212) 69.0 (56.1 – 80.0) 213 (203 – 221) 452 (437 – 498) 1,358
60 years and older
 1999–2000 178 (160 – 197) 47.6 (42.9 – 54.4) 196 (171 – 216) 496 (443 – 573) 1,256
 2001–2002 172 (162 – 184) 48.2 (43.8 – 52.0) 185 (170 – 201) 497 (469 – 534) 1,517
 2005–2006 165 (154 – 177) 52.4 (49.7 – 57.5) 176 (161 – 192) 422 (403 – 462) 1,384
Gender
(6 years and older)
Males
 1999–2000 199 (184 – 217) 65.3 (55.9 – 74.7) 213 (197 – 230) 462 (426 – 532) 2,974
 2001–2002 202 (193 – 211) 66.5 (56.0 – 77.1) 213 (207 – 222) 472 (445 – 499) 3,815
 2005–2006 192 (184 – 200) 74.5 (62.4 – 80.8) 198 (189 – 206) 434 (411 – 471) 3,528
Females
 1999–2000 200 (184 – 217) 64.8 (57.6 – 71.8) 217 (196 – 232) 468 (433 – 536) 3,155
 2001–2002 196 (187 – 205) 67.6 (60.6 – 74.7) 210 (200 – 220) 447 (420 – 483) 4,064
 2005–2006 184 (175 – 194) 67.7 (60.1 – 73.5) 194 (183 – 203) 419 (400 – 441) 3,689
Race/ethnicity
(6 years and older)
Mexican Americans
 1999–2000 222 (210 – 235) 104 (89.1 – 113) 225 (213 – 236) 468 (414 – 504) 1,772
 2001–2002 198 (190 – 206) 89.8 (80.5 – 92.6) 203 (190 – 214) 422 (390 – 458) 1,987
 2005–2006 204 (192 – 217) 93.8 (84.0 – 102) 209 (195 – 222) 437 (390 – 503) 1,841
Non-Hispanic Blacks
 1999–2000 213 (200 – 226) 94.5 (73.1 – 104) 217 (201 – 238) 437 (417 – 473) 1,515
 2001–2002 235 (222 – 248) 107 (83.5 – 118) 248 (233 – 261) 450 (426 – 478) 1,843
 2005–2006 214 (198 – 231) 92.0 (67.4 – 106) 219 (204 – 235) 429 (408 – 488) 1,865
Non-Hispanic Whites
 1999–2000 198 (179 – 219) 61.3 (52.8 – 70.1) 217 (192 – 234) 477 (439 – 542) 2,240
 2001–2002 193 (183 – 205) 60.4 (51.4 – 68.0) 209 (198 – 220) 472 (442 – 495) 3,426
 2005–2006 182 (173 – 191) 65.1 (57.4 – 72.3) 190 (179 – 200) 423 (407 – 445) 2,965
 
 












































































































































Figure 2.5.b. Serum gamma−tocopherol: Concentrations by survey cycle
Selected percentiles in µg/dL (95% confidence intervals), National Health and 
Nutrition Examination Survey, 1999–2002 and 2005–2006




























































































































































































































































































































































































































































































































































































































































































































































































































































































Non−Hispanic Blacks Non−Hispanic Whites 
Figure 2.6.a. Serum alpha−carotene: Concentrations by age group 
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Table 2.6.a.2. Serum alpha-carotene: Total population
Geometric mean and selected percentiles of serum concentrations (in µg/dL) for the total U.S. population aged 
6 years and older, National Health and Nutrition Examination Survey, 2005–2006. 
Geometric mean 
(95% conf. interval)
Selected percentiles (95% conf. interval) Sample 
size10th 50th 90th
Males and Females
Total, 6 years and older 2.76 (2.54 – 2.99) .772 (.718 – .823) 2.63 (2.40 – 2.84) 9.48 (8.58 – 10.6) 7,246
6–11 years 2.64 (2.32 – 3.01) .865 (.766 – .966) 2.59 (2.31 – 2.90) 8.34 (6.74 – 10.9) 860
12–19 years 1.85 (1.69 – 2.03) < LOD 1.72 (1.53 – 1.91) 5.55 (4.98 – 6.67) 1,950
20–39 years 2.48 (2.24 – 2.74) .702 (< LOD – .793) 2.36 (2.06 – 2.69) 8.65 (7.55 – 9.72) 1,684
40–59 years 3.15 (2.85 – 3.47) .836 (< LOD – .963) 3.01 (2.72 – 3.36) 11.8 (10.0 – 13.3) 1,365
60 years and older 3.42 (3.05 – 3.83) 1.02 (.832 – 1.17) 3.33 (2.86 – 3.86) 10.8 (9.64 – 13.1) 1,387
Males
Total, 6 years and older 2.37 (2.20 – 2.55) < LOD 2.23 (2.06 – 2.39) 7.74 (6.73 – 9.37) 3,544
6–11 years 2.68 (2.32 – 3.10) .885 (.780 – .985) 2.59 (2.36 – 2.91) 8.27 (5.98 – 12.0) 427
12–19 years 1.60 (1.46 – 1.76) < LOD 1.40 (1.29 – 1.61) 4.51 (3.69 – 5.54) 979
20–39 years 2.10 (1.95 – 2.27) < LOD 2.00 (1.79 – 2.19) 6.91 (6.14 – 7.26) 736
40–59 years 2.66 (2.38 – 2.96) .711 (< LOD – .910) 2.47 (2.24 – 2.76) 8.79 (7.13 – 11.5) 673
60 years and older 3.01 (2.61 – 3.46) .838 (.754 – .923) 3.09 (2.55 – 3.54) 9.76 (7.73 – 12.9) 729
Females
Total, 6 years and older 3.18 (2.89 – 3.50) .895 (.807 – .983) 3.01 (2.74 – 3.32) 10.8 (9.83 – 12.3) 3,702
6–11 years 2.60 (2.26 – 2.99) .854 (.712 – .972) 2.59 (2.14 – 2.97) 8.39 (6.99 – 11.1) 433
12–19 years 2.17 (1.98 – 2.39) .709 (< LOD – .777) 2.08 (1.89 – 2.30) 6.43 (5.53 – 7.15) 971
20–39 years 2.92 (2.51 – 3.39) .859 (< LOD – .969) 2.74 (2.41 – 3.31) 9.80 (8.53 – 11.9) 948
40–59 years 3.69 (3.25 – 4.17) .992 (.764 – 1.23) 3.54 (3.07 – 3.97) 13.7 (11.7 – 16.7) 692
60 years and older 3.80 (3.33 – 4.32) 1.18 (1.01 – 1.32) 3.50 (2.94 – 4.36) 11.6 (10.2 – 15.0) 658
< LOD means less than the limit of detection, which may vary for some compounds by year. See Appendix D for LOD.
Table 2.6.a.3. Serum alpha-carotene: Mexican Americans
Geometric mean and selected percentiles of serum concentrations (in µg/dL) for Mexican Americans in the U.S. 
population aged 6 years and older, National Health and Nutrition Examination Survey, 2005–2006. 
Geometric mean 
(95% conf. interval)
Selected percentiles (95% conf. interval) Sample 
size10th 50th 90th
Males and Females
Total, 6 years and older 2.99 (2.79 – 3.21) 1.07 (.952 – 1.21) 2.87 (2.61 – 3.21) 7.96 (7.58 – 8.67) 1,844
6–11 years 2.53 (2.21 – 2.89) .918 (.702 – 1.14) 2.47 (2.03 – 3.00) 6.79 (5.10 – 9.28) 295
12–19 years 2.06 (1.82 – 2.33) .847 (.723 – .952) 1.89 (1.70 – 2.22) 5.19 (4.56 – 5.91) 646
20–39 years 3.09 (2.78 – 3.42) 1.22 (1.07 – 1.33) 2.88 (2.56 – 3.37) 7.74 (7.18 – 8.74) 449
40–59 years 3.72 (3.31 – 4.19) 1.44 (.784 – 1.77) 3.57 (3.24 – 4.21) 10.5 (8.26 – 14.0) 246
60 years and older 3.76 (3.31 – 4.27) 1.28 (.767 – 1.60) 3.60 (3.22 – 4.31) 9.80 (8.51 – 16.0) 208
Males
Total, 6 years and older 2.72 (2.50 – 2.95) .997 (.890 – 1.09) 2.57 (2.22 – 3.00) 7.27 (6.99 – 7.73) 883
6–11 years 2.46 (2.16 – 2.81) .904 (< LOD – 1.25) 2.49 (1.94 – 3.20) 5.58 (4.47 – 10.7) 145
12–19 years 1.92 (1.68 – 2.19) .785 (< LOD – .874) 1.75 (1.50 – 2.05) 5.16 (3.85 – 6.20) 313
20–39 years 2.71 (2.30 – 3.20) 1.08 (.902 – 1.24) 2.47 (2.01 – 3.18) 7.32 (6.06 – 8.64) 198
40–59 years 3.49 (2.95 – 4.13) 1.43 (< LOD – 1.76) 3.35 (2.71 – 4.08) 9.79 (7.00 – 15.0) 122
60 years and older 3.23 (2.73 – 3.83) .939† (< LOD – 1.50) 3.18 (2.62 – 4.23) 8.07† (6.41 – 20.8) 105
Females
Total, 6 years and older 3.33 (3.07 – 3.61) 1.20 (1.06 – 1.30) 3.26 (2.95 – 3.50) 9.08 (8.35 – 9.84) 961
6–11 years 2.60 (2.17 – 3.12) .923 (< LOD – 1.15) 2.43 (1.99 – 3.17) 7.44 (5.70 – 9.89) 150
12–19 years 2.22 (1.95 – 2.53) .937 (.732 – 1.09) 2.08 (1.81 – 2.51) 5.21 (4.55 – 6.57) 333
20–39 years 3.61 (3.16 – 4.13) 1.47 (1.16 – 1.62) 3.45 (2.84 – 4.13) 9.06 (6.93 – 13.2) 251
40–59 years 3.99 (3.38 – 4.70) 1.39 (< LOD – 1.83) 3.82 (3.37 – 4.47) 10.6 (7.74 – 33.5) 124
60 years and older 4.27 (3.70 – 4.93) 1.52† (< LOD – 2.02) 4.13 (3.36 – 5.44) 9.87† (8.65 – 22.5) 103
< LOD means less than the limit of detection, which may vary for some compounds by year. See Appendix D for LOD. 
† Estimate is subject to greater uncertainty due to small cell size.
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Table 2.6.a.4. Serum alpha-carotene: Non-Hispanic blacks
Geometric mean and selected percentiles of serum concentrations (in µg/dL) for non-Hispanic blacks in the U.S. 
population aged 6 years and older, National Health and Nutrition Examination Survey, 2005–2006. 
Geometric mean 
(95% conf. interval)
Selected percentiles (95% conf. interval) Sample 
size10th 50th 90th
Males and Females
Total, 6 years and older 1.98 (1.74 – 2.26) < LOD 1.71 (1.49 – 1.99) 6.99 (5.49 – 9.49) 1,890
6–11 years 1.97 (1.68 – 2.30) .782 (< LOD – .865) 1.73 (1.47 – 2.11) 4.97 (3.84 – 7.31) 240
12–19 years 1.33 (1.22 – 1.46) < LOD 1.17 (1.08 – 1.27) 3.23 (2.79 – 4.25) 664
20–39 years 1.76 (1.47 – 2.10) < LOD 1.54 (1.27 – 1.85) 5.49 (3.81 – 10.9) 368
40–59 years 2.60 (2.18 – 3.10) < LOD 2.40 (1.86 – 3.11) 9.63 (7.77 – 12.4) 335
60 years and older 2.28 (2.05 – 2.54) .727 (< LOD – .860) 2.09 (1.72 – 2.38) 7.35 (6.25 – 9.09) 283
Males
Total, 6 years and older 1.79 (1.56 – 2.06) < LOD 1.55 (1.30 – 1.84) 6.12 (4.82 – 7.67) 948
6–11 years 2.11 (1.80 – 2.46) .934 (.761 – 1.00) 1.90 (1.51 – 2.50) 5.11 (4.03 – 6.81) 128
12–19 years 1.28 (1.17 – 1.40) < LOD 1.18 (1.10 – 1.27) 2.65 (2.27 – 3.64) 342
20–39 years 1.51 (1.27 – 1.80) < LOD 1.26 (1.08 – 1.43) 4.23 (3.53 – 10.1) 170
40–59 years 2.34 (1.84 – 2.96) < LOD 2.10 (1.65 – 3.05) 8.08 (6.39 – 18.0) 156
60 years and older 2.04 (1.78 – 2.34) < LOD 1.75 (1.48 – 2.32) 6.11 (5.37 – 7.68) 152
Females
Total, 6 years and older 2.17 (1.91 – 2.47) < LOD 1.91 (1.61 – 2.24) 8.09 (6.12 – 10.9) 942
6–11 years 1.84 (1.47 – 2.30) < LOD 1.56 (1.31 – 2.06) 4.55 (3.38 – 34.6) 112
12–19 years 1.40 (1.24 – 1.57) < LOD 1.16 (1.01 – 1.35) 3.98 (3.08 – 4.95) 322
20–39 years 2.00 (1.63 – 2.45) < LOD 1.83 (1.46 – 2.17) 7.48 (3.92 – 14.8) 198
40–59 years 2.85 (2.40 – 3.37) .763 (< LOD – .998) 2.59 (1.91 – 3.59) 10.2 (7.96 – 12.8) 179
60 years and older 2.47 (2.08 – 2.94) .778 (< LOD – .932) 2.28 (1.69 – 3.06) 8.43 (5.57 – 13.9) 131
< LOD means less than the limit of detection, which may vary for some compounds by year. See Appendix D for LOD.
Table 2.6.a.5. Serum alpha-carotene: Non-Hispanic whites
Geometric mean and selected percentiles of serum concentrations (in µg/dL) for non-Hispanic whites in the 
U.S. population aged 6 years and older, National Health and Nutrition Examination Survey, 2005–2006. 
Geometric mean 
(95% conf. interval)
Selected percentiles (95% conf. interval) Sample 
size10th 50th 90th
Males and Females
Total, 6 years and older 2.80 (2.60 – 3.02) .770 (< LOD – .835) 2.67 (2.47 – 2.89) 9.64 (8.79 – 10.7) 2,966
6–11 years 2.78 (2.38 – 3.24) .860 (.769 – .988) 2.77 (2.37 – 3.15) 8.80 (7.05 – 11.7) 231
12–19 years 1.95 (1.78 – 2.13) < LOD 1.85 (1.65 – 2.02) 6.10 (5.30 – 7.19) 496
20–39 years 2.39 (2.16 – 2.65) < LOD 2.31 (1.97 – 2.65) 8.10 (7.23 – 9.64) 710
40–59 years 3.12 (2.84 – 3.44) .832 (< LOD – .971) 2.95 (2.63 – 3.36) 11.9 (10.1 – 13.5) 683
60 years and older 3.44 (3.05 – 3.88) 1.05 (.832 – 1.24) 3.34 (2.82 – 3.89) 10.7 (9.59 – 12.9) 846
Males
Total, 6 years and older 2.38 (2.20 – 2.56) < LOD 2.27 (2.08 – 2.42) 7.73 (6.50 – 9.42) 1,470
6–11 years 2.80 (2.34 – 3.35) .853 (.749 – 1.02) 2.80 (2.40 – 2.99) 8.52 (5.74 – 23.7) 112
12–19 years 1.62 (1.47 – 1.78) < LOD 1.46 (1.26 – 1.72) 4.33 (3.63 – 5.81) 254
20–39 years 2.02 (1.87 – 2.18) < LOD 1.90 (1.65 – 2.22) 6.23 (5.68 – 7.29) 307
40–59 years 2.60 (2.33 – 2.90) < LOD 2.42 (2.19 – 2.68) 8.71 (6.82 – 10.2) 351
60 years and older 3.00 (2.57 – 3.49) .844 (.761 – .959) 3.09 (2.46 – 3.54) 9.36 (7.53 – 12.8) 446
Females
Total, 6 years and older 3.28 (3.00 – 3.59) .920 (.790 – 1.04) 3.10 (2.82 – 3.39) 11.2 (10.4 – 12.7) 1,496
6–11 years 2.75 (2.29 – 3.31) .864 (< LOD – 1.10) 2.76 (1.93 – 3.26) 9.09 (7.10 – 12.4) 119
12–19 years 2.39 (2.19 – 2.60) .723 (< LOD – .838) 2.22 (2.06 – 2.49) 6.93 (6.25 – 8.87) 242
20–39 years 2.83 (2.38 – 3.37) .826 (< LOD – .962) 2.69 (2.20 – 3.36) 9.45 (7.82 – 11.8) 403
40–59 years 3.73 (3.27 – 4.26) .964 (< LOD – 1.23) 3.57 (3.04 – 4.01) 14.4 (12.6 – 16.7) 332
60 years and older 3.86 (3.34 – 4.47) 1.24 (1.05 – 1.42) 3.54 (2.85 – 4.47) 12.0 (10.4 – 15.9) 400
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Table 2.6.b. Serum alpha-carotene: Concentrations by survey cycle
Geometric mean and selected percentiles of serum concentrations (in µg/dL) for the U.S. population, National 
Health and Nutrition Examination Survey, 2001–2002 and 2005–2006. 
Geometric mean 
(95% conf. interval)
Selected percentiles (95% conf. interval) Sample 
size5th 50th 95th
Total, 6 years and older
 2001–2002 2.48 (2.22 – 2.77) < LOD 2.39 (2.10 – 2.70) 12.2 (10.7 – 14.1) 7,929
 2005–2006 2.76 (2.54 – 2.99) < LOD 2.63 (2.40 – 2.84) 14.1 (12.4 – 16.5) 7,246
Age group
3–5 years
 2001–2002 2.41 (2.13 – 2.74) < LOD 2.14 (1.89 – 2.48) 12.2 (10.3 – 14.6) 430
6–11 years
 2001–2002 2.24 (2.00 – 2.51) < LOD 2.04 (1.84 – 2.28) 8.54 (6.94 – 13.3) 1,014
 2005–2006 2.64 (2.32 – 3.01) < LOD 2.59 (2.31 – 2.90) 11.5 (9.30 – 15.1) 860
12–19 years
 2001–2002 1.68 (1.52 – 1.86) < LOD 1.50 (1.37 – 1.74) 7.68 (6.61 – 9.52) 2,206
 2005–2006 1.85 (1.69 – 2.03) < LOD 1.72 (1.53 – 1.91) 7.91 (6.65 – 10.2) 1,950
20–39 years
 2001–2002 2.22 (1.93 – 2.56) < LOD 2.11 (1.82 – 2.49) 9.80 (8.96 – 12.6) 1,716
 2005–2006 2.48 (2.24 – 2.74) < LOD 2.36 (2.06 – 2.69) 11.3 (10.1 – 14.7) 1,684
40–59 years
 2001–2002 2.98 (2.60 – 3.42) < LOD 2.85 (2.47 – 3.28) 16.0 (12.8 – 20.7) 1,470
 2005–2006 3.15 (2.85 – 3.47) < LOD 3.01 (2.72 – 3.36) 17.0 (14.5 – 21.9) 1,365
60 years and older
 2001–2002 3.08 (2.74 – 3.46) < LOD 3.14 (2.71 – 3.61) 12.7 (12.0 – 13.7) 1,523
 2005–2006 3.42 (3.05 – 3.83) .711 (< LOD – .811) 3.33 (2.86 – 3.86) 17.0 (14.0 – 19.8) 1,387
Gender
(6 years and older)
Males
 2001–2002 2.22 (1.98 – 2.49) < LOD 2.07 (1.87 – 2.44) 10.3 (9.30 – 12.3) 3,835
 2005–2006 2.37 (2.20 – 2.55) < LOD 2.23 (2.06 – 2.39) 11.5 (9.92 – 13.9) 3,544
Females
 2001–2002 2.76 (2.47 – 3.07) < LOD 2.67 (2.35 – 2.97) 13.3 (11.8 – 16.2) 4,094
 2005–2006 3.18 (2.89 – 3.50) < LOD 3.01 (2.74 – 3.32) 16.4 (14.6 – 18.4) 3,702
Race/ethnicity
(6 years and older)
Mexican Americans
 2001–2002 2.73 (2.38 – 3.14) .726 (< LOD – .805) 2.63 (2.38 – 2.99) 10.1 (8.46 – 14.1) 1,990
 2005–2006 2.99 (2.79 – 3.21) .824 (.749 – .889) 2.87 (2.61 – 3.21) 10.8 (10.5 – 12.5) 1,844
Non-Hispanic Blacks
 2001–2002 1.77 (1.50 – 2.09) < LOD 1.58 (1.36 – 1.91) 10.1 (7.64 – 14.5) 1,864
 2005–2006 1.98 (1.74 – 2.26) < LOD 1.71 (1.49 – 1.99) 11.0 (8.83 – 14.8) 1,890
Non-Hispanic Whites
 2001–2002 2.57 (2.25 – 2.95) < LOD 2.48 (2.11 – 2.86) 12.8 (11.2 – 15.5) 3,450
 2005–2006 2.80 (2.60 – 3.02) < LOD 2.67 (2.47 – 2.89) 14.4 (12.8 – 16.7) 2,966
< LOD means less than the limit of detection, which may vary for some compounds by year. See Appendix D for LOD. 
 
















































































































Figure 2.6.b. Serum alpha−carotene: Concentrations by survey cycle
Selected percentiles in µg/dL (95% confidence intervals), National Health and 
Nutrition Examination Survey, 2001–2002 and 2005–2006
Values in the graph are suppressed if either the point estimate or the lower 95% confidence limit is noted as “< LOD” in the accompanying table.
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Figure 2.7.a. Serum trans−beta−carotene: Concentrations by age group
Geometric mean (95% confidence interval), National Health and Nutrition Examination Survey, 2005–2006
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Table 2.7.a.2. Serum trans-beta-carotene: Total population
Geometric mean and selected percentiles of serum concentrations (in µg/dL) for the total U.S. population aged 
6 years and older, National Health and Nutrition Examination Survey, 2005–2006. 
Geometric mean 
(95% conf. interval)
Selected percentiles (95% conf. interval) Sample 
size10th 50th 90th
Males and Females
Total, 6 years and older 12.1 (11.5 – 12.8) 4.26 (4.02 – 4.53) 11.6 (11.1 – 12.3) 37.1 (34.2 – 40.7) 7,254
6–11 years 13.0 (12.1 – 14.0) 6.21 (5.49 – 6.89) 12.7 (11.8 – 13.6) 27.4 (25.1 – 31.7) 860
12–19 years 9.24 (8.76 – 9.75) 4.21 (3.86 – 4.52) 8.96 (8.30 – 9.66) 20.3 (18.9 – 22.7) 1,954
20–39 years 10.4 (9.63 – 11.3) 3.85 (3.50 – 4.19) 9.97 (9.14 – 10.9) 30.4 (26.5 – 35.8) 1,688
40–59 years 12.8 (11.9 – 13.9) 4.12 (3.59 – 4.55) 12.4 (11.6 – 13.4) 42.7 (39.1 – 47.5) 1,365
60 years and older 16.4 (15.1 – 17.7) 5.27 (4.47 – 6.08) 15.9 (14.5 – 17.8) 51.0 (45.9 – 59.1) 1,387
Males
Total, 6 years and older 10.3 (9.89 – 10.8) 3.76 (3.48 – 4.02) 10.3 (9.62 – 10.9) 28.2 (26.4 – 31.4) 3,547
6–11 years 13.7 (12.6 – 15.0) 6.93 (5.62 – 7.94) 13.1 (12.1 – 14.3) 27.4 (23.5 – 34.7) 427
12–19 years 8.46 (7.93 – 9.03) 3.82 (3.27 – 4.29) 8.26 (7.75 – 8.90) 17.8 (17.2 – 18.7) 980
20–39 years 8.89 (8.36 – 9.46) 3.36 (3.02 – 3.80) 8.51 (7.91 – 9.14) 23.9 (22.2 – 26.7) 738
40–59 years 10.5 (9.38 – 11.7) 3.43 (2.20 – 4.20) 10.8 (9.45 – 12.3) 31.8 (27.9 – 36.0) 673
60 years and older 13.3 (11.9 – 14.8) 4.47 (3.75 – 5.33) 13.0 (11.5 – 14.4) 41.5 (33.8 – 51.1) 729
Females
Total, 6 years and older 14.2 (13.3 – 15.1) 5.00 (4.60 – 5.30) 13.2 (12.0 – 14.4) 43.9 (41.2 – 48.9) 3,707
6–11 years 12.4 (11.3 – 13.5) 5.61 (4.56 – 6.75) 11.8 (10.5 – 13.6) 27.4 (24.6 – 33.5) 433
12–19 years 10.1 (9.48 – 10.9) 4.73 (4.26 – 4.95) 9.76 (8.95 – 10.7) 24.6 (20.9 – 29.1) 974
20–39 years 12.2 (10.7 – 13.9) 4.39 (3.79 – 5.08) 11.4 (10.2 – 12.9) 37.0 (28.6 – 50.2) 950
40–59 years 15.5 (14.2 – 17.0) 5.07 (4.61 – 5.33) 14.5 (12.7 – 16.2) 53.2 (44.0 – 64.4) 692
60 years and older 19.5 (17.4 – 21.8) 6.30 (5.12 – 7.04) 19.4 (16.5 – 23.1) 62.3 (50.5 – 75.2) 658
Table 2.7.a.3. Serum trans-beta-carotene: Mexican Americans
Geometric mean and selected percentiles of serum concentrations (in µg/dL) for Mexican Americans in the U.S. 
population aged 6 years and older, National Health and Nutrition Examination Survey, 2005–2006. 
Geometric mean 
(95% conf. interval)
Selected percentiles (95% conf. interval) Sample 
size10th 50th 90th
Males and Females
Total, 6 years and older 11.5 (10.5 – 12.7) 4.48 (4.14 – 4.81) 11.3 (10.4 – 12.4) 29.7 (25.9 – 35.0) 1,844
6–11 years 11.4 (10.6 – 12.4) 5.74 (4.57 – 6.28) 11.0 (9.92 – 12.0) 24.2 (21.0 – 31.1) 295
12–19 years 9.02 (8.39 – 9.70) 4.07 (3.59 – 4.64) 9.05 (8.35 – 10.1) 18.6 (17.3 – 22.7) 646
20–39 years 11.5 (9.84 – 13.3) 4.45 (4.01 – 4.85) 11.3 (9.45 – 13.7) 29.9 (23.5 – 37.2) 449
40–59 years 12.8 (11.1 – 14.8) 4.15 (3.63 – 5.03) 12.7 (11.1 – 14.7) 32.5 (27.7 – 47.1) 246
60 years and older 14.8 (13.2 – 16.5) 5.31 (3.02 – 7.79) 14.7 (12.7 – 15.6) 43.1 (37.9 – 47.4) 208
Males
Total, 6 years and older 10.4 (9.29 – 11.6) 4.15 (3.63 – 4.46) 10.3 (9.20 – 11.5) 25.3 (22.6 – 30.4) 883
6–11 years 12.0 (11.2 – 12.8) 6.15 (4.40 – 7.62) 11.5 (10.4 – 12.6) 23.1 (19.7 – 34.4) 145
12–19 years 8.18 (7.37 – 9.07) 3.71 (3.32 – 4.25) 8.34 (6.90 – 9.63) 17.7 (15.3 – 19.6) 313
20–39 years 10.3 (8.45 – 12.6) 4.20 (3.00 – 4.71) 9.64 (7.83 – 12.8) 26.6 (22.0 – 36.9) 198
40–59 years 10.9 (8.97 – 13.2) 3.82 (2.55 – 4.31) 11.3 (9.45 – 13.4) 26.3 (21.6 – 35.9) 122
60 years and older 12.4 (10.6 – 14.6) 4.47† (2.51 – 6.70) 12.0 (9.45 – 15.9) 35.7† (19.8 – 154) 105
Females
Total, 6 years and older 12.9 (11.9 – 14.1) 5.08 (4.51 – 5.60) 12.5 (11.6 – 13.7) 34.4 (30.2 – 39.3) 961
6–11 years 10.9 (9.63 – 12.3) 5.10 (3.98 – 5.96) 10.2 (8.54 – 11.9) 24.3 (19.4 – 32.8) 150
12–19 years 10.0 (9.35 – 10.7) 4.83 (4.12 – 5.13) 10.2 (9.47 – 10.6) 20.9 (18.0 – 28.7) 333
20–39 years 13.0 (11.1 – 15.3) 5.15 (3.69 – 6.18) 12.6 (11.2 – 15.5) 33.8 (24.6 – 45.8) 251
40–59 years 15.3 (12.6 – 18.5) 5.06 (3.42 – 6.68) 14.4 (12.2 – 18.3) 41.2 (29.2 – 108) 124
60 years and older 17.0 (14.7 – 19.7) 5.97† (3.10 – 8.19) 15.1 (14.3 – 19.4) 44.5† (39.3 – 50.9) 103
† Estimate is subject to greater uncertainty due to small cell size. 
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Table 2.7.a.4. Serum trans-beta-carotene: Non-Hispanic blacks
Geometric mean and selected percentiles of serum concentrations (in µg/dL) for non-Hispanic blacks in the U.S. 
population aged 6 years and older, National Health and Nutrition Examination Survey, 2005–2006.
Geometric mean 
(95% conf. interval)
Selected percentiles (95% conf. interval) Sample 
size10th 50th 90th
Males and Females
Total, 6 years and older 10.8 (9.72 – 12.0) 4.00 (3.53 – 4.34) 10.5 (9.31 – 11.4) 31.2 (26.5 – 38.3) 1,891
6–11 years 11.9 (10.6 – 13.3) 6.30 (4.86 – 7.03) 11.6 (10.9 – 12.6) 23.0 (18.3 – 37.7) 240
12–19 years 8.46 (7.85 – 9.11) 4.09 (3.71 – 4.35) 8.13 (7.88 – 8.42) 17.9 (15.7 – 21.3) 665
20–39 years 9.32 (8.28 – 10.5) 3.85 (3.27 – 4.22) 8.49 (7.61 – 10.2) 23.4 (19.5 – 30.8) 368
40–59 years 12.1 (10.3 – 14.1) 3.46 (2.33 – 4.66) 12.3 (10.3 – 15.2) 40.9 (34.3 – 50.2) 335
60 years and older 14.7 (12.8 – 16.9) 4.60 (3.81 – 5.04) 15.3 (12.1 – 18.7) 44.8 (37.0 – 51.5) 283
Males
Total, 6 years and older 9.49 (8.62 – 10.4) 3.48 (3.00 – 3.95) 8.92 (8.05 – 9.95) 26.5 (23.0 – 32.4) 949
6–11 years 12.7 (11.1 – 14.5) 6.79 (5.53 – 7.49) 12.7 (10.7 – 14.9) 22.9 (18.7 – 55.1) 128
12–19 years 8.47 (7.78 – 9.21) 4.15 (3.18 – 4.70) 8.23 (7.85 – 8.76) 17.3 (15.8 – 19.7) 343
20–39 years 8.00 (7.09 – 9.02) 3.39 (2.51 – 3.99) 7.16 (6.35 – 7.95) 22.0 (19.3 – 26.4) 170
40–59 years 9.83 (8.14 – 11.9) 2.65 (1.98 – 3.42) 9.46 (7.15 – 13.1) 36.7 (26.2 – 66.7) 156
60 years and older 12.8 (11.3 – 14.5) 3.77 (3.46 – 4.61) 12.4 (10.7 – 15.1) 35.3 (29.1 – 52.0) 152
Females
Total, 6 years and older 12.1 (10.7 – 13.6) 4.49 (4.05 – 4.88) 11.5 (10.3 – 13.4) 35.5 (27.7 – 46.1) 942
6–11 years 11.1 (9.52 – 13.0) 5.32 (3.52 – 6.63) 11.3 (9.67 – 12.5) 22.3 (16.9 – 37.0) 112
12–19 years 8.45 (7.74 – 9.22) 4.00 (3.50 – 4.37) 8.03 (7.59 – 8.49) 18.6 (15.5 – 24.3) 322
20–39 years 10.6 (9.08 – 12.4) 4.27 (3.46 – 5.15) 10.8 (8.50 – 12.2) 25.4 (18.6 – 46.1) 198
40–59 years 14.4 (12.1 – 17.1) 4.85 (2.70 – 6.42) 14.5 (11.6 – 18.4) 44.9 (39.3 – 49.0) 179
60 years and older 16.3 (13.5 – 19.7) 4.83 (3.86 – 5.68) 17.6 (11.6 – 25.6) 46.5 (38.7 – 55.7) 131
Table 2.7.a.5. Serum trans-beta-carotene: Non-Hispanic whites
Geometric mean and selected percentiles of serum concentrations (in µg/dL) for non-Hispanic whites in the 
U.S. population aged 6 years and older, National Health and Nutrition Examination Survey, 2005–2006. 
Geometric mean 
(95% conf. interval)
Selected percentiles (95% conf. interval) Sample 
size10th 50th 90th
Males and Females
Total, 6 years and older 12.3 (11.6 – 13.1) 4.21 (3.81 – 4.60) 11.8 (11.2 – 12.6) 39.0 (34.8 – 43.4) 2,973
6–11 years 13.6 (12.4 – 14.9) 6.31 (5.42 – 7.09) 13.2 (12.1 – 14.3) 27.8 (24.9 – 36.2) 231
12–19 years 9.58 (8.94 – 10.3) 4.36 (3.85 – 4.71) 9.14 (8.12 – 10.5) 20.9 (19.0 – 26.6) 499
20–39 years 10.1 (9.08 – 11.1) 3.53 (3.18 – 3.94) 9.78 (8.70 – 10.6) 30.5 (25.2 – 39.1) 714
40–59 years 12.9 (11.8 – 14.0) 4.10 (3.54 – 4.59) 12.4 (11.4 – 13.5) 43.4 (39.4 – 48.4) 683
60 years and older 16.3 (14.9 – 17.8) 5.29 (4.22 – 6.19) 15.9 (14.2 – 18.1) 50.9 (44.8 – 64.2) 846
Males
Total, 6 years and older 10.4 (9.87 – 11.0) 3.71 (3.35 – 4.02) 10.5 (9.56 – 11.4) 28.6 (26.0 – 33.0) 1,472
6–11 years 14.3 (12.7 – 16.1) 7.16 (4.60 – 9.03) 13.4 (12.1 – 14.7) 26.3 (23.2 – 48.8) 112
12–19 years 8.77 (8.14 – 9.46) 3.91 (2.92 – 4.60) 8.49 (7.53 – 9.58) 17.9 (16.6 – 20.4) 254
20–39 years 8.65 (8.03 – 9.32) 3.13 (2.85 – 3.48) 8.30 (7.47 – 9.44) 23.8 (20.9 – 26.9) 309
40–59 years 10.6 (9.34 – 12.0) 3.45 (2.06 – 4.26) 11.0 (9.61 – 12.4) 30.6 (26.6 – 35.9) 351
60 years and older 13.0 (11.5 – 14.7) 4.39 (3.31 – 5.39) 12.6 (11.0 – 14.3) 41.0 (32.8 – 51.7) 446
Females
Total, 6 years and older 14.5 (13.5 – 15.6) 4.95 (4.33 – 5.45) 13.4 (12.2 – 15.0) 46.4 (41.5 – 53.3) 1,501
6–11 years 12.9 (11.2 – 14.8) 5.61 (2.70 – 7.13) 12.6 (9.76 – 15.1) 27.7 (24.8 – 40.6) 119
12–19 years 10.5 (9.71 – 11.5) 4.86 (4.27 – 5.37) 9.87 (8.71 – 11.3) 26.8 (21.8 – 30.1) 245
20–39 years 11.7 (9.95 – 13.8) 4.15 (3.18 – 4.99) 10.9 (9.35 – 12.7) 36.5 (26.6 – 60.7) 405
40–59 years 15.6 (14.1 – 17.2) 5.00 (4.17 – 5.44) 14.2 (12.0 – 17.1) 57.1 (44.0 – 69.2) 332
60 years and older 19.7 (17.4 – 22.3) 6.35 (5.12 – 7.18) 19.5 (16.2 – 23.5) 64.3 (50.2 – 75.5) 400
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Table 2.7.b. Serum trans-beta-carotene: Concentrations by survey cycle
Geometric mean and selected percentiles of serum concentrations (in µg/dL) for the U.S. population, National 
Health and Nutrition Examination Survey, 2001–2002 and 2005–2006. 
Geometric mean 
(95% conf. interval)
Selected percentiles (95% conf. interval) Sample 
size5th 50th 95th
Total, 6 years and older
 2001–2002 12.2 (11.5 – 12.9) 3.21 (2.95 – 3.46) 12.0 (11.3 – 12.6) 47.7 (44.2 – 52.1) 7,929
 2005–2006 12.1 (11.5 – 12.8) 3.18 (2.92 – 3.42) 11.6 (11.1 – 12.3) 53.3 (49.1 – 59.3) 7,254
Age group
3–5 years
 2001–2002 13.6 (12.5 – 14.6) 4.60 (3.79 – 5.00) 13.6 (12.1 – 15.2) 45.1 (35.8 – 56.3) 429
6–11 years
 2001–2002 13.3 (12.7 – 13.9) 5.44 (5.00 – 5.96) 13.2 (12.5 – 13.9) 32.9 (30.4 – 38.8) 1,012
 2005–2006 13.0 (12.1 – 14.0) 5.15 (4.11 – 5.61) 12.7 (11.8 – 13.6) 37.7 (29.9 – 49.2) 860
12–19 years
 2001–2002 9.69 (9.20 – 10.2) 3.34 (2.97 – 3.59) 9.63 (8.97 – 10.4) 28.2 (25.4 – 32.5) 2,206
 2005–2006 9.24 (8.76 – 9.75) 3.20 (2.87 – 3.52) 8.96 (8.30 – 9.66) 28.3 (26.3 – 30.7) 1,954
20–39 years
 2001–2002 10.3 (9.38 – 11.2) 2.90 (2.13 – 3.20) 9.81 (9.10 – 10.8) 39.8 (35.2 – 42.6) 1,716
 2005–2006 10.4 (9.63 – 11.3) 3.01 (2.79 – 3.23) 9.97 (9.14 – 10.9) 41.6 (36.9 – 53.3) 1,688
40–59 years
 2001–2002 13.3 (12.1 – 14.7) 3.30 (2.74 – 3.65) 13.0 (12.0 – 14.2) 60.0 (49.9 – 79.7) 1,471
 2005–2006 12.8 (11.9 – 13.9) 2.69 (2.15 – 3.41) 12.4 (11.6 – 13.4) 63.0 (53.5 – 73.8) 1,365
60 years and older
 2001–2002 16.5 (14.9 – 18.3) 3.51 (2.88 – 4.13) 17.5 (15.3 – 19.6) 61.4 (56.0 – 66.1) 1,524
 2005–2006 16.4 (15.1 – 17.7) 3.90 (3.43 – 4.17) 15.9 (14.5 – 17.8) 74.6 (66.3 – 83.4) 1,387
Gender
(6 years and older)
Males
 2001–2002 10.9 (10.2 – 11.6) 3.01 (2.68 – 3.25) 11.0 (10.3 – 11.6) 42.1 (37.5 – 45.5) 3,837
 2005–2006 10.3 (9.89 – 10.8) 2.77 (2.28 – 3.06) 10.3 (9.62 – 10.9) 40.8 (36.8 – 46.4) 3,547
Females
 2001–2002 13.6 (12.7 – 14.6) 3.57 (3.37 – 3.83) 13.1 (12.2 – 14.2) 54.1 (47.6 – 62.0) 4,092
 2005–2006 14.2 (13.3 – 15.1) 3.77 (3.51 – 4.05) 13.2 (12.0 – 14.4) 64.5 (58.3 – 73.6) 3,707
Race/ethnicity
(6 years and older)
Mexican Americans
 2001–2002 12.5 (11.6 – 13.4) 3.56 (3.12 – 3.83) 12.9 (11.6 – 13.9) 38.5 (34.5 – 47.5) 1,990
 2005–2006 11.5 (10.5 – 12.7) 3.49 (3.15 – 3.86) 11.3 (10.4 – 12.4) 39.2 (35.1 – 46.5) 1,844
Non-Hispanic Blacks
 2001–2002 10.8 (9.90 – 11.8) 2.83 (2.42 – 3.22) 10.7 (9.93 – 11.6) 40.3 (35.4 – 45.6) 1,864
 2005–2006 10.8 (9.72 – 12.0) 3.02 (2.57 – 3.36) 10.5 (9.31 – 11.4) 45.0 (38.3 – 53.7) 1,891
Non-Hispanic Whites
 2001–2002 12.5 (11.5 – 13.6) 3.35 (3.06 – 3.61) 12.1 (11.3 – 13.0) 50.8 (45.8 – 56.9) 3,450
 2005–2006 12.3 (11.6 – 13.1) 3.06 (2.80 – 3.41) 11.8 (11.2 – 12.6) 56.9 (50.4 – 64.9) 2,973
 
 
















































































































Figure 2.7.b. Serum trans−beta−carotene: Concentrations by survey cycle
Selected percentiles in µg/dL (95% confidence intervals), National Health and 
Nutrition Examination Survey, 2001–2002 and 2005–2006
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Table 2.8.a.2. Serum cis-beta-carotene: Total population
Geometric mean and selected percentiles of serum concentrations (in µg/dL) for the total U.S. population aged 
6 years and older, National Health and Nutrition Examination Survey, 2005–2006. 
Geometric mean 
(95% conf. interval)
Selected percentiles (95% conf. interval) Sample 
size10th 50th 90th
Males and Females
Total, 6 years and older * < LOD < LOD 2.10 (1.92 – 2.39) 6,616
6–11 years * < LOD < LOD 1.47 (1.28 – 1.78) 779
12–19 years * < LOD < LOD 1.12 (.995 – 1.26) 1,785
20–39 years * < LOD < LOD 1.78 (1.55 – 2.03) 1,528
40–59 years * < LOD .730 (< LOD – .783) 2.49 (2.18 – 2.86) 1,254
60 years and older 1.08 (.985 – 1.17) < LOD .903 (.811 – .992) 3.09 (2.62 – 3.64) 1,270
Males
Total, 6 years and older * < LOD < LOD 1.59 (1.43 – 1.86) 3,204
6–11 years * < LOD .704 (< LOD – .757) 1.52 (1.26 – 2.33) 386
12–19 years * < LOD < LOD .935 (.878 – 1.02) 886
20–39 years * < LOD < LOD 1.37 (1.23 – 1.59) 652
40–59 years * < LOD < LOD 1.75 (1.50 – 2.05) 616
60 years and older * < LOD .726 (< LOD – .817) 2.37 (1.91 – 2.99) 664
Females
Total, 6 years and older * < LOD .759 (.708 – .816) 2.70 (2.35 – 3.10) 3,412
6–11 years * < LOD < LOD 1.44 (1.21 – 1.74) 393
12–19 years * < LOD < LOD 1.35 (1.13 – 1.59) 899
20–39 years * < LOD < LOD 2.15 (1.77 – 3.04) 876
40–59 years 1.04 (.954 – 1.13) < LOD .827 (.745 – .963) 3.30 (2.72 – 3.78) 638
60 years and older 1.26 (1.11 – 1.41) < LOD 1.15 (.904 – 1.36) 3.69 (3.23 – 4.71) 606
< LOD means less than the limit of detection, which may vary for some compounds by year. See Appendix D for LOD. 
* Not calculated. Proportion of results below limit of detection was too high to provide a valid result. 
Table 2.8.a.3. Serum cis-beta-carotene: Mexican Americans
Geometric mean and selected percentiles of serum concentrations (in µg/dL) for Mexican Americans in the U.S. 
population aged 6 years and older, National Health and Nutrition Examination Survey, 2005–2006. 
Geometric mean 
(95% conf. interval)
Selected percentiles (95% conf. interval) Sample 
size10th 50th 90th
Males and Females
Total, 6 years and older * < LOD < LOD 1.70 (1.52 – 1.91) 1,707
6–11 years * < LOD < LOD 1.34 (1.09 – 1.67) 269
12–19 years * < LOD < LOD .975 (.899 – 1.15) 609
20–39 years * < LOD < LOD 1.73 (1.42 – 2.02) 402
40–59 years .880 (.780 – .992) < LOD .751 (< LOD – .864) 1.97 (1.65 – 2.75) 228
60 years and older .964 (.878 – 1.06) < LOD .854 (.778 – .919) 2.48 (2.05 – 3.55) 199
Males
Total, 6 years and older * < LOD < LOD 1.47 (1.21 – 1.71) 814
6–11 years * < LOD < LOD 1.34 (1.06 – 1.98) 131
12–19 years * < LOD < LOD .900 (.833 – 1.09) 299
20–39 years * < LOD < LOD 1.58 (1.16 – 2.07) 171
40–59 years * < LOD < LOD 1.57 (1.29 – 2.19) 114
60 years and older * < LOD† .718 (< LOD – .904) 1.61† (1.08 – 10.8) 99
Females
Total, 6 years and older * < LOD .720 (< LOD – .789) 1.95 (1.76 – 2.24) 893
6–11 years * < LOD < LOD 1.35 (1.06 – 1.72) 138
12–19 years * < LOD < LOD 1.10 (.944 – 1.46) 310
20–39 years * < LOD .774 (< LOD – .960) 1.88 (1.57 – 2.36) 231
40–59 years 1.00 (.839 – 1.19) < LOD .870 (.703 – 1.06) 2.23 (1.71 – 6.40) 114
60 years and older 1.09 (.959 – 1.24) < LOD† .923 (.853 – 1.06) 2.85† (2.37 – 4.06) 100
< LOD means less than the limit of detection, which may vary for some compounds by year. See Appendix D for LOD. 
* Not calculated. Proportion of results below limit of detection was too high to provide a valid result. 
† Estimate is subject to greater uncertainty due to small cell size.
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Table 2.8.a.4. Serum cis-beta-carotene: Non-Hispanic blacks
Geometric mean and selected percentiles of serum concentrations (in µg/dL) for non-Hispanic blacks in the U.S 
population aged 6 years and older, National Health and Nutrition Examination Survey, 2005–2006.
Geometric mean 
(95% conf. interval)
Selected percentiles (95% conf. interval) Sample 
size10th 50th 90th
Males and Females
Total, 6 years and older * < LOD < LOD 1.87 (1.59 – 2.49) 1,673
6–11 years * < LOD < LOD 1.33 (1.12 – 2.11) 208
12–19 years * < LOD < LOD 1.05 (.916 – 1.20) 580
20–39 years * < LOD < LOD 1.41 (1.24 – 1.84) 327
40–59 years * < LOD .778 (< LOD – .937) 2.54 (2.16 – 3.11) 298
60 years and older 1.04 (.906 – 1.19) < LOD .965 (.778 – 1.09) 2.80 (2.23 – 3.45) 260
Males
Total, 6 years and older * < LOD < LOD 1.61 (1.33 – 1.94) 827
6–11 years .807 (.695 – .937) < LOD .738 (< LOD – .876) 1.45 (1.13 – 6.80) 112
12–19 years * < LOD < LOD .997 (.882 – 1.17) 290
20–39 years * < LOD < LOD 1.27 (.962 – 1.84) 149
40–59 years * < LOD < LOD 2.28 (1.51 – 3.29) 136
60 years and older * < LOD .784 (< LOD – .927) 1.95 (1.64 – 3.14) 140
Females
Total, 6 years and older * < LOD .717 (< LOD – .832) 2.20 (1.83 – 2.77) 846
6–11 years * < LOD† < LOD 1.19† (1.03 – 1.99) 96
12–19 years * < LOD < LOD 1.08 (.914 – 1.42) 290
20–39 years * < LOD < LOD 1.62 (1.25 – 2.76) 178
40–59 years 1.01 (.886 – 1.16) < LOD .877 (.765 – 1.03) 2.82 (2.25 – 3.43) 162
60 years and older 1.17 (.947 – 1.44) < LOD 1.10 (.720 – 1.58) 3.16 (2.59 – 3.84) 120
< LOD means less than the limit of detection, which may vary for some compounds by year. See Appendix D for LOD. 
* Not calculated. Proportion of results below limit of detection was too high to provide a valid result. 
† Estimate is subject to greater uncertainty due to small cell size.
Table 2.8.a.5. Serum cis-beta-carotene: Non-Hispanic whites
Geometric mean and selected percentiles of serum concentrations (in µg/dL) for non-Hispanic whites in the 
U.S. population aged 6 years and older, National Health and Nutrition Examination Survey, 2005–2006. 
Geometric mean 
(95% conf. interval)
Selected percentiles (95% conf. interval) Sample 
size10th 50th 90th
Males and Females
Total, 6 years and older * < LOD < LOD 2.17 (1.92 – 2.55) 2,725
6–11 years * < LOD < LOD 1.46 (1.21 – 2.42) 212
12–19 years * < LOD < LOD 1.16 (.979 – 1.39) 462
20–39 years * < LOD < LOD 1.74 (1.44 – 2.15) 653
40–59 years * < LOD .720 (< LOD – .779) 2.50 (2.11 – 3.14) 634
60 years and older 1.07 (.967 – 1.18) < LOD .892 (.783 – 1.00) 3.09 (2.57 – 3.70) 764
Males
Total, 6 years and older * < LOD < LOD 1.59 (1.42 – 1.92) 1,336
6–11 years * < LOD† < LOD 1.49† (1.16 – 5.17) 102
12–19 years * < LOD < LOD .926 (.842 – 1.19) 231
20–39 years * < LOD < LOD 1.35 (1.18 – 1.59) 278
40–59 years * < LOD < LOD 1.69 (1.46 – 1.99) 324
60 years and older * < LOD < LOD 2.39 (1.82 – 3.14) 401
Females
Total, 6 years and older * < LOD .761 (.704 – .828) 2.79 (2.34 – 3.48) 1,389
6–11 years * < LOD† < LOD 1.43† (1.19 – 1.98) 110
12–19 years * < LOD < LOD 1.39 (1.12 – 1.85) 231
20–39 years * < LOD < LOD 2.14 (1.62 – 3.70) 375
40–59 years 1.03 (.941 – 1.13) < LOD .795 (.718 – .966) 3.55 (2.73 – 3.96) 310
60 years and older 1.26 (1.10 – 1.45) < LOD 1.16 (.875 – 1.38) 3.70 (3.16 – 4.80) 363
< LOD means less than the limit of detection, which may vary for some compounds by year. See Appendix D for LOD. 
* Not calculated. Proportion of results below limit of detection was too high to provide a valid result. 
† Estimate is subject to greater uncertainty due to small cell size.
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Table 2.8.b. Serum cis-beta-carotene: Concentrations by survey cycle
Geometric mean and selected percentiles of serum concentrations (in µg/dL) for the U.S. population, National 
Health and Nutrition Examination Survey, 2001–2002 and 2005–2006.
Geometric mean 
(95% conf. interval)
Selected percentiles (95% conf. interval) Sample 
size5th 50th 95th
Total, 6 years and older
 2001–2002 * < LOD < LOD 2.64 (2.41 – 2.87) 7,929
 2005–2006 * < LOD < LOD 3.20 (2.87 – 3.64) 6,616
Age group
3–5 years
 2001–2002 * < LOD < LOD 2.07 (1.88 – 2.62) 430
6–11 years
 2001–2002 * < LOD < LOD 1.64 (1.50 – 1.84) 1,014
 2005–2006 * < LOD < LOD 1.95 (1.63 – 2.68) 779
12–19 years
 2001–2002 * < LOD < LOD 1.39 (1.30 – 1.55) 2,206
 2005–2006 * < LOD < LOD 1.47 (1.33 – 1.81) 1,785
20–39 years
 2001–2002 * < LOD < LOD 2.05 (1.82 – 2.46) 1,716
 2005–2006 * < LOD < LOD 2.51 (2.08 – 3.19) 1,528
40–59 years
 2001–2002 * < LOD < LOD 3.30 (2.77 – 4.39) 1,470
 2005–2006 * < LOD .730 (< LOD – .783) 3.73 (3.21 – 4.44) 1,254
60 years and older
 2001–2002 1.02 (.943 – 1.11) < LOD .899 (.803 – 1.02) 3.50 (3.11 – 3.94) 1,523
 2005–2006 1.08 (.985 – 1.17) < LOD .903 (.811 – .992) 4.59 (3.93 – 5.32) 1,270
Gender
(6 years and older)
Males
 2001–2002 * < LOD < LOD 2.13 (1.94 – 2.41) 3,835
 2005–2006 * < LOD < LOD 2.26 (1.99 – 2.60) 3,204
Females
 2001–2002 * < LOD < LOD 3.08 (2.73 – 3.70) 4,094
 2005–2006 * < LOD .759 (.708 – .816) 3.88 (3.60 – 4.48) 3,412
Race/ethnicity
(6 years and older)
Mexican Americans
 2001–2002 * < LOD < LOD 2.06 (1.85 – 2.42) 1,990
 2005–2006 * < LOD < LOD 2.26 (1.97 – 2.59) 1,707
Non-Hispanic Blacks
 2001–2002 * < LOD < LOD 2.29 (1.96 – 2.69) 1,864
 2005–2006 * < LOD < LOD 2.81 (2.37 – 3.38) 1,673
Non-Hispanic Whites
 2001–2002 * < LOD < LOD 2.79 (2.48 – 3.28) 3,450
 2005–2006 * < LOD < LOD 3.44 (3.06 – 3.82) 2,725
< LOD means less than the limit of detection, which may vary for some compounds by year. See Appendix D for LOD. 
* Not calculated. Proportion of results below limit of detection was too high to provide a valid result. 










































































































Figure 2.8.b. Serum cis−beta−carotene: Concentrations by survey cycle
Selected percentiles in µg/dL (95% confidence intervals), National Health and 
Nutrition Examination Survey, 2001–2002 and 2005–2006
Values in the graph are suppressed if either the point estimate or the lower 95% confidence limit is noted as “< LOD” in the accompanying table.




































































































































































































































































































































































































































































































































































































































































































































































































































































































































































 Non−Hispanic Blacks Non−Hispanic Whites 
Figure 2.9.a. Serum beta−cryptoxanthin: Concentrations by age group 
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Table 2.9.a.2. Serum beta-cryptoxanthin: Total population
Geometric mean and selected percentiles of serum concentrations (in µg/dL) for the total U.S. population aged 
6 years and older, National Health and Nutrition Examination Survey, 2005–2006. 
Geometric mean 
(95% conf. interval)
Selected percentiles (95% conf. interval) Sample 
size10th 50th 90th
Males and Females
Total, 6 years and older 7.70 (7.34 – 8.08) 3.17 (2.95 – 3.36) 7.62 (7.24 – 7.99) 18.5 (17.5 – 19.7) 7,195
6–11 years 9.47 (8.88 – 10.1) 4.47 (3.95 – 5.23) 9.14 (8.52 – 9.66) 19.5 (17.8 – 21.7) 855
12–19 years 7.82 (7.42 – 8.23) 3.86 (3.64 – 4.01) 7.49 (7.01 – 7.99) 16.5 (15.2 – 17.8) 1,924
20–39 years 7.95 (7.52 – 8.40) 3.42 (3.06 – 3.76) 7.81 (7.31 – 8.18) 18.2 (16.7 – 20.0) 1,679
40–59 years 7.24 (6.60 – 7.94) 2.76 (2.48 – 3.06) 7.03 (6.50 – 7.82) 19.3 (17.2 – 21.2) 1,357
60 years and older 7.39 (6.86 – 7.97) 2.82 (2.40 – 3.01) 7.48 (7.03 – 8.13) 19.0 (17.4 – 20.7) 1,380
Males
Total, 6 years and older 7.51 (7.10 – 7.94) 3.13 (2.87 – 3.38) 7.49 (7.12 – 7.88) 18.0 (17.1 – 19.3) 3,514
6–11 years 9.70 (8.87 – 10.6) 4.86 (3.91 – 5.70) 9.33 (8.48 – 10.2) 19.2 (17.3 – 21.7) 426
12–19 years 7.89 (7.36 – 8.46) 3.95 (3.55 – 4.37) 7.65 (7.02 – 8.42) 16.9 (15.0 – 18.6) 961
20–39 years 7.86 (7.38 – 8.38) 3.49 (3.11 – 3.88) 7.74 (7.16 – 8.22) 17.9 (16.0 – 19.5) 735
40–59 years 6.84 (6.09 – 7.69) 2.58 (2.16 – 2.91) 6.74 (6.12 – 7.68) 18.8 (16.7 – 21.9) 668
60 years and older 7.01 (6.37 – 7.70) 2.87 (2.36 – 3.05) 7.16 (6.44 – 7.89) 17.6 (16.7 – 20.5) 724
Females
Total, 6 years and older 7.89 (7.53 – 8.27) 3.21 (2.99 – 3.40) 7.74 (7.28 – 8.14) 19.1 (17.9 – 20.2) 3,681
6–11 years 9.23 (8.67 – 9.83) 4.21 (3.49 – 4.98) 8.82 (8.30 – 9.60) 19.7 (17.8 – 23.4) 429
12–19 years 7.73 (7.26 – 8.23) 3.77 (3.48 – 3.96) 7.32 (6.78 – 8.01) 16.3 (14.9 – 17.8) 963
20–39 years 8.04 (7.52 – 8.59) 3.32 (2.93 – 3.81) 7.87 (7.27 – 8.51) 19.3 (17.0 – 23.4) 944
40–59 years 7.63 (6.94 – 8.39) 3.08 (2.66 – 3.33) 7.35 (6.62 – 8.25) 19.7 (17.2 – 20.9) 689
60 years and older 7.73 (7.04 – 8.48) 2.79 (2.34 – 3.03) 7.73 (7.23 – 8.79) 20.0 (18.1 – 22.9) 656
Table 2.9.a.3. Serum beta-cryptoxanthin: Mexican Americans
Geometric mean and selected percentiles of serum concentrations (in µg/dL) for Mexican Americans in the U.S. 
population aged 6 years and older, National Health and Nutrition Examination Survey, 2005–2006. 
Geometric mean 
(95% conf. interval)
Selected percentiles (95% conf. interval) Sample 
size10th 50th 90th
Males and Females
Total, 6 years and older 13.0 (11.8 – 14.3) 5.53 (5.21 – 5.91) 12.9 (11.9 – 14.2) 29.7 (25.9 – 34.0) 1,842
6–11 years 12.4 (11.4 – 13.5) 6.01 (4.82 – 6.78) 12.3 (11.0 – 14.0) 24.8 (23.0 – 27.8) 295
12–19 years 11.1 (10.3 – 12.1) 5.77 (5.11 – 6.34) 11.0 (10.2 – 12.1) 22.8 (19.2 – 26.1) 646
20–39 years 13.6 (11.7 – 16.0) 5.47 (4.92 – 6.41) 13.5 (11.7 – 15.7) 31.9 (26.5 – 45.3) 448
40–59 years 13.3 (11.7 – 15.2) 5.34 (4.80 – 5.81) 13.6 (11.9 – 15.8) 29.8 (25.8 – 35.3) 245
60 years and older 13.3 (11.4 – 15.6) 5.60 (2.79 – 7.53) 13.4 (11.3 – 15.8) 29.7 (24.7 – 42.9) 208
Males
Total, 6 years and older 12.6 (11.2 – 14.1) 5.38 (4.94 – 5.92) 12.7 (11.4 – 14.4) 27.9 (24.5 – 32.7) 881
6–11 years 12.5 (11.3 – 13.8) 6.02 (3.82 – 6.86) 12.5 (11.2 – 14.4) 24.3 (22.2 – 32.0) 145
12–19 years 10.7 (9.74 – 11.9) 6.00 (5.02 – 6.51) 10.5 (9.42 – 11.6) 21.7 (18.5 – 26.0) 313
20–39 years 13.5 (11.1 – 16.4) 5.38 (4.43 – 6.71) 13.8 (11.6 – 16.0) 29.6 (22.6 – 45.6) 197
40–59 years 12.6 (10.5 – 15.0) 5.06 (3.45 – 5.65) 13.0 (10.4 – 15.5) 30.6 (25.0 – 45.0) 121
60 years and older 12.0 (9.50 – 15.1) 4.24† (1.40 – 7.66) 11.4 (9.88 – 15.0) 26.9† (21.1 – 37.5) 105
Females
Total, 6 years and older 13.4 (12.2 – 14.6) 5.64 (5.31 – 6.10) 13.1 (12.2 – 14.2) 30.8 (26.8 – 39.3) 961
6–11 years 12.3 (11.3 – 13.5) 5.87 (4.89 – 6.83) 11.8 (10.9 – 13.3) 26.0 (21.9 – 28.8) 150
12–19 years 11.6 (10.6 – 12.7) 5.49 (4.35 – 6.31) 12.1 (10.9 – 13.0) 23.4 (19.9 – 30.4) 333
20–39 years 13.8 (11.7 – 16.2) 5.49 (4.69 – 6.54) 13.0 (11.0 – 16.0) 34.7 (29.7 – 47.2) 251
40–59 years 14.2 (12.2 – 16.4) 5.67 (3.59 – 7.24) 13.7 (12.5 – 16.3) 29.5 (24.9 – 36.5) 124
60 years and older 14.5 (11.8 – 18.0) 5.79† (3.11 – 7.70) 15.4 (12.2 – 17.4) 30.1† (25.5 – 59.9) 103
† Estimate is subject to greater uncertainty due to small cell size. 
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Table 2.9.a.4. Serum beta-cryptoxanthin: Non-Hispanic blacks
Geometric mean and selected percentiles of serum concentrations (in µg/dL) for non-Hispanic blacks in the U.S. 
population aged 6 years and older, National Health and Nutrition Examination Survey, 2005–2006. 
Geometric mean 
(95% conf. interval)
Selected percentiles (95% conf. interval) Sample 
size10th 50th 90th
Males and Females
Total, 6 years and older 8.34 (7.88 – 8.84) 3.72 (3.51 – 4.02) 8.23 (7.80 – 8.81) 18.1 (17.2 – 19.3) 1,848
6–11 years 11.9 (11.1 – 12.8) 6.05 (5.13 – 6.76) 11.7 (10.6 – 13.2) 22.8 (19.7 – 25.0) 237
12–19 years 8.69 (7.99 – 9.46) 4.54 (4.16 – 4.92) 8.47 (7.65 – 9.40) 17.4 (15.7 – 19.0) 637
20–39 years 8.26 (7.76 – 8.78) 3.97 (3.62 – 4.26) 7.95 (7.47 – 8.71) 16.3 (15.0 – 18.9) 363
40–59 years 7.89 (6.95 – 8.97) 2.90 (2.54 – 3.55) 7.98 (6.88 – 9.10) 18.8 (17.2 – 22.3) 332
60 years and older 7.38 (6.55 – 8.31) 3.16 (2.61 – 3.71) 7.31 (6.35 – 8.23) 16.8 (15.5 – 21.8) 279
Males
Total, 6 years and older 8.23 (7.64 – 8.87) 3.58 (3.20 – 3.89) 8.03 (7.38 – 8.90) 19.0 (17.7 – 20.9) 922
6–11 years 12.5 (11.2 – 14.0) 6.69 (4.92 – 7.69) 12.6 (10.6 – 14.7) 23.9 (21.5 – 25.6) 127
12–19 years 8.80 (8.01 – 9.67) 4.43 (3.92 – 4.96) 8.50 (7.75 – 9.40) 18.2 (15.8 – 20.7) 325
20–39 years 8.26 (7.73 – 8.83) 4.00 (3.65 – 4.31) 7.41 (7.04 – 7.98) 18.2 (15.3 – 21.6) 168
40–59 years 7.49 (6.22 – 9.03) 2.63 (2.42 – 2.81) 7.64 (6.42 – 9.09) 19.0 (17.1 – 24.6) 153
60 years and older 6.73 (6.08 – 7.45) 2.92 (2.43 – 3.29) 6.06 (5.09 – 7.20) 17.0 (15.6 – 17.8) 149
Females
Total, 6 years and older 8.44 (8.04 – 8.86) 3.87 (3.56 – 4.40) 8.39 (8.01 – 8.86) 17.3 (16.4 – 18.5) 926
6–11 years 11.2 (9.74 – 13.0) 5.33† (4.18 – 6.55) 10.8 (9.90 – 12.2) 19.6† (17.8 – 30.0) 110
12–19 years 8.59 (7.79 – 9.46) 4.66 (4.22 – 5.04) 8.46 (7.40 – 9.63) 16.6 (14.9 – 18.0) 312
20–39 years 8.25 (7.69 – 8.86) 3.73 (3.50 – 4.18) 8.14 (7.80 – 8.94) 15.6 (13.7 – 20.1) 195
40–59 years 8.24 (7.42 – 9.14) 3.64 (2.54 – 4.52) 8.22 (6.90 – 9.23) 18.5 (16.3 – 21.5) 179
60 years and older 7.89 (6.67 – 9.33) 3.67 (2.29 – 4.00) 7.96 (6.64 – 9.20) 16.5 (14.7 – 26.2) 130
† Estimate is subject to greater uncertainty due to small cell size.
Table 2.9.a.5. Serum beta-cryptoxanthin: Non-Hispanic whites
Geometric mean and selected percentiles of serum concentrations (in µg/dL) for non-Hispanic whites in the 
U.S. population aged 6 years and older, National Health and Nutrition Examination Survey, 2005–2006. 
Geometric mean 
(95% conf. interval)
Selected percentiles (95% conf. interval) Sample 
size10th 50th 90th
Males and Females
Total, 6 years and older 6.94 (6.59 – 7.32) 2.93 (2.72 – 3.14) 6.96 (6.62 – 7.38) 16.3 (15.3 – 17.4) 2,960
6–11 years 8.29 (7.73 – 8.89) 4.21 (3.43 – 4.88) 8.12 (7.60 – 8.69) 15.7 (14.5 – 17.9) 230
12–19 years 7.12 (6.60 – 7.68) 3.72 (3.31 – 3.93) 6.82 (6.07 – 7.64) 14.2 (13.1 – 16.1) 497
20–39 years 6.90 (6.60 – 7.21) 3.01 (2.73 – 3.40) 6.93 (6.69 – 7.24) 15.1 (13.3 – 16.5) 711
40–59 years 6.63 (5.99 – 7.33) 2.63 (2.35 – 2.88) 6.61 (6.11 – 7.28) 17.2 (14.6 – 20.0) 679
60 years and older 7.05 (6.51 – 7.64) 2.75 (2.28 – 2.96) 7.26 (6.66 – 7.79) 17.7 (16.8 – 19.6) 843
Males
Total, 6 years and older 6.83 (6.42 – 7.28) 2.92 (2.50 – 3.23) 6.90 (6.58 – 7.29) 15.9 (14.6 – 17.5) 1,468
6–11 years 8.45 (7.44 – 9.60) 4.43 (3.50 – 5.65) 7.99 (7.29 – 9.15) 15.9 (14.0 – 21.0) 112
12–19 years 7.38 (6.60 – 8.26) 3.87 (3.20 – 4.40) 7.10 (6.14 – 8.39) 14.5 (12.6 – 17.5) 253
20–39 years 6.94 (6.51 – 7.40) 3.15 (2.80 – 3.53) 7.06 (6.75 – 7.53) 14.0 (12.1 – 16.7) 309
40–59 years 6.39 (5.62 – 7.26) 2.42 (1.99 – 2.82) 6.31 (5.75 – 6.96) 17.6 (14.6 – 21.6) 350
60 years and older 6.66 (6.02 – 7.37) 2.78 (2.23 – 3.04) 6.94 (5.82 – 7.73) 17.0 (15.2 – 18.8) 444
Females
Total, 6 years and older 7.05 (6.69 – 7.43) 2.94 (2.70 – 3.20) 7.04 (6.59 – 7.55) 16.6 (15.4 – 18.1) 1,492
6–11 years 8.11 (7.34 – 8.95) 3.85 (3.04 – 4.45) 8.14 (7.69 – 8.60) 15.0 (13.3 – 22.0) 118
12–19 years 6.84 (6.25 – 7.48) 3.57 (2.93 – 3.86) 6.57 (5.73 – 7.38) 14.0 (12.8 – 16.4) 244
20–39 years 6.86 (6.45 – 7.28) 2.92 (2.53 – 3.38) 6.73 (6.29 – 7.41) 15.7 (13.5 – 18.2) 402
40–59 years 6.87 (6.18 – 7.64) 2.84 (2.52 – 3.24) 6.84 (6.09 – 7.85) 16.5 (14.4 – 19.9) 329
60 years and older 7.39 (6.69 – 8.17) 2.73 (2.26 – 2.94) 7.50 (6.74 – 8.69) 19.5 (17.0 – 21.2) 399
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Table 2.9.b. Serum beta-cryptoxanthin: Concentrations by survey cycle
Geometric mean and selected percentiles of serum concentrations (in µg/dL) for the U.S. population, National 
Health and Nutrition Examination Survey, 2001–2002 and 2005–2006. 
Geometric mean 
(95% conf. interval)
Selected percentiles (95% conf. interval) Sample 
size5th 50th 95th
Total, 6 years and older
 2001–2002 7.46 (7.06 – 7.87) 2.45 (2.20 – 2.68) 7.40 (7.00 – 7.82) 23.0 (20.9 – 25.5) 7,890
 2005–2006 7.70 (7.34 – 8.08) 2.46 (2.26 – 2.63) 7.62 (7.24 – 7.99) 24.1 (22.5 – 26.4) 7,195
Age group
3–5 years
 2001–2002 9.43 (8.40 – 10.6) 3.30 (1.88 – 3.96) 9.09 (7.81 – 10.4) 30.7 (25.3 – 43.1) 427
6–11 years
 2001–2002 9.40 (8.71 – 10.2) 3.92 (3.28 – 4.22) 9.05 (8.29 – 10.2) 26.1 (21.9 – 31.6) 1,006
 2005–2006 9.47 (8.88 – 10.1) 3.90 (3.32 – 4.23) 9.14 (8.52 – 9.66) 24.9 (23.0 – 28.7) 855
12–19 years
 2001–2002 7.63 (7.20 – 8.08) 3.05 (2.58 – 3.31) 7.45 (7.00 – 7.99) 19.8 (18.5 – 22.3) 2,199
 2005–2006 7.82 (7.42 – 8.23) 3.20 (2.91 – 3.50) 7.49 (7.01 – 7.99) 20.3 (18.8 – 23.4) 1,924
20–39 years
 2001–2002 7.11 (6.57 – 7.69) 2.40 (2.04 – 2.73) 6.83 (6.25 – 7.50) 22.9 (20.0 – 26.6) 1,707
 2005–2006 7.95 (7.52 – 8.40) 2.78 (2.50 – 2.97) 7.81 (7.31 – 8.18) 24.5 (21.7 – 28.8) 1,679
40–59 years
 2001–2002 7.28 (6.75 – 7.86) 2.39 (2.02 – 2.71) 7.16 (6.66 – 7.77) 23.2 (20.4 – 26.1) 1,459
 2005–2006 7.24 (6.60 – 7.94) 2.16 (1.80 – 2.40) 7.03 (6.50 – 7.82) 24.8 (21.5 – 29.2) 1,357
60 years and older
 2001–2002 7.44 (6.84 – 8.09) 1.94 (1.71 – 2.22) 7.64 (7.06 – 8.28) 23.5 (20.9 – 27.8) 1,519
 2005–2006 7.39 (6.86 – 7.97) 1.98 (1.62 – 2.25) 7.48 (7.03 – 8.13) 24.2 (22.7 – 27.6) 1,380
Gender
(6 years and older)
Males
 2001–2002 7.28 (6.89 – 7.69) 2.41 (2.10 – 2.66) 7.32 (6.82 – 7.81) 22.3 (20.4 – 25.0) 3,815
 2005–2006 7.51 (7.10 – 7.94) 2.41 (2.10 – 2.70) 7.49 (7.12 – 7.88) 22.8 (21.5 – 25.0) 3,514
Females
 2001–2002 7.63 (7.20 – 8.08) 2.48 (2.29 – 2.75) 7.45 (7.05 – 7.84) 23.8 (21.1 – 26.2) 4,075
 2005–2006 7.89 (7.53 – 8.27) 2.54 (2.24 – 2.69) 7.74 (7.28 – 8.14) 25.5 (23.4 – 28.1) 3,681
Race/ethnicity
(6 years and older)
Mexican Americans
 2001–2002 12.1 (11.2 – 13.2) 4.14 (3.71 – 4.53) 12.1 (10.9 – 13.5) 34.5 (32.1 – 38.5) 1,988
 2005–2006 13.0 (11.8 – 14.3) 4.42 (3.87 – 4.86) 12.9 (11.9 – 14.2) 36.2 (32.4 – 45.4) 1,842
Non-Hispanic Blacks
 2001–2002 8.03 (7.38 – 8.74) 2.99 (2.66 – 3.27) 7.92 (7.32 – 8.55) 23.0 (19.9 – 27.7) 1,859
 2005–2006 8.34 (7.88 – 8.84) 2.89 (2.59 – 3.11) 8.23 (7.80 – 8.81) 23.6 (20.8 – 27.8) 1,848
Non-Hispanic Whites
 2001–2002 6.80 (6.43 – 7.19) 2.36 (2.05 – 2.53) 6.71 (6.29 – 7.16) 19.6 (18.2 – 22.2) 3,422
 2005–2006 6.94 (6.59 – 7.32) 2.26 (2.07 – 2.44) 6.96 (6.62 – 7.38) 20.5 (19.7 – 21.9) 2,960
 
 
Figure 2.9.b. Serum beta−cryptoxanthin: Concentrations by survey cycle 
Selected percentiles in μg/dL (95% confidence intervals), National Health and 
























































1 1 1 
1 1 
1 


















































































Total 3−5y 6−11y 12−19y 20+y Males Females MA NHB NHW 
(6+y) (6+y) (6+y) (6+y) (6+y) (6+y) 
2. Fat-Soluble 1. WaterVitamins & Nutr-Soluble Vitaminsient  153153

































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Non−Hispanic Blacks Non−Hispanic Whites 
Figure 2.10.a. Serum lutein/zeaxanthin: Concentrations by age group 
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Table 2.10.a.2. Serum lutein/zeaxanthin: Total population
Geometric mean and selected percentiles of serum concentrations (in µg/dL) for the total U.S. population aged 
6 years and older, National Health and Nutrition Examination Survey, 2005–2006. 
Geometric mean 
(95% conf. interval)
Selected percentiles (95% conf. interval) Sample 
size10th 50th 90th
Males and Females
Total, 6 years and older 13.8 (13.4 – 14.2) 7.24 (6.91 – 7.49) 13.7 (13.2 – 14.1) 26.5 (25.7 – 27.3) 7,254
6–11 years 13.1 (12.6 – 13.7) 7.93 (6.84 – 8.54) 13.3 (12.8 – 13.9) 20.7 (20.1 – 22.0) 860
12–19 years 10.7 (10.3 – 11.1) 6.50 (6.19 – 6.74) 10.6 (10.0 – 11.1) 17.6 (16.9 – 18.4) 1,954
20–39 years 13.6 (13.1 – 14.1) 7.40 (6.64 – 7.83) 13.6 (12.9 – 14.4) 25.1 (23.4 – 27.1) 1,688
40–59 years 14.5 (13.8 – 15.2) 7.23 (6.70 – 7.58) 14.5 (13.7 – 15.2) 29.4 (27.5 – 31.0) 1,365
60 years and older 15.5 (14.9 – 16.2) 7.89 (7.52 – 8.13) 15.7 (15.0 – 16.5) 29.0 (27.3 – 31.9) 1,387
Males
Total, 6 years and older 13.6 (13.1 – 14.0) 7.22 (6.78 – 7.61) 13.5 (13.0 – 14.1) 25.6 (24.5 – 26.2) 3,547
6–11 years 13.4 (12.7 – 14.1) 8.08 (7.62 – 8.69) 13.6 (12.5 – 14.2) 20.5 (19.0 – 22.5) 427
12–19 years 10.5 (10.1 – 10.9) 6.49 (6.06 – 6.86) 10.3 (9.91 – 10.9) 17.3 (16.7 – 18.3) 980
20–39 years 13.4 (12.8 – 14.0) 7.26 (6.51 – 7.96) 13.4 (12.8 – 14.2) 23.8 (22.4 – 26.0) 738
40–59 years 14.2 (13.4 – 15.0) 7.22 (5.99 – 7.90) 14.1 (13.1 – 15.1) 27.6 (26.6 – 31.0) 673
60 years and older 15.5 (14.7 – 16.4) 7.94 (7.26 – 8.26) 15.9 (15.2 – 17.0) 27.8 (26.2 – 31.2) 729
Females
Total, 6 years and older 14.0 (13.5 – 14.4) 7.27 (6.77 – 7.56) 13.8 (13.3 – 14.4) 27.5 (26.7 – 28.5) 3,707
6–11 years 12.9 (12.1 – 13.7) 7.63 (5.98 – 8.50) 13.1 (12.6 – 13.7) 21.4 (19.9 – 23.6) 433
12–19 years 10.9 (10.3 – 11.4) 6.52 (5.98 – 6.93) 10.8 (10.1 – 11.5) 18.0 (16.9 – 19.1) 974
20–39 years 13.8 (13.2 – 14.5) 7.42 (6.59 – 7.80) 13.8 (12.9 – 14.8) 25.7 (23.9 – 28.0) 950
40–59 years 14.7 (13.9 – 15.6) 7.17 (6.76 – 7.56) 15.0 (13.8 – 16.2) 29.6 (28.9 – 32.2) 692
60 years and older 15.6 (14.8 – 16.4) 7.80 (7.40 – 8.17) 15.6 (14.1 – 16.7) 29.8 (28.0 – 32.8) 658
Table 2.10.a.3. Serum lutein/zeaxanthin: Mexican Americans
Geometric mean and selected percentiles of serum concentrations (in µg/dL) for Mexican Americans in the U.S. 
population aged 6 years and older, National Health and Nutrition Examination Survey, 2005–2006. 
Geometric mean 
(95% conf. interval)
Selected percentiles (95% conf. interval) Sample 
size10th 50th 90th
Males and Females
Total, 6 years and older 15.1 (14.5 – 15.8) 8.60 (8.07 – 9.17) 15.0 (14.4 – 15.6) 26.8 (25.2 – 28.6) 1,844
6–11 years 13.2 (12.4 – 14.0) 8.43 (6.89 – 9.35) 13.3 (12.2 – 14.1) 21.1 (19.3 – 23.5) 295
12–19 years 12.1 (11.5 – 12.7) 7.64 (7.22 – 8.01) 12.3 (11.7 – 12.9) 18.9 (18.0 – 20.0) 646
20–39 years 15.4 (14.3 – 16.6) 8.96 (8.09 – 9.65) 15.4 (14.2 – 17.3) 26.2 (23.4 – 30.5) 449
40–59 years 17.2 (16.0 – 18.5) 9.78 (7.36 – 11.0) 17.2 (16.2 – 18.5) 30.4 (27.3 – 36.3) 246
60 years and older 18.6 (16.7 – 20.7) 9.96 (7.59 – 12.0) 18.7 (16.9 – 20.3) 32.2 (30.1 – 34.4) 208
Males
Total, 6 years and older 15.4 (14.5 – 16.3) 8.81 (8.00 – 9.51) 15.1 (14.4 – 16.0) 28.1 (25.6 – 31.1) 883
6–11 years 13.0 (12.1 – 13.9) 8.75 (6.33 – 9.71) 13.1 (12.1 – 13.9) 19.6 (17.5 – 22.0) 145
12–19 years 11.7 (11.0 – 12.5) 7.62 (6.85 – 8.20) 12.0 (10.9 – 12.9) 18.2 (17.4 – 19.2) 313
20–39 years 16.0 (14.6 – 17.5) 9.47 (8.02 – 10.1) 15.8 (14.9 – 17.4) 28.5 (24.2 – 33.1) 198
40–59 years 17.7 (15.7 – 19.9) 8.69 (5.55 – 11.6) 17.6 (16.1 – 19.9) 31.1 (27.0 – 52.1) 122
60 years and older 19.1 (16.0 – 22.7) 10.7† (6.38 – 12.2) 18.5 (14.5 – 25.4) 34.1† (29.9 – 45.4) 105
Females
Total, 6 years and older 14.9 (14.2 – 15.6) 8.46 (7.68 – 9.34) 14.7 (14.1 – 15.5) 24.4 (23.3 – 27.0) 961
6–11 years 13.4 (12.5 – 14.4) 7.94 (6.66 – 8.97) 13.6 (11.9 – 14.4) 23.4 (19.8 – 27.1) 150
12–19 years 12.5 (11.9 – 13.1) 7.61 (7.08 – 8.14) 12.8 (12.3 – 13.1) 19.7 (18.3 – 20.8) 333
20–39 years 14.7 (13.7 – 15.9) 8.18 (7.42 – 9.74) 14.7 (13.1 – 16.9) 23.1 (22.2 – 27.0) 251
40–59 years 16.7 (15.6 – 18.0) 10.1 (7.40 – 10.9) 16.6 (14.5 – 18.4) 28.6 (23.7 – 44.2) 124
60 years and older 18.2 (16.1 – 20.7) 9.82† (7.45 – 11.7) 18.8 (16.2 – 21.7) 30.6† (28.3 – 33.6) 103
† Estimate is subject to greater uncertainty due to small cell size. 
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Table 2.10.a.4. Serum lutein/zeaxanthin: Non-Hispanic blacks
Geometric mean and selected percentiles of serum concentrations (in µg/dL) for non-Hispanic blacks in the U.S. 
population aged 6 years and older, National Health and Nutrition Examination Survey, 2005–2006. 
Geometric mean 
(95% conf. interval)
Selected percentiles (95% conf. interval) Sample 
size10th 50th 90th
Males and Females
Total, 6 years and older 15.3 (14.8 – 15.8) 8.61 (8.21 – 9.04) 15.4 (15.0 – 15.8) 26.6 (25.2 – 28.4) 1,891
6–11 years 15.8 (15.3 – 16.4) 10.5 (9.30 – 11.0) 16.2 (15.6 – 16.8) 23.9 (22.5 – 27.4) 240
12–19 years 12.9 (12.3 – 13.5) 7.94 (7.37 – 8.38) 13.0 (12.1 – 13.7) 20.9 (19.5 – 22.1) 665
20–39 years 14.5 (13.7 – 15.3) 8.29 (6.74 – 9.45) 14.4 (13.5 – 15.4) 25.3 (24.0 – 28.3) 368
40–59 years 16.4 (15.5 – 17.4) 8.77 (7.81 – 9.51) 17.0 (15.8 – 18.2) 28.6 (26.6 – 30.2) 335
60 years and older 17.4 (16.0 – 19.1) 8.99 (8.24 – 10.1) 17.7 (16.0 – 19.1) 31.5 (27.1 – 36.5) 283
Males
Total, 6 years and older 15.4 (14.9 – 15.9) 8.69 (8.26 – 9.42) 15.6 (14.9 – 16.3) 26.6 (25.6 – 28.4) 949
6–11 years 15.9 (14.9 – 16.9) 11.1 (10.3 – 11.9) 15.9 (15.0 – 17.2) 23.1 (21.9 – 26.9) 128
12–19 years 13.1 (12.4 – 13.8) 8.08 (7.27 – 8.68) 13.3 (12.2 – 14.6) 20.8 (19.6 – 21.9) 343
20–39 years 14.6 (13.8 – 15.5) 8.48 (6.56 – 9.65) 14.2 (13.1 – 15.7) 26.3 (23.2 – 29.1) 170
40–59 years 16.9 (15.8 – 18.1) 9.21 (7.66 – 9.97) 18.2 (15.6 – 19.3) 30.6 (27.5 – 36.0) 156
60 years and older 17.1 (16.2 – 18.1) 8.83 (7.79 – 9.64) 17.9 (17.2 – 18.8) 29.0 (25.9 – 34.0) 152
Females
Total, 6 years and older 15.2 (14.5 – 15.8) 8.51 (7.69 – 9.12) 15.3 (14.8 – 15.9) 26.4 (24.6 – 29.1) 942
6–11 years 15.8 (15.1 – 16.5) 9.57 (7.86 – 10.7) 16.5 (14.8 – 17.1) 24.0 (22.3 – 28.9) 112
12–19 years 12.7 (11.9 – 13.6) 7.70 (6.62 – 8.68) 12.7 (11.4 – 13.6) 21.1 (19.1 – 23.5) 322
20–39 years 14.4 (13.4 – 15.5) 8.03 (5.21 – 9.63) 14.7 (13.6 – 15.4) 24.6 (23.2 – 28.5) 198
40–59 years 16.0 (15.0 – 17.1) 8.72 (7.23 – 9.34) 16.6 (15.6 – 17.6) 26.9 (24.6 – 29.9) 179
60 years and older 17.7 (15.2 – 20.5) 9.08 (7.95 – 10.6) 17.3 (15.1 – 20.2) 33.2 (26.3 – 57.9) 131
Table 2.10.a.5. Serum lutein/zeaxanthin: Non-Hispanic whites
Geometric mean and selected percentiles of serum concentrations (in µg/dL) for non-Hispanic whites in the 
U.S. population aged 6 years and older, National Health and Nutrition Examination Survey, 2005–2006. 
Geometric mean 
(95% conf. interval)
Selected percentiles (95% conf. interval) Sample 
size10th 50th 90th
Males and Females
Total, 6 years and older 13.2 (12.8 – 13.6) 6.80 (6.48 – 7.16) 12.9 (12.5 – 13.4) 25.8 (25.1 – 26.9) 2,973
6–11 years 12.5 (11.8 – 13.3) 7.68 (6.04 – 8.34) 12.7 (12.2 – 13.6) 19.8 (18.3 – 23.1) 231
12–19 years 9.88 (9.46 – 10.3) 6.16 (5.75 – 6.48) 9.80 (9.34 – 10.3) 16.2 (15.0 – 17.1) 499
20–39 years 12.7 (12.2 – 13.1) 6.56 (5.93 – 7.39) 12.4 (11.7 – 13.2) 23.6 (22.1 – 26.9) 714
40–59 years 13.8 (13.0 – 14.6) 6.87 (6.26 – 7.25) 13.7 (12.6 – 15.1) 27.9 (26.7 – 30.2) 683
60 years and older 15.0 (14.4 – 15.7) 7.59 (7.25 – 7.97) 15.2 (14.2 – 15.8) 28.5 (26.4 – 31.4) 846
Males
Total, 6 years and older 13.0 (12.5 – 13.4) 6.87 (6.45 – 7.22) 12.8 (12.2 – 13.5) 24.4 (23.5 – 25.7) 1,472
6–11 years 12.9 (11.8 – 14.2) 7.95 (5.77 – 8.67) 13.0 (12.2 – 14.1) 18.9 (17.1 – 31.9) 112
12–19 years 9.75 (9.24 – 10.3) 6.23 (5.55 – 6.75) 9.71 (9.33 – 10.0) 15.6 (14.3 – 16.9) 254
20–39 years 12.4 (11.9 – 12.9) 6.55 (5.75 – 7.69) 12.3 (11.7 – 13.0) 22.7 (21.8 – 24.8) 309
40–59 years 13.6 (12.8 – 14.4) 6.96 (5.83 – 7.71) 13.4 (12.3 – 14.9) 26.6 (24.5 – 29.9) 351
60 years and older 15.0 (14.2 – 15.9) 7.59 (7.11 – 8.05) 15.4 (14.4 – 16.5) 26.6 (25.5 – 30.6) 446
Females
Total, 6 years and older 13.4 (12.9 – 13.8) 6.75 (6.20 – 7.26) 13.0 (12.4 – 13.7) 27.4 (26.0 – 28.1) 1,501
6–11 years 12.1 (11.1 – 13.2) 6.73 (5.07 – 8.32) 12.4 (11.1 – 13.2) 19.9 (18.2 – 28.1) 119
12–19 years 10.0 (9.21 – 10.9) 6.08 (5.23 – 6.57) 9.90 (9.18 – 11.1) 16.5 (15.3 – 18.1) 245
20–39 years 12.9 (12.2 – 13.6) 6.60 (5.82 – 7.42) 12.6 (11.2 – 14.4) 25.0 (22.3 – 28.5) 405
40–59 years 14.0 (13.0 – 15.0) 6.78 (5.98 – 7.28) 14.0 (12.5 – 15.7) 29.2 (27.5 – 30.7) 332
60 years and older 15.1 (14.3 – 15.9) 7.58 (6.96 – 8.05) 14.7 (13.6 – 16.2) 29.2 (27.6 – 32.6) 400
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Table 2.10.b. Serum lutein/zeaxanthin: Concentrations by survey cycle
Geometric mean and selected percentiles of serum concentrations (in µg/dL) for the U.S. population, National 
Health and Nutrition Examination Survey, 2001–2002 and 2005–2006. 
Geometric mean 
(95% conf. interval)
Selected percentiles (95% conf. interval) Sample 
size5th 50th 95th
Total, 6 years and older
 2001–2002 13.1 (12.5 – 13.6) 5.77 (5.53 – 6.00) 12.9 (12.2 – 13.5) 30.4 (28.6 – 32.2) 7,923
 2005–2006 13.8 (13.4 – 14.2) 5.90 (5.68 – 6.18) 13.7 (13.2 – 14.1) 31.3 (30.3 – 33.2) 7,254
Age group
3–5 years
 2001–2002 12.5 (11.8 – 13.2) 6.38 (5.82 – 7.04) 12.5 (12.0 – 13.1) 24.6 (22.2 – 31.5) 430
6–11 years
 2001–2002 12.5 (11.9 – 13.2) 6.61 (5.88 – 7.06) 12.3 (11.6 – 13.1) 24.8 (22.4 – 26.0) 1,014
 2005–2006 13.1 (12.6 – 13.7) 6.70 (5.50 – 7.67) 13.3 (12.8 – 13.9) 24.5 (23.5 – 27.4) 860
12–19 years
 2001–2002 10.4 (9.91 – 11.0) 4.99 (4.64 – 5.54) 10.4 (9.80 – 11.0) 20.9 (19.4 – 23.2) 2,205
 2005–2006 10.7 (10.3 – 11.1) 5.67 (5.21 – 5.91) 10.6 (10.0 – 11.1) 20.0 (19.1 – 21.1) 1,954
20–39 years
 2001–2002 12.1 (11.5 – 12.9) 5.47 (5.16 – 5.73) 12.0 (11.2 – 12.7) 27.1 (25.7 – 30.7) 1,714
 2005–2006 13.6 (13.1 – 14.1) 5.91 (5.19 – 6.41) 13.6 (12.9 – 14.4) 29.3 (27.7 – 32.1) 1,688
40–59 years
 2001–2002 14.4 (13.6 – 15.2) 6.47 (5.69 – 7.04) 14.1 (13.5 – 14.9) 32.6 (31.0 – 35.5) 1,468
 2005–2006 14.5 (13.8 – 15.2) 5.82 (5.28 – 6.13) 14.5 (13.7 – 15.2) 35.7 (33.3 – 37.8) 1,365
60 years and older
 2001–2002 15.2 (14.3 – 16.2) 6.14 (5.54 – 6.68) 15.3 (14.3 – 16.6) 35.1 (33.3 – 41.0) 1,522
 2005–2006 15.5 (14.9 – 16.2) 6.44 (6.02 – 6.69) 15.7 (15.0 – 16.5) 35.9 (32.8 – 40.3) 1,387
Gender
(6 years and older)
Males
 2001–2002 13.0 (12.5 – 13.6) 5.67 (5.35 – 6.01) 13.0 (12.4 – 13.6) 29.8 (28.3 – 31.7) 3,832
 2005–2006 13.6 (13.1 – 14.0) 5.93 (5.42 – 6.35) 13.5 (13.0 – 14.1) 30.7 (28.7 – 31.4) 3,547
Females
 2001–2002 13.1 (12.5 – 13.7) 5.87 (5.59 – 6.03) 12.7 (12.1 – 13.5) 31.4 (28.8 – 33.0) 4,091
 2005–2006 14.0 (13.5 – 14.4) 5.89 (5.69 – 6.13) 13.8 (13.3 – 14.4) 32.8 (31.0 – 35.7) 3,707
Race/ethnicity
(6 years and older)
Mexican Americans
 2001–2002 13.7 (13.3 – 14.2) 6.58 (6.15 – 6.84) 13.6 (13.2 – 14.1) 28.5 (26.8 – 30.7) 1,988
 2005–2006 15.1 (14.5 – 15.8) 7.41 (6.79 – 7.83) 15.0 (14.4 – 15.6) 31.3 (29.2 – 34.1) 1,844
Non-Hispanic Blacks
 2001–2002 14.2 (13.1 – 15.5) 6.80 (6.20 – 7.20) 14.1 (12.8 – 15.5) 30.7 (28.5 – 34.6) 1,864
 2005–2006 15.3 (14.8 – 15.8) 7.03 (6.33 – 7.71) 15.4 (15.0 – 15.8) 31.5 (29.4 – 35.1) 1,891
Non-Hispanic Whites
 2001–2002 12.6 (12.0 – 13.2) 5.60 (5.14 – 5.90) 12.4 (11.7 – 13.1) 28.8 (27.2 – 31.8) 3,447
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Figure 2.10.b. Serum lutein/zeaxanthin: Concentrations by survey cycle 
Selected percentiles in μg/dL (95% confidence intervals), National Health and 

Nutrition Examination Survey, 2001–2002 and 2005–2006
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Non−Hispanic Blacks Non−Hispanic Whites 
Figure 2.11.a. Serum trans−lycopene: Concentrations by age group 
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 Table 2.11.a.2. Serum trans-lycopene: Total population
Geometric mean and selected percentiles of serum concentrations (in µg/dL) for the total U.S. population aged 
6 years and older, National Health and Nutrition Examination Survey, 2005–2006. 
Geometric mean 
(95% conf. interval)
Selected percentiles (95% conf. interval) Sample 
size10th 50th 90th
Males and Females
Total, 6 years and older 21.2 (20.7 – 21.7) 10.7 (10.1 – 11.3) 22.7 (22.2 – 23.2) 38.9 (37.7 – 39.8) 7,254
6–11 years 21.7 (20.5 – 22.9) 11.6 (10.5 – 12.9) 22.5 (21.1 – 23.7) 38.3 (36.3 – 40.3) 860
12–19 years 21.9 (21.1 – 22.6) 12.9 (12.2 – 13.6) 22.3 (21.8 – 22.9) 37.2 (35.8 – 39.1) 1,954
20–39 years 23.9 (23.3 – 24.4) 13.4 (11.8 – 14.8) 25.1 (24.3 – 25.6) 40.2 (39.5 – 41.2) 1,688
40–59 years 21.6 (20.4 – 22.8) 11.0 (9.50 – 11.9) 23.2 (22.1 – 24.4) 39.9 (38.4 – 41.8) 1,365
60 years and older 16.4 (15.4 – 17.4) 7.14 (6.48 – 7.69) 17.8 (16.8 – 19.0) 33.7 (32.3 – 36.1) 1,387
Males
Total, 6 years and older 21.8 (21.0 – 22.6) 11.2 (10.3 – 11.8) 23.4 (22.6 – 24.3) 39.6 (38.1 – 41.0) 3,547
6–11 years 22.6 (21.4 – 23.9) 12.8 (11.0 – 14.4) 23.1 (21.8 – 24.3) 38.6 (36.9 – 40.8) 427
12–19 years 22.2 (21.4 – 23.0) 13.4 (11.5 – 14.2) 22.7 (22.0 – 23.6) 37.2 (36.3 – 38.7) 980
20–39 years 25.1 (24.0 – 26.2) 14.6 (11.9 – 15.8) 26.2 (24.9 – 27.4) 41.4 (40.0 – 43.7) 738
40–59 years 21.9 (20.1 – 23.9) 10.9 (8.58 – 12.4) 23.9 (22.3 – 25.6) 40.6 (37.3 – 43.9) 673
60 years and older 16.3 (15.1 – 17.6) 7.44 (6.33 – 7.78) 17.8 (16.4 – 19.1) 33.5 (31.3 – 36.8) 729
Females
Total, 6 years and older 20.6 (20.0 – 21.2) 10.3 (9.56 – 11.1) 22.2 (21.5 – 22.6) 38.2 (36.7 – 39.5) 3,707
6–11 years 20.8 (18.9 – 22.8) 10.4 (8.68 – 12.8) 21.7 (20.3 – 23.5) 37.3 (35.2 – 41.9) 433
12–19 years 21.5 (20.1 – 23.0) 12.8 (10.7 – 13.7) 21.9 (21.0 – 23.2) 37.1 (34.6 – 40.6) 974
20–39 years 22.7 (22.1 – 23.3) 12.9 (11.1 – 14.2) 23.7 (23.0 – 24.6) 39.0 (35.9 – 41.3) 950
40–59 years 21.3 (20.1 – 22.5) 11.0 (9.50 – 11.9) 22.4 (21.0 – 24.3) 39.3 (38.6 – 40.8) 692
60 years and older 16.4 (15.3 – 17.6) 6.89 (6.29 – 7.73) 17.9 (16.6 – 19.3) 34.2 (31.5 – 38.3) 658
Table 2.11.a.3. Serum trans-lycopene: Mexican Americans
Geometric mean and selected percentiles of serum concentrations (in µg/dL) for Mexican Americans in the U.S. 
population aged 6 years and older, National Health and Nutrition Examination Survey, 2005–2006. 
Geometric mean 
(95% conf. interval)
Selected percentiles (95% conf. interval) Sample 
size10th 50th 90th
Males and Females
Total, 6 years and older 19.5 (19.1 – 20.0) 10.7 (10.1 – 11.2) 20.2 (19.6 – 20.9) 33.7 (32.8 – 34.4) 1,844
6–11 years 19.6 (18.5 – 20.8) 11.0 (9.47 – 13.0) 20.1 (19.1 – 21.2) 32.4 (31.2 – 34.0) 295
12–19 years 20.0 (19.2 – 20.9) 12.0 (10.1 – 12.8) 20.9 (19.8 – 22.1) 33.5 (32.3 – 35.2) 646
20–39 years 20.9 (19.7 – 22.1) 11.6 (9.65 – 13.5) 22.0 (21.0 – 23.3) 34.7 (33.4 – 38.1) 449
40–59 years 18.4 (17.3 – 19.5) 10.0 (9.04 – 11.0) 18.8 (18.2 – 19.4) 32.8 (30.6 – 37.0) 246
60 years and older 15.5 (14.0 – 17.1) 7.71 (5.24 – 8.87) 16.1 (14.7 – 17.7) 28.6 (26.1 – 33.2) 208
Males
Total, 6 years and older 20.1 (19.4 – 20.8) 11.0 (9.96 – 12.0) 21.1 (20.1 – 22.2) 34.4 (32.2 – 37.6) 883
6–11 years 19.0 (17.8 – 20.2) 10.9 (9.33 – 12.7) 19.5 (18.2 – 20.5) 32.1 (28.9 – 36.1) 145
12–19 years 20.6 (19.2 – 22.1) 12.3 (8.72 – 13.6) 22.1 (19.9 – 23.4) 34.0 (32.7 – 35.5) 313
20–39 years 21.9 (20.0 – 23.9) 13.2 (8.92 – 15.1) 23.1 (21.5 – 24.9) 35.1 (32.1 – 44.4) 198
40–59 years 18.6 (17.1 – 20.2) 10.1 (7.36 – 11.3) 19.3 (17.8 – 20.7) 32.7 (28.9 – 39.9) 122
60 years and older 15.5 (12.9 – 18.6) 7.41† (2.71 – 8.77) 16.2 (13.9 – 19.3) 31.3† (25.2 – 56.0) 105
Females
Total, 6 years and older 19.0 (18.4 – 19.5) 10.5 (10.0 – 11.0) 19.4 (18.5 – 20.2) 33.3 (32.1 – 34.1) 961
6–11 years 20.4 (18.9 – 22.0) 11.4 (9.53 – 13.4) 21.2 (19.3 – 23.0) 32.5 (31.2 – 35.0) 150
12–19 years 19.4 (18.6 – 20.3) 11.8 (10.1 – 12.2) 20.0 (19.4 – 20.9) 32.9 (31.5 – 35.7) 333
20–39 years 19.7 (18.6 – 20.8) 10.8 (9.95 – 12.7) 20.0 (18.5 – 23.4) 34.1 (32.5 – 36.7) 251
40–59 years 18.1 (16.8 – 19.6) 10.0 (9.01 – 11.0) 18.0 (16.9 – 19.1) 32.8 (30.5 – 34.5) 124
60 years and older 15.5 (14.0 – 17.2) 7.98† (5.24 – 10.5) 16.0 (13.3 – 18.1) 26.7† (25.0 – 31.2) 103
† Estimate is subject to greater uncertainty due to small cell size. 
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Table 2.11.a.4. Serum trans-lycopene: Non-Hispanic blacks
Geometric mean and selected percentiles of serum concentrations (in µg/dL) for non-Hispanic blacks in the U.S. 
population aged 6 years and older, National Health and Nutrition Examination Survey, 2005–2006. 
Geometric mean 
(95% conf. interval)
Selected percentiles (95% conf. interval) Sample 
size10th 50th 90th
Males and Females
Total, 6 years and older 22.0 (20.9 – 23.2) 10.8 (9.77 – 11.8) 23.5 (22.6 – 24.7) 40.0 (39.1 – 41.7) 1,891
6–11 years 25.6 (23.3 – 28.2) 13.7 (11.1 – 17.0) 27.0 (24.6 – 28.9) 41.8 (38.7 – 45.9) 240
12–19 years 24.8 (23.5 – 26.2) 14.3 (12.9 – 15.4) 25.8 (23.6 – 27.4) 41.6 (39.1 – 44.9) 665
20–39 years 25.7 (24.2 – 27.2) 14.5 (12.4 – 15.6) 26.3 (25.0 – 27.8) 42.4 (39.6 – 47.1) 368
40–59 years 20.4 (19.1 – 21.8) 9.89 (8.68 – 10.8) 21.3 (19.9 – 23.3) 38.6 (36.2 – 43.4) 335
60 years and older 14.3 (13.1 – 15.7) 6.20 (4.94 – 6.93) 15.3 (14.5 – 16.5) 31.2 (27.5 – 35.7) 283
Males
Total, 6 years and older 23.1 (21.9 – 24.3) 11.2 (9.87 – 12.4) 24.9 (23.3 – 26.4) 41.8 (39.8 – 44.9) 949
6–11 years 26.2 (23.4 – 29.2) 16.4 (10.4 – 18.0) 27.0 (23.4 – 29.8) 40.1 (38.4 – 46.3) 128
12–19 years 25.5 (24.1 – 27.0) 14.9 (13.5 – 16.1) 26.2 (23.9 – 27.8) 43.2 (39.5 – 51.7) 343
20–39 years 28.0 (26.5 – 29.6) 15.3 (13.6 – 16.8) 27.9 (26.2 – 30.2) 47.8 (42.5 – 52.7) 170
40–59 years 20.5 (18.3 – 22.9) 9.19 (6.70 – 10.9) 22.1 (18.9 – 26.4) 38.6 (35.6 – 51.3) 156
60 years and older 14.6 (13.3 – 15.9) 5.56 (4.94 – 6.14) 15.5 (15.0 – 17.1) 32.1 (30.0 – 38.1) 152
Females
Total, 6 years and older 21.2 (19.8 – 22.7) 10.6 (9.30 – 11.6) 22.5 (21.1 – 23.7) 39.0 (37.2 – 41.0) 942
6–11 years 25.1 (22.4 – 28.1) 12.4 (9.15 – 15.1) 26.7 (24.9 – 28.9) 42.1 (38.4 – 49.7) 112
12–19 years 24.1 (21.9 – 26.6) 13.9 (10.5 – 15.5) 24.8 (22.1 – 27.6) 39.8 (36.6 – 43.9) 322
20–39 years 23.8 (21.8 – 26.1) 13.6 (10.9 – 15.7) 25.0 (22.1 – 27.2) 39.1 (37.4 – 41.6) 198
40–59 years 20.3 (19.2 – 21.6) 9.99 (9.03 – 11.3) 20.9 (18.1 – 23.3) 39.0 (34.8 – 44.3) 179
60 years and older 14.1 (12.1 – 16.5) 6.71 (3.54 – 7.89) 15.0 (13.0 – 17.4) 28.1 (24.6 – 39.1) 131
Table 2.11.a.5. Serum trans-lycopene: Non-Hispanic whites
Geometric mean and selected percentiles of serum concentrations (in µg/dL) for non-Hispanic whites in the 
U.S. population aged 6 years and older, National Health and Nutrition Examination Survey, 2005–2006. 
Geometric mean 
(95% conf. interval)
Selected percentiles (95% conf. interval) Sample 
size10th 50th 90th
Males and Females
Total, 6 years and older 21.3 (20.8 – 21.9) 10.8 (10.1 – 11.3) 23.0 (22.4 – 23.5) 39.1 (37.5 – 40.6) 2,973
6–11 years 21.4 (19.6 – 23.4) 11.1 (9.63 – 12.9) 22.1 (20.4 – 24.0) 37.5 (33.7 – 42.4) 231
12–19 years 21.6 (20.6 – 22.6) 13.0 (11.1 – 13.7) 22.1 (21.4 – 22.7) 37.0 (35.0 – 39.9) 499
20–39 years 24.6 (23.6 – 25.6) 13.7 (11.4 – 16.4) 25.6 (24.8 – 26.4) 40.7 (39.6 – 42.3) 714
40–59 years 22.3 (20.9 – 23.9) 11.7 (9.54 – 13.0) 24.2 (22.9 – 25.3) 40.5 (38.3 – 42.2) 683
60 years and older 16.6 (15.6 – 17.6) 7.32 (6.45 – 8.11) 18.0 (16.9 – 19.2) 34.2 (32.3 – 37.0) 846
Males
Total, 6 years and older 21.9 (21.0 – 22.9) 11.3 (10.3 – 11.9) 23.6 (22.7 – 24.8) 39.6 (37.9 – 41.6) 1,472
6–11 years 22.6 (20.7 – 24.6) 12.8 (8.41 – 14.9) 23.0 (21.1 – 24.8) 38.3 (33.4 – 43.2) 112
12–19 years 21.8 (20.6 – 23.2) 13.2 (10.0 – 14.3) 22.5 (21.1 – 24.3) 36.6 (35.8 – 38.4) 254
20–39 years 25.7 (24.2 – 27.2) 14.8 (11.8 – 17.1) 26.5 (25.1 – 28.4) 41.5 (39.6 – 46.1) 309
40–59 years 22.8 (20.6 – 25.2) 11.8 (8.02 – 14.0) 25.0 (23.2 – 27.0) 41.2 (38.1 – 44.0) 351
60 years and older 16.3 (15.0 – 17.8) 7.49 (6.36 – 8.08) 17.7 (16.0 – 19.2) 33.7 (31.3 – 37.0) 446
Females
Total, 6 years and older 20.8 (20.0 – 21.7) 10.2 (9.48 – 11.1) 22.4 (21.5 – 23.1) 38.5 (36.5 – 40.3) 1,501
6–11 years 20.1 (17.6 – 23.1) 9.66 (4.60 – 12.9) 20.7 (19.2 – 23.2) 36.7 (30.8 – 50.0) 119
12–19 years 21.3 (19.4 – 23.3) 12.7 (9.21 – 14.2) 21.6 (20.3 – 23.5) 37.2 (33.9 – 41.5) 245
20–39 years 23.5 (22.5 – 24.5) 13.0 (10.2 – 16.2) 24.6 (23.3 – 25.3) 40.2 (35.9 – 42.7) 405
40–59 years 21.8 (20.3 – 23.6) 11.7 (9.46 – 12.9) 23.4 (21.4 – 25.3) 39.7 (37.9 – 41.1) 332
60 years and older 16.9 (15.8 – 18.0) 7.00 (6.17 – 8.28) 18.3 (17.1 – 20.1) 34.4 (32.1 – 38.5) 400
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Table 2.11.b. Serum trans-lycopene: Concentrations by survey cycle
Geometric mean and selected percentiles of serum concentrations (in µg/dL) for the U.S. population, National 
Health and Nutrition Examination Survey, 2001–2002 and 2005–2006. 
Geometric mean 
(95% conf. interval)
Selected percentiles (95% conf. interval) Sample 
size5th 50th 95th
Total, 6 years and older
 2001–2002 20.6 (19.9 – 21.3) 7.87 (7.49 – 8.27) 22.2 (21.3 – 23.1) 42.5 (41.0 – 43.9) 7,921
 2005–2006 21.2 (20.7 – 21.7) 7.81 (7.33 – 8.40) 22.7 (22.2 – 23.2) 43.6 (42.4 – 44.9) 7,254
Age group
3–5 years
 2001–2002 16.1 (15.2 – 17.1) 6.16 (3.73 – 7.47) 17.3 (16.2 – 18.1) 33.9 (32.8 – 37.9) 427
6–11 years
 2001–2002 21.6 (20.7 – 22.5) 9.31 (8.20 – 9.83) 22.7 (21.4 – 23.6) 40.5 (37.7 – 47.0) 1,012
 2005–2006 21.7 (20.5 – 22.9) 9.48 (7.38 – 10.9) 22.5 (21.1 – 23.7) 42.8 (40.0 – 46.0) 860
12–19 years
 2001–2002 21.6 (21.1 – 22.1) 10.5 (9.69 – 11.1) 22.2 (21.8 – 22.7) 40.5 (38.1 – 43.2) 2,205
 2005–2006 21.9 (21.1 – 22.6) 9.91 (8.98 – 11.0) 22.3 (21.8 – 22.9) 42.6 (40.2 – 45.1) 1,954
20–39 years
 2001–2002 22.7 (21.5 – 23.9) 10.3 (9.02 – 11.5) 23.7 (22.5 – 24.9) 44.9 (42.4 – 47.1) 1,714
 2005–2006 23.9 (23.3 – 24.4) 10.7 (8.97 – 11.4) 25.1 (24.3 – 25.6) 46.1 (44.1 – 47.2) 1,688
40–59 years
 2001–2002 21.1 (20.1 – 22.1) 7.82 (7.02 – 8.61) 22.7 (21.4 – 24.1) 42.6 (41.2 – 43.8) 1,468
 2005–2006 21.6 (20.4 – 22.8) 7.69 (6.02 – 8.98) 23.2 (22.1 – 24.4) 44.6 (42.5 – 47.1) 1,365
60 years and older
 2001–2002 15.4 (14.6 – 16.3) 4.15 (2.92 – 5.13) 17.1 (16.1 – 17.9) 39.0 (36.4 – 41.3) 1,522
 2005–2006 16.4 (15.4 – 17.4) 5.19 (4.32 – 5.97) 17.8 (16.8 – 19.0) 38.8 (37.3 – 40.7) 1,387
Gender
(6 years and older)
Males
 2001–2002 21.4 (20.6 – 22.3) 8.02 (7.31 – 8.80) 23.3 (22.3 – 24.2) 44.2 (42.8 – 46.3) 3,832
 2005–2006 21.8 (21.0 – 22.6) 7.85 (6.99 – 8.89) 23.4 (22.6 – 24.3) 44.7 (43.7 – 47.0) 3,547
Females
 2001–2002 19.8 (19.2 – 20.5) 7.82 (7.13 – 8.34) 21.2 (20.4 – 22.0) 40.3 (38.9 – 42.1) 4,089
 2005–2006 20.6 (20.0 – 21.2) 7.76 (7.09 – 8.40) 22.2 (21.5 – 22.6) 42.3 (41.2 – 43.9) 3,707
Race/ethnicity
(6 years and older)
Mexican Americans
 2001–2002 20.0 (19.2 – 20.8) 8.89 (7.84 – 9.62) 20.7 (20.1 – 21.7) 39.8 (38.1 – 42.0) 1,987
 2005–2006 19.5 (19.1 – 20.0) 8.80 (7.83 – 9.29) 20.2 (19.6 – 20.9) 38.0 (36.4 – 40.2) 1,844
Non-Hispanic Blacks
 2001–2002 21.7 (21.0 – 22.3) 8.03 (6.83 – 9.11) 23.4 (22.2 – 24.3) 46.6 (44.9 – 49.0) 1,864
 2005–2006 22.0 (20.9 – 23.2) 8.11 (7.39 – 8.77) 23.5 (22.6 – 24.7) 47.0 (44.7 – 49.5) 1,891
Non-Hispanic Whites
 2001–2002 20.8 (20.1 – 21.6) 8.17 (7.55 – 8.72) 22.4 (21.3 – 23.5) 42.5 (40.9 – 44.0) 3,446
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Figure 2.11.b. Serum trans−lycopene: Concentrations by survey cycle 
Selected percentiles in μg/dL (95% confidence intervals), National Health and 

Nutrition Examination Survey, 2001–2002 and 2005–2006
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Non−Hispanic Blacks Non−Hispanic Whites 
Figure 2.12.a. Serum total lycopene: Concentrations by age group 
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Table 2.12.a.2. Serum total lycopene: Total population
Geometric mean and selected percentiles of serum concentrations (in µg/dL) for the total U.S. population aged 
6 years and older, National Health and Nutrition Examination Survey, 2005–2006. 
Geometric mean 
(95% conf. interval)
Selected percentiles (95% conf. interval) Sample 
size10th 50th 90th
Males and Females
Total, 6 years and older 39.4 (38.5 – 40.2) 20.5 (19.5 – 21.3) 41.8 (41.0 – 42.6) 71.2 (69.5 – 72.7) 7,149
6–11 years 39.7 (37.5 – 42.0) 21.5 (19.3 – 25.4) 40.9 (38.5 – 44.1) 67.6 (63.5 – 74.9) 851
12–19 years 39.5 (38.2 – 40.8) 23.5 (21.8 – 24.6) 40.6 (39.6 – 42.0) 66.3 (63.1 – 69.6) 1,907
20–39 years 43.8 (42.7 – 44.9) 24.6 (21.9 – 27.2) 45.2 (43.8 – 46.6) 74.0 (72.5 – 75.8) 1,667
40–59 years 40.5 (38.2 – 42.9) 21.0 (18.6 – 22.9) 43.1 (41.1 – 45.3) 72.8 (70.3 – 77.1) 1,346
60 years and older 31.5 (29.8 – 33.2) 14.3 (13.3 – 15.9) 33.5 (31.4 – 35.9) 62.8 (60.2 – 67.5) 1,378
Males
Total, 6 years and older 40.6 (39.3 – 42.0) 21.2 (20.1 – 22.2) 43.5 (42.2 – 44.7) 72.9 (70.9 – 75.6) 3,493
6–11 years 41.4 (39.2 – 43.8) 23.7 (20.3 – 26.4) 42.1 (39.7 – 44.9) 69.5 (63.4 – 78.2) 421
12–19 years 40.1 (38.5 – 41.8) 23.8 (21.3 – 26.0) 41.1 (40.0 – 42.5) 66.3 (64.6 – 69.4) 955
20–39 years 46.4 (44.5 – 48.5) 26.8 (22.9 – 30.6) 48.3 (45.5 – 51.0) 78.5 (74.6 – 81.9) 730
40–59 years 41.2 (37.7 – 45.0) 20.9 (15.2 – 23.9) 44.9 (42.6 – 47.1) 75.0 (71.0 – 81.4) 663
60 years and older 31.3 (29.1 – 33.7) 14.3 (12.6 – 15.9) 34.4 (31.6 – 36.4) 62.0 (59.0 – 69.3) 724
Females
Total, 6 years and older 38.2 (37.1 – 39.3) 19.9 (18.8 – 21.1) 40.1 (38.9 – 41.6) 69.3 (67.0 – 71.7) 3,656
6–11 years 37.9 (34.8 – 41.3) 19.4 (16.3 – 24.7) 39.8 (35.7 – 43.9) 66.2 (59.8 – 74.0) 430
12–19 years 38.8 (36.2 – 41.5) 23.4 (20.0 – 24.6) 40.1 (37.8 – 42.7) 65.3 (60.1 – 72.6) 952
20–39 years 41.3 (40.2 – 42.4) 22.6 (20.7 – 26.2) 42.7 (41.5 – 43.7) 71.6 (66.4 – 74.0) 937
40–59 years 39.8 (37.6 – 42.1) 20.9 (18.9 – 22.8) 41.1 (37.8 – 45.0) 71.3 (68.8 – 75.6) 683
60 years and older 31.6 (29.7 – 33.5) 14.2 (12.9 – 16.4) 33.0 (30.8 – 35.8) 64.6 (58.0 – 69.7) 654
Table 2.12.a.3. Serum total lycopene: Mexican Americans
Geometric mean and selected percentiles of serum concentrations (in µg/dL) for Mexican Americans in the U.S. 
population aged 6 years and older, National Health and Nutrition Examination Survey, 2005–2006. 
Geometric mean 
(95% conf. interval)
Selected percentiles (95% conf. interval) Sample 
size10th 50th 90th
Males and Females
Total, 6 years and older 36.2 (35.3 – 37.1) 20.5 (19.5 – 21.7) 37.4 (36.1 – 38.9) 61.5 (58.8 – 63.5) 1,818
6–11 years 35.5 (33.8 – 37.3) 21.0 (18.7 – 22.5) 35.5 (33.8 – 37.3) 58.4 (55.7 – 63.1) 292
12–19 years 35.7 (34.5 – 37.0) 21.8 (19.6 – 23.4) 37.4 (36.0 – 38.7) 58.5 (55.6 – 61.8) 639
20–39 years 38.8 (36.5 – 41.1) 22.7 (18.7 – 24.7) 41.0 (39.1 – 42.5) 63.8 (58.8 – 71.2) 441
40–59 years 34.8 (32.7 – 37.1) 19.6 (17.4 – 21.1) 35.1 (32.6 – 38.5) 60.7 (57.3 – 65.5) 240
60 years and older 29.9 (27.3 – 32.8) 14.7 (11.9 – 17.9) 30.1 (27.9 – 33.8) 54.7 (48.8 – 65.8) 206
Males
Total, 6 years and older 37.6 (36.3 – 39.0) 21.4 (19.9 – 23.0) 39.2 (36.9 – 40.8) 63.1 (59.5 – 68.0) 867
6–11 years 34.4 (32.6 – 36.4) 20.2 (17.8 – 22.4) 34.3 (31.7 – 36.1) 57.4 (50.5 – 73.4) 142
12–19 years 36.9 (34.6 – 39.4) 22.5 (19.2 – 24.6) 39.1 (36.8 – 40.7) 59.7 (55.9 – 63.9) 310
20–39 years 41.3 (37.8 – 45.1) 24.6 (16.6 – 27.7) 42.6 (40.6 – 45.6) 66.1 (58.3 – 94.4) 192
40–59 years 35.6 (32.6 – 38.8) 19.0 (14.4 – 22.6) 36.4 (33.4 – 40.5) 58.7 (56.0 – 74.3) 120
60 years and older 29.9 (25.1 – 35.7) 14.5† (5.80 – 18.2) 30.2 (26.0 – 36.1) 61.9† (48.0 – 86.3) 103
Females
Total, 6 years and older 34.8 (33.8 – 35.8) 20.0 (18.7 – 21.4) 35.3 (33.5 – 37.3) 59.5 (56.8 – 62.0) 951
6–11 years 36.7 (34.4 – 39.1) 21.1 (17.7 – 24.4) 36.7 (34.3 – 40.4) 58.8 (56.3 – 62.2) 150
12–19 years 34.5 (33.2 – 35.8) 20.6 (19.0 – 22.6) 34.8 (33.8 – 36.8) 57.8 (51.9 – 62.0) 329
20–39 years 35.9 (33.9 – 38.1) 20.2 (17.5 – 22.7) 37.4 (33.3 – 41.9) 61.4 (56.1 – 68.6) 249
40–59 years 34.0 (31.6 – 36.7) 19.6 (16.1 – 21.4) 33.0 (30.2 – 38.3) 61.0 (55.9 – 67.8) 120
60 years and older 29.9 (27.3 – 32.8) 16.1† (12.1 – 20.5) 29.2 (26.6 – 35.7) 52.7† (48.0 – 59.9) 103
† Estimate is subject to greater uncertainty due to small cell size. 
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Table 2.12.a.4. Serum total lycopene: Non-Hispanic blacks
Geometric mean and selected percentiles of serum concentrations (in µg/dL) for non-Hispanic blacks in the U.S. 
population aged 6 years and older, National Health and Nutrition Examination Survey, 2005–2006. 
Geometric mean 
(95% conf. interval)
Selected percentiles (95% conf. interval) Sample 
size10th 50th 90th
Males and Females
Total, 6 years and older 41.3 (39.2 – 43.5) 21.4 (19.5 – 23.1) 43.1 (41.1 – 45.5) 75.5 (72.1 – 79.6) 1,846
6–11 years 47.9 (43.3 – 52.9) 27.4 (20.5 – 31.8) 49.6 (44.6 – 56.3) 78.5 (73.9 – 84.4) 236
12–19 years 44.3 (42.3 – 46.4) 26.9 (23.9 – 29.0) 45.8 (42.8 – 47.8) 73.1 (69.2 – 78.2) 636
20–39 years 47.0 (44.2 – 50.1) 26.4 (23.2 – 29.6) 49.0 (45.5 – 52.3) 79.6 (76.1 – 82.9) 363
40–59 years 39.2 (36.4 – 42.2) 20.0 (17.1 – 21.4) 40.8 (37.7 – 43.4) 73.7 (66.9 – 84.2) 331
60 years and older 28.2 (26.0 – 30.6) 12.7 (10.4 – 15.4) 29.1 (26.6 – 32.7) 59.0 (53.0 – 68.4) 280
Males
Total, 6 years and older 43.6 (41.0 – 46.3) 22.9 (19.5 – 24.5) 45.8 (42.8 – 48.4) 81.2 (76.4 – 87.8) 922
6–11 years 49.5 (44.4 – 55.1) 30.6 (15.3 – 35.9) 50.4 (42.4 – 58.7) 76.8 (70.9 – 91.8) 126
12–19 years 45.7 (43.1 – 48.6) 28.9 (25.6 – 30.2) 46.7 (43.6 – 50.4) 76.3 (69.3 – 90.2) 324
20–39 years 51.6 (48.4 – 55.1) 29.7 (25.9 – 31.9) 51.4 (48.1 – 54.9) 86.3 (81.2 – 90.5) 169
40–59 years 40.0 (35.3 – 45.3) 18.4 (13.2 – 22.9) 41.1 (36.8 – 47.4) 82.9 (67.2 – 97.5) 153
60 years and older 28.9 (26.5 – 31.6) 12.5 (11.1 – 13.0) 31.1 (28.3 – 34.7) 59.5 (52.9 – 66.0) 150
Females
Total, 6 years and older 39.3 (37.0 – 41.8) 20.8 (18.5 – 22.2) 41.0 (39.4 – 43.0) 71.4 (68.7 – 74.1) 924
6–11 years 46.3 (41.2 – 52.1) 24.6† (17.9 – 27.5) 48.5 (44.6 – 54.8) 78.5† (72.8 – 84.6) 110
12–19 years 42.9 (39.5 – 46.4) 25.6 (20.1 – 28.1) 44.1 (39.8 – 48.0) 70.4 (67.3 – 75.3) 312
20–39 years 43.4 (39.8 – 47.3) 23.6 (21.0 – 28.0) 44.5 (40.4 – 50.6) 72.6 (68.4 – 76.7) 194
40–59 years 38.6 (36.3 – 41.0) 20.1 (17.1 – 21.5) 40.2 (36.7 – 43.0) 68.6 (63.6 – 75.8) 178
60 years and older 27.7 (24.1 – 31.9) 12.8 (8.09 – 17.2) 28.6 (24.8 – 32.4) 57.6 (45.4 – 82.2) 130
† Estimate is subject to greater uncertainty due to small cell size.
Table 2.12.a.5. Serum total lycopene: Non-Hispanic whites
Geometric mean and selected percentiles of serum concentrations (in µg/dL) for non-Hispanic whites in the 
U.S. population aged 6 years and older, National Health and Nutrition Examination Survey, 2005–2006. 
Geometric mean 
(95% conf. interval)
Selected percentiles (95% conf. interval) Sample 
size10th 50th 90th
Males and Females
Total, 6 years and older 39.6 (38.6 – 40.6) 20.4 (19.4 – 21.3) 42.4 (41.3 – 43.3) 71.5 (69.4 – 73.8) 2,943
6–11 years 39.3 (35.9 – 43.1) 20.7 (18.9 – 24.9) 40.6 (37.7 – 44.9) 64.8 (58.7 – 78.0) 230
12–19 years 39.2 (37.5 – 40.9) 23.3 (20.8 – 24.8) 40.7 (39.3 – 42.1) 66.2 (62.8 – 70.2) 489
20–39 years 44.8 (43.2 – 46.5) 25.3 (21.5 – 29.3) 45.9 (44.0 – 48.4) 75.4 (72.5 – 77.8) 706
40–59 years 41.6 (38.8 – 44.6) 22.2 (17.8 – 24.4) 44.7 (42.6 – 47.0) 73.9 (70.4 – 78.5) 674
60 years and older 31.7 (30.0 – 33.5) 14.4 (13.3 – 16.2) 33.9 (31.7 – 36.7) 62.9 (60.2 – 67.4) 844
Males
Total, 6 years and older 40.7 (39.2 – 42.3) 21.0 (19.7 – 22.0) 43.9 (42.5 – 45.2) 73.2 (70.9 – 76.0) 1,461
6–11 years 41.5 (38.1 – 45.3) 23.6† (19.7 – 26.4) 42.3 (39.5 – 45.7) 66.0† (58.8 – 81.5) 111
12–19 years 39.8 (37.1 – 42.6) 23.2 (19.9 – 27.0) 41.0 (38.4 – 43.0) 66.3 (63.5 – 69.8) 251
20–39 years 47.2 (44.7 – 49.8) 26.8 (21.7 – 31.6) 49.4 (45.9 – 52.3) 78.7 (73.9 – 85.0) 308
40–59 years 42.6 (38.4 – 47.1) 22.4 (15.0 – 27.3) 46.3 (44.0 – 49.0) 75.3 (70.9 – 82.7) 346
60 years and older 31.2 (28.6 – 34.0) 14.4 (12.3 – 16.1) 33.9 (30.8 – 36.5) 62.0 (58.8 – 69.7) 445
Females
Total, 6 years and older 38.5 (36.9 – 40.1) 19.7 (18.2 – 21.3) 40.7 (38.9 – 42.5) 69.6 (66.8 – 72.6) 1,482
6–11 years 37.0 (32.7 – 41.8) 19.1 (13.7 – 25.3) 39.1 (33.8 – 43.3) 61.9 (54.6 – 78.0) 119
12–19 years 38.6 (35.1 – 42.3) 23.6 (18.0 – 25.6) 40.4 (37.0 – 43.4) 64.4 (57.9 – 75.6) 238
20–39 years 42.5 (40.6 – 44.4) 22.9 (19.9 – 28.7) 43.2 (41.9 – 44.2) 72.1 (66.5 – 77.0) 398
40–59 years 40.7 (37.6 – 44.0) 21.6 (17.5 – 24.5) 42.4 (39.0 – 47.4) 72.1 (68.7 – 78.7) 328
60 years and older 32.2 (30.3 – 34.2) 14.3 (12.9 – 16.6) 33.8 (31.6 – 37.1) 64.5 (59.0 – 68.7) 399
† Estimate is subject to greater uncertainty due to small cell size. 
 








































































172 2nd National Report on Biochemical Indicators of Diet and Nutrition in the U.S. Population172
Vitamin D
Background Information

























































































































































































































1988-1994 2001-2002 2003-2006 














































































Mexican American Non-Hispanic black 
< 40 nmol/L
Non-Hispanic white 

















Changes in geometric mean concentrations across surveys:
•	 Geometric	mean	25(OH)D	concentrations	remained	steady	across	the	survey	cycles	
from	2001–2006	(Table	2.13.b).


































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Non−Hispanic Blacks Non−Hispanic Whites 
Figure 2.13.a. Serum 25−hydroxyvitamin D: Concentrations by age group 
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Table 2.13.a.2. Serum 25-hydroxyvitamin D: Total population
Geometric mean and selected percentiles of serum concentrations (in nmol/L) for the total U.S. population 
aged 1 year and older, National Health and Nutrition Examination Survey, 2003–2006. 
Geometric mean 
(95% conf. interval)
Selected percentiles (95% conf. interval) Sample 
size5th 50th 95th
Males and Females
Total, 1 year and older 55.6 (53.6 – 57.6) 23.2 (21.4 – 25.0) 58.0 (56.3 – 59.9) 96.6 (93.9 – 101) 16,604
1–5 years 68.6 (66.7 – 70.5) 41.6 (39.5 – 43.4) 68.8 (66.9 – 70.6) 99.6 (95.7 – 107) 1,799
6–11 years 63.8 (61.6 – 66.1) 35.3 (32.0 – 38.7) 64.5 (63.0 – 66.1) 97.2 (92.5 – 108) 1,768
12–19 years 55.1 (52.4 – 58.0) 22.7 (19.8 – 25.1) 57.6 (55.3 – 60.1) 98.4 (94.3 – 108) 4,044
20–39 years 54.5 (52.1 – 57.0) 21.8 (20.3 – 23.3) 56.6 (54.4 – 58.9) 102 (97.2 – 108) 3,262
40–59 years 53.6 (51.3 – 56.0) 21.7 (19.8 – 23.6) 56.0 (54.1 – 58.1) 94.3 (90.5 – 98.3) 2,660
60 years and older 54.1 (52.4 – 55.8) 23.1 (21.6 – 24.6) 56.9 (55.4 – 58.5) 91.9 (89.5 – 95.0) 3,071
Males
Total, 1 year and older 56.7 (54.7 – 58.7) 25.8 (23.8 – 27.3) 58.9 (57.1 – 60.7) 94.0 (90.7 – 97.7) 8,145
1–5 years 69.2 (67.0 – 71.5) 41.7 (40.1 – 43.5) 69.3 (66.7 – 71.6) 101 (96.7 – 106) 904
6–11 years 65.5 (63.2 – 67.9) 36.9 (32.5 – 40.3) 65.8 (64.3 – 67.6) 98.0 (92.4 – 116) 862
12–19 years 56.6 (54.0 – 59.3) 25.3 (22.5 – 28.0) 58.7 (56.4 – 61.2) 95.2 (88.8 – 105) 2,049
20–39 years 53.7 (51.4 – 56.1) 23.6 (20.9 – 25.7) 55.9 (53.7 – 57.8) 90.6 (87.7 – 96.7) 1,472
40–59 years 55.8 (53.3 – 58.4) 25.3 (22.4 – 27.0) 58.0 (55.8 – 60.8) 92.4 (88.1 – 98.7) 1,311
60 years and older 55.6 (53.7 – 57.7) 26.0 (23.8 – 27.9) 57.5 (55.6 – 59.7) 91.9 (89.1 – 97.2) 1,547
Females
Total, 1 year and older 54.5 (52.5 – 56.6) 21.2 (19.8 – 22.5) 57.2 (55.2 – 59.2) 99.4 (96.1 – 106) 8,459
1–5 years 67.9 (65.8 – 70.0) 41.3 (37.4 – 44.3) 68.4 (66.3 – 70.3) 98.1 (93.3 – 113) 895
6–11 years 61.9 (59.6 – 64.4) 34.0 (31.4 – 37.6) 62.8 (60.1 – 65.3) 96.4 (92.5 – 103) 906
12–19 years 53.6 (50.6 – 56.9) 20.6 (18.0 – 22.9) 56.4 (53.1 – 59.5) 106 (96.5 – 114) 1,995
20–39 years 55.3 (52.4 – 58.3) 20.5 (19.1 – 21.8) 57.6 (54.4 – 60.7) 110 (106 – 116) 1,790
40–59 years 51.6 (49.2 – 54.2) 19.4 (18.3 – 20.6) 54.1 (50.8 – 57.0) 95.1 (91.5 – 99.2) 1,349
60 years and older 52.9 (51.1 – 54.7) 21.7 (20.2 – 23.2) 56.4 (54.5 – 58.2) 92.0 (89.1 – 95.8) 1,524
Table 2.13.a.3. Serum 25-hydroxyvitamin D: Mexican Americans
Geometric mean and selected percentiles of serum concentrations (in nmol/L) for Mexican Americans in the 
U.S. population aged 1 year and older, National Health and Nutrition Examination Survey, 2003–2006. 
Geometric mean 
(95% conf. interval)
Selected percentiles (95% conf. interval) Sample 
size5th 50th 95th
Males and Females
Total, 1 year and older 48.7 (46.3 – 51.2) 21.5 (19.6 – 23.3) 49.9 (47.7 – 53.4) 81.8 (79.2 – 84.7) 4,275
1–5 years 64.8 (63.1 – 66.6) 42.5 (39.4 – 44.7) 64.3 (62.3 – 66.1) 93.8 (89.5 – 99.7) 584
6–11 years 56.9 (55.0 – 58.8) 32.7 (30.9 – 34.9) 58.2 (56.3 – 59.8) 82.9 (80.7 – 86.9) 589
12–19 years 46.8 (44.2 – 49.6) 22.0 (20.2 – 23.4) 47.8 (45.6 – 50.7) 74.8 (71.2 – 83.6) 1,288
20–39 years 46.6 (43.6 – 49.7) 20.6 (17.6 – 23.5) 48.0 (45.4 – 51.5) 78.0 (75.6 – 83.1) 789
40–59 years 44.4 (41.4 – 47.7) 19.4 (17.4 – 21.2) 45.8 (41.9 – 49.0) 79.8 (72.4 – 87.7) 472
60 years and older 45.0 (42.4 – 47.8) 20.1 (17.6 – 21.4) 45.9 (43.6 – 48.1) 79.5 (73.4 – 89.5) 553
Males
Total, 1 year and older 51.1 (48.7 – 53.7) 24.5 (21.7 – 26.6) 52.7 (49.4 – 55.5) 81.7 (79.0 – 85.2) 2,073
1–5 years 65.2 (63.9 – 66.5) 44.6 (40.5 – 45.8) 64.4 (63.1 – 65.6) 94.9 (88.6 – 109) 282
6–11 years 58.8 (56.8 – 60.8) 36.0 (32.3 – 38.8) 59.7 (57.8 – 62.3) 83.3 (80.5 – 92.2) 286
12–19 years 49.5 (46.6 – 52.6) 23.8 (21.5 – 26.2) 50.0 (47.4 – 54.0) 78.0 (72.7 – 85.8) 641
20–39 years 49.1 (45.5 – 52.8) 24.3 (19.7 – 26.2) 49.8 (47.1 – 54.1) 77.0 (73.1 – 86.5) 353
40–59 years 47.4 (44.0 – 51.0) 20.9 (15.3 – 25.9) 47.4 (44.6 – 54.3) 79.8 (72.2 – 92.8) 239
60 years and older 48.0 (44.0 – 52.2) 21.4 (18.3 – 25.0) 48.3 (43.6 – 54.3) 81.2 (74.4 – 96.7) 272
Females
Total, 1 year and older 46.2 (43.7 – 48.8) 19.8 (18.9 – 20.6) 47.7 (45.4 – 50.3) 82.1 (78.6 – 85.4) 2,202
1–5 years 64.5 (61.8 – 67.2) 40.5 (36.0 – 44.3) 64.2 (59.9 – 67.5) 92.9 (89.1 – 98.6) 302
6–11 years 54.8 (52.3 – 57.5) 31.1 (25.0 – 33.7) 56.6 (54.0 – 58.8) 82.3 (74.5 – 93.8) 303
12–19 years 44.1 (41.4 – 47.1) 20.4 (17.3 – 22.5) 45.6 (42.4 – 48.0) 73.2 (67.7 – 80.3) 647
20–39 years 43.9 (40.7 – 47.3) 18.5 (16.4 – 20.4) 44.9 (41.6 – 48.2) 80.2 (74.8 – 87.1) 436
40–59 years 41.5 (37.9 – 45.3) 18.7 (17.5 – 20.0) 42.8 (37.3 – 46.8) 79.6 (70.9 – 85.0) 233
60 years and older 42.7 (39.6 – 46.1) 19.1 (15.4 – 21.1) 44.3 (40.5 – 47.0) 78.0 (71.5 – 88.9) 281
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Table 2.13.a.4. Serum 25-hydroxyvitamin D: Non-Hispanic blacks
Geometric mean and selected percentiles of serum concentrations (in nmol/L) for non-Hispanic blacks in the 
U.S. population aged 1 year and older, National Health and Nutrition Examination Survey, 2003–2006. 
Geometric mean 
(95% conf. interval)
Selected percentiles (95% conf. interval) Sample 
size5th 50th 95th
Males and Females
Total, 1 year and older 36.1 (34.3 – 38.0) 14.3 (13.5 – 15.1) 36.6 (34.2 – 39.1) 70.9 (68.5 – 73.7) 4,349
1–5 years 55.5 (52.7 – 58.5) 29.4 (21.0 – 33.4) 57.5 (54.5 – 59.6) 86.6 (82.1 – 91.3) 503
6–11 years 48.1 (45.7 – 50.6) 24.8 (23.4 – 25.7) 49.4 (47.3 – 52.2) 73.8 (71.5 – 80.2) 561
12–19 years 34.2 (31.4 – 37.2) 13.8 (13.0 – 14.6) 34.6 (31.3 – 38.2) 68.3 (64.2 – 72.2) 1,421
20–39 years 32.5 (30.4 – 34.8) 13.7 (12.7 – 14.8) 31.5 (29.2 – 34.2) 64.0 (61.1 – 70.4) 716
40–59 years 34.1 (32.0 – 36.3) 13.3 (11.6 – 14.8) 34.7 (32.4 – 37.7) 66.2 (62.0 – 71.6) 626
60 years and older 36.2 (34.1 – 38.3) 15.0 (13.2 – 15.9) 36.3 (33.8 – 39.7) 72.9 (67.6 – 80.3) 522
Males
Total, 1 year and older 38.0 (35.9 – 40.3) 15.5 (14.0 – 16.6) 38.6 (35.9 – 41.4) 71.8 (69.0 – 78.6) 2,166
1–5 years 56.5 (52.5 – 60.7) 30.0 (21.7 – 34.0) 58.4 (54.3 – 61.6) 89.1 (81.9 – 98.4) 248
6–11 years 51.0 (48.1 – 54.1) 26.0 (23.0 – 28.4) 53.0 (49.3 – 56.5) 75.0 (70.5 – 88.7) 277
12–19 years 36.9 (34.0 – 40.0) 14.6 (13.2 – 15.9) 38.1 (34.9 – 41.0) 70.8 (66.6 – 75.9) 745
20–39 years 32.4 (29.8 – 35.1) 13.8 (11.6 – 15.2) 30.5 (28.4 – 33.3) 64.9 (59.0 – 82.3) 339
40–59 years 37.4 (34.8 – 40.2) 15.9 (14.0 – 17.1) 38.2 (34.2 – 42.2) 69.6 (62.4 – 77.2) 293
60 years and older 37.5 (34.9 – 40.3) 15.0 (12.8 – 16.6) 38.5 (34.7 – 42.7) 72.3 (66.1 – 79.2) 264
Females
Total, 1 year and older 34.5 (32.7 – 36.3) 13.6 (12.9 – 14.3) 34.9 (32.4 – 37.7) 69.6 (65.9 – 73.0) 2,183
1–5 years 54.6 (51.2 – 58.2) 28.4 (13.2 – 35.2) 56.0 (53.3 – 58.8) 83.1 (79.7 – 94.4) 255
6–11 years 45.3 (42.3 – 48.4) 23.6 (19.4 – 25.3) 46.0 (42.4 – 49.7) 73.0 (71.0 – 76.9) 284
12–19 years 31.5 (28.8 – 34.5) 13.3 (12.5 – 14.2) 31.3 (27.7 – 34.3) 64.7 (59.3 – 71.5) 676
20–39 years 32.7 (30.4 – 35.1) 13.7 (11.8 – 15.1) 32.4 (29.3 – 36.2) 63.0 (60.6 – 70.6) 377
40–59 years 31.5 (29.2 – 34.0) 12.2 (10.5 – 13.2) 32.5 (28.6 – 35.2) 63.2 (58.7 – 75.3) 333
60 years and older 35.3 (32.8 – 37.9) 15.0 (13.0 – 15.8) 34.7 (31.6 – 39.3) 73.5 (64.4 – 96.3) 258
Table 2.13.a.5. Serum 25-hydroxyvitamin D: Non-Hispanic whites
Geometric mean and selected percentiles of serum concentrations (in nmol/L) for non-Hispanic whites in the 
U.S. population aged 1 year and older, National Health and Nutrition Examination Survey, 2003–2006. 
Geometric mean 
(95% conf. interval)
Selected percentiles (95% conf. interval) Sample 
size5th 50th 95th
Males and Females
Total, 1 year and older 61.9 (60.3 – 63.4) 31.0 (29.1 – 32.6) 63.2 (61.8 – 64.6) 102 (97.8 – 106) 6,698
1–5 years 73.6 (71.3 – 76.0) 49.0 (44.1 – 51.7) 72.3 (70.7 – 74.2) 105 (97.8 – 118) 516
6–11 years 71.1 (68.2 – 74.1) 46.1 (43.5 – 48.1) 69.6 (67.5 – 71.8) 103 (96.1 – 119) 457
12–19 years 65.2 (63.0 – 67.4) 37.4 (35.6 – 40.1) 64.7 (62.9 – 66.6) 107 (100 – 113) 1,050
20–39 years 64.1 (61.8 – 66.5) 33.3 (29.8 – 36.3) 64.3 (61.8 – 66.6) 110 (107 – 115) 1,458
40–59 years 58.9 (56.8 – 61.0) 27.4 (25.9 – 30.2) 60.4 (58.0 – 63.2) 96.7 (92.5 – 103) 1,360
60 years and older 57.4 (55.9 – 58.9) 26.0 (24.2 – 27.7) 59.7 (58.3 – 61.1) 92.9 (90.8 – 97.2) 1,857
Males
Total, 1 year and older 62.4 (60.8 – 64.1) 33.7 (31.8 – 35.4) 63.6 (62.1 – 65.0) 97.4 (93.9 – 103) 3,303
1–5 years 74.1 (71.7 – 76.6) 47.1 (41.5 – 52.3) 72.7 (70.4 – 74.8) 105 (99.2 – 116) 279
6–11 years 72.6 (69.1 – 76.3) 47.1† (41.6 – 52.5) 70.9 (68.0 – 74.8) 105† (96.4 – 136) 219
12–19 years 65.4 (63.2 – 67.7) 40.6 (37.3 – 42.7) 65.3 (63.5 – 67.1) 99.6 (93.5 – 112) 528
20–39 years 61.6 (59.5 – 63.8) 33.5 (30.7 – 36.5) 62.3 (59.6 – 64.7) 96.8 (90.9 – 104) 641
40–59 years 60.7 (58.5 – 63.0) 31.8 (28.4 – 34.0) 62.6 (59.9 – 64.8) 96.1 (90.0 – 104) 691
60 years and older 58.7 (56.9 – 60.5) 30.5 (26.7 – 33.3) 60.0 (58.1 – 61.5) 92.7 (90.1 – 98.7) 945
Females
Total, 1 year and older 61.3 (59.6 – 63.1) 27.9 (25.6 – 30.3) 62.9 (61.0 – 64.5) 107 (102 – 111) 3,395
1–5 years 73.1 (69.8 – 76.5) 49.8 (45.5 – 52.8) 71.9 (69.3 – 75.8) 105 (94.9 – 122) 237
6–11 years 69.4 (66.6 – 72.4) 45.6 (42.7 – 47.6) 68.3 (65.6 – 70.8) 99.9 (94.8 – 109) 238
12–19 years 64.9 (61.7 – 68.3) 34.9 (31.1 – 37.5) 63.9 (61.4 – 67.0) 112 (106 – 127) 522
20–39 years 66.7 (63.5 – 70.0) 33.0 (26.4 – 37.1) 66.6 (63.5 – 69.6) 117 (112 – 128) 817
40–59 years 57.1 (54.6 – 59.7) 24.8 (19.9 – 27.0) 58.4 (55.6 – 61.9) 97.2 (93.4 – 105) 669
60 years and older 56.3 (54.6 – 58.0) 23.9 (22.0 – 25.7) 59.5 (57.8 – 61.2) 93.1 (90.0 – 99.8) 912
† Estimate is subject to greater uncertainty due to small cell size. 
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Table 2.13.b. Serum 25-hydroxyvitamin D: Concentrations by survey cycle
Geometric mean and selected percentiles of serum concentrations (in nmol/L) for the U.S. population, National 
Health and Nutrition Examination Survey, 2001–2006. 
Geometric mean 
(95% conf. interval)
Selected percentiles (95% conf. interval) Sample 
size5th 50th 95th
Total, 6 years and older
 2001–2002 54.7 (52.6 – 56.8) 22.6 (20.4 – 24.9) 57.1 (55.1 – 59.3) 96.8 (92.4 – 105) 7,807
 2003–2004 55.5 (52.5 – 58.7) 24.2 (20.9 – 26.3) 57.5 (54.7 – 60.6) 97.2 (92.8 – 104) 7,403
 2005–2006 54.3 (51.5 – 57.3) 21.8 (20.1 – 23.5) 57.2 (54.8 – 59.7) 95.9 (91.9 – 103) 7,402
Age group
1–5 years
 2003–2004 68.2 (65.9 – 70.5) 41.3 (37.6 – 44.4) 68.7 (66.8 – 70.6) 97.8 (96.3 – 101) 895
 2005–2006 69.0 (65.7 – 72.5) 41.8 (39.3 – 44.0) 69.1 (64.7 – 72.1) 103 (94.2 – 121) 904
6–11 years
 2001–2002 63.8 (60.5 – 67.3) 36.9 (31.9 – 39.7) 63.7 (60.4 – 66.8) 101 (90.1 – 138) 991
 2003–2004 63.4 (60.2 – 66.7) 34.8 (31.2 – 40.5) 64.5 (61.8 – 66.9) 94.3 (87.5 – 109) 846
 2005–2006 64.2 (60.8 – 67.7) 35.8 (31.9 – 38.6) 64.4 (62.6 – 66.8) 98.8 (92.5 – 129) 922
12–19 years
 2001–2002 55.1 (52.5 – 57.8) 24.5 (20.8 – 27.2) 56.7 (54.2 – 59.1) 96.1 (91.8 – 102) 2,167
 2003–2004 56.2 (52.2 – 60.6) 24.8 (21.0 – 27.3) 57.9 (53.9 – 61.8) 101 (94.1 – 112) 2,059
 2005–2006 54.0 (50.1 – 58.3) 21.2 (17.6 – 23.9) 57.3 (54.0 – 60.7) 96.3 (88.6 – 111) 1,985
20–39 years
 2001–2002 54.1 (51.8 – 56.5) 21.2 (19.4 – 23.1) 56.4 (54.0 – 59.0) 102 (94.8 – 110) 1,691
 2003–2004 54.4 (50.9 – 58.1) 22.5 (19.0 – 25.4) 56.1 (51.9 – 59.9) 104 (95.9 – 110) 1,559
 2005–2006 54.6 (51.1 – 58.4) 21.1 (19.0 – 23.3) 57.0 (54.2 – 60.1) 99.2 (95.5 – 113) 1,703
40–59 years
 2001–2002 54.0 (51.4 – 56.6) 21.4 (18.7 – 24.4) 56.8 (54.6 – 59.8) 94.9 (90.5 – 104) 1,449
 2003–2004 54.7 (51.1 – 58.5) 23.6 (18.7 – 26.9) 56.5 (53.6 – 60.2) 94.5 (89.0 – 102) 1,278
 2005–2006 52.6 (49.6 – 55.9) 20.8 (18.8 – 22.8) 55.5 (52.9 – 58.4) 94.1 (88.9 – 100) 1,382
60 years and older
 2001–2002 52.5 (49.9 – 55.3) 23.1 (21.1 – 24.4) 55.1 (52.4 – 57.7) 91.8 (88.4 – 95.0) 1,509
 2003–2004 55.2 (52.9 – 57.5) 24.2 (21.8 – 25.8) 57.6 (55.2 – 59.7) 94.1 (90.1 – 102) 1,661
 2005–2006 53.1 (50.4 – 55.9) 22.3 (20.4 – 24.3) 56.4 (54.1 – 58.9) 90.4 (87.5 – 93.9) 1,410
Gender
(6 years and older)
Males
 2001–2002 56.5 (54.5 – 58.6) 25.8 (23.8 – 27.2) 58.3 (56.3 – 60.7) 96.0 (91.2 – 105) 3,782
 2003–2004 56.8 (53.6 – 60.2) 27.0 (23.7 – 29.4) 58.6 (55.8 – 61.7) 92.1 (88.8 – 98.2) 3,638
 2005–2006 55.1 (52.4 – 58.0) 23.8 (21.5 – 25.6) 57.7 (55.7 – 60.1) 94.1 (88.1 – 102) 3,603
Females
 2001–2002 53.0 (50.6 – 55.5) 20.5 (18.0 – 22.7) 55.8 (53.5 – 58.1) 98.4 (92.6 – 108) 4,025
 2003–2004 54.3 (51.4 – 57.3) 21.3 (19.2 – 23.5) 56.3 (53.3 – 59.5) 103 (97.3 – 109) 3,765
 2005–2006 53.6 (50.5 – 56.9) 20.5 (18.6 – 22.3) 56.6 (53.8 – 59.5) 97.1 (93.1 – 107) 3,799
Race/ethnicity
(6 years and older)
Mexican Americans
 2001–2002 48.9 (46.2 – 51.8) 23.0 (21.3 – 24.5) 50.1 (47.1 – 52.7) 81.6 (77.3 – 91.2) 1,961
 2003–2004 48.7 (46.0 – 51.6) 22.8 (19.4 – 25.5) 50.2 (47.1 – 53.4) 80.5 (77.2 – 84.1) 1,802
 2005–2006 45.9 (41.9 – 50.2) 20.0 (16.3 – 22.6) 47.3 (43.3 – 52.8) 78.5 (73.0 – 84.5) 1,889
Non-Hispanic Blacks
 2001–2002 32.6 (31.3 – 34.0) 13.3 (10.9 – 14.4) 32.5 (31.1 – 34.2) 66.2 (63.9 – 68.5) 1,821
 2003–2004 36.3 (33.5 – 39.4) 14.3 (12.8 – 15.6) 37.0 (34.0 – 40.7) 69.1 (65.8 – 73.9) 1,914
 2005–2006 33.8 (31.6 – 36.2) 13.9 (13.0 – 14.8) 33.4 (30.7 – 37.1) 68.4 (64.5 – 71.1) 1,932
Non-Hispanic Whites
 2001–2002 60.9 (58.7 – 63.1) 29.9 (28.2 – 31.2) 62.2 (60.2 – 64.2) 102 (95.9 – 110) 3,416
 2003–2004 61.7 (59.3 – 64.2) 30.2 (27.0 – 33.6) 63.2 (60.8 – 65.2) 103 (97.3 – 109) 3,155
 2005–2006 61.0 (59.0 – 63.1) 31.0 (27.5 – 32.4) 62.3 (60.3 – 64.1) 99.0 (95.9 – 108) 3,027
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Figure 2.13.b. Serum 25−hydroxyvitamin D: Concentrations by survey cycle 
Selected percentiles in nmol/L (95% confidence intervals), National Health and 

Nutrition Examination Survey, 2001–2006
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Table 2.13.c.1. Serum 25-hydroxyvitamin D: Prevalence
Prevalence (in percent) of low serum 25-hydroxyvitamin D concentration (< 30 nmol/L) for the U.S. 





Estimated total  
number of persons
Total, 1 year and older 16,604 8.1 (6.7 – 9.8) 23,004,000
Age group
1–5 years 1,799 0.7 (0.4 – 1.3) 146,000
6–11 years 1,768 1.8 (1.3 – 2.6) 442,000
12–19 years 4,044 8.5 (6.5 – 11.2) 2,823,000
20–39 years 3,262 9.5 (7.6 – 11.8) 7,538,000
40–59 years 2,660 9.3 (7.4 – 11.7) 7,343,000
60 years and older 3,071 8.8 (7.3 – 10.5) 4,084,000
Gender
Males 8,145 6.3 (5.0 – 7.9) 8,735,000
Females 8,459 9.9 (8.1 – 11.9) 14,288,000
Race/ethnicity
Mexican Americans 4,275 11.3 (8.7 – 14.6) 2,919,000
Non-Hispanic Blacks 4,349 31.1 (27.4 – 35.1) 10,623,000
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Table 2.13.c.2. Serum 25-hydroxyvitamin D: Prevalence
Prevalence (in percent) of low serum 25-hydroxyvitamin D concentration (between 30–50 nmol/L) for the 




 (95% conf. interval)
Estimated total  
number of persons
Total, 1 year and older 16,604 23.6 (21.6 – 25.8) 66,859,000
Age group
1–5 years 1,799 8.9 (7.1 – 11.0) 1,799,000
6–11 years 1,768 14.1 (11.5 – 17.2) 3,407,000
12–19 years 4,044 24.2 (21.3 – 27.3) 8,005,000
20–39 years 3,262 26.2 (23.6 – 29.0) 20,908,000
40–59 years 2,660 25.0 (22.2 – 28.0) 19,729,000
60 years and older 3,071 25.5 (23.7 – 27.4) 11,879,000
Gender
Males 8,145 23.1 (20.8 – 25.6) 31,909,000
Females 8,459 24.1 (22.1 – 26.3) 34,955,000
Race/ethnicity
Mexican Americans 4,275 32.9 (29.6 – 36.4) 8,514,000
Non-Hispanic Blacks 4,349 39.5 (37.3 – 41.7) 13,483,000
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Table 2.13.c.3. Serum 25-hydroxyvitamin D: Prevalence
Prevalence (in percent) of low serum 25-hydroxyvitamin D concentration (< 40 nmol/L) for the U.S. 





Estimated total  
number of persons
Total, 1 year and older 16,604 17.2 (14.7 – 20.0) 49,431,000
Age group
1–5 years 1,799 2.7 (1.8 – 4.0) 541,000
6–11 years 1,768 5.7 (4.2 – 7.7) 1,358,000
12–19 years 4,044 17.1 (13.8 – 21.0) 5,729,000
20–39 years 3,262 19.7 (16.4 – 23.4) 15,722,000
40–59 years 2,660 20.0 (16.6 – 23.9) 16,400,000
60 years and older 3,071 17.8 (15.5 – 20.4) 8,602,000
Gender
Males 8,145 14.6 (12.3 – 17.4) 20,576,000
Females 8,459 19.6 (16.9 – 22.7) 28,869,000
Race/ethnicity
Mexican Americans 4,275 24.4 (20.1 – 29.3) 6,635,000
Non-Hispanic Blacks 4,349 51.6 (46.7 – 56.5) 17,968,000
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Table 2.13.c.4. Serum 25-hydroxyvitamin D: Prevalence
Prevalence (in percent) of high serum 25-hydroxyvitamin D concentration (> 125 nmol/L) for the U.S. 





Estimated total  
number of persons
Total, 1 year and older 16,604 0.9 (0.6 – 1.2) 2,449,000
Age group
1–5 years 1,799 § §
6–11 years 1,768 § §
12–19 years 4,044 1.4 (0.9 – 2.1) 450,000
20–39 years 3,262 1.5 (0.9 – 2.4) 1,193,000
40–59 years 2,660 0.6‡ (0.3 – 1.2) 498,000‡
60 years and older 3,071 0.3‡ (0.1 – 0.6) 134,000‡
Gender
Males 8,145 0.4 (0.3 – 0.7) 587,000
Females 8,459 1.3 (0.9 – 1.9) 1,867,000
Race/ethnicity
Mexican Americans 4,275 § §
Non-Hispanic Blacks 4,349 § §
Non-Hispanic Whites 6,698 1.2 (0.8 – 1.7) 2,283,000
‡ Estimate flagged: 30% ≤ RSE < 40% for the prevalence estimate. 
§ Estimate suppressed: RSE ≥ 40% for the prevalence estimate. 
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Table 2.13.d.1. Serum 25-hydroxyvitamin D: Prevalence by survey cycle
Prevalence (in percent) of low serum 25-hydroxyvitamin D concentration (< 30 nmol/L) for the U.S. population, 
National Health and Nutrition Examination Survey, 2001–2006. 
Sample size Prevalence (95% conf. interval) Estimated total number of persons
Total, 6 years and older
 2001–2002 7,807 8.4 (6.8 – 10.3) 21,467,000
 2003–2004 7,403 7.6 (5.5 – 10.5) 20,049,000
 2005–2006 7,402 9.5 (7.3 – 12.2) 25,318,000
Age group
1–5 years
 2003–2004 895 § §
 2005–2006 904 0.7‡ (0.3 – 1.5) 137,000‡
6–11 years
 2001–2002 991 § §
 2003–2004 846 1.5 (0.8 – 2.6) 350,000
 2005–2006 922 2.2 (1.4 – 3.5) 524,000
12–19 years
 2001–2002 2,167 7.0 (4.4 – 11.1) 2,266,000
 2003–2004 2,059 7.0 (4.6 – 10.7) 2,327,000
 2005–2006 1,985 10.0 (6.8 – 14.5) 3,353,000
20–39 years
 2001–2002 1,691 9.5 (7.7 – 11.5) 7,498,000
 2003–2004 1,559 9.3 (6.6 – 12.8) 7,391,000
 2005–2006 1,703 9.6 (6.9 – 13.3) 7,700,000
40–59 years
 2001–2002 1,449 9.4 (7.2 – 12.2) 7,125,000
 2003–2004 1,278 7.5 (4.8 – 11.4) 5,910,000
 2005–2006 1,382 11.0 (8.3 – 14.5) 9,054,000
60 years and older
 2001–2002 1,509 8.8 (6.7 – 11.3) 3,921,000
 2003–2004 1,661 8.3 (6.1 – 11.1) 3,841,000
 2005–2006 1,410 9.3 (7.2 – 11.8) 4,488,000
Gender
(6 years and older)
Males
 2001–2002 3,782 6.2 (4.9 – 7.9) 7,774,000
 2003–2004 3,638 5.3 (3.5 – 8.1) 6,830,000
 2005–2006 3,603 8.0 (6.0 – 10.6) 10,419,000
Females
 2001–2002 4,025 10.4 (8.2 – 13.0) 13,726,000
 2003–2004 3,765 9.8 (7.3 – 13.1) 13,254,000
 2005–2006 3,799 10.9 (8.2 – 14.2) 14,894,000
Race/ethnicity
(6 years and older)
Mexican Americans
 2001–2002 1,961 8.9 (6.7 – 11.6) 1,863,000
 2003–2004 1,802 9.7 (7.1 – 13.3) 2,218,000
 2005–2006 1,889 15.0 (10.2 – 21.5) 3,604,000
Non-Hispanic Blacks
 2001–2002 1,821 37.8 (34.5 – 41.2) 11,654,000
 2003–2004 1,914 28.5 (22.6 – 35.2) 8,872,000
 2005–2006 1,932 37.4 (32.2 – 42.9) 11,915,000
Non-Hispanic Whites
 2001–2002 3,416 3.7 (2.9 – 4.7) 6,654,000
 2003–2004 3,155 3.6 (2.6 – 4.9) 6,423,000
 2005–2006 3,027 4.0 (3.1 – 5.1) 7,240,000
‡ Estimate flagged: 30% ≤ RSE < 40% for the prevalence estimate. 
§ Estimate suppressed: RSE ≥ 40% for the prevalence estimate. 
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Table 2.13.d.2. Serum 25-hydroxyvitamin D: Prevalence by survey cycle
Prevalence (in percent) of low serum 25-hydroxyvitamin D concentration (between 30–50 nmol/L) for the U.S. 
population, National Health and Nutrition Examination Survey, 2001–2006. 
Sample size Prevalence (95% conf. interval) Estimated total number of persons
Total, 6 years and older
 2001–2002 7,807 24.0 (21.7 – 26.4) 61,533,000
 2003–2004 7,403 24.5 (21.2 – 28.1) 64,338,000
 2005–2006 7,402 24.5 (21.7 – 27.5) 65,423,000
Age group
1–5 years
 2003–2004 895 8.6 (6.4 – 11.5) 1,741,000
 2005–2006 904 9.2 (6.5 – 12.8) 1,857,000
6–11 years
 2001–2002 991 14.7 (10.9 – 19.6) 3,639,000
 2003–2004 846 13.3 (9.4 – 18.4) 3,199,000
 2005–2006 922 15.0 (11.5 – 19.3) 3,558,000
12–19 years
 2001–2002 2,167 23.6 (20.4 – 27.1) 7,638,000
 2003–2004 2,059 23.8 (19.4 – 28.9) 7,881,000
 2005–2006 1,985 24.6 (20.8 – 28.8) 8,214,000
20–39 years
 2001–2002 1,691 24.8 (21.8 – 28.1) 19,655,000
 2003–2004 1,559 27.5 (23.1 – 32.4) 21,959,000
 2005–2006 1,703 24.9 (21.9 – 28.1) 19,866,000
40–59 years
 2001–2002 1,449 24.3 (21.3 – 27.5) 18,368,000
 2003–2004 1,278 25.1 (21.0 – 29.6) 19,828,000
 2005–2006 1,382 24.8 (20.8 – 29.4) 20,365,000
60 years and older
 2001–2002 1,509 26.9 (23.0 – 31.2) 12,040,000
 2003–2004 1,661 23.8 (21.6 – 26.0) 11,054,000
 2005–2006 1,410 27.3 (24.1 – 30.6) 13,167,000
Gender
(6 years and older)
Males
 2001–2002 3,782 22.8 (20.4 – 25.4) 28,420,000
 2003–2004 3,638 23.6 (19.8 – 27.9) 30,162,000
 2005–2006 3,603 24.3 (21.2 – 27.8) 31,683,000
Females
 2001–2002 4,025 25.1 (22.5 – 27.9) 33,130,000
 2003–2004 3,765 25.4 (22.1 – 28.9) 34,190,000
 2005–2006 3,799 24.6 (21.6 – 27.8) 33,739,000
Race/ethnicity
(6 years and older)
Mexican Americans
 2001–2002 1,961 35.6 (31.0 – 40.5) 7,496,000
 2003–2004 1,802 34.9 (30.6 – 39.5) 7,963,000
 2005–2006 1,889 35.5 (30.0 – 41.3) 8,515,000
Non-Hispanic Blacks
 2001–2002 1,821 40.0 (37.5 – 42.6) 12,350,000
 2003–2004 1,914 42.2 (38.1 – 46.3) 13,140,000
 2005–2006 1,932 39.0 (36.1 – 42.0) 12,422,000
Non-Hispanic Whites
 2001–2002 3,416 18.7 (16.6 – 21.0) 33,627,000
 2003–2004 3,155 18.6 (15.6 – 22.1) 33,594,000
 2005–2006 3,027 18.9 (16.0 – 22.2) 34,271,000
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Table 2.13.d.3. Serum 25-hydroxyvitamin D: Prevalence by survey cycle
Prevalence (in percent) of low serum 25-hydroxyvitamin D concentration (< 40 nmol/L) for the U.S. population, 
National Health and Nutrition Examination Survey, 2001–2006. 
Sample size Prevalence (95% conf. interval) Estimated total number of persons
Total, 6 years and older
 2001–2002 7,807 18.2 (15.5 – 21.3) 46,723,000
 2003–2004 7,403 17.2 (13.3 – 21.9) 45,025,000
 2005–2006 7,402 18.9 (15.3 – 23.1) 50,461,000
Age group
1–5 years
 2003–2004 895 3.0 (1.6 – 5.5) 612,000
 2005–2006 904 2.3 (1.4 – 3.7) 467,000
6–11 years
 2001–2002 991 5.3 (3.2 – 8.7) 1,313,000
 2003–2004 846 5.8 (3.4 – 9.7) 1,399,000
 2005–2006 922 5.6 (4.0 – 7.9) 1,338,000
12–19 years
 2001–2002 2,167 17.5 (13.2 – 22.8) 5,660,000
 2003–2004 2,059 15.3 (11.2 – 20.6) 5,078,000
 2005–2006 1,985 18.9 (13.8 – 25.4) 6,325,000
20–39 years
 2001–2002 1,691 19.7 (16.2 – 23.6) 15,557,000
 2003–2004 1,559 19.9 (15.1 – 25.6) 15,829,000
 2005–2006 1,703 19.5 (14.9 – 25.2) 15,587,000
40–59 years
 2001–2002 1,449 19.1 (16.0 – 22.7) 14,488,000
 2003–2004 1,278 18.5 (13.6 – 24.6) 14,620,000
 2005–2006 1,382 21.5 (16.8 – 27.0) 17,595,000
60 years and older
 2001–2002 1,509 20.9 (16.9 – 25.7) 9,371,000
 2003–2004 1,661 16.4 (13.4 – 20.0) 7,646,000
 2005–2006 1,410 19.1 (15.5 – 23.4) 9,241,000
Gender
(6 years and older)
Males
 2001–2002 3,782 14.8 (12.6 – 17.3) 18,450,000
 2003–2004 3,638 14.2 (10.4 – 19.1) 18,138,000
 2005–2006 3,603 16.6 (13.4 – 20.4) 21,606,000
Females
 2001–2002 4,025 21.4 (18.1 – 25.3) 28,325,000
 2003–2004 3,765 20.0 (15.9 – 24.8) 26,932,000
 2005–2006 3,799 21.0 (16.8 – 26.0) 28,849,000
Race/ethnicity
(6 years and older)
Mexican Americans
 2001–2002 1,961 23.3 (19.0 – 28.2) 4,904,000
 2003–2004 1,802 24.5 (19.1 – 30.8) 5,582,000
 2005–2006 1,889 28.9 (21.3 – 37.9) 6,943,000
Non-Hispanic Blacks
 2001–2002 1,821 60.6 (57.1 – 64.1) 18,708,000
 2003–2004 1,914 51.0 (43.9 – 58.1) 15,900,000
 2005–2006 1,932 57.7 (50.3 – 64.7) 18,374,000
Non-Hispanic Whites
 2001–2002 3,416 10.4 (8.6 – 12.4) 18,638,000
 2003–2004 3,155 9.5 (7.0 – 12.8) 17,121,000
 2005–2006 3,027 10.1 (8.1 – 12.6) 18,342,000
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Table 2.13.d.4. Serum 25-hydroxyvitamin D: Prevalence by survey cycle
Prevalence (in percent) of high serum 25-hydroxyvitamin D concentration (> 125 nmol/L) for the U.S. 
population, National Health and Nutrition Examination Survey, 2001–2006. 
Sample size Prevalence (95% conf. interval) Estimated total number of persons
Total, 6 years and older
 2001–2002 7,807 0.8 (0.5 – 1.2) 1,998,000
 2003–2004 7,403 1.0 (0.5 – 1.7) 2,547,000
 2005–2006 7,402 0.8 (0.6 – 1.2) 2,224,000
Age group
1–5 years
 2003–2004 895 § §
 2005–2006 904 § §
6–11 years
 2001–2002 991 § §
 2003–2004 846 § §
 2005–2006 922 § §
12–19 years
 2001–2002 2,167 § §
 2003–2004 2,059 1.3 (0.7 – 2.3) 427,000
 2005–2006 1,985 1.4‡ (0.7 – 2.9) 478,000‡
20–39 years
 2001–2002 1,691 1.0 (0.6 – 1.8) 821,000
 2003–2004 1,559 1.7‡ (0.8 – 3.4) 1,334,000‡
 2005–2006 1,703 1.3 (0.7 – 2.4) 1,050,000
40–59 years
 2001–2002 1,449 0.8‡ (0.4 – 1.6) 616,000‡
 2003–2004 1,278 § §
 2005–2006 1,382 § §
60 years and older
 2001–2002 1,509 § §
 2003–2004 1,661 § §
 2005–2006 1,410 § §
Gender
(6 years and older)
Males
 2001–2002 3,782 § §
 2003–2004 3,638 § §
 2005–2006 3,603 0.5‡ (0.2 – 1.0) 649,000‡
Females
 2001–2002 4,025 1.1 (0.7 – 1.7) 1,395,000
 2003–2004 3,765 1.5 (0.8 – 2.9) 2,071,000
 2005–2006 3,799 1.1 (0.7 – 1.9) 1,574,000
Race/ethnicity
(6 years and older)
Mexican Americans
 2001–2002 1,961 § §
 2003–2004 1,802 § §
 2005–2006 1,889 § §
Non-Hispanic Blacks
 2001–2002 1,821 § §
 2003–2004 1,914 § §
 2005–2006 1,932 § §
Non-Hispanic Whites
 2001–2002 3,416 1.0 (0.7 – 1.5) 1,859,000
 2003–2004 3,155 1.3 (0.7 – 2.5) 2,391,000
 2005–2006 3,027 1.1 (0.7 – 1.7) 2,047,000
‡ Estimate flagged: 30% ≤ RSE < 40% for the prevalence estimate. 
§ Estimate suppressed: RSE ≥ 40% for the prevalence estimate. 



















































































































































































































Saturated (SFA) Monounsaturated (MUFA) Polyunsaturated (PUFA)
20:0 Arachidic acid 22:1n-9 Docosenoic acid 22:5n-6 Docosapentaenoic acid
24:0 Lignoceric acid 14:1n-5 Myristoleic acid 20:2n-6 Eicosadienoic acid
22:0 Doconsanoic acid 20:1n-9 Eicosenoic acid 22:4n-6 Docosatetraenoic acid
14:0 Myristic acid 24:1n-9 Nervonic acid 22:5n-3 Docosapentaenoic acid
18:0 Stearic acid 18:1n-9 cis-Vaccenic acid 20:5n-3 Eicosapentaenoic acid
16:0 Palmitic acid 16:1n-9 Palmitoleic acid 18:3n-6 gamma-Linolenic acid
















































































































ɨF TFMFDUFE PCTFSWBUJPOT NFOUJPOFE CFMPX BSF UBLFO GSPN UIF UBCMFT BOE ëHVSFT QSFTFOUFE OFYU 
4UBUFNFOUT BCPVU DBUFHPSJDBM EJêFSFODFT CFUXFFO EFNPHSBQIJD HSPVQT OPUFE CFMPX BSF CBTFE PO 
OPOPWFSMBQQJOH DPOëEFODF MJNJUT GSPN VOJWBSJBUF BOBMZTJT XJUIPVU BEKVTUJOH GPS EFNPHSBQIJD 
WBSJBCMFT FH BHF HFOEFS SBDFFUIOJDJUZ
 PS PUIFS CMPPE DPODFOUSBUJPO EFUFSNJOBOUT FH EJFUBSZ 
JOUBLF TVQQMFNFOU VTBHF TNPLJOH #.*
 " NVMUJWBSJBUF BOBMZTJT NBZ BMUFS UIF TJ[F BOE TUBUJTUJDBM 
TJHOJëDBODF PG UIFTF DBUFHPSJDBM EJêFSFODFT 'VSUIFSNPSF BEEJUJPOBM TJHOJëDBOU EJêFSFODFT PG 
TNBMMFS NBHOJUVEF NBZ CF QSFTFOU EFTQJUF UIFJS MBDL PG NFOUJPO IFSF FH JG DPOëEFODF MJNJUT 
TMJHIUMZ PWFSMBQ PS JG EJêFSFODFT BSF OPU TUBUJTUJDBMMZ TJHOJëDBOU CFGPSF DPWBSJBUF BEKVTUNFOU IBT 
PDDVSSFE
 'PS B TFMFDUJPO PG DJUBUJPOT PG EFTDSJQUJWF /)"/&4 QBQFST SFMBUFE UP UIFTF CJPDIFNJDBM 
JOEJDBUPST PG EJFU BOE OVUSJUJPO TFF Appendix G 
Geometric mean concentrations (NHANES 2003–2004): 
t ɨF NBKPSJUZ PG GBUUZ BDJET DJSDVMBUFE JO QMBTNB BU MPXFS DPODFOUSBUJPOT JO ZPVOHFS 
BEVMUT  Z




t	 8IJMF JO HFOFSBM QMBTNB DPODFOUSBUJPOT PG GBUUZ BDJET XFSF TJNJMBS JO NFO BOE XPNFO 
UIFSF XFSF B GFX MPOH DIBJO $$
 FYDFQUJPOT JO XIJDI DPODFOUSBUJPOT XFSF IJHIFS 
JO XPNFO UIBO JO NFO 5BCMFT BB
 
t	 1MBTNB DPODFOUSBUJPOT PG BQQSPYJNBUFMZ POFUIJSE PG 4'" BOE UISFFRVBSUFST PG 
.6'" XFSF GPVOE BU MPXFS DPODFOUSBUJPOT JO OPO)JTQBOJD CMBDLT DPNQBSFE XJUI 
OPO)JTQBOJD XIJUFT BOEPS .FYJDBO "NFSJDBOT /PUBCMZ OPO)JTQBOJD CMBDLT IBE 
TVCTUBOUJBMMZ MPXFS QMBTNB DPODFOUSBUJPOT PG NZSJTUJD 4'"
 BOE NZSJTUPMFJD .6'"
 
BDJE UIBO OPO)JTQBOJD XIJUFT PS .FYJDBO "NFSJDBOT 5BCMFT B BOE B
 
'PS 16'" UIF QJDUVSF XBT NJYFE XJUI FBDI SBDFFUIOJD HSPVQ IBWJOH IJHIFS PS MPXFS  
DPODFOUSBUJPOT PG BU MFBTU POF 16'" DPNQBSFE XJUI POF PS CPUI SBDFFUIOJD HSPVQT 
198198 2nd National Report on Biochemical Indicators of Diet and Nutrition in the U.S. Population 
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0 Non−Hispanic Blacks Non−Hispanic Whites 
Figure 2.14.a. Plasma myristic acid (14:0): Concentrations by age group 
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Table 2.14.a.2. Plasma myristic acid (14:0): Total population
Geometric mean and selected percentiles of plasma concentrations (in µmol/L) for the fasted U.S. population 
aged 20 years and older, National Health and Nutrition Examination Survey, 2003–2004. 
Geometric mean 
(95% conf. interval)
Selected percentiles (95% conf. interval) Sample 
size10th 50th 90th
Males and Females
Total, 20 years and older 119 (113 – 125) 57.9 (55.2 – 61.1) 116 (108 – 123) 248 (237 – 266) 1,796
20–39 years 110 (104 – 117) 52.8 (49.4 – 55.9) 106 (99.0 – 118) 240 (209 – 260) 603
40–59 years 126 (117 – 136) 61.8 (56.1 – 66.0) 120 (109 – 132) 266 (248 – 294) 514
60 years and older 121 (112 – 131) 61.4 (54.6 – 67.0) 120 (112 – 127) 238 (224 – 256) 679
Males
Total, 20 years and older 120 (112 – 129) 58.8 (54.7 – 61.5) 118 (105 – 129) 260 (243 – 272) 856
20–39 years 112 (102 – 122) 53.4 (47.6 – 57.8) 106 (93.5 – 122) 245 (209 – 284) 277
40–59 years 133 (120 – 147) 61.8 (57.5 – 70.6) 124 (109 – 154) 279 (265 – 336) 247
60 years and older 115 (106 – 126) 58.2 (47.3 – 67.9) 119 (112 – 123) 226 (201 – 244) 332
Females
Total, 20 years and older 117 (111 – 124) 56.6 (53.6 – 61.5) 115 (107 – 121) 242 (225 – 270) 940
20–39 years 109 (101 – 117) 51.3 (49.2 – 55.4) 106 (95.9 – 119) 226 (193 – 308) 326
40–59 years 120 (111 – 131) 61.5 (51.6 – 64.9) 115 (107 – 123) 249 (226 – 301) 267
60 years and older 126 (114 – 139) 64.1 (51.0 – 73.7) 121 (109 – 143) 244 (227 – 302) 347
Table 2.14.a.3. Plasma myristic acid (14:0): Mexican Americans
Geometric mean and selected percentiles of plasma concentrations (in µmol/L) for fasted Mexican Americans in 
the U.S. population aged 20 years and older, National Health and Nutrition Examination Survey, 2003–2004. 
Geometric mean 
(95% conf. interval)
Selected percentiles (95% conf. interval) Sample 
size10th 50th 90th
Males and Females
Total, 20 years and older 126 (110 – 144) 54.6 (49.2 – 62.0) 124 (108 – 144) 277 (244 – 352) 375
20–39 years 122 (95.1 – 155) 51.0 (45.4 – 56.1) 123 (83.9 – 158) 259 (212 – 1,990) 132
40–59 years 133 (112 – 159) 61.2† (46.5 – 76.0) 130 (95.3 – 155) 313† (248 – 387) 93
60 years and older 135 (124 – 146) 68.0 (64.2 – 75.1) 133 (112 – 160) 252 (224 – 315) 150
Males
Total, 20 years and older 126 (102 – 156) 56.3 (49.6 – 62.4) 123 (95.9 – 153) 282 (228 – 410) 188
20–39 years 123 (86.4 – 175) 51.8† (46.6 – 57.2) 123 (67.8 – 214) 274† (202 – 556) 67
40–59 years 136 (104 – 179) 68.5† (54.1 – 82.7) 125 (90.5 – 177) 305† (201 – 721) 48
60 years and older 117 (104 – 131) 65.6† (48.2 – 71.4) 117 (104 – 135) 199† (164 – 390) 73
Females
Total, 20 years and older 126 (110 – 145) 51.4 (40.7 – 65.3) 127 (108 – 152) 268 (240 – 339) 187
20–39 years 119 (92.9 – 153) 50.5† (39.7 – 66.1) 121 (93.6 – 150) 245† (173 – 2,410) 65
40–59 years 130 (99.5 – 169) 50.0† (36.9 – 74.6) 134 (83.1 – 193) 313† (248 – 460) 45
60 years and older 154 (131 – 180) 81.6† (54.5 – 95.1) 153 (120 – 195) 274† (228 – 391) 77
† Estimate is subject to greater uncertainty due to small cell size. 
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Table 2.14.a.4. Plasma myristic acid (14:0): Non-Hispanic blacks
Geometric mean and selected percentiles of plasma concentrations (in µmol/L) for fasted non-Hispanic blacks 
in the U.S. population aged 20 years and older, National Health and Nutrition Examination Survey, 2003–2004. 
Geometric mean 
(95% conf. interval)
Selected percentiles (95% conf. interval) Sample 
size10th 50th 90th
Males and Females
Total, 20 years and older 85.8 (78.9 – 93.3) 44.8 (38.0 – 50.1) 84.3 (72.0 – 95.0) 161 (146 – 201) 309
20–39 years 81.9 (72.7 – 92.2) 43.6 (33.7 – 48.1) 76.7 (66.9 – 92.1) 149 (128 – 249) 125
40–59 years 91.9 (82.8 – 102) 44.5† (28.4 – 51.6) 93.4 (82.5 – 106) 184† (150 – 249) 98
60 years and older 84.9 (76.3 – 94.5) 46.9† (36.2 – 58.7) 79.7 (71.8 – 95.2) 154† (129 – 188) 86
Males
Total, 20 years and older 87.3 (76.6 – 99.4) 40.9 (31.8 – 46.6) 85.3 (67.2 – 98.7) 170 (148 – 270) 142
20–39 years 82.7 (67.7 – 101) 39.7† (28.5 – 47.0) 71.6 (61.5 – 101) 167† (128 – 466) 57
40–59 years 98.8 (78.8 – 124) 41.2† (29.2 – 55.7) 97.8 (84.0 – 115) 229† (148 – 479) 42
60 years and older 78.0 (64.2 – 94.6) 43.7† (36.0 – 52.8) 67.4 (58.9 – 104) 143† (121 – 187) 43
Females
Total, 20 years and older 84.7 (76.2 – 94.2) 46.5 (39.2 – 51.8) 83.0 (69.2 – 99.1) 153 (135 – 189) 167
20–39 years 81.2 (72.4 – 91.2) 44.2† (33.9 – 51.5) 78.8 (64.6 – 98.7) 144† (110 – 259) 68
40–59 years 87.0 (72.2 – 105) 46.6† (27.8 – 51.5) 86.5 (64.8 – 106) 160† (123 – 690) 56
60 years and older 89.6 (78.3 – 103) 53.5† (39.8 – 63.8) 82.6 (73.5 – 103) 158† (120 – 194) 43
† Estimate is subject to greater uncertainty due to small cell size. 
Table 2.14.a.5. Plasma myristic acid (14:0): Non-Hispanic whites
Geometric mean and selected percentiles of plasma concentrations (in µmol/L) for fasted non-Hispanic whites 
in the U.S. population aged 20 years and older, National Health and Nutrition Examination Survey, 2003–2004. 
Geometric mean 
(95% conf. interval)
Selected percentiles (95% conf. interval) Sample 
size10th 50th 90th
Males and Females
Total, 20 years and older 123 (116 – 131) 61.6 (56.2 – 65.5) 119 (110 – 127) 250 (236 – 280) 982
20–39 years 118 (110 – 126) 56.9 (50.1 – 64.0) 115 (103 – 123) 244 (216 – 303) 294
40–59 years 127 (115 – 140) 63.8 (56.4 – 69.1) 120 (108 – 136) 266 (238 – 299) 279
60 years and older 124 (114 – 136) 61.8 (53.5 – 70.8) 121 (116 – 134) 241 (225 – 301) 409
Males
Total, 20 years and older 126 (115 – 137) 61.5 (56.0 – 67.2) 121 (107 – 141) 263 (243 – 273) 465
20–39 years 119 (107 – 133) 58.3 (35.4 – 67.0) 115 (98.2 – 140) 245 (206 – 337) 124
40–59 years 134 (120 – 151) 65.6 (57.8 – 72.3) 124 (108 – 163) 272 (264 – 317) 139
60 years and older 120 (108 – 134) 58.8 (46.7 – 72.3) 121 (115 – 127) 229 (203 – 262) 202
Females
Total, 20 years and older 121 (114 – 128) 61.5 (55.6 – 64.2) 118 (110 – 123) 247 (223 – 303) 517
20–39 years 116 (104 – 129) 55.5 (48.9 – 63.3) 114 (97.3 – 128) 240 (197 – 361) 170
40–59 years 121 (108 – 135) 62.2 (48.3 – 69.0) 115 (104 – 123) 237 (195 – 399) 140
60 years and older 128 (114 – 145) 64.1 (47.6 – 74.7) 124 (110 – 146) 248 (229 – 314) 207
 






















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Non−Hispanic Blacks Non−Hispanic Whites 
Figure 2.15.a. Plasma palmitic acid (16:0): Concentrations by age group 
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Table 2.15.a.2. Plasma palmitic acid (16:0): Total population
Geometric mean and selected percentiles of plasma concentrations (in µmol/L) for the fasted U.S. population 
aged 20 years and older, National Health and Nutrition Examination Survey, 2003–2004. 
Geometric mean 
(95% conf. interval)
Selected percentiles (95% conf. interval) Sample 
size10th 50th 90th
Males and Females
Total, 20 years and older 2,710 (2,640 – 2,780) 1,890 (1,820 – 1,930) 2,630 (2,540 – 2,730) 3,990 (3,820 – 4,360) 1,805
20–39 years 2,540 (2,470 – 2,610) 1,750 (1,660 – 1,810) 2,450 (2,380 – 2,540) 3,790 (3,540 – 4,260) 609
40–59 years 2,780 (2,680 – 2,880) 1,950 (1,910 – 1,990) 2,650 (2,530 – 2,800) 4,160 (3,840 – 4,570) 514
60 years and older 2,890 (2,790 – 2,990) 2,050 (1,960 – 2,140) 2,820 (2,740 – 2,940) 4,050 (3,840 – 4,430) 682
Males
Total, 20 years and older 2,700 (2,590 – 2,810) 1,880 (1,760 – 1,920) 2,610 (2,500 – 2,710) 4,010 (3,790 – 4,430) 863
20–39 years 2,540 (2,400 – 2,690) 1,740 (1,580 – 1,820) 2,470 (2,340 – 2,600) 3,690 (3,420 – 4,540) 282
40–59 years 2,840 (2,690 – 3,000) 1,950 (1,890 – 2,010) 2,700 (2,480 – 2,870) 4,420 (4,030 – 4,760) 247
60 years and older 2,750 (2,640 – 2,860) 1,960 (1,820 – 2,070) 2,730 (2,620 – 2,830) 3,790 (3,530 – 4,380) 334
Females
Total, 20 years and older 2,720 (2,640 – 2,800) 1,920 (1,820 – 1,970) 2,640 (2,540 – 2,760) 3,960 (3,810 – 4,370) 942
20–39 years 2,530 (2,440 – 2,640) 1,760 (1,670 – 1,840) 2,440 (2,350 – 2,580) 3,870 (3,510 – 4,530) 327
40–59 years 2,730 (2,620 – 2,840) 1,960 (1,820 – 2,090) 2,590 (2,530 – 2,760) 3,850 (3,620 – 4,630) 267
60 years and older 3,010 (2,870 – 3,150) 2,180 (2,050 – 2,230) 2,950 (2,760 – 3,150) 4,340 (4,000 – 4,570) 348
Table 2.15.a.3. Plasma palmitic acid (16:0): Mexican Americans
Geometric mean and selected percentiles of plasma concentrations (in µmol/L) for fasted Mexican Americans in 
the U.S. population aged 20 years and older, National Health and Nutrition Examination Survey, 2003–2004. 
Geometric mean 
(95% conf. interval)
Selected percentiles (95% conf. interval) Sample 
size10th 50th 90th
Males and Females
Total, 20 years and older 2,880 (2,710 – 3,050) 1,900 (1,720 – 2,050) 2,750 (2,620 – 2,970) 4,540 (4,130 – 5,550) 374
20–39 years 2,730 (2,510 – 2,970) 1,820 (1,390 – 1,970) 2,700 (2,350 – 2,890) 4,410 (3,700 – 5,680) 131
40–59 years 3,090 (2,820 – 3,380) 2,000† (1,480 – 2,330) 2,840 (2,610 – 3,290) 4,940† (4,130 – 6,470) 93
60 years and older 3,140 (3,010 – 3,280) 2,250 (1,970 – 2,420) 3,150 (3,010 – 3,300) 4,530 (3,910 – 5,350) 150
Males
Total, 20 years and older 2,850 (2,580 – 3,160) 1,890 (1,570 – 2,010) 2,690 (2,510 – 3,180) 4,500 (4,020 – 5,950) 188
20–39 years 2,730 (2,320 – 3,220) 1,770† (1,460 – 1,940) 2,540 (2,090 – 3,270) 4,400† (3,600 – 6,350) 67
40–59 years 3,110 (2,670 – 3,630) 1,950† (1,790 – 2,530) 2,830 (2,580 – 3,400) 4,580† (3,880 – 7,970) 48
60 years and older 2,910 (2,740 – 3,080) 2,090† (1,500 – 2,420) 2,900 (2,580 – 3,230) 3,810† (3,500 – 5,010) 73
Females
Total, 20 years and older 2,900 (2,660 – 3,170) 1,930 (1,330 – 2,180) 2,790 (2,450 – 3,280) 4,570 (4,060 – 5,360) 186
20–39 years 2,730 (2,430 – 3,070) 1,840† (1,300 – 2,150) 2,740 (2,230 – 3,080) 4,330† (3,560 – 6,760) 64
40–59 years 3,060 (2,650 – 3,530) 2,050† (1,480 – 2,330) 2,890 (2,460 – 3,500) 4,950† (3,540 – 6,010) 45
60 years and older 3,370 (3,050 – 3,740) 2,370† (2,060 – 2,540) 3,370 (2,780 – 3,790) 5,020† (4,210 – 6,170) 77
† Estimate is subject to greater uncertainty due to small cell size. 
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Table 2.15.a.4. Plasma palmitic acid (16:0): Non-Hispanic blacks
Geometric mean and selected percentiles of plasma concentrations (in µmol/L) for fasted non-Hispanic blacks 
in the U.S. population aged 20 years and older, National Health and Nutrition Examination Survey, 2003–2004. 
Geometric mean 
(95% conf. interval)
Selected percentiles (95% conf. interval) Sample 
size10th 50th 90th
Males and Females
Total, 20 years and older 2,450 (2,340 – 2,570) 1,750 (1,600 – 1,830) 2,330 (2,240 – 2,480) 3,430 (3,330 – 3,630) 310
20–39 years 2,350 (2,170 – 2,530) 1,680 (1,410 – 1,810) 2,190 (2,070 – 2,480) 3,390 (3,140 – 3,730) 126
40–59 years 2,520 (2,370 – 2,680) 1,790† (1,620 – 1,890) 2,350 (2,270 – 2,590) 3,430† (3,370 – 4,090) 98
60 years and older 2,620 (2,490 – 2,760) 2,030† (1,870 – 2,180) 2,510 (2,430 – 2,760) 3,450† (3,280 – 3,770) 86
Males
Total, 20 years and older 2,450 (2,280 – 2,640) 1,690 (1,550 – 1,810) 2,340 (2,180 – 2,500) 3,550 (3,170 – 4,270) 143
20–39 years 2,320 (2,080 – 2,600) 1,570† (1,310 – 1,770) 2,140 (1,930 – 2,710) 3,410† (2,940 – 9,940) 58
40–59 years 2,620 (2,330 – 2,940) 1,770† (1,380 – 1,950) 2,370 (2,290 – 2,620) 4,060† (2,900 – 8,390) 42
60 years and older 2,520 (2,260 – 2,820) 1,740† (1,640 – 1,910) 2,440 (2,150 – 2,980) 3,290† (3,000 – 4,330) 43
Females
Total, 20 years and older 2,450 (2,300 – 2,620) 1,800 (1,690 – 1,870) 2,330 (2,230 – 2,570) 3,380 (3,210 – 3,680) 167
20–39 years 2,370 (2,170 – 2,580) 1,700† (1,390 – 1,850) 2,230 (2,030 – 2,590) 3,350† (3,110 – 4,210) 68
40–59 years 2,450 (2,230 – 2,680) 1,780† (1,260 – 1,940) 2,330 (2,140 – 2,650) 3,370† (2,930 – 6,230) 56
60 years and older 2,690 (2,520 – 2,870) 2,180† (1,950 – 2,240) 2,530 (2,400 – 2,790) 3,510† (3,260 – 4,220) 43
† Estimate is subject to greater uncertainty due to small cell size. 
Table 2.15.a.5. Plasma palmitic acid (16:0): Non-Hispanic whites
Geometric mean and selected percentiles of plasma concentrations (in µmol/L) for fasted non-Hispanic whites 
in the U.S. population aged 20 years and older, National Health and Nutrition Examination Survey, 2003–2004. 
Geometric mean 
(95% conf. interval)
Selected percentiles (95% conf. interval) Sample 
size10th 50th 90th
Males and Females
Total, 20 years and older 2,720 (2,630 – 2,810) 1,900 (1,800 – 1,950) 2,650 (2,550 – 2,730) 3,960 (3,810 – 4,420) 991
20–39 years 2,550 (2,450 – 2,640) 1,720 (1,600 – 1,810) 2,450 (2,370 – 2,590) 3,790 (3,510 – 4,490) 300
40–59 years 2,750 (2,630 – 2,870) 1,950 (1,900 – 1,990) 2,640 (2,500 – 2,800) 4,040 (3,790 – 4,700) 279
60 years and older 2,910 (2,790 – 3,030) 2,040 (1,950 – 2,140) 2,840 (2,730 – 2,990) 4,150 (3,840 – 4,520) 412
Males
Total, 20 years and older 2,700 (2,580 – 2,840) 1,890 (1,750 – 1,940) 2,630 (2,500 – 2,740) 3,960 (3,770 – 4,500) 471
20–39 years 2,530 (2,360 – 2,720) 1,680 (1,540 – 1,800) 2,460 (2,350 – 2,620) 3,630 (3,260 – 5,810) 128
40–59 years 2,810 (2,630 – 2,990) 1,950 (1,890 – 2,010) 2,700 (2,460 – 2,930) 4,280 (3,850 – 4,740) 139
60 years and older 2,780 (2,640 – 2,920) 1,950 (1,760 – 2,070) 2,750 (2,600 – 2,930) 3,830 (3,530 – 4,690) 204
Females
Total, 20 years and older 2,730 (2,640 – 2,820) 1,920 (1,810 – 1,970) 2,650 (2,550 – 2,770) 3,970 (3,810 – 4,500) 520
20–39 years 2,560 (2,410 – 2,710) 1,740 (1,600 – 1,870) 2,440 (2,280 – 2,690) 3,890 (3,490 – 4,960) 172
40–59 years 2,690 (2,570 – 2,830) 1,940 (1,720 – 2,110) 2,580 (2,530 – 2,710) 3,780 (3,510 – 4,690) 140
60 years and older 3,020 (2,860 – 3,200) 2,140 (2,010 – 2,250) 2,960 (2,750 – 3,210) 4,440 (4,030 – 4,660) 208
 



























































































































































































































































































































































































































































































































































































































































































































































































































































Non−Hispanic Blacks Non−Hispanic Whites 
Figure 2.16.a. Plasma stearic acid (18:0): Concentrations by age group 
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Table 2.16.a.2. Plasma stearic acid (18:0): Total population
Geometric mean and selected percentiles of plasma concentrations (in µmol/L) for the fasted U.S. population 
aged 20 years and older, National Health and Nutrition Examination Survey, 2003–2004. 
Geometric mean 
(95% conf. interval)
Selected percentiles (95% conf. interval) Sample 
size10th 50th 90th
Males and Females
Total, 20 years and older 692 (678 – 706) 515 (489 – 531) 684 (663 – 705) 939 (914 – 963) 1,806
20–39 years 649 (635 – 664) 484 (468 – 498) 638 (624 – 659) 870 (831 – 932) 609
40–59 years 718 (698 – 738) 545 (520 – 557) 711 (682 – 733) 989 (955 – 1,030) 515
60 years and older 724 (703 – 746) 552 (538 – 567) 731 (697 – 763) 930 (893 – 976) 682
Males
Total, 20 years and older 690 (671 – 710) 509 (483 – 527) 673 (644 – 711) 967 (930 – 1,010) 864
20–39 years 660 (636 – 686) 484 (469 – 504) 643 (615 – 672) 888 (831 – 1,010) 282
40–59 years 728 (697 – 761) 548 (520 – 571) 711 (646 – 752) 1,020 (997 – 1,040) 248
60 years and older 679 (656 – 703) 514 (472 – 546) 679 (659 – 718) 874 (825 – 960) 334
Females
Total, 20 years and older 694 (677 – 712) 522 (484 – 543) 689 (667 – 712) 916 (892 – 951) 942
20–39 years 639 (620 – 658) 483 (454 – 504) 635 (622 – 658) 849 (817 – 919) 327
40–59 years 709 (685 – 733) 532 (478 – 566) 710 (687 – 733) 934 (900 – 990) 267
60 years and older 763 (736 – 790) 617 (573 – 628) 763 (735 – 786) 971 (914 – 1,020) 348
Table 2.16.a.3. Plasma stearic acid (18:0): Mexican Americans
Geometric mean and selected percentiles of plasma concentrations (in µmol/L) for fasted Mexican Americans in 
the U.S. population aged 20 years and older, National Health and Nutrition Examination Survey, 2003–2004. 
Geometric mean 
(95% conf. interval)
Selected percentiles (95% conf. interval) Sample 
size10th 50th 90th
Males and Females
Total, 20 years and older 710 (677 – 745) 503 (485 – 528) 710 (666 – 748) 997 (921 – 1,160) 374
20–39 years 678 (632 – 727) 492 (464 – 510) 664 (594 – 755) 971 (801 – 1,330) 131
40–59 years 756 (710 – 806) 534† (457 – 587) 746 (714 – 770) 1,060† (915 – 1,470) 93
60 years and older 776 (735 – 820) 602 (491 – 646) 767 (720 – 815) 1,060 (961 – 1,180) 150
Males
Total, 20 years and older 705 (651 – 764) 501 (480 – 522) 690 (611 – 766) 1,030 (919 – 1,210) 188
20–39 years 682 (596 – 779) 492† (456 – 508) 647 (540 – 805) 1,040† (830 – 1,330) 67
40–59 years 753 (675 – 841) 529† (469 – 595) 725 (656 – 815) 1,010† (911 – 1,490) 48
60 years and older 726 (678 – 776) 593† (457 – 610) 720 (658 – 783) 896† (832 – 1,300) 73
Females
Total, 20 years and older 716 (677 – 758) 514 (443 – 559) 730 (669 – 777) 996 (885 – 1,140) 186
20–39 years 673 (620 – 732) 481† (340 – 555) 678 (629 – 751) 835† (791 – 1,140) 64
40–59 years 759 (696 – 828) 519† (439 – 624) 756 (700 – 819) 1,070† (859 – 1,410) 45
60 years and older 826 (760 – 897) 624† (541 – 652) 810 (736 – 903) 1,100† (1,050 – 1,250) 77
† Estimate is subject to greater uncertainty due to small cell size. 
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Table 2.16.a.4. Plasma stearic acid (18:0): Non-Hispanic blacks
Geometric mean and selected percentiles of plasma concentrations (in µmol/L) for fasted non-Hispanic blacks 
in the U.S. population aged 20 years and older, National Health and Nutrition Examination Survey, 2003–2004. 
Geometric mean 
(95% conf. interval)
Selected percentiles (95% conf. interval) Sample 
size10th 50th 90th
Males and Females
Total, 20 years and older 676 (655 – 697) 509 (458 – 540) 669 (645 – 693) 886 (835 – 941) 310
20–39 years 645 (610 – 682) 483 (435 – 514) 641 (587 – 672) 887 (808 – 945) 126
40–59 years 706 (675 – 738) 542† (477 – 567) 693 (664 – 710) 908† (833 – 1,120) 98
60 years and older 705 (681 – 729) 561† (511 – 615) 711 (692 – 753) 834† (806 – 886) 86
Males
Total, 20 years and older 678 (645 – 713) 483 (455 – 524) 663 (618 – 696) 925 (854 – 1,110) 143
20–39 years 651 (602 – 704) 461† (422 – 517) 619 (569 – 687) 897† (803 – 2,540) 58
40–59 years 726 (665 – 792) 544† (475 – 557) 676 (621 – 738) 1,010† (877 – 1,670) 42
60 years and older 662 (608 – 720) 503† (334 – 555) 673 (615 – 738) 830† (782 – 974) 43
Females
Total, 20 years and older 674 (649 – 699) 514 (354 – 567) 674 (644 – 702) 834 (789 – 1,030) 167
20–39 years 639 (604 – 677) 496† (446 – 515) 645 (594 – 667) 833† (715 – 1,090) 68
40–59 years 691 (651 – 733) 526† (353 – 589) 693 (643 – 710) 826† (774 – 2,490) 56
60 years and older 733 (710 – 757) 638† (558 – 668) 718 (696 – 779) 842† (800 – 885) 43
† Estimate is subject to greater uncertainty due to small cell size. 
Table 2.16.a.5. Plasma stearic acid (18:0): Non-Hispanic whites
Geometric mean and selected percentiles of plasma concentrations (in µmol/L) for fasted non-Hispanic whites 
in the U.S. population aged 20 years and older, National Health and Nutrition Examination Survey, 2003–2004. 
Geometric mean 
(95% conf. interval)
Selected percentiles (95% conf. interval) Sample 
size10th 50th 90th
Males and Females
Total, 20 years and older 692 (676 – 709) 515 (484 – 533) 686 (663 – 709) 940 (913 – 973) 992
20–39 years 648 (627 – 669) 481 (441 – 507) 635 (614 – 661) 853 (823 – 953) 300
40–59 years 710 (689 – 733) 540 (494 – 565) 705 (675 – 727) 969 (946 – 1,020) 280
60 years and older 726 (700 – 753) 546 (524 – 566) 733 (695 – 770) 940 (900 – 1,020) 412
Males
Total, 20 years and older 691 (669 – 715) 512 (480 – 533) 678 (644 – 720) 959 (919 – 1,010) 472
20–39 years 662 (629 – 696) 484 (433 – 513) 654 (615 – 675) 844 (810 – 1,250) 128
40–59 years 723 (691 – 757) 558 (513 – 576) 709 (640 – 749) 1,020 (975 – 1,040) 140
60 years and older 681 (653 – 711) 508 (471 – 545) 687 (652 – 726) 880 (819 – 1,030) 204
Females
Total, 20 years and older 693 (673 – 713) 516 (481 – 537) 689 (664 – 713) 923 (899 – 954) 520
20–39 years 636 (607 – 666) 460 (427 – 510) 627 (608 – 658) 874 (818 – 1,000) 172
40–59 years 698 (672 – 725) 519 (441 – 554) 699 (675 – 730) 934 (902 – 966) 140
60 years and older 766 (733 – 801) 611 (543 – 630) 767 (735 – 801) 981 (911 – 1,050) 208
 






































































































































































































































































































































































































































































































































































































































































































































































































































































Non−Hispanic Blacks Non−Hispanic Whites 
Figure 2.17.a. Plasma arachidic acid (20:0): Concentrations by age group 
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Table 2.17.a.2. Plasma arachidic acid (20:0): Total population
Geometric mean and selected percentiles of plasma concentrations (in µmol/L) for the fasted U.S. population 
aged 20 years and older, National Health and Nutrition Examination Survey, 2003–2004. 
Geometric mean 
(95% conf. interval)
Selected percentiles (95% conf. interval) Sample 
size10th 50th 90th
Males and Females
Total, 20 years and older 23.4 (23.0 – 23.9) 17.6 (16.9 – 18.1) 23.2 (22.9 – 23.6) 31.2 (30.4 – 32.1) 1,757
20–39 years 22.2 (21.6 – 22.9) 16.6 (16.0 – 17.2) 22.1 (21.4 – 23.0) 29.5 (28.7 – 30.6) 592
40–59 years 23.9 (23.3 – 24.5) 18.3 (17.5 – 18.8) 23.5 (22.9 – 24.2) 31.4 (30.2 – 32.9) 500
60 years and older 24.8 (24.1 – 25.4) 18.5 (18.0 – 19.1) 24.9 (23.8 – 25.7) 32.9 (31.9 – 34.2) 665
Males
Total, 20 years and older 22.3 (21.8 – 22.8) 16.8 (16.0 – 17.5) 22.0 (21.7 – 22.3) 29.6 (29.0 – 31.0) 843
20–39 years 21.4 (20.6 – 22.3) 16.4 (15.2 – 17.1) 21.0 (20.5 – 21.8) 28.1 (26.1 – 31.6) 275
40–59 years 23.1 (22.2 – 23.9) 17.4 (16.6 – 18.0) 22.7 (22.0 – 23.8) 31.1 (29.2 – 32.1) 241
60 years and older 22.6 (22.1 – 23.0) 16.8 (15.8 – 18.1) 22.4 (21.8 – 23.0) 29.4 (28.9 – 30.4) 327
Females
Total, 20 years and older 24.5 (23.9 – 25.1) 18.7 (18.0 – 19.0) 24.3 (23.7 – 25.1) 32.3 (31.2 – 33.6) 914
20–39 years 23.1 (22.3 – 23.9) 16.9 (16.2 – 18.5) 23.4 (22.6 – 23.8) 30.1 (29.2 – 31.2) 317
40–59 years 24.6 (24.1 – 25.2) 18.9 (18.3 – 19.3) 24.2 (23.5 – 25.3) 32.6 (30.7 – 34.4) 259
60 years and older 26.7 (25.8 – 27.7) 20.1 (18.8 – 21.2) 26.9 (25.7 – 28.1) 35.4 (33.2 – 38.1) 338
Table 2.17.a.3. Plasma arachidic acid (20:0): Mexican Americans
Geometric mean and selected percentiles of plasma concentrations (in µmol/L) for fasted Mexican Americans in 
the U.S. population aged 20 years and older, National Health and Nutrition Examination Survey, 2003–2004. 
Geometric mean 
(95% conf. interval)
Selected percentiles (95% conf. interval) Sample 
size10th 50th 90th
Males and Females
Total, 20 years and older 22.5 (21.3 – 23.8) 16.9 (15.3 – 18.2) 22.4 (21.1 – 23.7) 29.6 (27.9 – 33.1) 367
20–39 years 22.2 (20.8 – 23.6) 16.5 (12.4 – 18.3) 21.8 (20.6 – 23.6) 29.5 (27.1 – 36.1) 130
40–59 years 23.0 (21.1 – 25.0) 16.9† (13.9 – 18.7) 23.0 (21.4 – 25.2) 30.6† (27.4 – 41.6) 91
60 years and older 22.7 (21.2 – 24.4) 17.4 (14.6 – 18.7) 22.9 (21.8 – 24.2) 29.3 (27.4 – 34.1) 146
Males
Total, 20 years and older 22.1 (20.6 – 23.7) 16.8 (9.37 – 18.3) 22.4 (20.5 – 23.8) 28.3 (26.9 – 32.7) 185
20–39 years 21.9 (20.2 – 23.9) 16.6† (11.7 – 19.0) 21.7 (19.6 – 23.9) 27.6† (24.5 – 36.3) 66
40–59 years 22.4 (19.9 – 25.3) 15.9† (12.5 – 19.1) 23.0 (19.4 – 25.4) 29.3† (26.8 – 31.9) 47
60 years and older 21.6 (19.5 – 24.0) 15.8† (9.37 – 18.7) 21.9 (20.2 – 24.7) 27.8† (25.5 – 32.7) 72
Females
Total, 20 years and older 23.0 (21.6 – 24.5) 16.8 (15.9 – 18.5) 22.5 (21.3 – 24.0) 31.0 (28.3 – 43.0) 182
20–39 years 22.5 (20.6 – 24.5) 16.4† (12.9 – 18.5) 21.8 (20.2 – 23.9) 29.7† (27.3 – 43.7) 64
40–59 years 23.6 (21.6 – 25.8) 17.3† (15.6 – 19.2) 22.8 (21.3 – 25.3) 31.8† (27.5 – 41.6) 44
60 years and older 23.8 (21.9 – 25.9) 18.5† (13.1 – 20.6) 23.9 (22.2 – 24.5) 30.2† (27.2 – 40.1) 74
† Estimate is subject to greater uncertainty due to small cell size. 
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Table 2.17.a.4. Plasma arachidic acid (20:0): Non-Hispanic blacks
Geometric mean and selected percentiles of plasma concentrations (in µmol/L) for fasted non-Hispanic blacks 
in the U.S. population aged 20 years and older, National Health and Nutrition Examination Survey, 2003–2004. 
Geometric mean 
(95% conf. interval)
Selected percentiles (95% conf. interval) Sample 
size10th 50th 90th
Males and Females
Total, 20 years and older 23.2 (22.1 – 24.3) 17.4 (15.9 – 18.4) 22.7 (21.9 – 23.5) 31.0 (29.3 – 33.1) 307
20–39 years 22.5 (21.3 – 23.8) 17.0 (13.7 – 18.5) 22.0 (21.4 – 22.8) 30.5 (28.0 – 34.0) 124
40–59 years 24.2 (22.6 – 25.8) 17.0† (15.3 – 19.1) 23.5 (22.5 – 25.2) 31.9† (29.4 – 35.9) 98
60 years and older 23.2 (21.7 – 24.7) 18.3† (15.4 – 18.8) 22.9 (21.1 – 25.6) 29.5† (28.3 – 35.6) 85
Males
Total, 20 years and older 22.4 (21.2 – 23.7) 15.9 (11.7 – 18.2) 21.5 (20.7 – 22.8) 31.2 (29.0 – 35.8) 142
20–39 years 21.4 (19.2 – 23.9) 14.9† (11.3 – 18.3) 20.7 (18.6 – 22.4) 31.2† (23.2 – 71.3) 57
40–59 years 24.3 (21.7 – 27.1) 16.1† (14.7 – 19.7) 23.1 (21.3 – 26.5) 31.7† (29.4 – 48.6) 42
60 years and older 21.6 (20.2 – 23.1) 15.5† (8.59 – 18.4) 21.2 (20.3 – 24.1) 27.9† (25.6 – 33.8) 43
Females
Total, 20 years and older 23.8 (22.6 – 25.1) 18.4 (16.2 – 19.9) 23.4 (22.2 – 25.1) 30.3 (28.7 – 34.8) 165
20–39 years 23.4 (22.0 – 25.0) 18.7† (14.9 – 20.5) 22.8 (21.9 – 25.3) 29.5† (27.8 – 32.5) 67
40–59 years 24.1 (22.7 – 25.6) 17.0† (14.8 – 20.5) 23.6 (21.8 – 25.8) 31.8† (27.7 – 54.9) 56
60 years and older 24.2 (21.5 – 27.1) 18.6† (14.3 – 20.6) 23.9 (19.8 – 29.5) 29.9† (29.3 – 37.1) 42
† Estimate is subject to greater uncertainty due to small cell size. 
Table 2.17.a.5. Plasma arachidic acid (20:0): Non-Hispanic whites
Geometric mean and selected percentiles of plasma concentrations (in µmol/L) for fasted non-Hispanic whites 
in the U.S. population aged 20 years and older, National Health and Nutrition Examination Survey, 2003–2004. 
Geometric mean 
(95% conf. interval)
Selected percentiles (95% conf. interval) Sample 
size10th 50th 90th
Males and Females
Total, 20 years and older 23.6 (23.0 – 24.2) 17.6 (16.7 – 18.4) 23.5 (22.9 – 24.0) 31.6 (30.6 – 32.6) 962
20–39 years 22.2 (21.3 – 23.1) 16.5 (15.4 – 17.0) 22.0 (20.9 – 23.5) 29.6 (28.3 – 31.3) 290
40–59 years 23.8 (23.1 – 24.6) 18.4 (17.4 – 19.3) 23.4 (22.9 – 24.1) 31.5 (29.9 – 34.3) 270
60 years and older 25.2 (24.6 – 25.9) 19.0 (18.0 – 19.4) 25.3 (24.4 – 26.4) 33.5 (32.2 – 35.6) 402
Males
Total, 20 years and older 22.4 (21.7 – 23.0) 16.7 (16.1 – 17.6) 22.0 (21.7 – 22.4) 29.8 (29.0 – 31.2) 460
20–39 years 21.2 (20.1 – 22.4) 16.3 (13.6 – 17.0) 20.8 (19.9 – 22.0) 28.5 (25.8 – 32.1) 125
40–59 years 23.0 (21.9 – 24.2) 17.6 (15.6 – 18.6) 22.5 (21.9 – 23.8) 31.1 (28.9 – 32.4) 136
60 years and older 22.9 (22.3 – 23.5) 16.9 (16.1 – 18.3) 22.8 (22.1 – 23.5) 29.6 (29.0 – 31.6) 199
Females
Total, 20 years and older 24.8 (24.0 – 25.7) 18.7 (17.7 – 19.1) 24.8 (23.8 – 25.7) 32.9 (31.4 – 35.6) 502
20–39 years 23.0 (21.9 – 24.3) 16.7 (15.9 – 17.7) 23.6 (22.3 – 24.4) 30.1 (29.3 – 31.3) 165
40–59 years 24.7 (24.0 – 25.5) 18.9 (18.2 – 19.7) 24.2 (23.3 – 25.5) 32.7 (30.5 – 37.1) 134
60 years and older 27.4 (26.4 – 28.4) 20.9 (19.1 – 21.7) 27.6 (26.5 – 28.8) 36.0 (33.6 – 38.6) 203
 




























































































































































































































































































































































































































































































































































































































































































































































































































































0 Non−Hispanic Blacks Non−Hispanic Whites 
Figure 2.18.a. Plasma docosanoic acid (22:0): Concentrations by age group 
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Table 2.18.a.2. Plasma docosanoic acid (22:0): Total population
Geometric mean and selected percentiles of plasma concentrations (in µmol/L) for the fasted U.S. population 
aged 20 years and older, National Health and Nutrition Examination Survey, 2003–2004. 
Geometric mean 
(95% conf. interval)
Selected percentiles (95% conf. interval) Sample 
size10th 50th 90th
Males and Females
Total, 20 years and older 69.3 (67.7 – 71.0) 50.1 (48.7 – 51.5) 69.5 (68.0 – 71.4) 95.3 (93.0 – 97.7) 1,739
20–39 years 66.5 (65.1 – 67.9) 49.7 (48.9 – 51.0) 66.5 (65.0 – 68.5) 89.5 (86.7 – 93.6) 589
40–59 years 71.8 (68.5 – 75.2) 51.9 (47.5 – 55.9) 74.0 (68.3 – 76.6) 96.4 (93.8 – 100) 496
60 years and older 70.2 (68.2 – 72.4) 49.1 (46.2 – 50.7) 70.9 (68.1 – 73.4) 100 (96.1 – 105) 654
Males
Total, 20 years and older 65.8 (64.0 – 67.7) 48.1 (45.1 – 49.7) 66.2 (64.2 – 68.3) 90.5 (88.2 – 92.5) 834
20–39 years 64.7 (62.6 – 66.8) 49.3 (46.8 – 51.2) 63.7 (61.0 – 66.2) 88.7 (82.6 – 93.6) 274
40–59 years 68.7 (65.3 – 72.2) 48.3 (43.0 – 51.4) 70.9 (66.0 – 74.5) 92.2 (89.0 – 96.9) 238
60 years and older 63.1 (60.8 – 65.5) 43.6 (40.8 – 47.0) 64.3 (60.6 – 67.9) 88.2 (85.2 – 91.7) 322
Females
Total, 20 years and older 72.8 (70.4 – 75.2) 52.4 (50.4 – 55.1) 73.7 (70.7 – 75.6) 98.7 (96.1 – 102) 905
20–39 years 68.3 (66.2 – 70.6) 50.9 (48.4 – 51.7) 69.4 (66.8 – 71.6) 91.4 (86.0 – 97.4) 315
40–59 years 74.9 (70.9 – 79.1) 56.6 (48.1 – 58.3) 76.5 (70.1 – 80.6) 99.0 (94.7 – 108) 258
60 years and older 76.6 (73.8 – 79.6) 54.1 (49.1 – 58.5) 75.7 (73.2 – 80.1) 107 (103 – 112) 332
Table 2.18.a.3. Plasma docosanoic acid (22:0): Mexican Americans
Geometric mean and selected percentiles of plasma concentrations (in µmol/L) for fasted Mexican Americans in 
the U.S. population aged 20 years and older, National Health and Nutrition Examination Survey, 2003–2004. 
Geometric mean 
(95% conf. interval)
Selected percentiles (95% conf. interval) Sample 
size10th 50th 90th
Males and Females
Total, 20 years and older 64.4 (61.3 – 67.7) 47.8 (41.7 – 51.6) 64.4 (60.9 – 67.4) 87.1 (81.5 – 95.4) 367
20–39 years 64.0 (60.8 – 67.4) 48.4 (42.0 – 50.6) 63.1 (59.7 – 66.8) 85.7 (80.1 – 95.4) 129
40–59 years 66.5 (61.6 – 71.8) 48.1† (35.5 – 55.5) 67.7 (64.3 – 71.7) 87.9† (80.6 – 106) 91
60 years and older 61.4 (56.4 – 66.9) 42.7 (38.6 – 47.2) 61.4 (59.8 – 64.2) 85.0 (74.6 – 120) 147
Males
Total, 20 years and older 64.0 (60.5 – 67.7) 48.2 (38.9 – 52.7) 64.4 (60.8 – 67.1) 85.2 (80.7 – 90.4) 185
20–39 years 65.2 (62.2 – 68.3) 49.6† (31.7 – 55.2) 63.8 (60.7 – 66.9) 86.8† (77.5 – 116) 65
40–59 years 63.1 (56.3 – 70.6) 44.8† (35.5 – 55.6) 65.0 (55.7 – 72.0) 81.4† (74.8 – 97.7) 47
60 years and older 59.6 (53.5 – 66.3) 38.8† (35.0 – 43.0) 61.3 (55.7 – 65.1) 87.6† (68.0 – 112) 73
Females
Total, 20 years and older 64.9 (60.6 – 69.6) 46.5 (41.2 – 50.7) 64.5 (59.9 – 71.3) 92.9 (79.5 – 120) 182
20–39 years 62.5 (57.1 – 68.4) 42.2† (38.2 – 50.3) 61.3 (55.1 – 70.9) 83.6† (76.3 – 97.3) 64
40–59 years 70.7 (65.1 – 76.6) 53.4† (37.4 – 57.1) 68.7 (65.7 – 76.7) 93.5† (85.0 – 106) 44
60 years and older 63.1 (56.5 – 70.6) 47.0† (34.0 – 54.2) 62.0 (57.9 – 66.5) 82.9† (75.2 – 116) 74
† Estimate is subject to greater uncertainty due to small cell size. 
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Table 2.18.a.4. Plasma docosanoic acid (22:0): Non-Hispanic blacks
Geometric mean and selected percentiles of plasma concentrations (in µmol/L) for fasted non-Hispanic blacks 
in the U.S. population aged 20 years and older, National Health and Nutrition Examination Survey, 2003–2004. 
Geometric mean 
(95% conf. interval)
Selected percentiles (95% conf. interval) Sample 
size10th 50th 90th
Males and Females
Total, 20 years and older 69.6 (66.5 – 73.0) 52.1 (46.8 – 53.9) 69.4 (64.3 – 74.7) 94.2 (91.4 – 101) 306
20–39 years 67.3 (63.9 – 70.8) 52.3 (42.4 – 54.1) 65.0 (62.8 – 71.2) 89.8 (86.7 – 97.6) 124
40–59 years 75.2 (70.9 – 79.7) 53.1† (42.9 – 59.2) 78.6 (71.7 – 82.9) 104† (91.6 – 118) 98
60 years and older 65.6 (61.9 – 69.5) 47.9† (27.8 – 53.2) 65.4 (61.9 – 68.1) 91.3† (81.1 – 118) 84
Males
Total, 20 years and older 66.1 (62.1 – 70.3) 47.6 (33.1 – 53.2) 64.6 (61.6 – 68.4) 90.2 (87.9 – 98.0) 141
20–39 years 63.5 (58.3 – 69.1) 49.2† (34.5 – 53.7) 61.5 (57.0 – 66.1) 86.6† (76.7 – 119) 57
40–59 years 73.0 (64.3 – 83.0) 44.8† (39.5 – 59.2) 74.5 (62.0 – 85.4) 93.5† (86.7 – 171) 42
60 years and older 59.6 (54.0 – 65.7) 41.2† (20.8 – 47.8) 60.2 (53.4 – 67.0) 81.3† (73.0 – 95.8) 42
Females
Total, 20 years and older 72.5 (69.2 – 76.0) 53.8 (50.3 – 56.1) 73.9 (66.3 – 78.4) 99.7 (91.4 – 106) 165
20–39 years 70.6 (65.5 – 76.0) 53.0† (40.9 – 57.0) 71.3 (63.1 – 79.9) 91.5† (88.3 – 96.2) 67
40–59 years 76.8 (72.5 – 81.4) 55.8† (43.3 – 61.0) 80.4 (72.4 – 84.5) 105† (91.6 – 117) 56
60 years and older 69.7 (62.7 – 77.4) 53.1† (41.5 – 55.8) 67.8 (59.0 – 76.7) 100† (79.0 – 123) 42
† Estimate is subject to greater uncertainty due to small cell size. 
Table 2.18.a.5. Plasma docosanoic acid (22:0): Non-Hispanic whites
Geometric mean and selected percentiles of plasma concentrations (in µmol/L) for fasted non-Hispanic whites 
in the U.S. population aged 20 years and older, National Health and Nutrition Examination Survey, 2003–2004. 
Geometric mean 
(95% conf. interval)
Selected percentiles (95% conf. interval) Sample 
size10th 50th 90th
Males and Females
Total, 20 years and older 70.4 (68.9 – 72.0) 50.8 (49.4 – 51.7) 70.9 (69.4 – 72.8) 96.4 (94.6 – 98.5) 947
20–39 years 67.1 (65.4 – 68.8) 49.9 (48.6 – 51.2) 68.1 (65.9 – 69.5) 90.6 (85.6 – 96.6) 288
40–59 years 72.3 (68.7 – 76.0) 52.1 (48.5 – 56.3) 74.3 (68.3 – 76.9) 96.5 (93.4 – 103) 267
60 years and older 72.3 (70.5 – 74.1) 50.1 (47.1 – 53.0) 72.5 (70.4 – 74.6) 102 (98.0 – 108) 392
Males
Total, 20 years and older 66.9 (64.8 – 69.0) 49.2 (46.5 – 51.0) 67.8 (65.4 – 69.6) 92.0 (88.7 – 94.5) 453
20–39 years 65.3 (62.5 – 68.2) 49.5 (44.6 – 51.7) 64.4 (61.8 – 68.6) 89.1 (80.8 – 97.3) 125
40–59 years 69.6 (66.0 – 73.4) 49.9 (41.9 – 55.0) 72.3 (66.0 – 75.2) 93.1 (90.8 – 96.8) 134
60 years and older 64.6 (61.6 – 67.7) 46.9 (43.1 – 49.4) 65.3 (62.4 – 69.7) 88.4 (85.6 – 92.0) 194
Females
Total, 20 years and older 73.9 (71.2 – 76.8) 52.8 (49.8 – 56.8) 74.4 (71.7 – 76.5) 99.3 (96.1 – 108) 494
20–39 years 68.8 (66.0 – 71.7) 51.0 (47.5 – 52.1) 69.4 (67.8 – 72.6) 92.8 (85.6 – 98.1) 163
40–59 years 75.0 (69.9 – 80.4) 56.4 (44.8 – 59.1) 76.5 (67.5 – 81.7) 98.6 (94.6 – 110) 133
60 years and older 79.5 (77.1 – 81.9) 57.0 (49.9 – 62.1) 78.5 (75.6 – 83.3) 109 (105 – 113) 198
 






































































































































































































































































































































































































































































































































































































































































































































































































































































Non−Hispanic Blacks Non−Hispanic Whites 
Figure 2.19.a. Plasma lignoceric acid (24:0): Concentrations by age group 
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Table 2.19.a.2. Plasma lignoceric acid (24:0): Total population
Geometric mean and selected percentiles of plasma concentrations (in µmol/L) for the fasted U.S. population 
aged 20 years and older, National Health and Nutrition Examination Survey, 2003–2004. 
Geometric mean 
(95% conf. interval)
Selected percentiles (95% conf. interval) Sample 
size10th 50th 90th
Males and Females
Total, 20 years and older 54.0 (52.8 – 55.3) 39.0 (37.4 – 40.6) 53.8 (52.6 – 55.6) 74.2 (72.2 – 76.4) 1,743
20–39 years 51.6 (50.3 – 53.0) 37.9 (36.6 – 39.6) 51.3 (49.8 – 52.9) 69.0 (66.5 – 71.8) 583
40–59 years 56.4 (54.2 – 58.7) 41.4 (37.9 – 43.7) 56.6 (54.1 – 59.6) 76.0 (72.9 – 79.2) 495
60 years and older 54.3 (52.7 – 56.0) 37.1 (33.6 – 39.5) 54.8 (52.4 – 57.5) 77.9 (76.4 – 81.4) 665
Males
Total, 20 years and older 53.7 (52.2 – 55.2) 39.1 (37.1 – 41.0) 53.7 (51.6 – 55.8) 72.6 (70.8 – 74.8) 836
20–39 years 53.1 (51.2 – 55.1) 39.5 (37.9 – 42.3) 52.1 (50.1 – 55.5) 70.9 (67.6 – 74.9) 272
40–59 years 56.3 (53.6 – 59.0) 41.1 (34.7 – 44.2) 56.1 (53.5 – 60.5) 75.1 (71.7 – 83.1) 238
60 years and older 50.3 (48.3 – 52.4) 33.6 (30.2 – 37.8) 50.4 (47.1 – 55.0) 70.2 (68.5 – 74.4) 326
Females
Total, 20 years and older 54.4 (52.6 – 56.2) 39.0 (36.5 – 41.6) 53.8 (52.7 – 56.1) 76.1 (72.5 – 78.4) 907
20–39 years 50.1 (48.7 – 51.6) 36.6 (34.8 – 37.9) 50.2 (48.9 – 51.9) 67.3 (64.9 – 69.6) 311
40–59 years 56.5 (53.9 – 59.3) 42.2 (39.0 – 43.6) 57.0 (53.5 – 60.0) 76.0 (72.2 – 79.6) 257
60 years and older 57.8 (55.5 – 60.2) 39.9 (35.3 – 42.3) 58.5 (55.2 – 61.3) 82.8 (78.9 – 89.0) 339
Table 2.19.a.3. Plasma lignoceric acid (24:0): Mexican Americans
Geometric mean and selected percentiles of plasma concentrations (in µmol/L) for fasted Mexican Americans in 
the U.S. population aged 20 years and older, National Health and Nutrition Examination Survey, 2003–2004. 
Geometric mean 
(95% conf. interval)
Selected percentiles (95% conf. interval) Sample 
size10th 50th 90th
Males and Females
Total, 20 years and older 50.4 (47.3 – 53.7) 37.1 (31.5 – 39.5) 50.1 (47.2 – 53.8) 69.4 (66.9 – 73.7) 355
20–39 years 50.1 (46.5 – 53.9) 37.1 (30.6 – 38.8) 49.2 (44.7 – 56.1) 68.7 (63.7 – 76.3) 120
40–59 years 52.5 (47.5 – 58.0) 38.8† (21.0 – 44.5) 53.3 (47.1 – 59.6) 71.6† (65.8 – 81.4) 89
60 years and older 46.7 (41.5 – 52.7) 33.0 (19.2 – 36.9) 47.1 (40.1 – 53.9) 66.4 (58.7 – 97.3) 146
Males
Total, 20 years and older 52.9 (49.2 – 56.9) 39.3 (33.0 – 43.1) 52.4 (48.7 – 56.2) 72.2 (67.8 – 77.5) 176
20–39 years 54.0 (50.3 – 58.1) 40.7† (37.8 – 44.4) 52.3 (48.1 – 57.7) 69.7† (63.8 – 84.8) 61
40–59 years 52.7 (45.9 – 60.5) 36.7† (28.8 – 45.9) 53.2 (46.0 – 60.5) 72.4† (65.3 – 81.2) 45
60 years and older 46.7 (40.9 – 53.4) 32.2† (19.2 – 36.7) 48.2 (38.4 – 54.3) 69.1† (55.8 – 89.1) 70
Females
Total, 20 years and older 47.6 (44.6 – 50.7) 32.6 (30.3 – 36.7) 46.5 (43.4 – 51.0) 67.8 (61.8 – 71.1) 179
20–39 years 45.3 (41.0 – 50.0) 32.0† (29.8 – 36.6) 43.2 (37.9 – 52.6) 64.6† (57.6 – 78.7) 59
40–59 years 52.2 (47.3 – 57.7) 39.2† (21.0 – 43.4) 53.3 (44.8 – 60.2) 69.6† (61.1 – 83.2) 44
60 years and older 46.7 (39.8 – 54.8) 34.7† (25.4 – 38.0) 45.3 (39.4 – 54.7) 63.8† (54.4 – 97.3) 76
† Estimate is subject to greater uncertainty due to small cell size. 
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Table 2.19.a.4. Plasma lignoceric acid (24:0): Non-Hispanic blacks
Geometric mean and selected percentiles of plasma concentrations (in µmol/L) for fasted non-Hispanic blacks 
in the U.S. population aged 20 years and older, National Health and Nutrition Examination Survey, 2003–2004. 
Geometric mean 
(95% conf. interval)
Selected percentiles (95% conf. interval) Sample 
size10th 50th 90th
Males and Females
Total, 20 years and older 53.3 (50.5 – 56.2) 38.6 (35.4 – 40.9) 53.1 (49.6 – 57.0) 71.8 (70.3 – 74.3) 302
20–39 years 51.2 (48.2 – 54.5) 37.2 (29.9 – 41.6) 49.9 (48.0 – 55.7) 67.9 (65.1 – 74.2) 123
40–59 years 57.6 (54.6 – 60.8) 40.9† (33.9 – 46.2) 58.1 (54.2 – 63.3) 73.0† (71.0 – 85.7) 95
60 years and older 50.9 (46.1 – 56.2) 37.3† (29.8 – 40.2) 50.8 (43.5 – 55.2) 74.1† (63.0 – 94.8) 84
Males
Total, 20 years and older 53.4 (50.0 – 56.9) 38.8 (27.0 – 43.3) 52.8 (49.1 – 58.6) 71.8 (68.1 – 80.6) 140
20–39 years 51.3 (47.2 – 55.7) 38.8† (26.2 – 43.5) 49.9 (46.3 – 55.9) 66.5† (63.1 – 83.8) 57
40–59 years 58.6 (52.1 – 65.9) 40.9† (32.2 – 48.9) 60.1 (50.6 – 70.1) 73.8† (70.1 – 112) 41
60 years and older 49.2 (44.5 – 54.4) 30.6† (24.0 – 40.9) 49.5 (44.5 – 54.7) 70.7† (62.3 – 79.1) 42
Females
Total, 20 years and older 53.2 (50.1 – 56.6) 38.2 (35.3 – 40.8) 53.3 (49.2 – 57.7) 72.0 (69.6 – 78.2) 162
20–39 years 51.2 (47.7 – 54.8) 36.8† (28.1 – 41.1) 49.7 (46.0 – 57.4) 69.3† (65.3 – 72.9) 66
40–59 years 56.8 (53.8 – 60.1) 39.9† (34.9 – 46.2) 56.6 (51.9 – 61.3) 72.2† (70.3 – 85.2) 54
60 years and older 52.0 (45.0 – 60.1) 39.7† (31.4 – 40.4) 52.4 (40.8 – 62.0) 78.2† (62.0 – 95.2) 42
† Estimate is subject to greater uncertainty due to small cell size. 
Table 2.19.a.5. Plasma lignoceric acid (24:0): Non-Hispanic whites
Geometric mean and selected percentiles of plasma concentrations (in µmol/L) for fasted non-Hispanic whites 
in the U.S. population aged 20 years and older, National Health and Nutrition Examination Survey, 2003–2004. 
Geometric mean 
(95% conf. interval)
Selected percentiles (95% conf. interval) Sample 
size10th 50th 90th
Males and Females
Total, 20 years and older 54.7 (53.4 – 56.0) 39.6 (37.7 – 41.6) 54.8 (53.0 – 56.5) 75.3 (73.0 – 77.3) 966
20–39 years 51.8 (50.1 – 53.6) 37.9 (35.9 – 41.2) 51.5 (49.4 – 53.9) 68.9 (66.0 – 72.6) 293
40–59 years 56.7 (54.2 – 59.3) 42.0 (38.6 – 43.2) 57.0 (53.6 – 60.8) 76.4 (72.8 – 80.8) 270
60 years and older 55.7 (54.1 – 57.3) 38.2 (33.4 – 41.0) 56.3 (54.0 – 58.6) 78.7 (76.9 – 82.3) 403
Males
Total, 20 years and older 54.1 (52.5 – 55.8) 39.4 (36.1 – 41.8) 54.7 (51.8 – 56.5) 72.8 (70.5 – 77.2) 461
20–39 years 53.2 (50.5 – 56.0) 39.4 (35.8 – 42.8) 52.5 (49.5 – 56.8) 70.5 (66.0 – 82.9) 126
40–59 years 56.9 (53.9 – 60.0) 42.1 (35.0 – 44.7) 57.1 (53.1 – 61.8) 76.6 (71.7 – 85.9) 135
60 years and older 51.1 (48.6 – 53.8) 34.8 (29.7 – 39.0) 51.4 (47.1 – 56.4) 70.2 (68.4 – 75.8) 200
Females
Total, 20 years and older 55.2 (53.1 – 57.4) 39.7 (36.6 – 42.5) 55.1 (53.0 – 57.3) 76.6 (74.2 – 79.2) 505
20–39 years 50.6 (48.5 – 52.8) 36.7 (32.4 – 41.2) 51.3 (48.6 – 53.2) 67.3 (64.8 – 69.9) 167
40–59 years 56.5 (53.2 – 59.9) 41.8 (38.2 – 43.1) 56.9 (53.0 – 62.0) 76.4 (71.8 – 81.2) 135
60 years and older 59.9 (57.8 – 62.0) 40.9 (36.7 – 44.9) 60.4 (58.3 – 62.5) 85.4 (79.9 – 91.5) 203
 











































































































































































































































































































































































































































































































































































































































































































































































































































































Non−Hispanic Blacks Non−Hispanic Whites 
Figure 2.20.a. Plasma myristoleic acid (14:1n–5): Concentrations by age group 
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Table 2.20.a.2. Plasma myristoleic acid (14:1n-5): Total population
Geometric mean and selected percentiles of plasma concentrations (in µmol/L) for the fasted U.S. population 
aged 20 years and older, National Health and Nutrition Examination Survey, 2003–2004. 
Geometric mean 
(95% conf. interval)
Selected percentiles (95% conf. interval) Sample 
size10th 50th 90th
Males and Females
Total, 20 years and older 6.57 (6.08 – 7.09) 2.41 (2.26 – 2.59) 6.50 (5.90 – 6.99) 18.5 (16.7 – 20.5) 1,808
20–39 years 6.21 (5.67 – 6.80) 2.33 (2.08 – 2.52) 6.05 (5.34 – 6.75) 16.9 (14.8 – 20.4) 610
40–59 years 7.06 (6.30 – 7.90) 2.53 (2.20 – 2.94) 6.87 (6.20 – 7.62) 19.6 (18.0 – 22.2) 515
60 years and older 6.39 (5.61 – 7.26) 2.43 (2.04 – 2.89) 6.40 (5.53 – 7.45) 17.3 (13.1 – 23.4) 683
Males
Total, 20 years and older 6.35 (5.70 – 7.07) 2.20 (2.01 – 2.35) 6.47 (5.47 – 7.28) 18.5 (16.5 – 21.2) 865
20–39 years 6.08 (5.23 – 7.08) 2.10 (2.03 – 2.33) 6.09 (5.00 – 7.32) 16.9 (14.5 – 23.9) 282
40–59 years 7.02 (6.06 – 8.12) 2.27 (1.80 – 2.81) 6.98 (5.49 – 8.66) 21.0 (18.5 – 26.2) 248
60 years and older 5.74 (5.08 – 6.48) 2.26 (1.68 – 2.61) 5.82 (5.44 – 6.42) 13.7 (10.9 – 20.0) 335
Females
Total, 20 years and older 6.77 (6.26 – 7.32) 2.73 (2.52 – 2.96) 6.51 (5.96 – 6.96) 18.4 (15.3 – 21.6) 943
20–39 years 6.34 (5.67 – 7.08) 2.62 (2.06 – 2.94) 5.91 (5.31 – 6.92) 17.2 (13.9 – 22.4) 328
40–59 years 7.09 (6.37 – 7.90) 2.87 (2.39 – 3.40) 6.81 (6.29 – 7.17) 18.7 (13.8 – 23.3) 267
60 years and older 6.97 (5.87 – 8.26) 2.91 (1.76 – 3.22) 6.89 (5.55 – 8.06) 20.0 (16.1 – 23.8) 348
Table 2.20.a.3. Plasma myristoleic acid (14:1n-5): Mexican Americans
Geometric mean and selected percentiles of plasma concentrations (in µmol/L) for fasted Mexican Americans in 
the U.S. population aged 20 years and older, National Health and Nutrition Examination Survey, 2003–2004. 
Geometric mean 
(95% conf. interval)
Selected percentiles (95% conf. interval) Sample 
size10th 50th 90th
Males and Females
Total, 20 years and older 6.95 (5.89 – 8.20) 2.26 (1.82 – 2.82) 6.83 (5.44 – 8.30) 19.4 (17.2 – 22.5) 376
20–39 years 6.79 (5.03 – 9.17) 2.11 (1.71 – 2.75) 6.39 (4.79 – 9.10) 18.7 (15.2 – 32.7) 132
40–59 years 7.17 (5.73 – 8.97) 2.48† (1.66 – 2.92) 6.96 (5.46 – 9.72) 20.0† (16.1 – 32.0) 93
60 years and older 7.30 (6.27 – 8.49) 3.03 (2.65 – 3.26) 7.48 (5.22 – 9.67) 16.7 (14.6 – 24.9) 151
Males
Total, 20 years and older 6.79 (5.24 – 8.79) 2.27 (1.79 – 2.93) 6.58 (4.63 – 8.66) 20.0 (15.8 – 24.9) 189
20–39 years 6.79 (4.48 – 10.3) 2.15† (1.85 – 2.42) 6.56 (3.74 – 11.8) 20.2† (15.3 – 42.7) 67
40–59 years 7.08 (4.81 – 10.4) 2.69† (1.87 – 3.06) 6.77 (3.71 – 12.3) 18.8† (14.0 – 52.0) 48
60 years and older 5.90 (4.57 – 7.62) 2.72† (1.76 – 3.30) 5.60 (3.54 – 8.59) 13.6† (9.90 – 18.3) 74
Females
Total, 20 years and older 7.16 (6.00 – 8.55) 2.03 (1.53 – 3.55) 6.86 (5.60 – 9.13) 18.7 (16.3 – 23.9) 187
20–39 years 6.78 (4.95 – 9.30) 1.96† (1.51 – 3.90) 6.02 (4.64 – 9.28) 16.3† (12.9 – 156) 65
40–59 years 7.27 (5.08 – 10.4) 1.93† (1.62 – 2.55) 7.32 (3.75 – 13.4) 22.2† (16.4 – 30.1) 45
60 years and older 8.88 (7.36 – 10.7) 3.63† (2.33 – 4.14) 9.24 (7.46 – 12.9) 17.4† (14.8 – 43.2) 77
† Estimate is subject to greater uncertainty due to small cell size. 
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Table 2.20.a.4. Plasma myristoleic acid (14:1n-5): Non-Hispanic blacks
Geometric mean and selected percentiles of plasma concentrations (in µmol/L) for fasted non-Hispanic blacks 
in the U.S. population aged 20 years and older, National Health and Nutrition Examination Survey, 2003–2004. 
Geometric mean 
(95% conf. interval)
Selected percentiles (95% conf. interval) Sample 
size10th 50th 90th
Males and Females
Total, 20 years and older 3.91 (3.50 – 4.38) 1.48 (1.28 – 1.69) 3.78 (3.17 – 4.49) 10.4 (8.24 – 12.7) 310
20–39 years 3.95 (3.33 – 4.70) 1.68 (1.29 – 1.90) 3.54 (3.05 – 4.70) 10.2 (7.80 – 12.7) 126
40–59 years 4.07 (3.55 – 4.66) 1.44† (1.07 – 1.66) 4.21 (2.82 – 4.90) 11.7† (8.28 – 21.4) 98
60 years and older 3.51 (3.15 – 3.92) 1.30† (1.07 – 1.63) 3.37 (2.94 – 4.54) 9.13† (7.34 – 11.4) 86
Males
Total, 20 years and older 3.95 (3.24 – 4.80) 1.23 (1.06 – 1.46) 4.23 (2.79 – 4.93) 11.3 (8.12 – 21.6) 143
20–39 years 3.99 (2.96 – 5.36) 1.37† (.992 – 1.92) 3.41 (2.61 – 5.34) 10.7† (7.65 – 61.3) 58
40–59 years 4.30 (3.03 – 6.10) 1.08† (.703 – 1.28) 4.74 (4.11 – 6.89) 12.4† (8.22 – 24.7) 42
60 years and older 3.13 (2.27 – 4.32) 1.30† (1.16 – 1.49) 2.53 (1.60 – 5.17) 8.55† (6.21 – 14.2) 43
Females
Total, 20 years and older 3.89 (3.46 – 4.37) 1.70 (1.43 – 2.07) 3.60 (3.10 – 4.46) 8.84 (7.45 – 12.7) 167
20–39 years 3.93 (3.38 – 4.56) 1.77† (1.45 – 1.94) 3.65 (3.11 – 4.77) 8.32† (6.65 – 12.6) 68
40–59 years 3.90 (3.15 – 4.82) 1.66† (1.44 – 2.21) 3.42 (2.47 – 4.70) 8.90† (7.34 – 19.3) 56
60 years and older 3.78 (3.23 – 4.42) 1.25† (.999 – 2.33) 3.54 (3.09 – 4.69) 9.24† (5.98 – 19.5) 43
† Estimate is subject to greater uncertainty due to small cell size. 
Table 2.20.a.5. Plasma myristoleic acid (14:1n-5): Non-Hispanic whites
Geometric mean and selected percentiles of plasma concentrations (in µmol/L) for fasted non-Hispanic whites 
in the U.S. population aged 20 years and older, National Health and Nutrition Examination Survey, 2003–2004. 
Geometric mean 
(95% conf. interval)
Selected percentiles (95% conf. interval) Sample 
size10th 50th 90th
Males and Females
Total, 20 years and older 7.07 (6.45 – 7.74) 2.83 (2.49 – 3.02) 6.84 (6.22 – 7.46) 19.5 (16.9 – 23.0) 992
20–39 years 6.97 (6.26 – 7.77) 2.79 (2.35 – 3.08) 6.61 (5.91 – 7.53) 18.5 (15.1 – 24.6) 300
40–59 years 7.39 (6.43 – 8.48) 2.87 (2.24 – 3.54) 6.97 (6.17 – 7.94) 19.8 (17.0 – 26.7) 280
60 years and older 6.72 (5.80 – 7.78) 2.63 (2.26 – 3.01) 6.72 (5.74 – 7.72) 17.9 (13.8 – 23.5) 412
Males
Total, 20 years and older 6.84 (6.01 – 7.79) 2.47 (2.07 – 2.86) 6.77 (5.68 – 7.91) 18.7 (16.9 – 22.7) 472
20–39 years 6.84 (5.71 – 8.20) 2.39 (2.03 – 2.95) 6.53 (5.25 – 8.27) 17.0 (14.4 – 31.7) 128
40–59 years 7.31 (6.16 – 8.67) 2.49 (1.82 – 2.96) 7.03 (4.70 – 10.4) 21.0 (18.1 – 27.6) 140
60 years and older 6.13 (5.25 – 7.15) 2.43 (1.75 – 2.89) 6.36 (5.73 – 6.86) 15.9 (11.0 – 23.9) 204
Females
Total, 20 years and older 7.28 (6.68 – 7.93) 3.16 (2.81 – 3.49) 6.86 (6.52 – 7.22) 19.6 (15.9 – 23.8) 520
20–39 years 7.09 (5.99 – 8.39) 2.94 (2.37 – 3.49) 6.67 (5.66 – 8.11) 19.0 (14.7 – 28.0) 172
40–59 years 7.46 (6.48 – 8.59) 3.56 (2.06 – 4.04) 6.84 (6.33 – 7.23) 18.9 (13.4 – 43.3) 140
60 years and older 7.27 (5.90 – 8.94) 3.01 (1.59 – 3.69) 7.09 (5.55 – 8.67) 20.7 (17.0 – 25.2) 208






































































































































































































































































































































































































































































































































































































































































































































































































































0 Non−Hispanic Blacks Non−Hispanic Whites 
Figure 2.21.a. Plasma palmitoleic acid (16:1n–7): Concentrations by age group 
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Table 2.21.a.2. Plasma palmitoleic acid (16:1n-7): Total population
Geometric mean and selected percentiles of plasma concentrations (in µmol/L) for the fasted U.S. population 
aged 20 years and older, National Health and Nutrition Examination Survey, 2003–2004. 
Geometric mean 
(95% conf. interval)
Selected percentiles (95% conf. interval) Sample 
size10th 50th 90th
Males and Females
Total, 20 years and older 217 (205 – 229) 105 (97.7 – 109) 213 (196 – 230) 454 (424 – 497) 1,805
20–39 years 195 (185 – 205) 92.3 (86.5 – 98.3) 185 (173 – 194) 411 (357 – 472) 610
40–59 years 228 (210 – 248) 106 (92.9 – 118) 228 (206 – 251) 475 (444 – 549) 514
60 years and older 238 (220 – 259) 122 (111 – 135) 241 (216 – 263) 467 (429 – 540) 681
Males
Total, 20 years and older 207 (190 – 225) 92.6 (84.0 – 98.9) 203 (182 – 225) 456 (400 – 525) 863
20–39 years 192 (171 – 215) 83.9 (76.9 – 93.8) 185 (169 – 211) 410 (344 – 542) 282
40–59 years 223 (198 – 251) 97.4 (78.0 – 108) 218 (184 – 273) 501 (450 – 594) 248
60 years and older 207 (191 – 224) 112 (92.6 – 121) 206 (186 – 228) 386 (339 – 450) 333
Females
Total, 20 years and older 226 (214 – 239) 114 (108 – 123) 226 (204 – 243) 453 (421 – 525) 942
20–39 years 197 (185 – 211) 108 (92.2 – 111) 184 (170 – 199) 406 (352 – 495) 328
40–59 years 233 (217 – 250) 126 (99.4 – 133) 231 (213 – 256) 455 (395 – 534) 266
60 years and older 267 (240 – 298) 137 (115 – 150) 271 (242 – 297) 537 (493 – 585) 348
Table 2.21.a.3. Plasma palmitoleic acid (16:1n-7): Mexican Americans
Geometric mean and selected percentiles of plasma concentrations (in µmol/L) for fasted Mexican Americans in 
the U.S. population aged 20 years and older, National Health and Nutrition Examination Survey, 2003–2004. 
Geometric mean 
(95% conf. interval)
Selected percentiles (95% conf. interval) Sample 
size10th 50th 90th
Males and Females
Total, 20 years and older 240 (209 – 277) 101 (64.3 – 131) 239 (204 – 281) 571 (498 – 645) 375
20–39 years 223 (181 – 274) 95.2 (60.0 – 129) 221 (175 – 274) 498 (386 – 737) 132
40–59 years 267 (232 – 307) 117† (79.8 – 143) 250 (233 – 272) 639† (545 – 804) 93
60 years and older 277 (262 – 292) 144 (136 – 158) 281 (250 – 308) 510 (446 – 587) 150
Males
Total, 20 years and older 237 (192 – 292) 96.0 (61.6 – 134) 226 (178 – 290) 578 (489 – 687) 188
20–39 years 225 (169 – 300) 92.8† (61.6 – 130) 215 (153 – 314) 519† (406 – 844) 67
40–59 years 267 (194 – 367) 111† (79.8 – 150) 240 (190 – 353) 715† (438 – 942) 48
60 years and older 230 (192 – 276) 131† (64.1 – 158) 223 (180 – 280) 375† (309 – 876) 73
Females
Total, 20 years and older 245 (207 – 291) 110 (61.1 – 132) 248 (188 – 316) 558 (421 – 749) 187
20–39 years 220 (172 – 281) 98.4† (60.0 – 130) 225 (161 – 293) 449† (352 – 1,110) 65
40–59 years 267 (204 – 350) 119† (88.5 – 144) 252 (148 – 396) 613† (517 – 766) 45
60 years and older 328 (284 – 378) 166† (120 – 215) 353 (281 – 398) 528† (469 – 739) 77
† Estimate is subject to greater uncertainty due to small cell size. 
2311. Water-Soluble Vitamins 2312. Fat-Soluble Vitamins & Nutrient
Table 2.21.a.4. Plasma palmitoleic acid (16:1n-7): Non-Hispanic blacks
Geometric mean and selected percentiles of plasma concentrations (in µmol/L) for fasted non-Hispanic blacks 
in the U.S. population aged 20 years and older, National Health and Nutrition Examination Survey, 2003–2004. 
Geometric mean 
(95% conf. interval)
Selected percentiles (95% conf. interval) Sample
10th 50th 90th size
Males and Females
Total, 20 years and older 157 (148 – 167) 78.0 (72.0 – 84.1) 151 (142 – 162) 326 (270 – 421) 310
20–39 years 149 (136 – 164) 78.7 (71.8 – 85.0) 148 (126 – 164) 309 (221 – 430) 126
40–59 years 161 (144 – 180) 72.4† (65.0 – 82.5) 149 (135 – 175) 333† (288 – 508) 98
60 years and older 171 (155 – 189) 89.5† (61.4 – 102) 171 (152 – 193) 316† (265 – 397) 86
Males
Total, 20 years and older 154 (138 – 172) 74.0 (53.3 – 82.4) 157 (132 – 174) 323 (267 – 437) 143
20–39 years 146 (126 – 169) 71.0† (47.0 – 79.4) 145 (122 – 168) 305† (220 – 863) 58
40–59 years 163 (128 – 206) 72.7† (42.6 – 81.3) 168 (115 – 204) 371† (231 – 814) 42
60 years and older 164 (130 – 205) 98.3† (60.8 – 114) 152 (123 – 206) 280† (222 – 430) 43
Females
Total, 20 years and older 159 (142 – 178) 84.4 (71.0 – 90.6) 149 (134 – 172) 331 (254 – 494) 167
20–39 years 152 (132 – 175) 85.4† (75.5 – 94.4) 147 (121 – 167) 314† (190 – 543) 68
40–59 years 160 (134 – 190) 71.3† (58.4 – 86.2) 144 (112 – 205) 317† (255 – 1,360) 56
60 years and older 176 (150 – 205) 89.4† (49.9 – 104) 178 (142 – 235) 322† (251 – 548) 43
† Estimate is subject to greater uncertainty due to small cell size. 
Table 2.21.a.5. Plasma palmitoleic acid (16:1n-7): Non-Hispanic whites
Geometric mean and selected percentiles of plasma concentrations (in µmol/L) for fasted non-Hispanic whites 
in the U.S. population aged 20 years and older, National Health and Nutrition Examination Survey, 2003–2004. 
Geometric mean 
(95% conf. interval)
Selected percentiles (95% conf. interval) Sample 
size10th 50th 90th
Males and Females
Total, 20 years and older 221 (208 – 236) 109 (99.2 – 116) 221 (201 – 237) 453 (411 – 498) 990
20–39 years 199 (184 – 215) 95.5 (84.0 – 109) 191 (174 – 207) 406 (348 – 496) 300
40–59 years 229 (208 – 251) 107 (96.8 – 126) 230 (214 – 253) 462 (409 – 525) 279
60 years and older 243 (221 – 267) 125 (114 – 136) 247 (219 – 272) 484 (415 – 556) 411
Males
Total, 20 years and older 208 (189 – 229) 95.8 (81.2 – 108) 202 (182 – 231) 447 (386 – 520) 471
20–39 years 190 (164 – 221) 83.9 (69.1 – 97.2) 185 (159 – 215) 359 (319 – 554) 128
40–59 years 222 (196 – 252) 98.2 (74.3 – 111) 223 (175 – 277) 470 (410 – 582) 140
60 years and older 211 (192 – 232) 113 (92.1 – 124) 201 (182 – 241) 392 (343 – 481) 203
Females
Total, 20 years and older 234 (219 – 249) 122 (108 – 133) 232 (220 – 250) 455 (408 – 538) 519
20–39 years 206 (187 – 228) 109 (91.9 – 118) 194 (173 – 221) 414 (346 – 644) 172
40–59 years 235 (216 – 256) 130 (99.9 – 146) 239 (220 – 257) 452 (362 – 532) 139
60 years and older 273 (238 – 314) 138 (108 – 165) 274 (243 – 303) 550 (460 – 661) 208
 





































































































































































































































































































































































































































































































































































































































































































































































































































0 Non−Hispanic Blacks Non−Hispanic Whites 
Figure 2.22.a. Plasma cis−vaccenic acid (18:1n–7): Concentrations by age group 

















































20−39 40−59 60+ 20−39 40−59 60+ 
Females Males 







Age (years) Age (years) 
20−39 40−59 60+ 
2. Fat-Soluble 1. WaterVitamins & Nutr-Soluble Vitaminsient  2332 3
234 2nd National Report on Biochemical Indicators of Diet and Nutrition in the U.S. Population234
Table 2.22.a.2. Plasma cis-vaccenic acid (18:1n-7): Total population
Geometric mean and selected percentiles of plasma concentrations (in µmol/L) for the fasted U.S. population 
aged 20 years and older, National Health and Nutrition Examination Survey, 2003–2004. 
Geometric mean 
(95% conf. interval)
Selected percentiles (95% conf. interval) Sample 
size10th 50th 90th
Males and Females
Total, 20 years and older 146 (141 – 150) 95.1 (89.2 – 99.8) 143 (139 – 148) 225 (216 – 234) 1,762
20–39 years 131 (126 – 138) 87.0 (78.0 – 93.7) 129 (122 – 137) 200 (190 – 215) 589
40–59 years 148 (143 – 154) 99.9 (92.1 – 104) 144 (139 – 150) 229 (211 – 262) 501
60 years and older 168 (162 – 173) 113 (107 – 119) 166 (162 – 172) 242 (231 – 259) 672
Males
Total, 20 years and older 145 (139 – 151) 95.1 (87.8 – 102) 141 (135 – 148) 222 (210 – 241) 845
20–39 years 132 (126 – 139) 87.9 (73.4 – 94.8) 129 (123 – 138) 197 (184 – 222) 273
40–59 years 149 (139 – 160) 99.8 (85.5 – 105) 146 (133 – 159) 240 (208 – 301) 242
60 years and older 160 (153 – 167) 109 (97.2 – 117) 161 (150 – 168) 226 (215 – 258) 330
Females
Total, 20 years and older 147 (141 – 153) 95.0 (88.5 – 99.8) 145 (139 – 151) 227 (213 – 238) 917
20–39 years 131 (123 – 139) 85.8 (78.0 – 92.8) 129 (119 – 138) 203 (190 – 222) 316
40–59 years 147 (140 – 154) 99.8 (87.5 – 105) 144 (139 – 147) 219 (187 – 301) 259
60 years and older 174 (166 – 181) 117 (107 – 127) 172 (163 – 182) 248 (237 – 273) 342
Table 2.22.a.3. Plasma cis-vaccenic acid (18:1n-7): Mexican Americans
Geometric mean and selected percentiles of plasma concentrations (in µmol/L) for fasted Mexican Americans in 
the U.S. population aged 20 years and older, National Health and Nutrition Examination Survey, 2003–2004. 
Geometric mean 
(95% conf. interval)
Selected percentiles (95% conf. interval) Sample 
size10th 50th 90th
Males and Females
Total, 20 years and older 152 (138 – 166) 97.2 (66.3 – 108) 146 (136 – 164) 240 (222 – 324) 373
20–39 years 140 (125 – 157) 83.4 (55.7 – 108) 140 (125 – 154) 226 (188 – 347) 130
40–59 years 168 (146 – 192) 102† (90.0 – 110) 157 (145 – 183) 270† (240 – 375) 92
60 years and older 179 (171 – 187) 123 (73.1 – 139) 177 (169 – 184) 277 (247 – 310) 151
Males
Total, 20 years and older 151 (130 – 176) 94.6 (58.1 – 111) 144 (127 – 178) 255 (217 – 331) 187
20–39 years 139 (117 – 166) 83.3† (58.1 – 108) 136 (117 – 168) 224† (179 – 350) 66
40–59 years 175 (142 – 216) 103† (88.8 – 127) 159 (139 – 212) 321† (229 – 454) 47
60 years and older 167 (142 – 197) 101† (68.8 – 140) 155 (140 – 209) 263† (217 – 634) 74
Females
Total, 20 years and older 152 (142 – 162) 97.2 (72.8 – 104) 153 (137 – 167) 235 (222 – 261) 186
20–39 years 141 (124 – 160) 87.7† (57.9 – 102) 144 (113 – 169) 221† (186 – 410) 64
40–59 years 159 (133 – 191) 98.6† (81.2 – 109) 151 (125 – 188) 246† (197 – 421) 45
60 years and older 190 (173 – 210) 130† (110 – 142) 187 (165 – 214) 284† (228 – 375) 77
† Estimate is subject to greater uncertainty due to small cell size. 
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Table 2.22.a.4. Plasma cis-vaccenic acid (18:1n-7): Non-Hispanic blacks
Geometric mean and selected percentiles of plasma concentrations (in µmol/L) for fasted non-Hispanic blacks 
in the U.S. population aged 20 years and older, National Health and Nutrition Examination Survey, 2003–2004. 
Geometric mean 
(95% conf. interval)
Selected percentiles (95% conf. interval) Sample 
size10th 50th 90th
Males and Females
Total, 20 years and older 129 (120 – 138) 82.6 (74.8 – 88.4) 125 (117 – 134) 202 (186 – 225) 305
20–39 years 119 (107 – 134) 80.5 (63.7 – 84.9) 112 (99.8 – 134) 184 (155 – 395) 124
40–59 years 133 (121 – 146) 80.1† (69.5 – 89.8) 124 (118 – 135) 204† (187 – 266) 96
60 years and older 151 (145 – 157) 108† (99.6 – 115) 143 (141 – 147) 218† (191 – 303) 85
Males
Total, 20 years and older 129 (119 – 139) 79.8 (71.9 – 84.8) 124 (117 – 134) 205 (185 – 235) 141
20–39 years 118 (104 – 133) 72.2† (54.1 – 82.8) 114 (89.0 – 136) 185† (136 – 435) 57
40–59 years 136 (117 – 158) 80.3† (69.7 – 90.3) 121 (117 – 132) 221† (188 – 409) 41
60 years and older 151 (136 – 168) 108† (89.1 – 116) 147 (136 – 168) 217† (179 – 250) 43
Females
Total, 20 years and older 129 (116 – 143) 84.9 (67.1 – 94.9) 126 (111 – 139) 197 (165 – 284) 164
20–39 years 121 (102 – 142) 82.6† (56.8 – 94.3) 111 (99.1 – 140) 177† (153 – 284) 67
40–59 years 130 (117 – 145) 76.7† (66.9 – 92.1) 128 (115 – 136) 197† (163 – 575) 55
60 years and older 150 (139 – 162) 108† (102 – 124) 141 (136 – 148) 214† (180 – 323) 42
† Estimate is subject to greater uncertainty due to small cell size. 
Table 2.22.a.5. Plasma cis-vaccenic acid (18:1n-7): Non-Hispanic whites
Geometric mean and selected percentiles of plasma concentrations (in µmol/L) for fasted non-Hispanic whites 
in the U.S. population aged 20 years and older, National Health and Nutrition Examination Survey, 2003–2004. 
Geometric mean 
(95% conf. interval)
Selected percentiles (95% conf. interval) Sample 
size10th 50th 90th
Males and Females
Total, 20 years and older 146 (140 – 152) 95.8 (89.8 – 102) 144 (139 – 149) 222 (211 – 234) 958
20–39 years 131 (123 – 139) 88.8 (70.0 – 95.5) 127 (120 – 138) 200 (183 – 218) 285
40–59 years 145 (139 – 153) 100 (89.1 – 104) 144 (137 – 149) 219 (199 – 244) 270
60 years and older 168 (162 – 174) 113 (106 – 117) 167 (162 – 172) 247 (231 – 261) 403
Males
Total, 20 years and older 144 (138 – 150) 96.3 (89.6 – 103) 141 (132 – 149) 217 (205 – 240) 456
20–39 years 131 (122 – 140) 92.8 (67.7 – 97.1) 125 (117 – 139) 185 (173 – 229) 121
40–59 years 145 (135 – 156) 99.8 (84.1 – 105) 144 (127 – 158) 224 (203 – 276) 136
60 years and older 161 (153 – 169) 109 (95.0 – 116) 163 (151 – 170) 229 (216 – 260) 199
Females
Total, 20 years and older 148 (141 – 154) 95.6 (87.9 – 103) 147 (141 – 152) 226 (209 – 240) 502
20–39 years 131 (122 – 141) 87.7 (61.8 – 95.4) 130 (121 – 139) 204 (187 – 234) 164
40–59 years 146 (137 – 155) 100 (86.2 – 105) 144 (139 – 148) 212 (180 – 322) 134
60 years and older 174 (166 – 183) 116 (103 – 128) 171 (162 – 183) 253 (235 – 279) 204
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Figure 2.23.a. Plasma oleic acid (18:1n–9): Concentrations by age group 
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Table 2.23.a.2. Plasma oleic acid (18:1n-9): Total population
Geometric mean and selected percentiles of plasma concentrations (in µmol/L) for the fasted U.S. population 
aged 20 years and older, National Health and Nutrition Examination Survey, 2003–2004. 
Geometric mean 
(95% conf. interval)
Selected percentiles (95% conf. interval) Sample 
size10th 50th 90th
Males and Females
Total, 20 years and older 2,100 (2,050 – 2,150) 1,360 (1,310 – 1,400) 2,070 (2,000 – 2,150) 3,230 (3,090 – 3,440) 1,798
20–39 years 1,910 (1,840 – 1,980) 1,240 (1,200 – 1,300) 1,840 (1,750 – 1,970) 2,900 (2,710 – 3,160) 608
40–59 years 2,160 (2,100 – 2,230) 1,410 (1,350 – 1,530) 2,120 (2,010 – 2,190) 3,380 (3,100 – 3,660) 512
60 years and older 2,360 (2,290 – 2,440) 1,630 (1,550 – 1,690) 2,380 (2,290 – 2,450) 3,360 (3,200 – 3,640) 678
Males
Total, 20 years and older 2,140 (2,060 – 2,220) 1,360 (1,310 – 1,410) 2,100 (2,010 – 2,200) 3,340 (3,060 – 3,660) 858
20–39 years 1,960 (1,850 – 2,080) 1,240 (1,220 – 1,310) 1,890 (1,770 – 2,060) 2,950 (2,640 – 3,700) 281
40–59 years 2,250 (2,120 – 2,400) 1,410 (1,310 – 1,550) 2,200 (1,970 – 2,350) 3,580 (3,180 – 4,480) 247
60 years and older 2,310 (2,220 – 2,400) 1,600 (1,400 – 1,730) 2,340 (2,170 – 2,420) 3,310 (3,040 – 3,850) 330
Females
Total, 20 years and older 2,070 (2,000 – 2,140) 1,380 (1,300 – 1,410) 2,020 (1,940 – 2,140) 3,180 (2,960 – 3,370) 940
20–39 years 1,860 (1,790 – 1,940) 1,220 (1,140 – 1,300) 1,780 (1,700 – 1,940) 2,820 (2,570 – 3,620) 327
40–59 years 2,080 (2,000 – 2,160) 1,400 (1,330 – 1,520) 2,000 (1,920 – 2,140) 3,100 (2,830 – 3,700) 265
60 years and older 2,410 (2,280 – 2,530) 1,660 (1,480 – 1,740) 2,430 (2,270 – 2,530) 3,410 (3,260 – 3,820) 348
Table 2.23.a.3. Plasma oleic acid (18:1n-9): Mexican Americans
Geometric mean and selected percentiles of plasma concentrations (in µmol/L) for fasted Mexican Americans in 
the U.S. population aged 20 years and older, National Health and Nutrition Examination Survey, 2003–2004. 
Geometric mean 
(95% conf. interval)
Selected percentiles (95% conf. interval) Sample 
size10th 50th 90th
Males and Females
Total, 20 years and older 2,240 (2,060 – 2,430) 1,410 (1,250 – 1,500) 2,170 (1,990 – 2,470) 3,680 (3,330 – 4,270) 375
20–39 years 2,080 (1,850 – 2,350) 1,320 (882 – 1,470) 2,020 (1,710 – 2,390) 3,330 (2,900 – 4,590) 132
40–59 years 2,460 (2,220 – 2,730) 1,610† (1,140 – 1,790) 2,330 (2,090 – 2,670) 4,210† (3,520 – 5,160) 93
60 years and older 2,630 (2,460 – 2,820) 1,800 (1,740 – 1,820) 2,650 (2,320 – 2,900) 3,730 (3,570 – 4,720) 150
Males
Total, 20 years and older 2,240 (1,970 – 2,540) 1,410 (1,150 – 1,510) 2,160 (1,820 – 2,570) 3,940 (3,120 – 4,880) 188
20–39 years 2,080 (1,720 – 2,500) 1,340† (989 – 1,480) 1,930 (1,530 – 2,550) 3,390† (2,640 – 5,270) 67
40–59 years 2,560 (2,160 – 3,040) 1,550† (1,280 – 1,980) 2,490 (2,000 – 3,090) 4,270† (3,570 – 5,640) 48
60 years and older 2,460 (2,160 – 2,800) 1,790† (1,030 – 1,830) 2,350 (1,900 – 3,040) 3,440† (3,270 – 4,860) 73
Females
Total, 20 years and older 2,240 (2,060 – 2,450) 1,400 (859 – 1,680) 2,160 (2,020 – 2,500) 3,500 (3,280 – 3,970) 187
20–39 years 2,090 (1,810 – 2,410) 1,240† (831 – 1,570) 2,020 (1,750 – 2,330) 3,210† (2,850 – 4,200) 65
40–59 years 2,350 (2,020 – 2,730) 1,590† (1,080 – 1,770) 2,200 (1,990 – 2,730) 3,760† (2,920 – 5,280) 45
60 years and older 2,800 (2,470 – 3,180) 1,890† (1,600 – 2,040) 2,730 (2,320 – 3,420) 4,260† (3,660 – 5,490) 77
† Estimate is subject to greater uncertainty due to small cell size. 
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Table 2.23.a.4. Plasma oleic acid (18:1n-9): Non-Hispanic blacks
Geometric mean and selected percentiles of plasma concentrations (in µmol/L) for fasted non-Hispanic blacks 
in the U.S. population aged 20 years and older, National Health and Nutrition Examination Survey, 2003–2004. 
Geometric mean 
(95% conf. interval)
Selected percentiles (95% conf. interval) Sample 
size10th 50th 90th
Males and Females
Total, 20 years and older 1,810 (1,730 – 1,890) 1,210 (1,170 – 1,260) 1,710 (1,620 – 1,830) 2,750 (2,610 – 2,990) 308
20–39 years 1,680 (1,560 – 1,810) 1,170 (1,050 – 1,210) 1,540 (1,470 – 1,760) 2,470 (2,310 – 3,740) 125
40–59 years 1,900 (1,750 – 2,050) 1,240† (1,060 – 1,310) 1,790 (1,640 – 1,970) 2,840† (2,610 – 3,590) 97
60 years and older 2,000 (1,870 – 2,150) 1,400† (1,190 – 1,570) 1,960 (1,800 – 2,190) 2,800† (2,670 – 3,020) 86
Males
Total, 20 years and older 1,850 (1,720 – 1,990) 1,200 (1,140 – 1,240) 1,720 (1,570 – 1,920) 2,930 (2,470 – 4,190) 142
20–39 years 1,710 (1,540 – 1,910) 1,140† (887 – 1,230) 1,560 (1,380 – 1,830) 2,480† (2,400 – 6,770) 57
40–59 years 2,000 (1,730 – 2,310) 1,290† (1,010 – 1,410) 1,850 (1,600 – 2,060) 3,160† (2,570 – 8,560) 42
60 years and older 1,980 (1,730 – 2,270) 1,350† (1,080 – 1,620) 1,960 (1,700 – 2,140) 2,870† (2,440 – 4,520) 43
Females
Total, 20 years and older 1,770 (1,670 – 1,890) 1,210 (1,150 – 1,280) 1,700 (1,600 – 1,840) 2,660 (2,460 – 2,960) 166
20–39 years 1,650 (1,510 – 1,810) 1,160† (1,080 – 1,250) 1,540 (1,470 – 1,710) 2,430† (2,130 – 3,240) 68
40–59 years 1,820 (1,640 – 2,030) 1,200† (863 – 1,280) 1,760 (1,620 – 2,010) 2,620† (2,360 – 6,740) 55
60 years and older 2,010 (1,880 – 2,160) 1,410† (1,280 – 1,590) 1,930 (1,700 – 2,400) 2,780† (2,640 – 3,030) 43
† Estimate is subject to greater uncertainty due to small cell size. 
Table 2.23.a.5. Plasma oleic acid (18:1n-9): Non-Hispanic whites
Geometric mean and selected percentiles of plasma concentrations (in µmol/L) for fasted non-Hispanic whites 
in the U.S. population aged 20 years and older, National Health and Nutrition Examination Survey, 2003–2004. 
Geometric mean 
(95% conf. interval)
Selected percentiles (95% conf. interval) Sample 
size10th 50th 90th
Males and Females
Total, 20 years and older 2,130 (2,060 – 2,200) 1,390 (1,320 – 1,480) 2,120 (2,020 – 2,180) 3,240 (3,100 – 3,430) 986
20–39 years 1,940 (1,820 – 2,050) 1,260 (1,140 – 1,360) 1,870 (1,750 – 2,040) 2,820 (2,630 – 3,710) 299
40–59 years 2,150 (2,070 – 2,220) 1,400 (1,320 – 1,550) 2,140 (2,030 – 2,180) 3,320 (3,020 – 3,600) 279
60 years and older 2,390 (2,310 – 2,470) 1,650 (1,530 – 1,730) 2,420 (2,330 – 2,480) 3,410 (3,250 – 3,700) 408
Males
Total, 20 years and older 2,170 (2,070 – 2,280) 1,380 (1,290 – 1,520) 2,150 (2,040 – 2,240) 3,300 (3,030 – 3,630) 468
20–39 years 1,990 (1,830 – 2,170) 1,250 (1,070 – 1,380) 1,960 (1,760 – 2,130) 2,830 (2,610 – 4,110) 128
40–59 years 2,230 (2,080 – 2,380) 1,390 (1,220 – 1,570) 2,200 (1,950 – 2,370) 3,460 (3,020 – 4,000) 140
60 years and older 2,350 (2,240 – 2,460) 1,600 (1,390 – 1,730) 2,400 (2,320 – 2,470) 3,340 (3,070 – 4,100) 200
Females
Total, 20 years and older 2,090 (2,010 – 2,180) 1,390 (1,320 – 1,470) 2,080 (1,970 – 2,160) 3,200 (2,910 – 3,660) 518
20–39 years 1,880 (1,770 – 2,000) 1,260 (1,120 – 1,360) 1,790 (1,670 – 2,010) 2,810 (2,530 – 3,860) 171
40–59 years 2,070 (1,980 – 2,170) 1,410 (1,100 – 1,560) 2,010 (1,890 – 2,160) 3,100 (2,720 – 3,910) 139
60 years and older 2,430 (2,300 – 2,560) 1,670 (1,470 – 1,810) 2,430 (2,250 – 2,540) 3,470 (3,220 – 4,060) 208
 














































































































































































































































































































































































































































































































































































































































































































































































































































































Non−Hispanic Blacks Non−Hispanic Whites 
Figure 2.24.a. Plasma eicosenoic acid (20:1n–9): Concentrations by age group 
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Table 2.24.a.2. Plasma eicosenoic acid (20:1n-9): Total population
Geometric mean and selected percentiles of plasma concentrations (in µmol/L) for the fasted U.S. population 
aged 20 years and older, National Health and Nutrition Examination Survey, 2003–2004. 
Geometric mean 
(95% conf. interval)
Selected percentiles (95% conf. interval) Sample 
size10th 50th 90th
Males and Females
Total, 20 years and older 13.6 (13.2 – 14.1) 8.46 (7.94 – 8.95) 13.3 (12.8 – 13.8) 22.2 (21.4 – 23.2) 1,805
20–39 years 12.6 (12.0 – 13.3) 7.85 (6.91 – 8.20) 12.1 (11.4 – 12.9) 21.6 (20.3 – 23.2) 608
40–59 years 13.5 (13.0 – 14.1) 8.71 (7.75 – 9.34) 13.2 (12.3 – 13.8) 22.3 (20.3 – 24.2) 514
60 years and older 15.6 (15.1 – 16.1) 10.7 (10.3 – 10.9) 15.1 (14.7 – 15.8) 23.1 (21.8 – 24.6) 683
Males
Total, 20 years and older 13.9 (13.3 – 14.5) 8.77 (8.41 – 8.97) 13.5 (12.9 – 14.2) 22.8 (21.2 – 24.7) 865
20–39 years 12.7 (11.9 – 13.5) 7.88 (6.97 – 8.43) 12.2 (11.6 – 13.0) 21.2 (17.8 – 25.8) 282
40–59 years 14.2 (13.3 – 15.3) 8.96 (8.39 – 9.70) 13.9 (12.7 – 14.7) 23.2 (20.5 – 31.5) 248
60 years and older 15.6 (15.0 – 16.2) 10.5 (10.2 – 10.9) 14.9 (14.4 – 16.1) 23.5 (21.8 – 24.8) 335
Females
Total, 20 years and older 13.4 (12.8 – 14.0) 8.18 (7.55 – 8.94) 13.0 (12.6 – 13.6) 21.8 (21.0 – 22.9) 940
20–39 years 12.6 (11.8 – 13.4) 7.74 (6.79 – 8.08) 12.0 (10.8 – 13.2) 21.7 (20.6 – 23.4) 326
40–59 years 12.9 (12.3 – 13.6) 8.31 (7.29 – 9.14) 12.5 (11.9 – 13.1) 19.9 (18.5 – 23.0) 266
60 years and older 15.6 (14.9 – 16.4) 10.8 (9.70 – 11.4) 15.1 (14.6 – 15.9) 22.6 (21.6 – 25.1) 348
Table 2.24.a.3. Plasma eicosenoic acid (20:1n-9): Mexican Americans
Geometric mean and selected percentiles of plasma concentrations (in µmol/L) for fasted Mexican Americans in 
the U.S. population aged 20 years and older, National Health and Nutrition Examination Survey, 2003–2004. 
Geometric mean 
(95% conf. interval)
Selected percentiles (95% conf. interval) Sample 
size10th 50th 90th
Males and Females
Total, 20 years and older 15.4 (14.4 – 16.5) 9.39 (8.68 – 10.3) 14.7 (13.7 – 16.4) 26.9 (22.7 – 33.2) 376
20–39 years 14.6 (13.2 – 16.2) 8.93 (7.04 – 9.80) 14.1 (12.1 – 16.5) 23.5 (20.3 – 40.8) 132
40–59 years 16.4 (14.8 – 18.2) 10.2† (7.11 – 11.7) 15.2 (14.6 – 16.8) 28.4† (25.1 – 32.9) 93
60 years and older 17.6 (16.3 – 19.1) 12.0 (10.4 – 12.6) 16.7 (14.6 – 19.8) 27.7 (24.8 – 37.1) 151
Males
Total, 20 years and older 15.4 (13.7 – 17.3) 9.18 (8.78 – 10.6) 14.7 (13.3 – 16.8) 26.1 (21.8 – 39.8) 189
20–39 years 14.5 (12.0 – 17.7) 8.87† (7.99 – 9.35) 14.2 (11.5 – 16.7) 22.7† (17.5 – 40.9) 67
40–59 years 17.0 (14.8 – 19.6) 10.5† (7.01 – 12.6) 15.3 (14.5 – 17.7) 30.7† (24.6 – 44.8) 48
60 years and older 17.0 (14.6 – 19.7) 11.7† (5.88 – 13.3) 16.4 (12.8 – 21.4) 25.3† (21.4 – 59.6) 74
Females
Total, 20 years and older 15.4 (14.4 – 16.5) 9.59 (6.32 – 10.4) 15.0 (13.6 – 16.6) 27.1 (22.6 – 35.3) 187
20–39 years 14.7 (13.2 – 16.4) 9.04† (6.32 – 10.1) 14.0 (11.6 – 16.6) 23.8† (21.5 – 38.7) 65
40–59 years 15.7 (13.3 – 18.6) 9.79† (6.66 – 11.9) 14.9 (12.8 – 18.8) 26.4† (19.1 – 38.4) 45
60 years and older 18.3 (15.9 – 21.0) 11.9† (9.58 – 13.0) 16.8 (14.6 – 21.4) 32.3† (24.3 – 38.0) 77
† Estimate is subject to greater uncertainty due to small cell size. 
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Table 2.24.a.4. Plasma eicosenoic acid (20:1n-9): Non-Hispanic blacks
Geometric mean and selected percentiles of plasma concentrations (in µmol/L) for fasted non-Hispanic blacks 
in the U.S. population aged 20 years and older, National Health and Nutrition Examination Survey, 2003–2004. 
Geometric mean 
(95% conf. interval)
Selected percentiles (95% conf. interval) Sample 
size10th 50th 90th
Males and Females
Total, 20 years and older 11.7 (11.0 – 12.4) 7.28 (6.35 – 7.86) 11.1 (10.2 – 12.1) 20.0 (17.7 – 22.1) 310
20–39 years 10.9 (9.78 – 12.1) 6.75 (6.07 – 7.51) 9.90 (9.05 – 11.4) 19.7 (15.0 – 25.9) 126
40–59 years 12.1 (10.9 – 13.3) 7.40† (5.83 – 8.31) 11.4 (10.1 – 12.4) 20.0† (16.8 – 33.4) 98
60 years and older 13.4 (12.7 – 14.1) 9.43† (8.18 – 9.88) 13.1 (12.2 – 14.6) 19.7† (17.7 – 24.3) 86
Males
Total, 20 years and older 11.9 (11.1 – 12.8) 7.12 (6.18 – 7.71) 11.0 (9.88 – 12.3) 21.2 (17.6 – 35.8) 143
20–39 years 10.9 (9.62 – 12.4) 6.33† (5.90 – 7.47) 9.97 (8.73 – 12.2) 17.2† (14.7 – 35.2) 58
40–59 years 12.8 (10.5 – 15.6) 7.86† (5.24 – 8.80) 11.1 (9.28 – 14.0) 21.3† (16.6 – 61.1) 42
60 years and older 13.6 (12.4 – 15.0) 9.07† (6.71 – 10.5) 12.3 (11.2 – 15.0) 22.3† (18.9 – 25.7) 43
Females
Total, 20 years and older 11.5 (10.4 – 12.7) 7.29 (6.37 – 7.99) 11.3 (9.96 – 12.5) 19.0 (15.8 – 25.1) 167
20–39 years 10.9 (9.36 – 12.6) 6.88† (5.96 – 7.70) 9.60 (8.86 – 11.9) 20.2† (14.6 – 26.0) 68
40–59 years 11.5 (10.2 – 12.9) 7.20† (5.09 – 7.95) 11.6 (9.98 – 12.5) 17.6† (14.1 – 40.8) 56
60 years and older 13.3 (12.4 – 14.2) 9.42† (8.21 – 9.77) 13.3 (12.6 – 14.6) 18.0† (15.3 – 24.3) 43
† Estimate is subject to greater uncertainty due to small cell size. 
Table 2.24.a.5. Plasma eicosenoic acid (20:1n-9): Non-Hispanic whites
Geometric mean and selected percentiles of plasma concentrations (in µmol/L) for fasted non-Hispanic whites 
in the U.S. population aged 20 years and older, National Health and Nutrition Examination Survey, 2003–2004. 
Geometric mean 
(95% conf. interval)
Selected percentiles (95% conf. interval) Sample 
size10th 50th 90th
Males and Females
Total, 20 years and older 13.6 (13.1 – 14.2) 8.60 (7.88 – 9.22) 13.4 (12.9 – 13.8) 22.0 (20.7 – 23.3) 989
20–39 years 12.6 (11.8 – 13.6) 7.88 (6.83 – 8.26) 12.1 (11.4 – 13.0) 21.6 (19.4 – 24.2) 298
40–59 years 13.3 (12.7 – 13.9) 8.71 (7.53 – 9.56) 13.0 (11.9 – 13.7) 21.7 (19.0 – 23.1) 279
60 years and older 15.8 (15.2 – 16.3) 10.8 (10.4 – 11.1) 15.2 (14.7 – 15.9) 23.1 (21.7 – 25.4) 412
Males
Total, 20 years and older 13.9 (13.2 – 14.5) 8.91 (8.24 – 9.44) 13.6 (12.9 – 14.2) 22.2 (20.4 – 24.2) 472
20–39 years 12.5 (11.5 – 13.7) 7.92 (6.33 – 8.95) 11.9 (11.4 – 13.0) 18.2 (15.7 – 42.2) 128
40–59 years 13.9 (12.9 – 15.0) 8.97 (7.92 – 9.80) 13.8 (11.9 – 14.7) 22.2 (19.9 – 25.5) 140
60 years and older 15.8 (15.1 – 16.6) 10.6 (10.2 – 11.2) 15.3 (14.7 – 16.4) 23.4 (21.7 – 26.6) 204
Females
Total, 20 years and older 13.4 (12.8 – 14.1) 8.17 (7.57 – 9.08) 13.1 (12.6 – 13.7) 21.8 (20.5 – 23.4) 517
20–39 years 12.7 (11.7 – 13.8) 7.83 (5.75 – 8.15) 12.3 (10.7 – 13.7) 21.7 (20.6 – 25.6) 170
40–59 years 12.6 (11.9 – 13.4) 8.42 (6.89 – 9.47) 12.1 (11.7 – 13.0) 19.0 (17.2 – 22.9) 139
60 years and older 15.7 (14.9 – 16.5) 10.9 (10.5 – 11.4) 15.1 (14.5 – 15.9) 22.8 (21.2 – 26.1) 208
 














































































































































































































































































































































































































































































































































































































































































































































































































































































































Non−Hispanic Blacks Non−Hispanic Whites 
Figure 2.25.a. Plasma docosenoic acid (22:1n–9): Concentrations by age group 
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Table 2.25.a.2. Plasma docosenoic acid (22:1n-9): Total population
Geometric mean and selected percentiles of plasma concentrations (in µmol/L) for the fasted U.S. population 
aged 20 years and older, National Health and Nutrition Examination Survey, 2003–2004. 
Geometric mean 
 (95% conf. interval)
Selected percentiles (95% conf. interval) Sample 
size10th 50th 90th
Males and Females
Total, 20 years and older 3.44 (2.97 – 3.99) 1.38 (.670 – 1.82) 3.62 (3.30 – 4.07) 8.15 (7.41 – 9.51) 1,604
20–39 years 3.36 (2.75 – 4.11) 1.38 (< LOD – 1.87) 3.46 (3.10 – 4.06) 8.64 (7.27 – 11.3) 533
40–59 years 3.39 (2.89 – 3.97) 1.21 (.624 – 1.79) 3.51 (3.16 – 4.23) 8.03 (7.04 – 9.44) 454
60 years and older 3.67 (3.18 – 4.24) 1.55 (.813 – 1.94) 3.93 (3.55 – 4.47) 7.86 (7.43 – 8.68) 617
Males
Total, 20 years and older 3.34 (2.85 – 3.92) 1.22 (.372 – 1.85) 3.54 (3.24 – 4.04) 8.37 (7.59 – 9.60) 767
20–39 years 3.33 (2.63 – 4.20) 1.11 (< LOD – 1.89) 3.38 (2.94 – 4.18) 9.18 (7.58 – 12.3) 249
40–59 years 3.32 (2.85 – 3.86) 1.21 (.324 – 1.87) 3.68 (3.16 – 4.39) 8.06 (6.79 – 9.60) 219
60 years and older 3.42 (2.95 – 3.95) 1.33 (.641 – 1.75) 3.65 (3.35 – 3.95) 7.93 (7.45 – 9.69) 299
Females
Total, 20 years and older 3.54 (3.04 – 4.12) 1.47 (.937 – 1.84) 3.66 (3.33 – 4.23) 7.82 (7.24 – 9.41) 837
20–39 years 3.40 (2.83 – 4.08) 1.44 (.483 – 1.70) 3.58 (2.95 – 4.23) 7.58 (6.98 – 14.6) 284
40–59 years 3.46 (2.85 – 4.19) 1.16 (.666 – 1.76) 3.44 (3.03 – 4.43) 7.92 (7.18 – 11.5) 235
60 years and older 3.89 (3.33 – 4.54) 1.77 (.727 – 2.27) 4.25 (3.69 – 5.32) 7.69 (7.38 – 8.54) 318
< LOD means less than the limit of detection, which may vary for some compounds by year. See Appendix D for LOD. 
 
Table 2.25.a.3. Plasma docosenoic acid (22:1n-9): Mexican Americans
Geometric mean and selected percentiles of plasma concentrations (in µmol/L) for fasted Mexican Americans in 
the U.S. population aged 20 years and older, National Health and Nutrition Examination Survey, 2003–2004. 
Geometric mean 
 (95% conf. interval)
Selected percentiles (95% conf. interval) Sample 
size10th 50th 90th
Males and Females
Total, 20 years and older 3.38 (2.83 – 4.03) 1.47 (.698 – 1.86) 3.69 (3.32 – 4.29) 7.40 (6.31 – 12.3) 345
20–39 years 3.70 (2.96 – 4.62) 1.58 (< LOD – 2.35) 3.97 (3.54 – 4.50) 7.41 (6.18 – 16.2) 117
40–59 years 2.97 (2.04 – 4.31) 1.20† (< LOD – 1.85) 3.45 (2.09 – 4.69) 7.48† (5.26 – 12.2) 91
60 years and older 3.04 (2.44 – 3.79) 1.48 (< LOD – 1.90) 3.41 (2.89 – 3.83) 6.86 (5.67 – 12.0) 137
Males
Total, 20 years and older 3.57 (2.84 – 4.49) 1.51 (< LOD – 1.96) 3.93 (3.52 – 4.30) 8.15 (6.07 – 23.8) 170
20–39 years 3.72 (2.68 – 5.16) 1.38† (< LOD – 2.15) 4.00 (3.27 – 4.92) 7.88† (6.00 – 23.8) 58
40–59 years 3.47 (2.50 – 4.81) 1.47† (< LOD – 2.04) 3.82 (2.77 – 4.66) 8.18† (5.28 – 11.5) 47
60 years and older 3.00 (1.75 – 5.14) 1.47† (< LOD – 2.17) 3.41 (1.76 – 5.76) 7.10† (5.04 – 13.1) 65
Females
Total, 20 years and older 3.16 (2.54 – 3.92) 1.43 (< LOD – 1.87) 3.55 (2.85 – 4.70) 6.83 (5.85 – 7.88) 175
20–39 years 3.67 (3.03 – 4.43) 1.68† (< LOD – 2.49) 3.76 (3.30 – 4.88) 7.10† (5.69 – 18.2) 59
40–59 years 2.48 (1.54 – 3.98) .740† (< LOD – 1.71) 2.87 (1.88 – 4.31) 6.29† (4.79 – 12.2) 44
60 years and older 3.08 (2.53 – 3.75) 1.48† (< LOD – 2.10) 3.39 (2.65 – 3.84) 6.46† (4.82 – 10.8) 72
< LOD means less than the limit of detection, which may vary for some compounds by year. See Appendix D for LOD. 
† Estimate is subject to greater uncertainty due to small cell size. 
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Table 2.25.a.4. Plasma docosenoic acid (22:1n-9): Non-Hispanic blacks
Geometric mean and selected percentiles of plasma concentrations (in µmol/L) for fasted non-Hispanic blacks 
in the U.S. population aged 20 years and older, National Health and Nutrition Examination Survey, 2003–2004. 
Geometric mean 
 (95% conf. interval)
Selected percentiles (95% conf. interval) Sample 
size10th 50th 90th
Males and Females
Total, 20 years and older 3.81 (3.39 – 4.29) 1.76 (.712 – 2.22) 3.83 (3.46 – 4.50) 8.37 (7.02 – 13.4) 280
20–39 years 3.52 (2.85 – 4.34) 1.68 (< LOD – 2.11) 3.54 (3.15 – 4.17) 8.10 (5.61 – 23.4) 116
40–59 years 4.04 (3.53 – 4.64) 1.64† (< LOD – 2.46) 4.52 (3.73 – 5.02) 8.15† (7.20 – 11.6) 82
60 years and older 4.28 (3.65 – 5.01) 2.24† (.542 – 2.55) 4.19 (3.30 – 5.58) 8.49† (7.12 – 19.0) 82
Males
Total, 20 years and older 3.66 (3.11 – 4.30) 1.82 (< LOD – 2.26) 3.63 (3.08 – 4.53) 9.58 (7.05 – 13.4) 130
20–39 years 3.31 (2.46 – 4.44) 1.50† (< LOD – 2.27) 3.28 (2.35 – 4.53) 7.50† (5.46 – 23.8) 54
40–59 years 3.95 (3.14 – 4.96) 1.76† (< LOD – 2.60) 4.00 (3.07 – 5.03) 9.73† (6.86 – 14.6) 35
60 years and older 4.34 (3.73 – 5.05) 1.86† (< LOD – 2.52) 3.87 (3.28 – 6.41) 9.45† (8.02 – 19.0) 41
Females
Total, 20 years and older 3.94 (3.40 – 4.56) 1.75 (1.28 – 2.16) 4.14 (3.39 – 4.92) 8.10 (6.84 – 16.2) 150
20–39 years 3.70 (2.87 – 4.77) 1.68† (< LOD – 2.25) 3.57 (3.18 – 4.43) 8.27† (5.30 – 19.7) 62
40–59 years 4.12 (3.48 – 4.89) 1.57† (.381 – 2.46) 4.86 (3.40 – 6.24) 8.08† (6.93 – 11.9) 47
60 years and older 4.24 (3.22 – 5.58) 2.30† (1.77 – 2.61) 4.23 (2.58 – 6.59) 7.56† (6.37 – 11.8) 41
< LOD means less than the limit of detection, which may vary for some compounds by year. See Appendix D for LOD. 
† Estimate is subject to greater uncertainty due to small cell size. 
Table 2.25.a.5. Plasma docosenoic acid (22:1n-9): Non-Hispanic whites
Geometric mean and selected percentiles of plasma concentrations (in µmol/L) for fasted non-Hispanic whites 
in the U.S. population aged 20 years and older, National Health and Nutrition Examination Survey, 2003–2004.  
Geometric mean 
 (95% conf. interval)
Selected percentiles (95% conf. interval) Sample 
size10th 50th 90th
Males and Females
Total, 20 years and older 3.36 (2.79 – 4.05) 1.18 (.420 – 1.78) 3.54 (3.16 – 4.23) 8.12 (7.40 – 9.59) 863
20–39 years 3.21 (2.41 – 4.27) 1.09 (< LOD – 1.87) 3.37 (2.71 – 4.30) 8.51 (7.27 – 11.9) 255
40–59 years 3.33 (2.77 – 4.01) 1.11 (.402 – 1.71) 3.44 (2.98 – 4.49) 8.10 (6.96 – 11.0) 242
60 years and older 3.63 (3.07 – 4.29) 1.49 (.647 – 1.90) 3.93 (3.52 – 4.55) 7.77 (7.44 – 8.50) 366
Males
Total, 20 years and older 3.21 (2.64 – 3.91) 1.09 (< LOD – 1.85) 3.48 (3.05 – 4.20) 8.14 (7.22 – 9.56) 412
20–39 years 3.10 (2.19 – 4.39) .749† (< LOD – 1.86) 3.20 (2.56 – 4.88) 8.97† (7.37 – 12.8) 110
40–59 years 3.21 (2.69 – 3.82) 1.08 (< LOD – 1.91) 3.52 (3.01 – 4.38) 7.62 (5.91 – 9.68) 122
60 years and older 3.38 (2.85 – 4.02) 1.37 (.534 – 1.82) 3.63 (3.33 – 4.15) 7.79 (6.98 – 9.24) 180
Females
Total, 20 years and older 3.51 (2.89 – 4.25) 1.36 (.604 – 1.76) 3.66 (3.21 – 4.30) 7.92 (7.38 – 10.4) 451
20–39 years 3.31 (2.57 – 4.24) 1.37 (< LOD – 1.89) 3.61 (2.73 – 4.30) 7.62 (6.64 – 16.9) 145
40–59 years 3.46 (2.74 – 4.36) 1.09 (.381 – 1.71) 3.43 (2.89 – 5.00) 8.43 (7.34 – 13.9) 120
60 years and older 3.85 (3.20 – 4.63) 1.54 (.484 – 2.18) 4.22 (3.61 – 5.48) 7.71 (7.39 – 8.61) 186
< LOD means less than the limit of detection, which may vary for some compounds by year. See Appendix D for LOD. 
† Estimate is subject to greater uncertainty due to small cell size. 





















































































































































































































































































































































































































































































































































































































































































































































































































































0 Non−Hispanic Blacks Non−Hispanic Whites 
Figure 2.26.a. Plasma nervonic acid (24:1n–9): Concentrations by age group 













































20−39 40−59 60+ 20−39 40−59 60+ 
Females Males 







Age (years) Age (years) 
20−39 40−59 60+ 
2. Fat-Soluble 1. WaterVitamins & Nutr-Soluble Vitaminsient  249249
250 2nd National Report on Biochemical Indicators of Diet and Nutrition in the U.S. Population250
Table 2.26.a.2. Plasma nervonic acid (24:1n-9): Total population
Geometric mean and selected percentiles of plasma concentrations (in µmol/L) for the fasted U.S. population 
aged 20 years and older, National Health and Nutrition Examination Survey, 2003–2004. 
Geometric mean 
(95% conf. interval)
Selected percentiles (95% conf. interval) Sample 
size10th 50th 90th
Males and Females
Total, 20 years and older 74.9 (72.4 – 77.4) 54.4 (51.9 – 56.6) 75.0 (72.0 – 77.7) 103 (99.6 – 108) 1,696
20–39 years 72.2 (68.7 – 75.8) 53.0 (48.3 – 56.2) 72.1 (67.8 – 77.2) 97.3 (94.2 – 103) 573
40–59 years 74.3 (71.5 – 77.1) 55.0 (52.8 – 57.6) 74.1 (71.4 – 77.6) 98.7 (94.9 – 105) 492
60 years and older 81.0 (77.7 – 84.6) 55.9 (51.8 – 60.0) 79.9 (77.2 – 84.8) 118 (110 – 124) 631
Males
Total, 20 years and older 72.0 (69.5 – 74.5) 52.8 (49.8 – 54.8) 71.9 (69.8 – 74.4) 98.6 (95.6 – 102) 816
20–39 years 70.9 (67.0 – 75.0) 52.5 (46.1 – 55.4) 69.2 (64.8 – 76.3) 99.1 (94.0 – 106) 267
40–59 years 72.1 (69.4 – 74.9) 53.1 (47.3 – 57.2) 72.6 (71.1 – 74.6) 96.2 (88.9 – 104) 240
60 years and older 73.9 (70.9 – 77.0) 51.4 (46.3 – 55.2) 74.2 (71.1 – 78.3) 103 (98.0 – 112) 309
Females
Total, 20 years and older 77.7 (74.8 – 80.7) 56.9 (52.7 – 59.5) 77.6 (74.3 – 80.0) 107 (101 – 115) 880
20–39 years 73.4 (70.0 – 77.0) 53.9 (48.4 – 58.2) 74.9 (71.5 – 77.6) 96.9 (92.9 – 104) 306
40–59 years 76.4 (73.2 – 79.8) 57.4 (51.9 – 59.8) 76.8 (70.4 – 81.2) 101 (97.7 – 109) 252
60 years and older 87.3 (82.8 – 92.0) 62.0 (55.7 – 65.4) 86.3 (80.7 – 92.6) 123 (119 – 135) 322
Table 2.26.a.3. Plasma nervonic acid (24:1n-9): Mexican Americans
Geometric mean and selected percentiles of plasma concentrations (in µmol/L) for fasted Mexican Americans in 
the U.S. population aged 20 years and older, National Health and Nutrition Examination Survey, 2003–2004. 
Geometric mean 
(95% conf. interval)
Selected percentiles (95% conf. interval) Sample 
size10th 50th 90th
Males and Females
Total, 20 years and older 74.4 (71.0 – 78.0) 55.3 (50.7 – 58.6) 76.0 (71.1 – 77.9) 99.1 (93.7 – 107) 373
20–39 years 73.9 (69.6 – 78.6) 55.3 (43.9 – 58.9) 75.8 (70.4 – 77.8) 96.1 (93.3 – 108) 129
40–59 years 73.9 (69.3 – 78.6) 54.3† (46.6 – 58.8) 74.0 (69.0 – 81.3) 96.6† (89.4 – 122) 93
60 years and older 78.6 (74.8 – 82.7) 58.7 (50.2 – 62.1) 80.2 (76.6 – 82.5) 105 (98.7 – 115) 151
Males
Total, 20 years and older 74.2 (71.0 – 77.6) 55.5 (52.7 – 57.7) 73.5 (70.5 – 77.7) 99.6 (93.4 – 107) 187
20–39 years 74.0 (70.5 – 77.6) 54.5† (46.3 – 58.7) 72.2 (69.5 – 78.7) 94.9† (91.2 – 107) 65
40–59 years 74.1 (68.4 – 80.2) 55.7† (46.0 – 59.9) 70.1 (66.9 – 80.6) 102† (89.0 – 127) 48
60 years and older 76.6 (69.3 – 84.7) 53.2† (39.5 – 63.4) 78.0 (66.3 – 88.3) 104† (97.5 – 157) 74
Females
Total, 20 years and older 74.6 (69.7 – 79.9) 55.2 (45.9 – 59.3) 77.2 (67.2 – 82.0) 96.6 (90.8 – 116) 186
20–39 years 73.9 (67.3 – 81.2) 55.3† (43.1 – 59.1) 77.1 (63.6 – 79.7) 98.6† (89.2 – 129) 64
40–59 years 73.6 (67.1 – 80.8) 50.9† (44.5 – 59.4) 78.4 (63.4 – 85.5) 92.1† (86.2 – 121) 45
60 years and older 80.5 (74.5 – 87.0) 60.5† (32.6 – 67.0) 80.6 (73.5 – 88.3) 104† (92.5 – 159) 77
† Estimate is subject to greater uncertainty due to small cell size. 
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Table 2.26.a.4. Plasma nervonic acid (24:1n-9): Non-Hispanic blacks
Geometric mean and selected percentiles of plasma concentrations (in µmol/L) for fasted non-Hispanic blacks 
in the U.S. population aged 20 years and older, National Health and Nutrition Examination Survey, 2003–2004. 
Geometric mean 
(95% conf. interval)
Selected percentiles (95% conf. interval) Sample 
size10th 50th 90th
Males and Females
Total, 20 years and older 77.3 (72.1 – 82.8) 54.4 (49.3 – 57.4) 77.5 (72.6 – 81.8) 110 (102 – 121) 288
20–39 years 73.1 (67.2 – 79.6) 50.9 (44.3 – 55.8) 74.1 (67.5 – 79.8) 101 (93.6 – 128) 116
40–59 years 79.9 (74.1 – 86.2) 56.3† (50.0 – 61.9) 78.7 (72.8 – 81.6) 112† (99.6 – 137) 93
60 years and older 84.1 (74.8 – 94.6) 55.3† (43.3 – 59.2) 87.7 (77.2 – 94.2) 122† (114 – 131) 79
Males
Total, 20 years and older 74.4 (67.7 – 81.8) 53.3 (45.2 – 55.5) 74.4 (67.4 – 81.1) 111 (97.0 – 128) 133
20–39 years 69.3 (58.5 – 82.0) 45.2† (23.7 – 53.9) 67.4 (60.3 – 80.6) 104† (81.7 – 129) 54
40–59 years 78.9 (72.2 – 86.3) 56.7† (53.9 – 66.2) 76.6 (68.8 – 81.4) 109† (94.2 – 133) 40
60 years and older 82.3 (73.6 – 92.0) 54.7† (49.6 – 62.2) 84.5 (59.7 – 104) 117† (104 – 129) 39
Females
Total, 20 years and older 79.6 (73.4 – 86.4) 55.7 (50.1 – 60.1) 79.3 (73.1 – 88.6) 109 (101 – 123) 155
20–39 years 76.6 (68.7 – 85.4) 55.6† (48.6 – 61.3) 75.4 (70.3 – 86.2) 98.9† (92.0 – 123) 62
40–59 years 80.6 (72.3 – 90.0) 55.5† (43.4 – 62.9) 79.2 (71.0 – 89.5) 112† (101 – 160) 53
60 years and older 85.3 (71.6 – 102) 51.8† (39.7 – 62.8) 89.2 (75.8 – 95.2) 123† (101 – 167) 40
† Estimate is subject to greater uncertainty due to small cell size. 
Table 2.26.a.5. Plasma nervonic acid (24:1n-9): Non-Hispanic whites
Geometric mean and selected percentiles of plasma concentrations (in µmol/L) for fasted non-Hispanic whites 
in the U.S. population aged 20 years and older, National Health and Nutrition Examination Survey, 2003–2004. 
Geometric mean 
(95% conf. interval)
Selected percentiles (95% conf. interval) Sample 
size10th 50th 90th
Males and Females
Total, 20 years and older 74.1 (71.3 – 77.0) 53.5 (51.3 – 56.2) 74.0 (71.0 – 77.4) 102 (98.6 – 109) 914
20–39 years 70.5 (66.5 – 74.8) 51.9 (45.2 – 56.2) 70.7 (64.8 – 76.2) 94.0 (88.1 – 109) 281
40–59 years 73.2 (70.1 – 76.5) 53.9 (51.0 – 57.6) 73.6 (69.8 – 77.6) 97.6 (91.9 – 108) 265
60 years and older 81.0 (77.1 – 85.1) 55.4 (51.8 – 58.7) 79.9 (75.7 – 85.4) 118 (109 – 132) 368
Males
Total, 20 years and older 70.6 (68.1 – 73.1) 52.1 (48.1 – 54.1) 71.0 (68.4 – 73.4) 97.2 (90.7 – 101) 437
20–39 years 68.4 (64.3 – 72.7) 52.0 (43.7 – 55.7) 66.3 (61.7 – 73.0) 92.2 (84.4 – 109) 120
40–59 years 71.0 (67.8 – 74.5) 52.8 (46.3 – 54.4) 72.3 (70.9 – 74.2) 93.2 (86.4 – 107) 135
60 years and older 73.0 (70.0 – 76.1) 50.9 (43.5 – 54.8) 73.7 (68.5 – 78.8) 102 (93.9 – 113) 182
Females
Total, 20 years and older 77.5 (73.8 – 81.3) 56.2 (51.9 – 59.2) 77.4 (72.4 – 81.0) 108 (101 – 119) 477
20–39 years 72.5 (67.9 – 77.5) 51.9 (45.2 – 57.6) 74.1 (68.9 – 78.3) 96.1 (90.0 – 115) 161
40–59 years 75.5 (71.7 – 79.4) 57.2 (51.9 – 59.3) 74.7 (68.4 – 80.7) 100 (94.7 – 109) 130
60 years and older 88.4 (83.1 – 94.1) 61.8 (53.5 – 68.4) 88.3 (79.8 – 96.5) 126 (119 – 137) 186
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Figure 2.27.a. Plasma linoleic acid (18:2n–6): Concentrations by age group 
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Table 2.27.a.2. Plasma linoleic acid (18:2n-6): Total population
Geometric mean and selected percentiles of plasma concentrations (in µmol/L) for the fasted U.S. population 
aged 20 years and older, National Health and Nutrition Examination Survey, 2003–2004. 
Geometric mean 
(95% conf. interval)
Selected percentiles (95% conf. interval) Sample 
size10th 50th 90th
Males and Females
Total, 20 years and older 3,450 (3,390 – 3,510) 2,610 (2,550 – 2,700) 3,430 (3,370 – 3,520) 4,570 (4,410 – 4,730) 1,806
20–39 years 3,340 (3,260 – 3,410) 2,570 (2,470 – 2,610) 3,310 (3,240 – 3,370) 4,410 (4,280 – 4,670) 610
40–59 years 3,520 (3,440 – 3,600) 2,700 (2,520 – 2,780) 3,500 (3,410 – 3,620) 4,700 (4,510 – 4,830) 515
60 years and older 3,520 (3,430 – 3,600) 2,690 (2,480 – 2,790) 3,570 (3,480 – 3,640) 4,580 (4,410 – 4,870) 681
Males
Total, 20 years and older 3,380 (3,300 – 3,470) 2,590 (2,480 – 2,680) 3,360 (3,240 – 3,450) 4,510 (4,240 – 4,720) 863
20–39 years 3,280 (3,190 – 3,380) 2,510 (2,420 – 2,600) 3,210 (3,150 – 3,320) 4,380 (4,030 – 4,910) 282
40–59 years 3,530 (3,430 – 3,620) 2,710 (2,600 – 2,790) 3,490 (3,350 – 3,640) 4,610 (4,350 – 4,860) 248
60 years and older 3,320 (3,220 – 3,420) 2,420 (2,320 – 2,570) 3,370 (3,180 – 3,510) 4,310 (4,160 – 4,680) 333
Females
Total, 20 years and older 3,500 (3,430 – 3,580) 2,640 (2,580 – 2,740) 3,530 (3,450 – 3,600) 4,660 (4,490 – 4,820) 943
20–39 years 3,390 (3,270 – 3,510) 2,590 (2,530 – 2,630) 3,390 (3,280 – 3,520) 4,420 (4,270 – 4,860) 328
40–59 years 3,510 (3,390 – 3,630) 2,630 (2,350 – 2,860) 3,530 (3,420 – 3,620) 4,790 (4,380 – 5,030) 267
60 years and older 3,690 (3,580 – 3,800) 2,870 (2,770 – 2,940) 3,700 (3,600 – 3,790) 4,820 (4,540 – 5,080) 348
Table 2.27.a.3. Plasma linoleic acid (18:2n-6): Mexican Americans
Geometric mean and selected percentiles of plasma concentrations (in µmol/L) for fasted Mexican Americans in 
the U.S. population aged 20 years and older, National Health and Nutrition Examination Survey, 2003–2004. 
Geometric mean 
(95% conf. interval)
Selected percentiles (95% conf. interval) Sample 
size10th 50th 90th
Males and Females
Total, 20 years and older 3,730 (3,570 – 3,900) 2,700 (2,500 – 2,900) 3,660 (3,510 – 3,900) 5,170 (4,740 – 5,900) 375
20–39 years 3,630 (3,350 – 3,920) 2,620 (2,350 – 2,730) 3,530 (3,280 – 3,960) 5,120 (4,570 – 6,320) 132
40–59 years 3,920 (3,720 – 4,130) 2,900† (2,410 – 3,150) 3,810 (3,690 – 4,100) 5,370† (4,730 – 7,050) 93
60 years and older 3,860 (3,540 – 4,210) 2,910 (2,120 – 3,360) 3,840 (3,530 – 4,250) 5,050 (4,590 – 6,170) 150
Males
Total, 20 years and older 3,700 (3,460 – 3,950) 2,630 (2,330 – 2,910) 3,640 (3,280 – 4,140) 5,100 (4,650 – 6,350) 188
20–39 years 3,600 (3,220 – 4,040) 2,490† (2,310 – 2,860) 3,500 (3,030 – 4,300) 5,020† (4,440 – 6,640) 67
40–59 years 3,890 (3,610 – 4,200) 3,010† (2,020 – 3,250) 3,860 (3,600 – 4,150) 5,050† (4,530 – 7,450) 48
60 years and older 3,750 (3,490 – 4,030) 2,750† (2,170 – 3,290) 3,760 (3,580 – 3,990) 4,960† (4,330 – 5,580) 73
Females
Total, 20 years and older 3,780 (3,610 – 3,960) 2,710 (2,260 – 3,040) 3,680 (3,530 – 3,920) 5,260 (4,810 – 5,960) 187
20–39 years 3,660 (3,320 – 4,030) 2,710† (1,840 – 3,050) 3,550 (3,470 – 3,910) 5,130† (4,350 – 6,500) 65
40–59 years 3,950 (3,680 – 4,250) 2,720† (2,350 – 3,130) 3,780 (3,580 – 4,330) 5,440† (4,800 – 6,970) 45
60 years and older 3,970 (3,440 – 4,580) 2,920† (2,120 – 3,520) 3,930 (3,450 – 4,570) 5,080† (4,570 – 6,220) 77
† Estimate is subject to greater uncertainty due to small cell size. 
2551. Water-Soluble Vitamins 2 52. Fat-Soluble Vitamins & Nutrient
Table 2.27.a.4. Plasma linoleic acid (18:2n-6): Non-Hispanic blacks
Geometric mean and selected percentiles of plasma concentrations (in µmol/L) for fasted non-Hispanic blacks 
in the U.S. population aged 20 years and older, National Health and Nutrition Examination Survey, 2003–2004. 
Geometric mean 
(95% conf. interval)
Selected percentiles (95% conf. interval) Sample 
size10th 50th 90th
Males and Females
Total, 20 years and older 3,210 (3,090 – 3,340) 2,430 (2,350 – 2,490) 3,130 (3,030 – 3,230) 4,250 (4,120 – 4,540) 310
20–39 years 3,140 (2,940 – 3,340) 2,360 (2,150 – 2,460) 3,050 (2,860 – 3,230) 4,200 (4,030 – 4,570) 126
40–59 years 3,280 (3,110 – 3,470) 2,540† (2,240 – 2,690) 3,160 (3,040 – 3,260) 4,330† (4,100 – 5,000) 98
60 years and older 3,290 (3,080 – 3,510) 2,470† (1,190 – 2,710) 3,410 (3,090 – 3,550) 4,210† (3,930 – 5,080) 86
Males
Total, 20 years and older 3,190 (3,070 – 3,320) 2,350 (2,180 – 2,480) 3,070 (2,980 – 3,190) 4,380 (3,940 – 4,840) 143
20–39 years 3,120 (2,900 – 3,350) 2,320† (1,800 – 2,450) 3,030 (2,790 – 3,290) 4,110† (3,750 – 7,040) 58
40–59 years 3,370 (3,190 – 3,570) 2,610† (2,200 – 2,750) 3,160 (2,990 – 3,280) 4,570† (4,110 – 8,980) 42
60 years and older 3,050 (2,750 – 3,380) 2,300† (1,190 – 2,500) 3,070 (2,730 – 3,650) 4,010† (3,800 – 4,250) 43
Females
Total, 20 years and older 3,230 (3,050 – 3,410) 2,460 (2,390 – 2,560) 3,180 (2,970 – 3,380) 4,210 (4,040 – 5,050) 167
20–39 years 3,160 (2,920 – 3,410) 2,410† (2,220 – 2,470) 3,100 (2,820 – 3,340) 4,230† (3,900 – 5,030) 68
40–59 years 3,220 (3,000 – 3,440) 2,490† (2,160 – 2,630) 3,100 (2,910 – 3,410) 4,120† (3,720 – 7,490) 56
60 years and older 3,450 (3,190 – 3,720) 2,640† (2,420 – 2,910) 3,430 (3,050 – 3,750) 4,350† (4,100 – 5,080) 43
† Estimate is subject to greater uncertainty due to small cell size. 
Table 2.27.a.5. Plasma linoleic acid (18:2n-6): Non-Hispanic whites
Geometric mean and selected percentiles of plasma concentrations (in µmol/L) for fasted non-Hispanic whites 
in the U.S. population aged 20 years and older, National Health and Nutrition Examination Survey, 2003–2004. 
Geometric mean 
(95% conf. interval)
Selected percentiles (95% conf. interval) Sample 
size10th 50th 90th
Males and Females
Total, 20 years and older 3,440 (3,370 – 3,510) 2,620 (2,530 – 2,710) 3,440 (3,360 – 3,540) 4,520 (4,340 – 4,720) 991
20–39 years 3,330 (3,250 – 3,420) 2,580 (2,520 – 2,620) 3,310 (3,250 – 3,380) 4,360 (4,130 – 4,730) 300
40–59 years 3,470 (3,370 – 3,580) 2,690 (2,360 – 2,830) 3,480 (3,340 – 3,620) 4,560 (4,300 – 4,820) 280
60 years and older 3,530 (3,430 – 3,630) 2,680 (2,420 – 2,800) 3,590 (3,490 – 3,690) 4,600 (4,440 – 4,930) 411
Males
Total, 20 years and older 3,360 (3,260 – 3,470) 2,580 (2,440 – 2,690) 3,370 (3,210 – 3,500) 4,330 (4,130 – 4,740) 471
20–39 years 3,250 (3,140 – 3,370) 2,530 (2,420 – 2,600) 3,210 (3,130 – 3,330) 4,150 (3,860 – 5,070) 128
40–59 years 3,480 (3,340 – 3,630) 2,710 (2,430 – 2,830) 3,480 (3,290 – 3,650) 4,430 (4,200 – 4,930) 140
60 years and older 3,330 (3,210 – 3,450) 2,420 (2,300 – 2,580) 3,370 (3,090 – 3,600) 4,320 (4,110 – 4,780) 203
Females
Total, 20 years and older 3,510 (3,430 – 3,590) 2,660 (2,570 – 2,770) 3,530 (3,420 – 3,610) 4,660 (4,480 – 4,820) 520
20–39 years 3,410 (3,240 – 3,580) 2,610 (2,430 – 2,740) 3,390 (3,250 – 3,580) 4,390 (4,180 – 4,970) 172
40–59 years 3,470 (3,330 – 3,610) 2,570 (2,220 – 2,870) 3,480 (3,340 – 3,610) 4,720 (4,290 – 4,940) 140
60 years and older 3,720 (3,580 – 3,860) 2,900 (2,810 – 2,970) 3,760 (3,640 – 3,840) 4,860 (4,530 – 5,140) 208
 




























































































































































































































































































































































































































































































































































































































































































































































































































































Non−Hispanic Blacks Non−Hispanic Whites 
Figure 2.28.a. Plasma alpha−linolenic acid (18:3n–3): Concentrations by age group 
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Table 2.28.a.2. Plasma alpha-linolenic acid (18:3n-3): Total population
Geometric mean and selected percentiles of plasma concentrations (in µmol/L) for the fasted U.S. population 
aged 20 years and older, National Health and Nutrition Examination Survey, 2003–2004. 
Geometric mean 
(95% conf. interval)
Selected percentiles (95% conf. interval) Sample
size10th 50th 90th
Males and Females
Total, 20 years and older 63.1 (60.5 – 65.8) 35.3 (33.1 – 38.0) 61.4 (58.9 – 63.7) 114 (110 – 121) 1,801
20–39 years 58.1 (55.8 – 60.6) 32.9 (30.8 – 34.2) 57.5 (55.2 – 59.9) 107 (98.2 – 116) 610
40–59 years 65.0 (60.7 – 69.6) 37.6 (31.3 – 40.5) 61.2 (58.2 – 66.9) 117 (110 – 128) 513
60 years and older 69.0 (65.2 – 73.0) 39.3 (34.8 – 43.2) 68.3 (64.9 – 72.3) 123 (112 – 137) 678
Males
Total, 20 years and older 62.1 (58.8 – 65.5) 33.6 (28.6 – 37.0) 59.9 (57.3 – 64.2) 116 (110 – 127) 859
20–39 years 56.9 (53.5 – 60.6) 31.6 (27.5 – 34.3) 55.7 (51.2 – 59.6) 107 (98.1 – 121) 282
40–59 years 65.9 (61.5 – 70.6) 34.5 (23.9 – 43.7) 63.6 (58.1 – 72.9) 125 (112 – 132) 246
60 years and older 65.4 (60.1 – 71.2) 35.3 (31.7 – 39.8) 63.8 (57.2 – 73.8) 120 (107 – 147) 331
Females
Total, 20 years and older 64.1 (61.1 – 67.2) 38.1 (35.1 – 39.7) 62.4 (59.9 – 65.5) 113 (106 – 122) 942
20–39 years 59.3 (56.1 – 62.7) 34.0 (30.7 – 36.2) 59.1 (56.0 – 62.6) 105 (93.4 – 125) 328
40–59 years 64.2 (58.4 – 70.4) 38.5 (34.1 – 40.6) 58.8 (55.3 – 65.7) 112 (103 – 125) 267
60 years and older 72.0 (67.3 – 77.1) 42.9 (36.5 – 47.5) 71.1 (66.9 – 76.6) 123 (109 – 141) 347
Table 2.28.a.3. Plasma alpha-linolenic acid (18:3n-3): Mexican Americans
Geometric mean and selected percentiles of plasma concentrations (in µmol/L) for fasted Mexican Americans in 
the U.S. population aged 20 years and older, National Health and Nutrition Examination Survey, 2003–2004. 
Geometric mean 
(95% conf. interval)
Selected percentiles (95% conf. interval) Sample 
size10th 50th 90th
Males and Females
Total, 20 years and older 69.0 (63.8 – 74.5) 39.4 (30.2 – 43.0) 66.2 (59.6 – 73.9) 133 (117 – 159) 375
20–39 years 65.6 (56.2 – 76.6) 36.8 (25.2 – 41.3) 61.4 (54.6 – 73.8) 125 (111 – 215) 132
40–59 years 73.8 (65.4 – 83.2) 43.8† (30.1 – 47.8) 70.5 (59.0 – 88.4) 133† (115 – 146) 93
60 years and older 76.1 (65.5 – 88.5) 43.6 (34.4 – 47.4) 75.9 (67.6 – 82.9) 136 (108 – 292) 150
Males
Total, 20 years and older 68.9 (61.1 – 77.7) 40.5 (25.8 – 43.5) 65.9 (54.6 – 80.2) 134 (113 – 201) 188
20–39 years 66.2 (52.3 – 83.9) 39.3† (22.8 – 42.6) 58.5 (44.6 – 86.5) 130† (91.9 – 222) 67
40–59 years 74.4 (59.7 – 92.8) 43.7† (22.7 – 50.8) 70.4 (55.6 – 95.9) 133† (105 – 421) 48
60 years and older 70.6 (60.3 – 82.5) 39.6† (31.8 – 47.0) 69.6 (55.1 – 79.4) 125† (94.7 – 292) 73
Females
Total, 20 years and older 69.1 (62.1 – 76.8) 37.5 (23.1 – 44.8) 66.2 (60.2 – 73.2) 131 (118 – 147) 187
20–39 years 64.7 (51.4 – 81.5) 32.7† (20.1 – 43.7) 63.6 (55.0 – 73.4) 125† (102 – 278) 65
40–59 years 73.0 (63.4 – 84.1) 41.4† (23.1 – 52.1) 69.0 (54.1 – 87.9) 132† (110 – 194) 45
60 years and older 81.6 (64.4 – 103) 45.2† (32.3 – 58.1) 82.0 (64.8 – 94.8) 144† (111 – 197) 77
† Estimate is subject to greater uncertainty due to small cell size. 
2591. Water-Soluble Vitamins 2592. Fat-Soluble Vitamins & Nutrient
Table 2.28.a.4. Plasma alpha-linolenic acid (18:3n-3): Non-Hispanic blacks
Geometric mean and selected percentiles of plasma concentrations (in µmol/L) for fasted non-Hispanic blacks 
in the U.S. population aged 20 years and older, National Health and Nutrition Examination Survey, 2003–2004. 
Geometric mean 
(95% conf. interval)
Selected percentiles (95% conf. interval) Sample 
size10th 50th 90th
Males and Females
Total, 20 years and older 53.8 (50.4 – 57.4) 31.8 (29.4 – 34.0) 50.5 (48.2 – 53.1) 91.7 (81.0 – 112) 310
20–39 years 50.4 (44.6 – 56.8) 30.7 (26.4 – 33.1) 48.1 (43.0 – 53.0) 76.8 (69.0 – 142) 126
40–59 years 56.2 (52.0 – 60.6) 32.8† (23.4 – 36.2) 51.5 (47.1 – 55.1) 99.0† (81.8 – 315) 98
60 years and older 59.4 (53.3 – 66.2) 35.9† (29.4 – 40.4) 60.0 (53.5 – 63.0) 92.9† (81.4 – 142) 86
Males
Total, 20 years and older 53.4 (48.6 – 58.7) 29.4 (24.1 – 32.4) 51.7 (44.9 – 55.3) 93.3 (78.9 – 149) 143
20–39 years 49.6 (41.2 – 59.8) 28.8† (13.3 – 33.5) 45.5 (42.4 – 57.9) 75.7† (65.3 – 523) 58
40–59 years 57.9 (49.9 – 67.2) 29.7† (18.1 – 35.2) 51.6 (40.9 – 63.7) 124† (97.4 – 284) 42
60 years and older 56.4 (48.8 – 65.1) 30.6† (25.3 – 39.9) 59.8 (46.2 – 72.5) 90.7† (79.0 – 105) 43
Females
Total, 20 years and older 54.1 (50.0 – 58.5) 34.4 (32.1 – 37.0) 50.3 (47.5 – 54.6) 88.9 (77.4 – 120) 167
20–39 years 51.0 (45.7 – 56.9) 32.7† (28.1 – 35.9) 48.2 (41.2 – 57.7) 80.1† (67.0 – 134) 68
40–59 years 54.9 (47.8 – 62.9) 35.2† (23.1 – 39.9) 51.2 (44.3 – 57.6) 84.7† (75.8 – 332) 56
60 years and older 61.4 (53.7 – 70.1) 38.8† (32.9 – 43.2) 59.2 (52.0 – 64.8) 101† (81.5 – 142) 43
† Estimate is subject to greater uncertainty due to small cell size. 
Table 2.28.a.5. Plasma alpha-linolenic acid (18:3n-3): Non-Hispanic whites
Geometric mean and selected percentiles of plasma concentrations (in µmol/L) for fasted non-Hispanic whites 
in the U.S. population aged 20 years and older, National Health and Nutrition Examination Survey, 2003–2004. 
Geometric mean 
(95% conf. interval)
Selected percentiles (95% conf. interval) Sample 
size10th 50th 90th
Males and Females
Total, 20 years and older 63.3 (59.9 – 66.8) 34.9 (32.3 – 38.0) 62.3 (58.9 – 65.7) 113 (109 – 120) 986
20–39 years 58.3 (55.5 – 61.3) 32.4 (30.2 – 34.1) 58.4 (56.4 – 61.9) 103 (93.8 – 116) 300
40–59 years 64.0 (57.9 – 70.7) 37.5 (28.1 – 40.8) 60.5 (57.3 – 68.0) 114 (108 – 123) 278
60 years and older 69.4 (65.1 – 74.0) 39.4 (34.3 – 44.1) 69.0 (65.1 – 72.7) 125 (111 – 140) 408
Males
Total, 20 years and older 61.8 (58.1 – 65.7) 33.0 (27.5 – 36.6) 60.6 (57.4 – 65.4) 113 (108 – 124) 467
20–39 years 55.7 (52.2 – 59.5) 30.6 (26.4 – 33.7) 55.1 (47.7 – 60.6) 103 (95.6 – 113) 128
40–59 years 64.8 (59.6 – 70.5) 33.7 (16.1 – 45.7) 63.6 (58.1 – 70.8) 116 (108 – 132) 138
60 years and older 65.8 (60.1 – 72.1) 36.0 (29.2 – 41.6) 63.8 (57.1 – 74.4) 118 (109 – 145) 201
Females
Total, 20 years and older 64.7 (61.0 – 68.5) 38.2 (34.6 – 40.0) 62.8 (59.8 – 67.0) 113 (106 – 121) 519
20–39 years 60.8 (56.7 – 65.1) 34.0 (30.4 – 37.3) 61.0 (56.4 – 66.1) 103 (88.8 – 128) 172
40–59 years 63.2 (55.2 – 72.3) 38.4 (33.6 – 40.7) 58.4 (52.1 – 68.1) 111 (102 – 120) 140
60 years and older 72.5 (67.0 – 78.5) 41.9 (34.7 – 48.1) 71.2 (67.3 – 76.6) 127 (108 – 154) 207
 



























































































































































































































































































































































































































































































































































































































































































































































































































































Figure 2.29.a. Plasma gamma−linolenic acid (18:3n–6): 
Concentrations by age group 
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Table 2.29.a.2. Plasma gamma-linolenic acid (18:3n-6): Total population
Geometric mean and selected percentiles of plasma concentrations (in µmol/L) for the fasted U.S. population 
aged 20 years and older, National Health and Nutrition Examination Survey, 2003–2004. 
Geometric mean 
(95% conf. interval)
Selected percentiles (95% conf. interval) Sample 
size10th 50th 90th
Males and Females
Total, 20 years and older 46.9 (45.0 – 49.0) 24.4 (22.9 – 25.8) 49.0 (46.4 – 51.5) 85.7 (82.1 – 90.3) 1,795
20–39 years 41.7 (39.4 – 44.1) 22.5 (20.6 – 24.1) 41.9 (38.7 – 46.5) 75.2 (69.9 – 80.9) 603
40–59 years 51.0 (48.4 – 53.8) 25.7 (23.4 – 29.5) 53.3 (50.1 – 56.4) 90.5 (87.1 – 94.7) 513
60 years and older 49.6 (45.9 – 53.6) 26.7 (23.9 – 29.1) 51.2 (46.1 – 57.0) 90.8 (82.8 – 101) 679
Males
Total, 20 years and older 48.0 (45.5 – 50.6) 25.6 (23.8 – 27.0) 50.0 (48.0 – 52.4) 85.7 (81.2 – 94.4) 855
20–39 years 45.7 (42.7 – 48.8) 25.1 (21.7 – 26.9) 48.8 (44.3 – 52.1) 79.5 (68.4 – 90.5) 277
40–59 years 52.7 (49.5 – 56.2) 26.3 (23.9 – 30.8) 55.7 (51.5 – 59.2) 91.9 (85.6 – 110) 246
60 years and older 44.3 (40.3 – 48.7) 24.7 (19.5 – 27.7) 44.5 (42.4 – 48.4) 79.8 (70.5 – 101) 332
Females
Total, 20 years and older 46.0 (43.7 – 48.4) 23.0 (21.5 – 24.8) 47.2 (44.0 – 50.6) 85.1 (80.4 – 89.8) 940
20–39 years 38.2 (35.3 – 41.3) 21.5 (16.6 – 23.1) 37.3 (34.7 – 41.3) 73.0 (62.6 – 79.0) 326
40–59 years 49.5 (46.3 – 53.0) 24.5 (20.1 – 27.8) 51.7 (48.2 – 55.8) 89.7 (81.9 – 101) 267
60 years and older 54.4 (50.0 – 59.2) 29.1 (26.2 – 30.6) 57.9 (50.7 – 64.5) 97.2 (88.0 – 105) 347
Table 2.29.a.3. Plasma gamma-linolenic acid (18:3n-6): Mexican Americans
Geometric mean and selected percentiles of plasma concentrations (in µmol/L) for fasted Mexican Americans in 
the U.S. population aged 20 years and older, National Health and Nutrition Examination Survey, 2003–2004. 
Geometric mean 
(95% conf. interval)
Selected percentiles (95% conf. interval) Sample 
size10th 50th 90th
Males and Females
Total, 20 years and older 41.8 (38.1 – 45.8) 19.5 (15.2 – 22.8) 43.1 (38.4 – 49.9) 83.5 (77.3 – 89.8) 375
20–39 years 38.5 (33.2 – 44.5) 18.1 (13.0 – 20.2) 40.4 (32.6 – 51.1) 71.2 (67.0 – 87.0) 132
40–59 years 47.4 (42.9 – 52.3) 24.2† (17.3 – 27.6) 48.3 (39.6 – 55.1) 94.9† (81.5 – 123) 93
60 years and older 46.9 (40.9 – 53.7) 24.0 (13.3 – 29.1) 48.7 (41.9 – 61.0) 86.0 (79.1 – 89.7) 150
Males
Total, 20 years and older 44.2 (38.1 – 51.2) 20.6 (14.5 – 26.3) 45.9 (38.4 – 54.8) 87.3 (74.0 – 91.6) 188
20–39 years 43.3 (34.6 – 54.2) 20.1† (7.22 – 25.2) 46.7 (32.8 – 60.0) 81.3† (67.1 – 107) 67
40–59 years 47.1 (37.9 – 58.6) 25.8† (9.42 – 31.7) 44.7 (38.0 – 55.2) 94.2† (70.9 – 155) 48
60 years and older 41.1 (33.5 – 50.5) 21.3† (11.1 – 25.6) 42.9 (26.9 – 60.8) 71.0† (57.5 – 131) 73
Females
Total, 20 years and older 39.0 (34.4 – 44.1) 16.5 (10.6 – 21.9) 40.1 (33.0 – 50.6) 82.4 (72.2 – 90.6) 187
20–39 years 32.8 (26.5 – 40.6) 14.7† (6.25 – 19.3) 34.6 (29.0 – 41.4) 61.6† (50.6 – 89.6) 65
40–59 years 47.6 (41.4 – 54.8) 21.0† (15.0 – 27.4) 51.3 (35.0 – 61.6) 94.9† (81.2 – 108) 45
60 years and older 52.9 (46.0 – 60.7) 26.6† (9.56 – 39.1) 55.3 (50.3 – 62.2) 88.9† (86.4 – 98.2) 77
† Estimate is subject to greater uncertainty due to small cell size. 
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Table 2.29.a.4. Plasma gamma-linolenic acid (18:3n-6): Non-Hispanic blacks
Geometric mean and selected percentiles of plasma concentrations (in µmol/L) for fasted non-Hispanic blacks 
in the U.S. population aged 20 years and older, National Health and Nutrition Examination Survey, 2003–2004. 
Geometric mean 
(95% conf. interval)
Selected percentiles (95% conf. interval) Sample 
size10th 50th 90th
Males and Females
Total, 20 years and older 42.5 (40.4 – 44.7) 23.7 (22.0 – 25.1) 42.8 (40.0 – 46.4) 73.7 (68.3 – 80.0) 309
20–39 years 38.0 (35.1 – 41.2) 22.1 (18.2 – 24.1) 37.1 (32.7 – 41.8) 67.3 (61.8 – 76.2) 125
40–59 years 49.2 (45.5 – 53.2) 27.0† (19.9 – 33.0) 50.1 (48.6 – 53.3) 82.2† (73.0 – 111) 98
60 years and older 42.9 (40.1 – 45.9) 25.3† (11.9 – 30.0) 45.8 (39.8 – 48.6) 68.5† (66.3 – 74.0) 86
Males
Total, 20 years and older 44.7 (41.2 – 48.4) 24.8 (22.5 – 27.5) 44.2 (38.7 – 51.2) 75.4 (72.8 – 88.6) 142
20–39 years 41.7 (37.3 – 46.6) 23.4† (14.7 – 26.3) 42.5 (32.5 – 52.0) 73.1† (60.3 – 181) 57
40–59 years 51.1 (45.1 – 57.8) 27.9† (23.2 – 34.8) 48.8 (39.2 – 58.8) 88.5† (73.1 – 121) 42
60 years and older 40.9 (35.6 – 46.9) 23.6† (20.0 – 26.3) 39.8 (33.3 – 51.3) 69.4† (57.4 – 83.1) 43
Females
Total, 20 years and older 40.9 (38.9 – 43.0) 22.4 (18.9 – 25.2) 41.7 (37.8 – 46.2) 69.3 (65.9 – 78.6) 167
20–39 years 35.3 (32.6 – 38.2) 21.2† (15.5 – 24.3) 36.7 (29.9 – 39.1) 60.0† (50.6 – 82.2) 68
40–59 years 47.9 (42.3 – 54.2) 21.8† (17.8 – 33.3) 50.8 (46.4 – 54.0) 78.1† (68.2 – 109) 56
60 years and older 44.2 (39.6 – 49.4) 25.4† (11.9 – 31.0) 46.8 (36.5 – 54.0) 68.3† (61.7 – 78.4) 43
† Estimate is subject to greater uncertainty due to small cell size. 
Table 2.29.a.5. Plasma gamma-linolenic acid (18:3n-6): Non-Hispanic whites
Geometric mean and selected percentiles of plasma concentrations (in µmol/L) for fasted non-Hispanic whites 
in the U.S. population aged 20 years and older, National Health and Nutrition Examination Survey, 2003–2004. 
Geometric mean 
(95% conf. interval)
Selected percentiles (95% conf. interval) Sample 
size10th 50th 90th
Males and Females
Total, 20 years and older 48.8 (46.1 – 51.6) 25.6 (23.9 – 27.8) 50.5 (47.5 – 53.2) 86.9 (82.2 – 93.2) 981
20–39 years 44.1 (40.9 – 47.6) 24.0 (21.8 – 26.7) 45.3 (39.0 – 50.9) 76.3 (69.5 – 84.7) 294
40–59 years 51.9 (48.1 – 56.0) 26.6 (22.8 – 32.2) 54.2 (50.0 – 58.7) 90.3 (86.4 – 94.7) 278
60 years and older 50.6 (46.1 – 55.5) 26.8 (22.8 – 29.6) 52.4 (46.2 – 58.7) 92.5 (83.2 – 104) 409
Males
Total, 20 years and older 49.6 (46.0 – 53.4) 26.3 (23.9 – 29.6) 51.4 (49.0 – 53.5) 86.1 (79.7 – 101) 464
20–39 years 47.7 (43.6 – 52.1) 26.3 (22.5 – 29.5) 49.8 (46.8 – 52.9) 80.5 (67.7 – 115) 124
40–59 years 54.4 (50.0 – 59.2) 28.5 (24.0 – 33.3) 56.9 (51.7 – 60.7) 92.4 (85.5 – 117) 138
60 years and older 44.7 (39.8 – 50.3) 24.6 (16.3 – 28.7) 44.6 (41.8 – 49.7) 80.9 (67.4 – 119) 202
Females
Total, 20 years and older 48.1 (45.4 – 50.9) 24.6 (22.4 – 27.7) 49.1 (45.1 – 53.5) 87.3 (82.1 – 92.2) 517
20–39 years 41.3 (37.2 – 45.8) 23.0 (20.1 – 25.2) 39.6 (35.8 – 45.4) 75.5 (64.7 – 81.7) 170
40–59 years 49.5 (44.8 – 54.8) 25.4 (19.2 – 31.5) 50.5 (46.2 – 56.1) 88.9 (77.0 – 103) 140
60 years and older 56.1 (50.6 – 62.2) 29.6 (22.8 – 33.5) 60.6 (52.8 – 66.0) 97.4 (88.3 – 107) 207
 












































































































































































































































































































































































































































































































































































































































































































































































































































































Non−Hispanic Blacks Non−Hispanic Whites 
Figure 2.30.a. Plasma eicosadienoic acid (20:2n–6): Concentrations by age group 
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Table 2.30.a.2. Plasma eicosadienoic acid (20:2n-6): Total population
Geometric mean and selected percentiles of plasma concentrations (in µmol/L) for the fasted U.S. population 
aged 20 years and older, National Health and Nutrition Examination Survey, 2003–2004. 
Geometric mean 
 (95% conf. interval)
Selected percentiles (95% conf. interval) Sample 
size10th 50th 90th
Males and Females
Total, 20 years and older 21.2 (20.7 – 21.8) 14.1 (13.5 – 14.6) 20.9 (20.3 – 21.6) 32.0 (30.8 – 33.8) 1,805
20–39 years 20.2 (19.5 – 20.9) 13.0 (12.0 – 13.7) 19.4 (18.6 – 20.3) 33.1 (30.9 – 36.6) 607
40–59 years 21.5 (20.6 – 22.3) 14.5 (13.2 – 15.3) 21.2 (20.3 – 22.4) 30.8 (30.0 – 33.7) 515
60 years and older 22.8 (22.1 – 23.5) 16.2 (15.2 – 16.8) 23.1 (22.3 – 23.6) 32.2 (31.0 – 33.4) 683
Males
Total, 20 years and older 20.4 (19.7 – 21.2) 13.9 (13.0 – 14.7) 20.2 (19.3 – 21.1) 29.6 (28.1 – 31.3) 865
20–39 years 19.3 (18.4 – 20.2) 13.1 (11.6 – 13.9) 19.2 (18.1 – 19.9) 28.3 (26.4 – 31.4) 282
40–59 years 21.2 (20.3 – 22.2) 14.5 (12.9 – 15.3) 20.9 (19.6 – 22.8) 30.3 (28.1 – 32.4) 248
60 years and older 21.4 (20.6 – 22.2) 15.3 (13.2 – 16.6) 21.0 (20.3 – 21.9) 29.5 (28.1 – 33.4) 335
Females
Total, 20 years and older 22.0 (21.3 – 22.7) 14.4 (13.7 – 14.8) 21.7 (21.0 – 22.3) 34.2 (32.5 – 36.2) 940
20–39 years 21.1 (20.1 – 22.3) 12.9 (12.2 – 13.8) 20.0 (19.0 – 21.2) 36.3 (34.3 – 39.4) 325
40–59 years 21.7 (20.6 – 22.9) 14.6 (12.2 – 15.7) 21.4 (20.5 – 22.2) 31.5 (29.9 – 37.8) 267
60 years and older 24.0 (23.1 – 24.9) 16.7 (15.6 – 17.7) 24.0 (23.1 – 25.4) 33.5 (32.4 – 35.7) 348
Table 2.30.a.3. Plasma eicosadienoic acid (20:2n-6): Mexican Americans
Geometric mean and selected percentiles of plasma concentrations (in µmol/L) for fasted Mexican Americans in 
the U.S. population aged 20 years and older, National Health and Nutrition Examination Survey, 2003–2004. 
Geometric mean 
 (95% conf. interval)
Selected percentiles (95% conf. interval) Sample 
size10th 50th 90th
Males and Females
Total, 20 years and older 25.2 (23.5 – 27.1) 15.7 (13.4 – 17.2) 24.9 (22.8 – 26.6) 42.1 (35.6 – 51.2) 375
20–39 years 24.3 (21.7 – 27.3) 14.1 (12.6 – 16.7) 23.5 (20.5 – 27.8) 43.9 (33.7 – 55.6) 131
40–59 years 26.6 (24.6 – 28.8) 17.7† (12.3 – 20.2) 25.5 (24.5 – 26.5) 42.3† (35.8 – 73.3) 93
60 years and older 26.8 (25.4 – 28.3) 19.9 (18.1 – 20.4) 26.4 (24.7 – 27.6) 37.0 (35.1 – 49.3) 151
Males
Total, 20 years and older 24.7 (22.2 – 27.5) 14.9 (13.0 – 17.2) 24.7 (22.4 – 26.6) 39.9 (31.9 – 63.7) 189
20–39 years 23.8 (20.1 – 28.2) 13.7† (12.1 – 15.9) 23.9 (19.8 – 28.8) 36.5† (28.8 – 56.4) 67
40–59 years 26.4 (24.2 – 28.9) 17.6† (12.5 – 20.6) 25.2 (23.8 – 26.9) 41.6† (34.7 – 73.3) 48
60 years and older 25.8 (23.6 – 28.2) 18.7† (10.7 – 20.5) 25.6 (22.1 – 27.9) 37.0† (31.3 – 69.2) 74
Females
Total, 20 years and older 25.9 (24.0 – 28.0) 16.7 (11.4 – 17.4) 25.1 (22.2 – 27.7) 45.8 (37.6 – 55.9) 186
20–39 years 25.1 (21.8 – 28.8) 14.5† (10.8 – 17.2) 22.7 (20.1 – 27.0) 48.8† (37.2 – 56.6) 64
40–59 years 26.8 (23.1 – 31.2) 18.3† (8.60 – 20.6) 25.7 (23.0 – 28.3) 42.2† (32.9 – 58.3) 45
60 years and older 27.8 (24.0 – 32.2) 20.2† (17.8 – 20.8) 26.9 (22.9 – 34.5) 36.1† (34.7 – 51.5) 77
† Estimate is subject to greater uncertainty due to small cell size. 
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Table 2.30.a.4. Plasma eicosadienoic acid (20:2n-6): Non-Hispanic blacks
Geometric mean and selected percentiles of plasma concentrations (in µmol/L) for fasted non-Hispanic blacks 
in the U.S. population aged 20 years and older, National Health and Nutrition Examination Survey, 2003–2004. 
Geometric mean 
 (95% conf. interval)
Selected percentiles (95% conf. interval) Sample 
size10th 50th 90th
Males and Females
Total, 20 years and older 19.2 (18.3 – 20.1) 12.8 (11.3 – 13.7) 19.0 (18.1 – 19.7) 27.8 (25.4 – 33.8) 310
20–39 years 18.3 (17.0 – 19.7) 12.2 (10.9 – 13.1) 17.9 (16.3 – 19.1) 26.4 (24.5 – 36.1) 126
40–59 years 19.8 (18.6 – 21.1) 13.3† (10.5 – 14.9) 19.2 (17.8 – 21.1) 28.1† (26.1 – 34.9) 98
60 years and older 20.5 (19.6 – 21.3) 14.2† (12.6 – 15.4) 21.1 (19.7 – 22.4) 27.5† (25.3 – 28.2) 86
Males
Total, 20 years and older 18.4 (17.3 – 19.5) 12.3 (10.9 – 13.3) 17.9 (16.5 – 19.2) 26.4 (24.3 – 31.6) 143
20–39 years 17.2 (16.4 – 18.1) 11.3† (9.43 – 13.2) 16.4 (16.0 – 18.2) 25.1† (22.0 – 48.7) 58
40–59 years 20.0 (17.8 – 22.3) 13.8† (10.2 – 15.5) 18.2 (16.8 – 20.4) 31.9† (26.2 – 52.2) 42
60 years and older 18.9 (16.7 – 21.3) 12.4† (8.53 – 14.5) 19.6 (17.1 – 21.5) 25.6† (23.5 – 35.0) 43
Females
Total, 20 years and older 19.8 (18.3 – 21.5) 12.9 (11.2 – 14.7) 19.4 (18.3 – 21.6) 28.2 (24.8 – 40.6) 167
20–39 years 19.3 (17.1 – 21.8) 12.5† (11.2 – 14.1) 18.5 (16.8 – 20.1) 32.1† (24.5 – 47.8) 68
40–59 years 19.7 (18.0 – 21.5) 12.9† (8.30 – 15.4) 19.3 (17.5 – 22.1) 27.0† (23.6 – 96.5) 56
60 years and older 21.5 (20.1 – 23.1) 15.9† (13.1 – 17.7) 21.9 (19.9 – 23.2) 27.7† (24.3 – 40.5) 43
† Estimate is subject to greater uncertainty due to small cell size.  
Table 2.30.a.5. Plasma eicosadienoic acid (20:2n-6): Non-Hispanic whites
Geometric mean and selected percentiles of plasma concentrations (in µmol/L) for fasted non-Hispanic whites 
in the U.S. population aged 20 years and older, National Health and Nutrition Examination Survey, 2003–2004. 
Geometric mean 
(95% conf. interval)
Selected percentiles (95% conf. interval) Sample 
size10th 50th 90th
Males and Females
Total, 20 years and older 20.9 (20.3 – 21.5) 14.0 (13.1 – 14.7) 20.7 (20.1 – 21.4) 31.0 (29.8 – 33.3) 990
20–39 years 19.7 (18.9 – 20.5) 12.8 (11.7 – 13.6) 19.3 (18.1 – 20.0) 33.1 (29.5 – 37.1) 298
40–59 years 20.8 (19.7 – 21.9) 13.9 (12.7 – 15.1) 20.8 (19.8 – 21.8) 30.2 (28.0 – 32.2) 280
60 years and older 22.7 (21.9 – 23.5) 16.0 (14.5 – 16.8) 23.0 (22.0 – 23.8) 31.9 (29.9 – 33.5) 412
Males
Total, 20 years and older 20.0 (19.3 – 20.7) 13.7 (12.8 – 14.8) 19.9 (18.9 – 20.8) 28.2 (27.1 – 30.4) 472
20–39 years 18.4 (17.4 – 19.5) 12.7 (10.9 – 13.9) 18.3 (17.3 – 19.4) 25.7 (23.3 – 29.6) 128
40–59 years 20.5 (19.4 – 21.6) 14.1 (12.8 – 15.1) 20.4 (18.7 – 22.5) 28.2 (27.3 – 30.6) 140
60 years and older 21.3 (20.4 – 22.2) 15.4 (12.9 – 16.7) 21.0 (20.1 – 22.1) 29.4 (28.0 – 33.4) 204
Females
Total, 20 years and older 21.8 (20.9 – 22.7) 14.3 (13.2 – 14.8) 21.5 (20.9 – 22.2) 33.8 (31.8 – 36.2) 518
20–39 years 20.9 (19.5 – 22.5) 12.8 (12.0 – 13.7) 20.0 (18.5 – 21.4) 36.9 (34.1 – 40.4) 170
40–59 years 21.1 (19.7 – 22.7) 13.8 (11.8 – 15.4) 21.1 (20.2 – 22.0) 30.9 (28.2 – 36.5) 140
60 years and older 23.9 (22.8 – 25.1) 16.5 (15.0 – 18.1) 24.1 (23.0 – 25.5) 33.2 (32.2 – 35.2) 208
 
 















































































































































































































































































































































































































































































































































































































































































































































































































































Figure 2.31.a. Plasma homo−gamma−linolenic acid (20:3n–6): 
Concentrations by age group 
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Table 2.31.a.2. Plasma homo-gamma-linolenic acid (20:3n-6): Total population
Geometric mean and selected percentiles of plasma concentrations (in µmol/L) for the fasted U.S. population 
aged 20 years and older, National Health and Nutrition Examination Survey, 2003–2004. 
Geometric mean 
(95% conf. interval)
Selected percentiles (95% conf. interval) Sample 
size10th 50th 90th
Males and Females
Total, 20 years and older 151 (147 – 156) 98.4 (95.2 – 102) 151 (145 – 156) 232 (221 – 245) 1,806
20–39 years 145 (140 – 149) 95.6 (92.4 – 99.4) 139 (135 – 146) 223 (213 – 239) 609
40–59 years 155 (147 – 163) 102 (94.2 – 107) 156 (147 – 164) 240 (222 – 258) 514
60 years and older 156 (148 – 164) 100 (94.3 – 104) 158 (148 – 167) 236 (222 – 250) 683
Males
Total, 20 years and older 145 (139 – 153) 96.7 (93.1 – 100) 144 (135 – 153) 222 (210 – 246) 864
20–39 years 141 (134 – 149) 95.2 (88.2 – 97.7) 137 (131 – 145) 219 (201 – 247) 282
40–59 years 153 (144 – 163) 101 (93.8 – 107) 155 (141 – 161) 232 (217 – 272) 247
60 years and older 140 (131 – 150) 92.2 (84.0 – 97.9) 141 (133 – 153) 203 (185 – 244) 335
Females
Total, 20 years and older 157 (152 – 162) 102 (96.6 – 105) 156 (150 – 163) 241 (227 – 258) 942
20–39 years 148 (142 – 154) 97.3 (91.9 – 103) 142 (135 – 156) 226 (209 – 270) 327
40–59 years 157 (148 – 167) 104 (93.3 – 107) 157 (151 – 166) 241 (214 – 264) 267
60 years and older 170 (162 – 178) 107 (98.4 – 115) 175 (159 – 185) 258 (236 – 274) 348
Table 2.31.a.3. Plasma homo-gamma-linolenic acid (20:3n-6): Mexican Americans
Geometric mean and selected percentiles of plasma concentrations (in µmol/L) for fasted Mexican Americans in 
the U.S. population aged 20 years and older, National Health and Nutrition Examination Survey, 2003–2004. 
Geometric mean 
(95% conf. interval)
Selected percentiles (95% conf. interval) Sample 
size10th 50th 90th
Males and Females
Total, 20 years and older 166 (154 – 179) 103 (90.3 – 109) 167 (153 – 180) 258 (245 – 293) 375
20–39 years 158 (140 – 177) 96.7 (82.8 – 104) 158 (131 – 189) 254 (239 – 295) 131
40–59 years 178 (166 – 192) 110† (81.4 – 129) 178 (168 – 186) 289† (241 – 360) 93
60 years and older 177 (169 – 185) 119 (108 – 130) 185 (169 – 199) 245 (237 – 261) 151
Males
Total, 20 years and older 161 (143 – 181) 103 (85.0 – 114) 161 (138 – 192) 246 (222 – 296) 189
20–39 years 157 (133 – 185) 102† (65.4 – 113) 148 (121 – 204) 248† (215 – 329) 67
40–59 years 171 (149 – 196) 111† (84.1 – 132) 168 (148 – 194) 244† (213 – 361) 48
60 years and older 160 (146 – 176) 113† (49.9 – 123) 165 (143 – 181) 228† (188 – 288) 74
Females
Total, 20 years and older 172 (155 – 190) 93.0 (65.6 – 109) 175 (159 – 201) 272 (240 – 716) 186
20–39 years 159 (135 – 188) 89.4† (55.8 – 103) 160 (127 – 200) 269† (225 – 716) 64
40–59 years 188 (162 – 217) 106† (65.9 – 149) 190 (171 – 214) 303† (244 – 372) 45
60 years and older 194 (183 – 207) 128† (117 – 135) 204 (193 – 214) 258† (238 – 328) 77
† Estimate is subject to greater uncertainty due to small cell size. 
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Table 2.31.a.4. Plasma homo-gamma-linolenic acid (20:3n-6): Non-Hispanic blacks
Geometric mean and selected percentiles of plasma concentrations (in µmol/L) for fasted non-Hispanic blacks 
in the U.S. population aged 20 years and older, National Health and Nutrition Examination Survey, 2003–2004. 
Geometric mean 
(95% conf. interval)
Selected percentiles (95% conf. interval) Sample 
size10th 50th 90th
Males and Females
Total, 20 years and older 131 (128 – 135) 91.5 (81.3 – 96.1) 131 (127 – 136) 187 (181 – 200) 310
20–39 years 129 (122 – 136) 88.0 (72.5 – 96.0) 128 (117 – 139) 186 (172 – 206) 126
40–59 years 136 (130 – 143) 98.8† (63.0 – 109) 134 (128 – 141) 198† (182 – 235) 98
60 years and older 130 (123 – 136) 85.9† (75.4 – 92.8) 134 (117 – 147) 183† (173 – 215) 86
Males
Total, 20 years and older 125 (119 – 131) 82.5 (73.7 – 94.9) 121 (112 – 130) 188 (173 – 203) 143
20–39 years 119 (111 – 128) 77.7† (53.1 – 94.7) 115 (106 – 130) 174† (168 – 196) 58
40–59 years 136 (129 – 144) 99.7† (71.4 – 105) 128 (118 – 147) 197† (174 – 261) 42
60 years and older 120 (107 – 134) 76.3† (45.9 – 90.2) 118 (105 – 141) 184† (156 – 213) 43
Females
Total, 20 years and older 136 (129 – 144) 93.0 (85.4 – 103) 135 (124 – 150) 186 (180 – 206) 167
20–39 years 137 (125 – 149) 92.6† (77.6 – 104) 134 (116 – 159) 193† (174 – 272) 68
40–59 years 136 (126 – 147) 94.2† (49.0 – 116) 135 (128 – 145) 189† (156 – 298) 56
60 years and older 136 (124 – 149) 92.6† (70.7 – 102) 144 (115 – 160) 182† (171 – 216) 43
† Estimate is subject to greater uncertainty due to small cell size. 
Table 2.31.a.5. Plasma homo-gamma-linolenic acid (20:3n-6): Non-Hispanic whites
Geometric mean and selected percentiles of plasma concentrations (in µmol/L) for fasted non-Hispanic whites 
in the U.S. population aged 20 years and older, National Health and Nutrition Examination Survey, 2003–2004. 
Geometric mean 
(95% conf. interval)
Selected percentiles (95% conf. interval) Sample 
size10th 50th 90th
Males and Females
Total, 20 years and older 152 (146 – 159) 99.3 (94.2 – 103) 152 (144 – 157) 233 (218 – 250) 991
20–39 years 147 (140 – 154) 97.2 (91.2 – 103) 140 (135 – 148) 226 (215 – 245) 300
40–59 years 154 (143 – 165) 101 (92.9 – 107) 156 (143 – 166) 232 (213 – 261) 279
60 years and older 158 (149 – 167) 100 (91.9 – 107) 160 (148 – 172) 242 (226 – 256) 412
Males
Total, 20 years and older 146 (137 – 155) 97.0 (90.8 – 101) 144 (134 – 155) 222 (206 – 254) 471
20–39 years 142 (129 – 156) 95.2 (73.6 – 101) 136 (126 – 147) 222 (187 – 279) 128
40–59 years 152 (139 – 165) 100 (90.4 – 107) 155 (134 – 165) 227 (210 – 284) 139
60 years and older 142 (132 – 153) 93.6 (86.9 – 99.4) 141 (133 – 154) 206 (184 – 250) 204
Females
Total, 20 years and older 159 (152 – 165) 104 (97.0 – 106) 157 (150 – 168) 242 (224 – 261) 520
20–39 years 151 (143 – 160) 99.5 (93.5 – 109) 141 (135 – 160) 232 (210 – 285) 172
40–59 years 156 (144 – 169) 103 (86.2 – 107) 156 (149 – 168) 240 (210 – 264) 140
60 years and older 172 (161 – 184) 107 (88.1 – 124) 177 (161 – 191) 260 (245 – 271) 208
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Figure 2.32.a. Plasma arachidonic acid (20:4n–6): Concentrations by age group 
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Table 2.32.a.2. Plasma arachidonic acid (20:4n-6): Total population
Geometric mean and selected percentiles of plasma concentrations (in µmol/L) for the fasted U.S. population 
aged 20 years and older, National Health and Nutrition Examination Survey, 2003–2004. 
Geometric mean 
(95% conf. interval)
Selected percentiles (95% conf. interval) Sample 
size10th 50th 90th
Males and Females
Total, 20 years and older 776 (761 – 791) 538 (516 – 560) 789 (772 – 805) 1,070 (1,040 – 1,110) 1,807
20–39 years 735 (716 – 755) 529 (510 – 542) 737 (713 – 761) 1,000 (959 – 1,080) 610
40–59 years 793 (772 – 814) 534 (488 – 569) 808 (785 – 829) 1,090 (1,050 – 1,140) 514
60 years and older 819 (798 – 841) 562 (533 – 591) 841 (814 – 868) 1,120 (1,090 – 1,140) 683
Males
Total, 20 years and older 764 (744 – 785) 534 (502 – 547) 780 (756 – 806) 1,040 (1,000 – 1,090) 864
20–39 years 739 (710 – 769) 533 (505 – 542) 736 (713 – 766) 999 (945 – 1,100) 282
40–59 years 792 (761 – 825) 529 (487 – 566) 823 (795 – 842) 1,070 (1,020 – 1,150) 247
60 years and older 761 (726 – 798) 532 (453 – 570) 796 (740 – 839) 1,030 (986 – 1,100) 335
Females
Total, 20 years and older 787 (769 – 806) 549 (517 – 575) 792 (769 – 821) 1,100 (1,050 – 1,160) 943
20–39 years 732 (710 – 755) 523 (497 – 552) 738 (705 – 766) 1,010 (956 – 1,120) 328
40–59 years 793 (755 – 833) 534 (464 – 597) 787 (753 – 864) 1,130 (1,020 – 1,230) 267
60 years and older 870 (844 – 896) 620 (551 – 654) 878 (854 – 904) 1,150 (1,120 – 1,200) 348
Table 2.32.a.3. Plasma arachidonic acid (20:4n-6): Mexican Americans
Geometric mean and selected percentiles of plasma concentrations (in µmol/L) for fasted Mexican Americans in 
the U.S. population aged 20 years and older, National Health and Nutrition Examination Survey, 2003–2004. 
Geometric mean 
(95% conf. interval)
Selected percentiles (95% conf. interval) Sample 
size10th 50th 90th
Males and Females
Total, 20 years and older 722 (678 – 768) 499 (439 – 536) 726 (675 – 768) 1,030 (975 – 1,080) 376
20–39 years 681 (631 – 735) 483 (413 – 526) 687 (628 – 745) 993 (892 – 1,070) 132
40–59 years 778 (718 – 844) 510† (420 – 602) 774 (749 – 835) 1,120† (948 – 1,350) 93
60 years and older 811 (777 – 846) 567 (496 – 592) 826 (769 – 874) 1,170 (1,050 – 1,330) 151
Males
Total, 20 years and older 719 (669 – 773) 502 (426 – 535) 745 (674 – 788) 1,030 (937 – 1,090) 189
20–39 years 689 (637 – 746) 503† (380 – 540) 707 (609 – 758) 983† (851 – 1,110) 67
40–59 years 770 (675 – 878) 489† (377 – 606) 800 (748 – 843) 1,040† (881 – 1,460) 48
60 years and older 776 (714 – 842) 527† (376 – 590) 811 (643 – 924) 1,090† (1,000 – 1,360) 74
Females
Total, 20 years and older 724 (659 – 796) 479 (352 – 582) 716 (653 – 782) 1,020 (945 – 1,310) 187
20–39 years 670 (591 – 760) 436† (352 – 539) 676 (626 – 723) 987† (856 – 1,310) 65
40–59 years 788 (711 – 874) 567† (447 – 616) 756 (652 – 885) 1,250† (964 – 1,430) 45
60 years and older 844 (790 – 902) 586† (580 – 600) 835 (810 – 873) 1,220† (987 – 1,940) 77
† Estimate is subject to greater uncertainty due to small cell size. 
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Table 2.32.a.4. Plasma arachidonic acid (20:4n-6): Non-Hispanic blacks
Geometric mean and selected percentiles of plasma concentrations (in µmol/L) for fasted non-Hispanic blacks 
in the U.S. population aged 20 years and older, National Health and Nutrition Examination Survey, 2003–2004. 
Geometric mean 
(95% conf. interval)
Selected percentiles (95% conf. interval) Sample 
size10th 50th 90th
Males and Females
Total, 20 years and older 884 (839 – 932) 630 (588 – 670) 883 (831 – 941) 1,220 (1,160 – 1,330) 310
20–39 years 836 (776 – 901) 602 (542 – 635) 839 (769 – 887) 1,210 (1,040 – 1,380) 126
40–59 years 936 (858 – 1,020) 681† (513 – 711) 942 (827 – 1,040) 1,230† (1,170 – 1,760) 98
60 years and older 919 (859 – 983) 714† (534 – 744) 933 (830 – 1,030) 1,200† (1,160 – 1,330) 86
Males
Total, 20 years and older 870 (817 – 925) 591 (512 – 659) 859 (811 – 976) 1,200 (1,130 – 1,330) 143
20–39 years 811 (737 – 892) 580† (479 – 616) 812 (692 – 891) 1,120† (1,020 – 1,660) 58
40–59 years 953 (875 – 1,040) 666† (501 – 727) 984 (780 – 1,070) 1,230† (1,110 – 2,240) 42
60 years and older 886 (774 – 1,010) 535† (226 – 722) 940 (833 – 1,050) 1,180† (1,130 – 1,440) 43
Females
Total, 20 years and older 895 (829 – 967) 648 (588 – 704) 884 (823 – 958) 1,230 (1,130 – 1,470) 167
20–39 years 858 (773 – 952) 616† (570 – 661) 857 (746 – 955) 1,230† (1,010 – 1,390) 68
40–59 years 923 (818 – 1,040) 679† (468 – 714) 912 (824 – 1,020) 1,230† (1,100 – 2,020) 56
60 years and older 940 (889 – 995) 740† (715 – 762) 916 (809 – 1,040) 1,220† (1,130 – 1,490) 43
† Estimate is subject to greater uncertainty due to small cell size. 
Table 2.32.a.5. Plasma arachidonic acid (20:4n-6): Non-Hispanic whites
Geometric mean and selected percentiles of plasma concentrations (in µmol/L) for fasted non-Hispanic whites 
in the U.S. population aged 20 years and older, National Health and Nutrition Examination Survey, 2003–2004. 
Geometric mean 
(95% conf. interval)
Selected percentiles (95% conf. interval) Sample 
size10th 50th 90th
Males and Females
Total, 20 years and older 773 (752 – 795) 539 (497 – 569) 785 (767 – 807) 1,050 (1,010 – 1,100) 991
20–39 years 733 (711 – 755) 533 (490 – 569) 736 (706 – 766) 971 (929 – 1,060) 300
40–59 years 782 (749 – 817) 531 (465 – 579) 800 (777 – 830) 1,040 (1,010 – 1,120) 279
60 years and older 815 (788 – 843) 562 (504 – 604) 839 (811 – 870) 1,110 (1,070 – 1,140) 412
Males
Total, 20 years and older 760 (733 – 788) 534 (488 – 558) 783 (752 – 810) 1,000 (981 – 1,050) 471
20–39 years 731 (702 – 762) 527 (480 – 562) 735 (698 – 771) 957 (899 – 1,160) 128
40–59 years 789 (748 – 832) 539 (476 – 569) 823 (786 – 863) 1,030 (997 – 1,160) 139
60 years and older 752 (711 – 795) 524 (444 – 573) 769 (715 – 833) 998 (962 – 1,110) 204
Females
Total, 20 years and older 785 (761 – 811) 552 (500 – 583) 786 (769 – 816) 1,080 (1,040 – 1,160) 520
20–39 years 733 (701 – 768) 532 (432 – 583) 738 (699 – 768) 997 (920 – 1,150) 172
40–59 years 776 (722 – 835) 530 (403 – 598) 780 (726 – 858) 1,060 (991 – 1,240) 140
60 years and older 873 (841 – 905) 610 (541 – 665) 889 (857 – 916) 1,150 (1,120 – 1,200) 208
 































































































































































































































































































































































































































































































































































































































































































































































































































































Figure 2.33.a. Plasma eicosapentaenoic acid (20:5n–3): 
Concentrations by age group 
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Table 2.33.a.2. Plasma eicosapentaenoic acid (20:5n-3): Total population
Geometric mean and selected percentiles of plasma concentrations (in µmol/L) for the fasted U.S. population 
aged 20 years and older, National Health and Nutrition Examination Survey, 2003–2004. 
Geometric mean 
(95% conf. interval)
Selected percentiles (95% conf. interval) Sample 
size10th 50th 90th
Males and Females
Total, 20 years and older 42.1 (39.5 – 45.0) 20.8 (18.9 – 22.2) 40.9 (37.6 – 43.8) 89.9 (80.0 – 99.9) 1,806
20–39 years 35.9 (33.8 – 38.1) 18.2 (16.7 – 20.2) 34.2 (32.0 – 36.2) 74.5 (64.8 – 94.2) 609
40–59 years 45.5 (41.8 – 49.5) 22.8 (19.4 – 26.2) 45.0 (41.0 – 48.3) 92.8 (81.5 – 103) 515
60 years and older 48.5 (43.3 – 54.4) 24.4 (15.6 – 29.1) 49.4 (43.5 – 53.8) 100 (90.6 – 116) 682
Males
Total, 20 years and older 43.1 (39.8 – 46.6) 21.0 (18.5 – 23.0) 41.4 (37.6 – 45.1) 92.8 (81.4 – 104) 863
20–39 years 38.7 (35.6 – 42.0) 18.7 (16.8 – 20.6) 36.1 (34.3 – 40.5) 86.1 (70.8 – 108) 281
40–59 years 47.3 (42.5 – 52.7) 23.4 (20.8 – 26.6) 45.7 (40.0 – 48.9) 97.4 (82.2 – 136) 248
60 years and older 44.2 (38.7 – 50.5) 22.1 (10.4 – 27.5) 44.6 (38.7 – 51.3) 88.7 (74.8 – 109) 334
Females
Total, 20 years and older 41.3 (38.7 – 44.1) 20.4 (18.5 – 22.2) 40.1 (37.5 – 43.1) 86.3 (76.6 – 101) 943
20–39 years 33.3 (30.9 – 36.0) 17.4 (15.8 – 19.8) 31.4 (30.1 – 34.1) 64.6 (56.5 – 80.8) 328
40–59 years 43.9 (40.1 – 48.1) 21.9 (17.2 – 27.5) 43.4 (40.3 – 47.8) 84.6 (76.6 – 100) 267
60 years and older 52.4 (47.2 – 58.1) 25.2 (21.5 – 29.7) 51.7 (49.2 – 57.1) 105 (94.5 – 134) 348
Table 2.33.a.3. Plasma eicosapentaenoic acid (20:5n-3): Mexican Americans
Geometric mean and selected percentiles of plasma concentrations (in µmol/L) for fasted Mexican Americans in 
the U.S. population aged 20 years and older, National Health and Nutrition Examination Survey, 2003–2004. 
Geometric mean 
(95% conf. interval)
Selected percentiles (95% conf. interval) Sample 
size10th 50th 90th
Males and Females
Total, 20 years and older 31.0 (28.7 – 33.5) 15.8 (11.1 – 18.4) 31.4 (28.4 – 35.4) 63.8 (58.1 – 70.0) 375
20–39 years 28.0 (24.9 – 31.4) 15.4 (8.96 – 18.3) 28.3 (21.7 – 35.1) 59.1 (50.9 – 68.1) 132
40–59 years 35.5 (30.7 – 41.0) 17.0† (12.2 – 19.0) 35.9 (31.0 – 40.8) 76.2† (56.8 – 91.5) 93
60 years and older 38.2 (35.8 – 40.7) 17.9 (12.9 – 21.6) 40.5 (34.3 – 43.5) 72.9 (61.1 – 95.6) 150
Males
Total, 20 years and older 33.1 (29.9 – 36.8) 16.4 (15.5 – 18.4) 34.3 (29.0 – 37.9) 68.9 (60.4 – 77.9) 188
20–39 years 30.6 (25.4 – 36.8) 16.1† (9.95 – 18.9) 29.4 (22.2 – 40.7) 63.9† (50.2 – 78.0) 67
40–59 years 39.3 (31.6 – 48.8) 16.2† (11.8 – 22.3) 37.6 (30.0 – 51.3) 82.2† (66.1 – 180) 48
60 years and older 33.6 (29.9 – 37.8) 16.0† (12.8 – 18.3) 34.4 (24.2 – 43.5) 56.5† (48.9 – 161) 73
Females
Total, 20 years and older 28.6 (24.9 – 32.8) 13.8 (7.13 – 18.3) 29.1 (23.4 – 35.1) 60.2 (49.1 – 76.5) 187
20–39 years 24.8 (20.1 – 30.7) 10.8† (6.03 – 18.2) 23.5 (19.9 – 31.6) 53.1† (39.3 – 90.1) 65
40–59 years 31.6 (27.4 – 36.4) 17.1† (8.81 – 19.8) 31.3 (26.8 – 37.9) 55.9† (46.3 – 84.0) 45
60 years and older 42.9 (36.7 – 50.1) 22.2† (8.91 – 26.3) 43.3 (38.1 – 49.3) 85.0† (63.7 – 147) 77
† Estimate is subject to greater uncertainty due to small cell size. 
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Table 2.33.a.4. Plasma eicosapentaenoic acid (20:5n-3): Non-Hispanic blacks
Geometric mean and selected percentiles of plasma concentrations (in µmol/L) for fasted non-Hispanic blacks 
in the U.S. population aged 20 years and older, National Health and Nutrition Examination Survey, 2003–2004. 
Geometric mean 
(95% conf. interval)
Selected percentiles (95% conf. interval) Sample 
size10th 50th 90th
Males and Females
Total, 20 years and older 38.8 (34.7 – 43.4) 19.9 (17.5 – 21.2) 36.1 (33.0 – 41.6) 80.3 (64.8 – 121) 310
20–39 years 33.9 (28.3 – 40.8) 17.9 (15.0 – 20.1) 32.6 (25.1 – 40.6) 64.8 (53.4 – 253) 126
40–59 years 42.9 (37.2 – 49.6) 20.8† (16.4 – 24.8) 39.9 (35.3 – 44.2) 96.3† (72.1 – 147) 98
60 years and older 46.0 (39.2 – 53.9) 27.2† (19.4 – 30.4) 44.5 (36.2 – 51.1) 88.6† (64.3 – 209) 86
Males
Total, 20 years and older 39.9 (34.4 – 46.2) 18.9 (15.3 – 22.2) 35.5 (32.4 – 41.6) 106 (70.6 – 134) 143
20–39 years 34.9 (26.9 – 45.3) 16.6† (12.9 – 19.5) 33.3 (24.6 – 43.0) 64.8† (51.9 – 150) 58
40–59 years 44.4 (37.5 – 52.5) 21.0† (17.3 – 26.5) 36.0 (30.8 – 50.1) 117† (79.5 – 206) 42
60 years and older 48.4 (34.5 – 67.7) 26.1† (7.52 – 32.4) 44.4 (35.0 – 59.2) 102† (61.1 – 209) 43
Females
Total, 20 years and older 38.0 (34.0 – 42.4) 20.1 (18.5 – 21.4) 36.2 (30.4 – 43.9) 71.2 (61.3 – 105) 167
20–39 years 33.2 (27.9 – 39.5) 18.6† (13.2 – 20.4) 29.7 (25.6 – 35.7) 64.3† (44.7 – 253) 68
40–59 years 41.8 (34.9 – 50.2) 19.8† (12.6 – 25.5) 41.3 (35.8 – 46.4) 71.2† (64.0 – 193) 56
60 years and older 44.5 (39.7 – 50.0) 25.5† (20.0 – 30.5) 44.1 (35.2 – 51.1) 75.9† (62.8 – 104) 43
† Estimate is subject to greater uncertainty due to small cell size. 
Table 2.33.a.5. Plasma eicosapentaenoic acid (20:5n-3): Non-Hispanic whites
Geometric mean and selected percentiles of plasma concentrations (in µmol/L) for fasted non-Hispanic whites 
in the U.S. population aged 20 years and older, National Health and Nutrition Examination Survey, 2003–2004. 
Geometric mean 
(95% conf. interval)
Selected percentiles (95% conf. interval) Sample 
size10th 50th 90th
Males and Females
Total, 20 years and older 43.5 (39.8 – 47.7) 21.9 (18.6 – 24.7) 42.6 (38.1 – 46.0) 90.5 (78.4 – 102) 991
20–39 years 37.5 (34.3 – 41.0) 20.4 (16.3 – 21.9) 35.3 (32.0 – 38.3) 74.7 (63.8 – 110) 299
40–59 years 45.8 (41.5 – 50.6) 23.9 (18.8 – 27.7) 45.2 (40.5 – 48.7) 89.0 (78.7 – 101) 280
60 years and older 49.0 (42.5 – 56.5) 23.5 (11.7 – 29.6) 49.9 (44.2 – 54.8) 101 (91.7 – 117) 412
Males
Total, 20 years and older 44.3 (40.1 – 48.9) 21.9 (17.3 – 25.8) 43.1 (37.6 – 47.6) 89.8 (78.2 – 105) 471
20–39 years 40.1 (35.9 – 44.7) 20.6 (16.9 – 22.7) 37.8 (34.8 – 42.9) 89.0 (67.8 – 119) 127
40–59 years 48.0 (42.2 – 54.6) 25.1 (20.7 – 27.5) 47.3 (40.0 – 50.2) 92.4 (80.9 – 140) 140
60 years and older 44.3 (38.0 – 51.6) 21.8 (10.3 – 28.6) 44.8 (37.6 – 52.3) 87.2 (75.6 – 105) 204
Females
Total, 20 years and older 42.9 (39.0 – 47.2) 21.8 (18.3 – 24.6) 42.0 (37.9 – 45.6) 91.3 (76.7 – 104) 520
20–39 years 35.4 (31.7 – 39.4) 18.2 (15.8 – 21.9) 31.9 (30.2 – 37.0) 68.2 (54.3 – 112) 172
40–59 years 43.8 (39.1 – 48.9) 22.3 (12.3 – 30.0) 43.3 (37.8 – 48.4) 81.0 (74.2 – 100) 140
60 years and older 53.5 (46.4 – 61.6) 24.6 (18.7 – 30.9) 53.5 (49.3 – 59.7) 110 (96.5 – 138) 208
 















































































































































































































































































































































































































































































































































































































































































































































































































































































Figure 2.34.a. Plasma docosatetraenoic acid (22:4n–6): 
Concentrations by age group 
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Table 2.34.a.2. Plasma docosatetraenoic acid (22:4n-6): Total population
Geometric mean and selected percentiles of plasma concentrations (in µmol/L) for the fasted U.S. population 
aged 20 years and older, National Health and Nutrition Examination Survey, 2003–2004. 
Geometric mean 
(95% conf. interval)
Selected percentiles (95% conf. interval) Sample 
size10th 50th 90th
Males and Females
Total, 20 years and older 25.0 (24.4 – 25.6) 16.8 (15.7 – 17.4) 24.7 (24.1 – 25.6) 37.7 (36.7 – 39.4) 1,808
20–39 years 24.4 (23.4 – 25.4) 16.7 (15.0 – 17.5) 23.9 (23.1 – 24.9) 37.1 (34.7 – 39.1) 610
40–59 years 25.5 (24.5 – 26.4) 17.0 (14.8 – 18.0) 25.0 (24.3 – 26.6) 39.4 (37.4 – 41.6) 515
60 years and older 25.3 (24.6 – 26.0) 16.7 (16.0 – 17.5) 25.7 (24.5 – 26.6) 37.0 (36.3 – 38.3) 683
Males
Total, 20 years and older 25.3 (24.4 – 26.2) 16.9 (15.8 – 18.0) 25.0 (24.3 – 26.1) 38.2 (36.5 – 40.0) 865
20–39 years 25.2 (23.8 – 26.6) 17.1 (14.8 – 18.7) 24.5 (23.6 – 26.1) 38.3 (35.5 – 40.8) 282
40–59 years 26.1 (24.9 – 27.3) 17.3 (14.7 – 19.5) 25.9 (24.5 – 27.9) 39.8 (36.8 – 43.7) 248
60 years and older 24.1 (22.9 – 25.3) 16.0 (14.8 – 16.8) 24.3 (22.5 – 26.5) 35.9 (34.2 – 37.6) 335
Females
Total, 20 years and older 24.7 (24.0 – 25.5) 16.5 (15.4 – 17.4) 24.5 (23.6 – 25.6) 37.5 (36.0 – 40.6) 943
20–39 years 23.6 (22.5 – 24.8) 15.8 (14.4 – 17.1) 23.1 (21.3 – 24.7) 35.9 (32.7 – 38.8) 328
40–59 years 24.9 (23.4 – 26.5) 15.6 (14.5 – 17.5) 24.6 (23.4 – 26.4) 38.3 (35.3 – 43.3) 267
60 years and older 26.3 (25.1 – 27.6) 17.6 (16.4 – 18.5) 26.2 (24.9 – 27.8) 38.3 (36.3 – 43.9) 348
 
Table 2.34.a.3. Plasma docosatetraenoic acid (22:4n-6): Mexican Americans
Geometric mean and selected percentiles of plasma concentrations (in µmol/L) for fasted Mexican Americans in 
the U.S. population aged 20 years and older, National Health and Nutrition Examination Survey, 2003–2004. 
Geometric mean 
(95% conf. interval)
Selected percentiles (95% conf. interval) Sample 
size10th 50th 90th
Males and Females
Total, 20 years and older 27.5 (25.6 – 29.5) 17.9 (15.5 – 19.6) 27.4 (25.1 – 29.6) 43.1 (40.6 – 46.6) 376
20–39 years 26.3 (24.0 – 28.8) 16.4 (12.1 – 19.5) 26.1 (21.9 – 29.9) 41.1 (36.6 – 47.8) 132
40–59 years 29.1 (26.8 – 31.6) 18.2† (13.2 – 20.2) 28.4 (26.2 – 31.2) 45.6† (42.2 – 59.9) 93
60 years and older 30.5 (29.3 – 31.8) 20.6 (17.6 – 22.4) 30.2 (28.3 – 32.1) 43.6 (40.4 – 48.5) 151
Males
Total, 20 years and older 27.7 (25.0 – 30.8) 18.4 (13.6 – 20.3) 27.3 (24.4 – 31.1) 41.5 (39.1 – 48.7) 189
20–39 years 26.9 (23.6 – 30.6) 18.5† (12.6 – 20.7) 26.2 (22.5 – 29.9) 40.4† (36.1 – 58.6) 67
40–59 years 29.1 (24.5 – 34.6) 17.9† (13.8 – 21.3) 28.3 (25.3 – 33.8) 44.6† (37.0 – 63.5) 48
60 years and older 29.4 (26.2 – 32.9) 18.8† (17.0 – 21.2) 28.5 (24.6 – 34.1) 45.0† (37.4 – 67.2) 74
Females
Total, 20 years and older 27.2 (24.6 – 30.1) 16.9 (11.4 – 19.7) 27.6 (23.8 – 30.3) 43.5 (40.3 – 50.5) 187
20–39 years 25.5 (22.2 – 29.2) 15.6† (11.2 – 18.0) 25.1 (20.0 – 32.3) 42.9† (34.4 – 58.4) 65
40–59 years 29.0 (25.6 – 32.9) 18.5† (13.2 – 21.6) 27.2 (23.7 – 31.6) 45.8† (42.0 – 61.3) 45
60 years and older 31.6 (30.2 – 33.1) 20.8† (17.8 – 25.8) 31.1 (29.8 – 33.2) 41.7† (36.9 – 66.9) 77
† Estimate is subject to greater uncertainty due to small cell size. 
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Table 2.34.a.4. Plasma docosatetraenoic acid (22:4n-6): Non-Hispanic blacks
Geometric mean and selected percentiles of plasma concentrations (in µmol/L) for fasted non-Hispanic blacks 
in the U.S. population aged 20 years and older, National Health and Nutrition Examination Survey, 2003–2004. 
Geometric mean 
(95% conf. interval)
Selected percentiles (95% conf. interval) Sample 
size10th 50th 90th
Males and Females
Total, 20 years and older 26.0 (25.1 – 26.8) 17.4 (15.5 – 18.7) 25.8 (24.3 – 26.8) 38.6 (37.0 – 41.1) 310
20–39 years 25.3 (24.1 – 26.4) 17.5 (14.8 – 18.9) 24.0 (22.6 – 26.3) 37.8 (34.6 – 44.2) 126
40–59 years 27.2 (25.0 – 29.5) 17.4† (14.3 – 19.8) 26.7 (24.7 – 28.2) 41.1† (38.8 – 46.3) 98
60 years and older 25.6 (22.9 – 28.6) 16.8† (9.11 – 20.5) 25.8 (24.0 – 29.4) 35.7† (33.3 – 40.3) 86
Males
Total, 20 years and older 26.7 (24.6 – 28.9) 17.5 (13.0 – 19.5) 25.8 (23.0 – 29.1) 41.6 (38.0 – 46.0) 143
20–39 years 25.7 (24.1 – 27.5) 17.5† (11.3 – 19.7) 23.8 (21.7 – 27.5) 39.9† (34.0 – 75.9) 58
40–59 years 28.6 (24.8 – 33.0) 18.0† (12.7 – 20.7) 26.9 (23.7 – 30.4) 41.9† (36.6 – 96.8) 42
60 years and older 25.6 (20.3 – 32.3) 15.3† (9.11 – 23.9) 26.0 (24.1 – 31.6) 37.0† (32.0 – 47.5) 43
Females
Total, 20 years and older 25.4 (24.0 – 27.0) 17.3 (15.1 – 18.7) 25.6 (23.6 – 27.2) 36.4 (34.4 – 40.4) 167
20–39 years 24.9 (23.1 – 26.8) 17.5† (13.4 – 19.2) 24.5 (22.3 – 27.7) 35.9† (30.8 – 46.3) 68
40–59 years 26.1 (22.7 – 30.1) 15.6† (13.4 – 20.0) 26.6 (22.7 – 27.9) 39.1† (31.1 – 118) 56
60 years and older 25.6 (23.6 – 27.6) 17.5† (13.4 – 21.3) 25.1 (23.5 – 27.4) 35.5† (32.5 – 36.6) 43
† Estimate is subject to greater uncertainty due to small cell size. 
Table 2.34.a.5. Plasma docosatetraenoic acid (22:4n-6): Non-Hispanic whites
Geometric mean and selected percentiles of plasma concentrations (in µmol/L) for fasted non-Hispanic whites 
in the U.S. population aged 20 years and older, National Health and Nutrition Examination Survey, 2003–2004. 
Geometric mean 
(95% conf. interval)
Selected percentiles (95% conf. interval) Sample 
size10th 50th 90th
Males and Females
Total, 20 years and older 24.8 (23.9 – 25.6) 16.8 (15.6 – 17.5) 24.6 (23.9 – 25.6) 36.8 (35.3 – 37.9) 992
20–39 years 24.1 (22.8 – 25.6) 16.4 (14.6 – 17.6) 23.8 (22.9 – 24.9) 35.5 (32.1 – 39.6) 300
40–59 years 25.0 (23.5 – 26.6) 17.2 (14.5 – 18.6) 24.7 (23.6 – 26.5) 36.8 (34.8 – 41.3) 280
60 years and older 25.2 (24.3 – 26.0) 16.6 (15.6 – 17.4) 25.6 (24.1 – 27.0) 36.9 (36.3 – 38.2) 412
Males
Total, 20 years and older 24.9 (23.8 – 26.1) 16.9 (15.0 – 18.1) 24.7 (24.0 – 26.1) 36.7 (35.1 – 38.3) 472
20–39 years 24.8 (22.9 – 26.7) 17.0 (12.5 – 18.9) 24.3 (23.3 – 26.1) 36.3 (33.0 – 39.7) 128
40–59 years 25.8 (24.1 – 27.5) 17.8 (10.9 – 19.8) 25.2 (24.4 – 27.9) 36.9 (35.2 – 44.0) 140
60 years and older 23.9 (22.5 – 25.4) 15.9 (14.5 – 16.8) 24.1 (22.1 – 26.6) 34.9 (33.5 – 37.2) 204
Females
Total, 20 years and older 24.6 (23.7 – 25.6) 16.6 (15.4 – 17.4) 24.4 (23.5 – 25.6) 36.9 (34.4 – 41.0) 520
20–39 years 23.6 (21.9 – 25.4) 15.8 (14.3 – 17.2) 23.0 (21.0 – 25.1) 34.6 (31.9 – 45.6) 172
40–59 years 24.4 (22.4 – 26.6) 15.9 (13.7 – 18.0) 24.3 (22.5 – 25.9) 35.5 (32.9 – 44.5) 140
60 years and older 26.3 (25.0 – 27.6) 17.3 (16.5 – 18.0) 26.2 (24.7 – 28.1) 38.7 (36.3 – 44.4) 208
 













































































































































































































































































































































































































































































































































































































































































































































































































































































Figure 2.35.a. Plasma docosapentaenoic−3 acid (22:5n–3): 
Concentrations by age group 
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Table 2.35.a.2. Plasma docosapentaenoic-3 acid (22:5n-3): Total population
Geometric mean and selected percentiles of plasma concentrations (in µmol/L) for the fasted U.S. population 
aged 20 years and older, National Health and Nutrition Examination Survey, 2003–2004. 
Geometric mean 
(95% conf. interval)
Selected percentiles (95% conf. interval) Sample 
size10th 50th 90th
Males and Females
Total, 20 years and older 41.6 (40.2 – 43.1) 27.4 (26.2 – 28.4) 41.4 (40.0 – 42.8) 62.3 (60.4 – 65.4) 1,808
20–39 years 38.1 (37.1 – 39.0) 26.1 (24.8 – 26.7) 38.0 (36.8 – 39.3) 54.8 (52.4 – 59.9) 610
40–59 years 43.1 (41.1 – 45.3) 27.6 (26.0 – 29.8) 43.2 (40.6 – 46.0) 65.2 (61.6 – 69.7) 515
60 years and older 45.5 (42.3 – 48.8) 29.6 (25.8 – 33.7) 45.7 (42.8 – 49.1) 67.6 (63.0 – 72.4) 683
Males
Total, 20 years and older 42.8 (41.0 – 44.8) 28.8 (26.9 – 30.4) 42.5 (40.6 – 44.1) 63.7 (60.0 – 68.0) 865
20–39 years 40.8 (39.1 – 42.6) 27.3 (25.6 – 29.1) 40.5 (38.5 – 42.9) 59.1 (54.0 – 66.2) 282
40–59 years 44.9 (41.9 – 48.0) 30.2 (28.4 – 31.6) 44.2 (40.7 – 47.8) 68.0 (63.3 – 77.9) 248
60 years and older 43.1 (39.2 – 47.4) 28.7 (23.4 – 33.1) 42.9 (40.9 – 47.2) 60.3 (58.1 – 66.1) 335
Females
Total, 20 years and older 40.5 (39.1 – 42.0) 26.2 (24.8 – 27.4) 40.6 (38.8 – 42.0) 61.4 (59.9 – 65.0) 943
20–39 years 35.6 (34.4 – 36.7) 23.9 (22.8 – 25.7) 35.8 (34.2 – 37.7) 50.4 (48.4 – 56.6) 328
40–59 years 41.6 (39.3 – 44.1) 26.1 (23.1 – 27.7) 41.9 (39.3 – 44.7) 61.2 (58.6 – 71.2) 267
60 years and older 47.5 (44.8 – 50.3) 30.0 (26.8 – 34.2) 48.0 (44.5 – 50.6) 70.1 (67.7 – 74.5) 348
Table 2.35.a.3. Plasma docosapentaenoic-3 acid (22:5n-3): Mexican Americans
Geometric mean and selected percentiles of plasma concentrations (in µmol/L) for fasted Mexican Americans in 
the U.S. population aged 20 years and older, National Health and Nutrition Examination Survey, 2003–2004. 
Geometric mean 
(95% conf. interval)
Selected percentiles (95% conf. interval) Sample 
size10th 50th 90th
Males and Females
Total, 20 years and older 39.9 (37.2 – 42.9) 25.9 (20.2 – 29.5) 40.0 (36.4 – 44.1) 61.2 (57.8 – 67.9) 376
20–39 years 36.9 (33.4 – 40.7) 24.4 (15.2 – 27.2) 36.8 (34.2 – 39.9) 54.9 (50.1 – 75.1) 132
40–59 years 44.5 (39.4 – 50.3) 27.8† (25.5 – 30.9) 44.9 (39.4 – 48.2) 69.4† (58.3 – 127) 93
60 years and older 46.5 (45.2 – 47.9) 30.5 (25.7 – 35.6) 46.6 (44.5 – 50.8) 67.4 (57.5 – 80.9) 151
Males
Total, 20 years and older 41.6 (37.6 – 46.0) 26.8 (22.1 – 30.9) 40.5 (36.3 – 46.4) 67.4 (59.1 – 74.5) 189
20–39 years 38.9 (34.0 – 44.4) 25.4† (15.2 – 30.7) 37.2 (35.5 – 40.8) 60.5† (52.3 – 73.1) 67
40–59 years 47.3 (37.9 – 59.0) 29.4† (26.2 – 31.9) 46.6 (33.3 – 60.1) 76.8† (55.8 – 127) 48
60 years and older 44.3 (40.8 – 48.0) 27.9† (20.5 – 32.2) 46.4 (40.6 – 50.0) 63.3† (55.2 – 83.1) 74
Females
Total, 20 years and older 38.0 (34.6 – 41.6) 24.3 (13.1 – 29.6) 39.2 (34.1 – 44.9) 57.5 (52.2 – 60.8) 187
20–39 years 34.3 (29.6 – 39.9) 20.0† (12.1 – 28.3) 35.3 (30.6 – 41.1) 50.6† (47.1 – 85.4) 65
40–59 years 41.6 (38.4 – 45.0) 25.9† (17.2 – 32.5) 41.5 (36.9 – 47.2) 60.2† (55.9 – 74.8) 45
60 years and older 48.7 (45.6 – 52.0) 31.5† (27.6 – 39.2) 50.2 (44.4 – 52.9) 69.2† (57.4 – 90.2) 77
† Estimate is subject to greater uncertainty due to small cell size. 
2871. Water-Soluble Vitamins 2872. Fat-Soluble Vitamins & Nutrient
Table 2.35.a.4. Plasma docosapentaenoic-3 acid (22:5n-3): Non-Hispanic blacks
Geometric mean and selected percentiles of plasma concentrations (in µmol/L) for fasted non-Hispanic blacks 
in the U.S. population aged 20 years and older, National Health and Nutrition Examination Survey, 2003–2004. 
Geometric mean 
(95% conf. interval)
Selected percentiles (95% conf. interval) Sample 
size10th 50th 90th
Males and Females
Total, 20 years and older 38.9 (36.8 – 41.0) 25.6 (24.6 – 26.5) 38.1 (36.2 – 40.0) 59.3 (55.1 – 62.4) 310
20–39 years 36.0 (32.7 – 39.5) 24.3 (21.5 – 25.8) 35.2 (32.0 – 38.1) 54.6 (48.6 – 63.5) 126
40–59 years 41.1 (37.4 – 45.2) 26.6† (24.3 – 28.0) 40.0 (35.2 – 44.2) 60.3† (57.2 – 84.5) 98
60 years and older 43.0 (40.4 – 45.8) 30.5† (21.3 – 34.2) 43.0 (39.5 – 47.7) 60.6† (54.6 – 63.6) 86
Males
Total, 20 years and older 40.8 (38.5 – 43.2) 26.1 (24.7 – 29.2) 38.7 (37.7 – 41.4) 60.2 (58.8 – 69.2) 143
20–39 years 38.1 (33.8 – 43.0) 25.3† (20.3 – 28.5) 37.7 (32.3 – 39.9) 59.8† (44.2 – 131) 58
40–59 years 43.4 (41.7 – 45.1) 28.4† (24.7 – 30.5) 40.3 (38.6 – 42.1) 68.5† (57.2 – 108) 42
60 years and older 44.4 (41.1 – 48.0) 31.7† (17.8 – 36.7) 44.9 (40.9 – 50.5) 60.5† (58.2 – 64.6) 43
Females
Total, 20 years and older 37.4 (35.0 – 40.1) 24.4 (22.4 – 26.2) 36.8 (34.3 – 40.1) 54.4 (51.8 – 62.5) 167
20–39 years 34.3 (31.2 – 37.7) 21.9† (18.8 – 25.8) 33.5 (28.9 – 38.8) 53.0† (45.4 – 64.5) 68
40–59 years 39.5 (33.5 – 46.5) 23.9† (20.6 – 27.1) 39.3 (33.9 – 44.8) 58.0† (48.6 – 148) 56
60 years and older 42.2 (39.0 – 45.7) 29.5† (25.6 – 34.3) 41.7 (37.8 – 47.7) 56.6† (52.5 – 70.1) 43
† Estimate is subject to greater uncertainty due to small cell size. 
Table 2.35.a.5. Plasma docosapentaenoic-3 acid (22:5n-3): Non-Hispanic whites
Geometric mean and selected percentiles of plasma concentrations (in µmol/L) for fasted non-Hispanic whites 
in the U.S. population aged 20 years and older, National Health and Nutrition Examination Survey, 2003–2004. 
Geometric mean 
(95% conf. interval)
Selected percentiles (95% conf. interval) Sample 
size10th 50th 90th
Males and Females
Total, 20 years and older 42.1 (40.1 – 44.1) 27.7 (26.1 – 29.0) 42.2 (40.4 – 43.8) 62.8 (60.0 – 67.4) 992
20–39 years 38.8 (37.5 – 40.2) 26.7 (24.8 – 28.1) 38.8 (36.8 – 41.0) 54.7 (52.1 – 61.5) 300
40–59 years 42.8 (40.1 – 45.7) 27.6 (24.8 – 30.1) 43.3 (39.7 – 47.0) 63.6 (60.8 – 68.0) 280
60 years and older 45.6 (41.8 – 49.8) 29.5 (25.0 – 33.7) 45.8 (42.5 – 50.1) 68.0 (64.1 – 73.0) 412
Males
Total, 20 years and older 43.1 (40.7 – 45.6) 29.2 (26.9 – 31.2) 43.1 (40.6 – 45.3) 63.0 (59.6 – 66.9) 472
20–39 years 41.5 (39.4 – 43.6) 27.5 (26.4 – 29.3) 42.3 (39.1 – 44.4) 56.4 (53.0 – 72.1) 128
40–59 years 44.5 (41.1 – 48.2) 30.8 (27.1 – 32.2) 44.2 (39.7 – 48.3) 66.1 (61.6 – 75.0) 140
60 years and older 43.0 (38.4 – 48.1) 29.5 (14.9 – 33.9) 42.7 (39.7 – 47.5) 60.2 (57.3 – 70.0) 204
Females
Total, 20 years and older 41.2 (39.3 – 43.1) 26.5 (24.5 – 28.2) 41.3 (38.8 – 43.0) 62.4 (59.2 – 71.1) 520
20–39 years 36.6 (34.7 – 38.6) 24.8 (22.8 – 28.3) 36.8 (34.2 – 38.5) 50.0 (46.5 – 61.2) 172
40–59 years 41.1 (38.0 – 44.6) 26.0 (22.3 – 27.7) 42.0 (38.8 – 46.6) 60.1 (57.1 – 73.0) 140
60 years and older 48.0 (44.4 – 51.8) 29.5 (24.8 – 34.5) 48.4 (44.1 – 52.6) 72.4 (68.4 – 75.1) 208
 

















































































































































































































































































































































































































































































































































































































































































































































































































































































Figure 2.36.a. Plasma docosapentaenoic−6 acid (22:5n–6): 
Concentrations by age group 
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Table 2.36.a.2. Plasma docosapentaenoic-6 acid (22:5n-6): Total population
Geometric mean and selected percentiles of plasma concentrations (in µmol/L) for the fasted U.S. population 
aged 20 years and older, National Health and Nutrition Examination Survey, 2003–2004. 
Geometric mean 
(95% conf. interval)
Selected percentiles (95% conf. interval) Sample 
size10th 50th 90th
Males and Females
Total, 20 years and older 19.6 (18.9 – 20.4) 11.8 (11.4 – 12.3) 19.3 (18.6 – 20.1) 32.5 (31.4 – 33.9) 1,808
20–39 years 19.5 (18.6 – 20.5) 11.8 (11.2 – 12.9) 18.8 (17.9 – 20.0) 32.4 (31.3 – 34.8) 610
40–59 years 19.4 (18.4 – 20.4) 11.5 (11.2 – 12.1) 19.0 (18.3 – 20.5) 31.8 (29.8 – 34.2) 515
60 years and older 20.3 (19.5 – 21.2) 12.2 (10.6 – 12.8) 20.5 (19.5 – 21.5) 33.2 (31.2 – 38.6) 683
Males
Total, 20 years and older 18.6 (17.7 – 19.7) 11.7 (11.0 – 12.3) 18.6 (17.8 – 19.3) 29.8 (28.8 – 32.1) 865
20–39 years 18.4 (17.3 – 19.6) 12.1 (10.8 – 13.1) 18.0 (17.1 – 18.7) 29.6 (27.2 – 33.4) 282
40–59 years 19.0 (17.7 – 20.3) 11.8 (10.6 – 12.4) 19.0 (17.6 – 20.7) 29.4 (28.1 – 33.3) 248
60 years and older 18.4 (17.2 – 19.7) 10.4 (9.64 – 11.7) 18.7 (17.7 – 20.0) 31.2 (27.9 – 35.6) 335
Females
Total, 20 years and older 20.6 (19.8 – 21.4) 12.0 (11.3 – 12.7) 20.5 (19.2 – 21.7) 34.5 (33.0 – 36.6) 943
20–39 years 20.6 (19.4 – 21.9) 11.6 (9.88 – 13.0) 20.5 (18.7 – 22.2) 35.0 (32.4 – 41.2) 328
40–59 years 19.8 (18.3 – 21.3) 11.3 (10.7 – 12.1) 19.1 (17.8 – 21.7) 34.3 (31.1 – 36.4) 267
60 years and older 22.0 (20.7 – 23.3) 13.7 (12.4 – 14.4) 22.0 (20.7 – 23.1) 35.5 (31.4 – 48.5) 348
Table 2.36.a.3. Plasma docosapentaenoic-6 acid (22:5n-6): Mexican Americans
Geometric mean and selected percentiles of plasma concentrations (in µmol/L) for fasted Mexican Americans in 
the U.S. population aged 20 years and older, National Health and Nutrition Examination Survey, 2003–2004. 
Geometric mean 
(95% conf. interval)
Selected percentiles (95% conf. interval) Sample 
size10th 50th 90th
Males and Females
Total, 20 years and older 23.5 (21.0 – 26.2) 14.1 (11.5 – 15.0) 22.8 (19.7 – 27.1) 42.8 (38.9 – 46.1) 376
20–39 years 22.0 (19.6 – 24.8) 13.2 (9.09 – 14.9) 21.0 (18.0 – 25.7) 40.8 (33.5 – 45.8) 132
40–59 years 24.9 (21.6 – 28.7) 14.2† (8.50 – 16.5) 24.7 (20.6 – 29.6) 43.8† (38.4 – 52.6) 93
60 years and older 28.5 (24.4 – 33.3) 17.8 (15.1 – 19.7) 28.2 (23.4 – 33.9) 45.1 (36.8 – 71.9) 151
Males
Total, 20 years and older 22.4 (19.8 – 25.4) 13.7 (10.4 – 15.7) 21.2 (19.1 – 26.0) 38.7 (34.0 – 44.6) 189
20–39 years 21.1 (18.5 – 24.1) 13.3† (9.51 – 15.4) 19.8 (17.6 – 23.2) 33.4† (29.0 – 51.2) 67
40–59 years 24.1 (19.7 – 29.6) 13.8† (6.48 – 17.7) 24.5 (18.1 – 33.3) 42.5† (31.7 – 52.7) 48
60 years and older 26.7 (22.9 – 31.2) 16.4† (12.7 – 19.2) 26.1 (20.7 – 33.2) 41.8† (35.3 – 56.1) 74
Females
Total, 20 years and older 24.8 (21.5 – 28.7) 14.1 (9.21 – 15.0) 24.5 (20.1 – 31.4) 44.7 (41.4 – 53.8) 187
20–39 years 23.4 (19.3 – 28.2) 12.0† (8.52 – 14.8) 22.1 (15.0 – 32.1) 45.5† (35.2 – 104) 65
40–59 years 25.8 (20.4 – 32.6) 14.4† (10.5 – 16.8) 24.6 (18.0 – 35.8) 43.5† (37.4 – 70.9) 45
60 years and older 30.3 (23.9 – 38.3) 19.5† (14.3 – 21.0) 28.8 (22.4 – 41.5) 48.8† (37.9 – 71.9) 77
† Estimate is subject to greater uncertainty due to small cell size. 
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Table 2.36.a.4. Plasma docosapentaenoic-6 acid (22:5n-6): Non-Hispanic blacks
Geometric mean and selected percentiles of plasma concentrations (in µmol/L) for fasted non-Hispanic blacks 
in the U.S. population aged 20 years and older, National Health and Nutrition Examination Survey, 2003–2004. 
Geometric mean 
(95% conf. interval)
Selected percentiles (95% conf. interval) Sample 
size10th 50th 90th
Males and Females
Total, 20 years and older 21.3 (20.3 – 22.4) 12.4 (10.4 – 13.5) 20.8 (19.7 – 22.4) 35.3 (33.3 – 41.5) 310
20–39 years 21.0 (19.2 – 22.8) 12.8 (11.7 – 13.4) 19.9 (18.3 – 23.5) 34.8 (31.5 – 50.8) 126
40–59 years 21.5 (19.4 – 23.7) 12.1† (9.42 – 13.5) 21.7 (19.7 – 22.6) 34.9† (30.5 – 44.0) 98
60 years and older 22.1 (18.4 – 26.6) 12.8† (5.89 – 14.9) 22.9 (17.6 – 28.4) 37.7† (32.6 – 45.7) 86
Males
Total, 20 years and older 20.0 (18.1 – 22.2) 11.7 (9.26 – 13.2) 19.8 (18.3 – 21.6) 34.8 (30.9 – 43.6) 143
20–39 years 18.8 (17.2 – 20.6) 11.4† (5.94 – 13.4) 18.9 (15.9 – 19.9) 32.8† (27.6 – 47.8) 58
40–59 years 21.4 (18.2 – 25.1) 12.2† (9.72 – 13.8) 21.7 (18.1 – 23.2) 32.9† (27.0 – 89.5) 42
60 years and older 21.1 (15.6 – 28.7) 9.26† (5.89 – 15.5) 21.5 (16.0 – 31.7) 39.9† (32.2 – 50.3) 43
Females
Total, 20 years and older 22.4 (20.3 – 24.7) 13.0 (10.3 – 14.6) 22.0 (19.5 – 25.3) 35.3 (33.0 – 45.2) 167
20–39 years 22.9 (19.3 – 27.2) 14.0† (9.93 – 16.1) 22.2 (18.4 – 27.0) 35.3† (31.8 – 100) 68
40–59 years 21.6 (18.7 – 24.9) 11.1† (8.75 – 13.5) 21.3 (18.9 – 26.4) 35.1† (28.2 – 99.4) 56
60 years and older 22.8 (19.3 – 26.9) 13.0† (7.21 – 15.0) 23.2 (17.4 – 29.7) 33.7† (32.4 – 47.7) 43
† Estimate is subject to greater uncertainty due to small cell size. 
Table 2.36.a.5. Plasma docosapentaenoic-6 acid (22:5n-6): Non-Hispanic whites
Geometric mean and selected percentiles of plasma concentrations (in µmol/L) for fasted non-Hispanic whites 
in the U.S. population aged 20 years and older, National Health and Nutrition Examination Survey, 2003–2004. 
Geometric mean 
(95% conf. interval)
Selected percentiles (95% conf. interval) Sample 
size10th 50th 90th
Males and Females
Total, 20 years and older 19.1 (18.3 – 19.9) 11.7 (11.0 – 12.3) 18.9 (18.3 – 19.8) 31.1 (29.4 – 32.6) 992
20–39 years 19.0 (17.9 – 20.2) 11.6 (9.68 – 12.9) 18.5 (17.3 – 20.3) 31.3 (29.1 – 33.0) 300
40–59 years 18.7 (17.3 – 20.3) 11.4 (10.1 – 12.6) 18.6 (17.6 – 19.6) 29.6 (27.6 – 33.3) 280
60 years and older 19.9 (19.2 – 20.6) 11.9 (10.4 – 12.8) 20.1 (19.3 – 21.3) 31.9 (30.5 – 35.2) 412
Males
Total, 20 years and older 18.0 (17.0 – 19.1) 11.4 (10.1 – 12.3) 18.3 (17.6 – 19.0) 28.3 (26.7 – 30.8) 472
20–39 years 17.7 (16.3 – 19.2) 11.5 (8.97 – 13.1) 17.5 (16.8 – 18.5) 27.4 (22.5 – 39.7) 128
40–59 years 18.3 (16.9 – 19.8) 11.6 (8.23 – 13.7) 18.8 (16.9 – 20.2) 28.7 (25.9 – 31.6) 140
60 years and older 18.1 (16.8 – 19.5) 10.4 (9.64 – 11.7) 18.6 (16.9 – 20.4) 29.9 (26.7 – 33.1) 204
Females
Total, 20 years and older 20.2 (19.3 – 21.1) 12.1 (11.2 – 12.8) 20.2 (18.6 – 21.6) 32.9 (31.3 – 35.6) 520
20–39 years 20.3 (18.9 – 21.9) 11.5 (9.55 – 13.2) 20.5 (18.0 – 22.5) 32.6 (30.9 – 42.8) 172
40–59 years 19.2 (17.1 – 21.4) 11.4 (10.0 – 12.5) 18.4 (16.8 – 21.9) 32.3 (27.4 – 37.2) 140
60 years and older 21.5 (20.4 – 22.7) 13.5 (12.0 – 14.1) 21.6 (20.5 – 22.9) 33.6 (30.5 – 49.5) 208
 














































































































































































































































































































































































































































































































































































































































































































































































































































Figure 2.37.a. Plasma docosahexaenoic acid (22:6n–3): 
Concentrations by age group 
Geometric mean (95% confidence interval), National Health and 
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Table 2.37.a.2. Plasma docosahexaenoic acid (22:6n-3): Total population
Geometric mean and selected percentiles of plasma concentrations (in µmol/L) for the fasted U.S. population 
aged 20 years and older, National Health and Nutrition Examination Survey, 2003–2004. 
Geometric mean 
(95% conf. interval)
Selected percentiles (95% conf. interval) Sample 
size10th 50th 90th
Males and Females
Total, 20 years and older 125 (118 – 133) 71.7 (67.1 – 74.9) 121 (114 – 128) 227 (208 – 244) 1,808
20–39 years 115 (108 – 122) 67.0 (62.3 – 71.6) 111 (102 – 119) 204 (187 – 234) 610
40–59 years 125 (115 – 136) 70.1 (62.3 – 77.7) 121 (111 – 136) 217 (201 – 244) 515
60 years and older 145 (135 – 156) 84.2 (73.5 – 94.3) 142 (132 – 154) 247 (234 – 268) 683
Males
Total, 20 years and older 117 (110 – 125) 67.9 (62.5 – 71.7) 114 (107 – 123) 206 (189 – 235) 865
20–39 years 107 (99.5 – 115) 62.3 (57.6 – 68.1) 102 (93.2 – 113) 186 (170 – 209) 282
40–59 years 122 (110 – 135) 68.7 (61.4 – 74.4) 118 (106 – 135) 219 (189 – 296) 248
60 years and older 131 (119 – 143) 77.8 (53.6 – 92.8) 125 (117 – 142) 219 (194 – 256) 335
Females
Total, 20 years and older 133 (125 – 141) 75.6 (68.7 – 80.0) 127 (121 – 135) 238 (223 – 256) 943
20–39 years 123 (115 – 133) 72.4 (61.8 – 78.6) 117 (110 – 127) 220 (194 – 283) 328
40–59 years 128 (117 – 138) 72.3 (59.3 – 79.4) 124 (112 – 143) 210 (201 – 256) 267
60 years and older 158 (148 – 169) 91.4 (82.5 – 99.1) 154 (144 – 168) 272 (249 – 307) 348
Table 2.37.a.3. Plasma docosahexaenoic acid (22:6n-3): Mexican Americans
Geometric mean and selected percentiles of plasma concentrations (in µmol/L) for fasted Mexican Americans in 
the U.S. population aged 20 years and older, National Health and Nutrition Examination Survey, 2003–2004. 
Geometric mean 
(95% conf. interval)
Selected percentiles (95% conf. interval) Sample 
size10th 50th 90th
Males and Females
Total, 20 years and older 111 (105 – 119) 67.1 (57.8 – 73.0) 111 (99.8 – 123) 185 (165 – 199) 376
20–39 years 102 (91.1 – 114) 60.0 (55.3 – 67.6) 100 (80.6 – 122) 161 (150 – 204) 132
40–59 years 127 (117 – 137) 84.9† (56.6 – 94.3) 125 (112 – 139) 189† (163 – 266) 93
60 years and older 129 (118 – 142) 81.2 (61.1 – 92.2) 131 (114 – 144) 202 (185 – 246) 151
Males
Total, 20 years and older 107 (99.7 – 114) 64.8 (55.1 – 69.2) 104 (95.3 – 124) 165 (158 – 188) 189
20–39 years 96.1 (85.8 – 108) 59.4† (52.4 – 67.1) 99.4 (78.2 – 119) 147† (136 – 158) 67
40–59 years 129 (110 – 152) 83.3† (66.8 – 93.9) 127 (101 – 153) 194† (155 – 355) 48
60 years and older 120 (109 – 132) 69.0† (46.1 – 90.1) 121 (105 – 143) 190† (159 – 272) 74
Females
Total, 20 years and older 118 (105 – 131) 68.8 (52.3 – 83.3) 116 (102 – 133) 191 (166 – 250) 187
20–39 years 110 (90.5 – 134) 60.4† (54.0 – 73.7) 109 (75.7 – 150) 191† (158 – 325) 65
40–59 years 124 (111 – 139) 87.9† (52.3 – 99.1) 119 (110 – 139) 173† (150 – 268) 45
60 years and older 139 (115 – 168) 88.9† (77.0 – 107) 133 (109 – 164) 229† (183 – 334) 77
† Estimate is subject to greater uncertainty due to small cell size. 
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Table 2.37.a.4. Plasma docosahexaenoic acid (22:6n-3): Non-Hispanic blacks
Geometric mean and selected percentiles of plasma concentrations (in µmol/L) for fasted non-Hispanic blacks 
in the U.S. population aged 20 years and older, National Health and Nutrition Examination Survey, 2003–2004. 
Geometric mean 
(95% conf. interval)
Selected percentiles (95% conf. interval) Sample 
size10th 50th 90th
Males and Females
Total, 20 years and older 140 (124 – 157) 83.4 (72.4 – 90.8) 133 (118 – 152) 251 (207 – 333) 310
20–39 years 128 (107 – 153) 77.2 (66.4 – 89.0) 119 (103 – 140) 237 (177 – 367) 126
40–59 years 142 (127 – 159) 84.1† (69.9 – 95.8) 133 (119 – 157) 234† (204 – 374) 98
60 years and older 173 (155 – 193) 117† (56.2 – 135) 173 (149 – 197) 258† (216 – 368) 86
Males
Total, 20 years and older 129 (114 – 147) 72.4 (60.4 – 82.2) 124 (110 – 145) 233 (198 – 361) 143
20–39 years 112 (89.9 – 141) 67.9† (52.5 – 76.1) 107 (84.5 – 140) 193† (143 – 367) 58
40–59 years 143 (124 – 165) 77.8† (62.1 – 89.4) 131 (113 – 171) 283† (217 – 404) 42
60 years and older 161 (138 – 189) 113† (47.5 – 127) 159 (144 – 175) 251† (195 – 368) 43
Females
Total, 20 years and older 148 (129 – 171) 96.2 (80.8 – 104) 136 (120 – 176) 254 (203 – 442) 167
20–39 years 142 (118 – 172) 93.1† (80.7 – 98.8) 127 (106 – 186) 254† (191 – 340) 68
40–59 years 141 (121 – 165) 90.3† (47.6 – 110) 132 (119 – 163) 208† (184 – 442) 56
60 years and older 181 (162 – 201) 121† (63.8 – 136) 182 (149 – 213) 258† (222 – 351) 43
† Estimate is subject to greater uncertainty due to small cell size. 
Table 2.37.a.5. Plasma docosahexaenoic acid (22:6n-3): Non-Hispanic whites
Geometric mean and selected percentiles of plasma concentrations (in µmol/L) for fasted non-Hispanic whites 
in the U.S. population aged 20 years and older, National Health and Nutrition Examination Survey, 2003–2004. 
Geometric mean 
(95% conf. interval)
Selected percentiles (95% conf. interval) Sample 
size10th 50th 90th
Males and Females
Total, 20 years and older 122 (113 – 130) 69.8 (64.4 – 74.5) 117 (110 – 127) 215 (202 – 235) 992
20–39 years 111 (102 – 121) 65.2 (58.4 – 72.4) 110 (97.8 – 118) 201 (170 – 258) 300
40–59 years 118 (108 – 130) 65.9 (55.3 – 75.7) 114 (106 – 128) 206 (181 – 252) 280
60 years and older 142 (131 – 155) 84.2 (67.8 – 95.3) 136 (125 – 154) 244 (233 – 266) 412
Males
Total, 20 years and older 113 (105 – 122) 65.3 (59.6 – 71.8) 112 (102 – 121) 198 (178 – 229) 472
20–39 years 102 (94.4 – 110) 60.8 (54.8 – 68.1) 96.1 (84.4 – 113) 180 (157 – 212) 128
40–59 years 115 (103 – 128) 64.9 (53.7 – 73.5) 113 (97.8 – 127) 194 (167 – 303) 140
60 years and older 128 (116 – 142) 77.0 (49.3 – 93.0) 121 (113 – 141) 213 (188 – 254) 204
Females
Total, 20 years and older 130 (120 – 140) 74.4 (65.3 – 79.0) 124 (116 – 133) 229 (209 – 259) 520
20–39 years 121 (109 – 134) 72.4 (54.3 – 79.2) 114 (104 – 127) 204 (178 – 315) 172
40–59 years 122 (111 – 133) 68.0 (52.5 – 78.9) 120 (106 – 139) 207 (188 – 244) 140
60 years and older 156 (142 – 170) 89.5 (81.0 – 97.4) 150 (132 – 174) 274 (243 – 330) 208
 























































300 2nd National Report on Biochemical Indicators of Diet and Nutrition in the U.S. Population
Iron-Status Indicators
Background Information








































































































































   





























































































Serum body iron stores








Figure H.3.a. Age-adjusted prevalence estimates of low body iron stores 
(< 0 mg/kg) in U.S. children and women by race/ethnicity, National 
Health and Nutrition Examination Survey, 2003–2006. 
Error bars represent 95% confidence intervals. Bars not sharing a common letter 
differ within children and women (p < 0.05). Age adjustment was done using 
direct standardization. 
igure H.3.b. Prevalence estimates of low serum ferritin, high serum 
oluble transferrin receptor, and low serum body iron in U.S. women 
2–49 years of age, National Health and Nutrition Examination Survey, 
003–2006. 
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Figure H.3.c. Age-adjusted prevalence estimates of low (< 15 ng/mL) and high serum ferritin (> 200 ng/mL for men and > 150 ng/
mL for women) in U.S. men and women aged 12–49 years, National Health and Nutrition Examination Survey, 1999–2006.
Error bars represent 95% confidence intervals. Within each ferritin status category, bars not sharing a common letter differ (p < 0.05). Age adjustment 
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Figure H.3.d. Age-adjusted geometric mean concentrations of serum ferritin in U.S. women aged 12–49 years by race/ethnicity, 
National Health and Nutrition Examination Survey, 1988–2006. 
Error bars represent 95% confidence intervals. Within a demographic group, bars not sharing a common letter differ (p < 0.05). Age adjustment was 
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Non−Hispanic Blacks Non−Hispanic Whites 
Figure 3.1. a . Serum ferritin: Concentrations by age group 
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Table 3.1.a.2. Serum ferritin: Total population
Geometric mean and selected percentiles of serum concentrations (in ng/mL) for children aged 1–5 years and 
women aged 12–49 years in the U.S. population, National Health and Nutrition Examination Survey, 2003–2006. 
Geometric mean 
(95% conf. interval)
Selected percentiles (95% conf. interval) Sample 
size5th 50th 95th
Males and Females
Total, Children 1–5 years, 
women 12–49 years 35.7 (34.4 – 37.1) 6.99 (6.15 – 7.71) 36.2 (34.7 – 38.1) 143 (133 – 157) 6,012
1–5 years 26.2 (25.2 – 27.3) 9.14 (7.87 – 9.82) 26.7 (25.5 – 27.9) 65.6 (59.6 – 68.1) 1,482
Males
1–5 years 26.2 (24.9 – 27.7) 8.90 (8.01 – 9.68) 26.9 (25.1 – 28.5) 63.6 (56.9 – 70.7) 757
Females
Total, 1–5, 12–49 years 36.6 (35.2 – 38.1) 6.80 (5.96 – 7.56) 38.1 (36.0 – 39.4) 145 (136 – 165) 5,255
1–5 years 26.3 (24.9 – 27.7) 9.29 (6.81 – 10.1) 26.5 (24.8 – 28.0) 67.0 (59.2 – 74.3) 725
12–19 years 29.3 (27.7 – 30.9) 6.83 (5.19 – 7.77) 31.9 (29.9 – 33.3) 81.4 (76.7 – 92.2) 1,991
20–39 years 38.1 (36.1 – 40.2) 7.19 (5.66 – 8.21) 40.5 (38.3 – 43.3) 135 (114 – 159) 1,780
40–49 years 43.2 (39.0 – 47.7) 5.81 (4.73 – 7.10) 45.9 (40.5 – 50.7) 211 (184 – 262) 759
Table 3.1.a.3. Serum ferritin: Mexican Americans
Geometric mean and selected percentiles of serum concentrations (in ng/mL) for Mexican-American children 




Selected percentiles (95% conf. interval) Sample 
size5th 50th 95th
Males and Females
Total, Children 1–5 years, 
women 12–49 years 30.2 (27.5 – 33.1) 4.87 (4.62 – 5.46) 31.7 (28.7 – 34.0) 121 (101 – 161) 1,704
1–5 years 24.5 (22.8 – 26.3) 6.44 (4.69 – 7.69) 25.5 (23.5 – 27.6) 68.9 (57.7 – 83.3) 468
Males
1–5 years 23.5 (21.3 – 25.9) 6.04 (4.33 – 7.21) 24.6 (23.1 – 27.0) 63.8 (52.5 – 118) 225
Females
Total, 1–5, 12–49 years 31.0 (28.0 – 34.5) 4.84 (4.59 – 5.33) 33.2 (29.3 – 36.1) 126 (104 – 167) 1,479
1–5 years 25.5 (23.6 – 27.6) 6.81 (4.56 – 9.78) 26.7 (23.2 – 29.8) 69.6 (60.7 – 88.6) 243
12–19 years 26.6 (24.8 – 28.5) 6.35 (4.85 – 7.38) 27.3 (25.5 – 29.2) 89.6 (80.6 – 97.3) 647
20–39 years 33.7 (29.2 – 38.9) 4.89 (4.62 – 5.51) 37.1 (31.6 – 43.9) 139 (106 – 213) 434
40–49 years 33.1 (25.7 – 42.7) 4.27† (3.48 – 4.66) 34.3 (28.3 – 42.9) 170† (134 – 262) 155
† Estimate is subject to greater uncertainty due to small cell size. 
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Table 3.1.a.4. Serum ferritin: Non-Hispanic blacks
Geometric mean and selected percentiles of serum concentrations (in ng/mL) for non-Hispanic black children 




Selected percentiles (95% conf. interval) Sample 
size5th 50th 95th
Males and Females
Total, Children 1–5 years, 
women 12–49 years 33.5 (31.4 – 35.7) 5.49 (4.69 – 6.46) 33.7 (31.8 – 35.8) 165 (133 – 201) 1,676
1–5 years 30.8 (28.9 – 32.8) 11.4 (9.51 – 14.2) 30.7 (28.7 – 32.7) 72.5 (65.8 – 88.9) 429
Males
1–5 years 30.0 (27.3 – 32.9) 10.6† (5.39 – 14.4) 29.6 (26.6 – 33.4) 66.2† (58.1 – 96.6) 218
Females
Total, 1–5, 12–49 years 33.8 (31.5 – 36.2) 5.26 (4.56 – 6.25) 34.1 (32.1 – 36.9) 171 (139 – 207) 1,458
1–5 years 31.7 (29.8 – 33.7) 12.4† (9.78 – 14.6) 31.6 (29.1 – 33.6) 75.8† (67.6 – 89.4) 211
12–19 years 28.2 (25.5 – 31.2) 6.61 (4.97 – 7.55) 31.1 (27.4 – 33.7) 88.7 (79.4 – 104) 674
20–39 years 30.1 (27.9 – 32.4) 5.02 (4.22 – 6.08) 31.1 (28.4 – 34.1) 132 (122 – 173) 375
40–49 years 49.6 (40.4 – 61.0) 4.31† (< LOD – 8.31) 53.5 (42.2 – 63.9) 257† (207 – 531) 198
< LOD means less than the limit of detection, which may vary for some compounds by year. See Appendix D for LOD. 
† Estimate is subject to greater uncertainty due to small cell size. 
Table 3.1.a.5. Serum ferritin: Non-Hispanic whites
Geometric mean and selected percentiles of serum concentrations (in ng/mL) for non-Hispanic white children 




Selected percentiles (95% conf. interval) Sample 
size5th 50th 95th
Males and Females
Total, Children 1–5 years, 
women 12–49 years 37.5 (35.5 – 39.6) 8.07 (6.52 – 8.85) 38.2 (35.9 – 39.8) 143 (131 – 159) 2,089
1–5 years 25.9 (24.2 – 27.7) 9.30 (8.13 – 10.0) 26.3 (24.4 – 28.1) 61.4 (55.7 – 67.8) 416
Males
1–5 years 26.1 (23.8 – 28.6) 9.13 (4.71 – 10.5) 27.1 (24.3 – 29.7) 56.9 (53.5 – 89.4) 229
Females
Total, 1–5, 12–49 years 38.5 (36.3 – 40.7) 7.96 (6.36 – 8.78) 39.4 (37.2 – 41.0) 144 (135 – 167) 1,860
1–5 years 25.6 (23.4 – 27.9) 9.40† (5.96 – 10.3) 25.5 (23.4 – 27.8) 63.7† (53.8 – 87.4) 187
12–19 years 30.0 (27.7 – 32.6) 6.88 (4.67 – 8.55) 33.0 (31.1 – 34.9) 78.2 (70.9 – 93.0) 520
20–39 years 41.0 (37.8 – 44.5) 8.75 (7.16 – 10.1) 42.3 (39.2 – 47.0) 134 (112 – 171) 812
40–49 years 43.6 (38.3 – 49.6) 6.61 (4.82 – 8.43) 46.1 (39.7 – 51.2) 212 (164 – 266) 341
† Estimate is subject to greater uncertainty due to small cell size. 
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Table 3.1.b. Serum ferritin: Concentrations by survey cycle
Geometric mean and selected percentiles of serum concentrations (in ng/mL) for children aged 1–5 and women 
aged 12–49 years in the U.S. population, National Health and Nutrition Examination Survey, 1999–2006. 
Geometric mean 
 (95% conf. interval)
Selected percentiles (95% conf. interval) Sample 
size5th 50th 95th
Total (Children 1–5 years, women 12–49 years)
 1999–2000 38.8 (36.7 – 41.0) 8.06 (5.23 – 9.99) 38.3 (34.7 – 42.5) 139 (129 – 173) 2,919
 2001–2002 36.1 (34.2 – 38.0) 5.23 ** 35.2 (33.2 – 37.2) 149 (136 – 175) 3,365
 2003–2004 36.4 (34.7 – 38.3) 7.70 (5.80 – 8.58) 36.1 (34.6 – 38.6) 151 (141 – 173) 2,981
 2005–2006 35.0 (32.9 – 37.2) 6.46 (5.69 – 7.19) 36.2 (33.6 – 38.7) 135 (113 – 167) 3,031
Age group
1–5 years (Children)
 1999–2000 28.7 (26.9 – 30.7) 10.6 (5.95 – 13.5) 28.2 (26.0 – 31.6) 74.6 (57.9 – 94.2) 680
 2001–2002 27.9 (25.6 – 30.5) 6.43 (5.23 – 9.79) 28.2 (26.2 – 30.4) 78.6 (68.5 – 105) 843
 2003–2004 25.2 (23.7 – 26.8) 9.27 (8.08 – 9.76) 24.9 (23.2 – 26.7) 64.0 (57.0 – 67.8) 796
 2005–2006 27.6 (26.0 – 29.2) 8.95 (7.95 – 9.78) 28.5 (27.4 – 30.1) 66.7 (63.2 – 77.2) 686
12–19 years (Women)
 1999–2000 32.5 (29.6 – 35.8) 9.26 (5.23 – 10.4) 32.8 (29.6 – 37.1) 83.3 (79.4 – 99.7) 1,048
 2001–2002 30.1 (28.5 – 31.9) 6.55 (5.23 – 8.62) 32.5 (29.9 – 33.7) 84.5 (79.3 – 95.6) 1,120
 2003–2004 28.0 (25.5 – 30.7) 6.11 (4.43 – 7.97) 30.1 (27.9 – 32.7) 86.4 (75.6 – 102) 998
 2005–2006 30.6 (28.6 – 32.8) 7.21 (5.52 – 8.79) 33.4 (30.9 – 35.7) 79.0 (75.0 – 94.0) 993
20–39 years (Women)
 1999–2000 40.0 (36.0 – 44.4) 5.23 ** 43.5 (36.3 – 52.2) 137 (118 – 187) 838
 2001–2002 37.8 (35.2 – 40.5) 5.23 ** 38.3 (34.5 – 41.7) 142 (119 – 192) 992
 2003–2004 39.8 (37.1 – 42.7) 8.40 (7.52 – 9.20) 41.1 (39.2 – 44.6) 132 (111 – 172) 822
 2005–2006 36.5 (33.5 – 39.9) 5.60 (4.70 – 7.17) 39.2 (34.1 – 44.6) 135 (110 – 179) 958
40–49 years (Women)
 1999–2000 50.3 (43.6 – 57.9) 9.15 (5.23 – 12.1) 50.0 (42.8 – 59.8) 227 (202 – 275) 353
 2001–2002 43.7 (39.3 – 48.6) 5.23 ** 46.5 (39.2 – 53.9) 221 (195 – 249) 410
 2003–2004 46.6 (39.9 – 54.4) 5.16 (4.21 – 8.44) 47.1 (43.5 – 53.6) 227 (197 – 317) 365
 2005–2006 40.0 (34.5 – 46.3) 6.26 (4.89 – 6.96) 41.6 (34.0 – 51.7) 169 (144 – 264) 394
Gender
Males (1–5 years)
 1999–2000 27.4 (25.4 – 29.6) 10.8 (6.11 – 13.1) 26.6 (24.7 – 28.4) 73.7 (55.4 – 95.7) 377
 2001–2002 26.1 (23.4 – 29.0) 5.23 ** 27.4 (24.4 – 30.3) 77.9 (67.2 – 112) 428
 2003–2004 25.0 (23.1 – 27.1) 9.19 (6.68 – 10.2) 24.8 (22.5 – 27.0) 57.3 (55.3 – 67.6) 415
 2005–2006 27.8 (25.8 – 29.9) 8.71 (8.18 – 9.54) 29.3 (26.9 – 31.0) 70.4 (55.8 – 105) 342
Females (1–5, 12–49 years)
 1999–2000 40.0 (37.7 – 42.5) 7.86 (5.23 – 9.85) 40.8 (37.0 – 45.1) 146 (132 – 179) 2,542
 2001–2002 37.0 (35.2 – 38.9) 5.23 ** 36.3 (34.5 – 38.3) 157 (141 – 186) 2,937
 2003–2004 37.7 (35.6 – 39.8) 7.60 (5.49 – 8.51) 38.7 (36.0 – 40.1) 158 (143 – 186) 2,566
 2005–2006 35.6 (33.4 – 37.9) 6.31 (5.46 – 7.04) 37.2 (34.2 – 40.0) 137 (115 – 176) 2,689
Race/ethnicity (Children 1–5 years, women 12–49 years)
Mexican Americans
 1999–2000 29.0 (26.6 – 31.6) 5.23 ** 30.2 (27.9 – 32.7) 117 (81.2 – 179) 1,077
 2001–2002 27.9 (25.6 – 30.4) 5.23 ** 28.9 (26.8 – 31.3) 102 (82.4 – 162) 967
 2003–2004 32.0 (27.4 – 37.4) 6.36 (4.30 – 7.98) 33.2 (28.1 – 36.8) 140 (98.8 – 203) 793
 2005–2006 28.4 (25.7 – 31.4) 4.57 (4.01 – 5.22) 29.7 (27.6 – 32.9) 106 (98.4 – 119) 911
Non-Hispanic Blacks
 1999–2000 38.5 (34.3 – 43.3) 5.23 ** 38.1 (33.1 – 44.9) 171 (130 – 382) 690
 2001–2002 35.8 (31.0 – 41.3) 5.23 ** 36.1 (32.7 – 40.2) 187 (138 – 263) 855
 2003–2004 34.1 (30.5 – 38.2) 5.74 (4.17 – 7.50) 33.1 (30.0 – 36.9) 172 (127 – 267) 870
 2005–2006 32.7 (30.5 – 35.1) 5.35 (4.67 – 6.15) 34.3 (31.1 – 38.1) 145 (127 – 179) 806
Non-Hispanic Whites
 1999–2000 41.1 (38.4 – 44.0) 9.77 (5.23 – 12.4) 41.0 (35.1 – 47.1) 146 (131 – 181) 838
 2001–2002 37.0 (34.2 – 40.1) 6.86 (5.23 – 8.38) 35.5 (32.8 – 38.6) 141 (124 – 188) 1,236
 2003–2004 37.7 (35.1 – 40.5) 8.37 (4.79 – 10.0) 38.3 (35.6 – 39.7) 147 (136 – 190) 1,069
 2005–2006 37.3 (34.1 – 40.7) 7.57 (6.33 – 8.68) 38.1 (34.4 – 41.1) 135 (113 – 176) 1,020
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Figure 3.1.b. Serum ferritin: Concentrations by survey cycle 
Selected percentiles in ng/mL (95% confidence intervals), National Health and 
Nutrition Examination Survey, 1999–2006 
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Table 3.1.c.1. Serum ferritin: Prevalence
Prevalence (in percent) of low serum ferritin concentration (< 12 ng/mL) for children in the U.S. 




 (95% conf. interval)
Estimated total 
number of persons
Children, 1–5 years 1,482 8.9 (7.1 – 11.2) 1,810,000
Gender
Males 757 9.2 (7.1 – 11.9) 953,000
Females 725 8.6 (6.2 – 11.8) 855,000
Race/ethnicity
Mexican Americans 468 11.4 (8.6 – 15.1) 348,000
Non-Hispanic Blacks 429 4.9 (3.1 – 7.8) 148,000





Table 3.1.c.2. Serum ferritin: Prevalence
Prevalence (in percent) of low serum ferritin concentration (< 15 ng/mL) for women in the U.S. 




 (95% conf. interval)
Estimated total 
number of persons
Women, 12–49 years 4,530 13.6 (12.2 – 15.2) 10,748,000
Age group
12–19 years 1,991 15.2 (12.4 – 18.4) 2,462,000
20–49 years 2,539 13.2 (11.8 – 14.8) 8,299,000
Race/ethnicity
Mexican Americans 1,236 18.6 (14.9 – 23.0) 1,427,000
Non-Hispanic Blacks 1,247 19.9 (17.9 – 22.1) 2,140,000
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Table 3.1.c.3. Serum ferritin: Prevalence
Prevalence (in percent) of high serum ferritin concentration (> 150 ng/mL) for women in the U.S. 




 (95% conf. interval)
Estimated total 
number of persons
Women, 12–49 years 4,530 5.2 (4.2 – 6.4) 4,086,000
Age group
12–19 years 1,991 0.9‡ (0.5 – 1.8) 149,000‡
20–49 years 2,539 6.2 (5.0 – 7.7) 3,900,000
Race/ethnicity
Mexican Americans 1,236 4.2 (2.5 – 7.2) 324,000
Non-Hispanic Blacks 1,247 7.1 (5.0 – 9.9) 759,000
Non-Hispanic Whites 1,673 4.9 (3.7 – 6.3) 2,495,000




Table 3.1.d.1. Serum ferritin: Prevalence by survey cycle
Prevalence (in percent) of low serum ferritin concentration (< 12 ng/mL) for children in the U.S. population 
aged 1–5 years, National Health and Nutrition  Examination Survey, 1999–2006. 
Sample size Prevalence (95% conf. interval) Estimated total number of persons
Children, 1–5 years
 1999–2000 680 5.7 (3.3 – 9.6) 1,133,000
 2001–2002 843 10.0 (7.0 – 13.9) 1,935,000
 2003–2004 796 9.0 (6.6 – 12.3) 1,828,000
 2005–2006 686 8.8 (6.0 – 12.8) 1,782,000
Gender
Males
 1999–2000 377 5.9 (3.3 – 10.4) 599,000
 2001–2002 428 13.3 (8.6 – 20.1) 1,326,000
 2003–2004 415 9.4 (6.6 – 13.3) 970,000
 2005–2006 342 9.0 (5.8 – 13.8) 933,000
Females
 1999–2000 303 5.5‡ (2.4 – 12.0) 530,000‡
 2001–2002 415 6.5 (4.3 – 9.6) 613,000
 2003–2004 381 8.6 (5.6 – 12.8) 854,000
 2005–2006 344 8.6 (4.8 – 14.9) 849,000
Race/ethnicity
Mexican Americans
 1999–2000 269 11.7 (7.7 – 17.4) 305,000
 2001–2002 246 10.1 (7.4 – 13.6) 283,000
 2003–2004 230 12.5 (7.6 – 19.8) 380,000
 2005–2006 238 10.2 (8.1 – 12.8) 329,000
Non-Hispanic Blacks
 1999–2000 168 4.7 (2.6 – 8.4) 142,000
 2001–2002 247 § §
 2003–2004 252 6.0 (3.1 – 11.3) 180,000
 2005–2006 177 3.4‡ (1.7 – 6.9) 100,000‡
Non-Hispanic Whites
 1999–2000 161 2.9‡ (1.3 – 6.1) 346,000‡
 2001–2002 259 11.9 (7.1 – 19.2) 1,357,000
 2003–2004 230 9.4 (5.5 – 15.5) 1,088,000
 2005–2006 186 10.3 (6.1 – 16.7) 1,157,000
‡ Estimate flagged: 30% ≤ RSE < 40% for the prevalence estimate. 
§ Estimate suppressed: RSE ≥ 40% for the prevalence estimate. 
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Table 3.1.d.2. Serum ferritin: Prevalence by survey cycle
Prevalence (in percent) of low serum ferritin concentration (< 15 ng/mL) for women in the U.S. population 
aged 12–49 years, National Health and Nutrition Examination Survey, 1999–2006. 
Sample size Prevalence (95% conf. interval) Estimated total number of persons
Women, 12–49 years
 1999–2000 2,239 11.4 (9.4 – 13.9) 8,767,000
 2001–2002 2,522 13.9 (12.2 – 15.8) 10,821,000
 2003–2004 2,185 13.2 (10.7 – 16.3) 10,460,000
 2005–2006 2,345 14.0 (12.6 – 15.5) 11,069,000
Age group
12–19 years
 1999–2000 1,048 11.5 (8.5 – 15.3) 1,781,000
 2001–2002 1,120 13.9 (11.2 – 17.1) 2,201,000
 2003–2004 998 17.4 (12.8 – 23.3) 2,825,000
 2005–2006 993 12.9 (10.0 – 16.5) 2,119,000
20–49 years
 1999–2000 1,191 11.4 (9.2 – 14.2) 6,986,000
 2001–2002 1,402 13.9 (12.0 – 16.0) 8,620,000
 2003–2004 1,187 12.2 (9.7 – 15.2) 7,670,000
 2005–2006 1,352 14.2 (12.8 – 15.7) 8,938,000
Race/ethnicity
Mexican Americans
 1999–2000 808 18.8 (12.3 – 27.5) 1,140,000
 2001–2002 721 21.9 (18.8 – 25.4) 1,541,000
 2003–2004 563 16.7 (11.7 – 23.2) 1,276,000
 2005–2006 673 20.6 (15.3 – 27.2) 1,632,000
Non-Hispanic Blacks
 1999–2000 522 16.4 (11.2 – 23.4) 1,764,000
 2001–2002 608 19.5 (12.3 – 29.6) 2,091,000
 2003–2004 618 19.1 (16.4 – 22.0) 2,051,000
 2005–2006 629 20.7 (17.5 – 24.4) 2,256,000
Non-Hispanic Whites
 1999–2000 677 9.1 (6.7 – 12.2) 4,741,000
 2001–2002 977 11.6 (9.5 – 14.2) 6,025,000
 2003–2004 839 11.8 (8.3 – 16.5) 6,032,000
 2005–2006 834 10.9 (8.5 – 13.8) 5,500,000
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Table 3.1.d.3. Serum ferritin: Prevalence by survey cycle
Prevalence (in percent) of low serum ferritin concentration (< 15 ng/mL) for males in the U.S. population aged 
6 years and older, National Health and Nutrition Examination Survey, 1999–2002. 
Sample size Prevalence (95% conf. interval) Estimated total number of persons
Males, 6 years and older
 1999–2000 3,488 1.1 (0.6 – 2.0) 1,323,000
 2001–2002 3,849 1.3 (0.9 – 1.7) 1,576,000
Age group
6–11 years
 1999–2000 463 § §
 2001–2002 509 § §
12–19 years
 1999–2000 1,078 2.1‡ (1.0 – 4.2) 336,000‡
 2001–2002 1,094 2.8‡ (1.4 – 5.4) 463,000‡
20–39 years
 1999–2000 632 § §
 2001–2002 724 0.5‡ (0.2 – 1.0) 176,000‡
40–59 years
 1999–2000 570 § §
 2001–2002 770 § §
60 years and older
 1999–2000 745 § §
 2001–2002 752 2.0 (1.1 – 3.4) 384,000
Race/ethnicity
Mexican Americans
 1999–2000 1,196 1.0 (0.5 – 1.8) 91,000
 2001–2002 958 0.7‡ (0.3 – 1.5) 77,000‡
Non-Hispanic Blacks
 1999–2000 781 § §
 2001–2002 921 1.3‡ (0.7 – 2.7) 187,000‡
Non-Hispanic Whites
 1999–2000 1,223 1.3‡ (0.6 – 2.7) 1,100,000‡
 2001–2002 1,678 1.3 (0.9 – 1.9) 1,159,000
‡ Estimate flagged: 30% ≤ RSE < 40% for the prevalence estimate. 
§ Estimate suppressed: RSE ≥ 40% for the prevalence estimate. 
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Table 3.1.d.4. Serum ferritin: Prevalence by survey cycle
Prevalence (in percent) of high serum ferritin concentration (> 150 ng/mL) for women in the U.S. population 
aged 12–49 years, National Health and Nutrition Examination Survey, 1999–2006. 
Sample size Prevalence (95% conf. interval) Estimated total number of persons
Women, 12–49 years
 1999–2000 2,239 5.3 (4.0 – 7.0) 4,069,000
 2001–2002 2,522 5.6 (4.5 – 7.0) 4,374,000
 2003–2004 2,185 6.0 (4.7 – 7.5) 4,711,000
 2005–2006 2,345 4.4 (2.9 – 6.6) 3,470,000
Age group
12–19 years
 1999–2000 1,048 § §
 2001–2002 1,120 § §
 2003–2004 998 § §
 2005–2006 993 1.4‡ (0.6 – 3.2) 237,000‡
20–49 years
 1999–2000 1,191 6.3 (4.8 – 8.3) 3,878,000
 2001–2002 1,402 6.8 (5.3 – 8.5) 4,196,000
 2003–2004 1,187 7.3 (5.9 – 9.1) 4,600,000
 2005–2006 1,352 5.1 (3.2 – 7.9) 3,202,000
Race/ethnicity
Mexican Americans
 1999–2000 808 3.7‡ (1.7 – 7.9) 224,000‡
 2001–2002 721 3.5 (1.8 – 6.8) 249,000
 2003–2004 563 5.6‡ (2.7 – 11.3) 429,000‡
 2005–2006 673 2.9‡ (1.4 – 5.7) 226,000‡
Non-Hispanic Blacks
 1999–2000 522 7.8 (5.2 – 11.6) 840,000
 2001–2002 608 7.7 (5.0 – 11.8) 828,000
 2003–2004 618 8.3 (4.6 – 14.7) 895,000
 2005–2006 629 5.7 (4.2 – 7.9) 625,000
Non-Hispanic Whites
 1999–2000 677 5.7 (4.1 – 8.0) 3,000,000
 2001–2002 977 5.0 (3.4 – 7.2) 2,579,000
 2003–2004 839 5.7 (4.1 – 7.8) 2,926,000
 2005–2006 834 4.0 (2.5 – 6.3) 2,026,000
‡ Estimate flagged: 30% ≤ RSE < 40% for the prevalence estimate. 
§ Estimate suppressed: RSE ≥ 40% for the prevalence estimate. 
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Table 3.1.d.5. Serum ferritin: Prevalence by survey cycle
Prevalence (in percent) of high serum ferritin concentration (> 200 ng/mL) for males in the U.S. population 
aged 12 years and older, National Health and Nutrition Examination Survey, 1999–2002. 
Sample size Prevalence (95% conf. interval) Estimated total number of persons
Males, 12 years and older
 1999–2000 3,025 31.8 (27.7 – 36.3) 34,391,000
 2001–2002 3,340 32.7 (30.1 – 35.5) 36,644,000
Age group
12–19 years
 1999–2000 1,078 3.3 (1.8 – 6.0) 538,000
 2001–2002 1,094 1.7 (1.0 – 2.9) 283,000
20–39 years
 1999–2000 632 33.1 (26.8 – 40.1) 12,720,000
 2001–2002 724 31.0 (27.1 – 35.1) 12,101,000
40–59 years
 1999–2000 570 39.9 (33.0 – 47.1) 13,748,000
 2001–2002 770 44.5 (39.0 – 50.2) 16,443,000
60 years and older
 1999–2000 745 39.1 (33.2 – 45.2) 7,336,000
 2001–2002 752 37.2 (32.3 – 42.4) 7,219,000
Race/ethnicity
Mexican Americans
 1999–2000 998 27.4 (23.1 – 32.1) 2,155,000
 2001–2002 819 25.8 (21.3 – 31.0) 2,430,000
Non-Hispanic Blacks
 1999–2000 652 37.8 (32.8 – 43.2) 4,574,000
 2001–2002 746 33.7 (28.7 – 39.2) 4,079,000
Non-Hispanic Whites
 1999–2000 1,122 32.4 (27.5 – 37.6) 25,539,000
 2001–2002 1,518 33.1 (29.9 – 36.5) 26,398,000
 
 

















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Non−Hispanic Blacks Non−Hispanic Whites 
Figure 3.2.a. Serum soluble transferrin receptor: Concentrations by age group 
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Table 3.2.a.2. Serum soluble transferrin receptor: Total population
Geometric mean and selected percentiles of serum concentrations (in mg/L) for children aged 1–5 years and 
women aged 12–49 years in the U.S. population, National Health and Nutrition Examination Survey, 2003–2006. 
Geometric mean 
(95% conf. interval)
Selected percentiles (95% conf. interval) Sample 
size5th 50th 95th
Males and Females
Total, Children 1–5 years, 
women 12–49 years 3.57 (3.51 – 3.63) 2.11 (1.99 – 2.20) 3.46 (3.37 – 3.55) 6.04 (5.90 – 6.36) 5,856
1–5 years 4.30 (4.24 – 4.37) 2.98 (2.91 – 3.06) 4.21 (4.11 – 4.29) 6.00 (5.91 – 6.42) 1,375
Males
1–5 years 4.38 (4.28 – 4.48) 3.06 (2.95 – 3.18) 4.26 (4.13 – 4.41) 6.25 (5.94 – 6.63) 698
Females
Total, 1–5, 12–49 years 3.51 (3.45 – 3.57) 2.07 (1.97 – 2.18) 3.37 (3.29 – 3.47) 6.02 (5.83 – 6.36) 5,158
1–5 years 4.22 (4.12 – 4.31) 2.90 (2.83 – 3.00) 4.10 (3.99 – 4.27) 5.91 (5.68 – 6.16) 677
12–19 years 3.50 (3.44 – 3.55) 2.27 (2.20 – 2.35) 3.38 (3.32 – 3.46) 5.36 (5.22 – 5.82) 1,968
20–39 years 3.42 (3.36 – 3.49) 2.02 (1.95 – 2.13) 3.23 (3.15 – 3.32) 6.00 (5.75 – 6.36) 1,761
40–49 years 3.52 (3.38 – 3.65) 1.97 (1.93 – 2.05) 3.35 (3.17 – 3.56) 6.43 (6.07 – 6.98) 752
 
Table 3.2.a.3. Serum soluble transferrin receptor: Mexican Americans
Geometric mean and selected percentiles of serum concentrations (in mg/L) for Mexican-American children 




Selected percentiles (95% conf. interval) Sample 
size5th 50th 95th
Males and Females
Total, Children 1–5 years, 
women 12–49 years 3.62 (3.53 – 3.72) 2.16 (2.06 – 2.24) 3.52 (3.42 – 3.62) 6.38 (5.92 – 7.10) 1,643
1–5 years 4.30 (4.17 – 4.43) 2.99 (2.94 – 3.07) 4.15 (3.99 – 4.32) 6.40 (6.06 – 7.18) 422
Males
1–5 years 4.38 (4.21 – 4.56) 3.09† (2.90 – 3.21) 4.18 (4.00 – 4.36) 6.89† (6.00 – 8.30) 203
Females
Total, 1–5, 12–49 years 3.55 (3.45 – 3.65) 2.13 (2.01 – 2.22) 3.41 (3.27 – 3.54) 6.32 (5.85 – 7.25) 1,440
1–5 years 4.21 (4.08 – 4.35) 2.93† (2.58 – 3.07) 4.10 (3.94 – 4.31) 6.01† (5.66 – 7.53) 219
12–19 years 3.57 (3.46 – 3.68) 2.26 (2.18 – 2.36) 3.44 (3.33 – 3.59) 5.92 (5.27 – 6.92) 637
20–39 years 3.40 (3.27 – 3.54) 2.02 (1.93 – 2.12) 3.19 (3.01 – 3.40) 5.99 (5.62 – 7.63) 430
40–49 years 3.63 (3.32 – 3.96) 2.22† (1.80 – 2.30) 3.34 (3.02 – 3.71) 7.75† (6.29 – 11.7) 154
† Estimate is subject to greater uncertainty due to small cell size. 
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Table 3.2.a.4. Serum soluble transferrin receptor: Non-Hispanic blacks
Geometric mean and selected percentiles of serum concentrations (in mg/L) for non-Hispanic black children 




Selected percentiles (95% conf. interval) Sample 
size5th 50th 95th
Males and Females
Total, Children 1–5 years, 
women 12–49 years 4.19 (4.10 – 4.29) 2.47 (2.31 – 2.57) 3.97 (3.91 – 4.04) 8.02 (7.31 – 9.69) 1,634
1–5 years 4.55 (4.43 – 4.67) 3.11 (3.02 – 3.29) 4.37 (4.26 – 4.56) 6.68 (6.31 – 7.16) 401
Males
1–5 years 4.70 (4.56 – 4.86) 3.24† (3.06 – 3.37) 4.58 (4.30 – 4.89) 6.76† (6.42 – 7.77) 199
Females
Total, 1–5, 12–49 years 4.15 (4.05 – 4.26) 2.43 (2.27 – 2.55) 3.94 (3.86 – 4.00) 8.49 (7.37 – 9.87) 1,435
1–5 years 4.40 (4.21 – 4.59) 3.05† (2.73 – 3.23) 4.26 (4.00 – 4.47) 6.49† (5.96 – 7.16) 202
12–19 years 3.88 (3.77 – 4.00) 2.42 (2.25 – 2.52) 3.76 (3.66 – 3.87) 6.46 (6.14 – 7.07) 668
20–39 years 4.23 (4.08 – 4.39) 2.41 (2.06 – 2.58) 3.97 (3.85 – 4.15) 9.70 (7.33 – 10.5) 368
40–49 years 4.17 (3.89 – 4.47) 2.34† (1.94 – 2.61) 3.87 (3.51 – 4.08) 9.72† (8.28 – 13.2) 197
† Estimate is subject to greater uncertainty due to small cell size. 
Table 3.2.a.5. Serum soluble transferrin receptor: Non-Hispanic whites
Geometric mean and selected percentiles of serum concentrations (in mg/L) for non-Hispanic white children 




Selected percentiles (95% conf. interval) Sample 
size5th 50th 95th
Males and Females
Total, Children 1–5 years, 
women 12–49 years 3.43 (3.35 – 3.52) 2.02 (1.94 – 2.17) 3.32 (3.22 – 3.44) 5.59 (5.28 – 6.07) 2,048
1–5 years 4.22 (4.11 – 4.32) 2.91 (2.78 – 3.04) 4.15 (4.01 – 4.28) 5.90 (5.63 – 6.19) 391
Males
1–5 years 4.31 (4.16 – 4.46) 2.98† (2.91 – 3.15) 4.22 (3.99 – 4.48) 5.95† (5.67 – 6.83) 215
Females
Total, 1–5, 12–49 years 3.38 (3.30 – 3.47) 2.00 (1.97 – 2.05) 3.25 (3.14 – 3.37) 5.53 (5.18 – 6.08) 1,833
1–5 years 4.11 (3.96 – 4.27) 2.85† (2.64 – 2.97) 4.05 (3.88 – 4.27) 5.64† (5.36 – 6.64) 176
12–19 years 3.40 (3.33 – 3.46) 2.25 (2.12 – 2.35) 3.29 (3.20 – 3.37) 4.98 (4.78 – 5.49) 514
20–39 years 3.27 (3.18 – 3.36) 1.97 (1.94 – 2.01) 3.10 (3.00 – 3.20) 5.44 (4.96 – 6.01) 806
40–49 years 3.42 (3.26 – 3.59) 1.96 (1.92 – 2.01) 3.31 (3.03 – 3.57) 6.02 (5.41 – 6.76) 337
† Estimate is subject to greater uncertainty due to small cell size. 
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Table 3.2.b. Serum soluble transferrin receptor: Concentrations by survey cycle
Geometric mean and selected percentiles of serum concentrations (in mg/L) for children aged 1–5 and women 
aged 12–49 years in the U.S. population, National Health and Nutrition Examination Survey, 2003–2006. 
Geometric mean 
(95% conf. interval)
Selected percentiles (95% conf. interval) Sample 
size5th 50th 95th
Total (Children 1–5 years, women 12–49 years) 
 2003–2004 3.63 (3.54 – 3.71) 2.06 (1.94 – 2.36) 3.55 (3.43 – 3.66) 5.96 (5.75 – 6.41) 2,831
 2005–2006 3.51 (3.42 – 3.60) 2.13 (2.00 – 2.20) 3.36 (3.28 – 3.47) 6.16 (5.77 – 6.63) 3,025
Age group
1–5 years (Children)
 2003–2004 4.44 (4.34 – 4.55) 3.28 (3.13 – 3.38) 4.33 (4.21 – 4.45) 5.99 (5.83 – 6.83) 696
 2005–2006 4.16 (4.04 – 4.27) 2.86 (2.79 – 2.93) 4.06 (3.89 – 4.21) 6.08 (5.79 – 6.48) 679
12–19 years (Women)
 2003–2004 3.57 (3.48 – 3.66) 2.29 (2.15 – 2.46) 3.49 (3.32 – 3.62) 5.72 (5.26 – 6.39) 975
 2005–2006 3.43 (3.36 – 3.49) 2.26 (2.13 – 2.35) 3.33 (3.25 – 3.38) 5.23 (5.01 – 5.81) 993
20–39 years (Women)
 2003–2004 3.49 (3.43 – 3.56) 2.02 (1.93 – 2.27) 3.33 (3.23 – 3.41) 5.96 (5.73 – 6.32) 803
 2005–2006 3.35 (3.24 – 3.47) 2.02 (1.90 – 2.13) 3.16 (3.04 – 3.31) 6.07 (5.54 – 6.57) 958
40–49 years (Women)
 2003–2004 3.49 (3.28 – 3.71) 1.96 (1.94 – 1.99) 3.33 (2.98 – 3.63) 6.01 (5.39 – 7.56) 357
 2005–2006 3.54 (3.36 – 3.74) 2.05 (1.66 – 2.23) 3.37 (3.19 – 3.65) 6.86 (6.22 – 7.89) 395
Gender
Males (1–5 years)
 2003–2004 4.54 (4.39 – 4.70) 3.32 (3.20 – 3.41) 4.40 (4.23 – 4.56) 6.38 (5.94 – 7.23) 358
 2005–2006 4.21 (4.05 – 4.38) 2.94 (2.74 – 3.02) 4.16 (3.90 – 4.34) 6.04 (5.69 – 6.52) 340
Females (1–5, 12–49 years)
 2003–2004 3.56 (3.47 – 3.65) 2.03 (1.93 – 2.32) 3.45 (3.31 – 3.59) 5.94 (5.64 – 6.37) 2,473
 2005–2006 3.46 (3.37 – 3.55) 2.11 (1.96 – 2.19) 3.31 (3.22 – 3.39) 6.17 (5.77 – 6.69) 2,685
Race/ethnicity (Children 1–5 years, women 12–49 years)
Mexican Americans
 2003–2004 3.63 (3.53 – 3.73) 2.18 (1.99 – 2.37) 3.59 (3.44 – 3.80) 5.88 (5.49 – 6.42) 734
 2005–2006 3.62 (3.46 – 3.79) 2.15 (2.02 – 2.24) 3.46 (3.28 – 3.62) 7.32 (6.16 – 8.70) 909
Non-Hispanic Blacks
 2003–2004 4.18 (4.04 – 4.33) 2.54 (2.33 – 2.65) 3.96 (3.89 – 4.06) 7.97 (6.94 – 9.88) 832
 2005–2006 4.20 (4.08 – 4.33) 2.36 (2.19 – 2.56) 4.00 (3.86 – 4.13) 8.17 (7.15 – 10.4) 802
Non-Hispanic Whites
 2003–2004 3.51 (3.37 – 3.65) 1.99 (1.98 – 2.03) 3.44 (3.22 – 3.63) 5.68 (5.16 – 6.38) 1,026
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Figure 3.2.b. Serum soluble transferrin receptor: Concentrations by survey cycle 
Selected percentiles in mg/L (95% confidence intervals), National Health and 

Nutrition Examination Survey, 2003–2006
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Table 3.2.c. Serum soluble transferrin receptor: Prevalence
Prevalence (in percent) of high serum soluble transferrin receptor concentration (> 4.4 mg/L) for 





 (95% conf. interval)
Estimated total  
number of persons
Women, 12–49 years 4,481 18.9 (17.0 – 20.9) 14,918,000
Age group
12–19 years 1,968 16.9 (14.7 – 19.3) 2,741,000
20–49 years 2,513 19.4 (17.3 – 21.6) 12,159,000
Race/ethnicity
Mexican Americans 1,221 19.0 (15.5 – 23.0) 1,451,000
Non-Hispanic Blacks 1,233 34.9 (31.6 – 38.4) 3,756,000
Non-Hispanic Whites 1,657 16.0 (13.6 – 18.7) 8,177,000
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Table 3.2.d. Serum soluble transferrin receptor: Prevalence by survey cycle
Prevalence (in percent) of high serum soluble transferrin receptor concentration (> 4.4 mg/L) for women in the 
U.S. population aged 12–49 years, National Health and Nutrition Examination Survey, 2003–2006. 
Sample size Prevalence (95% conf. interval) Estimated total number of persons
Women, 12–49 years
 2003–2004 2,135 18.8 (16.3 – 21.6) 14,862,000
 2005–2006 2,346 18.9 (16.0 – 22.3) 15,017,000
Age group
12–19 years
 2003–2004 975 17.4 (14.0 – 21.3) 2,818,000
 2005–2006 993 16.4 (13.5 – 19.8) 2,694,000
20–49 years
 2003–2004 1,160 19.2 (16.3 – 22.4) 12,031,000
 2005–2006 1,353 19.6 (16.4 – 23.2) 12,296,000
Race/ethnicity
Mexican Americans
 2003–2004 547 18.7 (13.3 – 25.7) 1,435,000
 2005–2006 674 19.2 (14.6 – 24.7) 1,516,000
Non-Hispanic Blacks
 2003–2004 604 33.2 (28.9 – 37.7) 3,568,000
 2005–2006 629 36.7 (31.6 – 42.1) 3,988,000
Non-Hispanic Whites
 2003–2004 823 16.1 (12.5 – 20.5) 8,258,000
 2005–2006 834 15.8 (12.6 – 19.6) 7,991,000
 
































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Non−Hispanic Blacks Non−Hispanic Whites 
Figure 3.3.a. Body iron: by age group 
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Table 3.3.a.2. Body iron: Total population
Arithmetic mean and selected percentiles of body iron (in mg/kg) for children aged 1–5 years and women aged 
12–49 years in the U.S. population, National Health and Nutrition Examination Survey, 2003–2006. 
Arithmetic mean 
(95% conf. interval)
Selected percentiles (95% conf. interval) Sample 
size5th 50th 95th
Males and Females
Total, Children 1–5 years, 
women 12–49 years 5.16 (5.01 – 5.31) -1.83 (-2.60 – -1.41) 5.43 (5.32 – 5.58) 10.8 (10.6 – 11.2) 5,845
1–5 years 3.47 (3.31 – 3.63) -.648 (-1.26 – -.159) 3.64 (3.44 – 3.79) 6.89 (6.72 – 7.06) 1,369
Males
1–5 years 3.38 (3.17 – 3.59) -.715 (-1.36 – -.262) 3.52 (3.32 – 3.80) 6.91 (6.65 – 7.30) 695
Females
Total, Children 1–5 years, 
women 12–49 years 5.30 (5.13 – 5.46) -2.01 (-2.70 – -1.43) 5.65 (5.49 – 5.76) 11.0 (10.7 – 11.4) 5,150
1–5 years 3.57 (3.36 – 3.78) -.196 (-2.11 – .411) 3.70 (3.41 – 4.04) 6.89 (6.67 – 7.27) 674
12–19 years 4.49 (4.26 – 4.72) -1.59 (-2.69 – -.763) 4.96 (4.71 – 5.16) 8.84 (8.35 – 9.34) 1,967
20–39 years 5.51 (5.29 – 5.73) -1.75 (-2.81 – -1.22) 5.88 (5.69 – 6.17) 10.7 (10.2 – 11.1) 1,758
40–49 years 5.88 (5.46 – 6.30) -2.85 (-3.78 – -1.84) 6.37 (5.86 – 6.82) 12.4 (11.7 – 12.9) 751
 
Table 3.3.a.3. Body iron: Mexican Americans
Arithmetic mean and selected percentiles of body iron (in mg/kg) for Mexican American children aged 1–5 




Selected percentiles (95% conf. interval) Sample 
size5th 50th 95th
Males and Females
Total, Children 1–5 years, 
women 12–49 years 4.49 (4.10 – 4.88) -3.16 (-3.81 – -2.03) 4.75 (4.44 – 5.12) 10.4 (9.73 – 11.2) 1,641
1–5 years 3.16 (2.84 – 3.48) -2.09 (-3.35 – -1.36) 3.48 (3.13 – 3.78) 6.99 (6.57 – 7.93) 422
Males
1–5 years 2.95 (2.48 – 3.41) -2.71† (-4.72 – -1.59) 3.34 (2.99 – 3.77) 6.92† (5.95 – 9.30) 203
Females
Total, Children 1–5 years, 
women 12–49 years 4.66 (4.23 – 5.10) -3.17 (-3.82 – -1.90) 5.02 (4.60 – 5.44) 10.6 (9.79 – 11.4) 1,438
1–5 years 3.38 (3.04 – 3.72) -1.88† (-2.87 – -.828) 3.55 (3.22 – 4.15) 6.99† (6.78 – 8.13) 219
12–19 years 4.07 (3.76 – 4.39) -1.76 (-3.29 – -.981) 4.46 (4.26 – 4.68) 8.99 (8.51 – 9.69) 637
20–39 years 5.07 (4.48 – 5.67) -3.15 (-4.31 – -1.66) 5.72 (4.93 – 6.28) 10.7 (9.89 – 12.0) 429
40–49 years 4.89 (3.74 – 6.04) -4.89† (-6.96 – -3.40) 5.33 (4.42 – 6.59) 11.1† (10.4 – 15.1) 153
† Estimate is subject to greater uncertainty due to small cell size. 
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Table 3.3.a.4. Body iron: Non-Hispanic blacks
Arithmetic mean and selected percentiles of body iron (in mg/kg) for non-Hispanic black children aged 1–5 




Selected percentiles (95% conf. interval) Sample 
size5th 50th 95th
Males and Females
Total, Children 1–5 years, 
women 12–49 years 4.37 (4.10 – 4.64) -3.79 (-4.61 – -2.88) 4.66 (4.30 – 5.05) 11.0 (10.3 – 11.6) 1,633
1–5 years 3.83 (3.56 – 4.09) -.115 (-.906 – .776) 3.95 (3.78 – 4.25) 7.51 (6.80 – 8.03) 401
Males
1–5 years 3.63 (3.25 – 4.00) -.328† (-2.15 – .070) 3.77 (3.17 – 4.19) 6.90† (6.55 – 8.03) 199
Females
Total, Children 1–5 years, 
women 12–49 years 4.43 (4.14 – 4.72) -3.94 (-4.87 – -3.04) 4.80 (4.35 – 5.16) 11.0 (10.4 – 11.9) 1,434
1–5 years 4.03 (3.73 – 4.34) .658† (-.541 – .981) 4.17 (3.92 – 4.35) 7.71† (6.93 – 8.09) 202
12–19 years 3.99 (3.56 – 4.42) -2.53 (-3.91 – -1.71) 4.46 (4.09 – 4.79) 8.91 (8.38 – 9.43) 667
20–39 years 3.96 (3.63 – 4.28) -4.12 (-5.73 – -3.46) 4.35 (4.08 – 4.86) 9.96 (9.46 – 11.2) 368
40–49 years 5.78 (4.86 – 6.69) -5.62† (-9.51 – -2.80) 6.68 (5.78 – 7.32) 12.9† (11.9 – 15.4) 197
† Estimate is subject to greater uncertainty due to small cell size. 
Table 3.3.a.5. Body iron: Non-Hispanic whites
Arithmetic mean and selected percentiles of body iron (in mg/kg) for non-Hispanic white children aged 1–5 




Selected percentiles (95% conf. interval) Sample 
size5th 50th 95th
Males and Females
Total, Children 1–5 years, 
women 12–49 years 5.46 (5.24 – 5.69) -1.21 (-2.34 – -.516) 5.66 (5.49 – 5.81) 10.9 (10.5 – 11.5) 2,041
1–5 years 3.51 (3.27 – 3.74) -.264 (-1.28 – .300) 3.56 (3.34 – 3.92) 6.89 (6.64 – 7.00) 385
Males
1–5 years 3.42 (3.09 – 3.75) -.571† (-1.39 – .140) 3.50 (3.06 – 4.01) 6.91† (6.45 – 7.33) 212
Females
Total, Children 1–5 years, 
women 12–49 years 5.60 (5.36 – 5.84) -1.27 (-2.60 – -.546) 5.81 (5.66 – 6.02) 11.0 (10.7 – 11.5) 1,829
1–5 years 3.61 (3.33 – 3.89) .062† (-3.13 – .791) 3.67 (3.35 – 4.03) 6.70† (6.45 – 7.27) 173
12–19 years 4.68 (4.35 – 5.02) -1.48 (-3.15 – -.417) 5.17 (4.86 – 5.50) 8.84 (8.29 – 9.62) 514
20–39 years 5.93 (5.58 – 6.28) -.640 (-2.73 – .779) 6.16 (5.82 – 6.59) 10.7 (10.2 – 11.4) 805
40–49 years 6.01 (5.45 – 6.57) -2.26 (-3.78 – -1.01) 6.36 (5.77 – 6.99) 12.4 (11.6 – 13.0) 337
† Estimate is subject to greater uncertainty due to small cell size. 
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Table 3.3.b. Body iron: By survey cycle
Arithmetic mean and selected percentiles of body iron (in mg/kg) for children aged 1–5 years and women aged 
12–49 years in the U.S. population, National Health and Nutrition Examination Survey, 2003–2006. 
Arithmetic mean 
(95% conf. interval)
Selected percentiles (95% conf. interval) Sample 
size5th 50th 95th
Total (Children 1–5 years, women 12–49 years) 
 2003–2004 5.21 (5.03 – 5.39) -1.60 (-2.96 – -.854) 5.43 (5.32 – 5.55) 10.9 (10.7 – 11.3) 2,826
 2005–2006 5.11 (4.85 – 5.38) -2.04 (-2.73 – -1.43) 5.43 (5.08 – 5.71) 10.8 (10.2 – 11.5) 3,019
Age group
1–5 years (Children)
 2003–2004 3.25 (3.01 – 3.50) -.651 (-1.73 – .144) 3.34 (2.99 – 3.66) 6.55 (6.39 – 6.73) 694
 2005–2006 3.70 (3.47 – 3.94) -.642 (-1.65 – -.080) 3.91 (3.70 – 4.14) 7.00 (6.92 – 7.33) 675
12–19 years (Women)
 2003–2004 4.27 (3.89 – 4.66) -2.23 (-3.93 – -.653) 4.71 (4.27 – 5.11) 8.89 (8.29 – 9.73) 974
 2005–2006 4.71 (4.45 – 4.96) -1.45 (-2.64 – -.527) 5.10 (4.85 – 5.33) 8.53 (8.31 – 9.55) 993
20–39 years (Women)
 2003–2004 5.61 (5.33 – 5.89) -1.21 (-2.14 – -.835) 6.07 (5.69 – 6.25) 10.4 (9.92 – 11.1) 801
 2005–2006 5.42 (5.04 – 5.79) -2.55 (-3.91 – -1.41) 5.83 (5.44 – 6.27) 10.8 (10.2 – 11.9) 957
40–49 years (Women)
 2003–2004 6.22 (5.61 – 6.82) -3.28 (-3.80 – -1.85) 6.85 (6.21 – 7.33) 12.7 (12.0 – 13.4) 357
 2005–2006 5.55 (4.89 – 6.21) -2.47 (-4.61 – -1.59) 5.96 (5.33 – 6.66) 11.8 (11.1 – 13.1) 394
Gender
Males (1–5 years)
 2003–2004 3.11 (2.76 – 3.46) -.719 (-1.89 – -.152) 3.13 (2.70 – 3.65) 6.21 (5.74 – 6.92) 358
 2005–2006 3.68 (3.41 – 3.95) -.746 (-1.32 – -.268) 3.91 (3.48 – 4.41) 7.24 (6.81 – 8.27) 337
Females (1–5, 12–49 years)
 2003–2004 5.38 (5.18 – 5.58) -1.76 (-3.18 – -.854) 5.66 (5.50 – 5.80) 11.0 (10.7 – 11.5) 2,468
 2005–2006 5.22 (4.94 – 5.49) -2.20 (-2.98 – -1.52) 5.60 (5.32 – 5.84) 10.9 (10.2 – 11.6) 2,682
Race/ethnicity (Children 1–5 years, women 12–49 years)
Mexican Americans
 2003–2004 4.74 (4.13 – 5.35) -2.05 (-3.57 – -1.13) 4.94 (4.28 – 5.64) 10.6 (9.69 – 12.5) 734
 2005–2006 4.26 (3.78 – 4.73) -3.70 (-5.21 – -2.73) 4.71 (4.31 – 5.05) 9.91 (9.73 – 10.8) 907
Non-Hispanic Blacks
 2003–2004 4.48 (4.02 – 4.94) -3.79 (-5.06 – -2.47) 4.68 (4.15 – 5.24) 11.1 (9.95 – 12.7) 831
 2005–2006 4.26 (3.94 – 4.58) -3.96 (-4.99 – -2.62) 4.66 (4.16 – 5.17) 10.6 (9.86 – 11.4) 802
Non-Hispanic Whites
 2003–2004 5.45 (5.14 – 5.75) -.903 (-3.69 – .285) 5.57 (5.43 – 5.76) 11.0 (10.5 – 11.6) 1,023
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  Figure 3.3.b. Body iron: By Survey Cycle 
Selected percentiles in mg/kg (95% confidence intervals), National Health and 
Nutrition Examination Survey, 2003–2006 
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Table 3.3.c.1. Body iron: Prevalence
Prevalence (in percent) of low body iron (< 0 mg/kg) for children in the U.S. population aged 1–5 years, 





Estimated total  
number of persons
Children, 1–5 years 1,369 6.7 (5.0 – 8.8) 1,350,000
Gender
Males 695 7.8 (5.6 – 10.8) 807,000
Females 674 5.4 (3.4 – 8.3) 534,000
Race/ethnicity
Mexican Americans 422 10.9 (8.1 – 14.6) 333,000
Non-Hispanic Blacks 401 5.1 (3.0 – 8.6) 154,000
Non-Hispanic Whites 385 5.8 (3.6 – 9.1) 670,000
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Table 3.3.c.2. Body iron: Prevalence
Prevalence (in percent) of low body iron (< 0 mg/kg) for women in the U.S. population aged 12–49 




 (95% conf. interval)
Estimated total  
number of persons
Women, 12–49 years 4,476 9.5 (8.6 – 10.5) 7,515,000
Age group
12–19 years 1,967 9.3 (7.4 – 11.6) 1,508,000
20–49 years 2,509 9.6 (8.6 – 10.7) 6,006,000
Race/ethnicity
Mexican Americans 1,219 13.2 (10.2 – 16.9) 1,007,000
Non-Hispanic Blacks 1,232 16.2 (13.9 – 18.7) 1,739,000
Non-Hispanic Whites 1,656 7.4 (5.8 – 9.4) 3,803,000
 
338 2nd National Report on Biochemical Indicators of Diet and Nutrition in the U.S. Population
Table 3.3.d.1. Body iron: Prevalence by survey cycle
Prevalence (in percent) of low body iron (< 0 mg/kg) for children in the U.S. population aged 1–5 years, 
National Health and Nutrition Examination Survey, 2003–2006. 
Sample size Prevalence (95% conf. interval) Estimated total number of persons
Children, 1–5 years
 2003–2004 694 6.5 (4.3 – 9.8) 1,321,000
 2005–2006 675 6.8 (4.5 – 10.2) 1,377,000
Gender
Males
 2003–2004 358 8.3 (4.9 – 13.7) 854,000
 2005–2006 337 7.3 (4.7 – 11.1) 755,000
Females
 2003–2004 336 4.5 (2.7 – 7.4) 449,000
 2005–2006 338 6.3‡ (3.1 – 12.4) 620,000‡
Race/ethnicity
Mexican Americans
 2003–2004 187 13.3 (8.4 – 20.5) 405,000
 2005–2006 235 8.6 (6.0 – 12.1) 275,000
Non-Hispanic Blacks
 2003–2004 228 6.1‡ (3.1 – 11.8) 183,000‡
 2005–2006 173 § §
Non-Hispanic Whites
 2003–2004 201 4.6‡ (2.1 – 10.0) 538,000‡
 2005–2006 184 7.0 (3.8 – 12.5) 792,000
‡ Estimate flagged: 30% ≤ RSE < 40% for the prevalence estimate. 
§ Estimate suppressed: RSE ≥ 40% for the prevalence estimate. 
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Table 3.3.d.2. Body iron: Prevalence by survey cycle
Prevalence (in percent) of low body iron (< 0 mg/kg) for women in the U.S. population aged 12–49 years, 
National Health and Nutrition Examination Survey, 2003–2006. 
Sample size Prevalence (95% conf. interval) Estimated total number of persons
Women, 12–49 years
 2003–2004 2,132 8.6 (7.0 – 10.4) 6,773,000
 2005–2006 2,344 10.4 (9.3 – 11.7) 8,266,000
Age group
12–19 years
 2003–2004 974 9.0 (6.3 – 12.6) 1,455,000
 2005–2006 993 9.6 (6.9 – 13.2) 1,576,000
20–49 years
 2003–2004 1,158 8.5 (6.8 – 10.5) 5,322,000
 2005–2006 1,351 10.6 (9.5 – 11.9) 6,681,000
Race/ethnicity
Mexican Americans
 2003–2004 547 11.2 (7.6 – 16.2) 857,000
 2005–2006 672 15.1 (10.5 – 21.2) 1,193,000
Non-Hispanic Blacks
 2003–2004 603 16.0 (12.8 – 19.8) 1,720,000
 2005–2006 629 16.3 (13.1 – 20.1) 1,777,000
Non-Hispanic Whites
 2003–2004 822 6.9 (4.4 – 10.6) 3,530,000
 2005–2006 834 8.0 (6.0 – 10.5) 4,023,000
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Iodine
Background Information































































Epidemiological criteria for assessing iodine nutrition based on median urinary iodine 
concentrations of school-age children (> 6 years)* (World Health Organization 2007)
Median Urinary 
Iodine (ng/mL)
Iodine Intake Iodine Status
< 20 Insufficient Severe iodine deficiency
20–49 Insufficient Moderate iodine deficiency
50–99 Insufficient Mild iodine deficiency
100–199 Adequate Adequate iodine nutrition
200–299 Above requirements
Likely to provide adequate intake for pregnant/lactating 
women but may pose a slight risk of more than adequate 
intake in the overall population
≥ 300 Excessive Risk for adverse health consequences (e.g., iodine-induced hyperthyroidism, autoimmune thyroid diseases)







































For more information about iodine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Figure H.3.e. Median concentrations of urinary iodine in the U.S. population aged 6 years and older by age group and gender 
associated with estimated iodine intake, National Health and Nutrition Examination Survey, 2001–2006. 
Error bars represent 95% confidence intervals. 






Figure H.3.f. Age-adjusted geometric mean concentrations of urinary iodine in the U.S. population aged 6 years and older by gender or 
race/ethnicity, National Health and Nutrition Examination Survey, 1988–2006. 
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Non−Hispanic Blacks Non−Hispanic Whites 
Figure 3.4.a. Urinary iodine: Concentrations by age group 
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Table 3.4.a.2. Urinary iodine: Total population
Geometric mean and selected percentiles of urine concentrations (in ng/mL) for the total U.S. population aged 
6 years and older, National Health and Nutrition Examination Survey, 2003–2006. 
Geometric mean 
(95% conf. interval)
Selected percentiles (95% conf. interval) Sample 
size10th 50th 90th
Males and Females
Total, 6 years and older 156 (148 – 163) 47.9 (42.9 – 53.9) 162 (154 – 170) 444 (422 – 467) 5,175
6–11 years 222 (201 – 245) 77.6 (55.8 – 94.7) 232 (208 – 270) 581 (515 – 754) 666
12–19 years 179 (161 – 199) 55.5 (44.3 – 68.0) 186 (171 – 203) 518 (465 – 658) 1,443
20–39 years 135 (126 – 144) 42.0 (33.9 – 52.9) 140 (129 – 149) 368 (323 – 416) 1,134
40–59 years 137 (128 – 147) 40.4 (36.9 – 45.7) 145 (136 – 156) 388 (359 – 423) 919
60 years and older 187 (170 – 205) 61.3 (52.0 – 68.5) 181 (168 – 202) 523 (463 – 580) 1,013
Males
Total, 6 years and older 174 (164 – 185) 56.4 (48.0 – 65.2) 180 (172 – 189) 465 (441 – 500) 2,477
6–11 years 250 (212 – 295) 94.3 (55.4 – 115) 264 (212 – 313) 653 (498 – 1,080) 307
12–19 years 200 (181 – 222) 73.1 (54.8 – 87.7) 198 (184 – 220) 525 (479 – 707) 693
20–39 years 154 (142 – 167) 53.6 (38.8 – 65.1) 160 (143 – 174) 408 (327 – 478) 512
40–59 years 149 (137 – 163) 48.3 (38.6 – 59.5) 148 (138 – 166) 395 (363 – 458) 454
60 years and older 211 (191 – 233) 65.1 (46.9 – 88.2) 205 (193 – 228) 538 (469 – 652) 511
Females
Total, 6 years and older 140 (133 – 147) 41.4 (37.7 – 46.8) 144 (137 – 153) 412 (389 – 453) 2,698
6–11 years 195 (176 – 215) 61.8 (45.8 – 81.5) 210 (174 – 232) 549 (423 – 718) 359
12–19 years 160 (137 – 186) 46.1 (29.2 – 59.0) 166 (143 – 191) 487 (421 – 633) 750
20–39 years 118 (107 – 131) 35.4 (30.4 – 43.8) 119 (108 – 136) 333 (300 – 406) 622
40–59 years 127 (116 – 139) 36.4 (28.2 – 40.1) 140 (123 – 161) 368 (333 – 418) 465
60 years and older 169 (151 – 189) 60.2 (48.9 – 67.7) 157 (134 – 176) 483 (413 – 590) 502
Table 3.4.a.3. Urinary iodine: Mexican Americans
Geometric mean and selected percentiles of urine concentrations (in ng/mL) for Mexican Americans in the U.S. 
population aged 6 years and older, National Health and Nutrition Examination Survey, 2003–2006. 
Geometric mean 
(95% conf. interval)
Selected percentiles (95% conf. interval) Sample 
size10th 50th 90th
Males and Females
Total, 6 years and older 173 (161 – 185) 59.9 (52.3 – 68.3) 186 (173 – 195) 450 (404 – 518) 1,320
6–11 years 223 (196 – 253) 80.8 (54.8 – 98.9) 235 (208 – 265) 544 (469 – 713) 217
12–19 years 174 (155 – 194) 56.6 (44.9 – 62.7) 176 (163 – 203) 488 (414 – 596) 466
20–39 years 169 (153 – 186) 65.7 (55.6 – 78.5) 187 (165 – 198) 401 (352 – 547) 283
40–59 years 151 (124 – 184) 45.4 (33.9 – 59.5) 158 (123 – 196) 382 (305 – 699) 165
60 years and older 175 (148 – 207) 57.2 (43.7 – 69.2) 159 (128 – 193) 444 (377 – 690) 189
Males
Total, 6 years and older 173 (162 – 185) 61.8 (56.1 – 71.9) 184 (165 – 199) 454 (404 – 510) 623
6–11 years 224 (187 – 269) 85.2† (41.0 – 133) 236 (209 – 271) 519† (422 – 836) 96
12–19 years 194 (164 – 230) 60.8 (46.1 – 78.1) 199 (169 – 234) 549 (432 – 747) 221
20–39 years 167 (148 – 189) 62.3 (58.5 – 78.1) 184 (146 – 202) 386 (334 – 591) 134
40–59 years 139 (112 – 171) 45.1† (31.2 – 61.1) 122 (107 – 168) 369† (298 – 1,260) 77
60 years and older 196 (166 – 232) 70.5† (30.1 – 92.3) 196 (155 – 243) 495† (365 – 6,920) 95
Females
Total, 6 years and older 172 (159 – 187) 57.0 (45.9 – 67.4) 190 (164 – 205) 444 (373 – 566) 697
6–11 years 221 (182 – 269) 75.9 (47.0 – 94.8) 226 (180 – 270) 584 (456 – 1,110) 121
12–19 years 154 (134 – 178) 49.4 (34.7 – 61.1) 163 (142 – 188) 428 (338 – 695) 245
20–39 years 171 (148 – 198) 68.9 (39.1 – 81.4) 187 (145 – 219) 402 (348 – 569) 149
40–59 years 165 (128 – 212) 45.9† (20.2 – 64.8) 199 (145 – 218) 385† (295 – 1,150) 88
60 years and older 159 (117 – 218) 52.5† (34.2 – 61.4) 128 (107 – 163) 425† (283 – 1,010,900) 94
† Estimate is subject to greater uncertainty due to small cell size. 
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Table 3.4.a.4. Urinary iodine: Non-Hispanic blacks
Geometric mean and selected percentiles of urine concentrations (in ng/mL) for non-Hispanic blacks in the U.S. 
population aged 6 years and older, National Health and Nutrition Examination Survey, 2003–2006. 
Geometric mean 
(95% conf. interval)
Selected percentiles (95% conf. interval) Sample 
size10th 50th 90th
Males and Females
Total, 6 years and older 141 (131 – 151) 51.7 (47.6 – 57.0) 141 (128 – 152) 374 (322 – 423) 1,363
6–11 years 186 (163 – 213) 62.4 (45.7 – 76.1) 190 (168 – 217) 459 (387 – 682) 221
12–19 years 149 (137 – 163) 55.0 (47.9 – 61.0) 148 (138 – 168) 394 (351 – 475) 515
20–39 years 128 (113 – 145) 57.3 (47.2 – 66.3) 125 (116 – 160) 283 (242 – 310) 238
40–59 years 140 (124 – 160) 48.3 (35.7 – 59.1) 134 (122 – 144) 428 (337 – 485) 219
60 years and older 128 (108 – 151) 42.1 (35.0 – 50.6) 128 (102 – 146) 326 (259 – 529) 170
Males
Total, 6 years and older 158 (145 – 172) 58.1 (51.7 – 69.8) 159 (142 – 176) 408 (335 – 456) 663
6–11 years 208 (172 – 251) 75.9† (48.1 – 102) 205 (172 – 284) 500† (393 – 952) 106
12–19 years 161 (145 – 178) 61.4 (47.3 – 76.3) 155 (141 – 177) 409 (342 – 588) 260
20–39 years 141 (125 – 160) 61.0† (46.8 – 72.0) 154 (117 – 185) 292† (259 – 398) 108
40–59 years 161 (134 – 192) 55.5† (34.1 – 77.7) 145 (125 – 198) 429† (329 – 518) 104
60 years and older 145 (105 – 200) 42.6† (31.1 – 55.9) 141 (93.6 – 204) 414† (249 – 8,300) 85
Females
Total, 6 years and older 127 (117 – 138) 49.0 (41.9 – 53.8) 128 (121 – 136) 329 (307 – 380) 700
6–11 years 166 (145 – 190) 44.7 (39.2 – 67.1) 168 (151 – 211) 409 (381 – 581) 115
12–19 years 139 (124 – 156) 50.9 (36.2 – 59.2) 139 (125 – 164) 387 (312 – 475) 255
20–39 years 118 (98.4 – 142) 54.2 (27.1 – 66.6) 123 (105 – 148) 237 (212 – 342) 130
40–59 years 125 (107 – 147) 44.8 (30.9 – 53.4) 122 (103 – 137) 390 (290 – 516) 115
60 years and older 116 (91.7 – 148) 42.0† (12.9 – 50.6) 115 (83.6 – 146) 271† (244 – 466) 85
† Estimate is subject to greater uncertainty due to small cell size. 
Table 3.4.a.5. Urinary iodine: Non-Hispanic whites
Geometric mean and selected percentiles of urine concentrations (in ng/mL) for non-Hispanic whites in the U.S. 
population aged 6 years and older, National Health and Nutrition Examination Survey, 2003–2006. 
Geometric mean 
(95% conf. interval)
Selected percentiles (95% conf. interval) Sample 
size10th 50th 90th
Males and Females
Total, 6 years and older 159 (151 – 168) 47.0 (41.1 – 54.3) 166 (156 – 176) 461 (427 – 489) 2,085
6–11 years 237 (208 – 271) 81.0 (55.0 – 103) 267 (202 – 315) 620 (536 – 978) 169
12–19 years 187 (160 – 218) 48.9 (36.7 – 73.4) 194 (172 – 224) 561 (481 – 744) 365
20–39 years 133 (122 – 145) 39.9 (32.0 – 49.0) 139 (125 – 150) 378 (318 – 461) 494
40–59 years 140 (131 – 151) 40.3 (35.6 – 48.7) 153 (139 – 167) 389 (361 – 424) 453
60 years and older 193 (175 – 214) 65.3 (55.5 – 74.1) 193 (172 – 211) 538 (460 – 598) 604
Males
Total, 6 years and older 182 (170 – 195) 58.0 (47.5 – 69.5) 187 (176 – 199) 481 (450 – 548) 996
6–11 years 292 (230 – 371) 112† (46.9 – 132) 315 (229 – 381) 741† (503 – 1,600) 76
12–19 years 213 (185 – 246) 77.2 (38.8 – 102) 208 (187 – 242) 564 (483 – 770) 174
20–39 years 159 (141 – 179) 51.0 (36.9 – 71.6) 163 (139 – 186) 413 (322 – 516) 211
40–59 years 153 (140 – 168) 49.7 (38.4 – 65.5) 153 (137 – 173) 396 (355 – 464) 229
60 years and older 220 (198 – 245) 66.6 (45.4 – 93.4) 218 (197 – 249) 548 (483 – 666) 306
Females
Total, 6 years and older 141 (132 – 149) 39.6 (33.9 – 44.0) 148 (137 – 157) 423 (390 – 471) 1,089
6–11 years 191 (166 – 221) 58.9† (38.5 – 81.6) 194 (150 – 251) 554† (423 – 855) 93
12–19 years 162 (127 – 206) 36.9 (18.6 – 58.0) 171 (138 – 227) 538 (431 – 793) 191
20–39 years 112 (98.2 – 129) 32.3 (22.5 – 41.6) 115 (102 – 130) 327 (278 – 461) 283
40–59 years 129 (117 – 143) 33.6 (24.7 – 40.7) 150 (123 – 178) 368 (334 – 425) 224
60 years and older 174 (153 – 197) 63.3 (50.0 – 72.8) 166 (137 – 191) 482 (401 – 613) 298
† Estimate is subject to greater uncertainty due to small cell size. 
350 2nd National Report on Biochemical Indicators of Diet and Nutrition in the U.S. Population
Table 3.4.b. Urinary iodine: Concentrations by survey cycle
Geometric mean and selected percentiles of urine concentrations (in ng/mL) for the U.S. population, National 
Health and Nutrition Examination Survey, 2001–2006. 
Geometric mean 
(95% conf. interval)
Selected percentiles (95% conf. interval) Sample 
size5th 50th 95th
Total, 6 years and older
 2001–2002 162 (152 – 172) 30.1 (24.9 – 35.5) 168 (158 – 177) 713 (627 – 809) 2,837
 2003–2004 150 (141 – 160) 28.9 (24.9 – 33.7) 160 (146 – 172) 569 (493 – 660) 2,526
 2005–2006 161 (150 – 174) 36.0 (29.0 – 39.1) 164 (154 – 174) 665 (580 – 762) 2,649
Age group
6–11 years
 2001–2002 235 (208 – 266) 51.8 (25.5 – 65.9) 249 (220 – 288) 771 (700 – 918) 374
 2003–2004 209 (183 – 239) 45.7 (37.4 – 54.0) 229 (187 – 279) 613 (553 – 1,180) 315
 2005–2006 235 (201 – 276) 60.2 (28.0 – 80.9) 238 (197 – 279) 967 (673 – 2,950) 351
12–19 years
 2001–2002 192 (178 – 207) 38.3 (23.5 – 47.2) 205 (189 – 214) 803 (710 – 968) 831
 2003–2004 166 (141 – 195) 33.5 (17.9 – 46.4) 178 (144 – 203) 645 (503 – 924) 721
 2005–2006 193 (167 – 224) 38.2 (25.1 – 51.8) 194 (177 – 224) 797 (713 – 1,160) 722
20–39 years
 2001–2002 148 (132 – 166) 27.8 (22.0 – 40.6) 153 (136 – 173) 536 (473 – 762) 627
 2003–2004 138 (125 – 151) 23.8 (18.5 – 32.3) 146 (123 – 165) 564 (446 – 746) 517
 2005–2006 132 (120 – 145) 31.9 (22.3 – 40.0) 134 (124 – 143) 483 (412 – 601) 617
40–59 years
 2001–2002 140 (121 – 162) 24.5 (21.1 – 30.0) 141 (119 – 169) 689 (525 – 1,330) 496
 2003–2004 132 (119 – 147) 24.9 (13.1 – 35.0) 142 (128 – 161) 478 (422 – 690) 434
 2005–2006 143 (129 – 158) 34.6 (20.1 – 38.3) 148 (131 – 173) 519 (431 – 640) 485
60 years and older
 2001–2002 177 (156 – 200) 40.7 (30.1 – 48.7) 171 (152 – 198) 744 (617 – 1,250) 509
 2003–2004 169 (152 – 189) 39.7 (29.9 – 45.9) 170 (148 – 196) 635 (518 – 776) 539
 2005–2006 205 (175 – 240) 47.9 (35.6 – 59.7) 195 (172 – 223) 826 (620 – 4,220) 474
Gender
Males
 2001–2002 192 (178 – 208) 41.7 (35.0 – 48.0) 196 (179 – 209) 769 (630 – 981) 1,333
 2003–2004 169 (156 – 183) 38.8 (25.9 – 44.3) 178 (164 – 193) 584 (475 – 786) 1,229
 2005–2006 179 (163 – 197) 38.0 (32.9 – 44.8) 182 (172 – 195) 702 (595 – 960) 1,248
Females
 2001–2002 137 (127 – 148) 24.6 (21.3 – 29.2) 140 (126 – 156) 653 (576 – 736) 1,504
 2003–2004 134 (125 – 145) 25.0 (23.0 – 29.0) 141 (127 – 155) 559 (493 – 584) 1,297
 2005–2006 146 (136 – 158) 31.2 (20.6 – 39.0) 147 (137 – 155) 592 (544 – 693) 1,401
Race/ethnicity
Mexican Americans
 2001–2002 176 (163 – 189) 33.7 (29.0 – 42.3) 187 (168 – 206) 673 (527 – 883) 720
 2003–2004 168 (152 – 187) 38.7 (19.9 – 52.0) 186 (166 – 194) 568 (444 – 1,020) 617
 2005–2006 177 (161 – 195) 44.6 (34.7 – 54.0) 184 (165 – 210) 640 (531 – 1,030) 703
Non-Hispanic Blacks
 2001–2002 156 (137 – 178) 38.6 (30.6 – 45.7) 143 (124 – 172) 716 (608 – 918) 670
 2003–2004 134 (120 – 149) 42.3 (33.6 – 44.9) 131 (121 – 146) 456 (386 – 599) 634
 2005–2006 147 (133 – 163) 34.3 (27.8 – 42.0) 149 (137 – 164) 510 (440 – 678) 729
Non-Hispanic Whites
 2001–2002 163 (150 – 176) 29.2 (22.7 – 35.6) 169 (160 – 181) 734 (604 – 875) 1,222
 2003–2004 154 (144 – 164) 28.8 (23.9 – 33.8) 166 (151 – 181) 572 (486 – 684) 1,080






































































Figure 3.4.b. Urinary iodine: Concentrations by survey cycle 
Selected percentiles in ng/mL (95% confidence intervals), National Health and 
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Non−Hispanic Blacks Non−Hispanic Whites 
Geometric mean (95% confidence interval), National Health and Nutrition Examination Survey, 2003–2006 
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Table 3.5.a.2. Urinary iodine (creatinine corrected): Total population
Geometric mean and selected percentiles of urine concentrations (in µg/g creatinine) for the total U.S. 
population aged 6 years and older, National Health and Nutrition Examination Survey, 2003–2006. 
Geometric mean 
(95% conf. interval)
Selected percentiles (95% conf. interval) Sample 
size10th 50th 90th
Males and Females
Total, 6 years and older 155 (147 – 163) 59.8 (56.4 – 64.0) 149 (140 – 156) 410 (391 – 438) 5,174
6–11 years 269 (244 – 297) 105 (92.1 – 115) 266 (240 – 293) 631 (590 – 820) 666
12–19 years 134 (124 – 145) 55.9 (49.7 – 61.9) 125 (115 – 137) 346 (301 – 386) 1,442
20–39 years 119 (111 – 127) 50.5 (46.7 – 55.0) 111 (103 – 119) 289 (271 – 324) 1,134
40–59 years 145 (136 – 156) 58.4 (50.9 – 63.7) 146 (132 – 158) 357 (322 – 408) 919
60 years and older 224 (209 – 241) 83.6 (75.9 – 92.3) 214 (191 – 237) 552 (481 – 635) 1,013
Males
Total, 6 years and older 145 (137 – 153) 56.5 (52.3 – 60.2) 138 (129 – 149) 382 (357 – 414) 2,477
6–11 years 283 (248 – 323) 108 (83.8 – 131) 280 (245 – 322) 631 (589 – 1,060) 307
12–19 years 134 (122 – 148) 52.4 (46.2 – 58.2) 132 (117 – 149) 347 (300 – 413) 693
20–39 years 114 (106 – 123) 50.3 (44.9 – 54.6) 103 (93.8 – 114) 276 (264 – 335) 512
40–59 years 129 (119 – 140) 52.1 (45.8 – 60.0) 126 (113 – 136) 311 (274 – 392) 454
60 years and older 198 (183 – 215) 73.1 (67.3 – 83.9) 180 (168 – 205) 440 (407 – 481) 511
Females
Total, 6 years and older 165 (156 – 174) 63.9 (57.9 – 69.6) 157 (148 – 169) 439 (403 – 481) 2,697
6–11 years 256 (228 – 286) 99.9 (87.8 – 114) 247 (227 – 293) 630 (529 – 821) 359
12–19 years 134 (121 – 148) 59.3 (51.3 – 64.9) 121 (111 – 131) 332 (292 – 403) 749
20–39 years 123 (112 – 136) 51.0 (45.8 – 57.9) 118 (107 – 130) 292 (254 – 359) 622
40–59 years 162 (148 – 178) 63.8 (55.7 – 70.9) 166 (145 – 188) 408 (344 – 482) 465
60 years and older 247 (224 – 272) 92.2 (79.1 – 104) 243 (221 – 262) 617 (554 – 696) 502
Table 3.5.a.3. Urinary iodine (creatinine corrected): Mexican Americans
Geometric mean and selected percentiles of urine concentrations (in µg/g creatinine) for Mexican Americans in 
the U.S. population aged 6 years and older, National Health and Nutrition Examination Survey, 2003–2006. 
Geometric mean 
(95% conf. interval)
Selected percentiles (95% conf. interval) Sample 
size10th 50th 90th
Males and Females
Total, 6 years and older 160 (151 – 170) 67.5 (60.4 – 70.6) 156 (146 – 163) 383 (343 – 470) 1,319
6–11 years 276 (246 – 311) 123 (103 – 138) 267 (242 – 293) 619 (468 – 925) 217
12–19 years 146 (131 – 163) 61.9 (53.6 – 72.7) 143 (128 – 157) 344 (285 – 468) 465
20–39 years 137 (125 – 149) 59.7 (53.7 – 71.1) 137 (120 – 147) 293 (261 – 384) 283
40–59 years 146 (129 – 164) 66.0 (55.3 – 69.3) 148 (124 – 161) 317 (292 – 382) 165
60 years and older 222 (193 – 255) 85.2 (67.8 – 101) 210 (167 – 247) 459 (385 – 725) 189
Males
Total, 6 years and older 148 (137 – 159) 60.0 (56.3 – 65.7) 147 (131 – 163) 361 (319 – 428) 623
6–11 years 269 (236 – 307) 126† (81.6 – 166) 278 (226 – 318) 541† (454 – 725) 96
12–19 years 147 (125 – 173) 58.5 (46.3 – 72.5) 141 (121 – 168) 346 (282 – 519) 221
20–39 years 124 (111 – 139) 55.7 (46.1 – 64.8) 121 (109 – 146) 244 (220 – 435) 134
40–59 years 133 (111 – 160) 58.9† (40.2 – 67.6) 136 (101 – 161) 318† (285 – 383) 77
60 years and older 189 (167 – 213) 81.1† (67.3 – 99.9) 168 (144 – 204) 410† (319 – 1,020) 95
Females
Total, 6 years and older 174 (164 – 186) 73.4 (67.6 – 78.3) 162 (156 – 177) 416 (352 – 488) 696
6–11 years 284 (237 – 340) 116 (101 – 134) 250 (224 – 299) 656 (468 – 2,530) 121
12–19 years 145 (129 – 162) 67.1 (55.5 – 74.4) 144 (123 – 157) 333 (267 – 492) 244
20–39 years 153 (139 – 168) 73.4 (51.7 – 84.7) 143 (125 – 162) 344 (293 – 446) 149
40–59 years 160 (141 – 182) 68.0† (59.1 – 82.3) 160 (141 – 181) 308† (264 – 434) 88
60 years and older 253 (204 – 315) 86.1† (23.2 – 124) 232 (196 – 265) 502† (415 – 2,790) 94
† Estimate is subject to greater uncertainty due to small cell size. 
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Table 3.5.a.4. Urinary iodine (creatinine corrected): Non-Hispanic blacks
Geometric mean and selected percentiles of urine concentrations (in µg/g creatinine) for non-Hispanic blacks 
in the U.S. population aged 6 years and older, National Health and Nutrition Examination Survey, 2003–2006. 
Geometric mean 
(95% conf. interval)
Selected percentiles (95% conf. interval) Sample 
size10th 50th 90th
Males and Females
Total, 6 years and older 98.6 (91.2 – 106) 39.0 (35.8 – 41.7) 90.4 (83.4 – 99.1) 264 (248 – 293) 1,363
6–11 years 188 (164 – 214) 80.2 (67.6 – 87.6) 180 (152 – 221) 448 (376 – 558) 221
12–19 years 90.8 (83.6 – 98.6) 40.5 (36.5 – 42.5) 87.0 (78.8 – 95.5) 223 (191 – 258) 515
20–39 years 75.5 (67.9 – 83.9) 35.6 (31.1 – 38.6) 72.6 (63.6 – 80.4) 209 (137 – 254) 238
40–59 years 98.3 (88.0 – 110) 38.1 (32.9 – 45.4) 90.5 (78.2 – 103) 257 (217 – 296) 219
60 years and older 123 (106 – 143) 46.0 (40.3 – 50.9) 108 (98.4 – 129) 337 (251 – 498) 170
Males
Total, 6 years and older 101 (90.7 – 112) 37.6 (33.7 – 41.2) 92.1 (80.8 – 103) 294 (254 – 360) 663
6–11 years 187 (152 – 231) 73.7† (52.4 – 87.7) 178 (142 – 244) 447† (360 – 898) 106
12–19 years 90.1 (81.4 – 99.7) 37.4 (31.5 – 41.8) 84.8 (75.5 – 97.0) 224 (196 – 264) 260
20–39 years 76.2 (67.5 – 85.9) 35.3† (27.7 – 38.4) 71.7 (62.5 – 78.5) 215† (127 – 285) 108
40–59 years 105 (87.6 – 126) 34.3† (29.7 – 47.5) 93.8 (73.4 – 130) 286† (239 – 559) 104
60 years and older 123 (89.2 – 170) 41.0† (34.7 – 49.6) 103 (78.5 – 159) 365† (242 – 4,440) 85
Females
Total, 6 years and older 96.5 (89.3 – 104) 39.3 (35.7 – 44.7) 89.3 (84.3 – 97.6) 247 (218 – 285) 700
6–11 years 188 (167 – 211) 83.8 (68.1 – 98.7) 185 (152 – 220) 442 (375 – 548) 115
12–19 years 91.5 (82.1 – 102) 42.8 (36.5 – 46.2) 88.5 (76.0 – 99.7) 205 (164 – 311) 255
20–39 years 74.9 (64.2 – 87.5) 36.1 (30.0 – 39.1) 72.7 (60.5 – 84.3) 196 (130 – 248) 130
40–59 years 92.9 (83.6 – 103) 39.5 (29.3 – 47.1) 88.5 (73.7 – 99.0) 217 (196 – 284) 115
60 years and older 123 (99.9 – 152) 50.2† (30.9 – 61.9) 111 (97.1 – 134) 255† (229 – 540) 85
† Estimate is subject to greater uncertainty due to small cell size. 
Table 3.5.a.5. Urinary iodine (creatinine corrected): Non-Hispanic whites
Geometric mean and selected percentiles of urine concentrations (in µg/g creatinine) for non-Hispanic whites 
in the U.S. population aged 6 years and older, National Health and Nutrition Examination Survey, 2003–2006. 
Geometric mean 
(95% conf. interval)
Selected percentiles (95% conf. interval) Sample 
size10th 50th 90th
Males and Females
Total, 6 years and older 167 (161 – 174) 67.2 (63.6 – 69.2) 158 (151 – 169) 430 (404 – 472) 2,085
6–11 years 299 (261 – 342) 114 (92.8 – 132) 289 (259 – 348) 663 (616 – 1,050) 169
12–19 years 147 (134 – 161) 63.3 (54.3 – 69.8) 135 (122 – 155) 374 (311 – 447) 365
20–39 years 125 (118 – 133) 55.5 (47.8 – 62.1) 115 (107 – 124) 298 (274 – 345) 494
40–59 years 155 (145 – 166) 62.7 (56.4 – 69.7) 155 (140 – 174) 364 (327 – 419) 453
60 years and older 236 (218 – 256) 94.3 (82.5 – 102) 233 (196 – 248) 559 (481 – 657) 604
Males
Total, 6 years and older 157 (149 – 165) 64.0 (61.1 – 67.2) 150 (140 – 156) 396 (368 – 428) 996
6–11 years 337 (272 – 417) 131† (63.9 – 170) 326 (268 – 429) 811† (610 – 2,040) 76
12–19 years 149 (135 – 163) 59.4 (49.6 – 67.3) 143 (129 – 170) 378 (301 – 455) 174
20–39 years 122 (111 – 135) 57.5 (46.5 – 65.4) 104 (93.8 – 122) 292 (265 – 349) 211
40–59 years 137 (126 – 149) 59.3 (48.9 – 64.1) 136 (120 – 152) 313 (274 – 414) 229
60 years and older 208 (192 – 226) 82.9 (70.7 – 95.2) 189 (173 – 215) 440 (402 – 522) 306
Females
Total, 6 years and older 178 (169 – 188) 70.6 (64.9 – 74.3) 169 (156 – 183) 464 (431 – 514) 1,089
6–11 years 265 (225 – 311) 99.1† (84.0 – 118) 262 (227 – 315) 640† (474 – 1,020) 93
12–19 years 145 (127 – 167) 65.0 (56.0 – 74.0) 127 (112 – 152) 368 (292 – 499) 191
20–39 years 128 (116 – 142) 51.3 (45.4 – 62.5) 123 (110 – 141) 295 (242 – 391) 283
40–59 years 175 (159 – 193) 70.6 (58.0 – 79.3) 179 (152 – 202) 433 (362 – 496) 224
60 years and older 261 (232 – 294) 104 (81.2 – 119) 255 (236 – 280) 630 (556 – 697) 298
† Estimate is subject to greater uncertainty due to small cell size. 
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Table 3.5.b. Urinary iodine (creatinine corrected): Concentrations by survey cycle
Geometric mean and selected percentiles of urine concentrations (in µg/g creatinine) for the U.S. population, 
National Health and Nutrition Examination Survey, 2001–2006. 
Geometric mean 
(95% conf. interval)
Selected percentiles (95% conf. interval) Sample 
size5th 50th 95th
Total, 6 years and older
 2001–2002 163 (153 – 173) 50.0 (46.8 – 54.0) 151 (141 – 165) 620 (567 – 687) 2,835
 2003–2004 146 (135 – 158) 45.4 (39.4 – 49.3) 142 (130 – 154) 492 (449 – 585) 2,525
 2005–2006 163 (153 – 175) 50.0 (45.0 – 54.7) 155 (143 – 169) 620 (549 – 733) 2,649
Age group
6–11 years
 2001–2002 273 (246 – 304) 94.5 (75.7 – 106) 257 (220 – 319) 923 (772 – 1,140) 374
 2003–2004 254 (228 – 283) 84.4 (71.9 – 98.7) 246 (233 – 269) 718 (615 – 1,210) 315
 2005–2006 286 (242 – 339) 82.5 (64.3 – 98.9) 288 (236 – 362) 947 (654 – 2,300) 351
12–19 years
 2001–2002 149 (137 – 161) 52.5 (47.8 – 58.9) 138 (129 – 146) 601 (450 – 721) 830
 2003–2004 124 (109 – 141) 45.4 (36.3 – 49.9) 117 (104 – 132) 381 (314 – 532) 720
 2005–2006 145 (130 – 162) 45.4 (39.8 – 51.9) 138 (117 – 163) 477 (434 – 829) 722
20–39 years
 2001–2002 135 (127 – 143) 46.7 (42.2 – 49.5) 128 (118 – 136) 470 (443 – 577) 627
 2003–2004 115 (104 – 127) 39.2 (33.9 – 44.9) 108 (99.3 – 119) 407 (319 – 559) 517
 2005–2006 123 (112 – 135) 43.9 (39.1 – 49.0) 114 (97.7 – 131) 378 (339 – 592) 617
40–59 years
 2001–2002 151 (130 – 175) 44.7 (37.9 – 54.5) 142 (120 – 176) 522 (427 – 712) 496
 2003–2004 138 (126 – 152) 42.0 (34.9 – 49.9) 136 (126 – 150) 436 (392 – 561) 434
 2005–2006 152 (137 – 170) 47.0 (40.9 – 56.5) 153 (126 – 179) 492 (429 – 544) 485
60 years and older
 2001–2002 216 (192 – 244) 67.1 (51.2 – 75.5) 199 (179 – 230) 751 (632 – 1,000) 508
 2003–2004 204 (188 – 222) 67.2 (60.3 – 74.0) 197 (178 – 233) 595 (521 – 726) 539
 2005–2006 246 (218 – 277) 68.4 (65.8 – 72.8) 235 (193 – 256) 858 (697 – 5,190) 474
Gender
Males
 2001–2002 156 (143 – 171) 47.0 (43.7 – 51.1) 145 (137 – 160) 578 (514 – 674) 1,333
 2003–2004 137 (127 – 148) 41.7 (36.3 – 46.4) 132 (121 – 146) 481 (417 – 590) 1,229
 2005–2006 152 (140 – 165) 47.8 (42.6 – 50.4) 147 (132 – 158) 540 (480 – 795) 1,248
Females
 2001–2002 170 (161 – 179) 55.2 (48.0 – 57.1) 158 (146 – 168) 670 (585 – 748) 1,502
 2003–2004 155 (142 – 169) 46.9 (41.8 – 52.7) 151 (133 – 167) 532 (452 – 630) 1,296
 2005–2006 176 (163 – 189) 54.4 (44.6 – 60.3) 164 (150 – 179) 687 (598 – 829) 1,401
Race/ethnicity
Mexican Americans
 2001–2002 164 (152 – 176) 56.0 (49.4 – 61.0) 154 (140 – 177) 589 (469 – 754) 720
 2003–2004 152 (138 – 169) 51.3 (42.1 – 58.9) 147 (133 – 164) 481 (389 – 1,100) 616
 2005–2006 167 (154 – 181) 56.2 (51.7 – 60.0) 163 (153 – 179) 544 (454 – 728) 703
Non-Hispanic Blacks
 2001–2002 113 (103 – 124) 36.8 (27.9 – 42.8) 103 (93.5 – 115) 440 (361 – 645) 669
 2003–2004 92.1 (81.2 – 104) 33.1 (29.7 – 33.8) 84.6 (73.1 – 97.6) 336 (296 – 375) 634
 2005–2006 105 (96.7 – 115) 33.7 (29.8 – 37.7) 96.6 (87.0 – 111) 397 (315 – 513) 729
Non-Hispanic Whites
 2001–2002 175 (163 – 188) 55.1 (48.3 – 58.2) 164 (151 – 176) 652 (576 – 749) 1,221
 2003–2004 159 (150 – 168) 50.9 (46.3 – 58.2) 153 (147 – 161) 526 (442 – 621) 1,080
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Figure 3.5.b. Urinary iodine (creatinine corrected): Concentrations by survey cycle 
Selected percentiles in μg/g creatinine (95% confidence intervals), 

National Health and Nutrition Examination Survey, 2001–2006 
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3614. Isoflavones and Lignans









362 2nd National Report on Biochemical Indicators of Diet and Nutrition in the U.S. Population
Isoflavones and Lignans
Background Information

























































































364 2nd National Report on Biochemical Indicators of Diet and Nutrition in the U.S. Population









































3654. Isoflavones and Lignans
Figure H.4.a. Geometric mean concentrations of urinary isoflavones and lignans in the U.S. population aged 6 years and older, 
National Health and Nutrition Examination Survey, 2003–2006. 



































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Non−Hispanic Blacks Non−Hispanic Whites 
Figure 4.1.a. Urinary genistein: Concentrations by age group 
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Table 4.1.a.2. Urinary genistein: Total population
Geometric mean and selected percentiles of urine concentrations (in µg/L) for the total U.S. population aged 6 
years and older, National Health and Nutrition Examination Survey, 2003–2006. 
Geometric mean 
 (95% conf. interval)
Selected percentiles (95% conf. interval) Sample 
size10th 50th 90th
Males and Females
Total, 6 years and older 29.9 (28.0 – 31.8) 4.18 (3.88 – 4.51) 26.1 (23.8 – 28.5) 274 (246 – 304) 5,122
6–11 years 36.0 (30.9 – 41.9) 6.11 (4.50 – 7.43) 31.7 (26.6 – 35.8) 276 (215 – 355) 692
12–19 years 34.4 (30.7 – 38.6) 4.87 (4.11 – 5.91) 27.6 (23.6 – 33.2) 303 (237 – 367) 1,422
20–39 years 28.5 (25.0 – 32.5) 4.25 (3.30 – 5.01) 23.7 (20.4 – 27.5) 237 (185 – 322) 1,137
40–59 years 28.1 (25.1 – 31.5) 3.76 (3.33 – 3.96) 26.2 (20.7 – 30.2) 307 (242 – 374) 901
60 years and older 29.5 (26.1 – 33.3) 4.09 (3.31 – 4.77) 27.5 (22.4 – 31.7) 244 (212 – 311) 970
Males
Total, 6 years and older 32.9 (30.2 – 35.7) 4.91 (4.35 – 5.39) 28.5 (25.7 – 32.0) 301 (247 – 337) 2,496
6–11 years 34.9 (28.9 – 42.1) 6.44 (4.51 – 8.48) 29.8 (22.4 – 35.8) 215 (177 – 369) 340
12–19 years 37.1 (31.3 – 44.0) 5.45 (4.48 – 6.96) 31.9 (24.2 – 42.5) 261 (209 – 402) 728
20–39 years 32.0 (27.8 – 36.7) 4.95 (3.48 – 5.71) 25.9 (21.5 – 32.0) 300 (197 – 397) 499
40–59 years 32.0 (26.9 – 38.0) 4.14 (3.42 – 5.17) 29.1 (21.7 – 34.2) 324 (227 – 510) 451
60 years and older 31.9 (26.6 – 38.3) 4.73 (3.78 – 5.83) 28.9 (20.6 – 36.6) 230 (183 – 337) 478
Females
Total, 6 years and older 27.2 (24.9 – 29.9) 3.73 (3.23 – 4.07) 23.8 (20.8 – 27.0) 253 (222 – 302) 2,626
6–11 years 37.2 (28.2 – 49.0) 5.55 (3.39 – 7.52) 34.9 (25.3 – 44.7) 278 (239 – 407) 352
12–19 years 31.7 (26.6 – 37.9) 3.85 (3.34 – 5.15) 24.3 (20.0 – 31.7) 321 (220 – 413) 694
20–39 years 25.5 (20.7 – 31.3) 3.81 (2.25 – 4.32) 22.1 (18.9 – 26.9) 208 (154 – 318) 638
40–59 years 24.9 (21.3 – 29.0) 3.14 (2.70 – 3.91) 20.4 (16.6 – 27.0) 256 (175 – 408) 450
60 years and older 27.7 (23.1 – 33.2) 3.34 (2.11 – 4.74) 26.6 (19.2 – 32.0) 243 (208 – 322) 492
Table 4.1.a.3. Urinary genistein: Mexican Americans
Geometric mean and selected percentiles of urine concentrations (in µg/L) for Mexican Americans in the U.S. 
population aged 6 years and older, National Health and Nutrition Examination Survey, 2003–2006. 
Geometric mean 
 (95% conf. interval)
Selected percentiles (95% conf. interval) Sample 
size10th 50th 90th
Males and Females
Total, 6 years and older 29.3 (26.8 – 32.0) 4.38 (3.48 – 5.15) 25.8 (22.2 – 29.0) 301 (242 – 341) 1,287
6–11 years 32.4 (24.4 – 43.1) 5.65 (4.27 – 6.93) 27.5 (19.2 – 35.8) 293 (127 – 645) 231
12–19 years 35.6 (29.8 – 42.6) 5.60 (4.70 – 6.58) 30.7 (26.9 – 36.0) 315 (171 – 493) 445
20–39 years 26.8 (23.1 – 31.0) 4.03 (2.23 – 5.44) 21.3 (16.7 – 26.1) 325 (229 – 461) 282
40–59 years 29.1 (21.9 – 38.8) 4.18 (2.24 – 5.48) 27.5 (17.8 – 38.2) 253 (132 – 506) 157
60 years and older 25.9 (20.6 – 32.6) 3.09 (2.42 – 3.67) 29.8 (17.7 – 35.2) 228 (138 – 335) 172
Males
Total, 6 years and older 30.9 (26.4 – 36.3) 4.76 (3.89 – 5.84) 25.9 (21.4 – 31.5) 304 (200 – 457) 625
6–11 years 30.5 (22.1 – 42.0) 6.04 (3.33 – 7.64) 23.1 (17.9 – 34.9) 212 (101 – 566) 112
12–19 years 37.0 (30.3 – 45.3) 6.17 (4.86 – 7.61) 31.6 (26.1 – 40.7) 243 (160 – 424) 228
20–39 years 29.0 (21.3 – 39.5) 4.54 (2.37 – 5.97) 21.0 (15.5 – 36.1) 331 (185 – 646) 117
40–59 years 31.4 (19.5 – 50.6) 3.89† (1.51 – 6.76) 27.8 (13.3 – 43.9) 259† (86.0 – 4,840) 85
60 years and older 30.0 (17.7 – 50.9) 3.47† (1.78 – 5.40) 34.5 (16.9 – 56.7) 178† (97.8 – 2,730) 83
Females
Total, 6 years and older 27.5 (23.3 – 32.5) 3.76 (2.76 – 4.71) 25.2 (19.3 – 31.2) 286 (206 – 371) 662
6–11 years 34.6 (22.2 – 54.1) 5.17 (2.04 – 6.90) 34.0 (21.2 – 44.3) 303 (118 – 2,670) 119
12–19 years 34.2 (26.4 – 44.3) 5.03 (3.49 – 6.31) 29.4 (19.4 – 38.1) 407 (192 – 554) 217
20–39 years 24.4 (16.8 – 35.4) 3.41 (1.71 – 4.29) 20.3 (15.3 – 34.0) 251 (97.7 – 827) 165
40–59 years 26.9 (19.9 – 36.3) 4.15† (1.15 – 5.49) 26.5 (18.5 – 43.2) 199† (79.1 – 832) 72
60 years and older 23.0 (14.2 – 37.1) 2.53† (< LOD – 4.40) 17.8 (12.5 – 36.4) 258† (108 – 681) 89
< LOD means less than the limit of detection, which may vary for some compounds by year. See Appendix D for LOD.
† Estimate is subject to greater uncertainty due to small cell size.  
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Table 4.1.a.4. Urinary genistein: Non-Hispanic blacks
Geometric mean and selected percentiles of urine concentrations (in µg/L) for non-Hispanic blacks in the U.S. 
population aged 6 years and older, National Health and Nutrition Examination Survey, 2003–2006. 
Geometric mean 
 (95% conf. interval)
Selected percentiles (95% conf. interval) Sample 
size10th 50th 90th
Males and Females
Total, 6 years and older 31.8 (27.1 – 37.3) 5.01 (4.16 – 5.69) 27.8 (23.0 – 34.7) 269 (206 – 331) 1,343
6–11 years 38.4 (29.9 – 49.4) 5.60 (3.37 – 7.09) 34.7 (25.1 – 46.0) 311 (215 – 640) 207
12–19 years 42.7 (37.0 – 49.2) 6.66 (5.91 – 7.91) 35.3 (29.1 – 44.4) 286 (227 – 400) 496
20–39 years 29.0 (22.5 – 37.4) 5.04 (3.86 – 6.11) 24.7 (17.2 – 33.2) 198 (152 – 390) 249
40–59 years 32.2 (24.2 – 43.0) 4.30 (2.56 – 6.18) 29.9 (20.7 – 45.8) 318 (167 – 547) 231
60 years and older 22.9 (17.5 – 30.0) 3.42 (3.12 – 4.54) 20.6 (14.9 – 32.7) 171 (99.8 – 326) 160
Males
Total, 6 years and older 35.4 (30.1 – 41.7) 5.67 (4.64 – 6.71) 30.4 (26.5 – 36.3) 293 (214 – 401) 661
6–11 years 38.5 (26.8 – 55.3) 4.06† (1.87 – 7.03) 36.7 (18.6 – 54.7) 360† (205 – 747) 99
12–19 years 44.5 (36.0 – 55.0) 6.90 (4.87 – 8.70) 35.4 (27.4 – 48.1) 282 (193 – 844) 258
20–39 years 35.4 (26.1 – 48.0) 6.47 (4.28 – 9.07) 27.4 (18.8 – 43.5) 310 (158 – 413) 116
40–59 years 33.1 (24.0 – 45.8) 4.50 (2.29 – 7.00) 30.7 (20.4 – 47.7) 265 (153 – 434) 114
60 years and older 26.7 (20.0 – 35.6) 4.67† (3.31 – 6.20) 24.1 (17.1 – 35.7) 145† (110 – 525) 74
Females
Total, 6 years and older 29.1 (23.5 – 35.9) 4.46 (3.51 – 5.35) 24.9 (19.1 – 35.1) 249 (172 – 336) 682
6–11 years 38.4 (27.0 – 54.5) 6.52† (4.22 – 7.95) 31.4 (19.2 – 45.9) 272† (170 – 1,510) 108
12–19 years 40.9 (35.2 – 47.6) 6.54 (4.59 – 8.23) 35.2 (26.4 – 47.9) 286 (223 – 376) 238
20–39 years 24.6 (17.4 – 35.0) 4.47 (1.60 – 5.45) 20.2 (13.7 – 31.3) 165 (103 – 387) 133
40–59 years 31.5 (19.5 – 51.0) 3.75 (2.08 – 6.18) 27.6 (15.3 – 58.7) 349 (148 – 870) 117
60 years and older 20.8 (13.2 – 32.7) 3.22† (2.12 – 4.03) 18.2 (9.40 – 33.0) 170† (50.8 – 19,800) 86
† Estimate is subject to greater uncertainty due to small cell size.  
Table 4.1.a.5. Urinary genistein: Non-Hispanic whites
Geometric mean and selected percentiles of urine concentrations (in µg/L) for non-Hispanic whites in the U.S. 
population aged 6 years and older, National Health and Nutrition Examination Survey, 2003–2006. 
Geometric mean 
 (95% conf. interval)
Selected percentiles (95% conf. interval) Sample 
size10th 50th 90th
Males and Females
Total, 6 years and older 28.8 (26.7 – 31.1) 4.00 (3.69 – 4.23) 25.3 (22.3 – 28.3) 257 (229 – 302) 2,108
6–11 years 34.9 (28.4 – 42.9) 5.95 (4.33 – 7.79) 29.1 (22.3 – 41.7) 247 (179 – 378) 193
12–19 years 32.8 (28.4 – 37.9) 4.48 (3.60 – 5.63) 24.7 (20.4 – 32.0) 298 (223 – 368) 378
20–39 years 26.9 (22.6 – 32.2) 3.82 (2.28 – 4.71) 22.8 (19.1 – 27.9) 218 (163 – 319) 494
40–59 years 27.0 (23.4 – 31.1) 3.44 (2.90 – 3.98) 26.0 (18.7 – 30.3) 307 (225 – 421) 448
60 years and older 30.2 (26.6 – 34.2) 4.23 (3.01 – 5.32) 28.0 (22.3 – 32.2) 242 (211 – 308) 595
Males
Total, 6 years and older 31.8 (28.5 – 35.5) 4.75 (4.15 – 5.31) 27.0 (22.4 – 31.9) 274 (227 – 340) 1,035
6–11 years 34.1 (25.0 – 46.4) 6.75† (4.40 – 9.87) 26.6 (18.1 – 42.0) 209† (154 – 400) 99
12–19 years 34.9 (27.3 – 44.7) 5.07 (4.12 – 7.35) 25.4 (19.0 – 41.1) 262 (205 – 392) 191
20–39 years 29.4 (23.6 – 36.6) 4.32 (2.26 – 5.49) 23.6 (18.7 – 32.9) 233 (155 – 418) 217
40–59 years 32.3 (26.3 – 39.7) 4.15 (3.03 – 5.45) 29.0 (21.1 – 37.1) 336 (225 – 590) 229
60 years and older 31.6 (25.7 – 38.8) 4.77 (3.79 – 6.83) 28.5 (19.5 – 39.4) 220 (172 – 341) 299
Females
Total, 6 years and older 26.2 (23.4 – 29.2) 3.30 (2.72 – 3.94) 23.6 (19.4 – 27.3) 243 (207 – 306) 1,073
6–11 years 35.8 (25.2 – 50.9) 4.98† (1.29 – 7.17) 39.3 (20.8 – 54.2) 271† (153 – 919) 94
12–19 years 30.7 (24.1 – 39.0) 3.62 (2.73 – 5.14) 22.4 (17.2 – 33.7) 311 (207 – 416) 187
20–39 years 24.7 (19.0 – 32.1) 3.18 (1.91 – 4.28) 22.2 (16.3 – 29.1) 210 (149 – 353) 277
40–59 years 22.5 (18.4 – 27.4) 2.93 (1.90 – 3.80) 18.3 (14.9 – 26.8) 232 (154 – 472) 219
60 years and older 29.1 (24.0 – 35.3) 3.67 (1.76 – 5.32) 27.5 (21.6 – 32.3) 244 (197 – 336) 296
† Estimate is subject to greater uncertainty due to small cell size.  
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Table 4.1.b. Urinary genistein: Concentrations by survey cycle
Geometric mean and selected percentiles of urine concentrations (in µg/L) for the U.S. population, National 
Health and Nutrition Examination Survey, 1999–2006. 
Geometric mean 
 (95% conf. interval)
Selected percentiles (95% conf. interval) Sample 
size5th 50th 95th
Total, 6 years and older
 1999–2000 24.4 (19.7 – 30.3) < LOD 27.0 (22.5 – 32.4) 563 (437 – 727) 2,557
 2001–2002 33.0 (30.1 – 36.2) 2.64 (2.24 – 2.89) 28.9 (26.8 – 31.7) 619 (536 – 720) 2,794
 2003–2004 31.1 (29.0 – 33.3) 2.63 (1.99 – 3.28) 26.2 (23.8 – 29.6) 525 (411 – 619) 2,594
 2005–2006 28.7 (25.8 – 32.0) 2.33 (1.93 – 2.74) 25.9 (20.9 – 29.6) 522 (438 – 590) 2,528
Age group
6–11 years
 1999–2000 27.6 (21.1 – 36.1) .922 (< LOD – 3.07) 31.7 (18.4 – 42.6) 376 (287 – 712) 331
 2001–2002 39.2 (33.4 – 46.0) 5.09 (3.88 – 6.13) 31.5 (25.8 – 39.2) 501 (329 – 1,150) 396
 2003–2004 33.6 (27.8 – 40.6) 4.40 (3.23 – 5.98) 29.2 (22.9 – 37.8) 351 (220 – 433) 341
 2005–2006 38.6 (29.8 – 49.9) 3.84 (< LOD – 5.12) 34.3 (25.3 – 42.4) 625 (402 – 2,960) 351
12–19 years
 1999–2000 43.7 (34.2 – 55.7) 2.85 (1.97 – 4.17) 44.9 (34.5 – 59.5) 543 (363 – 842) 754
 2001–2002 34.1 (27.2 – 42.8) 3.70 (2.00 – 5.17) 29.0 (26.0 – 32.8) 469 (380 – 708) 744
 2003–2004 34.7 (29.3 – 41.0) 3.24 (2.06 – 4.10) 29.0 (23.3 – 37.4) 522 (367 – 675) 729
 2005–2006 34.1 (28.8 – 40.5) 3.35 (2.39 – 4.19) 26.7 (20.5 – 35.4) 481 (404 – 1,070) 693
20–39 years
 1999–2000 28.7 (21.7 – 37.8) < LOD 28.5 (23.2 – 35.8) 704 (453 – 1,540) 536
 2001–2002 34.4 (28.2 – 41.9) 2.42 (1.37 – 3.16) 30.4 (25.3 – 38.5) 611 (489 – 797) 604
 2003–2004 29.1 (24.5 – 34.6) 2.41 (1.40 – 3.83) 24.9 (21.0 – 29.6) 436 (396 – 567) 554
 2005–2006 27.9 (22.7 – 34.4) 2.16 (1.42 – 3.27) 22.3 (18.6 – 29.0) 556 (412 – 938) 583
40–59 years
 1999–2000 15.5 (10.1 – 23.7) < LOD 21.3 (13.0 – 28.2) 464 (313 – 1,320) 420
 2001–2002 32.9 (27.6 – 39.4) 2.74 (.916 – 3.38) 29.3 (24.3 – 34.7) 719 (541 – 1,210) 531
 2003–2004 32.4 (27.6 – 38.1) 2.44 (1.75 – 3.38) 27.3 (20.8 – 33.1) 664 (535 – 1,110) 452
 2005–2006 24.5 (20.8 – 29.0) 2.06 (1.14 – 2.70) 24.9 (17.5 – 30.1) 466 (348 – 637) 449
60 years and older
 1999–2000 21.7 (16.9 – 27.9) < LOD 22.5 (17.7 – 30.3) 352 (279 – 904) 516
 2001–2002 26.7 (21.8 – 32.7) 1.94 (1.26 – 2.56) 25.0 (20.0 – 32.2) 496 (280 – 1,240) 519
 2003–2004 28.6 (24.2 – 33.9) 2.13 (1.26 – 2.66) 25.9 (20.1 – 34.2) 386 (314 – 575) 518
 2005–2006 30.3 (25.2 – 36.5) 2.18 (1.17 – 3.21) 28.8 (22.1 – 33.0) 469 (318 – 867) 452
Gender
Males
 1999–2000 29.8 (22.2 – 40.0) < LOD 31.8 (26.4 – 37.0) 684 (441 – 1,440) 1,222
 2001–2002 32.2 (27.9 – 37.2) 2.61 (1.94 – 3.33) 29.3 (25.6 – 33.7) 474 (348 – 727) 1,375
 2003–2004 33.7 (29.6 – 38.4) 3.33 (2.46 – 4.18) 27.3 (23.8 – 33.0) 561 (444 – 655) 1,244
 2005–2006 32.0 (28.6 – 36.0) 2.83 (2.34 – 3.45) 29.1 (23.0 – 33.8) 488 (411 – 622) 1,252
Females
 1999–2000 20.3 (17.0 – 24.2) < LOD 23.1 (20.2 – 26.2) 442 (345 – 674) 1,335
 2001–2002 33.7 (30.9 – 36.8) 2.62 (2.25 – 2.87) 28.6 (26.3 – 31.9) 663 (602 – 811) 1,419
 2003–2004 28.7 (25.5 – 32.4) 2.05 (1.71 – 2.65) 25.0 (22.5 – 28.4) 466 (362 – 621) 1,350
 2005–2006 25.9 (22.3 – 29.9) 1.93 (1.58 – 2.34) 22.3 (17.8 – 27.4) 524 (413 – 694) 1,276
Race/ethnicity
Mexican Americans
 1999–2000 31.1 (25.1 – 38.5) .628 (< LOD – 2.04) 30.0 (25.2 – 37.4) 572 (471 – 1,550) 819
 2001–2002 28.3 (22.0 – 36.4) 2.80 (1.56 – 3.90) 25.4 (19.9 – 32.4) 423 (340 – 543) 679
 2003–2004 31.1 (27.5 – 35.2) 3.38 (2.23 – 4.24) 25.2 (19.2 – 32.2) 643 (566 – 865) 653
 2005–2006 27.6 (24.4 – 31.2) 2.11 (1.23 – 2.93) 26.3 (21.7 – 29.8) 412 (333 – 626) 634
Non-Hispanic Blacks
 1999–2000 26.5 (19.0 – 36.9) < LOD 32.8 (24.6 – 41.4) 456 (363 – 766) 597
 2001–2002 37.9 (27.3 – 52.6) 2.49 (1.53 – 4.06) 35.9 (23.9 – 51.2) 598 (446 – 1,300) 692
 2003–2004 32.6 (24.2 – 44.0) 3.00 (2.00 – 4.16) 27.7 (19.4 – 44.9) 506 (334 – 875) 681
 2005–2006 31.0 (26.7 – 36.1) 3.00 (2.16 – 3.55) 27.8 (23.1 – 34.9) 452 (372 – 883) 662
Non-Hispanic Whites
 1999–2000 23.7 (19.1 – 29.4) < LOD 25.6 (22.0 – 32.0) 564 (413 – 742) 901
 2001–2002 30.9 (27.7 – 34.3) 2.43 (2.03 – 2.75) 27.3 (24.5 – 30.7) 623 (521 – 746) 1,211
 2003–2004 30.9 (28.4 – 33.6) 2.34 (1.71 – 3.29) 26.2 (22.8 – 30.9) 501 (384 – 619) 1,069
 2005–2006 26.9 (23.6 – 30.6) 2.10 (1.58 – 2.57) 23.7 (19.0 – 29.0) 500 (397 – 623) 1,039
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Figure 4.1.b. Urinary genistein: Concentrations by survey cycle 
Selected percentiles in μg/L (95% confidence intervals), National Health and 





































































































































































Total 3−5y 6−11y 12−19y 20+y Males Females MA NHB NHW 
(6+y) 
Values in the graph are suppressed if either the point estimate or the lower 95% confidence limit is noted as “< LOD” in the accompanying table. 
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Figure 4.2.a. Urinary genistein (creatinine corrected): 
Concentrations  by age group 
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Table 4.2.a.2. Urinary genistein (creatinine corrected): Total population
Geometric mean and selected percentiles of urine concentrations (in µg/g creatinine) for the total U.S. 
population aged 6 years and older, National Health and Nutrition Examination Survey, 2003–2006. 
Geometric mean 
 (95% conf. interval)
Selected percentiles (95% conf. interval) Sample 
size10th 50th 90th
Males and Females
Total, 6 years and older 28.5 (26.9 – 30.2) 4.53 (4.29 – 4.79) 23.8 (21.6 – 26.1) 236 (210 – 270) 5,122
6–11 years 39.0 (33.7 – 45.1) 6.68 (5.55 – 8.43) 34.5 (27.4 – 38.3) 271 (216 – 388) 692
12–19 years 25.6 (23.0 – 28.5) 4.36 (3.90 – 4.67) 20.4 (17.8 – 24.8) 189 (151 – 236) 1,422
20–39 years 24.3 (21.8 – 27.1) 4.15 (3.81 – 4.55) 20.7 (17.8 – 23.6) 184 (144 – 236) 1,137
40–59 years 28.4 (25.2 – 32.1) 4.04 (3.52 – 4.65) 23.6 (19.1 – 27.8) 270 (207 – 415) 901
60 years and older 34.5 (31.4 – 38.0) 5.51 (4.85 – 6.21) 28.6 (24.5 – 32.6) 287 (226 – 398) 970
Males
Total, 6 years and older 26.1 (24.0 – 28.3) 4.29 (4.03 – 4.56) 22.1 (19.5 – 24.9) 205 (179 – 237) 2,496
6–11 years 35.0 (28.8 – 42.4) 6.30 (5.10 – 7.99) 29.8 (21.2 – 38.2) 272 (158 – 503) 340
12–19 years 25.2 (21.1 – 30.0) 4.38 (3.66 – 4.66) 20.3 (17.0 – 29.0) 154 (128 – 256) 728
20–39 years 23.3 (20.8 – 26.1) 3.96 (3.39 – 4.38) 20.0 (16.0 – 24.4) 204 (149 – 244) 499
40–59 years 25.4 (21.6 – 29.8) 3.68 (3.27 – 4.51) 20.2 (16.8 – 25.5) 228 (155 – 386) 451
60 years and older 29.4 (24.8 – 34.7) 5.20 (4.11 – 6.32) 25.0 (20.0 – 30.4) 200 (151 – 259) 478
Females
Total, 6 years and older 31.1 (28.3 – 34.1) 4.80 (4.35 – 5.45) 25.8 (22.9 – 28.1) 274 (230 – 320) 2,626
6–11 years 43.8 (33.4 – 57.4) 8.16 (4.38 – 10.4) 37.7 (26.4 – 50.0) 270 (212 – 798) 352
12–19 years 26.1 (22.5 – 30.3) 4.35 (3.72 – 5.23) 20.6 (16.5 – 24.8) 208 (164 – 269) 694
20–39 years 25.3 (20.9 – 30.7) 4.50 (3.83 – 5.53) 21.0 (17.6 – 26.9) 170 (124 – 289) 638
40–59 years 31.7 (26.2 – 38.3) 4.34 (2.99 – 5.61) 26.6 (21.3 – 32.6) 340 (210 – 631) 450
60 years and older 39.2 (33.9 – 45.4) 5.70 (4.76 – 6.64) 31.6 (25.8 – 39.0) 361 (289 – 530) 492
Table 4.2.a.3. Urinary genistein (creatinine corrected): Mexican Americans
Geometric mean and selected percentiles of urine concentrations (in µg/g creatinine) for Mexican Americans in 
the U.S. population aged 6 years and older, National Health and Nutrition Examination Survey, 2003–2006. 
Geometric mean 
 (95% conf. interval)
Selected percentiles (95% conf. interval) Sample 
size10th 50th 90th
Males and Females
Total, 6 years and older 26.4 (24.2 – 28.8) 4.25 (3.81 – 4.70) 22.4 (19.5 – 24.6) 212 (186 – 275) 1,287
6–11 years 40.7 (31.0 – 53.5) 7.48 (5.51 – 9.00) 31.6 (22.8 – 44.7) 304 (161 – 1,100) 231
12–19 years 27.5 (23.7 – 32.0) 5.58 (4.31 – 6.56) 22.4 (18.9 – 26.4) 208 (139 – 366) 445
20–39 years 21.6 (18.6 – 25.2) 3.65 (2.96 – 4.28) 16.2 (13.1 – 20.9) 204 (138 – 255) 282
40–59 years 26.7 (20.1 – 35.4) 3.71 (2.37 – 4.69) 25.4 (16.8 – 33.8) 229 (131 – 629) 157
60 years and older 32.0 (23.9 – 42.9) 5.10 (2.91 – 6.94) 31.2 (22.8 – 40.4) 233 (141 – 535) 172
Males
Total, 6 years and older 24.4 (20.6 – 28.9) 4.10 (3.50 – 4.54) 22.2 (17.2 – 26.4) 203 (136 – 275) 625
6–11 years 36.6 (25.7 – 52.1) 7.40 (5.50 – 9.04) 30.2 (19.7 – 43.0) 251 (129 – 659) 112
12–19 years 26.8 (21.9 – 32.8) 5.68 (4.54 – 6.56) 23.0 (16.8 – 30.7) 151 (116 – 347) 228
20–39 years 21.1 (15.6 – 28.5) 3.54 (2.60 – 4.32) 17.2 (12.4 – 23.3) 199 (112 – 328) 117
40–59 years 23.0 (14.4 – 36.9) 3.31† (1.22 – 4.36) 20.9 (8.19 – 31.2) 192† (92.0 – 2,070) 85
60 years and older 26.7 (16.1 – 44.4) 4.18† (1.75 – 7.13) 29.0 (10.9 – 49.6) 159† (59.4 – 4,830) 83
Females
Total, 6 years and older 28.7 (25.0 – 32.9) 4.59 (3.67 – 5.88) 22.9 (18.5 – 27.1) 262 (189 – 391) 662
6–11 years 45.6 (31.5 – 66.2) 7.46 (4.51 – 9.99) 37.3 (20.3 – 68.7) 311 (166 – 1,460) 119
12–19 years 28.2 (23.4 – 34.1) 5.47 (2.84 – 7.19) 21.7 (17.8 – 28.9) 269 (155 – 425) 217
20–39 years 22.3 (15.8 – 31.3) 3.60 (2.14 – 6.28) 15.8 (12.0 – 23.4) 199 (116 – 728) 165
40–59 years 31.3 (24.2 – 40.4) 4.10† (.565 – 6.37) 32.5 (18.1 – 44.1) 296† (151 – 594) 72
60 years and older 37.0 (22.8 – 60.0) 5.54† (< LOD – 8.83) 31.6 (13.4 – 82.7) 261† (142 – 745) 89
< LOD means less than the limit of detection for the uncorrected urine values, which may vary for some compounds by year. See Appendix D for LOD.
† Estimate is subject to greater uncertainty due to small cell size.  
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Table 4.2.a.4. Urinary genistein (creatinine corrected): Non-Hispanic blacks
Geometric mean and selected percentiles of urine concentrations (in µg/g creatinine) for non-Hispanic blacks 
in the U.S. population aged 6 years and older, National Health and Nutrition Examination Survey, 2003–2006. 
Geometric mean 
 (95% conf. interval)
Selected percentiles (95% conf. interval) Sample 
size10th 50th 90th
Males and Females
Total, 6 years and older 22.3 (19.6 – 25.5) 3.95 (3.34 – 4.63) 19.1 (15.7 – 22.2) 159 (137 – 211) 1,343
6–11 years 36.1 (28.1 – 46.3) 6.36 (4.62 – 7.24) 25.2 (22.0 – 37.0) 325 (198 – 811) 207
12–19 years 24.5 (21.6 – 27.9) 4.32 (3.87 – 5.01) 22.0 (16.7 – 25.6) 150 (125 – 214) 496
20–39 years 17.9 (14.7 – 21.9) 3.49 (2.75 – 4.31) 14.0 (11.3 – 19.5) 123 (82.7 – 209) 249
40–59 years 23.4 (18.7 – 29.3) 3.30 (2.54 – 4.71) 21.4 (17.4 – 26.3) 173 (128 – 458) 231
60 years and older 20.4 (16.4 – 25.5) 4.39 (3.33 – 4.93) 17.5 (11.4 – 22.8) 130 (84.1 – 218) 160
Males
Total, 6 years and older 20.7 (17.9 – 23.8) 3.40 (2.80 – 4.38) 17.6 (13.9 – 21.4) 173 (137 – 213) 661
6–11 years 36.4 (25.8 – 51.2) 4.60† (3.12 – 7.24) 24.9 (19.2 – 47.2) 396† (214 – 869) 99
12–19 years 23.8 (19.6 – 28.8) 3.95 (3.32 – 4.73) 21.2 (14.5 – 25.8) 159 (122 – 246) 258
20–39 years 17.0 (13.0 – 22.1) 3.20 (2.32 – 3.87) 12.6 (9.92 – 20.3) 150 (86.4 – 209) 116
40–59 years 18.9 (13.8 – 26.0) 2.97 (1.59 – 4.57) 17.4 (9.55 – 25.7) 140 (86.9 – 359) 114
60 years and older 19.6 (14.6 – 26.3) 3.86† (2.60 – 5.06) 18.3 (11.1 – 25.0) 112† (65.3 – 220) 74
Females
Total, 6 years and older 23.8 (19.8 – 28.6) 4.65 (3.49 – 5.61) 20.4 (16.4 – 25.3) 156 (123 – 244) 682
6–11 years 35.8 (24.8 – 51.6) 6.98† (5.89 – 8.65) 25.0 (20.5 – 37.1) 261† (113 – 1,290) 108
12–19 years 25.3 (21.7 – 29.4) 4.87 (3.83 – 5.77) 22.7 (15.5 – 28.5) 143 (105 – 292) 238
20–39 years 18.8 (14.2 – 24.8) 3.79 (2.53 – 5.95) 14.3 (10.5 – 21.9) 119 (77.3 – 252) 133
40–59 years 27.9 (18.7 – 41.8) 3.62 (2.57 – 5.58) 24.7 (17.9 – 34.9) 221 (114 – 570) 117
60 years and older 21.0 (14.5 – 30.3) 4.51† (2.75 – 6.49) 16.5 (9.90 – 29.0) 134† (83.9 – 254) 86
† Estimate is subject to greater uncertainty due to small cell size.  
Table 4.2.a.5. Urinary genistein (creatinine corrected): Non-Hispanic whites
Geometric mean and selected percentiles of urine concentrations (in µg/g creatinine) for non-Hispanic whites 
in the U.S. population aged 6 years and older, National Health and Nutrition Examination Survey, 2003–2006. 
Geometric mean 
 (95% conf. interval)
Selected percentiles (95% conf. interval) Sample 
size10th 50th 90th
Males and Females
Total, 6 years and older 29.3 (27.3 – 31.4) 4.55 (4.17 – 4.93) 24.9 (22.1 – 27.7) 241 (209 – 291) 2,108
6–11 years 37.8 (31.2 – 45.8) 6.34 (5.11 – 8.41) 34.8 (24.5 – 43.0) 255 (175 – 577) 193
12–19 years 25.8 (22.3 – 29.7) 4.33 (3.67 – 4.93) 19.5 (16.7 – 26.0) 181 (143 – 247) 378
20–39 years 24.8 (21.4 – 28.9) 4.16 (3.52 – 4.76) 21.7 (18.1 – 28.3) 181 (134 – 289) 494
40–59 years 29.0 (25.3 – 33.2) 4.00 (3.18 – 4.90) 23.6 (17.7 – 30.3) 273 (202 – 477) 448
60 years and older 36.0 (32.8 – 39.6) 5.83 (4.85 – 6.54) 30.0 (26.4 – 34.1) 292 (224 – 431) 595
Males
Total, 6 years and older 26.6 (23.9 – 29.5) 4.40 (3.87 – 4.86) 22.7 (19.4 – 26.2) 204 (169 – 261) 1,035
6–11 years 33.0 (23.9 – 45.6) 5.93† (4.89 – 8.18) 24.8 (17.3 – 40.0) 195† (126 – 945) 99
12–19 years 24.9 (19.3 – 32.3) 4.34 (3.13 – 5.24) 18.9 (14.5 – 31.4) 144 (121 – 311) 191
20–39 years 23.3 (19.3 – 28.2) 3.96 (2.52 – 4.69) 20.7 (15.9 – 28.7) 189 (105 – 339) 217
40–59 years 27.1 (22.5 – 32.5) 3.85 (3.22 – 4.95) 21.3 (16.4 – 27.9) 244 (155 – 623) 229
60 years and older 29.4 (24.5 – 35.4) 5.47 (3.88 – 6.92) 26.2 (20.0 – 33.5) 190 (147 – 263) 299
Females
Total, 6 years and older 32.3 (29.0 – 35.9) 4.69 (4.14 – 5.40) 27.4 (23.5 – 32.6) 289 (227 – 361) 1,073
6–11 years 44.4 (31.3 – 62.8) 8.19† (2.79 – 11.4) 43.0 (26.0 – 58.2) 266† (164 – 1,300) 94
12–19 years 26.7 (21.7 – 32.8) 4.15 (3.63 – 5.22) 20.5 (15.8 – 26.1) 203 (156 – 342) 187
20–39 years 26.5 (20.8 – 33.7) 4.51 (3.50 – 5.62) 22.3 (18.1 – 33.0) 172 (126 – 300) 277
40–59 years 31.1 (25.1 – 38.6) 3.92 (2.63 – 5.82) 25.6 (17.7 – 34.1) 317 (180 – 675) 219
60 years and older 42.2 (36.1 – 49.3) 6.05 (4.82 – 7.49) 33.7 (27.6 – 42.2) 404 (291 – 567) 296
† Estimate is subject to greater uncertainty due to small cell size.  
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Table 4.2.b. Urinary genistein (creatinine corrected): Concentrations by survey cycle
Geometric mean and selected percentiles of urine concentrations (in µg/g creatinine) for the U.S. population, 
National Health and Nutrition Examination Survey, 1999–2006. 
Geometric mean 
 (95% conf. interval)
Selected percentiles (95% conf. interval) Sample 
size5th 50th 95th
Total, 6 years and older
 1999–2000 22.3 (17.7 – 28.1) <LOD 23.8 (18.9 – 28.7) 380 (341 – 523) 2,557
 2001–2002 30.9 (28.5 – 33.6) 3.52 (3.07 – 3.80) 25.8 (23.5 – 29.2) 426 (375 – 491) 2,794
 2003–2004 29.1 (27.3 – 31.0) 3.39 (2.80 – 3.69) 24.5 (21.4 – 27.4) 507 (399 – 619) 2,594
 2005–2006 28.0 (25.3 – 31.0) 2.98 (2.42 – 3.44) 23.2 (20.4 – 26.4) 576 (423 – 759) 2,528
Age group
6–11 years
 1999–2000 28.3 (21.1 – 37.9) 1.84 (<LOD – 3.04) 27.8 (15.8 – 41.1) 489 (282 – 794) 331
 2001–2002 44.5 (37.0 – 53.5) 6.82 (4.89 – 8.11) 37.7 (30.0 – 48.3) 489 (276 – 934) 396
 2003–2004 35.8 (29.7 – 43.0) 5.15 (3.19 – 6.46) 34.7 (25.3 – 43.1) 293 (175 – 1,130) 341
 2005–2006 42.5 (33.1 – 54.6) 4.86 (< LOD – 6.37) 34.0 (24.2 – 40.9) 985 (580 – 1,850) 351
12–19 years
 1999–2000 29.4 (22.3 – 38.8) 2.12 (.684 – 3.24) 31.9 (24.3 – 41.6) 331 (199 – 1,360) 754
 2001–2002 26.3 (21.3 – 32.5) 3.43 (2.34 – 4.13) 21.0 (18.1 – 26.5) 321 (294 – 487) 744
 2003–2004 25.9 (21.8 – 30.9) 3.45 (2.56 – 4.00) 21.8 (17.0 – 28.6) 366 (322 – 464) 729
 2005–2006 25.3 (22.1 – 29.0) 3.32 (2.25 – 3.67) 19.5 (16.3 – 23.8) 367 (238 – 617) 693
20–39 years
 1999–2000 22.7 (17.3 – 29.9) <LOD 22.8 (17.0 – 27.2) 417 (355 – 738) 536
 2001–2002 27.8 (23.8 – 32.4) 3.29 (2.22 – 3.92) 22.9 (18.7 – 29.8) 379 (329 – 476) 604
 2003–2004 24.5 (21.9 – 27.4) 2.97 (2.55 – 3.69) 19.7 (17.3 – 23.4) 320 (271 – 557) 554
 2005–2006 24.1 (19.8 – 29.3) 2.55 (1.85 – 3.76) 21.3 (16.5 – 27.5) 447 (288 – 734) 583
40–59 years
 1999–2000 15.7 (10.3 – 24.1) <LOD 16.3 (12.5 – 26.8) 374 (246 – 894) 420
 2001–2002 32.7 (27.8 – 38.6) 3.54 (2.26 – 4.12) 28.7 (24.2 – 32.1) 461 (377 – 1,260) 531
 2003–2004 31.1 (26.4 – 36.6) 3.18 (1.96 – 3.75) 24.9 (19.7 – 29.8) 676 (496 – 1,670) 452
 2005–2006 26.1 (21.5 – 31.7) 2.46 (1.82 – 2.97) 21.5 (16.8 – 29.2) 578 (326 – 1,220) 449
60 years and older
 1999–2000 26.1 (21.7 – 31.3) <LOD 27.3 (20.4 – 35.9) 371 (252 – 691) 516
 2001–2002 31.6 (25.8 – 38.8) 3.00 (2.36 – 3.76) 25.5 (20.7 – 33.3) 491 (323 – 1,310) 519
 2003–2004 33.9 (29.7 – 38.7) 3.39 (2.78 – 4.33) 29.5 (23.8 – 34.6) 539 (444 – 754) 518
 2005–2006 35.2 (30.3 – 40.8) 4.13 (3.34 – 5.27) 27.9 (23.0 – 35.0) 589 (402 – 776) 452
Gender
Males
 1999–2000 23.3 (16.8 – 32.3) <LOD 23.8 (17.7 – 31.9) 510 (329 – 893) 1,222
 2001–2002 26.2 (23.1 – 29.8) 3.62 (2.52 – 4.01) 22.0 (19.4 – 26.2) 341 (282 – 427) 1,375
 2003–2004 26.4 (22.8 – 30.5) 3.40 (2.66 – 3.63) 21.5 (17.6 – 26.3) 414 (346 – 574) 1,244
 2005–2006 25.8 (23.4 – 28.4) 2.68 (1.98 – 3.40) 22.7 (19.3 – 26.2) 430 (319 – 629) 1,252
Females
 1999–2000 21.3 (17.5 – 26.0) <LOD 23.1 (17.5 – 29.2) 357 (309 – 432) 1,335
 2001–2002 36.2 (32.8 – 39.9) 3.50 (3.02 – 3.85) 29.5 (25.4 – 34.1) 540 (430 – 756) 1,419
 2003–2004 31.9 (28.7 – 35.5) 3.29 (2.60 – 4.33) 27.1 (23.6 – 31.6) 545 (410 – 775) 1,350
 2005–2006 30.3 (25.8 – 35.5) 3.07 (2.34 – 3.76) 23.5 (20.1 – 29.4) 658 (446 – 912) 1,276
Race/ethnicity
Mexican Americans
 1999–2000 28.4 (23.3 – 34.7) 1.40 (<LOD – 2.74) 27.9 (22.5 – 35.0) 557 (322 – 1,290) 819
 2001–2002 26.6 (21.6 – 32.9) 3.75 (2.96 – 4.09) 20.9 (16.1 – 28.7) 371 (280 – 484) 679
 2003–2004 28.0 (24.8 – 31.8) 3.35 (2.29 – 3.99) 23.4 (18.8 – 28.1) 594 (426 – 884) 653
 2005–2006 24.9 (22.1 – 28.0) 2.66 (1.46 – 3.47) 21.7 (18.1 – 23.7) 334 (277 – 520) 634
Non-Hispanic Blacks
 1999–2000 17.0 (12.2 – 23.6) <LOD 19.4 (15.7 – 26.1) 284 (229 – 449) 597
 2001–2002 26.4 (19.2 – 36.4) 2.91 (2.56 – 3.44) 22.7 (16.4 – 33.4) 369 (237 – 788) 692
 2003–2004 23.0 (18.1 – 29.1) 3.11 (2.73 – 3.33) 20.4 (14.3 – 27.3) 304 (210 – 547) 681
 2005–2006 21.7 (18.8 – 25.1) 2.58 (1.59 – 3.17) 18.5 (14.9 – 21.5) 350 (247 – 548) 662
Non-Hispanic Whites
 1999–2000 23.3 (18.5 – 29.3) <LOD 25.6 (19.4 – 31.7) 380 (346 – 574) 901
 2001–2002 30.5 (28.1 – 33.0) 3.54 (2.96 – 3.81) 25.2 (23.3 – 28.7) 424 (376 – 494) 1,211
 2003–2004 30.5 (28.1 – 33.1) 3.37 (2.66 – 3.83) 26.3 (21.7 – 31.4) 544 (362 – 747) 1,069
 2005–2006 28.2 (25.1 – 31.8) 2.98 (2.18 – 3.59) 23.5 (20.0 – 29.0) 615 (427 – 810) 1,039
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Values in the graph are suppressed if either the point estimate or the lower 95% confidence limit is noted as “< LOD” in the accompanying table. 
Figure 4.2.b. Urinary genistein (creatinine corrected): 
Concentrations by survey cycle 
Selected percentiles in μg/g creatinine (95% confidence intervals), National Health and 
Nutrition Examination Survey, 1999–2006
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Non−Hispanic Blacks Non−Hispanic Whites 
Figure 4.3.a. Urinary daidzein: Concentrations by age group 
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Table 4.3.a.2. Urinary daidzein: Total population
Geometric mean and selected percentiles of urine concentrations (in µg/L) for the total U.S. population aged 6 
years and older, National Health and Nutrition Examination Survey, 2003–2006. 
Geometric mean 
 (95% conf. interval)
Selected percentiles (95% conf. interval) Sample 
size10th 50th 90th
Males and Females
Total, 6 years and older 66.6 (62.1 – 71.5) 8.65 (7.74 – 9.48) 60.4 (54.7 – 65.9) 613 (525 – 684) 5,122
6–11 years 89.4 (77.7 – 103) 15.7 (12.2 – 18.1) 68.4 (59.2 – 86.6) 653 (619 – 916) 692
12–19 years 91.6 (80.5 – 104) 14.5 (11.8 – 15.8) 77.3 (65.0 – 94.5) 834 (659 – 969) 1,422
20–39 years 61.6 (53.3 – 71.3) 8.20 (6.00 – 10.4) 54.3 (47.2 – 65.9) 571 (422 – 752) 1,137
40–59 years 60.9 (54.9 – 67.6) 7.71 (6.35 – 8.67) 56.5 (47.0 – 65.5) 572 (410 – 807) 901
60 years and older 60.9 (52.7 – 70.5) 7.92 (6.54 – 9.19) 60.5 (48.9 – 73.4) 471 (399 – 618) 970
Males
Total, 6 years and older 73.8 (67.2 – 81.1) 9.92 (8.68 – 11.9) 66.0 (58.0 – 73.7) 695 (589 – 786) 2,496
6–11 years 87.3 (72.9 – 105) 17.5 (12.2 – 21.0) 64.0 (51.5 – 91.4) 874 (497 – 1,150) 340
12–19 years 103 (85.2 – 124) 17.3 (13.9 – 19.4) 86.6 (64.8 – 107) 863 (526 – 1,320) 728
20–39 years 70.4 (58.8 – 84.2) 9.80 (5.43 – 12.8) 65.3 (51.7 – 75.0) 729 (544 – 968) 499
40–59 years 68.4 (57.9 – 80.8) 8.55 (7.15 – 9.37) 66.2 (47.7 – 84.7) 671 (409 – 930) 451
60 years and older 64.4 (52.0 – 79.9) 9.16 (7.75 – 11.8) 57.7 (43.8 – 78.5) 561 (417 – 749) 478
Females
Total, 6 years and older 60.4 (55.3 – 66.0) 7.79 (6.41 – 8.76) 55.5 (49.5 – 61.5) 507 (431 – 619) 2,626
6–11 years 91.6 (72.4 – 116) 14.3 (9.67 – 17.9) 78.1 (57.3 – 99.4) 643 (455 – 882) 352
12–19 years 81.0 (69.6 – 94.3) 11.1 (9.30 – 14.5) 71.1 (59.6 – 93.6) 812 (604 – 936) 694
20–39 years 54.0 (44.1 – 66.2) 7.31 (5.72 – 9.03) 47.9 (38.1 – 63.9) 383 (309 – 585) 638
40–59 years 54.6 (47.9 – 62.3) 6.98 (4.64 – 8.60) 48.2 (40.6 – 58.2) 511 (395 – 736) 450
60 years and older 58.3 (48.5 – 70.2) 7.04 (4.21 – 8.11) 60.9 (46.8 – 80.2) 403 (362 – 562) 492
Table 4.3.a.3. Urinary daidzein: Mexican Americans
Geometric mean and selected percentiles of urine concentrations (in µg/L) for Mexican Americans in the U.S. 
population aged 6 years and older, National Health and Nutrition Examination Survey, 2003–2006. 
Geometric mean 
 (95% conf. interval)
Selected percentiles (95% conf. interval) Sample 
size10th 50th 90th
Males and Females
Total, 6 years and older 59.0 (54.1 – 64.4) 7.94 (6.47 – 8.95) 48.6 (44.8 – 56.8) 671 (496 – 848) 1,287
6–11 years 78.3 (61.0 – 100) 16.6 (11.6 – 18.1) 64.5 (51.3 – 83.2) 588 (321 – 2,270) 231
12–19 years 87.3 (72.5 – 105) 12.3 (8.90 – 16.5) 74.6 (62.2 – 96.1) 812 (558 – 1,000) 445
20–39 years 50.5 (42.9 – 59.3) 6.19 (4.34 – 8.14) 35.3 (28.1 – 47.1) 821 (468 – 1,160) 282
40–59 years 55.4 (43.6 – 70.3) 7.50 (4.68 – 10.4) 48.2 (38.0 – 62.6) 475 (347 – 1,260) 157
60 years and older 42.1 (31.0 – 57.3) 5.61 (2.89 – 7.89) 40.7 (22.8 – 61.7) 366 (222 – 1,200) 172
Males
Total, 6 years and older 60.8 (52.2 – 70.9) 8.82 (7.42 – 9.78) 48.2 (40.1 – 56.8) 742 (484 – 1,050) 625
6–11 years 76.3 (57.3 – 102) 17.3 (7.01 – 20.6) 60.0 (41.0 – 109) 481 (312 – 1,370) 112
12–19 years 90.0 (69.7 – 116) 16.0 (9.79 – 17.8) 84.7 (53.8 – 129) 590 (408 – 1,270) 228
20–39 years 52.0 (37.9 – 71.3) 7.67 (3.36 – 10.2) 36.0 (27.9 – 48.7) 846 (468 – 1,330) 117
40–59 years 60.4 (39.7 – 92.0) 8.25† (4.94 – 10.0) 47.8 (21.4 – 81.5) 790† (356 – 4,980) 85
60 years and older 41.1 (23.7 – 71.4) 7.55† (1.89 – 9.13) 40.0 (15.3 – 84.1) 329† (154 – 2,020) 83
Females
Total, 6 years and older 57.1 (48.9 – 66.7) 6.73 (5.24 – 8.15) 49.8 (42.3 – 64.2) 556 (418 – 871) 662
6–11 years 80.5 (53.3 – 121) 14.4 (5.79 – 22.1) 65.4 (49.0 – 98.4) 735 (283 – 3,410) 119
12–19 years 84.6 (67.0 – 107) 10.4 (8.24 – 13.6) 71.1 (56.2 – 97.1) 867 (623 – 1,380) 217
20–39 years 48.7 (32.2 – 73.6) 5.71 (3.33 – 8.01) 32.3 (23.7 – 67.2) 594 (295 – 1,790) 165
40–59 years 50.4 (35.6 – 71.2) 5.24† (3.72 – 11.2) 48.4 (35.4 – 84.6) 346† (267 – 484) 72
60 years and older 42.9 (25.7 – 71.5) 5.28† (1.79 – 7.45) 40.1 (18.6 – 73.7) 381† (226 – 2,270) 89
† Estimate is subject to greater uncertainty due to small cell size.  
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Table 4.3.a.4. Urinary daidzein: Non-Hispanic blacks
Geometric mean and selected percentiles of urine concentrations (in µg/L) for non-Hispanic blacks in the U.S. 
population aged 6 years and older, National Health and Nutrition Examination Survey, 2003–2006. 
Geometric mean 
 (95% conf. interval)
Selected percentiles (95% conf. interval) Sample 
size10th 50th 90th
Males and Females
Total, 6 years and older 78.4 (67.6 – 90.9) 9.87 (8.52 – 11.6) 72.3 (61.3 – 85.2) 639 (474 – 766) 1,343
6–11 years 102 (80.6 – 129) 11.5 (8.37 – 16.0) 95.8 (70.0 – 129) 927 (487 – 2,170) 207
12–19 years 120 (104 – 139) 17.5 (13.5 – 20.8) 111 (92.3 – 144) 895 (756 – 1,160) 496
20–39 years 68.4 (53.2 – 88.0) 11.3 (8.37 – 13.1) 50.7 (41.3 – 76.5) 601 (408 – 893) 249
40–59 years 77.2 (59.6 – 99.9) 8.40 (6.24 – 11.2) 75.0 (58.8 – 111) 457 (377 – 839) 231
60 years and older 53.5 (37.7 – 75.8) 7.55 (4.20 – 9.29) 46.9 (28.8 – 78.8) 361 (259 – 823) 160
Males
Total, 6 years and older 90.2 (75.1 – 108) 12.1 (8.49 – 14.2) 83.6 (64.7 – 110) 724 (584 – 1,050) 661
6–11 years 101 (70.3 – 145) 11.2† (4.75 – 15.9) 103 (42.5 – 215) 1,050† (534 – 2,140) 99
12–19 years 132 (107 – 164) 19.4 (11.4 – 24.1) 120 (95.6 – 152) 1,140 (766 – 1,980) 258
20–39 years 94.7 (64.5 – 139) 13.2 (7.79 – 16.6) 67.3 (41.4 – 151) 851 (564 – 1,400) 116
40–59 years 78.7 (54.4 – 114) 8.53 (6.17 – 13.3) 83.2 (58.0 – 134) 390 (368 – 701) 114
60 years and older 53.1 (37.3 – 75.7) 8.34† (7.92 – 12.2) 40.3 (27.8 – 70.4) 325† (169 – 1,800) 74
Females
Total, 6 years and older 69.7 (57.7 – 84.2) 9.41 (7.40 – 11.2) 64.7 (54.2 – 77.9) 476 (427 – 675) 682
6–11 years 103 (74.2 – 142) 11.0† (7.50 – 24.0) 85.1 (58.3 – 129) 687† (398 – 7,580) 108
12–19 years 109 (91.8 – 129) 14.3 (9.60 – 22.6) 104 (73.9 – 142) 757 (652 – 1,140) 238
20–39 years 52.7 (37.2 – 74.6) 9.40 (5.61 – 12.1) 43.3 (26.0 – 75.9) 408 (280 – 622) 133
40–59 years 75.9 (51.0 – 113) 7.94 (4.01 – 11.8) 69.9 (47.9 – 109) 462 (369 – 2,070) 117
60 years and older 53.7 (31.4 – 91.7) 6.06† (2.92 – 9.07) 55.3 (22.5 – 106) 368† (257 – 1,170) 86
† Estimate is subject to greater uncertainty due to small cell size.  
Table 4.3.a.5. Urinary daidzein: Non-Hispanic whites
Geometric mean and selected percentiles of urine concentrations (in µg/L) for non-Hispanic whites in the U.S. 
population aged 6 years and older, National Health and Nutrition Examination Survey, 2003–2006. 
Geometric mean 
 (95% conf. interval)
Selected percentiles (95% conf. interval) Sample 
size10th 50th 90th
Males and Females
Total, 6 years and older 63.9 (58.7 – 69.6) 8.36 (6.60 – 9.38) 58.5 (52.0 – 65.3) 571 (479 – 684) 2,108
6–11 years 86.5 (70.6 – 106) 16.0 (11.4 – 20.6) 66.6 (56.0 – 93.6) 643 (450 – 985) 193
12–19 years 91.5 (77.3 – 108) 15.2 (10.6 – 17.3) 76.3 (59.5 – 100) 824 (606 – 977) 378
20–39 years 58.5 (47.8 – 71.7) 6.75 (4.48 – 10.3) 53.0 (44.8 – 66.9) 484 (343 – 753) 494
40–59 years 57.9 (50.4 – 66.5) 7.22 (5.29 – 8.66) 50.6 (41.9 – 65.3) 575 (407 – 893) 448
60 years and older 61.6 (52.9 – 71.8) 8.03 (6.59 – 9.36) 61.2 (49.1 – 78.5) 469 (396 – 662) 595
Males
Total, 6 years and older 70.2 (62.0 – 79.4) 9.34 (7.77 – 12.2) 63.8 (54.1 – 72.9) 680 (509 – 779) 1,035
6–11 years 83.9 (62.4 – 113) 18.4† (7.93 – 21.7) 63.1 (49.4 – 94.1) 651† (271 – 1,180) 99
12–19 years 102 (78.3 – 134) 16.6 (12.7 – 23.1) 80.1 (55.1 – 118) 812 (466 – 1,440) 191
20–39 years 63.4 (48.0 – 83.7) 8.03 (3.27 – 14.2) 59.0 (43.8 – 77.0) 575 (341 – 1,010) 217
40–59 years 66.9 (54.2 – 82.7) 8.29 (6.53 – 9.37) 63.4 (42.1 – 83.3) 670 (409 – 970) 229
60 years and older 64.3 (50.0 – 82.9) 9.18 (6.88 – 12.0) 58.7 (42.2 – 88.7) 591 (416 – 762) 299
Females
Total, 6 years and older 58.3 (52.6 – 64.7) 7.50 (5.79 – 8.68) 53.1 (47.0 – 61.0) 484 (397 – 608) 1,073
6–11 years 89.7 (67.1 – 120) 14.9† (5.43 – 19.0) 89.1 (50.9 – 141) 583† (352 – 7,440) 94
12–19 years 81.0 (66.4 – 98.8) 11.8 (7.34 – 15.8) 73.3 (52.3 – 101) 817 (455 – 970) 187
20–39 years 54.0 (42.7 – 68.5) 6.43 (5.19 – 8.74) 51.1 (38.2 – 64.5) 382 (293 – 683) 277
40–59 years 50.0 (42.1 – 59.4) 5.98 (3.46 – 8.36) 43.5 (32.6 – 53.4) 514 (309 – 843) 219
60 years and older 59.6 (49.4 – 71.8) 7.25 (3.83 – 8.51) 61.4 (49.3 – 83.1) 401 (357 – 656) 296
† Estimate is subject to greater uncertainty due to small cell size.  
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Table 4.3.b. Urinary daidzein: Concentrations by survey cycle
Geometric mean and selected percentiles of urine concentrations (in µg/L) for the U.S. population, National 
Health and Nutrition Examination Survey, 1999–2006. 
Geometric mean 
 (95% conf. interval)
Selected percentiles (95% conf. interval) Sample 
size5th 50th 95th
Total, 6 years and older
 1999–2000 75.1 (61.9 – 91.1) 6.56 (3.36 – 8.12) 69.8 (58.1 – 82.4) 1,310 (1,030 – 1,550) 2,553
 2001–2002 51.7 (46.6 – 57.5) < LOD 52.3 (49.0 – 57.5) 1,240 (919 – 1,850) 2,794
 2003–2004 66.7 (60.4 – 73.7) 5.71 (4.00 – 6.43) 62.0 (54.1 – 69.7) 1,070 (924 – 1,330) 2,594
 2005–2006 66.5 (59.7 – 74.1) 4.98 (3.70 – 6.58) 58.8 (51.4 – 67.7) 1,180 (1,010 – 1,380) 2,528
Age group
6–11 years
 1999–2000 90.5 (75.1 – 109) 8.59 (1.43 – 13.6) 100 (71.0 – 129) 1,110 (707 – 1,740) 330
 2001–2002 84.9 (71.6 – 101) 11.3 (3.15 – 12.4) 72.1 (56.6 – 96.9) 1,050 (684 – 1,650) 396
 2003–2004 84.9 (71.6 – 101) 13.2 (9.77 – 16.2) 65.6 (56.7 – 92.7) 788 (644 – 1,070) 341
 2005–2006 94.1 (74.3 – 119) 7.73 (6.35 – 10.8) 73.8 (56.1 – 95.1) 1,870 (1,130 – 6,350) 351
12–19 years
 1999–2000 123 (91.4 – 166) 14.7 (7.23 – 17.6) 124 (85.6 – 165) 1,460 (1,100 – 3,300) 753
 2001–2002 69.3 (52.6 – 91.3) 2.63 (< LOD – 6.02) 69.8 (53.2 – 87.5) 1,330 (977 – 2,110) 744
 2003–2004 89.0 (75.2 – 105) 9.05 (6.06 – 9.91) 77.9 (60.1 – 104) 1,190 (927 – 1,970) 729
 2005–2006 94.4 (76.0 – 117) 9.14 (6.14 – 11.0) 76.9 (59.6 – 102) 1,370 (981 – 2,270) 693
20–39 years
 1999–2000 80.6 (64.3 – 101) 7.55 (3.34 – 9.89) 67.1 (55.6 – 82.5) 1,730 (983 – 4,150) 534
 2001–2002 51.5 (42.7 – 62.1) < LOD 50.7 (40.4 – 64.9) 1,200 (763 – 1,930) 604
 2003–2004 59.9 (47.6 – 75.3) 4.82 (3.21 – 6.58) 56.1 (44.9 – 69.0) 1,170 (809 – 1,480) 554
 2005–2006 63.4 (51.7 – 77.6) 4.81 (2.19 – 6.27) 52.3 (44.7 – 68.5) 1,360 (737 – 2,240) 583
40–59 years
 1999–2000 55.4 (39.0 – 78.6) 2.50 (< LOD – 7.77) 56.7 (40.8 – 70.7) 1,060 (801 – 1,520) 420
 2001–2002 50.6 (40.4 – 63.3) < LOD 53.1 (39.3 – 68.2) 1,760 (859 – 3,030) 531
 2003–2004 67.9 (58.3 – 79.2) 5.13 (3.05 – 6.43) 62.2 (46.1 – 78.7) 1,290 (840 – 3,440) 452
 2005–2006 54.9 (47.3 – 63.7) 3.79 (2.99 – 5.86) 50.5 (41.4 – 61.9) 983 (665 – 1,300) 449
60 years and older
 1999–2000 64.6 (53.0 – 78.8) 6.47 (5.61 – 9.10) 61.5 (45.9 – 85.0) 665 (556 – 991) 516
 2001–2002 32.0 (26.2 – 39.0) < LOD 33.8 (28.4 – 40.4) 636 (397 – 1,990) 519
 2003–2004 55.7 (44.4 – 69.9) 4.07 (2.51 – 5.72) 56.5 (43.8 – 76.3) 780 (585 – 1,660) 518
 2005–2006 66.4 (54.6 – 80.8) 4.76 (1.85 – 8.24) 62.5 (43.9 – 89.5) 952 (707 – 1,600) 452
Gender
Males
 1999–2000 88.9 (71.4 – 111) 7.75 (5.85 – 10.4) 80.5 (66.9 – 112) 1,540 (1,020 – 2,240) 1,220
 2001–2002 49.8 (42.8 – 57.9) < LOD 50.7 (46.9 – 55.6) 918 (727 – 1,400) 1,375
 2003–2004 73.8 (63.4 – 85.9) 6.35 (3.20 – 8.53) 65.2 (56.4 – 76.4) 1,200 (1,020 – 1,370) 1,244
 2005–2006 73.9 (65.3 – 83.6) 6.32 (4.02 – 7.91) 66.2 (53.9 – 78.3) 1,180 (1,000 – 1,430) 1,252
Females
 1999–2000 64.1 (52.9 – 77.6) 5.62 (1.86 – 7.80) 57.6 (45.2 – 73.2) 1,210 (652 – 2,010) 1,333
 2001–2002 53.6 (48.1 – 59.8) < LOD 55.4 (49.8 – 62.4) 1,440 (1,190 – 1,990) 1,419
 2003–2004 60.7 (53.6 – 68.8) 4.61 (3.50 – 5.95) 57.4 (49.3 – 67.3) 884 (670 – 1,390) 1,350
 2005–2006 60.1 (52.5 – 68.9) 4.40 (2.99 – 5.94) 52.4 (45.0 – 61.4) 1,140 (843 – 1,480) 1,276
Race/ethnicity
Mexican Americans
 1999–2000 78.9 (59.8 – 104) 6.78 (4.37 – 8.83) 66.1 (48.8 – 90.2) 1,340 (977 – 3,000) 816
 2001–2002 39.2 (28.5 – 54.0) < LOD 39.8 (28.8 – 59.7) 880 (633 – 1,770) 679
 2003–2004 57.4 (50.2 – 65.7) 4.90 (3.74 – 5.99) 45.4 (35.3 – 53.3) 1,380 (954 – 1,720) 653
 2005–2006 60.6 (53.3 – 68.9) 4.35 (2.74 – 5.80) 54.0 (44.1 – 64.5) 1,320 (981 – 1,550) 634
Non-Hispanic Blacks
 1999–2000 91.5 (71.1 – 118) 7.48 (< LOD – 11.2) 102 (84.0 – 131) 1,030 (771 – 1,640) 596
 2001–2002 66.3 (47.7 – 91.9) < LOD 72.9 (52.5 – 96.5) 1,410 (950 – 2,850) 692
 2003–2004 75.5 (56.5 – 101) 7.09 (5.71 – 8.69) 67.6 (51.5 – 89.3) 1,150 (699 – 2,380) 681
 2005–2006 81.3 (71.6 – 92.4) 6.97 (4.66 – 7.57) 76.5 (69.9 – 94.7) 1,200 (878 – 1,960) 662
Non-Hispanic Whites
 1999–2000 74.7 (61.8 – 90.3) 7.25 (3.27 – 8.95) 66.8 (57.0 – 77.4) 1,360 (990 – 1,730) 901
 2001–2002 48.6 (43.8 – 53.9) < LOD 49.8 (45.8 – 53.1) 1,140 (811 – 1,910) 1,211
 2003–2004 65.9 (58.7 – 74.0) 5.10 (3.33 – 6.39) 62.3 (53.0 – 71.3) 1,050 (843 – 1,360) 1,069
 2005–2006 62.0 (54.4 – 70.7) 4.55 (3.17 – 6.33) 54.1 (46.9 – 63.9) 1,030 (884 – 1,310) 1,039
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Values in the graph are suppressed if either the point estimate or the lower 95% confidence limit is noted as “< LOD” in the accompanying table. 
Figure 4.3.b. Urinary daidzein: Concentrations by survey cycle 
Selected percentiles in μg/L (95% confidence intervals), National Health and 

Nutrition Examination Survey, 1999–2006
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Non−Hispanic Blacks Non−Hispanic Whites 
Figure 4.4.a. Urinary daidzein (creatinine corrected): Concentrations by age group 
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Table 4.4.a.2. Urinary daidzein (creatinine corrected): Total population
Geometric mean and selected percentiles of urine concentrations (in µg/g creatinine) for the total U.S. 
population aged 6 years and older, National Health and Nutrition Examination Survey, 2003–2006. 
Geometric mean 
 (95% conf. interval)
Selected percentiles (95% conf. interval) Sample 
size10th 50th 90th
Males and Females
Total, 6 years and older 63.7 (60.0 – 67.5) 9.68 (8.96 – 10.5) 54.6 (50.2 – 58.5) 522 (463 – 593) 5,122
6–11 years 96.8 (85.1 – 110) 19.0 (14.8 – 23.0) 72.6 (63.3 – 87.8) 697 (580 – 924) 692
12–19 years 68.3 (60.0 – 77.7) 11.5 (9.80 – 12.7) 56.2 (47.3 – 69.0) 522 (419 – 738) 1,422
20–39 years 52.5 (46.6 – 59.3) 8.66 (7.41 – 9.62) 44.6 (37.9 – 52.2) 424 (338 – 501) 1,137
40–59 years 61.6 (56.1 – 67.8) 8.59 (7.78 – 9.25) 51.7 (46.0 – 58.2) 570 (410 – 894) 901
60 years and older 71.4 (63.3 – 80.5) 11.3 (10.1 – 12.0) 63.9 (51.3 – 78.0) 565 (462 – 702) 970
Males
Total, 6 years and older 58.6 (53.5 – 64.1) 8.91 (8.16 – 9.82) 49.9 (45.5 – 55.2) 467 (421 – 543) 2,496
6–11 years 87.5 (73.6 – 104) 15.8 (11.8 – 21.6) 68.2 (54.2 – 82.8) 733 (435 – 1,190) 340
12–19 years 69.8 (57.3 – 85.0) 11.6 (9.54 – 13.5) 53.9 (43.2 – 69.7) 580 (404 – 842) 728
20–39 years 51.3 (44.0 – 59.9) 7.55 (6.03 – 9.50) 43.4 (36.9 – 50.3) 451 (379 – 595) 499
40–59 years 54.2 (46.0 – 63.9) 7.88 (6.08 – 8.73) 47.0 (38.7 – 60.1) 458 (305 – 766) 451
60 years and older 59.3 (49.0 – 71.9) 10.0 (8.24 – 11.5) 51.0 (43.3 – 65.7) 423 (370 – 565) 478
Females
Total, 6 years and older 68.9 (63.4 – 74.9) 10.7 (9.41 – 12.2) 60.0 (51.0 – 68.9) 582 (493 – 702) 2,626
6–11 years 108 (86.1 – 135) 22.3 (14.6 – 27.7) 84.3 (68.0 – 112) 696 (561 – 1,060) 352
12–19 years 66.7 (58.4 – 76.1) 11.4 (9.31 – 13.0) 58.6 (45.9 – 76.2) 514 (379 – 662) 694
20–39 years 53.8 (44.6 – 64.9) 9.21 (7.51 – 10.7) 46.6 (34.7 – 63.9) 349 (237 – 654) 638
40–59 years 69.6 (60.7 – 79.8) 9.63 (7.84 – 12.3) 57.3 (48.8 – 68.7) 699 (459 – 1,130) 450
60 years and older 82.6 (70.8 – 96.4) 12.7 (10.2 – 14.5) 75.0 (58.7 – 92.5) 686 (537 – 965) 492
  
Table 4.4.a.3. Urinary daidzein (creatinine corrected): Mexican Americans
Geometric mean and selected percentiles of urine concentrations (in µg/g creatinine) for Mexican Americans in 
the U.S. population aged 6 years and older, National Health and Nutrition Examination Survey, 2003–2006. 
Geometric mean 
 (95% conf. interval)
Selected percentiles (95% conf. interval) Sample 
size10th 50th 90th
Males and Females
Total, 6 years and older 53.2 (47.7 – 59.3) 6.93 (6.05 – 7.61) 47.7 (38.6 – 56.1) 527 (431 – 601) 1,287
6–11 years 98.3 (76.7 – 126) 20.2 (16.6 – 23.2) 80.4 (62.1 – 108) 601 (332 – 1,940) 231
12–19 years 67.5 (56.8 – 80.1) 10.8 (7.46 – 13.3) 57.9 (49.4 – 71.5) 492 (380 – 834) 445
20–39 years 40.7 (33.7 – 49.2) 5.59 (4.19 – 7.06) 30.1 (24.2 – 42.4) 499 (290 – 809) 282
40–59 years 50.7 (39.5 – 65.0) 6.01 (4.56 – 7.76) 45.9 (30.2 – 62.8) 537 (275 – 990) 157
60 years and older 52.0 (36.8 – 73.4) 6.95 (5.30 – 8.24) 49.3 (31.5 – 75.6) 344 (253 – 971) 172
Males
Total, 6 years and older 48.0 (40.5 – 56.9) 6.05 (5.04 – 7.07) 40.4 (30.2 – 56.1) 469 (355 – 594) 625
6–11 years 91.5 (66.0 – 127) 20.4 (15.5 – 23.2) 74.0 (50.3 – 130) 429 (313 – 1,510) 112
12–19 years 65.2 (50.4 – 84.4) 12.3 (7.04 – 13.8) 55.2 (37.2 – 91.2) 424 (302 – 861) 228
20–39 years 37.8 (27.7 – 51.5) 4.82 (2.22 – 6.78) 27.8 (20.6 – 44.4) 432 (264 – 899) 117
40–59 years 44.3 (29.3 – 67.1) 5.90† (3.67 – 7.61) 29.8 (16.1 – 73.2) 552† (258 – 1,640) 85
60 years and older 36.7 (21.9 – 61.5) 5.57† (4.50 – 6.89) 35.3 (15.0 – 66.2) 309† (110 – 2,740) 83
Females
Total, 6 years and older 59.6 (50.8 – 69.9) 7.76 (6.39 – 9.44) 53.5 (43.2 – 62.6) 602 (406 – 897) 662
6–11 years 106 (74.4 – 151) 20.1 (13.5 – 27.3) 85.2 (68.2 – 112) 898 (305 – 3,630) 119
12–19 years 69.9 (57.9 – 84.3) 10.1 (6.44 – 13.3) 65.8 (43.1 – 81.9) 736 (477 – 881) 217
20–39 years 44.5 (29.8 – 66.4) 6.66 (4.07 – 8.39) 33.2 (18.7 – 56.2) 569 (207 – 2,670) 165
40–59 years 58.7 (42.8 – 80.4) 6.72† (4.24 – 11.8) 52.7 (40.8 – 75.2) 427† (256 – 924) 72
60 years and older 69.2 (41.2 – 116) 8.25† (3.99 – 13.0) 64.1 (24.7 – 157) 443† (255 – 2,030) 89
† Estimate is subject to greater uncertainty due to small cell size.  
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Table 4.4.a.4. Urinary daidzein (creatinine corrected): Non-Hispanic blacks
Geometric mean and selected percentiles of urine concentrations (in µg/g creatinine) for non-Hispanic blacks 
in the U.S. population aged 6 years and older, National Health and Nutrition Examination Survey, 2003–2006. 
Geometric mean 
 (95% conf. interval)
Selected percentiles (95% conf. interval) Sample 
size10th 50th 90th
Males and Females
Total, 6 years and older 55.0 (48.8 – 62.1) 8.72 (7.34 – 9.46) 48.0 (39.1 – 59.6) 437 (389 – 538) 1,343
6–11 years 95.6 (75.9 – 121) 13.3 (11.1 – 18.8) 81.9 (67.4 – 108) 1,010 (647 – 1,910) 207
12–19 years 69.0 (60.5 – 78.8) 9.54 (8.52 – 11.6) 66.5 (51.3 – 85.0) 496 (424 – 640) 496
20–39 years 42.4 (34.5 – 52.2) 6.72 (5.68 – 9.60) 28.1 (23.4 – 44.7) 368 (211 – 702) 249
40–59 years 56.1 (45.9 – 68.6) 8.30 (5.49 – 10.0) 48.7 (38.5 – 66.9) 422 (290 – 614) 231
60 years and older 47.7 (35.0 – 64.9) 9.05 (6.31 – 10.7) 42.0 (25.3 – 67.0) 295 (223 – 603) 160
Males
Total, 6 years and older 52.7 (44.7 – 62.0) 7.20 (6.40 – 8.99) 44.4 (32.0 – 63.8) 440 (391 – 532) 661
6–11 years 95.5 (67.1 – 136) 11.2† (8.55 – 13.9) 94.6 (39.1 – 139) 1,210† (646 – 2,090) 99
12–19 years 70.8 (58.3 – 86.0) 9.79 (7.70 – 11.8) 70.0 (53.8 – 88.7) 584 (426 – 910) 258
20–39 years 45.4 (31.9 – 64.8) 6.49 (3.95 – 8.98) 27.2 (20.2 – 77.0) 410 (234 – 1,360) 116
40–59 years 45.0 (31.4 – 64.5) 6.01 (3.03 – 8.96) 42.1 (29.9 – 58.2) 338 (222 – 684) 114
60 years and older 39.0 (26.7 – 56.8) 7.23† (4.44 – 11.3) 25.7 (19.2 – 50.9) 238† (114 – 996) 74
Females
Total, 6 years and older 57.1 (48.2 – 67.6) 9.36 (7.44 – 11.4) 49.4 (39.9 – 66.3) 419 (330 – 593) 682
6–11 years 95.7 (68.8 – 133) 18.3† (6.78 – 23.1) 77.5 (61.2 – 95.9) 758† (307 – 2,820) 108
12–19 years 67.3 (56.6 – 80.0) 9.35 (7.76 – 13.2) 62.7 (46.6 – 85.6) 458 (328 – 895) 238
20–39 years 40.1 (30.2 – 53.3) 7.29 (4.25 – 11.4) 29.9 (23.8 – 42.2) 310 (153 – 668) 133
40–59 years 67.3 (48.1 – 94.2) 9.31 (6.16 – 12.6) 55.0 (35.4 – 90.6) 552 (299 – 922) 117
60 years and older 54.2 (34.6 – 84.9) 9.07† (4.74 – 11.6) 55.5 (26.1 – 79.8) 312† (185 – 1,040) 86
† Estimate is subject to greater uncertainty due to small cell size.  
Table 4.4.a.5. Urinary daidzein (creatinine corrected): Non-Hispanic whites
Geometric mean and selected percentiles of urine concentrations (in µg/g creatinine) for non-Hispanic whites 
in the U.S. population aged 6 years and older, National Health and Nutrition Examination Survey, 2003–2006. 
Geometric mean 
 (95% conf. interval)
Selected percentiles (95% conf. interval) Sample 
size10th 50th 90th
Males and Females
Total, 6 years and older 65.1 (60.7 – 69.7) 10.0 (8.80 – 11.4) 56.0 (50.6 – 60.8) 519 (451 – 658) 2,108
6–11 years 93.9 (77.9 – 113) 17.1 (11.9 – 25.8) 70.3 (57.7 – 96.8) 577 (423 – 991) 193
12–19 years 71.8 (60.1 – 85.8) 12.3 (10.4 – 13.6) 57.5 (46.0 – 74.4) 563 (415 – 763) 378
20–39 years 54.0 (45.5 – 64.1) 9.24 (7.14 – 10.8) 46.4 (37.6 – 57.0) 403 (315 – 578) 494
40–59 years 62.2 (55.5 – 69.8) 8.59 (7.54 – 10.0) 52.9 (43.2 – 60.5) 582 (397 – 1,030) 448
60 years and older 73.5 (65.4 – 82.6) 11.4 (10.1 – 12.6) 65.9 (55.2 – 80.0) 548 (459 – 714) 595
Males
Total, 6 years and older 58.7 (52.2 – 65.9) 9.03 (8.12 – 10.5) 49.9 (43.4 – 57.4) 6456 (369 – 638) 1,035
6–11 years 81.3 (60.7 – 109) 15.6† (10.8 – 22.6) 60.2 (45.1 – 95.9) 540† (287 – 2,790) 99
12–19 years 73.1 (55.1 – 97.1) 12.3 (8.32 – 16.7) 54.3 (40.6 – 82.5) 653 (397 – 892) 191
20–39 years 50.3 (39.2 – 64.7) 8.53 (4.63 – 10.7) 41.7 (33.8 – 54.3) 425 (296 – 777) 217
40–59 years 56.0 (46.0 – 68.2) 8.18 (5.53 – 8.99) 46.0 (37.2 – 62.3) 465 (304 – 946) 229
60 years and older 60.0 (48.0 – 74.9) 10.1 (8.07 – 11.6) 54.2 (40.5 – 79.6) 402 (357 – 501) 299
Females
Total, 6 years and older 71.9 (65.4 – 79.1) 11.6 (9.27 – 13.6) 63.3 (53.8 – 73.5) 589 (484 – 818) 1,073
6–11 years 111 (84.1 – 146) 23.8† (12.9 – 33.2) 94.0 (66.0 – 124) 578† (397 – 1,780) 94
12–19 years 70.4 (58.7 – 84.5) 12.2 (7.26 – 16.3) 66.9 (43.9 – 86.4) 520 (372 – 713) 187
20–39 years 57.9 (46.6 – 71.9) 10.1 (7.66 – 13.0) 47.8 (35.8 – 67.5) 385 (237 – 817) 277
40–59 years 69.2 (59.3 – 80.8) 9.16 (7.25 – 13.0) 57.6 (46.3 – 71.7) 894 (410 – 1,310) 219
60 years and older 86.3 (74.3 – 100) 13.4 (10.1 – 15.6) 78.0 (59.8 – 97.1) 656 (519 – 974) 296
† Estimate is subject to greater uncertainty due to small cell size.  
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Table 4.4.b. Urinary daidzein (creatinine corrected): Concentrations by survey cycle
Geometric mean and selected percentiles of urine concentrations (in µg/g creatinine) for the U.S. population, 
National Health and Nutrition Examination Survey, 1999–2006. 
Geometric mean 
 (95% conf. interval)
Selected percentiles (95% conf. interval) Sample 
size5th 50th 95th
Total, 6 years and older
 1999–2000 68.5 (55.9 – 83.9) 6.25 (2.72 – 8.90) 65.1 (52.8 – 80.8) 943 (838 – 1,150) 2,553
 2001–2002 48.5 (43.7 – 54.0) <LOD 48.3 (43.2 – 56.3) 955 (805 – 1,220) 2,794
 2003–2004 62.5 (58.3 – 67.0) 6.82 (5.96 – 7.48) 56.0 (49.9 – 63.5) 1,050 (858 – 1,150) 2,594
 2005–2006 64.8 (58.7 – 71.6) 6.88 (6.01 – 7.54) 52.3 (47.9 – 59.7) 1,070 (924 – 1,380) 2,528
Age group
6–11 years
 1999–2000 92.6 (76.3 – 112) 10.7 (8.22 – 13.1) 93.0 (72.1 – 114) 1,050 (835 – 2,070) 330
 2001–2002 96.4 (79.0 – 118) 13.0 (6.07 – 14.7) 85.9 (60.7 – 126) 934 (712 – 1,370) 396
 2003–2004 90.4 (77.2 – 106) 15.8 (8.36 – 20.2) 72.4 (58.2 – 99.0) 700 (563 – 1,660) 341
 2005–2006 104 (83.1 – 130) 10.8 (8.23 – 13.3) 73.8 (59.5 – 93.5) 2,350 (1,430 – 4,630) 351
12–19 years
 1999–2000 83.1 (58.4 – 118) 7.76 (3.13 – 11.0) 84.8 (54.0 – 123) 991 (725 – 2,680) 753
 2001–2002 53.4 (40.8 – 70.0) 2.77 (<LOD – 4.26) 50.8 (38.8 – 77.4) 1,030 (677 – 1,580) 744
 2003–2004 66.6 (55.7 – 79.6) 8.31 (6.76 – 9.40) 56.3 (45.0 – 74.4) 873 (667 – 1,270) 729
 2005–2006 70.0 (56.9 – 86.2) 7.67 (5.31 – 10.3) 54.7 (42.8 – 74.1) 914 (714 – 1,950) 693
20–39 years
 1999–2000 63.9 (50.7 – 80.6) 5.10 (2.37 – 8.40) 52.8 (41.0 – 81.7) 1,100 (811 – 1,740) 534
 2001–2002 41.6 (35.1 – 49.4) <LOD 43.0 (30.4 – 54.2) 849 (615 – 1,040) 604
 2003–2004 50.5 (43.0 – 59.3) 5.95 (4.11 – 7.11) 42.6 (36.1 – 50.6) 870 (570 – 1,360) 554
 2005–2006 54.6 (45.0 – 66.4) 5.60 (3.60 – 7.48) 47.0 (34.2 – 65.2) 875 (645 – 1,200) 583
40–59 years
 1999–2000 56.2 (39.7 – 79.6) 3.39 (<LOD – 8.27) 50.3 (39.1 – 71.2) 827 (624 – 1,360) 420
 2001–2002 50.2 (40.3 – 62.7) <LOD 53.3 (40.4 – 67.5) 1,220 (848 – 2,140) 531
 2003–2004 65.1 (56.5 – 75.2) 5.51 (4.02 – 7.94) 58.2 (48.9 – 70.6) 1,220 (713 – 4,260) 452
 2005–2006 58.5 (50.8 – 67.4) 6.35 (3.70 – 7.64) 46.1 (40.8 – 56.2) 1,090 (714 – 2,890) 449
60 years and older
 1999–2000 77.6 (63.4 – 94.8) 8.64 (5.52 – 12.0) 82.7 (61.7 – 104) 761 (575 – 996) 516
 2001–2002 37.9 (31.0 – 46.3) <LOD 36.0 (25.9 – 44.2) 726 (502 – 1,780) 519
 2003–2004 65.9 (55.1 – 78.9) 8.01 (6.03 – 9.02) 61.8 (48.0 – 78.2) 973 (653 – 1,870) 518
 2005–2006 77.1 (65.2 – 91.1) 9.10 (6.42 – 11.4) 64.5 (49.7 – 87.6) 1,020 (827 – 1,610) 452
Gender
Males
 1999–2000 69.7 (54.7 – 88.8) 6.40 (1.93 – 9.19) 69.8 (52.1 – 84.2) 1,040 (908 – 1,180) 1,220
 2001–2002 40.5 (34.8 – 47.1) <LOD 41.6 (34.6 – 47.9) 773 (615 – 969) 1,375
 2003–2004 57.7 (49.4 – 67.3) 6.10 (4.73 – 7.35) 48.9 (42.3 – 58.2) 918 (699 – 1,230) 1,244
 2005–2006 59.5 (53.3 – 66.3) 6.42 (4.79 – 7.34) 50.7 (43.2 – 57.6) 926 (814 – 1,170) 1,252
Females
 1999–2000 67.4 (54.8 – 82.9) 5.93 (2.71 – 8.38) 62.1 (51.2 – 80.8) 845 (622 – 1,420) 1,333
 2001–2002 57.6 (50.8 – 65.2) <LOD 59.1 (48.2 – 72.9) 1,170 (949 – 1,430) 1,419
 2003–2004 67.4 (60.8 – 74.9) 7.43 (6.03 – 8.22) 64.9 (54.7 – 73.3) 1,090 (820 – 1,490) 1,350
 2005–2006 70.4 (61.3 – 80.8) 7.47 (5.83 – 8.70) 57.1 (45.2 – 71.2) 1,180 (1,020 – 1,860) 1,276
Race/ethnicity
Mexican Americans
 1999–2000 72.4 (59.1 – 88.9) 6.47 (3.20 – 8.73) 64.0 (46.9 – 90.9) 1,380 (886 – 3,380) 816
 2001–2002 36.9 (27.8 – 49.0) <LOD 37.0 (24.9 – 57.3) 718 (584 – 1,220) 679
 2003–2004 51.8 (45.0 – 59.6) 4.37 (2.94 – 5.89) 47.7 (36.4 – 58.1) 1,120 (870 – 1,380) 653
 2005–2006 54.7 (45.6 – 65.7) 4.79 (3.91 – 5.94) 47.2 (36.0 – 60.6) 917 (662 – 1,130) 634
Non-Hispanic Blacks
 1999–2000 58.7 (46.0 – 74.9) 3.74 (<LOD – 6.58) 67.0 (52.1 – 86.0) 797 (598 – 945) 596
 2001–2002 46.2 (33.2 – 64.3) <LOD 49.5 (35.7 – 69.9) 927 (620 – 1,820) 692
 2003–2004 53.2 (42.4 – 66.7) 5.94 (3.99 – 6.84) 45.3 (30.0 – 72.1) 706 (564 – 1,030) 681
 2005–2006 57.0 (50.3 – 64.5) 5.39 (4.33 – 6.69) 48.5 (42.1 – 59.5) 902 (643 – 1,350) 662
Non-Hispanic Whites
 1999–2000 73.6 (60.7 – 89.2) 8.09 (3.07 – 10.9) 67.9 (57.2 – 81.4) 917 (794 – 1,390) 901
 2001–2002 48.0 (43.5 – 53.0) <LOD 47.0 (42.8 – 55.4) 954 (838 – 1,220) 1,211
 2003–2004 64.9 (59.9 – 70.4) 7.20 (6.28 – 8.08) 58.2 (50.9 – 66.8) 1,090 (818 – 1,320) 1,069
 2005–2006 65.2 (57.9 – 73.3) 7.34 (5.54 – 8.21) 52.6 (46.5 – 60.6) 1,070 (896 – 1,460) 1,039
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Values in the graph are suppressed if either the point estimate or the lower 95% confidence limit is noted as “< LOD” in the accompanying table. 
Figure 4.4.b. Urinary daidzein (creatinine corrected): 
Concentrations by survey cycle 
Selected percentiles in μg/g creatinine (95% confidence intervals), National Health and 
Nutrition Examination Survey, 1999–2006
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Figure 4.5.a. Urinary equol: Concentrations by age group 
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Table 4.5.a.2. Urinary equol: Total population
Geometric mean and selected percentiles of urine concentrations (in µg/L) for the total U.S. population aged 6 
years and older, National Health and Nutrition Examination Survey, 2003–2006. 
Geometric mean 
 (95% conf. interval)
Selected percentiles (95% conf. interval) Sample 
size10th 50th 90th
Males and Females
Total, 6 years and older 8.21 (7.61 – 8.85) 1.49 (1.30 – 1.60) 8.33 (7.59 – 9.06) 36.7 (33.8 – 39.7) 5,117
6–11 years 12.8 (11.1 – 14.8) 2.75 (2.10 – 3.50) 13.2 (10.8 – 16.0) 45.5 (41.5 – 65.3) 692
12–19 years 11.1 (10.0 – 12.2) 2.61 (2.29 – 2.90) 10.8 (9.61 – 11.7) 42.8 (38.6 – 47.0) 1,422
20–39 years 8.39 (7.41 – 9.50) 1.50 (1.20 – 1.80) 8.80 (7.71 – 9.78) 36.5 (30.8 – 42.8) 1,137
40–59 years 6.85 (6.06 – 7.75) 1.28 (1.07 – 1.41) 6.37 (5.36 – 7.63) 33.3 (29.7 – 37.5) 897
60 years and older 6.96 (6.06 – 8.00) 1.30 (1.09 – 1.51) 7.07 (6.06 – 8.03) 32.0 (24.4 – 39.1) 969
Males
Total, 6 years and older 8.85 (8.10 – 9.66) 1.60 (1.38 – 1.99) 9.07 (8.18 – 10.0) 38.6 (34.4 – 42.9) 2,492
6–11 years 15.0 (12.6 – 17.8) 3.79 (2.20 – 5.37) 16.4 (13.2 – 19.2) 50.1 (43.4 – 74.2) 340
12–19 years 12.0 (10.5 – 13.7) 2.67 (2.24 – 3.29) 11.7 (10.6 – 12.7) 44.8 (36.9 – 69.0) 728
20–39 years 8.42 (7.10 – 9.99) 1.47 (1.03 – 1.83) 8.70 (7.21 – 10.0) 41.3 (31.1 – 52.6) 499
40–59 years 7.16 (6.07 – 8.44) 1.42 (1.20 – 1.79) 7.44 (5.69 – 8.91) 30.0 (24.3 – 37.4) 447
60 years and older 8.22 (6.78 – 9.98) 1.50 (1.23 – 1.83) 8.44 (7.09 – 10.1) 36.2 (27.5 – 46.9) 478
Females
Total, 6 years and older 7.65 (6.95 – 8.42) 1.30 (1.19 – 1.50) 7.49 (6.81 – 8.27) 34.8 (32.1 – 38.7) 2,625
6–11 years 10.9 (9.07 – 13.1) 2.43 (1.59 – 2.80) 10.1 (9.16 – 12.5) 43.5 (35.0 – 69.5) 352
12–19 years 10.1 (8.93 – 11.5) 2.49 (1.87 – 2.83) 9.39 (8.03 – 11.4) 40.4 (34.8 – 47.1) 694
20–39 years 8.36 (7.09 – 9.86) 1.50 (1.06 – 1.97) 9.07 (7.09 – 10.6) 32.2 (28.2 – 40.7) 638
40–59 years 6.58 (5.45 – 7.95) .939 (.529 – 1.29) 5.69 (4.68 – 6.95) 34.5 (30.9 – 45.9) 450
60 years and older 6.10 (5.03 – 7.39) 1.18 (.974 – 1.40) 5.80 (5.20 – 7.32) 26.4 (19.2 – 40.6) 491
  
Table 4.5.a.3. Urinary equol: Mexican Americans
Geometric mean and selected percentiles of urine concentrations (in µg/L) for Mexican Americans in the U.S. 
population aged 6 years and older, National Health and Nutrition Examination Survey, 2003–2006. 
Geometric mean 
 (95% conf. interval)
Selected percentiles (95% conf. interval) Sample 
size10th 50th 90th
Males and Females
Total, 6 years and older 6.06 (5.46 – 6.72) 1.27 (1.01 – 1.49) 5.87 (5.28 – 6.69) 25.8 (20.9 – 35.4) 1,287
6–11 years 9.49 (7.78 – 11.6) 1.60 (1.05 – 2.47) 9.20 (6.88 – 11.7) 45.5 (37.6 – 85.8) 231
12–19 years 8.07 (7.04 – 9.24) 1.60 (1.44 – 2.01) 7.08 (6.25 – 8.19) 35.7 (27.8 – 49.2) 445
20–39 years 5.71 (4.97 – 6.56) 1.27 (.967 – 1.51) 5.59 (4.49 – 6.42) 21.9 (17.9 – 39.2) 282
40–59 years 4.63 (3.73 – 5.75) 1.08 (< LOD – 1.48) 4.99 (3.92 – 5.86) 19.0 (14.0 – 25.0) 157
60 years and older 4.10 (3.21 – 5.23) .631 (.379 – .946) 4.73 (3.19 – 6.60) 16.6 (10.8 – 27.3) 172
Males
Total, 6 years and older 5.92 (5.25 – 6.68) 1.29 (1.04 – 1.57) 5.69 (4.89 – 6.81) 24.6 (19.8 – 32.9) 625
6–11 years 10.1 (7.14 – 14.3) 2.17 (.735 – 3.86) 9.71 (6.15 – 14.4) 40.8 (26.9 – 88.4) 112
12–19 years 8.75 (7.28 – 10.5) 1.83 (1.35 – 2.32) 7.71 (6.15 – 9.42) 41.1 (28.6 – 61.8) 228
20–39 years 4.81 (3.96 – 5.86) 1.15 (.685 – 1.41) 4.55 (3.70 – 6.03) 18.0 (12.6 – 40.6) 117
40–59 years 5.22 (4.05 – 6.72) 1.18† (.707 – 1.98) 5.27 (4.28 – 6.94) 19.5† (12.5 – 31.6) 85
60 years and older 4.36 (3.01 – 6.31) .600† (< LOD – 1.47) 4.99 (3.05 – 6.89) 17.3† (9.44 – 65.3) 83
Females
Total, 6 years and older 6.21 (5.35 – 7.22) 1.20 (.793 – 1.51) 6.18 (5.15 – 7.09) 28.0 (20.7 – 39.6) 662
6–11 years 8.89 (6.62 – 11.9) 1.47 (.569 – 2.34) 8.44 (5.75 – 11.4) 57.0 (37.3 – 202) 119
12–19 years 7.41 (6.32 – 8.69) 1.50 (.916 – 2.21) 6.81 (5.51 – 8.03) 28.4 (19.3 – 52.0) 217
20–39 years 6.99 (5.35 – 9.13) 1.37 (.689 – 1.85) 6.79 (4.70 – 9.31) 35.2 (19.6 – 66.9) 165
40–59 years 4.07 (2.94 – 5.64) .861† (< LOD – 1.36) 3.89 (2.93 – 5.72) 18.3† (14.0 – 34.4) 72
60 years and older 3.90 (2.50 – 6.08) .671† (< LOD – 1.12) 4.41 (2.15 – 7.53) 14.8† (9.40 – 80.2) 89
< LOD means less than the limit of detection, which may vary for some compounds by year. See Appendix D for LOD. 
† Estimate is subject to greater uncertainty due to small cell size. 
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Table 4.5.a.4. Urinary equol: Non-Hispanic blacks
Geometric mean and selected percentiles of urine concentrations (in µg/L) for non-Hispanic blacks in the U.S. 
population aged 6 years and older, National Health and Nutrition Examination Survey, 2003–2006. 
Geometric mean 
 (95% conf. interval)
Selected percentiles (95% conf. interval) Sample 
size10th 50th 90th
Males and Females
Total, 6 years and older 7.13 (6.35 – 8.01) 1.49 (1.28 – 1.70) 6.82 (6.08 – 8.20) 31.3 (27.1 – 36.6) 1,340
6–11 years 11.9 (9.99 – 14.2) 3.00 (2.09 – 3.59) 10.8 (8.53 – 14.0) 54.2 (40.6 – 79.7) 207
12–19 years 9.86 (8.44 – 11.5) 2.40 (1.99 – 2.78) 8.98 (7.83 – 10.3) 42.5 (35.2 – 61.4) 496
20–39 years 7.03 (5.93 – 8.34) 1.50 (1.01 – 2.10) 6.94 (5.91 – 9.58) 24.6 (21.6 – 32.3) 249
40–59 years 5.91 (4.67 – 7.49) 1.19 (.705 – 1.60) 5.49 (4.44 – 7.21) 33.4 (21.8 – 45.8) 228
60 years and older 4.79 (3.89 – 5.91) .852 (.685 – 1.10) 5.17 (4.14 – 6.24) 21.8 (17.1 – 30.7) 160
Males
Total, 6 years and older 7.47 (6.72 – 8.30) 1.57 (1.36 – 1.74) 6.78 (5.94 – 8.18) 31.5 (27.0 – 39.4) 658
6–11 years 13.3 (10.4 – 17.1) 3.43† (1.29 – 4.53) 12.7 (9.66 – 14.9) 71.1† (35.1 – 125) 99
12–19 years 10.8 (8.60 – 13.5) 2.73 (1.99 – 3.07) 9.98 (7.56 – 12.6) 40.1 (32.6 – 70.0) 258
20–39 years 7.77 (6.53 – 9.24) 1.46 (1.21 – 2.10) 6.65 (5.38 – 9.46) 27.4 (23.1 – 45.5) 116
40–59 years 5.52 (4.14 – 7.35) 1.46† (1.11 – 1.67) 5.13 (4.01 – 7.66) 24.5† (13.5 – 51.5) 111
60 years and older 4.15 (3.25 – 5.29) .758† (< LOD – 1.27) 4.28 (3.25 – 5.82) 21.7† (10.8 – 66.2) 74
Females
Total, 6 years and older 6.87 (5.87 – 8.04) 1.25 (.765 – 1.80) 6.86 (5.92 – 8.46) 30.3 (25.2 – 37.5) 682
6–11 years 10.6 (7.95 – 14.2) 2.52† (1.45 – 3.58) 9.24 (6.86 – 12.6) 47.6† (30.5 – 124) 108
12–19 years 9.01 (7.47 – 10.9) 2.08 (1.31 – 2.78) 8.50 (7.01 – 9.53) 43.6 (31.4 – 71.3) 238
20–39 years 6.49 (5.06 – 8.33) 1.50 (.605 – 2.40) 7.06 (4.83 – 10.1) 22.2 (17.7 – 30.1) 133
40–59 years 6.25 (4.47 – 8.74) .702 (.318 – 1.88) 5.84 (4.69 – 8.20) 37.0 (24.8 – 63.0) 117
60 years and older 5.26 (4.08 – 6.78) .872† (.723 – 1.03) 5.43 (3.80 – 8.00) 21.8† (17.4 – 37.7) 86
< LOD means less than the limit of detection, which may vary for some compounds by year. See Appendix D for LOD. 
† Estimate is subject to greater uncertainty due to small cell size. 
Table 4.5.a.5. Urinary equol: Non-Hispanic whites
Geometric mean and selected percentiles of urine concentrations (in µg/L) for non-Hispanic whites in the U.S. 
population aged 6 years and older, National Health and Nutrition Examination Survey, 2003–2006. 
Geometric mean 
 (95% conf. interval)
Selected percentiles (95% conf. interval) Sample 
size10th 50th 90th
Males and Females
Total, 6 years and older 8.78 (7.99 – 9.65) 1.54 (1.30 – 1.80) 9.15 (8.27 – 9.99) 38.2 (34.4 – 43.0) 2,106
6–11 years 14.7 (11.9 – 18.1) 3.40 (2.09 – 5.41) 16.3 (12.7 – 18.8) 44.9 (38.1 – 78.1) 193
12–19 years 12.1 (10.6 – 13.8) 3.09 (2.50 – 3.61) 11.9 (10.6 – 13.6) 42.0 (36.7 – 46.5) 378
20–39 years 9.62 (8.11 – 11.4) 1.57 (1.13 – 2.04) 10.0 (8.77 – 11.7) 42.8 (32.6 – 57.5) 494
40–59 years 7.04 (6.11 – 8.12) 1.29 (.848 – 1.49) 6.87 (5.37 – 8.81) 33.8 (30.8 – 37.4) 447
60 years and older 7.65 (6.47 – 9.04) 1.46 (1.17 – 1.88) 7.66 (6.29 – 8.72) 33.6 (25.9 – 47.8) 594
Males
Total, 6 years and older 9.68 (8.71 – 10.8) 1.71 (1.40 – 2.10) 10.0 (8.94 – 11.1) 40.1 (36.0 – 45.2) 1,034
6–11 years 17.5 (13.8 – 22.2) 5.59† (2.11 – 6.02) 17.5 (13.5 – 24.4) 44.9† (39.9 – 115) 99
12–19 years 13.4 (11.3 – 16.0) 3.28 (1.89 – 4.54) 12.2 (11.3 – 15.4) 45.0 (36.6 – 79.1) 191
20–39 years 9.63 (7.72 – 12.0) 1.54 (1.00 – 2.07) 10.0 (8.68 – 11.5) 44.3 (32.4 – 82.8) 217
40–59 years 7.61 (6.19 – 9.35) 1.41 (1.08 – 1.91) 7.93 (5.97 – 9.71) 31.4 (26.6 – 42.6) 228
60 years and older 9.32 (7.43 – 11.7) 1.73 (1.27 – 2.50) 9.42 (7.36 – 12.1) 37.6 (30.7 – 55.2) 299
Females
Total, 6 years and older 7.98 (7.02 – 9.06) 1.45 (1.20 – 1.60) 7.86 (6.93 – 9.16) 35.6 (31.7 – 42.8) 1,072
6–11 years 12.0 (8.61 – 16.7) 2.61† (.948 – 3.85) 12.3 (9.15 – 17.3) 43.2† (27.4 – 91.7) 94
12–19 years 10.8 (8.95 – 13.0) 2.76 (1.92 – 3.64) 11.1 (8.16 – 13.8) 39.9 (32.0 – 45.3) 187
20–39 years 9.60 (7.63 – 12.1) 1.66 (.954 – 2.27) 10.3 (7.50 – 12.8) 37.3 (29.2 – 72.9) 277
40–59 years 6.52 (5.18 – 8.20) .967 (.492 – 1.32) 6.18 (4.63 – 7.52) 33.9 (30.9 – 47.3) 219
60 years and older 6.54 (5.19 – 8.25) 1.27 (.956 – 1.58) 6.08 (5.27 – 8.01) 29.4 (18.6 – 55.9) 295
† Estimate is subject to greater uncertainty due to small cell size.  
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Table 4.5.b. Urinary equol: Concentrations by survey cycle
Geometric mean and selected percentiles of urine concentrations (in µg/L) for the U.S. population, National 
Health and Nutrition Examination Survey, 1999–2006. 
Geometric mean 
 (95% conf. interval)
Selected percentiles (95% conf. interval) Sample 
size5th 50th 95th
Total, 6 years and older
 1999–2000 8.37 (7.21 – 9.72) < LOD 8.00 (6.29 – 9.82) 53.7 (41.6 – 79.6) 2,182
 2001–2002 9.17 (7.76 – 10.8) < LOD 8.94 (7.36 – 10.4) 73.5 (56.4 – 95.8) 2,794
 2003–2004 8.02 (7.07 – 9.10) .934 (.655 – 1.11) 7.98 (6.77 – 9.36) 64.8 (47.0 – 100) 2,590
 2005–2006 8.40 (7.63 – 9.24) .878 (.698 – 1.08) 8.60 (7.91 – 9.17) 64.5 (56.9 – 80.5) 2,527
Age group
6–11 years
 1999–2000 10.4 (7.65 – 14.3) < LOD 11.5 (5.76 – 18.5) 55.4 (32.5 – 310) 272
 2001–2002 12.2 (10.2 – 14.6) < LOD 13.7 (11.1 – 16.1) 84.5 (53.6 – 214) 396
 2003–2004 12.4 (9.71 – 15.8) 1.92 (1.00 – 2.31) 12.0 (8.45 – 17.6) 85.4 (49.1 – 251) 341
 2005–2006 13.3 (11.3 – 15.7) 1.90 (1.02 – 2.49) 13.4 (12.1 – 16.6) 70.3 (54.3 – 228) 351
12–19 years
 1999–2000 10.9 (8.64 – 13.8) < LOD 10.7 (8.57 – 13.3) 71.6 (51.1 – 235) 657
 2001–2002 10.2 (8.50 – 12.1) < LOD 10.4 (8.27 – 12.5) 68.9 (48.1 – 106) 744
 2003–2004 10.6 (8.96 – 12.4) 1.64 (1.05 – 2.11) 10.5 (8.73 – 12.1) 61.8 (46.0 – 113) 729
 2005–2006 11.6 (10.3 – 13.0) 1.49 (1.19 – 2.04) 11.2 (9.48 – 12.3) 81.6 (54.9 – 148) 693
20–39 years
 1999–2000 7.66 (6.63 – 8.86) < LOD 7.55 (5.49 – 9.38) 38.1 (35.6 – 69.4) 439
 2001–2002 9.35 (7.40 – 11.8) < LOD 9.25 (6.95 – 11.3) 67.0 (49.7 – 111) 604
 2003–2004 8.81 (7.29 – 10.6) .980 (.509 – 1.31) 9.11 (7.18 – 10.8) 99.6 (44.4 – 221) 554
 2005–2006 8.00 (6.71 – 9.54) .820 (.587 – 1.18) 8.60 (7.42 – 9.73) 57.1 (45.0 – 95.1) 583
40–59 years
 1999–2000 7.80 (6.17 – 9.84) < LOD 7.28 (4.97 – 9.09) 53.7 (34.0 – 3,160) 378
 2001–2002 8.92 (7.27 – 10.9) < LOD 8.12 (6.43 – 10.1) 102 (44.7 – 312) 531
 2003–2004 6.65 (5.61 – 7.87) .613 (.372 – 1.04) 6.09 (4.66 – 8.60) 51.6 (38.0 – 140) 448
 2005–2006 7.05 (5.83 – 8.54) .542 (.325 – 1.07) 6.76 (5.33 – 8.36) 63.8 (38.6 – 542) 449
60 years and older
 1999–2000 8.04 (6.93 – 9.33) < LOD 7.33 (5.55 – 9.70) 54.8 (35.9 – 237) 436
 2001–2002 7.18 (5.83 – 8.85) < LOD 5.68 (3.76 – 8.16) 51.0 (41.8 – 113) 519
 2003–2004 6.16 (4.93 – 7.68) .754 (< LOD – 1.02) 5.88 (4.99 – 7.75) 39.6 (32.2 – 176) 518
 2005–2006 7.84 (6.60 – 9.31) .940 (.599 – 1.16) 7.80 (6.29 – 8.95) 55.5 (42.4 – 326) 451
Gender
Males
 1999–2000 9.15 (7.37 – 11.4) < LOD 8.44 (6.38 – 11.2) 68.8 (45.0 – 170) 1,042
 2001–2002 9.41 (7.99 – 11.1) < LOD 9.14 (7.65 – 10.6) 61.4 (52.6 – 87.6) 1,375
 2003–2004 8.56 (7.54 – 9.72) 1.07 (.861 – 1.26) 8.70 (7.18 – 10.2) 72.3 (50.8 – 112) 1,240
 2005–2006 9.13 (7.99 – 10.4) 1.19 (.892 – 1.29) 9.40 (8.15 – 10.6) 61.7 (53.1 – 94.2) 1,252
Females
 1999–2000 7.70 (6.79 – 8.74) < LOD 7.56 (5.92 – 8.98) 48.2 (37.6 – 70.9) 1,140
 2001–2002 8.94 (7.38 – 10.8) < LOD 8.54 (6.72 – 10.6) 79.3 (58.9 – 130) 1,419
 2003–2004 7.55 (6.44 – 8.84) .792 (.480 – 1.02) 7.29 (6.12 – 8.96) 60.2 (43.8 – 145) 1,350
 2005–2006 7.75 (6.85 – 8.78) .684 (.486 – .877) 7.56 (6.93 – 8.36) 69.0 (54.8 – 119) 1,275
Race/ethnicity
Mexican Americans
 1999–2000 5.24 (4.77 – 5.75) < LOD 4.51 (3.75 – 5.25) 30.3 (22.6 – 62.5) 726
 2001–2002 7.22 (6.04 – 8.62) < LOD 6.49 (4.52 – 8.98) 42.1 (40.1 – 48.7) 679
 2003–2004 6.08 (5.08 – 7.28) .927 (.625 – 1.18) 5.64 (4.65 – 6.77) 43.5 (36.2 – 108) 653
 2005–2006 6.04 (5.31 – 6.87) .663 (.440 – .961) 6.12 (5.32 – 7.09) 47.6 (36.7 – 83.0) 634
Non-Hispanic Blacks
 1999–2000 6.67 (5.16 – 8.63) < LOD 6.12 (3.87 – 9.88) 36.5 (30.0 – 52.0) 504
 2001–2002 7.11 (6.01 – 8.42) < LOD 6.00 (4.62 – 7.48) 45.2 (40.7 – 99.6) 692
 2003–2004 7.32 (6.13 – 8.73) .753 (.505 – 1.11) 7.85 (6.09 – 9.58) 46.9 (39.8 – 62.3) 678
 2005–2006 6.96 (5.89 – 8.22) .868 (.686 – 1.05) 6.37 (5.48 – 7.85) 48.6 (39.2 – 64.9) 662
Non-Hispanic Whites
 1999–2000 9.38 (7.94 – 11.1) < LOD 8.98 (6.99 – 11.8) 56.1 (45.4 – 95.5) 744
 2001–2002 9.89 (7.90 – 12.4) < LOD 9.93 (7.31 – 12.5) 74.1 (55.1 – 108) 1,211
 2003–2004 8.51 (7.22 – 10.0) .996 (.618 – 1.19) 8.72 (6.95 – 10.3) 72.9 (46.8 – 120) 1,068
 2005–2006 9.05 (8.08 – 10.1) .965 (.606 – 1.27) 9.48 (8.56 – 10.3) 68.9 (56.9 – 105) 1,038
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Values in the graph are suppressed if either the point estimate or the lower 95% confidence limit is noted as “< LOD” in the accompanying table. 
Figure 4.5.b. Urinary equol: Concentrations by survey cycle 
Selected percentiles in μg/L (95% confidence intervals), National Health and 

Nutrition Examination Survey, 1999–2006
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 Non−Hispanic Blacks Non−Hispanic Whites 
Figure 4.6.a. Urinary equol (creatinine corrected): Concentrations by age group 
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Table 4.6.a.2. Urinary equol (creatinine corrected): Total population
Geometric mean and selected percentiles of urine concentrations (in µg/g creatinine) for the total U.S. 
population aged 6 years and older, National Health and Nutrition Examination Survey, 2003–2006. 
Geometric mean 
 (95% conf. interval)
Selected percentiles (95% conf. interval) Sample 
size10th 50th 90th
Males and Females
Total, 6 years and older 7.85 (7.31 – 8.43) 1.72 (1.54 – 1.90) 7.64 (7.10 – 8.15) 30.7 (28.8 – 32.6) 5,117
6–11 years 13.9 (12.4 – 15.6) 3.64 (2.88 – 4.34) 14.4 (12.3 – 16.0) 44.9 (40.5 – 57.6) 692
12–19 years 8.24 (7.40 – 9.19) 2.09 (1.87 – 2.39) 8.04 (7.17 – 8.69) 31.3 (26.0 – 35.0) 1,422
20–39 years 7.15 (6.38 – 8.02) 1.45 (1.17 – 1.73) 7.06 (6.25 – 7.86) 29.5 (23.7 – 34.6) 1,137
40–59 years 6.95 (6.07 – 7.96) 1.40 (1.14 – 1.60) 6.57 (5.54 – 7.54) 25.6 (21.3 – 34.3) 897
60 years and older 8.16 (7.32 – 9.08) 2.14 (1.86 – 2.43) 8.13 (7.12 – 8.80) 27.1 (21.6 – 34.0) 969
Males
Total, 6 years and older 7.02 (6.46 – 7.64) 1.48 (1.28 – 1.76) 6.84 (6.27 – 7.53) 28.8 (25.7 – 31.7) 2,492
6–11 years 15.0 (12.9 – 17.5) 3.84 (3.12 – 4.90) 16.1 (14.7 – 19.0) 45.4 (37.2 – 90.4) 340
12–19 years 8.15 (7.01 – 9.47) 1.92 (1.72 – 2.25) 8.15 (6.93 – 9.51) 31.3 (25.8 – 47.4) 728
20–39 years 6.14 (5.31 – 7.10) 1.26 (.981 – 1.47) 5.83 (4.99 – 6.67) 25.2 (20.0 – 34.6) 499
40–59 years 5.69 (4.78 – 6.77) 1.18 (.790 – 1.58) 5.53 (4.55 – 6.67) 21.8 (15.9 – 33.7) 447
60 years and older 7.58 (6.47 – 8.88) 1.87 (1.37 – 2.25) 7.28 (6.43 – 8.67) 28.8 (20.8 – 34.1) 478
Females
Total, 6 years and older 8.72 (8.02 – 9.49) 1.95 (1.67 – 2.16) 8.36 (7.88 – 8.98) 32.3 (30.1 – 34.9) 2,625
6–11 years 12.8 (11.0 – 15.0) 3.24 (2.47 – 4.43) 12.8 (10.1 – 14.7) 44.8 (39.8 – 57.7) 352
12–19 years 8.35 (7.44 – 9.37) 2.33 (1.89 – 2.72) 7.94 (7.03 – 8.71) 30.5 (22.8 – 37.1) 694
20–39 years 8.32 (7.03 – 9.84) 1.87 (1.20 – 2.15) 8.08 (7.13 – 9.13) 32.2 (25.0 – 38.8) 638
40–59 years 8.39 (7.05 – 9.98) 1.51 (1.19 – 1.86) 7.92 (6.51 – 9.40) 31.4 (24.1 – 43.1) 450
60 years and older 8.65 (7.36 – 10.2) 2.41 (2.00 – 2.83) 8.44 (7.65 – 9.39) 26.8 (20.4 – 39.8) 491
Table 4.6.a.3. Urinary equol (creatinine corrected): Mexican Americans
Geometric mean and selected percentiles of urine concentrations (in µg/g creatinine) for Mexican Americans in 
the U.S. population aged 6 years and older, National Health and Nutrition Examination Survey, 2003–2006. 
Geometric mean 
 (95% conf. interval)
Selected percentiles (95% conf. interval) Sample 
size10th 50th 90th
Males and Females
Total, 6 years and older 5.46 (4.94 – 6.04) 1.29 (1.14 – 1.43) 4.84 (4.34 – 5.48) 22.4 (19.7 – 27.6) 1,287
6–11 years 11.9 (10.4 – 13.7) 2.42 (1.84 – 4.06) 10.9 (8.91 – 13.8) 58.9 (30.4 – 121) 231
12–19 years 6.23 (5.49 – 7.07) 1.62 (1.35 – 1.73) 5.57 (4.69 – 6.09) 25.3 (19.7 – 34.5) 445
20–39 years 4.61 (3.91 – 5.42) 1.12 (.736 – 1.37) 4.10 (3.26 – 4.90) 19.6 (15.2 – 31.0) 282
40–59 years 4.24 (3.57 – 5.04) 1.23 (< LOD – 1.43) 4.11 (3.40 – 4.80) 14.0 (11.8 – 27.0) 157
60 years and older 5.06 (4.22 – 6.06) 1.46 (.752 – 1.97) 4.82 (3.84 – 6.04) 19.0 (10.5 – 61.0) 172
Males
Total, 6 years and older 4.67 (4.08 – 5.35) 1.16 (.883 – 1.34) 4.23 (3.78 – 5.04) 18.9 (16.3 – 21.2) 625
6–11 years 12.1 (9.02 – 16.2) 3.55 (1.73 – 4.93) 10.6 (8.24 – 16.2) 35.9 (27.4 – 108) 112
12–19 years 6.33 (5.37 – 7.48) 1.60 (1.35 – 1.82) 5.58 (4.35 – 6.84) 27.5 (19.6 – 43.7) 228
20–39 years 3.50 (2.79 – 4.38) .804 (.519 – 1.20) 3.42 (2.99 – 4.15) 11.5 (7.33 – 21.7) 117
40–59 years 3.83 (3.11 – 4.70) 1.27† (.640 – 1.40) 3.78 (3.16 – 4.90) 11.4† (8.79 – 26.7) 85
60 years and older 3.88 (2.81 – 5.35) 1.16† (< LOD – 1.91) 4.17 (3.23 – 5.83) 10.5† (7.12 – 60.1) 83
Females
Total, 6 years and older 6.48 (5.83 – 7.21) 1.57 (1.37 – 1.84) 5.75 (4.93 – 6.55) 29.0 (24.0 – 34.5) 662
6–11 years 11.7 (9.26 – 14.8) 2.14 (1.07 – 3.77) 10.9 (8.65 – 13.4) 88.9 (28.8 – 177) 119
12–19 years 6.12 (5.10 – 7.36) 1.59 (1.13 – 1.80) 5.50 (4.49 – 6.06) 24.0 (15.6 – 40.4) 217
20–39 years 6.39 (5.00 – 8.15) 1.62 (1.14 – 2.09) 5.39 (4.01 – 7.25) 30.4 (19.7 – 58.3) 165
40–59 years 4.74 (3.71 – 6.04) .933† (< LOD – 1.67) 4.23 (3.33 – 5.37) 21.0† (13.1 – 31.3) 72
60 years and older 6.28 (4.18 – 9.43) 1.82† (< LOD – 2.38) 5.43 (3.77 – 8.92) 24.4† (11.9 – 201) 89
< LOD means less than the limit of detection for the uncorrected urine values, which may vary for some compounds by year. See Appendix D for LOD. 
† Estimate is subject to greater uncertainty due to small cell size. 
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Table 4.6.a.4. Urinary equol (creatinine corrected): Non-Hispanic blacks
Geometric mean and selected percentiles of urine concentrations (in µg/g creatinine) for non-Hispanic blacks 
in the U.S. population aged 6 years and older, National Health and Nutrition Examination Survey, 2003–2006. 
Geometric mean 
 (95% conf. interval)
Selected percentiles (95% conf. interval) Sample 
size10th 50th 90th
Males and Females
Total, 6 years and older 5.02 (4.48 – 5.62) 1.19 (1.02 – 1.41) 4.88 (4.40 – 5.59) 20.8 (18.2 – 23.7) 1,340
6–11 years 11.2 (9.38 – 13.3) 3.12 (2.54 – 3.56) 9.67 (7.96 – 11.3) 47.8 (34.3 – 64.1) 207
12–19 years 5.66 (4.86 – 6.60) 1.45 (1.14 – 1.68) 5.37 (4.61 – 6.33) 21.5 (16.8 – 27.9) 496
20–39 years 4.36 (3.81 – 4.98) 1.02 (.802 – 1.36) 4.87 (4.24 – 5.64) 12.3 (10.8 – 17.6) 249
40–59 years 4.33 (3.36 – 5.58) 1.02 (.520 – 1.41) 4.06 (2.87 – 5.29) 19.7 (16.8 – 25.8) 228
60 years and older 4.28 (3.53 – 5.19) 1.08 (.798 – 1.38) 4.22 (3.62 – 5.09) 16.7 (13.6 – 23.6) 160
Males
Total, 6 years and older 4.37 (3.86 – 4.95) 1.01 (.775 – 1.18) 4.24 (3.60 – 4.97) 19.1 (15.2 – 23.4) 658
6–11 years 12.6 (9.98 – 15.9) 3.44† (1.39 – 4.49) 11.0 (8.57 – 14.3) 52.6† (28.7 – 99.7) 99
12–19 years 5.77 (4.53 – 7.34) 1.45 (.957 – 1.76) 5.39 (4.19 – 6.65) 21.7 (15.8 – 36.8) 258
20–39 years 3.73 (3.09 – 4.50) .892 (.630 – 1.05) 3.82 (3.14 – 5.00) 12.1 (10.5 – 15.9) 116
40–59 years 3.18 (2.40 – 4.21) .865† (.471 – 1.24) 2.92 (2.24 – 4.31) 11.6† (6.28 – 27.1) 111
60 years and older 3.04 (2.42 – 3.82) .742† (< LOD – .959) 3.22 (2.07 – 4.15) 13.5† (9.29 – 22.1) 74
Females
Total, 6 years and older 5.63 (4.95 – 6.40) 1.41 (1.18 – 1.59) 5.45 (4.77 – 6.45) 22.1 (18.5 – 25.5) 682
6–11 years 9.92 (7.41 – 13.3) 2.69† (1.59 – 3.38) 8.60 (6.65 – 11.1) 43.5† (30.1 – 68.7) 108
12–19 years 5.56 (4.61 – 6.70) 1.43 (1.03 – 1.81) 5.30 (4.05 – 7.15) 20.9 (16.0 – 28.0) 238
20–39 years 4.94 (4.12 – 5.92) 1.34 (.768 – 1.89) 5.12 (4.53 – 6.44) 12.3 (10.8 – 20.2) 133
40–59 years 5.55 (3.94 – 7.81) 1.12 (.501 – 1.51) 5.32 (3.42 – 7.37) 24.3 (18.4 – 65.6) 117
60 years and older 5.31 (4.14 – 6.80) 1.51† (1.22 – 1.63) 4.81 (3.98 – 6.91) 19.3† (14.1 – 32.3) 86
< LOD means less than the limit of detection for the uncorrected urine values, which may vary for some compounds by year. See Appendix D for LOD. 
† Estimate is subject to greater uncertainty due to small cell size. 
Table 4.6.a.5. Urinary equol (creatinine corrected): Non-Hispanic whites
Geometric mean and selected percentiles of urine concentrations (in µg/g creatinine) for non-Hispanic whites 
in the U.S. population aged 6 years and older, National Health and Nutrition Examination Survey, 2003–2006. 
Geometric mean 
 (95% conf. interval)
Selected percentiles (95% conf. interval) Sample 
size10th 50th 90th
Males and Females
Total, 6 years and older 8.94 (8.26 – 9.67) 2.12 (1.87 – 2.32) 8.65 (7.95 – 9.50) 32.4 (30.4 – 34.8) 2,106
6–11 years 16.0 (13.4 – 19.0) 4.07 (2.54 – 5.84) 17.1 (14.2 – 20.0) 44.8 (39.0 – 81.4) 193
12–19 years 9.48 (8.25 – 10.9) 2.75 (1.97 – 3.28) 9.27 (8.04 – 10.9) 32.1 (26.2 – 38.2) 378
20–39 years 8.87 (7.54 – 10.4) 1.95 (1.28 – 2.31) 8.50 (7.25 – 9.93) 33.2 (26.3 – 55.1) 494
40–59 years 7.58 (6.57 – 8.75) 1.51 (1.15 – 2.02) 7.18 (6.03 – 8.73) 26.5 (21.7 – 35.0) 447
60 years and older 9.12 (8.02 – 10.4) 2.55 (2.13 – 2.94) 8.66 (7.89 – 9.39) 29.1 (22.3 – 38.7) 594
Males
Total, 6 years and older 8.10 (7.34 – 8.94) 1.91 (1.41 – 2.23) 7.87 (6.92 – 8.89) 30.4 (27.1 – 33.9) 1,034
6–11 years 17.0 (13.8 – 20.9) 4.06† (2.35 – 6.86) 18.4 (15.2 – 21.9) 44.2† (34.9 – 132) 99
12–19 years 9.58 (7.86 – 11.7) 2.18 (1.78 – 3.30) 9.53 (7.67 – 11.5) 32.8 (26.7 – 59.8) 191
20–39 years 7.64 (6.35 – 9.19) 1.59 (1.13 – 2.24) 7.09 (6.21 – 9.30) 28.9 (21.8 – 47.5) 217
40–59 years 6.38 (5.14 – 7.92) 1.17 (.741 – 2.01) 6.44 (4.85 – 7.62) 23.5 (17.7 – 53.0) 228
60 years and older 8.68 (7.23 – 10.4) 2.36 (1.85 – 2.71) 8.31 (6.94 – 9.56) 29.0 (21.6 – 39.1) 299
Females
Total, 6 years and older 9.84 (8.90 – 10.9) 2.32 (2.00 – 2.77) 9.24 (8.62 – 10.3) 34.0 (30.6 – 39.7) 1,072
6–11 years 14.8 (11.2 – 19.7) 4.05† (.890 – 6.10) 14.1 (11.8 – 18.0) 44.8† (36.8 – 90.7) 94
12–19 years 9.37 (7.98 – 11.0) 3.02 (2.28 – 3.55) 8.70 (7.53 – 11.0) 30.7 (21.3 – 37.5) 187
20–39 years 10.3 (8.07 – 13.1) 2.14 (1.19 – 2.98) 9.09 (8.00 – 11.7) 38.3 (29.8 – 75.9) 277
40–59 years 9.02 (7.44 – 10.9) 1.67 (1.22 – 2.59) 8.68 (6.70 – 12.1) 31.7 (21.7 – 44.0) 219
60 years and older 9.49 (7.84 – 11.5) 2.84 (2.12 – 3.20) 8.89 (8.06 – 10.1) 29.4 (21.0 – 49.8) 295
† Estimate is subject to greater uncertainty due to small cell size.  
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Table 4.6.b. Urinary equol (creatinine corrected): Concentrations by survey cycle
Geometric mean and selected percentiles of urine concentrations (in µg/g creatinine) for the U.S. population, 
National Health and Nutrition Examination Survey, 1999–2006. 
Geometric mean 
 (95% conf. interval)
Selected percentiles (95% conf. interval) Sample 
size5th 50th 95th
Total, 6 years and older
 1999–2000 7.70 (6.82 – 8.70) <LOD 7.96 (6.93 – 9.34) 50.0 (43.2 – 67.5) 2,182
 2001–2002 8.60 (7.26 – 10.2) <LOD 7.98 (6.64 – 9.71) 62.5 (52.1 – 87.0) 2,794
 2003–2004 7.52 (6.83 – 8.29) 1.01 (.861 – 1.18) 7.29 (6.56 – 8.18) 50.1 (39.9 – 75.5) 2,590
 2005–2006 8.18 (7.33 – 9.14) 1.08 (.861 – 1.31) 7.92 (7.01 – 8.75) 67.5 (48.6 – 104) 2,527
Age group
6–11 years
 1999–2000 10.3 (7.82 – 13.5) <LOD 11.3 (7.61 – 16.0) 46.6 (33.5 – 151) 272
 2001–2002 13.9 (11.2 – 17.2) <LOD 14.0 (10.6 – 17.0) 80.8 (59.5 – 211) 396
 2003–2004 13.2 (10.9 – 15.9) 2.59 (1.57 – 3.11) 12.9 (9.20 – 17.4) 93.4 (49.7 – 134) 341
 2005–2006 14.7 (12.6 – 17.1) 2.41 (1.21 – 3.27) 15.3 (13.7 – 17.4) 87.6 (57.6 – 267) 351
12–19 years
 1999–2000 7.61 (6.17 – 9.39) <LOD 7.94 (6.84 – 9.24) 47.2 (28.6 – 243) 657
 2001–2002 7.83 (6.68 – 9.17) <LOD 7.76 (6.30 – 9.13) 52.6 (36.0 – 160) 744
 2003–2004 7.90 (6.59 – 9.49) 1.41 (.856 – 1.87) 8.11 (6.82 – 9.03) 40.4 (32.8 – 100) 729
 2005–2006 8.61 (7.53 – 9.83) 1.60 (1.28 – 1.87) 8.03 (7.15 – 9.27) 60.5 (37.4 – 141) 693
20–39 years
 1999–2000 6.20 (5.22 – 7.38) <LOD 6.32 (5.37 – 7.59) 34.1 (30.5 – 50.5) 439
 2001–2002 7.56 (6.16 – 9.27) <LOD 6.83 (5.60 – 8.78) 53.5 (39.0 – 126) 604
 2003–2004 7.42 (6.36 – 8.66) .902 (.750 – 1.26) 6.88 (5.90 – 7.89) 104 (37.2 – 238) 554
 2005–2006 6.90 (5.76 – 8.27) .887 (.644 – 1.06) 7.09 (5.80 – 8.37) 47.2 (32.9 – 171) 583
40–59 years
 1999–2000 7.84 (6.30 – 9.76) <LOD 8.06 (6.05 – 9.76) 69.0 (41.9 – 1,680) 378
 2001–2002 8.86 (7.19 – 10.9) <LOD 7.83 (6.18 – 9.71) 81.9 (55.3 – 138) 531
 2003–2004 6.40 (5.47 – 7.49) .777 (.615 – 1.05) 6.54 (5.03 – 7.69) 38.1 (24.2 – 534) 448
 2005–2006 7.51 (6.01 – 9.39) .895 (.343 – 1.34) 6.61 (5.24 – 8.53) 108 (35.1 – 734) 449
60 years and older
 1999–2000 9.72 (8.33 – 11.3) <LOD 9.63 (7.42 – 11.3) 80.7 (41.1 – 448) 436
 2001–2002 8.50 (7.02 – 10.3) <LOD 7.78 (6.48 – 10.1) 63.7 (38.1 – 161) 519
 2003–2004 7.28 (6.19 – 8.56) 1.27 (<LOD – 1.52) 7.63 (6.22 – 8.79) 33.7 (24.8 – 256) 518
 2005–2006 9.09 (7.93 – 10.4) 1.38 (1.09 – 1.82) 8.40 (7.49 – 9.42) 51.1 (34.1 – 291) 451
Gender
Males
 1999–2000 7.01 (5.93 – 8.29) <LOD 7.31 (5.71 – 8.74) 53.8 (38.9 – 88.4) 1,042
 2001–2002 7.66 (6.39 – 9.18) <LOD 7.43 (5.83 – 9.14) 53.9 (40.7 – 75.8) 1,375
 2003–2004 6.71 (6.02 – 7.47) .912 (.762 – 1.09) 6.62 (5.80 – 7.28) 51.0 (38.7 – 76.6) 1,240
 2005–2006 7.35 (6.40 – 8.43) .984 (.599 – 1.25) 7.02 (5.94 – 8.63) 57.4 (43.3 – 85.6) 1,252
Females
 1999–2000 8.41 (7.33 – 9.66) <LOD 8.71 (7.52 – 10.2) 46.2 (43.1 – 55.6) 1,140
 2001–2002 9.60 (7.99 – 11.5) <LOD 8.66 (7.02 – 10.6) 84.6 (62.4 – 118) 1,419
 2003–2004 8.38 (7.39 – 9.51) 1.15 (.893 – 1.53) 8.29 (7.08 – 9.29) 45.4 (39.0 – 103) 1,350
 2005–2006 9.07 (8.04 – 10.2) 1.24 (.885 – 1.41) 8.48 (7.90 – 9.19) 83.5 (53.4 – 165) 1,275
Race/ethnicity
Mexican Americans
 1999–2000 4.89 (4.36 – 5.47) <LOD 4.73 (3.90 – 5.23) 37.0 (26.7 – 62.3) 726
 2001–2002 6.79 (5.82 – 7.92) <LOD 6.81 (5.66 – 8.02) 41.2 (34.5 – 54.2) 679
 2003–2004 5.48 (4.60 – 6.54) .932 (.609 – 1.17) 4.69 (4.02 – 5.77) 35.5 (29.2 – 113) 653
 2005–2006 5.45 (4.84 – 6.14) .738 (.548 – 1.02) 4.98 (4.38 – 5.85) 39.4 (31.9 – 81.2) 634
Non-Hispanic Blacks
 1999–2000 4.31 (3.36 – 5.52) <LOD 4.54 (2.90 – 6.22) 25.8 (20.3 – 33.3) 504
 2001–2002 4.96 (4.19 – 5.86) <LOD 4.37 (3.70 – 5.41) 35.2 (25.4 – 47.4) 692
 2003–2004 5.17 (4.38 – 6.10) .759 (.484 – .958) 5.18 (4.67 – 5.97) 29.7 (24.9 – 51.5) 678
 2005–2006 4.88 (4.11 – 5.78) .769 (.595 – 1.02) 4.72 (3.58 – 5.98) 31.0 (25.4 – 53.3) 662
Non-Hispanic Whites
 1999–2000 9.31 (8.01 – 10.8) <LOD 9.57 (7.91 – 11.2) 56.2 (46.6 – 73.0) 744
 2001–2002 9.77 (7.86 – 12.1) <LOD 9.14 (7.06 – 12.1) 65.9 (56.8 – 85.0) 1,211
 2003–2004 8.39 (7.46 – 9.43) 1.11 (.914 – 1.35) 8.17 (7.13 – 9.23) 56.0 (38.7 – 116) 1,068
 2005–2006 9.51 (8.48 – 10.7) 1.31 (1.03 – 1.68) 9.15 (8.06 – 10.5) 77.4 (48.6 – 146) 1,038
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Figure 4.6.b. Urinary equol (creatinine corrected): 
Concentrations by survey cycle 
Selected percentiles in μg/g creatinine (95% confidence intervals), National Health and 
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Total 3−5y 6−11y 12−19y 20+y Males Females MA NHB NHW 
(6+y) 
Values in the graph are suppressed if either the point estimate or the lower 95% confidence limit is noted as “< LOD” in the accompanying table. 
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 Non−Hispanic Blacks Non−Hispanic Whites 
Figure 4.7.a. Urinary O−desmethylangolensin: Concentrations by age group 
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Table 4.7.a.2. Urinary O-desmethylangolensin: Total population
Geometric mean and selected percentiles of urine concentrations (in µg/L) for the total U.S. population aged 6 
years and older, National Health and Nutrition Examination Survey, 2003–2006. 
Geometric mean 
 (95% conf. interval)
Selected percentiles (95% conf. interval) Sample 
size10th 50th 90th
Males and Females
Total, 6 years and older 4.80 (4.42 – 5.22) .243 (.210 – .276) 4.09 (3.67 – 4.53) 97.6 (88.0 – 115) 5,109
6–11 years 6.74 (5.30 – 8.59) .472 (.297 – .655) 6.17 (4.56 – 8.88) 107 (74.1 – 159) 692
12–19 years 7.35 (6.18 – 8.74) .397 (.300 – .479) 6.38 (5.25 – 8.33) 108 (89.5 – 171) 1,422
20–39 years 4.13 (3.52 – 4.86) .228 (< LOD – .276) 3.32 (2.79 – 3.90) 86.5 (65.6 – 136) 1,129
40–59 years 4.42 (3.81 – 5.13) < LOD 3.88 (2.93 – 5.02) 114 (71.0 – 181) 899
60 years and older 4.42 (3.69 – 5.30) .237 (< LOD – .293) 3.71 (2.97 – 4.90) 84.9 (60.5 – 116) 967
Males
Total, 6 years and older 4.92 (4.29 – 5.63) .280 (.231 – .328) 4.21 (3.60 – 5.20) 91.2 (73.4 – 117) 2,492
6–11 years 6.83 (4.77 – 9.78) .501 (.234 – .705) 5.60 (3.59 – 9.19) 117 (69.6 – 238) 340
12–19 years 9.13 (7.17 – 11.6) .433 (.341 – .546) 8.73 (6.49 – 11.5) 127 (102 – 253) 728
20–39 years 4.38 (3.41 – 5.61) .213 (< LOD – .299) 3.63 (3.06 – 4.49) 89.8 (63.3 – 175) 498
40–59 years 4.04 (3.27 – 4.99) .278 (.207 – .339) 3.34 (2.48 – 4.96) 69.6 (52.0 – 138) 451
60 years and older 4.39 (3.39 – 5.69) .261 (< LOD – .363) 4.05 (3.01 – 5.43) 75.8 (54.6 – 103) 475
Females
Total, 6 years and older 4.70 (4.26 – 5.18) .213 (< LOD – .258) 3.92 (3.35 – 4.56) 105 (80.6 – 151) 2,617
6–11 years 6.65 (5.16 – 8.58) .392 (.252 – .653) 6.91 (4.76 – 9.15) 100 (60.7 – 158) 352
12–19 years 5.83 (4.79 – 7.10) .324 (.220 – .480) 4.28 (3.15 – 5.79) 92.9 (71.4 – 104) 694
20–39 years 3.91 (3.12 – 4.89) .244 (< LOD – .300) 2.83 (2.02 – 3.94) 80.6 (58.4 – 155) 631
40–59 years 4.82 (3.87 – 6.01) < LOD 4.46 (3.00 – 6.43) 181 (99.3 – 275) 448
60 years and older 4.45 (3.52 – 5.62) .224 (< LOD – .279) 3.45 (2.71 – 5.36) 88.7 (59.8 – 153) 492
< LOD means less than the limit of detection, which may vary for some compounds by year. See Appendix D for LOD.  
Table 4.7.a.3. Urinary O-desmethylangolensin: Mexican Americans
Geometric mean and selected percentiles of urine concentrations (in µg/L) for Mexican Americans in the U.S. 
population aged 6 years and older, National Health and Nutrition Examination Survey, 2003–2006. 
Geometric mean 
 (95% conf. interval)
Selected percentiles (95% conf. interval) Sample 
size10th 50th 90th
Males and Females
Total, 6 years and older 2.79 (2.29 – 3.39) < LOD 1.93 (1.34 – 2.62) 62.4 (50.0 – 89.5) 1,286
6–11 years 6.57 (4.75 – 9.07) .446 (.306 – .603) 6.92 (3.88 – 11.0) 103 (58.3 – 189) 231
12–19 years 6.38 (4.66 – 8.73) .324 (.213 – .396) 5.77 (4.16 – 8.32) 134 (87.6 – 271) 445
20–39 years 1.92 (1.45 – 2.53) < LOD 1.06 (.693 – 1.53) 58.2 (24.5 – 110) 281
40–59 years 1.91 (1.41 – 2.59) < LOD 1.21 (.806 – 2.20) 31.7 (21.3 – 70.6) 157
60 years and older 2.15 (1.43 – 3.23) < LOD 1.47 (.853 – 2.99) 27.9 (17.2 – 50.3) 172
Males
Total, 6 years and older 2.83 (2.20 – 3.65) < LOD 1.92 (1.23 – 2.79) 61.5 (47.3 – 89.9) 625
6–11 years 7.12 (4.64 – 10.9) .506 (.307 – .700) 7.04 (2.90 – 15.9) 115 (61.2 – 275) 112
12–19 years 6.77 (4.40 – 10.4) .365 (.241 – .462) 6.56 (3.54 – 11.1) 122 (55.4 – 286) 228
20–39 years 1.71 (1.16 – 2.51) < LOD .783 (.607 – 1.47) 39.2 (18.1 – 121) 117
40–59 years 2.46 (1.55 – 3.91) < LOD† 1.80 (.755 – 3.23) 48.1† (21.9 – 342) 85
60 years and older 2.19 (1.09 – 4.41) < LOD† 1.39 (.695 – 5.52) 21.6† (14.0 – 607) 83
Females
Total, 6 years and older 2.74 (2.17 – 3.45) < LOD 1.97 (1.27 – 2.85) 64.9 (39.2 – 111) 661
6–11 years 6.03 (4.19 – 8.68) .378 (.290 – .531) 6.65 (3.89 – 10.5) 81.9 (32.7 – 296) 119
12–19 years 5.99 (4.33 – 8.29) .302 (< LOD – .381) 4.71 (3.81 – 7.61) 176 (93.4 – 325) 217
20–39 years 2.20 (1.33 – 3.63) < LOD 1.31 (.772 – 2.43) 63.7 (19.3 – 235) 164
40–59 years 1.45 (.886 – 2.38) < LOD† 1.06 (.513 – 1.97) 20.7† (10.1 – 73.1) 72
60 years and older 2.12 (1.13 – 3.98) < LOD† 1.45 (.808 – 4.19) 38.7† (11.3 – 1,390) 89
< LOD means less than the limit of detection, which may vary for some compounds by year. See Appendix D for LOD. 
† Estimate is subject to greater uncertainty due to small cell size. 
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Table 4.7.a.4. Urinary O-desmethylangolensin: Non-Hispanic blacks
Geometric mean and selected percentiles of urine concentrations (in µg/L) for non-Hispanic blacks in the U.S. 
population aged 6 years and older, National Health and Nutrition Examination Survey, 2003–2006. 
Geometric mean 
 (95% conf. interval)
Selected percentiles (95% conf. interval) Sample 
size10th 50th 90th
Males and Females
Total, 6 years and older 5.69 (4.70 – 6.90) .267 (.210 – .342) 4.56 (3.88 – 5.72) 113 (89.0 – 157) 1,342
6–11 years 10.6 (7.76 – 14.4) .639 (.244 – 1.24) 11.1 (7.91 – 16.4) 164 (106 – 338) 207
12–19 years 9.85 (8.13 – 11.9) .565 (.391 – .896) 10.2 (7.23 – 15.0) 121 (100 – 172) 496
20–39 years 4.31 (3.05 – 6.07) < LOD 3.25 (2.16 – 4.64) 90.8 (51.6 – 170) 249
40–59 years 5.54 (4.02 – 7.64) .265 (< LOD – .380) 4.61 (2.91 – 7.10) 124 (80.1 – 220) 231
60 years and older 3.60 (2.02 – 6.39) .215 (< LOD – .279) 2.57 (1.49 – 4.67) 82.6 (47.3 – 341) 159
Males
Total, 6 years and older 6.62 (5.17 – 8.47) .297 (.206 – .458) 5.48 (4.13 – 8.91) 114 (90.2 – 168) 660
6–11 years 11.9 (7.59 – 18.6) .854† (.360 – 1.53) 10.8 (5.47 – 20.0) 182† (106 – 764) 99
12–19 years 11.4 (8.83 – 14.7) .580 (.376 – .969) 12.7 (7.98 – 17.0) 145 (111 – 241) 258
20–39 years 6.79 (3.90 – 11.8) .226 (< LOD – .614) 4.57 (2.91 – 12.9) 122 (82.3 – 400) 116
40–59 years 4.89 (3.12 – 7.67) .244 (< LOD – .474) 4.83 (2.15 – 9.22) 69.3 (46.5 – 216) 114
60 years and older 2.91 (1.60 – 5.30) .212† (< LOD – .298) 2.70 (1.05 – 4.21) 48.7† (20.0 – 868) 73
Females
Total, 6 years and older 5.01 (3.87 – 6.50) .246 (< LOD – .334) 4.09 (2.94 – 5.38) 112 (82.0 – 160) 682
6–11 years 9.36 (6.05 – 14.5) .364† (< LOD – 1.11) 11.9 (7.46 – 16.4) 121† (56.0 – 502) 108
12–19 years 8.51 (6.68 – 10.8) .551 (.259 – .963) 7.87 (5.52 – 14.0) 98.0 (77.3 – 143) 238
20–39 years 2.98 (1.78 – 5.01) < LOD 2.17 (1.14 – 4.46) 49.2 (27.2 – 160) 133
40–59 years 6.15 (3.81 – 9.90) .280 (.207 – .388) 4.44 (2.60 – 8.52) 203 (106 – 486) 117
60 years and older 4.11 (1.92 – 8.80) .217† (< LOD – .363) 2.45 (1.37 – 8.03) 91.7† (67.0 – 322) 86
< LOD means less than the limit of detection, which may vary for some compounds by year. See Appendix D for LOD. 
† Estimate is subject to greater uncertainty due to small cell size. 
Table 4.7.a.5. Urinary O-desmethylangolensin: Non-Hispanic whites
Geometric mean and selected percentiles of urine concentrations (in µg/L) for non-Hispanic whites in the U.S. 
population aged 6 years and older, National Health and Nutrition Examination Survey, 2003–2006. 
Geometric mean 
 (95% conf. interval)
Selected percentiles (95% conf. interval) Sample 
size10th 50th 90th
Males and Females
Total, 6 years and older 4.99 (4.55 – 5.46) .247 (.201 – .293) 4.35 (3.90 – 5.12) 97.9 (86.2 – 123) 2,100
6–11 years 6.20 (4.18 – 9.18) .443 (< LOD – .679) 5.49 (3.39 – 9.17) 95.4 (60.4 – 203) 193
12–19 years 7.55 (5.92 – 9.63) .401 (.259 – .571) 6.85 (5.13 – 9.64) 103 (85.0 – 205) 378
20–39 years 4.64 (3.67 – 5.85) .264 (< LOD – .331) 3.71 (2.94 – 5.33) 104 (65.2 – 161) 488
40–59 years 4.54 (3.75 – 5.51) < LOD 4.14 (2.91 – 5.62) 121 (67.5 – 185) 447
60 years and older 4.67 (3.89 – 5.60) .248 (< LOD – .320) 4.09 (3.25 – 5.34) 84.4 (57.6 – 117) 594
Males
Total, 6 years and older 4.88 (4.11 – 5.80) .290 (.217 – .350) 4.21 (3.40 – 5.41) 88.8 (67.8 – 120) 1,034
6–11 years 5.78 (3.26 – 10.3) .445† (< LOD – .719) 4.99 (1.97 – 10.4) 88.6† (40.8 – 580) 99
12–19 years 9.72 (7.00 – 13.5) .429 (.295 – .611) 9.13 (6.14 – 13.6) 125 (88.5 – 365) 191
20–39 years 4.46 (3.13 – 6.36) .236 (< LOD – .365) 3.56 (2.79 – 5.63) 78.4 (48.1 – 189) 217
40–59 years 4.09 (3.19 – 5.24) .294 (.201 – .354) 3.02 (2.28 – 5.24) 70.4 (51.0 – 170) 229
60 years and older 4.58 (3.35 – 6.27) .266 (< LOD – .384) 4.17 (3.21 – 6.29) 72.6 (50.6 – 103) 298
Females
Total, 6 years and older 5.09 (4.45 – 5.82) .209 (< LOD – .277) 4.53 (3.79 – 5.58) 112 (74.9 – 175) 1,066
6–11 years 6.72 (4.42 – 10.2) .438† (< LOD – .745) 6.05 (3.68 – 12.2) 105† (48.1 – 310) 94
12–19 years 5.73 (4.21 – 7.80) .299 (< LOD – .615) 3.99 (2.90 – 8.09) 88.8 (61.2 – 170) 187
20–39 years 4.83 (3.50 – 6.66) .295 (.221 – .349) 3.90 (2.73 – 6.07) 114 (58.4 – 303) 271
40–59 years 5.06 (3.68 – 6.95) < LOD 5.51 (2.99 – 7.16) 181 (67.3 – 333) 218
60 years and older 4.74 (3.78 – 5.94) .237 (< LOD – .311) 3.90 (2.86 – 6.17) 85.9 (53.0 – 168) 296
< LOD means less than the limit of detection, which may vary for some compounds by year. See Appendix D for LOD. 
† Estimate is subject to greater uncertainty due to small cell size. 
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Table 4.7.b. Urinary O-desmethylangolensin: Concentrations by survey cycle
Geometric mean and selected percentiles of urine concentrations (in µg/L) for the U.S. population, National 
Health and Nutrition Examination Survey, 1999–2006. 
Geometric mean 
 (95% conf. interval)
Selected percentiles (95% conf. interval) Sample 
size5th 50th 95th
Total, 6 years and older
 1999–2000 4.39 (3.37 – 5.73) < LOD 4.97 (3.67 – 6.74) 218 (186 – 247) 2,271
 2001–2002 4.08 (3.53 – 4.73) < LOD 3.30 (2.64 – 4.11) 260 (177 – 492) 2,794
 2003–2004 4.91 (4.34 – 5.55) < LOD 4.55 (3.99 – 5.16) 229 (186 – 364) 2,581
 2005–2006 4.70 (4.17 – 5.31) < LOD 3.70 (3.14 – 4.25) 264 (213 – 386) 2,528
Age group
6–11 years
 1999–2000 5.60 (3.85 – 8.15) < LOD 7.48 (3.42 – 15.1) 175 (79.4 – 273) 287
 2001–2002 6.19 (4.51 – 8.49) < LOD 5.85 (3.88 – 9.42) 278 (177 – 522) 396
 2003–2004 6.32 (4.30 – 9.30) .319 (< LOD – .590) 6.07 (3.48 – 10.5) 137 (92.3 – 283) 341
 2005–2006 7.20 (5.20 – 9.96) < LOD 6.16 (3.98 – 10.9) 356 (207 – 506) 351
12–19 years
 1999–2000 6.04 (3.76 – 9.70) < LOD 7.58 (5.18 – 13.2) 194 (136 – 301) 667
 2001–2002 5.92 (4.46 – 7.86) < LOD 5.19 (3.72 – 7.59) 298 (179 – 435) 744
 2003–2004 6.36 (4.95 – 8.18) < LOD 5.27 (3.89 – 8.00) 256 (179 – 416) 729
 2005–2006 8.50 (6.48 – 11.2) .244 (< LOD – .337) 8.06 (5.57 – 11.6) 380 (168 – 869) 693
20–39 years
 1999–2000 4.00 (2.73 – 5.86) < LOD 4.44 (2.77 – 5.87) 306 (252 – 462) 481
 2001–2002 3.36 (2.61 – 4.34) < LOD 2.48 (1.80 – 3.00) 248 (128 – 680) 604
 2003–2004 4.25 (3.24 – 5.58) < LOD 3.65 (2.74 – 4.89) 317 (154 – 483) 546
 2005–2006 4.03 (3.29 – 4.93) < LOD 3.00 (2.17 – 3.78) 235 (154 – 336) 583
40–59 years
 1999–2000 4.20 (3.13 – 5.62) < LOD 4.24 (2.78 – 6.11) 171 (119 – 304) 365
 2001–2002 5.07 (3.45 – 7.46) < LOD 4.39 (2.61 – 7.20) 381 (206 – 1,000) 531
 2003–2004 5.13 (4.34 – 6.07) < LOD 5.13 (3.52 – 6.44) 222 (180 – 753) 450
 2005–2006 3.84 (2.97 – 4.97) < LOD 2.92 (1.72 – 4.29) 274 (214 – 587) 449
60 years and older
 1999–2000 3.93 (2.75 – 5.62) < LOD 4.80 (3.04 – 8.37) 111 (74.5 – 185) 471
 2001–2002 2.32 (1.83 – 2.94) < LOD 1.73 (1.16 – 2.30) 98.3 (70.6 – 464) 519
 2003–2004 4.17 (3.09 – 5.63) < LOD 3.69 (2.71 – 5.88) 203 (129 – 394) 515
 2005–2006 4.68 (3.70 – 5.91) < LOD 3.76 (2.74 – 5.45) 171 (92.6 – 486) 452
Gender
Males
 1999–2000 4.97 (3.71 – 6.66) < LOD 5.62 (4.23 – 8.78) 234 (180 – 332) 1,087
 2001–2002 3.81 (3.08 – 4.71) < LOD 3.29 (2.52 – 4.38) 194 (134 – 356) 1,375
 2003–2004 4.90 (3.93 – 6.12) < LOD 4.53 (3.32 – 5.49) 221 (163 – 359) 1,240
 2005–2006 4.93 (4.13 – 5.89) < LOD 3.99 (3.34 – 5.43) 234 (178 – 341) 1,252
Females
 1999–2000 3.92 (2.97 – 5.16) < LOD 4.22 (3.24 – 5.48) 191 (149 – 245) 1,184
 2001–2002 4.36 (3.64 – 5.23) < LOD 3.34 (2.47 – 4.50) 377 (232 – 750) 1,419
 2003–2004 4.91 (4.26 – 5.66) < LOD 4.59 (3.91 – 5.51) 277 (168 – 450) 1,341
 2005–2006 4.50 (3.90 – 5.20) < LOD 3.29 (2.71 – 4.24) 283 (199 – 499) 1,276
Race/ethnicity
Mexican Americans
 1999–2000 2.40 (1.55 – 3.73) < LOD 2.14 (1.40 – 3.43) 191 (128 – 323) 721
 2001–2002 2.44 (1.51 – 3.94) < LOD 1.38 (.501 – 3.33) 151 (80.1 – 498) 679
 2003–2004 2.54 (1.86 – 3.48) < LOD 1.85 (.928 – 3.30) 141 (105 – 272) 652
 2005–2006 3.04 (2.29 – 4.05) < LOD 2.00 (1.36 – 2.84) 151 (95.3 – 271) 634
Non-Hispanic Blacks
 1999–2000 5.75 (4.60 – 7.20) < LOD 8.78 (5.90 – 10.9) 184 (138 – 320) 527
 2001–2002 5.38 (4.01 – 7.21) < LOD 5.19 (3.04 – 7.31) 308 (193 – 430) 692
 2003–2004 5.55 (4.07 – 7.57) < LOD 4.21 (3.25 – 6.49) 219 (182 – 375) 680
 2005–2006 5.83 (4.49 – 7.58) < LOD 4.84 (3.94 – 6.45) 292 (173 – 471) 662
Non-Hispanic Whites
 1999–2000 4.53 (3.23 – 6.37) < LOD 4.98 (3.38 – 7.14) 225 (189 – 255) 810
 2001–2002 4.13 (3.44 – 4.96) < LOD 3.35 (2.61 – 4.32) 261 (178 – 546) 1,211
 2003–2004 5.28 (4.65 – 5.99) < LOD 5.23 (4.53 – 5.78) 242 (186 – 407) 1,061
 2005–2006 4.72 (4.09 – 5.45) < LOD 3.72 (3.21 – 4.59) 246 (184 – 391) 1,039
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Values in the graph are suppressed if either the point estimate or the lower 95% confidence limit is noted as “< LOD” in the accompanying table. 
Figure 4.7.b. Urinary O−desmethylangolensin: Concentrations by survey cycle 
Selected percentiles in μg/L (95% confidence intervals), National Health and 

Nutrition Examination Survey, 1999–2006
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Figure 4.8.a. Urinary O−desmethylangolensin (creatinine corrected): 
Concentrations by age group 
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Table 4.8.a.2. Urinary O-desmethylangolensin (creatinine corrected): 
Total population
Geometric mean and selected percentiles of urine concentrations (in µg/g creatinine) for the total U.S. 
population aged 6 years and older, National Health and Nutrition Examination Survey, 2003–2006. 
Geometric mean 
 (95% conf. interval)
Selected percentiles (95% conf. interval) Sample 
size10th 50th 90th
Males and Females
Total, 6 years and older 4.58 (4.25 – 4.94) .312 (.289 – .338) 3.89 (3.51 – 4.33) 93.2 (81.6 – 109) 5,109
6–11 years 7.31 (5.72 – 9.33) .587 (.389 – .800) 6.11 (4.49 – 8.22) 109 (84.7 – 165) 692
12–19 years 5.47 (4.64 – 6.46) .320 (.289 – .402) 4.67 (3.74 – 6.52) 86.1 (61.4 – 129) 1,422
20–39 years 3.51 (3.05 – 4.04) .248 (< LOD – .299) 3.10 (2.38 – 3.74) 78.0 (63.1 – 97.3) 1,129
40–59 years 4.48 (3.89 – 5.16) < LOD 3.51 (2.96 – 4.33) 138 (76.1 – 190) 899
60 years and older 5.18 (4.38 – 6.13) .384 (< LOD – .472) 4.37 (3.42 – 5.80) 79.2 (65.8 – 119) 967
Males
Total, 6 years and older 3.90 (3.42 – 4.44) .281 (.233 – .323) 3.41 (2.81 – 4.09) 73.1 (58.7 – 85.3) 2,492
6–11 years 6.85 (4.87 – 9.63) .496 (.308 – .801) 5.45 (3.39 – 8.21) 126 (81.4 – 215) 340
12–19 years 6.19 (4.90 – 7.82) .315 (.219 – .487) 6.40 (4.16 – 8.62) 94.4 (61.8 – 169) 728
20–39 years 3.19 (2.53 – 4.03) .196 (< LOD – .283) 2.68 (2.00 – 4.15) 67.3 (46.0 – 93.6) 498
40–59 years 3.20 (2.57 – 3.99) .251 (.200 – .312) 2.76 (2.03 – 3.84) 51.5 (37.2 – 94.2) 451
60 years and older 4.03 (3.22 – 5.05) .341 (< LOD – .424) 3.75 (2.54 – 5.01) 64.8 (40.6 – 107) 475
Females
Total, 6 years and older 5.35 (4.85 – 5.91) .342 (< LOD – .385) 4.40 (3.76 – 5.25) 131 (95.9 – 158) 2,617
6–11 years 7.83 (6.01 – 10.2) .682 (.379 – .857) 7.16 (5.34 – 9.21) 100 (77.5 – 164) 352
12–19 years 4.80 (4.03 – 5.72) .321 (.278 – .392) 4.02 (3.17 – 4.75) 74.9 (54.2 – 120) 694
20–39 years 3.86 (3.08 – 4.83) .301 (< LOD – .337) 3.44 (2.23 – 4.59) 86.8 (63.3 – 139) 631
40–59 years 6.16 (5.10 – 7.43) < LOD 5.00 (3.20 – 6.49) 192 (152 – 316) 448
60 years and older 6.31 (4.96 – 8.01) .426 (< LOD – .643) 5.49 (3.84 – 7.18) 102 (74.4 – 155) 492
< LOD means less than the limit of detection for the uncorrected urine values, which may vary for some compounds by year. See Appendix D for LOD.  
Table 4.8.a.3. Urinary O-desmethylangolensin (creatinine corrected): 
Mexican Americans
Geometric mean and selected percentiles of urine concentrations (in µg/g creatinine) for Mexican Americans in 
the U.S. population aged 6 years and older, National Health and Nutrition Examination Survey, 2003–2006. 
Geometric mean 
 (95% conf. interval)
Selected percentiles (95% conf. interval) Sample 
size10th 50th 90th
Males and Females
Total, 6 years and older 2.51 (2.01 – 3.14) < LOD 1.68 (1.09 – 2.45) 52.7 (39.7 – 74.3) 1,286
6–11 years 8.24 (6.07 – 11.2) .539 (.345 – .845) 7.19 (4.88 – 12.9) 102 (73.3 – 160) 231
12–19 years 4.93 (3.63 – 6.69) .295 (.240 – .365) 4.46 (3.00 – 6.97) 103 (59.6 – 155) 445
20–39 years 1.55 (1.12 – 2.14) < LOD .843 (.692 – 1.16) 33.8 (17.5 – 80.4) 281
40–59 years 1.75 (1.28 – 2.40) < LOD 1.01 (.818 – 2.03) 27.3 (22.5 – 52.6) 157
60 years and older 2.66 (1.82 – 3.88) < LOD 1.95 (1.08 – 3.72) 35.9 (25.1 – 63.6) 172
Males
Total, 6 years and older 2.24 (1.69 – 2.96) < LOD 1.33 (.935 – 2.07) 45.9 (34.6 – 74.9) 625
6–11 years 8.54 (5.71 – 12.8) .532 (.307 – 1.03) 7.44 (4.18 – 16.7) 110 (72.7 – 274) 112
12–19 years 4.90 (3.18 – 7.55) .292 (.208 – .428) 4.55 (2.36 – 10.5) 103 (43.8 – 146) 228
20–39 years 1.24 (.818 – 1.88) < LOD .732 (.591 – .930) 28.8 (13.4 – 95.5) 117
40–59 years 1.81 (1.17 – 2.79) < LOD† .997 (.601 – 3.02) 36.6† (16.9 – 156) 85
60 years and older 1.96 (1.00 – 3.82) < LOD† 1.44 (.646 – 3.16) 20.4† (12.1 – 159) 83
Females
Total, 6 years and older 2.86 (2.22 – 3.68) < LOD 2.16 (1.36 – 3.15) 59.6 (41.4 – 96.0) 661
6–11 years 7.94 (5.56 – 11.4) .527 (.268 – .811) 6.00 (4.39 – 12.1) 93.0 (62.8 – 156) 119
12–19 years 4.95 (3.71 – 6.60) .295 (< LOD – .342) 4.20 (2.93 – 6.89) 100 (72.2 – 243) 217
20–39 years 2.01 (1.21 – 3.35) < LOD 1.01 (.703 – 2.25) 40.5 (13.8 – 203) 164
40–59 years 1.69 (1.02 – 2.80) < LOD† 1.01 (.870 – 2.39) 27.1† (16.3 – 66.5) 72
60 years and older 3.41 (1.90 – 6.13) < LOD† 2.79 (1.08 – 7.40) 45.9† (23.0 – 803) 89
< LOD means less than the limit of detection for the uncorrected urine values, which may vary for some compounds by year. See Appendix D for LOD. 
† Estimate is subject to greater uncertainty due to small cell size. 
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Table 4.8.a.4. Urinary O-desmethylangolensin (creatinine corrected): 
Non-Hispanic blacks
Geometric mean and selected percentiles of urine concentrations (in µg/g creatinine) for non-Hispanic blacks 
in the U.S. population aged 6 years and older, National Health and Nutrition Examination Survey, 2003–2006. 
Geometric mean 
 (95% conf. interval)
Selected percentiles (95% conf. interval) Sample 
size10th 50th 90th
Males and Females
Total, 6 years and older 4.00 (3.35 – 4.77) .249 (.208 – .295) 3.47 (2.48 – 4.61) 75.6 (60.8 – 97.4) 1,342
6–11 years 9.91 (7.22 – 13.6) .701 (.469 – .983) 10.1 (7.06 – 15.0) 160 (85.0 – 249) 207
12–19 years 5.66 (4.68 – 6.84) .336 (.262 – .519) 6.00 (4.57 – 8.05) 72.7 (53.8 – 100) 496
20–39 years 2.67 (1.93 – 3.69) < LOD 1.99 (1.21 – 3.33) 45.7 (34.3 – 82.1) 249
40–59 years 4.03 (3.01 – 5.39) .241 (< LOD – .319) 3.60 (1.85 – 6.21) 77.7 (58.0 – 133) 231
60 years and older 3.20 (1.86 – 5.51) .194 (< LOD – .342) 2.34 (1.45 – 4.24) 73.0 (30.4 – 296) 159
Males
Total, 6 years and older 3.86 (3.06 – 4.88) .233 (.157 – .322) 3.81 (2.31 – 4.93) 69.7 (52.6 – 92.1) 660
6–11 years 11.2 (7.16 – 17.6) .797† (.574 – 1.50) 10.7 (5.44 – 15.8) 173† (85.5 – 476) 99
12–19 years 6.09 (4.69 – 7.91) .324 (.199 – .529) 6.53 (4.50 – 9.81) 81.0 (52.5 – 137) 258
20–39 years 3.26 (1.91 – 5.56) .157 (< LOD – .342) 2.38 (1.20 – 6.28) 62.5 (41.0 – 133) 116
40–59 years 2.80 (1.83 – 4.28) .194 (< LOD – .310) 2.10 (1.14 – 5.38) 46.0 (20.8 – 121) 114
60 years and older 2.12 (1.13 – 3.98) .146† (< LOD – .217) 1.87 (.716 – 3.04) 28.2† (12.9 – 664) 73
Females
Total, 6 years and older 4.11 (3.19 – 5.30) .265 (< LOD – .330) 3.28 (2.29 – 5.29) 78.9 (62.4 – 126) 682
6–11 years 8.73 (5.75 – 13.3) .509† (< LOD – 1.10) 9.53 (5.79 – 15.3) 145† (55.0 – 522) 108
12–19 years 5.25 (4.09 – 6.74) .338 (.222 – .575) 5.33 (3.56 – 8.34) 56.7 (46.9 – 78.1) 238
20–39 years 2.27 (1.36 – 3.79) < LOD 1.83 (.829 – 4.09) 34.9 (21.9 – 122) 133
40–59 years 5.45 (3.42 – 8.68) .276 (.197 – .411) 4.28 (1.91 – 7.76) 148 (74.5 – 835) 117
60 years and older 4.15 (2.06 – 8.34) .334† (< LOD – .461) 2.59 (1.22 – 6.75) 88.1† (36.1 – 366) 86
< LOD means less than the limit of detection for the uncorrected urine values, which may vary for some compounds by year. See Appendix D for LOD. 
† Estimate is subject to greater uncertainty due to small cell size. 
Table 4.8.a.5. Urinary O-desmethylangolensin (creatinine corrected): 
Non-Hispanic whites
Geometric mean and selected percentiles of urine concentrations (in µg/g creatinine) for non-Hispanic whites 
in the U.S. population aged 6 years and older, National Health and Nutrition Examination Survey, 2003–2006. 
Geometric mean 
 (95% conf. interval)
Selected percentiles (95% conf. interval) Sample 
size10th 50th 90th
Males and Females
Total, 6 years and older 5.07 (4.68 – 5.49) .347 (.312 – .382) 4.30 (3.85 – 4.69) 100 (86.1 – 136) 2,100
6–11 years 6.72 (4.52 – 9.99) .515 (< LOD – .823) 5.35 (3.55 – 8.26) 126 (75.5 – 219) 193
12–19 years 5.92 (4.64 – 7.57) .342 (.259 – .492) 4.83 (3.42 – 8.22) 91.6 (59.4 – 149) 378
20–39 years 4.25 (3.40 – 5.30) .321 (< LOD – .376) 3.90 (3.10 – 4.89) 86.6 (67.4 – 129) 488
40–59 years 4.89 (4.13 – 5.79) < LOD 3.75 (3.03 – 4.81) 160 (88.4 – 194) 447
60 years and older 5.57 (4.72 – 6.57) .417 (< LOD – .498) 4.76 (3.87 – 6.27) 78.8 (65.6 – 120) 594
Males
Total, 6 years and older 4.08 (3.45 – 4.83) .304 (.237 – .370) 3.57 (2.90 – 4.35) 73.4 (58.4 – 88.8) 1,034
6–11 years 5.60 (3.23 – 9.71) .403† (< LOD – .810) 4.09 (2.17 – 8.47) 109† (43.9 – 358) 99
12–19 years 6.94 (4.98 – 9.67) .311 (.186 – .652) 6.78 (3.52 – 13.0) 103 (58.5 – 260) 191
20–39 years 3.54 (2.51 – 5.00) .257 (< LOD – .350) 3.16 (2.22 – 4.91) 69.1 (48.0 – 95.7) 217
40–59 years 3.42 (2.66 – 4.40) .278 (.191 – .389) 2.96 (2.16 – 3.95) 55.5 (36.3 – 150) 229
60 years and older 4.27 (3.25 – 5.62) .354 (< LOD – .493) 3.86 (2.76 – 5.25) 60.7 (37.5 – 117) 298
Females
Total, 6 years and older 6.27 (5.53 – 7.11) .400 (< LOD – .428) 5.31 (4.37 – 6.35) 141 (108 – 183) 1,066
6–11 years 8.31 (5.47 – 12.6) .803† (< LOD – 1.05) 6.95 (4.34 – 11.5) 132† (75.9 – 259) 94
12–19 years 4.99 (3.73 – 6.67) .347 (< LOD – .484) 4.27 (3.11 – 5.86) 74.7 (47.4 – 131) 187
20–39 years 5.12 (3.67 – 7.15) .359 (.304 – .418) 4.61 (3.37 – 6.48) 103 (66.8 – 197) 271
40–59 years 7.01 (5.37 – 9.15) < LOD 5.48 (3.20 – 7.60) 194 (157 – 323) 218
60 years and older 6.86 (5.44 – 8.66) .484 (< LOD – .719) 5.96 (4.28 – 7.84) 104 (73.9 – 167) 296
< LOD means less than the limit of detection for the uncorrected urine values, which may vary for some compounds by year. See Appendix D for LOD. 
† Estimate is subject to greater uncertainty due to small cell size. 
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Table 4.8.b. Urinary O-desmethylangolensin (creatinine corrected): 
Concentrations by survey cycle
Geometric mean and selected percentiles of urine concentrations (in µg/g creatinine) for the U.S. population, 
National Health and Nutrition Examination Survey, 1999–2006. 
Geometric mean 
 (95% conf. interval)
Selected percentiles (95% conf. interval) Sample 
size5th 50th 95th
Total, 6 years and older
 1999–2000 4.03 (2.97 – 5.45) <LOD 4.44 (3.11 – 6.27) 165 (143 – 220) 2,271
 2001–2002 3.83 (3.32 – 4.42) <LOD 3.23 (2.56 – 4.12) 281 (157 – 433) 2,794
 2003–2004 4.58 (4.19 – 5.01) <LOD 4.09 (3.55 – 4.58) 201 (185 – 271) 2,581
 2005–2006 4.59 (4.04 – 5.21) <LOD 3.66 (3.12 – 4.41) 211 (182 – 326) 2,528
Age group
6–11 years
 1999–2000 6.00 (4.04 – 8.91) <LOD 7.13 (4.26 – 16.0) 172 (98.0 – 264) 287
 2001–2002 7.03 (5.05 – 9.77) <LOD 6.47 (4.28 – 11.4) 302 (155 – 468) 396
 2003–2004 6.73 (4.55 – 9.97) .389 (<LOD – .743) 5.92 (4.10 – 8.22) 146 (88.9 – 382) 341
 2005–2006 7.93 (5.73 – 11.0) <LOD 7.15 (3.86 – 11.3) 340 (253 – 495) 351
12–19 years
 1999–2000 4.13 (2.33 – 7.35) <LOD 5.68 (2.94 – 11.0) 117 (77.3 – 337) 667
 2001–2002 4.57 (3.44 – 6.07) <LOD 3.86 (2.87 – 5.32) 249 (134 – 331) 744
 2003–2004 4.76 (3.71 – 6.11) <LOD 4.25 (3.22 – 6.13) 182 (119 – 269) 729
 2005–2006 6.30 (4.89 – 8.13) .274 (<LOD – .304) 5.67 (3.60 – 8.37) 251 (127 – 705) 693
20–39 years
 1999–2000 3.18 (2.13 – 4.76) <LOD 3.53 (2.09 – 5.26) 226 (165 – 272) 481
 2001–2002 2.72 (2.10 – 3.51) <LOD 2.06 (1.55 – 2.97) 152 (99.5 – 442) 604
 2003–2004 3.55 (2.86 – 4.40) <LOD 2.98 (2.24 – 3.75) 214 (114 – 434) 546
 2005–2006 3.47 (2.84 – 4.25) <LOD 3.22 (2.11 – 4.37) 166 (136 – 207) 583
40–59 years
 1999–2000 4.26 (3.27 – 5.56) <LOD 3.57 (2.42 – 6.26) 156 (133 – 261) 365
 2001–2002 5.04 (3.50 – 7.26) <LOD 4.39 (2.65 – 7.23) 473 (212 – 885) 531
 2003–2004 4.93 (4.19 – 5.80) <LOD 4.29 (3.06 – 6.30) 227 (190 – 612) 450
 2005–2006 4.09 (3.19 – 5.24) <LOD 3.01 (2.16 – 4.19) 259 (189 – 800) 449
60 years and older
 1999–2000 4.66 (3.13 – 6.94) <LOD 6.37 (3.15 – 11.3) 104 (81.6 – 172) 471
 2001–2002 2.75 (2.14 – 3.52) <LOD 1.86 (1.30 – 2.79) 150 (78.7 – 449) 519
 2003–2004 4.93 (3.88 – 6.28) <LOD 4.37 (3.20 – 6.17) 239 (136 – 418) 515
 2005–2006 5.42 (4.19 – 7.02) <LOD 4.31 (2.90 – 7.08) 244 (111 – 754) 452
Gender
Males
 1999–2000 3.95 (2.79 – 5.58) <LOD 4.50 (2.96 – 6.47) 209 (130 – 265) 1,087
 2001–2002 3.10 (2.48 – 3.86) <LOD 2.87 (2.00 – 3.89) 152 (101 – 334) 1,375
 2003–2004 3.83 (3.10 – 4.73) <LOD 3.33 (2.45 – 4.35) 193 (128 – 255) 1,240
 2005–2006 3.97 (3.33 – 4.72) <LOD 3.48 (2.75 – 4.33) 165 (144 – 230) 1,252
Females
 1999–2000 4.10 (3.00 – 5.60) <LOD 4.17 (3.10 – 6.33) 155 (119 – 341) 1,184
 2001–2002 4.68 (3.87 – 5.68) <LOD 3.74 (2.78 – 4.87) 398 (199 – 741) 1,419
 2003–2004 5.45 (4.71 – 6.30) <LOD 4.81 (4.08 – 5.89) 243 (194 – 318) 1,341
 2005–2006 5.27 (4.56 – 6.09) <LOD 3.98 (3.07 – 5.49) 323 (201 – 683) 1,276
Race/ethnicity
Mexican Americans
 1999–2000 2.19 (1.49 – 3.24) <LOD 1.87 (1.16 – 3.04) 135 (96.7 – 290) 721
 2001–2002 2.30 (1.48 – 3.57) <LOD 1.45 (.769 – 3.15) 107 (59.9 – 303) 679
 2003–2004 2.30 (1.68 – 3.15) <LOD 1.65 (.847 – 3.02) 125 (89.4 – 171) 652
 2005–2006 2.75 (1.92 – 3.93) <LOD 1.68 (1.06 – 2.91) 134 (74.9 – 204) 634
Non-Hispanic Blacks
 1999–2000 3.65 (2.92 – 4.57) <LOD 5.21 (3.70 – 6.74) 117 (83.6 – 283) 527
 2001–2002 3.75 (2.75 – 5.11) <LOD 3.54 (2.13 – 5.48) 217 (102 – 371) 692
 2003–2004 3.90 (3.02 – 5.04) <LOD 3.13 (1.94 – 5.59) 146 (127 – 231) 680
 2005–2006 4.09 (3.13 – 5.34) <LOD 4.20 (2.48 – 5.69) 207 (113 – 454) 662
Non-Hispanic Whites
 1999–2000 4.48 (3.11 – 6.47) <LOD 4.72 (2.91 – 7.48) 178 (148 – 227) 810
 2001–2002 4.08 (3.41 – 4.88) <LOD 3.51 (2.46 – 4.57) 300 (158 – 505) 1,211
 2003–2004 5.18 (4.71 – 5.70) <LOD 4.58 (4.15 – 5.31) 225 (189 – 308) 1,061
 2005–2006 4.96 (4.33 – 5.69) <LOD 3.96 (3.28 – 4.67) 227 (184 – 333) 1,039



































































































































































































































Values in the graph are suppressed if either the point estimate or the lower 95% confidence limit is noted as “< LOD” in the accompanying table. 
Figure 4.8.b. Urinary O−desmethylangolensin (creatinine corrected): 
Concentrations by survey cycle 
Selected percentiles in μg/g creatinine (95% confidence intervals), National Health and 
Nutrition Examination Survey, 1999–2006
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Non−Hispanic Blacks Non−Hispanic Whites 
Figure 4.9.a. Urinary enterodiol: Concentrations by age group 








































6−11 12−19 20−39 40−59 60+ 6−11 12−19 20−39 40−59 60+ 
Females Males 







Age (years) Age (years) 
6−11 12−19 20−39 40−59 60+ 
4. Isoflavones and Lignans 415
416 2nd National Report on Biochemical Indicators of Diet and Nutrition in the U.S. Population
Table 4.9.a.2. Urinary enterodiol: Total population
Geometric mean and selected percentiles of urine concentrations (in µg/L) for the total U.S. population aged 6 
years and older, National Health and Nutrition Examination Survey, 2003–2006. 
Geometric mean 
 (95% conf. interval)
Selected percentiles (95% conf. interval) Sample 
size10th 50th 90th
Males and Females
Total, 6 years and older 38.6 (35.8 – 41.6) 5.86 (4.78 – 6.69) 43.9 (41.1 – 47.2) 243 (231 – 260) 5,122
6–11 years 37.4 (32.2 – 43.3) 8.10 (6.48 – 9.64) 40.2 (35.8 – 45.4) 150 (126 – 204) 692
12–19 years 42.0 (38.3 – 46.1) 8.12 (6.76 – 9.75) 44.2 (39.5 – 50.3) 192 (168 – 229) 1,422
20–39 years 39.2 (34.7 – 44.2) 5.37 (4.41 – 6.89) 43.7 (39.7 – 49.9) 237 (216 – 267) 1,137
40–59 years 37.2 (31.3 – 44.1) 3.96 (2.46 – 6.11) 44.8 (37.6 – 51.6) 266 (250 – 284) 901
60 years and older 38.5 (34.3 – 43.2) 5.80 (3.81 – 6.96) 44.9 (38.9 – 52.6) 256 (219 – 280) 970
Males
Total, 6 years and older 40.1 (35.9 – 44.7) 6.59 (5.15 – 7.44) 45.9 (41.2 – 49.2) 255 (228 – 269) 2,496
6–11 years 38.4 (31.1 – 47.5) 8.71 (5.91 – 13.1) 39.7 (34.8 – 47.9) 144 (119 – 267) 340
12–19 years 42.6 (37.3 – 48.7) 8.25 (6.58 – 10.2) 48.4 (38.5 – 56.4) 196 (170 – 250) 728
20–39 years 38.9 (31.6 – 47.9) 5.61 (3.56 – 7.73) 43.8 (36.7 – 50.8) 236 (202 – 293) 499
40–59 years 40.8 (32.8 – 50.7) 5.03 (2.54 – 8.69) 47.7 (38.3 – 54.0) 279 (261 – 332) 451
60 years and older 40.1 (33.1 – 48.7) 6.13 (4.41 – 7.48) 50.2 (41.1 – 56.3) 256 (210 – 307) 478
Females
Total, 6 years and older 37.2 (33.7 – 41.1) 5.09 (4.12 – 6.40) 42.3 (39.6 – 45.9) 237 (211 – 262) 2,626
6–11 years 36.3 (30.5 – 43.1) 7.66 (5.98 – 9.58) 40.7 (32.9 – 49.6) 157 (120 – 220) 352
12–19 years 41.4 (36.8 – 46.6) 8.00 (5.89 – 10.0) 41.9 (37.7 – 46.4) 181 (155 – 221) 694
20–39 years 39.4 (34.2 – 45.5) 4.90 (4.25 – 6.75) 43.7 (39.8 – 53.3) 243 (209 – 301) 638
40–59 years 34.1 (27.1 – 42.9) 3.31 (1.49 – 5.80) 41.6 (34.4 – 51.5) 244 (205 – 278) 450
60 years and older 37.3 (31.9 – 43.6) 4.59 (2.99 – 6.98) 42.3 (33.7 – 51.7) 255 (204 – 302) 492
Table 4.9.a.3. Urinary enterodiol: Mexican Americans
Geometric mean and selected percentiles of urine concentrations (in µg/L) for Mexican Americans in the U.S. 
population aged 6 years and older, National Health and Nutrition Examination Survey, 2003–2006. 
Geometric mean 
 (95% conf. interval)
Selected percentiles (95% conf. interval) Sample 
size10th 50th 90th
Males and Females
Total, 6 years and older 35.6 (31.2 – 40.5) 4.89 (4.22 – 5.85) 39.9 (35.5 – 44.6) 227 (182 – 294) 1,287
6–11 years 27.4 (21.8 – 34.5) 2.79 (1.96 – 5.28) 33.0 (24.6 – 40.2) 166 (130 – 245) 231
12–19 years 35.6 (30.9 – 41.1) 5.80 (3.99 – 8.54) 42.0 (34.8 – 48.2) 178 (141 – 203) 445
20–39 years 38.2 (29.5 – 49.6) 5.52 (3.85 – 7.09) 41.8 (31.6 – 52.4) 245 (183 – 438) 282
40–59 years 39.5 (28.6 – 54.5) 5.19 (1.73 – 11.5) 41.1 (31.9 – 53.6) 272 (192 – 385) 157
60 years and older 28.4 (22.0 – 36.8) 3.31 (1.54 – 5.74) 35.1 (22.0 – 49.2) 165 (111 – 340) 172
Males
Total, 6 years and older 34.9 (28.8 – 42.2) 4.34 (3.14 – 6.04) 43.3 (35.6 – 49.9) 206 (165 – 288) 625
6–11 years 28.1 (19.2 – 40.9) 2.97 (.785 – 7.94) 34.7 (22.8 – 48.2) 135 (92.4 – 185) 112
12–19 years 34.5 (26.5 – 45.0) 4.74 (2.34 – 9.50) 41.5 (30.3 – 52.8) 189 (126 – 266) 228
20–39 years 33.4 (22.2 – 50.1) 4.48 (.741 – 7.36) 42.6 (24.6 – 55.0) 204 (135 – 414) 117
40–59 years 42.7 (28.2 – 64.6) 4.04† (< LOD – 14.4) 51.2 (32.8 – 64.8) 256† (170 – 404) 85
60 years and older 40.6 (25.5 – 64.6) 4.67† (2.24 – 6.33) 42.7 (19.6 – 89.1) 222† (160 – 2,850) 83
Females
Total, 6 years and older 36.3 (32.0 – 41.2) 5.48 (4.68 – 6.52) 37.1 (31.4 – 42.1) 238 (185 – 325) 662
6–11 years 26.7 (20.1 – 35.4) 2.49 (1.71 – 4.92) 30.5 (20.3 – 43.1) 196 (136 – 335) 119
12–19 years 36.9 (32.0 – 42.4) 7.51 (5.16 – 9.36) 42.2 (35.0 – 53.7) 162 (118 – 195) 217
20–39 years 44.9 (32.5 – 62.1) 6.26 (3.86 – 9.31) 41.4 (27.8 – 61.5) 306 (193 – 937) 165
40–59 years 36.3 (22.5 – 58.5) 5.97† (< LOD – 11.6) 31.7 (19.0 – 59.2) 274† (189 – 476) 72
60 years and older 21.3 (15.0 – 30.3) 2.49† (.826 – 4.86) 28.1 (16.1 – 45.6) 115† (67.5 – 254) 89
< LOD means less than the limit of detection, which may vary for some compounds by year. See Appendix D for LOD. 
† Estimate is subject to greater uncertainty due to small cell size. 
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Table 4.9.a.4. Urinary enterodiol: Non-Hispanic blacks
Geometric mean and selected percentiles of urine concentrations (in µg/L) for non-Hispanic blacks in the U.S. 
population aged 6 years and older, National Health and Nutrition Examination Survey, 2003–2006. 
Geometric mean 
 (95% conf. interval)
Selected percentiles (95% conf. interval) Sample 
size10th 50th 90th
Males and Females
Total, 6 years and older 37.4 (33.8 – 41.3) 6.94 (5.78 – 8.13) 43.1 (38.4 – 47.4) 202 (164 – 241) 1,343
6–11 years 39.0 (32.6 – 46.6) 8.75 (7.57 – 10.9) 38.5 (32.6 – 47.4) 144 (113 – 222) 207
12–19 years 40.4 (35.8 – 45.5) 7.82 (6.32 – 10.2) 45.9 (40.2 – 53.4) 203 (158 – 252) 496
20–39 years 34.4 (28.9 – 40.8) 4.70 (2.73 – 9.26) 43.1 (30.9 – 49.3) 182 (138 – 247) 249
40–59 years 38.3 (31.0 – 47.3) 6.45 (3.55 – 9.50) 42.9 (34.8 – 56.0) 229 (159 – 306) 231
60 years and older 38.6 (29.7 – 50.2) 5.01 (2.37 – 11.3) 41.5 (33.1 – 54.2) 213 (143 – 308) 160
Males
Total, 6 years and older 35.8 (31.0 – 41.4) 7.23 (5.38 – 9.93) 41.2 (37.1 – 44.8) 199 (145 – 256) 661
6–11 years 36.7 (30.6 – 44.0) 8.71† (5.22 – 12.3) 37.6 (32.5 – 45.6) 130† (93.9 – 271) 99
12–19 years 41.5 (35.7 – 48.2) 8.60 (6.42 – 10.6) 46.0 (36.3 – 56.7) 220 (161 – 274) 258
20–39 years 34.8 (25.0 – 48.5) 9.49 (1.28 – 12.7) 42.3 (28.4 – 49.0) 194 (117 – 649) 116
40–59 years 34.2 (25.5 – 45.8) 6.41 (.424 – 11.2) 40.1 (31.0 – 51.0) 181 (103 – 339) 114
60 years and older 33.8 (22.6 – 50.5) 3.16† (< LOD – 9.91) 38.8 (22.4 – 60.4) 235† (178 – 506) 74
Females
Total, 6 years and older 38.8 (33.8 – 44.5) 6.71 (4.70 – 8.09) 45.3 (36.5 – 52.9) 209 (159 – 246) 682
6–11 years 41.5 (28.5 – 60.3) 8.80† (5.57 – 12.1) 38.5 (25.1 – 63.3) 162† (105 – 734) 108
12–19 years 39.3 (34.1 – 45.3) 7.36 (4.62 – 10.8) 45.8 (38.4 – 54.9) 181 (148 – 227) 238
20–39 years 34.0 (25.1 – 45.9) 4.44 (1.93 – 7.72) 43.6 (29.2 – 57.8) 163 (129 – 250) 133
40–59 years 42.1 (31.0 – 57.1) 6.38 (3.20 – 9.27) 47.1 (30.4 – 65.8) 241 (167 – 440) 117
60 years and older 42.0 (31.7 – 55.6) 8.15† (2.80 – 14.6) 44.5 (31.8 – 61.6) 173† (120 – 404) 86
< LOD means less than the limit of detection, which may vary for some compounds by year. See Appendix D for LOD. 
† Estimate is subject to greater uncertainty due to small cell size. 
Table 4.9.a.5. Urinary enterodiol: Non-Hispanic whites
Geometric mean and selected percentiles of urine concentrations (in µg/L) for non-Hispanic whites in the U.S. 
population aged 6 years and older, National Health and Nutrition Examination Survey, 2003–2006. 
Geometric mean 
 (95% conf. interval)
Selected percentiles (95% conf. interval) Sample 
size10th 50th 90th
Males and Females
Total, 6 years and older 38.7 (34.9 – 42.8) 5.87 (4.61 – 6.90) 44.2 (40.2 – 49.6) 244 (228 – 264) 2,108
6–11 years 39.3 (30.9 – 50.1) 8.74 (6.52 – 13.2) 40.4 (34.8 – 48.0) 139 (115 – 232) 193
12–19 years 42.1 (36.3 – 48.8) 8.80 (6.91 – 10.6) 42.8 (36.5 – 54.4) 176 (154 – 230) 378
20–39 years 40.0 (33.4 – 47.9) 5.42 (4.12 – 7.14) 43.8 (36.4 – 55.7) 238 (207 – 296) 494
40–59 years 36.3 (29.2 – 45.1) 3.71 (2.29 – 6.10) 45.2 (35.6 – 54.8) 264 (243 – 281) 448
60 years and older 38.8 (34.2 – 43.9) 5.91 (3.70 – 7.29) 46.0 (38.9 – 56.1) 258 (213 – 280) 595
Males
Total, 6 years and older 41.1 (35.5 – 47.6) 6.75 (5.23 – 8.72) 46.4 (40.6 – 52.7) 259 (222 – 275) 1,035
6–11 years 40.8 (29.6 – 56.1) 9.08† (4.58 – 17.3) 39.9 (32.8 – 49.3) 129† (109 – 356) 99
12–19 years 42.5 (35.6 – 50.7) 9.11 (6.18 – 11.8) 48.2 (36.1 – 57.6) 176 (148 – 252) 191
20–39 years 40.6 (30.3 – 54.3) 5.50 (3.34 – 9.65) 43.8 (33.6 – 59.1) 238 (184 – 394) 217
40–59 years 42.2 (31.6 – 56.5) 5.30 (2.37 – 10.1) 48.1 (36.7 – 58.2) 280 (259 – 415) 229
60 years and older 39.4 (31.3 – 49.4) 6.58 (4.37 – 8.47) 50.3 (40.5 – 56.9) 246 (182 – 286) 299
Females
Total, 6 years and older 36.4 (31.6 – 41.9) 4.79 (3.03 – 6.57) 42.3 (38.0 – 49.9) 240 (201 – 273) 1,073
6–11 years 37.7 (28.8 – 49.2) 7.98† (2.17 – 11.7) 41.0 (29.3 – 54.4) 155† (94.9 – 369) 94
12–19 years 41.6 (33.6 – 51.6) 8.15 (5.01 – 13.4) 40.1 (34.9 – 51.0) 174 (131 – 278) 187
20–39 years 39.4 (31.4 – 49.4) 4.87 (3.72 – 7.60) 46.0 (34.2 – 56.9) 236 (183 – 332) 277
40–59 years 31.2 (23.5 – 41.4) 2.52 (.780 – 5.15) 40.5 (31.0 – 55.4) 242 (189 – 276) 219
60 years and older 38.3 (32.0 – 45.8) 4.66 (2.91 – 7.14) 44.6 (33.4 – 58.2) 263 (207 – 309) 296
† Estimate is subject to greater uncertainty due to small cell size.  
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Table 4.9.b. Urinary enterodiol: Concentrations by survey cycle
Geometric mean and selected percentiles of urine concentrations (in µg/L) for the U.S. population, National 
Health and Nutrition Examination Survey, 1999–2006. 
Geometric mean 
 (95% conf. interval)
Selected percentiles (95% conf. interval) Sample 
size5th 50th 95th
Total, 6 years and older
 1999–2000 26.6 (21.9 – 32.3) < LOD 33.9 (29.5 – 38.7) 263 (219 – 338) 2,527
 2001–2002 35.7 (32.5 – 39.3) 2.10 (< LOD – 3.07) 39.3 (36.4 – 43.1) 253 (225 – 307) 2,794
 2003–2004 39.5 (36.1 – 43.3) 2.45 (1.76 – 2.91) 44.8 (40.7 – 50.3) 367 (318 – 424) 2,594
 2005–2006 37.7 (33.2 – 42.9) 2.47 (.884 – 3.82) 42.4 (39.3 – 47.2) 378 (316 – 447) 2,528
Age group
6–11 years
 1999–2000 26.5 (17.1 – 41.0) < LOD 29.3 (21.2 – 43.4) 272 (203 – 477) 327
 2001–2002 33.6 (29.8 – 37.8) 3.40 (1.90 – 5.06) 35.5 (29.4 – 43.5) 202 (170 – 333) 396
 2003–2004 42.0 (34.5 – 51.1) 6.62 (2.92 – 8.30) 42.0 (34.6 – 49.1) 311 (230 – 523) 341
 2005–2006 33.2 (26.1 – 42.3) 2.86 (1.71 – 6.66) 38.5 (34.7 – 44.3) 178 (136 – 377) 351
12–19 years
 1999–2000 29.8 (23.8 – 37.2) < LOD 34.0 (27.8 – 42.0) 252 (193 – 357) 744
 2001–2002 35.3 (30.5 – 40.9) 3.30 (2.02 – 5.23) 37.6 (34.8 – 42.9) 235 (172 – 344) 744
 2003–2004 45.1 (39.4 – 51.6) 5.28 (3.63 – 6.65) 46.2 (38.8 – 56.8) 324 (276 – 416) 729
 2005–2006 39.1 (34.0 – 45.0) 4.19 (1.72 – 6.24) 41.0 (36.8 – 46.4) 264 (232 – 367) 693
20–39 years
 1999–2000 27.4 (22.1 – 34.1) < LOD 36.0 (29.9 – 41.3) 230 (177 – 401) 535
 2001–2002 35.3 (29.5 – 42.3) < LOD 42.5 (36.6 – 47.6) 244 (213 – 371) 604
 2003–2004 39.7 (33.2 – 47.5) 2.69 (1.32 – 3.59) 44.5 (37.7 – 53.9) 372 (308 – 654) 554
 2005–2006 38.6 (32.3 – 46.2) 3.01 (1.16 – 4.28) 43.5 (34.5 – 53.8) 352 (289 – 519) 583
40–59 years
 1999–2000 26.1 (21.4 – 31.8) < LOD 34.6 (28.9 – 41.2) 280 (249 – 406) 414
 2001–2002 37.3 (29.2 – 47.7) < LOD 40.5 (34.5 – 50.9) 289 (232 – 488) 531
 2003–2004 35.3 (28.6 – 43.6) 1.36 (< LOD – 2.16) 42.6 (36.3 – 50.6) 418 (283 – 712) 452
 2005–2006 39.0 (29.4 – 51.8) 2.30 (< LOD – 4.32) 45.9 (34.1 – 59.0) 445 (287 – 651) 449
60 years and older
 1999–2000 23.7 (18.8 – 30.0) < LOD 29.7 (21.9 – 37.4) 264 (167 – 479) 507
 2001–2002 35.4 (30.0 – 41.8) 2.87 (1.55 – 4.49) 36.5 (30.2 – 46.0) 224 (195 – 364) 519
 2003–2004 41.7 (36.7 – 47.4) 2.84 (1.82 – 4.35) 50.8 (43.2 – 58.3) 309 (265 – 615) 518
 2005–2006 35.6 (29.0 – 43.8) 1.66 (< LOD – 3.05) 39.9 (31.1 – 51.8) 415 (322 – 614) 452
Gender
Males
 1999–2000 25.3 (19.5 – 32.7) < LOD 33.0 (28.0 – 37.9) 258 (179 – 324) 1,206
 2001–2002 35.2 (31.8 – 39.1) < LOD 40.4 (36.8 – 44.2) 263 (225 – 351) 1,375
 2003–2004 39.7 (36.2 – 43.6) 2.43 (.998 – 3.97) 45.1 (40.6 – 50.6) 360 (275 – 515) 1,244
 2005–2006 40.4 (32.8 – 49.8) 2.64 (.957 – 4.13) 46.1 (39.1 – 52.0) 413 (291 – 544) 1,252
Females
 1999–2000 27.9 (23.4 – 33.3) < LOD 36.0 (29.9 – 40.2) 280 (228 – 397) 1,321
 2001–2002 36.2 (32.2 – 40.7) 3.20 (< LOD – 4.75) 38.5 (35.3 – 43.4) 246 (222 – 286) 1,419
 2003–2004 39.3 (33.8 – 45.5) 2.60 (1.33 – 3.36) 44.8 (38.5 – 52.7) 396 (313 – 485) 1,350
 2005–2006 35.4 (30.3 – 41.2) 2.43 (.524 – 3.72) 41.0 (35.7 – 45.3) 338 (272 – 477) 1,276
Race/ethnicity
Mexican Americans
 1999–2000 21.7 (19.5 – 24.1) < LOD 27.9 (24.6 – 34.6) 212 (171 – 258) 791
 2001–2002 30.5 (25.7 – 36.3) 1.62 (< LOD – 2.79) 33.8 (29.0 – 39.1) 240 (198 – 304) 679
 2003–2004 33.1 (26.4 – 41.6) 1.90 (< LOD – 3.68) 38.5 (31.7 – 47.1) 298 (201 – 4,230) 653
 2005–2006 38.1 (32.2 – 45.1) 2.60 (1.91 – 3.84) 40.5 (35.4 – 47.5) 382 (295 – 514) 634
Non-Hispanic Blacks
 1999–2000 25.7 (21.5 – 30.6) < LOD 31.2 (24.4 – 35.9) 266 (219 – 356) 597
 2001–2002 35.1 (28.8 – 42.8) 2.08 (< LOD – 3.42) 38.8 (33.3 – 49.8) 222 (178 – 386) 692
 2003–2004 40.3 (34.7 – 46.8) 3.23 (1.48 – 4.64) 47.2 (40.7 – 54.4) 284 (244 – 442) 681
 2005–2006 34.7 (30.1 – 40.1) 2.73 (2.01 – 3.30) 38.4 (33.3 – 45.1) 268 (248 – 382) 662
Non-Hispanic Whites
 1999–2000 29.1 (24.2 – 35.1) < LOD 37.5 (31.6 – 43.7) 271 (219 – 401) 899
 2001–2002 35.6 (31.8 – 40.0) 1.82 (< LOD – 3.21) 40.4 (36.5 – 44.7) 254 (219 – 341) 1,211
 2003–2004 40.1 (35.6 – 45.1) 2.64 (1.59 – 3.48) 45.9 (38.9 – 55.3) 368 (305 – 441) 1,069
 2005–2006 37.3 (31.2 – 44.6) 2.36 (.472 – 3.81) 42.6 (37.1 – 49.6) 366 (286 – 456) 1,039
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Values in the graph are suppressed if either the point estimate or the lower 95% confidence limit is noted as “< LOD” in the accompanying table. 
Figure 4.9.b. Urinary enterodiol: Concentrations by survey cycle 
Selected percentiles in μg/L (95% confidence intervals), National Health and 

Nutrition Examination Survey, 1999–2006
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Figure 4.10.a. Urinary enterodiol (creatinine corrected): 
Concentrations by age group 
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Table 4.10.a.2. Urinary enterodiol (creatinine corrected): Total population
Geometric mean and selected percentiles of urine concentrations (in µg/g creatinine) for the total U.S. 
population aged 6 years and older, National Health and Nutrition Examination Survey, 2003–2006. 
Geometric mean 
 (95% conf. interval)
Selected percentiles (95% conf. interval) Sample 
size10th 50th 90th
Males and Females
Total, 6 years and older 36.9 (34.3 – 39.7) 6.26 (5.53 – 7.25) 41.1 (38.2 – 44.1) 202 (185 – 213) 5,122
6–11 years 40.5 (35.1 – 46.7) 8.85 (6.90 – 12.2) 43.6 (38.1 – 48.1) 166 (134 – 201) 692
12–19 years 31.3 (28.7 – 34.1) 6.90 (5.55 – 8.00) 33.6 (31.9 – 36.1) 130 (117 – 154) 1,422
20–39 years 33.4 (29.3 – 38.1) 5.04 (4.01 – 6.33) 34.9 (31.6 – 43.0) 185 (156 – 230) 1,137
40–59 years 37.6 (31.8 – 44.5) 5.64 (3.76 – 7.61) 42.7 (36.6 – 50.2) 217 (201 – 275) 901
60 years and older 45.1 (39.9 – 50.9) 7.91 (6.45 – 9.98) 51.0 (47.1 – 55.6) 228 (198 – 290) 970
Males
Total, 6 years and older 31.8 (28.5 – 35.5) 5.68 (4.73 – 6.43) 34.6 (32.0 – 38.0) 176 (150 – 210) 2,496
6–11 years 38.5 (31.7 – 46.9) 8.54 (6.17 – 13.0) 38.3 (33.3 – 46.1) 144 (117 – 205) 340
12–19 years 28.9 (25.7 – 32.5) 5.59 (5.19 – 7.40) 32.6 (28.5 – 34.9) 123 (113 – 134) 728
20–39 years 28.3 (23.0 – 34.9) 4.69 (3.28 – 5.94) 29.9 (25.6 – 35.5) 152 (128 – 253) 499
40–59 years 32.3 (25.6 – 40.8) 5.53 (3.19 – 7.12) 33.7 (28.4 – 43.1) 207 (158 – 305) 451
60 years and older 36.9 (30.3 – 45.1) 6.29 (4.32 – 8.00) 43.8 (38.4 – 51.5) 204 (169 – 240) 478
Females
Total, 6 years and older 42.5 (38.9 – 46.4) 7.53 (5.73 – 8.57) 48.4 (45.0 – 54.6) 210 (198 – 234) 2,626
6–11 years 42.7 (35.9 – 50.8) 9.12 (6.71 – 12.6) 48.1 (40.3 – 57.8) 177 (140 – 218) 352
12–19 years 34.1 (30.1 – 38.5) 8.29 (4.44 – 9.54) 36.0 (32.2 – 39.7) 144 (119 – 165) 694
20–39 years 39.2 (33.9 – 45.5) 5.48 (3.87 – 7.78) 46.3 (35.7 – 57.4) 203 (165 – 243) 638
40–59 years 43.4 (35.2 – 53.6) 5.72 (2.41 – 9.51) 52.6 (42.7 – 63.1) 231 (207 – 301) 450
60 years and older 52.8 (46.0 – 60.6) 9.89 (7.70 – 11.6) 57.4 (50.4 – 65.3) 249 (201 – 407) 492
Table 4.10.a.3. Urinary enterodiol (creatinine corrected): Mexican Americans
Geometric mean and selected percentiles of urine concentrations (in µg/g creatinine) for Mexican Americans in 
the U.S. population aged 6 years and older, National Health and Nutrition Examination Survey, 2003–2006. 
Geometric mean 
 (95% conf. interval)
Selected percentiles (95% conf. interval) Sample 
size10th 50th 90th
Males and Females
Total, 6 years and older 32.1 (27.9 – 36.9) 4.54 (3.80 – 6.35) 35.1 (30.5 – 39.3) 185 (145 – 226) 1,287
6–11 years 34.4 (27.9 – 42.4) 5.18 (3.71 – 6.71) 37.2 (33.9 – 44.9) 178 (135 – 226) 231
12–19 years 27.5 (23.8 – 31.9) 4.55 (3.18 – 7.34) 33.6 (28.0 – 37.6) 123 (96.1 – 147) 445
20–39 years 30.9 (23.4 – 40.7) 4.02 (2.24 – 6.39) 31.1 (27.4 – 39.6) 203 (126 – 343) 282
40–59 years 36.1 (27.6 – 47.3) 5.14 (2.37 – 11.4) 35.2 (27.5 – 43.1) 234 (172 – 328) 157
60 years and older 35.1 (29.0 – 42.6) 5.53 (5.00 – 7.33) 40.9 (32.0 – 50.3) 171 (127 – 206) 172
Males
Total, 6 years and older 27.6 (22.7 – 33.4) 3.88 (2.69 – 5.22) 33.1 (27.7 – 39.2) 145 (125 – 188) 625
6–11 years 33.6 (24.5 – 46.3) 5.54 (1.57 – 10.7) 39.3 (30.6 – 49.5) 136 (109 – 223) 112
12–19 years 25.0 (19.6 – 31.9) 3.94 (1.46 – 7.15) 31.8 (22.5 – 38.9) 128 (88.0 – 179) 228
20–39 years 24.2 (16.6 – 35.3) 3.11 (.554 – 5.48) 27.9 (20.7 – 38.8) 126 (93.7 – 316) 117
40–59 years 31.3 (21.1 – 46.5) 4.37† (< LOD – 9.03) 36.9 (24.4 – 56.4) 151† (125 – 326) 85
60 years and older 36.1 (23.6 – 55.3) 5.32† (1.31 – 7.57) 42.1 (24.2 – 74.3) 180† (111 – 3,470) 83
Females
Total, 6 years and older 37.9 (33.8 – 42.5) 6.60 (4.51 – 9.67) 35.9 (33.1 – 40.5) 214 (182 – 310) 662
6–11 years 35.2 (26.6 – 46.6) 5.04 (3.18 – 6.59) 36.4 (28.5 – 45.9) 189 (140 – 434) 119
12–19 years 30.4 (26.0 – 35.7) 6.37 (3.16 – 9.37) 36.5 (29.2 – 40.5) 111 (87.0 – 153) 217
20–39 years 41.1 (30.3 – 55.6) 6.65 (2.66 – 10.7) 34.6 (28.4 – 43.7) 225 (156 – 1,900) 165
40–59 years 42.2 (28.5 – 62.7) 10.9† (< LOD – 15.6) 34.7 (24.5 – 42.5) 322† (224 – 401) 72
60 years and older 34.4 (25.4 – 46.4) 7.20† (1.42 – 12.2) 39.5 (30.7 – 49.7) 134† (114 – 219) 89
< LOD means less than the limit of detection for the uncorrected urine values, which may vary for some compounds by year. See Appendix D for LOD. 
† Estimate is subject to greater uncertainty due to small cell size. 
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Table 4.10.a.4. Urinary enterodiol (creatinine corrected): Non-Hispanic blacks
Geometric mean and selected percentiles of urine concentrations (in µg/g creatinine) for non-Hispanic blacks 
in the U.S. population aged 6 years and older, National Health and Nutrition Examination Survey, 2003–2006. 
Geometric mean 
 (95% conf. interval)
Selected percentiles (95% conf. interval) Sample 
size10th 50th 90th
Males and Females
Total, 6 years and older 26.3 (23.5 – 29.3) 5.31 (4.24 – 6.34) 27.8 (24.9 – 31.4) 125 (110 – 152) 1,343
6–11 years 36.6 (30.6 – 43.8) 9.75 (7.92 – 11.3) 34.5 (25.8 – 45.8) 136 (108 – 215) 207
12–19 years 23.2 (20.8 – 25.8) 4.63 (3.25 – 5.70) 26.0 (23.5 – 29.3) 97.7 (86.3 – 107) 496
20–39 years 21.3 (17.7 – 25.7) 3.72 (2.11 – 6.01) 23.0 (17.8 – 28.7) 114 (101 – 145) 249
40–59 years 27.8 (22.9 – 33.9) 4.81 (3.72 – 6.10) 31.2 (25.2 – 42.5) 138 (98.2 – 207) 231
60 years and older 34.4 (27.2 – 43.5) 6.11 (3.63 – 7.83) 40.0 (25.1 – 53.3) 158 (126 – 211) 160
Males
Total, 6 years and older 20.9 (17.8 – 24.6) 4.17 (3.10 – 5.70) 23.1 (21.0 – 25.9) 103 (84.9 – 141) 661
6–11 years 34.7 (28.7 – 41.9) 9.17† (6.49 – 13.8) 27.8 (23.6 – 42.1) 133† (87.7 – 254) 99
12–19 years 22.2 (19.3 – 25.5) 3.94 (2.80 – 5.30) 25.8 (22.0 – 30.4) 98.2 (78.0 – 114) 258
20–39 years 16.7 (12.1 – 23.1) 3.28 (.958 – 7.92) 15.6 (13.4 – 23.1) 98.0 (48.0 – 228) 116
40–59 years 19.5 (14.7 – 25.9) 3.83 (.303 – 5.78) 24.4 (19.1 – 30.5) 88.7 (62.6 – 143) 114
60 years and older 24.8 (17.4 – 35.3) 2.85† (< LOD – 5.98) 29.4 (16.7 – 46.4) 154† (105 – 375) 74
Females
Total, 6 years and older 31.8 (27.2 – 37.1) 6.96 (4.95 – 7.88) 34.8 (28.3 – 44.5) 145 (124 – 183) 682
6–11 years 38.7 (26.3 – 56.9) 9.48† (5.62 – 11.4) 36.2 (23.8 – 63.6) 138† (104 – 671) 108
12–19 years 24.3 (21.1 – 27.9) 5.67 (2.69 – 8.07) 26.0 (22.5 – 31.5) 97.2 (83.9 – 118) 238
20–39 years 25.8 (18.5 – 36.1) 4.01 (1.38 – 6.49) 28.5 (21.8 – 40.2) 122 (104 – 202) 133
40–59 years 37.3 (27.8 – 50.0) 7.65 (4.05 – 10.2) 45.8 (26.5 – 61.7) 186 (131 – 262) 117
60 years and older 42.4 (32.8 – 54.7) 7.78† (3.31 – 15.1) 42.5 (29.1 – 68.6) 157† (127 – 219) 86
< LOD means less than the limit of detection for the uncorrected urine values, which may vary for some compounds by year. See Appendix D for LOD. 
† Estimate is subject to greater uncertainty due to small cell size. 
Table 4.10.a.5. Urinary enterodiol (creatinine corrected): Non-Hispanic whites
Geometric mean and selected percentiles of urine concentrations (in µg/g creatinine) for non-Hispanic whites 
in the U.S. population aged 6 years and older, National Health and Nutrition Examination Survey, 2003–2006. 
Geometric mean 
 (95% conf. interval)
Selected percentiles (95% conf. interval) Sample 
size10th 50th 90th
Males and Females
Total, 6 years and older 39.4 (35.5 – 43.6) 6.60 (5.58 – 8.19) 45.4 (40.8 – 49.6) 205 (186 – 224) 2,108
6–11 years 42.6 (34.0 – 53.4) 11.1 (5.34 – 16.8) 46.1 (37.0 – 52.0) 151 (121 – 226) 193
12–19 years 33.0 (28.8 – 37.8) 7.53 (5.66 – 9.35) 34.6 (31.7 – 40.5) 132 (117 – 163) 378
20–39 years 36.9 (30.1 – 45.0) 5.49 (3.01 – 7.72) 42.6 (32.9 – 54.0) 187 (154 – 248) 494
40–59 years 39.0 (31.5 – 48.3) 5.69 (3.16 – 8.27) 46.7 (37.1 – 56.0) 217 (195 – 290) 448
60 years and older 46.2 (40.4 – 52.9) 8.98 (6.44 – 11.1) 52.2 (47.7 – 56.5) 234 (199 – 291) 595
Males
Total, 6 years and older 34.4 (29.6 – 40.0) 6.14 (4.80 – 7.62) 37.5 (32.7 – 42.5) 186 (150 – 238) 1,035
6–11 years 39.5 (29.3 – 53.4) 12.2† (1.42 – 18.9) 38.4 (31.5 – 49.8) 127† (93.3 – 328) 99
12–19 years 30.3 (26.1 – 35.3) 6.16 (5.29 – 8.96) 33.2 (27.5 – 40.5) 123 (111 – 139) 191
20–39 years 32.2 (23.7 – 43.7) 5.54 (2.27 – 8.17) 32.5 (23.0 – 47.3) 185 (128 – 338) 217
40–59 years 35.4 (26.0 – 48.1) 5.70 (2.28 – 9.38) 37.4 (28.6 – 50.0) 213 (158 – 341) 229
60 years and older 36.7 (29.0 – 46.4) 6.56 (2.03 – 10.7) 44.0 (38.4 – 52.2) 195 (164 – 241) 299
Females
Total, 6 years and older 44.9 (39.5 – 51.0) 7.63 (5.36 – 9.36) 55.6 (47.8 – 60.8) 216 (199 – 251) 1,073
6–11 years 46.6 (36.2 – 60.0) 10.2† (4.05 – 15.4) 53.8 (41.4 – 64.6) 171† (131 – 302) 94
12–19 years 36.2 (29.2 – 44.9) 8.91 (4.19 – 10.9) 39.1 (31.4 – 46.2) 151 (117 – 216) 187
20–39 years 42.2 (33.9 – 52.5) 4.89 (2.69 – 8.91) 56.3 (40.0 – 66.8) 203 (159 – 275) 277
40–59 years 43.1 (32.8 – 56.7) 5.49 (1.59 – 9.39) 58.2 (42.5 – 71.1) 217 (204 – 305) 219
60 years and older 55.5 (48.1 – 64.0) 10.2 (7.90 – 12.2) 60.5 (51.3 – 67.3) 291 (203 – 469) 296
† Estimate is subject to greater uncertainty due to small cell size.  
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Table 4.10.b. Urinary enterodiol (creatinine corrected): Concentrations by 
survey cycle
Geometric mean and selected percentiles of urine concentrations (in µg/g creatinine) for the U.S. population, 
National Health and Nutrition Examination Survey, 1999–2006. 
Geometric mean 
 (95% conf. interval)
Selected percentiles (95% conf. interval) Sample 
size5th 50th 95th
Total, 6 years and older
 1999–2000 24.2 (20.3 – 28.9) <LOD 29.9 (25.1 – 34.7) 239 (203 – 320) 2,527
 2001–2002 33.5 (30.7 – 36.7) 2.54 (<LOD – 2.96) 37.6 (33.0 – 42.0) 224 (201 – 249) 2,794
 2003–2004 37.0 (33.6 – 40.7) 2.45 (1.86 – 3.57) 41.7 (38.0 – 45.4) 293 (249 – 376) 2,594
 2005–2006 36.8 (32.7 – 41.4) 2.95 (1.16 – 4.43) 40.9 (36.0 – 46.1) 323 (283 – 421) 2,528
Age group
6–11 years
 1999–2000 27.0 (18.6 – 39.3) <LOD 33.5 (22.1 – 43.6) 278 (199 – 534) 327
 2001–2002 38.1 (32.5 – 44.7) 3.88 (2.45 – 5.14) 39.3 (31.0 – 53.1) 303 (244 – 390) 396
 2003–2004 44.7 (37.4 – 53.5) 6.38 (3.61 – 8.72) 46.5 (38.6 – 58.0) 213 (184 – 414) 341
 2005–2006 36.6 (28.9 – 46.4) 4.69 (1.80 – 7.52) 37.8 (33.0 – 46.5) 221 (186 – 349) 351
12–19 years
 1999–2000 20.1 (16.7 – 24.2) <LOD 24.0 (19.9 – 30.1) 157 (125 – 176) 744
 2001–2002 27.2 (23.3 – 31.8) 2.75 (1.30 – 4.91) 28.7 (25.0 – 34.8) 150 (116 – 316) 744
 2003–2004 33.8 (30.3 – 37.7) 4.69 (2.38 – 5.62) 34.7 (33.3 – 38.2) 216 (155 – 344) 729
 2005–2006 29.0 (25.2 – 33.3) 3.01 (2.13 – 3.60) 31.1 (28.0 – 36.1) 165 (160 – 214) 693
20–39 years
 1999–2000 21.7 (17.1 – 27.6) <LOD 26.4 (21.4 – 32.4) 232 (149 – 371) 535
 2001–2002 28.5 (23.7 – 34.3) <LOD 30.2 (25.2 – 39.4) 187 (156 – 277) 604
 2003–2004 33.5 (27.4 – 40.9) 2.26 (1.63 – 2.71) 33.8 (27.9 – 46.2) 299 (245 – 425) 554
 2005–2006 33.3 (27.5 – 40.3) 2.39 (.618 – 4.04) 36.2 (30.4 – 47.2) 318 (207 – 523) 583
40–59 years
 1999–2000 26.4 (21.9 – 31.9) <LOD 31.8 (27.4 – 38.7) 293 (217 – 358) 414
 2001–2002 37.1 (30.0 – 45.7) <LOD 44.2 (37.7 – 51.2) 246 (180 – 305) 531
 2003–2004 33.8 (27.6 – 41.5) 1.16 (<LOD – 2.44) 40.8 (33.6 – 47.8) 369 (241 – 719) 452
 2005–2006 41.6 (31.7 – 54.5) 2.95 (<LOD – 5.29) 46.6 (34.2 – 61.6) 375 (276 – 802) 449
60 years and older
 1999–2000 28.6 (23.0 – 35.6) <LOD 33.5 (29.2 – 43.9) 258 (186 – 430) 507
 2001–2002 41.9 (35.8 – 49.2) 3.67 (2.14 – 6.71) 46.3 (41.8 – 50.8) 238 (220 – 360) 519
 2003–2004 49.4 (42.8 – 57.0) 5.75 (1.73 – 6.45) 57.1 (51.9 – 63.1) 309 (230 – 697) 518
 2005–2006 41.3 (33.4 – 51.1) 2.15 (<LOD – 5.47) 45.4 (38.7 – 52.1) 418 (290 – 798) 452
Gender
Males
 1999–2000 19.8 (15.4 – 25.4) <LOD 25.3 (20.6 – 31.1) 198 (153 – 287) 1,206
 2001–2002 28.7 (26.0 – 31.7) <LOD 31.4 (27.0 – 36.7) 212 (184 – 259) 1,375
 2003–2004 31.1 (27.5 – 35.0) 2.03 (1.17 – 3.66) 34.8 (32.2 – 38.4) 249 (195 – 368) 1,244
 2005–2006 32.5 (26.7 – 39.5) 2.46 (.565 – 4.41) 34.2 (29.5 – 41.0) 310 (229 – 493) 1,252
Females
 1999–2000 29.3 (25.0 – 34.4) <LOD 35.3 (29.6 – 41.6) 320 (233 – 370) 1,321
 2001–2002 38.9 (34.9 – 43.3) 3.35 (<LOD – 4.62) 43.8 (39.3 – 48.7) 234 (185 – 305) 1,419
 2003–2004 43.6 (38.3 – 49.7) 2.76 (2.24 – 4.15) 49.0 (43.4 – 57.7) 375 (280 – 464) 1,350
 2005–2006 41.4 (36.1 – 47.4) 3.10 (.952 – 5.10) 48.2 (41.8 – 55.7) 372 (277 – 473) 1,276
Race/ethnicity
Mexican Americans
 1999–2000 19.6 (17.3 – 22.2) <LOD 23.2 (19.8 – 28.6) 193 (164 – 233) 791
 2001–2002 28.7 (24.5 – 33.7) 2.60 (<LOD – 3.88) 31.0 (27.0 – 36.9) 220 (157 – 338) 679
 2003–2004 29.9 (23.8 – 37.4) 1.88 (<LOD – 2.68) 33.8 (26.7 – 42.4) 240 (211 – 401) 653
 2005–2006 34.4 (28.3 – 41.8) 3.45 (2.15 – 3.97) 35.3 (30.9 – 39.6) 314 (245 – 578) 634
Non-Hispanic Blacks
 1999–2000 16.5 (13.9 – 19.5) <LOD 18.4 (14.4 – 22.8) 173 (136 – 311) 597
 2001–2002 24.5 (19.4 – 30.8) 1.76 (<LOD – 3.48) 27.0 (22.6 – 33.4) 157 (127 – 387) 692
 2003–2004 28.4 (24.2 – 33.3) 3.18 (2.04 – 3.81) 30.1 (26.1 – 36.0) 202 (158 – 230) 681
 2005–2006 24.3 (20.5 – 28.9) 1.66 (.980 – 2.91) 25.3 (22.1 – 30.3) 186 (147 – 251) 662
Non-Hispanic Whites
 1999–2000 28.7 (24.5 – 33.6) <LOD 34.4 (28.9 – 39.3) 252 (210 – 366) 899
 2001–2002 35.2 (31.5 – 39.4) 2.50 (<LOD – 2.90) 40.8 (34.4 – 46.8) 225 (198 – 276) 1,211
 2003–2004 39.5 (34.5 – 45.3) 2.71 (2.21 – 3.73) 45.5 (38.4 – 53.4) 299 (249 – 402) 1,069
 2005–2006 39.2 (33.3 – 46.1) 2.99 (.537 – 5.09) 45.0 (39.4 – 50.2) 330 (284 – 441) 1,039




















































































Figure 4.10.b. Urinary enterodiol (creatinine corrected): 
Concentrations by survey cycle 
Selected percentiles in μg/g creatinine (95% confidence intervals), National Health and 

























































































































































Total 3−5y 6−11y 12−19y 20+y Males Females MA NHB NHW 
(6+y) 
Values in the graph are suppressed if either the point estimate or the lower 95% confidence limit is noted as “< LOD” in the accompanying table. 
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Non−Hispanic Blacks Non−Hispanic Whites 
Figure 4.11.a. Urinary enterolactone: Concentrations by age group 
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Table 4.11.a.2. Urinary enterolactone: Total population
Geometric mean and selected percentiles of urine concentrations (in µg/L) for the total U.S. population aged 6 
years and older, National Health and Nutrition Examination Survey, 2003–2006. 
Geometric mean 
 (95% conf. interval)
Selected percentiles (95% conf. interval) Sample 
size10th 50th 90th
Males and Females
Total, 6 years and older 290 (266 – 317) 26.5 (23.0 – 30.9) 390 (350 – 435) 1,810 (1,700 – 1,970) 5,122
6–11 years 340 (287 – 403) 56.2 (32.4 – 76.6) 413 (334 – 503) 1,490 (1,200 – 1,880) 692
12–19 years 303 (270 – 339) 27.3 (19.2 – 44.1) 394 (363 – 445) 1,680 (1,490 – 1,910) 1,422
20–39 years 272 (236 – 314) 26.5 (20.2 – 35.4) 349 (307 – 413) 1,780 (1,540 – 2,060) 1,137
40–59 years 271 (231 – 317) 19.8 (14.2 – 26.7) 389 (310 – 461) 1,950 (1,560 – 2,430) 901
60 years and older 327 (288 – 371) 30.1 (18.9 – 42.3) 476 (396 – 559) 2,020 (1,790 – 2,300) 970
Males
Total, 6 years and older 307 (275 – 343) 28.8 (23.3 – 36.5) 424 (378 – 468) 1,910 (1,730 – 2,060) 2,496
6–11 years 408 (324 – 514) 79.9 (45.3 – 126) 481 (381 – 582) 1,520 (1,140 – 2,130) 340
12–19 years 318 (272 – 371) 28.6 (20.1 – 51.1) 418 (369 – 495) 1,800 (1,530 – 2,240) 728
20–39 years 259 (211 – 318) 26.2 (16.7 – 37.4) 334 (244 – 427) 1,790 (1,530 – 2,320) 499
40–59 years 297 (241 – 365) 21.7 (12.8 – 32.5) 427 (309 – 537) 2,050 (1,530 – 2,950) 451
60 years and older 373 (318 – 438) 38.9 (20.7 – 59.7) 551 (441 – 651) 2,040 (1,690 – 2,720) 478
Females
Total, 6 years and older 275 (242 – 313) 24.6 (19.9 – 28.9) 364 (321 – 422) 1,770 (1,540 – 2,000) 2,626
6–11 years 280 (233 – 336) 32.3 (24.1 – 57.3) 346 (260 – 445) 1,420 (1,080 – 2,230) 352
12–19 years 288 (250 – 331) 23.3 (16.5 – 47.6) 372 (320 – 421) 1,520 (1,370 – 1,730) 694
20–39 years 286 (242 – 337) 27.3 (20.2 – 38.7) 354 (311 – 443) 1,760 (1,360 – 2,500) 638
40–59 years 248 (197 – 313) 19.3 (10.8 – 26.6) 349 (271 – 421) 1,840 (1,450 – 2,330) 450
60 years and older 294 (239 – 362) 26.8 (16.3 – 41.8) 424 (323 – 541) 2,010 (1,700 – 2,280) 492
Table 4.11.a.3. Urinary enterolactone: Mexican Americans
Geometric mean and selected percentiles of urine concentrations (in µg/L) for Mexican Americans in the U.S. 
population aged 6 years and older, National Health and Nutrition Examination Survey, 2003–2006. 
Geometric mean 
 (95% conf. interval)
Selected percentiles (95% conf. interval) Sample 
size10th 50th 90th
Males and Females
Total, 6 years and older 315 (282 – 352) 39.4 (28.0 – 48.8) 402 (364 – 435) 1,630 (1,460 – 1,930) 1,287
6–11 years 278 (238 – 325) 53.7 (36.8 – 70.2) 348 (265 – 403) 1,100 (898 – 1,510) 231
12–19 years 344 (288 – 411) 54.9 (36.7 – 77.6) 447 (386 – 526) 1,590 (1,280 – 2,050) 445
20–39 years 329 (276 – 393) 38.9 (21.1 – 56.1) 389 (334 – 471) 1,900 (1,470 – 2,650) 282
40–59 years 295 (220 – 396) 28.5 (12.0 – 43.9) 411 (286 – 578) 1,510 (1,260 – 2,150) 157
60 years and older 305 (192 – 484) 29.7 (6.75 – 60.8) 438 (204 – 673) 1,800 (1,270 – 5,730) 172
Males
Total, 6 years and older 320 (276 – 372) 38.3 (25.0 – 51.0) 423 (362 – 501) 1,700 (1,490 – 2,030) 625
6–11 years 305 (243 – 382) 55.3 (34.8 – 94.5) 367 (243 – 433) 1,210 (862 – 1,960) 112
12–19 years 331 (249 – 440) 46.6 (31.6 – 67.2) 441 (325 – 562) 1,660 (1,180 – 2,480) 228
20–39 years 303 (224 – 411) 25.1 (6.52 – 63.5) 390 (276 – 518) 1,890 (1,350 – 2,780) 117
40–59 years 340 (230 – 504) 28.6† (12.2 – 44.6) 540 (286 – 673) 1,500† (1,250 – 3,450) 85
60 years and older 399 (215 – 739) 38.2† (4.50 – 106) 521 (205 – 1,080) 2,030† (1,350 – 6,680) 83
Females
Total, 6 years and older 309 (268 – 356) 43.0 (21.6 – 57.0) 366 (317 – 436) 1,560 (1,280 – 1,960) 662
6–11 years 252 (201 – 316) 46.3 (32.3 – 56.2) 319 (243 – 407) 1,010 (776 – 1,740) 119
12–19 years 358 (286 – 449) 65.0 (31.6 – 94.3) 446 (356 – 567) 1,460 (1,160 – 2,040) 217
20–39 years 363 (283 – 466) 45.0 (14.8 – 74.7) 383 (310 – 566) 1,900 (1,260 – 3,510) 165
40–59 years 253 (177 – 360) 21.0† (5.66 – 44.2) 317 (192 – 525) 1,440† (920 – 3,070) 72
60 years and older 245 (142 – 423) 18.4† (5.17 – 52.4) 267 (149 – 676) 1,690† (994 – 3,320) 89
† Estimate is subject to greater uncertainty due to small cell size.  
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Table 4.11.a.4. Urinary enterolactone: Non-Hispanic blacks
Geometric mean and selected percentiles of urine concentrations (in µg/L) for non-Hispanic blacks in the U.S. 
population aged 6 years and older, National Health and Nutrition Examination Survey, 2003–2006. 
Geometric mean 
 (95% conf. interval)
Selected percentiles (95% conf. interval) Sample 
size10th 50th 90th
Males and Females
Total, 6 years and older 299 (270 – 331) 26.0 (21.3 – 43.2) 421 (365 – 469) 1,580 (1,450 – 1,790) 1,343
6–11 years 429 (362 – 509) 117 (55.9 – 164) 419 (348 – 565) 1,560 (1,350 – 2,070) 207
12–19 years 370 (335 – 408) 46.6 (30.1 – 64.8) 523 (472 – 569) 1,640 (1,460 – 1,970) 496
20–39 years 264 (215 – 326) 23.0 (10.3 – 45.2) 437 (305 – 538) 1,410 (1,210 – 2,230) 249
40–59 years 248 (195 – 316) 19.8 (7.86 – 31.8) 326 (239 – 423) 1,630 (1,390 – 2,210) 231
60 years and older 349 (267 – 455) 39.2 (14.7 – 66.3) 551 (368 – 611) 1,760 (1,270 – 2,330) 160
Males
Total, 6 years and older 320 (272 – 375) 30.8 (17.1 – 56.8) 439 (339 – 549) 1,740 (1,480 – 2,210) 661
6–11 years 425 (348 – 519) 123† (89.3 – 164) 363 (303 – 558) 1,460† (1,320 – 2,160) 99
12–19 years 397 (345 – 457) 58.9 (34.1 – 79.3) 502 (412 – 605) 1,770 (1,420 – 2,810) 258
20–39 years 287 (212 – 389) 24.9 (6.85 – 46.6) 444 (248 – 595) 1,860 (1,430 – 3,290) 116
40–59 years 288 (198 – 419) 16.4 (2.90 – 78.2) 344 (236 – 698) 1,880 (1,380 – 2,860) 114
60 years and older 295 (191 – 456) 17.8† (4.36 – 60.4) 520 (287 – 646) 1,290† (1,080 – 2,200) 74
Females
Total, 6 years and older 282 (253 – 315) 23.9 (18.9 – 43.7) 418 (356 – 464) 1,470 (1,310 – 1,750) 682
6–11 years 434 (324 – 582) 94.1† (22.9 – 174) 531 (364 – 624) 1,590† (1,140 – 2,390) 108
12–19 years 344 (294 – 402) 33.9 (15.3 – 59.8) 530 (439 – 596) 1,590 (1,350 – 1,910) 238
20–39 years 247 (187 – 327) 18.0 (8.47 – 45.5) 421 (246 – 540) 1,180 (934 – 1,760) 133
40–59 years 220 (166 – 291) 21.5 (6.67 – 39.7) 303 (178 – 410) 1,530 (1,140 – 2,250) 117
60 years and older 387 (271 – 553) 44.3† (10.3 – 109) 575 (365 – 666) 1,770† (1,430 – 2,340) 86
† Estimate is subject to greater uncertainty due to small cell size.  
Table 4.11.a.5. Urinary enterolactone: Non-Hispanic whites
Geometric mean and selected percentiles of urine concentrations (in µg/L) for non-Hispanic whites in the U.S. 
population aged 6 years and older, National Health and Nutrition Examination Survey, 2003–2006. 
Geometric mean 
 (95% conf. interval)
Selected percentiles (95% conf. interval) Sample 
size10th 50th 90th
Males and Females
Total, 6 years and older 287 (256 – 322) 26.3 (22.3 – 31.2) 387 (336 – 447) 1,810 (1,650 – 2,010) 2,108
6–11 years 355 (279 – 452) 56.3 (25.8 – 99.3) 456 (279 – 562) 1,480 (1,100 – 2,250) 193
12–19 years 292 (248 – 344) 27.1 (17.2 – 54.8) 369 (325 – 424) 1,660 (1,390 – 1,950) 378
20–39 years 254 (207 – 312) 26.3 (18.2 – 35.4) 313 (235 – 389) 1,640 (1,410 – 2,290) 494
40–59 years 266 (219 – 323) 19.1 (12.2 – 26.9) 393 (300 – 480) 1,850 (1,510 – 2,440) 448
60 years and older 347 (301 – 401) 33.4 (20.6 – 45.2) 495 (427 – 588) 2,060 (1,800 – 2,400) 595
Males
Total, 6 years and older 308 (265 – 358) 29.4 (22.9 – 38.0) 434 (374 – 489) 1,900 (1,660 – 2,160) 1,035
6–11 years 454 (328 – 629) 97.2† (29.3 – 181) 528 (338 – 805) 1,560† (1,070 – 2,670) 99
12–19 years 304 (245 – 379) 27.8 (10.6 – 56.7) 391 (337 – 493) 1,760 (1,360 – 2,340) 191
20–39 years 234 (173 – 316) 25.4 (9.45 – 38.0) 269 (194 – 400) 1,570 (1,300 – 2,460) 217
40–59 years 303 (232 – 397) 22.0 (9.47 – 38.6) 437 (304 – 578) 2,130 (1,580 – 2,880) 229
60 years and older 404 (339 – 482) 40.6 (21.8 – 72.4) 596 (454 – 697) 2,080 (1,700 – 2,780) 299
Females
Total, 6 years and older 268 (227 – 316) 24.6 (19.0 – 29.0) 350 (294 – 415) 1,760 (1,450 – 2,090) 1,073
6–11 years 267 (199 – 358) 26.4† (12.5 – 71.6) 278 (207 – 488) 1,390† (1,040 – 3,010) 94
12–19 years 279 (224 – 347) 21.0 (14.5 – 64.0) 336 (257 – 404) 1,540 (1,020 – 1,990) 187
20–39 years 277 (224 – 342) 26.9 (19.5 – 35.1) 335 (264 – 408) 1,770 (1,230 – 2,790) 277
40–59 years 232 (177 – 305) 17.1 (8.39 – 26.9) 348 (220 – 423) 1,730 (1,250 – 2,200) 219
60 years and older 308 (245 – 388) 29.2 (17.2 – 42.6) 434 (323 – 570) 2,040 (1,690 – 2,360) 296
† Estimate is subject to greater uncertainty due to small cell size.  
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Table 4.11.b. Urinary enterolactone: Concentrations by survey cycle
Geometric mean and selected percentiles of urine concentrations (in µg/L) for the U.S. population, National 
Health and Nutrition Examination Survey, 1999–2006. 
Geometric mean 
 (95% conf. interval)
Selected percentiles (95% conf. interval) Sample 
size5th 50th 95th
Total, 6 years and older
 1999–2000 239 (200 – 286) 8.77 (4.68 – 13.0) 315 (246 – 380) 2,800 (2,520 – 3,200) 2,548
 2001–2002 259 (233 – 287) 9.27 (6.84 – 11.8) 350 (314 – 389) 2,720 (1,970 – 3,440) 2,794
 2003–2004 298 (265 – 334) 13.9 (10.0 – 17.9) 395 (332 – 462) 2,620 (2,370 – 2,980) 2,594
 2005–2006 283 (245 – 327) 9.40 (5.54 – 14.3) 384 (339 – 456) 2,880 (2,540 – 3,170) 2,528
Age group
6–11 years
 1999–2000 308 (219 – 432) 34.7 (< LOD – 45.9) 354 (243 – 473) 2,790 (1,850 – 4,390) 331
 2001–2002 288 (245 – 339) 23.4 (12.0 – 41.1) 329 (275 – 405) 2,190 (1,520 – 2,610) 396
 2003–2004 384 (287 – 513) 36.1 (8.67 – 75.5) 414 (303 – 557) 2,300 (1,750 – 3,760) 341
 2005–2006 300 (242 – 373) 19.6 (4.34 – 30.0) 390 (279 – 544) 1,890 (1,420 – 2,630) 351
12–19 years
 1999–2000 250 (191 – 327) 10.0 (3.06 – 16.5) 316 (244 – 408) 2,920 (2,270 – 4,630) 746
 2001–2002 267 (231 – 308) 16.1 (10.1 – 20.0) 318 (256 – 398) 2,170 (1,620 – 3,480) 744
 2003–2004 314 (267 – 369) 18.4 (6.64 – 26.0) 399 (335 – 461) 2,620 (2,120 – 3,080) 729
 2005–2006 292 (245 – 348) 9.91 (5.93 – 14.9) 393 (350 – 490) 2,320 (1,830 – 3,090) 693
20–39 years
 1999–2000 231 (182 – 293) 8.06 (1.33 – 17.0) 303 (228 – 380) 2,660 (2,310 – 4,310) 535
 2001–2002 242 (196 – 301) 8.89 (6.56 – 10.9) 335 (263 – 419) 2,890 (1,870 – 4,740) 604
 2003–2004 279 (224 – 349) 14.1 (6.47 – 23.0) 372 (289 – 474) 2,500 (1,830 – 3,330) 554
 2005–2006 265 (218 – 322) 9.63 (4.72 – 19.0) 337 (276 – 381) 3,130 (2,410 – 7,470) 583
40–59 years
 1999–2000 211 (161 – 278) 2.50 (.690 – 7.44) 297 (229 – 401) 2,970 (2,250 – 5,070) 420
 2001–2002 250 (187 – 333) 7.35 (3.98 – 11.5) 369 (278 – 429) 2,880 (1,870 – 4,820) 531
 2003–2004 271 (231 – 319) 10.2 (7.40 – 12.5) 372 (281 – 429) 2,720 (2,350 – 4,400) 452
 2005–2006 270 (203 – 360) 5.04 (2.73 – 13.3) 397 (299 – 539) 3,060 (2,260 – 4,030) 449
60 years and older
 1999–2000 261 (205 – 331) 10.3 (4.10 – 18.7) 315 (238 – 417) 2,680 (2,240 – 4,580) 516
 2001–2002 288 (247 – 334) 8.74 (3.09 – 17.8) 386 (311 – 451) 2,450 (1,710 – 3,460) 519
 2003–2004 327 (287 – 372) 17.3 (9.92 – 21.1) 457 (367 – 547) 2,690 (2,360 – 3,170) 518
 2005–2006 327 (260 – 410) 11.9 (6.63 – 17.1) 507 (374 – 632) 2,680 (2,070 – 4,400) 452
Gender
Males
 1999–2000 254 (212 – 304) 10.4 (6.45 – 12.8) 351 (266 – 417) 2,720 (2,460 – 3,480) 1,219
 2001–2002 262 (233 – 295) 9.23 (6.76 – 10.9) 339 (314 – 386) 3,040 (2,310 – 4,570) 1,375
 2003–2004 314 (280 – 351) 17.8 (10.7 – 21.9) 424 (375 – 474) 2,610 (2,120 – 3,340) 1,244
 2005–2006 301 (247 – 368) 9.40 (4.26 – 14.9) 421 (347 – 512) 3,110 (2,750 – 3,520) 1,252
Females
 1999–2000 226 (180 – 284) 6.64 (.711 – 16.8) 287 (237 – 340) 2,810 (2,280 – 4,450) 1,329
 2001–2002 255 (226 – 288) 9.25 (5.66 – 13.9) 356 (298 – 397) 2,190 (1,720 – 3,140) 1,419
 2003–2004 283 (233 – 343) 10.5 (9.33 – 15.6) 369 (282 – 464) 2,620 (2,270 – 3,420) 1,350
 2005–2006 267 (220 – 324) 9.18 (6.13 – 15.1) 357 (318 – 444) 2,650 (2,210 – 3,340) 1,276
Race/ethnicity
Mexican Americans
 1999–2000 212 (169 – 265) 6.58 (.710 – 13.4) 281 (232 – 338) 2,690 (2,430 – 3,350) 813
 2001–2002 275 (221 – 342) 12.6 (4.92 – 26.8) 347 (313 – 395) 2,320 (1,650 – 3,490) 679
 2003–2004 275 (239 – 316) 9.35 (6.08 – 15.6) 375 (316 – 434) 2,240 (1,920 – 3,170) 653
 2005–2006 359 (311 – 415) 26.7 (18.2 – 38.6) 418 (363 – 514) 2,640 (2,010 – 3,390) 634
Non-Hispanic Blacks
 1999–2000 262 (194 – 352) 8.91 (.671 – 17.0) 360 (293 – 449) 2,480 (1,990 – 4,170) 594
 2001–2002 279 (224 – 347) 7.85 (3.49 – 15.7) 420 (339 – 488) 1,980 (1,690 – 2,530) 692
 2003–2004 324 (282 – 372) 15.5 (6.01 – 26.1) 425 (358 – 525) 2,230 (1,960 – 2,630) 681
 2005–2006 276 (237 – 322) 7.55 (5.86 – 11.4) 410 (346 – 483) 2,560 (2,210 – 3,030) 662
Non-Hispanic Whites
 1999–2000 247 (196 – 312) 8.26 (2.25 – 15.6) 317 (241 – 401) 2,990 (2,530 – 4,070) 901
 2001–2002 268 (236 – 305) 9.30 (6.94 – 11.8) 356 (308 – 398) 2,780 (1,960 – 3,810) 1,211
 2003–2004 301 (256 – 355) 16.3 (10.1 – 19.8) 397 (307 – 490) 2,650 (2,340 – 3,340) 1,069
 2005–2006 274 (228 – 329) 9.17 (4.29 – 14.8) 372 (318 – 459) 2,900 (2,420 – 3,340) 1,039























































































































































































































































Total 3−5y 6−11y 12−19y 20+y Males Females MA NHB NHW 
(6+y) 
Values in the graph are suppressed if either the point estimate or the lower 95% confidence limit is noted as “< LOD” in the accompanying table. 
Figure 4.11.b. Urinary enterolactone: Concentrations by survey cycle 
Selected percentiles in μg/L (95% confidence intervals), National Health and 
Nutrition Examination Survey, 1999–2006 
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Figure 4.12.a. Urinary enterolactone (creatinine corrected): 
Concentrations by age group 
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Table 4.12.a.2. Urinary enterolactone (creatinine corrected): Total population
Geometric mean and selected percentiles of urine concentrations (in µg/g creatinine) for the total U.S. 
population aged 6 years and older, National Health and Nutrition Examination Survey, 2003–2006. 
Geometric mean 
 (95% conf. interval)
Selected percentiles (95% conf. interval) Sample 
size10th 50th 90th
Males and Females
Total, 6 years and older 277 (252 – 305) 26.1 (20.3 – 31.3) 375 (341 – 418) 1,620 (1,480 – 1,800) 5,122
6–11 years 368 (312 – 434) 79.9 (44.5 – 104) 463 (382 – 535) 1,480 (1,200 – 1,900) 692
12–19 years 225 (203 – 250) 22.6 (18.0 – 36.1) 290 (271 – 307) 1,140 (996 – 1,220) 1,422
20–39 years 232 (200 – 269) 20.0 (15.1 – 28.5) 314 (273 – 363) 1,460 (1,250 – 1,720) 1,137
40–59 years 274 (231 – 326) 21.1 (15.4 – 28.7) 366 (323 – 468) 1,720 (1,510 – 2,100) 901
60 years and older 383 (334 – 438) 33.8 (22.8 – 46.9) 582 (502 – 671) 2,130 (1,840 – 2,310) 970
Males
Total, 6 years and older 244 (216 – 275) 21.0 (16.3 – 28.5) 336 (298 – 371) 1,400 (1,290 – 1,580) 2,496
6–11 years 409 (329 – 508) 91.0 (45.7 – 127) 471 (395 – 622) 1,380 (1,190 – 2,000) 340
12–19 years 215 (188 – 247) 20.9 (13.6 – 34.9) 292 (258 – 312) 1,150 (924 – 1,390) 728
20–39 years 189 (152 – 234) 16.8 (11.7 – 21.7) 257 (209 – 315) 1,290 (1,050 – 1,610) 499
40–59 years 235 (187 – 296) 18.5 (12.7 – 30.6) 328 (267 – 417) 1,450 (1,230 – 1,930) 451
60 years and older 344 (289 – 409) 35.8 (16.2 – 57.6) 522 (452 – 576) 1,720 (1,490 – 2,210) 478
Females
Total, 6 years and older 313 (275 – 357) 30.0 (22.8 – 35.5) 418 (360 – 481) 1,840 (1,640 – 2,210) 2,626
6–11 years 329 (271 – 399) 56.3 (31.6 – 89.2) 431 (324 – 515) 1,660 (1,080 – 2,310) 352
12–19 years 237 (208 – 270) 25.5 (14.5 – 43.8) 285 (251 – 320) 1,080 (918 – 1,230) 694
20–39 years 284 (237 – 340) 30.8 (15.9 – 42.8) 377 (315 – 431) 1,640 (1,360 – 2,360) 638
40–59 years 316 (253 – 395) 23.7 (15.5 – 32.1) 424 (334 – 585) 2,130 (1,580 – 2,940) 450
60 years and older 417 (336 – 517) 28.3 (19.4 – 53.4) 636 (511 – 784) 2,290 (2,020 – 2,730) 492
  
Table 4.12.a.3. Urinary enterolactone (creatinine corrected): Mexican Americans
Geometric mean and selected percentiles of urine concentrations (in µg/g creatinine) for Mexican Americans in 
the U.S. population aged 6 years and older, National Health and Nutrition Examination Survey, 2003–2006. 
Geometric mean 
 (95% conf. interval)
Selected percentiles (95% conf. interval) Sample 
size10th 50th 90th
Males and Females
Total, 6 years and older 284 (251 – 322) 37.6 (27.2 – 48.7) 366 (331 – 417) 1,410 (1,240 – 1,620) 1,287
6–11 years 349 (304 – 400) 79.6 (57.9 – 113) 404 (338 – 472) 1,330 (1,020 – 1,670) 231
12–19 years 266 (225 – 315) 40.1 (26.8 – 56.0) 343 (286 – 397) 1,160 (986 – 1,320) 445
20–39 years 266 (218 – 324) 29.6 (14.6 – 47.7) 328 (257 – 408) 1,480 (1,210 – 1,940) 282
40–59 years 270 (203 – 358) 25.4 (10.6 – 46.6) 400 (291 – 589) 1,190 (898 – 1,770) 157
60 years and older 376 (246 – 576) 29.4 (8.02 – 89.3) 487 (332 – 761) 1,800 (1,550 – 2,210) 172
Males
Total, 6 years and older 253 (219 – 291) 31.0 (22.9 – 44.1) 334 (287 – 401) 1,210 (1,020 – 1,480) 625
6–11 years 365 (292 – 457) 88.4 (58.8 – 127) 403 (290 – 494) 1,390 (956 – 1,970) 112
12–19 years 240 (185 – 312) 31.2 (18.5 – 42.9) 289 (241 – 375) 1,170 (928 – 1,530) 228
20–39 years 220 (167 – 290) 27.2 (3.66 – 48.2) 257 (222 – 396) 1,270 (930 – 1,900) 117
40–59 years 249 (174 – 358) 23.3† (6.34 – 49.2) 399 (235 – 603) 898† (841 – 1,530) 85
60 years and older 355 (200 – 631) 37.2† (3.60 – 128) 503 (322 – 714) 1,540† (1,100 – 6,820) 83
Females
Total, 6 years and older 322 (275 – 378) 40.7 (28.9 – 66.8) 382 (331 – 484) 1,600 (1,330 – 1,870) 662
6–11 years 332 (267 – 413) 64.3 (34.7 – 110) 401 (311 – 538) 1,130 (861 – 1,830) 119
12–19 years 296 (235 – 372) 57.9 (30.5 – 99.0) 378 (316 – 443) 1,100 (860 – 1,350) 217
20–39 years 332 (257 – 430) 39.7 (17.2 – 71.6) 361 (292 – 548) 1,630 (1,300 – 3,210) 165
40–59 years 294 (209 – 414) 28.5† (3.25 – 64.6) 374 (215 – 655) 1,390† (1,090 – 2,590) 72
60 years and older 395 (235 – 663) 25.8† (5.58 – 112) 487 (197 – 1,220) 1,880† (1,590 – 4,100) 89
† Estimate is subject to greater uncertainty due to small cell size.  
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Table 4.12.a.4. Urinary enterolactone (creatinine corrected): Non-Hispanic blacks
Geometric mean and selected percentiles of urine concentrations (in µg/g creatinine) for non-Hispanic blacks 
in the U.S. population aged 6 years and older, National Health and Nutrition Examination Survey, 2003–2006. 
Geometric mean 
 (95% conf. interval)
Selected percentiles (95% conf. interval) Sample 
size10th 50th 90th
Males and Females
Total, 6 years and older 210 (189 – 233) 20.2 (13.8 – 30.9) 294 (274 – 325) 1,080 (995 – 1,210) 1,343
6–11 years 403 (342 – 476) 126 (82.0 – 147) 469 (378 – 550) 1,300 (1,080 – 1,660) 207
12–19 years 212 (194 – 232) 30.8 (19.9 – 38.3) 282 (251 – 313) 843 (755 – 1,010) 496
20–39 years 164 (133 – 201) 15.8 (10.5 – 22.2) 263 (194 – 306) 914 (741 – 1,040) 249
40–59 years 180 (143 – 228) 11.8 (5.52 – 24.1) 264 (207 – 321) 1,080 (933 – 1,390) 231
60 years and older 311 (242 – 399) 25.1 (12.7 – 61.0) 489 (325 – 693) 1,430 (1,210 – 1,770) 160
Males
Total, 6 years and older 187 (157 – 222) 20.0 (11.2 – 31.3) 267 (223 – 305) 1,050 (940 – 1,200) 661
6–11 years 401 (329 – 489) 122† (69.6 – 153) 417 (332 – 523) 1,220† (1,020 – 1,730) 99
12–19 years 212 (186 – 243) 31.8 (19.4 – 44.2) 264 (222 – 301) 923 (767 – 1,320) 258
20–39 years 138 (103 – 185) 12.2 (2.62 – 27.1) 192 (113 – 291) 969 (657 – 1,180) 116
40–59 years 165 (114 – 238) 10.2 (3.65 – 35.8) 233 (167 – 305) 1,040 (711 – 1,440) 114
60 years and older 217 (142 – 330) 14.8† (3.29 – 51.0) 329 (249 – 440) 1,090† (842 – 3,370) 74
Females
Total, 6 years and older 231 (207 – 259) 20.3 (13.3 – 35.8) 317 (286 – 349) 1,150 (974 – 1,410) 682
6–11 years 405 (308 – 532) 127† (20.6 – 163) 512 (386 – 585) 1,360† (898 – 2,610) 108
12–19 years 212 (180 – 250) 26.0 (11.1 – 39.8) 299 (249 – 360) 814 (727 – 927) 238
20–39 years 188 (144 – 246) 16.1 (7.55 – 32.9) 276 (197 – 347) 820 (619 – 1,360) 133
40–59 years 195 (147 – 258) 11.4 (5.89 – 33.6) 289 (205 – 392) 1,170 (928 – 1,600) 117
60 years and older 391 (275 – 557) 40.6† (9.12 – 96.7) 707 (327 – 822) 1,620† (1,380 – 2,090) 86
† Estimate is subject to greater uncertainty due to small cell size.  
Table 4.12.a.5. Urinary enterolactone (creatinine corrected): Non-Hispanic whites
Geometric mean and selected percentiles of urine concentrations (in µg/g creatinine) for non-Hispanic whites 
in the U.S. population aged 6 years and older, National Health and Nutrition Examination Survey, 2003–2006. 
Geometric mean 
(95% conf. interval)
Selected percentiles (95% conf. interval) Sample 
size10th 50th 90th
Males and Females
Total, 6 years and older 292 (258 – 331) 26.3 (20.0 – 31.5) 406 (350 – 469) 1,680 (1,510 – 2,020) 2,108
6–11 years 385 (305 – 486) 80.8 (35.3 – 113) 467 (367 – 615) 1,380 (1,170 – 2,000) 193
12–19 years 229 (196 – 267) 22.7 (14.2 – 39.5) 277 (247 – 318) 1,150 (959 – 1,320) 378
20–39 years 234 (188 – 292) 18.7 (12.5 – 29.1) 319 (258 – 417) 1,550 (1,200 – 2,350) 494
40–59 years 286 (232 – 352) 22.5 (14.8 – 30.7) 379 (323 – 500) 1,810 (1,500 – 2,210) 448
60 years and older 415 (358 – 480) 38.5 (23.7 – 57.9) 611 (529 – 717) 2,210 (1,850 – 2,610) 595
Males
Total, 6 years and older 258 (219 – 304) 20.6 (16.0 – 30.1) 360 (309 – 418) 1,490 (1,320 – 1,680) 1,035
6–11 years 440 (322 – 602) 111† (32.6 – 149) 478 (380 – 740) 1,330† (1,150 – 2,850) 99
12–19 years 217 (178 – 265) 20.8 (13.2 – 36.5) 295 (230 – 345) 1,150 (843 – 1,400) 191
20–39 years 185 (134 – 256) 16.1 (5.82 – 20.9) 263 (176 – 362) 1,330 (1,010 – 2,350) 217
40–59 years 254 (190 – 338) 18.8 (12.8 – 34.3) 338 (267 – 497) 1,570 (1,270 – 2,040) 229
60 years and older 377 (313 – 454) 38.1 (18.3 – 61.4) 551 (467 – 666) 1,820 (1,480 – 2,430) 299
Females
Total, 6 years and older 330 (280 – 389) 31.3 (23.1 – 39.4) 447 (375 – 526) 1,990 (1,660 – 2,530) 1,073
6–11 years 330 (250 – 436) 57.0† (24.7 – 98.5) 427 (257 – 554) 1,690† (1,010 – 2,420) 94
12–19 years 242 (198 – 296) 28.8 (12.4 – 75.4) 264 (238 – 320) 1,180 (909 – 1,350) 187
20–39 years 296 (236 – 373) 30.0 (13.3 – 48.8) 417 (312 – 470) 1,690 (1,250 – 3,260) 277
40–59 years 322 (247 – 419) 25.9 (15.8 – 32.6) 445 (323 – 614) 2,130 (1,500 – 3,470) 219
60 years and older 447 (355 – 562) 35.6 (21.3 – 69.1) 662 (529 – 845) 2,400 (2,090 – 3,040) 296
† Estimate is subject to greater uncertainty due to small cell size.  
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Table 4.12.b. Urinary enterolactone (creatinine corrected): 
Concentrations by survey cycle
Geometric mean and selected percentiles of urine concentrations (in µg/g creatinine) for the U.S. population, 
National Health and Nutrition Examination Survey, 1999–2006. 
Geometric mean 
(95% conf. interval)
Selected percentiles (95% conf. interval) Sample 
size5th 50th 95th
Total, 6 years and older
 1999–2000 218 (184 – 260) 7.15 (4.06 – 9.89) 284 (247 – 336) 2,250 (1,890 – 2,930) 2,548
 2001–2002 243 (220 – 268) 7.63 (5.19 – 10.3) 323 (293 – 360) 2,120 (1,790 – 2,460) 2,794
 2003–2004 279 (245 – 317) 12.3 (9.27 – 14.5) 371 (325 – 430) 2,400 (2,030 – 2,890) 2,594
 2005–2006 276 (237 – 321) 9.89 (6.76 – 13.8) 382 (330 – 447) 2,640 (2,260 – 3,380) 2,528
Age group
6–11 years
 1999–2000 315 (238 – 416) 38.6 (<LOD – 66.8) 380 (269 – 431) 2,040 (1,640 – 3,510) 331
 2001–2002 327 (274 – 391) 27.3 (10.5 – 59.2) 349 (264 – 477) 1,980 (1,570 – 3,360) 396
 2003–2004 409 (310 – 540) 41.0 (11.1 – 79.7) 469 (356 – 628) 2,300 (1,750 – 3,390) 341
 2005–2006 331 (268 – 408) 23.4 (8.67 – 46.6) 456 (326 – 526) 1,820 (1,580 – 2,970) 351
12–19 years
 1999–2000 169 (133 – 214) 6.86 (2.00 – 13.6) 209 (172 – 263) 1,820 (1,340 – 2,460) 746
 2001–2002 206 (178 – 239) 12.2 (7.63 – 14.1) 254 (224 – 292) 1,500 (1,240 – 2,730) 744
 2003–2004 235 (202 – 273) 14.7 (6.78 – 20.2) 285 (256 – 307) 1,510 (1,310 – 2,700) 729
 2005–2006 216 (184 – 254) 9.50 (5.93 – 13.1) 296 (254 – 335) 1,410 (1,170 – 1,890) 693
20–39 years
 1999–2000 183 (143 – 235) 5.46 (.836 – 8.94) 248 (199 – 291) 1,900 (1,480 – 3,890) 535
 2001–2002 196 (160 – 240) 4.83 (2.86 – 9.88) 298 (251 – 334) 1,670 (1,430 – 2,450) 604
 2003–2004 235 (186 – 299) 10.0 (4.07 – 14.8) 324 (250 – 422) 2,140 (1,640 – 3,890) 554
 2005–2006 229 (187 – 279) 9.40 (4.07 – 16.0) 299 (256 – 348) 2,630 (1,680 – 6,020) 583
40–59 years
 1999–2000 215 (165 – 279) 4.14 (1.49 – 8.85) 282 (244 – 375) 2,520 (2,030 – 4,780) 420
 2001–2002 248 (191 – 321) 5.90 (3.49 – 10.7) 335 (266 – 435) 2,450 (1,600 – 4,940) 531
 2003–2004 260 (218 – 310) 8.64 (6.33 – 13.5) 354 (300 – 444) 2,450 (2,010 – 4,240) 452
 2005–2006 288 (213 – 389) 8.45 (3.84 – 13.9) 394 (306 – 602) 3,380 (2,280 – 4,890) 449
60 years and older
 1999–2000 313 (227 – 432) 14.0 (3.73 – 20.9) 431 (312 – 611) 2,530 (1,940 – 4,500) 516
 2001–2002 341 (296 – 392) 9.15 (4.22 – 17.6) 432 (383 – 476) 2,550 (2,130 – 3,030) 519
 2003–2004 387 (330 – 453) 18.4 (10.5 – 21.5) 547 (439 – 682) 2,690 (2,340 – 3,340) 518
 2005–2006 379 (300 – 478) 11.9 (6.12 – 17.7) 597 (495 – 730) 3,030 (2,250 – 4,480) 452
Gender
Males
 1999–2000 199 (170 – 234) 7.25 (3.82 – 9.99) 262 (231 – 309) 2,020 (1,810 – 2,480) 1,219
 2001–2002 213 (191 – 238) 6.70 (4.49 – 9.78) 287 (256 – 317) 1,960 (1,620 – 2,660) 1,375
 2003–2004 245 (215 – 280) 12.8 (9.17 – 14.8) 330 (289 – 372) 2,030 (1,770 – 2,390) 1,244
 2005–2006 243 (196 – 300) 8.40 (4.08 – 13.6) 336 (280 – 416) 2,200 (1,930 – 2,640) 1,252
Females
 1999–2000 238 (191 – 297) 7.08 (2.40 – 14.0) 303 (263 – 378) 2,550 (2,010 – 3,520) 1,329
 2001–2002 274 (241 – 312) 9.46 (5.43 – 13.8) 356 (314 – 405) 2,140 (1,970 – 2,430) 1,419
 2003–2004 314 (257 – 385) 11.2 (8.54 – 17.0) 414 (330 – 501) 2,810 (2,290 – 3,940) 1,350
 2005–2006 313 (261 – 375) 12.4 (9.39 – 15.7) 419 (342 – 527) 3,080 (2,520 – 4,780) 1,276
Race/ethnicity
Mexican Americans
 1999–2000 194 (165 – 228) 3.78 (2.01 – 15.3) 253 (224 – 282) 2,020 (1,700 – 2,810) 813
 2001–2002 259 (213 – 314) 13.0 (3.24 – 23.2) 361 (298 – 409) 1,630 (1,320 – 3,010) 679
 2003–2004 248 (217 – 282) 6.88 (4.10 – 14.5) 349 (310 – 397) 1,800 (1,470 – 2,260) 653
 2005–2006 324 (267 – 393) 26.3 (13.0 – 36.2) 378 (321 – 471) 2,030 (1,680 – 2,770) 634
Non-Hispanic Blacks
 1999–2000 168 (124 – 226) 3.12 (.422 – 9.24) 215 (175 – 276) 1,590 (1,220 – 3,280) 594
 2001–2002 195 (153 – 248) 6.71 (4.02 – 9.33) 303 (257 – 334) 1,460 (1,110 – 1,730) 692
 2003–2004 228 (194 – 268) 10.8 (4.54 – 17.1) 300 (274 – 341) 1,460 (1,220 – 2,110) 681
 2005–2006 193 (167 – 223) 6.32 (4.70 – 8.61) 285 (249 – 330) 1,490 (1,290 – 1,660) 662
Non-Hispanic Whites
 1999–2000 243 (194 – 304) 7.71 (3.26 – 11.8) 324 (280 – 389) 2,490 (2,010 – 3,540) 901
 2001–2002 265 (232 – 302) 7.97 (5.19 – 11.8) 340 (299 – 393) 2,400 (1,980 – 2,900) 1,211
 2003–2004 297 (248 – 356) 13.5 (9.57 – 17.5) 409 (331 – 492) 2,590 (2,040 – 3,380) 1,069
 2005–2006 288 (238 – 347) 11.0 (5.96 – 14.9) 403 (329 – 497) 2,910 (2,310 – 4,180) 1,039











































































































































































































































Total 3−5y 6−11y 12−19y 20+y Males Females MA NHB NHW 
(6+y) 
Values in the graph are suppressed if either the point estimate or the lower 95% confidence limit is noted as “< LOD” in the accompanying table. 
Figure 4.12.b. Urinary enterolactone (creatinine corrected): 
Concentrations by survey cycle 
Selected percentiles in μg/g creatinine (95% confidence intervals), National Health and 
Nutrition Examination Survey, 1999–2006
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Figure H.5.a. Geometric mean of glycidamide-to-acrylamide hemoglobin adduct ratio in the U.S. population aged 3 years and older, 
National Health and Nutrition Examination Survey, 2003–2004.
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Figure 5.1.a. Acrylamide hemoglobin adduct: Concentrations by age group 
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Table 5.1.a.2. Acrylamide hemoglobin adduct: Total population
Geometric mean and selected percentiles of whole blood concentrations (in pmol/g Hb) for the total U.S. 
population aged 3 years and older, National Health and Nutrition Examination Survey, 2003–2004. 
Geometric mean 
 (95%  conf. interval)
Selected percentiles (95% conf. interval) Sample 
size10th 50th 90th
Males and Females
Total, 3 years and older 61.2 (58.1 – 64.4) 33.7 (32.4 – 35.1) 54.7 (52.8 – 57.6) 140 (125 – 155) 7,101
3–5 years 59.4 (53.6 – 65.7) 38.5 (33.3 – 42.9) 58.2 (52.5 – 64.7) 90.2 (83.2 – 108) 350
6–11 years 58.6 (56.1 – 61.2) 39.6 (37.9 – 42.7) 57.3 (55.1 – 59.6) 86.7 (81.9 – 93.0) 769
12–19 years 57.4 (54.4 – 60.5) 35.6 (33.8 – 37.1) 54.4 (52.1 – 57.3) 99.9 (91.0 – 115) 1,889
20–39 years 68.5 (64.1 – 73.3) 35.1 (32.5 – 37.7) 59.8 (57.0 – 63.9) 164 (153 – 195) 1,406
40–59 years 64.0 (59.9 – 68.4) 33.5 (31.9 – 35.3) 55.1 (52.1 – 59.1) 160 (142 – 190) 1,164
60 years and older 50.1 (47.9 – 52.3) 29.6 (27.7 – 31.2) 46.5 (44.1 – 49.1) 96.1 (90.2 – 107) 1,523
Males
Total, 3 years and older 63.9 (60.2 – 67.9) 33.6 (31.3 – 35.6) 56.9 (53.6 – 60.0) 152 (140 – 177) 3,509
3–5 years 59.8 (53.2 – 67.2) 38.8 (30.3 – 43.5) 57.8 (49.4 – 65.8) 91.4 (82.7 – 115) 189
6–11 years 58.1 (55.2 – 61.1) 39.6 (35.4 – 41.9) 56.6 (54.7 – 59.3) 86.5 (81.2 – 91.3) 370
12–19 years 57.8 (53.7 – 62.3) 35.0 (32.0 – 37.2) 53.9 (51.1 – 57.7) 107 (94.6 – 127) 976
20–39 years 73.0 (66.9 – 79.7) 35.0 (30.8 – 38.7) 63.8 (59.3 – 68.6) 209 (168 – 228) 655
40–59 years 66.7 (62.2 – 71.6) 33.4 (29.3 – 36.0) 57.3 (51.0 – 64.1) 177 (150 – 205) 572
60 years and older 52.6 (47.8 – 57.9) 29.1 (27.4 – 31.3) 48.0 (42.9 – 52.8) 117 (96.9 – 143) 747
Females
Total, 3 years and older 58.7 (55.9 – 61.5) 33.9 (32.7 – 35.1) 53.3 (51.8 – 55.8) 125 (112 – 143) 3,592
3–5 years 58.9 (52.9 – 65.5) 37.6 (22.3 – 43.7) 59.5 (53.1 – 63.3) 86.1 (79.4 – 134) 161
6–11 years 59.1 (56.5 – 61.8) 40.4 (36.7 – 44.2) 57.4 (55.2 – 60.2) 86.9 (81.0 – 97.5) 399
12–19 years 56.9 (54.5 – 59.5) 36.9 (33.7 – 37.9) 55.3 (53.0 – 57.7) 97.5 (87.4 – 109) 913
20–39 years 64.3 (60.5 – 68.3) 35.2 (33.0 – 37.5) 56.8 (54.4 – 59.5) 152 (131 – 163) 751
40–59 years 61.6 (56.6 – 67.0) 33.4 (32.1 – 35.4) 53.8 (50.2 – 58.9) 151 (125 – 186) 592
60 years and older 48.1 (46.7 – 49.6) 29.8 (27.2 – 31.7) 45.4 (44.3 – 46.9) 84.0 (77.5 – 93.6) 776
Table 5.1.a.3. Acrylamide hemoglobin adduct: Mexican Americans
Geometric mean and selected percentiles of whole blood concentrations (in pmol/g Hb) for Mexican Americans 
in the U.S. population aged 3 years and older, National Health and Nutrition Examination Survey, 2003–2004. 
Geometric mean 
 (95%  conf. interval)
Selected percentiles (95% conf. interval) Sample 
size10th 50th 90th
Males and Females
Total, 3 years and older 61.7 (58.7 – 64.9) 40.0 (38.2 – 42.1) 57.4 (54.4 – 60.3) 101 (95.4 – 115) 1,792
3–5 years 62.0 (57.8 – 66.6) 45.6† (39.5 – 48.1) 59.6 (56.9 – 65.0) 87.4† (78.8 – 104) 90
6–11 years 61.6 (58.2 – 65.3) 44.3 (40.9 – 45.6) 61.4 (55.9 – 67.0) 88.3 (84.0 – 96.4) 250
12–19 years 57.3 (53.8 – 61.0) 38.7 (37.4 – 40.1) 55.2 (51.4 – 59.8) 86.9 (79.6 – 96.5) 590
20–39 years 64.5 (59.9 – 69.5) 40.7 (38.6 – 42.6) 57.5 (54.6 – 60.4) 118 (96.2 – 191) 321
40–59 years 60.9 (55.2 – 67.1) 38.7 (33.8 – 42.2) 56.1 (48.4 – 63.9) 117 (91.6 – 153) 208
60 years and older 57.5 (53.9 – 61.4) 36.5 (31.9 – 38.3) 53.9 (50.0 – 57.9) 108 (91.3 – 120) 333
Males
Total, 3 years and older 65.7 (60.9 – 70.9) 41.4 (38.6 – 43.4) 58.2 (55.0 – 62.6) 122 (103 – 185) 882
3–5 years 63.2 (57.5 – 69.5) 47.3† (40.5 – 48.8) 59.8 (57.1 – 65.5) 88.0† (74.1 – 122) 47
6–11 years 63.5 (59.7 – 67.6) 44.5 (40.8 – 48.3) 62.5 (59.6 – 68.1) 92.0 (84.2 – 102) 117
12–19 years 60.1 (55.8 – 64.8) 39.4 (36.8 – 41.5) 56.8 (53.7 – 61.0) 96.3 (85.5 – 124) 301
20–39 years 70.8 (60.5 – 82.9) 42.1 (37.6 – 44.7) 59.4 (53.2 – 66.6) 176 (111 – 353) 146
40–59 years 63.0 (57.3 – 69.3) 39.2† (25.0 – 44.2) 54.8 (50.1 – 59.7) 124† (92.9 – 193) 109
60 years and older 61.6 (57.0 – 66.5) 36.7 (32.5 – 38.2) 58.0 (51.6 – 64.0) 118 (101 – 151) 162
Females
Total, 3 years and older 57.6 (54.8 – 60.6) 39.0 (36.5 – 40.8) 55.4 (52.0 – 59.4) 89.0 (82.5 – 96.2) 910
3–5 years 60.7 (55.9 – 65.8) 43.4† (36.4 – 48.5) 59.5 (49.3 – 68.0) 82.5† (77.2 – 102) 43
6–11 years 59.5 (55.3 – 64.1) 44.0 (39.6 – 45.0) 58.4 (52.3 – 65.7) 82.2 (79.6 – 96.2) 133
12–19 years 54.5 (50.1 – 59.3) 38.1 (35.0 – 39.7) 53.1 (47.3 – 60.0) 79.4 (72.0 – 93.5) 289
20–39 years 58.2 (54.6 – 62.0) 39.1 (34.9 – 41.9) 55.1 (50.8 – 60.9) 94.5 (81.1 – 108) 175
40–59 years 58.6 (51.4 – 66.7) 38.7† (35.6 – 39.6) 57.8 (45.5 – 66.9) 94.9† (82.2 – 138) 99
60 years and older 54.2 (48.2 – 60.9) 35.7 (19.3 – 40.4) 50.5 (46.3 – 57.3) 85.6 (79.3 – 110) 171
† Estimate is subject to greater uncertainty due to small cell size.  
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Table 5.1.a.4. Acrylamide hemoglobin adduct: Non-Hispanic blacks
Geometric mean and selected percentiles of whole blood concentrations (in pmol/g Hb) for non-Hispanic blacks 
in the U.S. population aged 3 years and older, National Health and Nutrition Examination Survey, 2003–2004. 
Geometric mean 
 (95%  conf. interval)
Selected percentiles (95% conf. interval) Sample 
size10th 50th 90th
Males and Females
Total, 3 years and older 63.8 (57.1 – 71.2) 32.3 (30.6 – 33.9) 57.0 (51.9 – 64.0) 156 (123 – 210) 1,818
3–5 years 58.7 (53.4 – 64.5) 39.9 (34.1 – 44.1) 56.0 (53.0 – 62.9) 87.1 (74.3 – 156) 126
6–11 years 57.1 (53.6 – 60.8) 38.6 (33.8 – 41.1) 56.7 (52.3 – 60.4) 85.6 (77.4 – 97.8) 277
12–19 years 58.6 (53.3 – 64.3) 34.4 (31.6 – 36.7) 55.2 (52.3 – 58.9) 110 (97.5 – 138) 667
20–39 years 73.8 (60.9 – 89.4) 33.2 (29.8 – 37.8) 64.4 (53.5 – 80.8) 209 (155 – 293) 290
40–59 years 67.9 (59.3 – 77.8) 32.3 (28.5 – 34.5) 59.4 (49.7 – 69.9) 182 (152 – 250) 259
60 years and older 48.1 (42.3 – 54.6) 24.5 (21.4 – 26.1) 43.1 (39.3 – 50.7) 106 (94.7 – 133) 199
Males
Total, 3 years and older 68.7 (60.8 – 77.6) 32.1 (29.1 – 34.8) 61.7 (55.2 – 68.2) 194 (140 – 241) 918
3–5 years 58.5 (52.4 – 65.4) 37.0† (25.8 – 45.7) 55.7 (52.2 – 65.1) 88.3† (74.7 – 158) 70
6–11 years 54.5 (51.1 – 58.1) 37.7 (31.8 – 40.3) 55.5 (48.5 – 59.4) 75.3 (70.6 – 97.3) 133
12–19 years 60.7 (53.5 – 68.9) 35.2 (30.8 – 37.2) 55.8 (50.8 – 63.8) 121 (102 – 161) 356
20–39 years 89.4 (72.1 – 111) 34.0 (29.9 – 40.4) 86.5 (66.6 – 110) 240 (202 – 361) 142
40–59 years 70.0 (59.3 – 82.6) 29.0 (20.9 – 33.2) 63.9 (51.4 – 72.9) 207 (158 – 290) 123
60 years and older 54.2 (45.8 – 64.2) 25.4† (21.5 – 28.9) 46.2 (40.9 – 61.0) 116† (98.5 – 230) 94
Females
Total, 3 years and older 59.8 (53.4 – 66.8) 32.4 (30.2 – 34.4) 54.5 (48.3 – 60.5) 133 (106 – 171) 900
3–5 years 58.9 (52.3 – 66.3) 43.6† (32.2 – 45.3) 56.2 (48.4 – 67.3) 82.9† (67.1 – 129) 56
6–11 years 60.1 (55.2 – 65.4) 39.4 (35.3 – 43.2) 58.1 (52.1 – 68.0) 95.1 (85.5 – 106) 144
12–19 years 56.5 (52.2 – 61.0) 33.5 (30.4 – 36.7) 53.7 (51.3 – 57.4) 106 (86.0 – 136) 311
20–39 years 63.2 (52.5 – 75.9) 32.8 (27.1 – 37.6) 56.4 (45.3 – 69.7) 153 (106 – 290) 148
40–59 years 66.3 (57.0 – 77.1) 35.1 (24.1 – 39.3) 56.5 (47.1 – 71.0) 173 (147 – 228) 136
60 years and older 44.2 (38.2 – 51.2) 23.7† (19.4 – 26.0) 41.1 (37.8 – 46.9) 92.1† (69.4 – 143) 105
† Estimate is subject to greater uncertainty due to small cell size.  
Table 5.1.a.5. Acrylamide hemoglobin adduct: Non-Hispanic whites
Geometric mean and selected percentiles of whole blood concentrations (in pmol/g Hb) for non-Hispanic whites 
in the U.S. population aged 3 years and older, National Health and Nutrition Examination Survey, 2003–2004. 
Geometric mean 
 (95%  conf. interval)
Selected percentiles (95% conf. interval) Sample 
size10th 50th 90th
Males and Females
Total, 3 years and older 62.3 (58.9 – 65.9) 34.0 (32.5 – 35.7) 55.2 (52.9 – 58.5) 145 (130 – 165) 2,958
3–5 years 61.1 (51.7 – 72.2) 39.0† (20.8 – 44.7) 58.5 (47.7 – 78.2) 98.7† (82.6 – 118) 93
6–11 years 59.0 (56.2 – 62.0) 39.9 (35.1 – 44.6) 58.0 (55.2 – 60.3) 85.9 (80.4 – 91.5) 178
12–19 years 58.6 (55.3 – 62.2) 36.3 (33.3 – 38.5) 54.9 (52.7 – 57.9) 105 (95.0 – 120) 505
20–39 years 72.2 (67.6 – 77.0) 35.7 (31.4 – 39.4) 63.5 (59.2 – 68.5) 174 (157 – 198) 663
40–59 years 65.3 (60.6 – 70.4) 33.7 (32.1 – 36.1) 56.2 (52.1 – 61.1) 167 (143 – 206) 606
60 years and older 50.4 (47.9 – 53.0) 30.6 (28.5 – 31.9) 46.8 (43.9 – 49.7) 92.3 (84.1 – 113) 913
Males
Total, 3 years and older 64.7 (60.6 – 69.0) 33.9 (31.4 – 36.3) 57.4 (53.1 – 60.9) 155 (141 – 187) 1,441
3–5 years 60.9 (49.4 – 75.0) 41.3† (31.0 – 45.6) 57.3 (44.2 – 82.0) 103† (81.4 – 118) 50
6–11 years 58.6 (55.5 – 61.9) 40.0† (30.1 – 46.5) 56.6 (54.7 – 59.1) 85.9† (77.4 – 94.8) 84
12–19 years 57.8 (53.5 – 62.5) 34.4 (31.7 – 37.0) 52.9 (50.2 – 57.0) 109 (94.7 – 134) 257
20–39 years 76.3 (70.4 – 82.8) 36.1 (30.0 – 41.0) 67.0 (60.9 – 73.8) 213 (166 – 228) 293
40–59 years 68.0 (62.5 – 74.0) 34.6 (29.3 – 38.0) 58.2 (50.8 – 66.1) 183 (150 – 213) 302
60 years and older 52.0 (46.7 – 57.8) 29.8 (27.5 – 31.5) 47.8 (42.4 – 52.5) 110 (87.5 – 136) 455
Females
Total, 3 years and older 60.2 (57.0 – 63.5) 34.3 (32.8 – 35.5) 54.0 (52.1 – 57.1) 135 (119 – 154) 1,517
3–5 years 61.4 (51.2 – 73.6) 37.6† (20.8 – 44.2) 62.2 (47.4 – 75.7) 91.2† (79.5 – 238) 43
6–11 years 59.4 (55.7 – 63.4) 39.7† (28.6 – 44.8) 58.5 (55.3 – 61.2) 84.6† (78.2 – 141) 94
12–19 years 59.5 (56.1 – 63.2) 38.1 (34.4 – 40.4) 57.4 (54.1 – 59.9) 100 (92.2 – 117) 248
20–39 years 68.3 (64.0 – 72.9) 35.4 (30.6 – 39.3) 59.6 (54.7 – 65.8) 160 (147 – 182) 370
40–59 years 62.8 (56.9 – 69.2) 33.3 (32.2 – 35.2) 54.5 (50.3 – 60.7) 155 (129 – 217) 304
60 years and older 49.2 (47.8 – 50.6) 31.3 (29.5 – 33.2) 45.7 (45.0 – 47.4) 84.3 (74.6 – 103) 458
† Estimate is subject to greater uncertainty due to small cell size.  

































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































0 Non−Hispanic Blacks Non−Hispanic Whites 
Figure 5.2.a. Glycidamide hemoglobin adduct: Concentrations by age group 
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Table 5.2.a.2. Glycidamide hemoglobin adduct: Total population
Geometric mean and selected percentiles of whole blood concentrations (in pmol/g Hb) for the total U.S. 
population aged 3 years and older, National Health and Nutrition Examination Survey, 2003–2004. 
Geometric mean 
 (95%  conf. interval)
Selected percentiles (95% conf. interval) Sample 
size10th 50th 90th
Males and Females
Total, 3 years and older 59.3 (56.7 – 62.1) 30.6 (28.7 – 32.4) 59.9 (57.5 – 62.4) 130 (120 – 140) 7,278
3–5 years 71.6 (66.9 – 76.7) 47.8 (39.0 – 51.4) 71.1 (67.0 – 79.1) 118 (107 – 126) 411
6–11 years 74.1 (70.3 – 78.2) 47.5 (43.8 – 49.4) 75.0 (70.9 – 77.9) 121 (113 – 135) 784
12–19 years 55.4 (51.1 – 60.1) 31.5 (27.3 – 33.8) 59.2 (56.1 – 62.0) 113 (96.8 – 141) 1,931
20–39 years 65.0 (61.4 – 68.9) 33.0 (29.9 – 35.4) 64.0 (60.1 – 68.8) 149 (136 – 167) 1,446
40–59 years 60.1 (56.8 – 63.5) 30.6 (27.7 – 32.8) 58.8 (55.1 – 61.1) 139 (124 – 158) 1,177
60 years and older 45.5 (42.8 – 48.3) 24.4 (22.6 – 25.6) 46.8 (44.8 – 49.2) 96.2 (90.6 – 103) 1,529
Males
Total, 3 years and older 59.5 (56.9 – 62.3) 29.8 (27.6 – 32.0) 59.3 (56.9 – 61.7) 136 (124 – 148) 3,604
3–5 years 72.4 (67.5 – 77.7) 47.9 (38.4 – 52.2) 70.7 (66.8 – 76.6) 117 (99.9 – 145) 215
6–11 years 75.7 (71.8 – 79.9) 48.2 (45.6 – 50.3) 75.7 (69.9 – 79.6) 118 (112 – 140) 381
12–19 years 52.8 (48.2 – 57.8) 29.3 (24.5 – 32.7) 57.0 (53.2 – 61.0) 111 (97.5 – 134) 1,000
20–39 years 64.6 (60.9 – 68.6) 32.0 (28.6 – 33.8) 60.6 (57.6 – 65.9) 163 (149 – 174) 681
40–59 years 59.9 (56.3 – 63.8) 29.6 (26.1 – 32.8) 58.9 (54.3 – 62.2) 140 (128 – 164) 577
60 years and older 46.3 (42.8 – 50.1) 24.4 (22.2 – 25.7) 45.8 (41.6 – 48.6) 106 (95.4 – 129) 750
Females
Total, 3 years and older 59.1 (56.0 – 62.5) 31.3 (29.1 – 33.4) 60.4 (57.5 – 63.9) 125 (116 – 135) 3,674
3–5 years 70.8 (63.8 – 78.7) 45.8 (34.1 – 53.1) 72.1 (65.7 – 82.0) 118 (104 – 130) 196
6–11 years 72.4 (67.2 – 77.9) 46.3 (43.6 – 48.3) 73.7 (69.6 – 77.9) 122 (106 – 142) 403
12–19 years 58.3 (52.8 – 64.5) 33.7 (28.7 – 35.7) 60.9 (56.5 – 65.8) 114 (95.9 – 160) 931
20–39 years 65.5 (61.4 – 69.8) 35.2 (31.0 – 38.2) 67.7 (61.4 – 73.7) 136 (123 – 160) 765
40–59 years 60.2 (55.3 – 65.6) 30.7 (27.8 – 34.3) 58.6 (53.1 – 64.8) 137 (115 – 160) 600
60 years and older 44.8 (41.8 – 48.1) 24.4 (21.3 – 26.3) 47.7 (45.2 – 50.8) 87.0 (81.1 – 93.8) 779
Table 5.2.a.3. Glycidamide hemoglobin adduct: Mexican Americans
Geometric mean and selected percentiles of whole blood concentrations (in pmol/g Hb) for Mexican Americans 
in the U.S. population aged 3 years and older, National Health and Nutrition Examination Survey, 2003–2004. 
Geometric mean 
 (95%  conf. interval)
Selected percentiles (95% conf. interval) Sample 
size10th 50th 90th
Males and Females
Total, 3 years and older 64.7 (61.2 – 68.4) 39.4 (38.4 – 40.5) 65.4 (61.1 – 69.8) 118 (111 – 130) 1,841
3–5 years 75.5 (67.6 – 84.3) 49.6 (40.2 – 55.0) 74.4 (65.9 – 87.3) 114 (103 – 164) 117
6–11 years 78.5 (72.8 – 84.6) 52.1 (46.5 – 55.3) 78.5 (76.0 – 81.4) 126 (116 – 140) 256
12–19 years 58.7 (53.3 – 64.5) 37.0 (32.2 – 40.3) 62.3 (55.8 – 67.0) 99.7 (93.8 – 115) 601
20–39 years 64.7 (58.2 – 72.0) 39.0 (35.1 – 42.2) 63.9 (59.4 – 70.5) 128 (108 – 168) 324
40–59 years 61.2 (52.8 – 71.0) 38.4 (17.5 – 41.0) 60.5 (52.9 – 73.0) 115 (103 – 144) 212
60 years and older 57.1 (53.8 – 60.5) 33.1 (29.3 – 36.1) 55.8 (50.6 – 61.9) 107 (97.6 – 117) 331
Males
Total, 3 years and older 64.2 (60.0 – 68.7) 38.3 (33.3 – 39.7) 63.6 (59.3 – 68.4) 129 (114 – 160) 909
3–5 years 77.6 (67.7 – 89.1) 52.5† (35.6 – 58.5) 75.7 (68.5 – 87.5) 124† (101 – 187) 58
6–11 years 82.6 (74.3 – 91.7) 55.2 (48.0 – 60.9) 79.7 (77.4 – 88.6) 128 (115 – 161) 125
12–19 years 60.0 (52.4 – 68.6) 36.4 (28.3 – 40.4) 63.4 (56.3 – 68.4) 115 (91.4 – 159) 306
20–39 years 64.4 (55.9 – 74.2) 38.2 (29.2 – 40.6) 60.1 (54.5 – 67.4) 161 (107 – 279) 146
40–59 years 56.0 (47.0 – 66.6) 32.8† (4.98 – 39.7) 56.5 (49.9 – 62.8) 111† (94.7 – 157) 111
60 years and older 55.6 (52.4 – 59.0) 30.3 (17.5 – 35.1) 54.6 (51.7 – 58.5) 110 (97.4 – 141) 163
Females
Total, 3 years and older 65.2 (60.7 – 70.0) 41.9 (39.3 – 44.1) 67.7 (61.8 – 73.7) 111 (106 – 120) 932
3–5 years 73.2 (63.2 – 84.9) 46.6† (42.6 – 49.5) 72.9 (58.1 – 88.9) 108† (91.8 – 155) 59
6–11 years 73.8 (66.6 – 81.8) 47.4 (43.0 – 52.2) 74.0 (66.4 – 81.5) 119 (108 – 144) 131
12–19 years 57.3 (52.7 – 62.4) 37.1 (33.5 – 40.9) 61.2 (54.4 – 67.2) 94.5 (88.0 – 102) 295
20–39 years 65.1 (55.1 – 76.8) 42.4 (28.4 – 46.4) 68.9 (63.2 – 77.5) 114 (104 – 131) 178
40–59 years 67.4 (57.3 – 79.3) 39.8† (34.4 – 43.6) 67.4 (54.8 – 81.6) 118† (105 – 156) 101
60 years and older 58.4 (52.1 – 65.5) 36.0 (27.3 – 39.4) 56.8 (46.6 – 65.2) 104 (87.4 – 124) 168
† Estimate is subject to greater uncertainty due to small cell size.  
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Table 5.2.a.4. Glycidamide hemoglobin adduct: Non-Hispanic blacks
Geometric mean and selected percentiles of whole blood concentrations (in pmol/g Hb) for non-Hispanic blacks 
in the U.S. population aged 3 years and older, National Health and Nutrition Examination Survey, 2003–2004. 
Geometric mean 
 (95%  conf. interval)
Selected percentiles (95% conf. interval) Sample 
size10th 50th 90th
Males and Females
Total, 3 years and older 53.6 (50.6 – 56.7) 27.1 (24.4 – 29.8) 55.5 (51.9 – 59.2) 121 (110 – 142) 1,900
3–5 years 66.3 (58.9 – 74.6) 41.3 (26.9 – 48.6) 70.0 (58.0 – 79.8) 101 (96.2 – 112) 141
6–11 years 58.7 (54.5 – 63.2) 35.8 (27.2 – 41.1) 63.0 (57.3 – 69.2) 108 (96.7 – 126) 282
12–19 years 49.7 (47.0 – 52.5) 27.0 (24.8 – 29.3) 52.6 (49.5 – 56.1) 106 (87.7 – 124) 690
20–39 years 63.5 (56.8 – 71.1) 33.4 (26.9 – 35.7) 63.7 (55.8 – 73.8) 144 (120 – 228) 311
40–59 years 50.6 (45.2 – 56.7) 23.5 (17.5 – 29.4) 50.9 (46.2 – 56.4) 133 (95.3 – 186) 265
60 years and older 36.3 (32.9 – 40.1) 15.4 (10.4 – 19.4) 39.7 (36.6 – 42.9) 84.6 (79.9 – 98.7) 211
Males
Total, 3 years and older 54.8 (49.8 – 60.4) 26.5 (23.5 – 28.6) 56.4 (52.2 – 61.8) 134 (114 – 162) 956
3–5 years 65.8 (54.8 – 79.0) 40.1† (< LOD – 49.0) 70.8 (54.1 – 84.2) 100† (95.0 – 130) 77
6–11 years 59.5 (53.9 – 65.7) 35.7 (4.48 – 43.5) 62.9 (54.4 – 68.5) 108 (92.6 – 141) 133
12–19 years 48.5 (44.4 – 53.0) 25.3 (21.2 – 27.8) 51.0 (46.6 – 56.0) 113 (90.4 – 141) 369
20–39 years 71.1 (60.0 – 84.3) 33.3 (27.7 – 36.6) 70.1 (57.1 – 83.5) 152 (121 – 309) 154
40–59 years 46.9 (39.1 – 56.2) 17.5 (4.35 – 20.9) 50.3 (43.7 – 56.6) 156 (101 – 207) 124
60 years and older 38.8 (34.7 – 43.3) 19.9† (9.71 – 22.2) 41.2 (33.6 – 47.1) 81.8† (74.1 – 120) 99
Females
Total, 3 years and older 52.5 (49.6 – 55.5) 28.0 (22.2 – 32.1) 55.0 (50.3 – 60.1) 114 (101 – 132) 944
3–5 years 66.9 (60.4 – 74.1) 40.4† (30.2 – 55.7) 68.3 (58.2 – 79.8) 100† (89.7 – 109) 64
6–11 years 57.9 (49.9 – 67.1) 35.7 (< LOD – 41.3) 63.5 (54.0 – 74.1) 106 (96.3 – 120) 149
12–19 years 50.8 (47.2 – 54.7) 30.7 (24.9 – 33.1) 54.1 (50.7 – 57.8) 98.7 (83.2 – 122) 321
20–39 years 58.0 (51.8 – 64.9) 33.3 (< LOD – 35.7) 60.3 (52.6 – 69.8) 130 (111 – 183) 157
40–59 years 53.9 (49.1 – 59.1) 29.8 (22.5 – 33.3) 50.9 (46.1 – 57.8) 115 (90.7 – 169) 141
60 years and older 34.7 (29.2 – 41.2) 14.1 (< LOD – 19.4) 38.7 (34.4 – 42.9) 87.3 (74.8 – 103) 112
< LOD means less than the limit of detection, which may vary for some compounds by year. See Appendix D for LOD. 
† Estimate is subject to greater uncertainty due to small cell size. 
Table 5.2.a.5. Glycidamide hemoglobin adduct: Non-Hispanic whites
Geometric mean and selected percentiles of whole blood concentrations (in pmol/g Hb) for non-Hispanic whites 
in the U.S. population aged 3 years and older, National Health and Nutrition Examination Survey, 2003–2004. 
Geometric mean 
 (95%  conf. interval)
Selected percentiles (95% conf. interval) Sample 
size10th 50th 90th
Males and Females
Total, 3 years and older 61.1 (57.6 – 64.9) 31.1 (28.9 – 32.8) 60.6 (57.8 – 64.2) 135 (124 – 149) 3,008
3–5 years 75.5 (67.8 – 84.1) 50.7† (37.9 – 53.7) 72.3 (65.8 – 88.4) 121† (114 – 133) 110
6–11 years 78.5 (73.8 – 83.6) 51.3 (43.2 – 55.7) 76.0 (74.1 – 79.5) 123 (109 – 150) 183
12–19 years 57.9 (52.8 – 63.5) 33.4 (27.6 – 34.9) 60.4 (57.1 – 62.9) 115 (97.9 – 148) 512
20–39 years 68.5 (63.9 – 73.5) 32.9 (29.7 – 37.3) 67.5 (61.1 – 72.9) 160 (142 – 176) 682
40–59 years 62.8 (58.4 – 67.5) 31.9 (29.1 – 34.2) 60.4 (56.8 – 64.4) 143 (129 – 164) 610
60 years and older 46.6 (43.1 – 50.5) 25.0 (23.3 – 26.6) 47.7 (45.1 – 50.9) 96.7 (89.9 – 106) 911
Males
Total, 3 years and older 61.0 (57.6 – 64.6) 30.2 (28.2 – 32.5) 60.1 (57.3 – 62.8) 140 (125 – 155) 1,473
3–5 years 74.2 (66.5 – 82.7) 48.0† (37.9 – 55.0) 68.7 (60.3 – 88.3) 118† (98.8 – 195) 58
6–11 years 79.8 (74.8 – 85.1) 55.5† (47.5 – 57.9) 75.8 (70.9 – 84.9) 116† (108 – 156) 87
12–19 years 54.4 (48.8 – 60.7) 30.4 (24.0 – 34.3) 57.3 (53.2 – 60.5) 102 (93.6 – 143) 264
20–39 years 66.7 (62.4 – 71.3) 31.9 (28.5 – 35.3) 62.9 (58.3 – 67.8) 170 (154 – 182) 308
40–59 years 63.7 (58.1 – 69.8) 32.3 (26.5 – 35.6) 60.6 (56.6 – 64.6) 141 (129 – 168) 303
60 years and older 46.9 (42.4 – 51.7) 24.5 (21.1 – 26.4) 45.9 (41.5 – 49.1) 106 (95.5 – 128) 453
Females
Total, 3 years and older 61.2 (57.1 – 65.7) 31.7 (29.1 – 34.3) 61.1 (57.9 – 65.8) 132 (120 – 147) 1,535
3–5 years 77.1 (66.0 – 90.1) 51.9† (< LOD – 60.9) 78.6 (62.4 – 100) 124† (101 – 135) 52
6–11 years 77.2 (70.7 – 84.2) 48.7† (39.3 – 53.1) 76.6 (71.9 – 80.3) 125† (99.1 – 197) 96
12–19 years 62.0 (54.9 – 70.0) 34.4 (27.2 – 41.5) 63.0 (57.9 – 69.5) 119 (99.0 – 168) 248
20–39 years 70.5 (64.4 – 77.1) 36.5 (28.0 – 42.6) 71.2 (63.9 – 78.3) 142 (130 – 191) 374
40–59 years 61.9 (55.7 – 68.9) 30.9 (27.7 – 35.5) 60.0 (54.1 – 68.0) 144 (116 – 182) 307
60 years and older 46.5 (42.7 – 50.6) 25.7 (23.9 – 26.9) 49.3 (46.3 – 51.5) 87.1 (80.4 – 97.9) 458
< LOD means less than the limit of detection, which may vary for some compounds by year. See Appendix D for LOD. 
† Estimate is subject to greater uncertainty due to small cell size. 














































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Non−Hispanic Blacks Non−Hispanic Whites 
Figure 5.3.a. Glycidamide−to−acrylamide hemoglobin adduct ratio: By age group 
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Table 5.3.a.2. Glycidamide-to-acrylamide hemoglobin adduct ratio: Total population
Geometric mean and selected percentiles of ratio (no units) of whole blood concentrations (in pmol/g Hb) for 
the total U.S. population aged 3 years and older, National Health and Nutrition Examination Survey, 2003–2004.
Geometric mean 
 (95%  conf. interval)
Selected percentiles (95% conf. interval) Sample 
size10th 50th 90th
Males and Females
Total, 3 years and older .958 (.923 – .995) .642 (.620 – .661) 1.01 (.984 – 1.03) 1.48 (1.42 – 1.54) 6,844
3–5 years 1.25 (1.18 – 1.32) .944 (.647 – 1.05) 1.28 (1.23 – 1.38) 1.61 (1.57 – 1.78) 336
6–11 years 1.25 (1.20 – 1.30) .899 (.853 – .923) 1.28 (1.23 – 1.33) 1.72 (1.61 – 1.96) 742
12–19 years .952 (.889 – 1.02) .670 (.609 – .719) 1.01 (.987 – 1.04) 1.45 (1.37 – 1.62) 1,817
20–39 years .939 (.896 – .985) .643 (.606 – .668) .988 (.939 – 1.03) 1.43 (1.38 – 1.51) 1,364
40–59 years .926 (.883 – .970) .618 (.561 – .643) .974 (.935 – 1.01) 1.41 (1.36 – 1.51) 1,124
60 years and older .900 (.855 – .948) .607 (.550 – .649) .961 (.928 – .984) 1.39 (1.32 – 1.49) 1,461
Males
Total, 3 years and older .918 (.886 – .951) .610 (.585 – .632) .955 (.926 – .990) 1.41 (1.35 – 1.49) 3,389
3–5 years 1.25 (1.16 – 1.35) .863 (.621 – 1.06) 1.26 (1.22 – 1.38) 1.60 (1.54 – 1.86) 181
6–11 years 1.28 (1.22 – 1.35) .899 (.846 – .983) 1.31 (1.22 – 1.39) 1.72 (1.66 – 1.97) 359
12–19 years .908 (.842 – .980) .651 (.599 – .677) .984 (.952 – 1.01) 1.38 (1.34 – 1.47) 944
20–39 years .874 (.832 – .918) .607 (.562 – .641) .895 (.862 – .939) 1.25 (1.20 – 1.34) 638
40–59 years .883 (.848 – .920) .573 (.537 – .618) .933 (.895 – .979) 1.34 (1.23 – 1.49) 549
60 years and older .865 (.823 – .908) .558 (.508 – .629) .905 (.860 – .943) 1.35 (1.26 – 1.47) 718
Females
Total, 3 years and older .999 (.956 – 1.04) .679 (.641 – .711) 1.06 (1.02 – 1.09) 1.52 (1.47 – 1.61) 3,455
3–5 years 1.25 (1.17 – 1.34) .971 (.811 – 1.04) 1.29 (1.22 – 1.45) 1.64 (1.51 – 2.07) 155
6–11 years 1.22 (1.15 – 1.29) .898 (.833 – .923) 1.27 (1.20 – 1.29) 1.71 (1.58 – 2.00) 383
12–19 years 1.00 (.928 – 1.08) .730 (.635 – .776) 1.04 (1.00 – 1.10) 1.57 (1.41 – 1.84) 873
20–39 years 1.01 (.958 – 1.07) .690 (.651 – .701) 1.08 (1.02 – 1.13) 1.55 (1.47 – 1.70) 726
40–59 years .967 (.904 – 1.03) .639 (.563 – .706) 1.01 (.957 – 1.07) 1.47 (1.39 – 1.59) 575
60 years and older .929 (.865 – .998) .647 (.534 – .710) .998 (.969 – 1.04) 1.41 (1.35 – 1.52) 743
Table 5.3.a.3. Glycidamide-to-acrylamide hemoglobin adduct ratio: Mexican 
Americans
Geometric mean and selected percentiles of ratio (no units) of whole blood concentrations (in pmol/g Hb) for 
Mexican Americans in the U.S. population aged 3 years and older, National Health and Nutrition Examination 
Survey, 2003–2004.
Geometric mean 
 (95%  conf. interval)
Selected percentiles (95% conf. interval) Sample 
size10th 50th 90th
Males and Females
Total, 3 years and older 1.05 (.987 – 1.11) .748 (.697 – .780) 1.09 (1.03 – 1.16) 1.57 (1.46 – 1.75) 1,739
3–5 years 1.32 (1.26 – 1.40) 1.06† (.957 – 1.11) 1.33 (1.25 – 1.41) 1.59† (1.54 – 1.88) 89
6–11 years 1.27 (1.17 – 1.37) .953 (.923 – .989) 1.25 (1.19 – 1.34) 1.76 (1.57 – 2.53) 244
12–19 years 1.03 (.965 – 1.09) .767 (.717 – .822) 1.05 (.999 – 1.12) 1.50 (1.42 – 1.73) 568
20–39 years .997 (.904 – 1.10) .689 (.608 – .755) 1.06 (.972 – 1.14) 1.56 (1.42 – 1.77) 312
40–59 years .999 (.918 – 1.09) .718 (.616 – .772) 1.04 (.988 – 1.12) 1.51 (1.36 – 2.60) 202
60 years and older .989 (.908 – 1.08) .716 (.561 – .774) .996 (.936 – 1.05) 1.38 (1.28 – 1.62) 324
Males
Total, 3 years and older .977 (.916 – 1.04) .689 (.616 – .722) 1.01 (.949 – 1.07) 1.52 (1.41 – 1.60) 858
3–5 years 1.35 (1.25 – 1.46) 1.09† (1.02 – 1.15) 1.33 (1.14 – 1.54) 1.60† (1.55 – 1.95) 46
6–11 years 1.29 (1.16 – 1.44) .984 (.102 – 1.06) 1.26 (1.19 – 1.38) 1.85 (1.57 – 4.24) 117
12–19 years .996 (.880 – 1.13) .750 (.602 – .813) 1.03 (.948 – 1.12) 1.49 (1.42 – 1.67) 290
20–39 years .907 (.823 – 1.00) .660 (.532 – .708) .930 (.877 – 1.02) 1.39 (1.19 – 1.64) 141
40–59 years .886 (.775 – 1.01) .611† (.197 – .722) .946 (.872 – 1.01) 1.34† (1.24 – 1.60) 106
60 years and older .906 (.820 – 1.00) .642 (.087 – .750) .937 (.877 – 1.00) 1.28 (1.23 – 1.36) 158
Females
Total, 3 years and older 1.12 (1.06 – 1.19) .847 (.801 – .890) 1.17 (1.10 – 1.25) 1.62 (1.49 – 1.96) 881
3–5 years 1.30 (1.22 – 1.38) .993† (.905 – 1.11) 1.32 (1.25 – 1.40) 1.58† (1.45 – 1.76) 43
6–11 years 1.23 (1.10 – 1.38) .926 (.860 – .977) 1.25 (1.16 – 1.33) 1.68 (1.57 – 1.95) 127
12–19 years 1.06 (1.01 – 1.11) .820 (.716 – .870) 1.08 (1.02 – 1.16) 1.54 (1.39 – 2.11) 278
20–39 years 1.10 (.980 – 1.24) .871 (.658 – .936) 1.17 (1.10 – 1.27) 1.70 (1.50 – 2.10) 171
40–59 years 1.14 (1.04 – 1.25) .823† (.754 – .889) 1.16 (1.04 – 1.36) 1.54† (1.43 – 2.60) 96
60 years and older 1.07 (.919 – 1.24) .777 (.486 – .881) 1.05 (.881 – 1.28) 1.48 (1.32 – 3.87) 166
† Estimate is subject to greater uncertainty due to small cell size.  
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Table 5.3.a.4. Glycidamide-to-acrylamide hemoglobin adduct ratio: 
Non-Hispanic blacks
Geometric mean and selected percentiles of ratio (no units) of whole blood concentrations (in pmol/g Hb) for 
non-Hispanic blacks in the U.S. population aged 3 years and older, National Health and Nutrition Examination 
Survey, 2003–2004.
Geometric mean 
 (95%  conf. interval)
Selected percentiles (95% conf. interval) Sample 
size10th 50th 90th
Males and Females
Total, 3 years and older .830 (.762 – .904) .526 (.440 – .588) .893 (.845 – .949) 1.39 (1.27 – 1.60) 1,736
3–5 years 1.15 (1.08 – 1.23) .865 (.697 – .961) 1.15 (1.07 – 1.24) 1.53 (1.37 – 1.83) 122
6–11 years 1.02 (.927 – 1.13) .708 (.563 – .793) 1.10 (1.00 – 1.20) 1.74 (1.58 – 1.92) 265
12–19 years .834 (.752 – .925) .582 (.484 – .635) .893 (.858 – .931) 1.38 (1.26 – 1.66) 637
20–39 years .865 (.768 – .975) .547 (.424 – .604) .900 (.827 – .974) 1.39 (1.24 – 1.64) 277
40–59 years .720 (.642 – .807) .427 (.340 – .509) .805 (.746 – .874) 1.19 (1.11 – 1.35) 248
60 years and older .752 (.652 – .868) .458 (.184 – .542) .822 (.743 – .915) 1.24 (1.15 – 1.62) 187
Males
Total, 3 years and older .782 (.721 – .847) .512 (.429 – .546) .830 (.784 – .878) 1.31 (1.20 – 1.53) 875
3–5 years 1.17 (1.10 – 1.24) .940† (< LOD – .985) 1.14 (1.08 – 1.24) 1.57† (1.39 – 1.82) 68
6–11 years 1.10 (.985 – 1.23) .711 (.560 – .831) 1.12 (1.02 – 1.20) 1.78 (1.66 – 2.11) 126
12–19 years .770 (.666 – .890) .554 (.420 – .613) .833 (.808 – .859) 1.30 (1.12 – 1.64) 341
20–39 years .797 (.739 – .860) .490 (.431 – .537) .808 (.741 – .880) 1.18 (1.06 – 1.77) 136
40–59 years .628 (.532 – .741) .413 (.073 – .483) .727 (.643 – .809) 1.11 (1.02 – 1.24) 115
60 years and older .717 (.592 – .869) .457† (.046 – .565) .766 (.691 – .853) 1.15† (1.02 – 2.25) 89
Females
Total, 3 years and older .875 (.788 – .972) .581 (.412 – .643) .951 (.885 – 1.00) 1.42 (1.31 – 1.62) 861
3–5 years 1.14 (1.02 – 1.27) .792† (.716 – .967) 1.16 (1.03 – 1.26) 1.48† (1.32 – 2.00) 54
6–11 years .947 (.807 – 1.11) .690 (< LOD – .784) 1.08 (.955 – 1.21) 1.55 (1.32 – 2.11) 139
12–19 years .905 (.815 – 1.00) .603 (.447 – .701) .983 (.921 – 1.05) 1.44 (1.31 – 1.82) 296
20–39 years .924 (.778 – 1.10) .602 (< LOD – .726) .974 (.885 – 1.12) 1.52 (1.36 – 1.89) 141
40–59 years .802 (.728 – .885) .463 (.380 – .602) .870 (.805 – .926) 1.24 (1.15 – 1.48) 133
60 years and older .778 (.643 – .941) .425† (< LOD – .574) .831 (.766 – 1.00) 1.32† (1.15 – 3.57) 98
< LOD means less than the limit of detection for either the whole blood acrylamide adduct or the glycidamide adduct, which may vary for some compounds by year. See Appendix D for LOD.
† Estimate is subject to greater uncertainty due to small cell size.
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Table 5.3.a.5. Glycidamide-to-acrylamide hemoglobin adduct ratio: 
Non-Hispanic whites
Geometric mean and selected percentiles of ratio (no units) of whole blood concentrations (in pmol/g Hb) for 
non-Hispanic whites in the U.S. population aged 3 years and older, National Health and Nutrition Examination 
Survey, 2003–2004.
Geometric mean 
 (95%  conf. interval)
Selected percentiles (95% conf. interval) Sample 
size10th 50th 90th
Males and Females
Total, 3 years and older .967 (.932 – 1.00) .651 (.629 – .675) 1.01 (.984 – 1.03) 1.47 (1.41 – 1.53) 2,859
3–5 years 1.28 (1.15 – 1.43) .863† (.097 – 1.18) 1.32 (1.23 – 1.47) 1.61† (1.56 – 2.05) 89
6–11 years 1.31 (1.23 – 1.38) .939 (.852 – .989) 1.32 (1.27 – 1.38) 1.72 (1.55 – 2.41) 172
12–19 years .979 (.901 – 1.06) .699 (.642 – .748) 1.02 (.981 – 1.07) 1.42 (1.36 – 1.61) 490
20–39 years .939 (.896 – .984) .645 (.610 – .678) .984 (.924 – 1.02) 1.42 (1.37 – 1.51) 648
40–59 years .948 (.910 – .988) .629 (.591 – .658) .986 (.954 – 1.02) 1.41 (1.34 – 1.50) 586
60 years and older .914 (.859 – .972) .631 (.553 – .669) .966 (.935 – .989) 1.40 (1.33 – 1.55) 874
Males
Total, 3 years and older .927 (.898 – .958) .627 (.605 – .649) .955 (.922 – .993) 1.39 (1.33 – 1.48) 1,400
3–5 years 1.24 (1.07 – 1.43) .842† (.621 – 1.10) 1.27 (1.10 – 1.46) 1.57† (1.48 – 2.06) 48
6–11 years 1.32 (1.24 – 1.41) .944† (.748 – 1.03) 1.33 (1.27 – 1.42) 1.70† (1.57 – 2.25) 82
12–19 years .947 (.862 – 1.04) .669 (.609 – .722) 1.01 (.940 – 1.04) 1.37 (1.32 – 1.41) 254
20–39 years .862 (.820 – .905) .609 (.549 – .644) .886 (.852 – .930) 1.24 (1.20 – 1.30) 289
40–59 years .922 (.891 – .954) .619 (.557 – .649) .945 (.910 – .987) 1.33 (1.23 – 1.44) 291
60 years and older .880 (.835 – .929) .570 (.512 – .636) .922 (.862 – .953) 1.38 (1.27 – 1.49) 436
Females
Total, 3 years and older 1.01 (.961 – 1.05) .681 (.648 – .706) 1.06 (1.02 – 1.09) 1.52 (1.45 – 1.62) 1,459
3–5 years 1.33 (1.17 – 1.51) 1.01† (< LOD – 1.19) 1.46 (1.26 – 1.48) 1.72† (1.51 – 2.09) 41
6–11 years 1.29 (1.19 – 1.40) .923† (.777 – .995) 1.28 (1.20 – 1.39) 1.79† (1.54 – 2.97) 90
12–19 years 1.02 (.929 – 1.11) .743 (.636 – .786) 1.05 (.996 – 1.13) 1.57 (1.37 – 1.87) 236
20–39 years 1.02 (.954 – 1.10) .691 (.654 – .700) 1.06 (1.00 – 1.14) 1.55 (1.46 – 1.77) 359
40–59 years .975 (.899 – 1.06) .639 (.513 – .736) 1.02 (.969 – 1.08) 1.43 (1.38 – 1.63) 295
60 years and older .942 (.866 – 1.02) .658 (.528 – .724) 1.00 (.968 – 1.05) 1.43 (1.35 – 1.56) 438
< LOD means less than the limit of detection for either the whole blood acrylamide adduct or the glycidamide adduct, which may vary for some compounds by year. See Appendix D for LOD.
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Appendix A
NHANES Reports Related to Nutritional Status
National Center for Health Statistics (NCHS) Data Briefs
http://www.cdc.gov/nchs/products/databriefs.htm 
Looker AC, Johnson CL, Lacher DA, Pfeiffer CM, Schleicher RL, Sempos CT. Vitamin D status: 
United States, 2001–2006. NCHS Data Brief, No 59. Hyattsville, MD: National Center for 
Health Statistics. 2011.
McDowell MA, Lacher DA, Pfeiffer CM, Mulinare J, Picciano MF, Rader JI, et al. Blood Folate 
Levels: The Latest NHANES Results. NCHS Data Brief, No 6. Hyattsville, MD: National 
Center for Health Statistics. 2008.
National Center for Health Statistics (NCHS) Advance Data Reports
http://www.cdc.gov/nchs/products/ad.htm
Advance Data No. 349. Prevalence of leading types of dietary supplements used in the Third 
National Health and Nutrition Examination Survey, 1988–94. 8 pp. (PHS) 2005–1250.
Advance Data No. 348. Dietary intake of fats and fatty acids for the United States population: 
1999-2000. 7 pp. (PHS) 2005–1250.
Advance Data No. 341. Dietary intake of selected minerals for the United States population: 
1999–2000. 6 pp. (PHS) 2004–1250.
Advance Data No. 339. Dietary intake of selected vitamins for the United States population: 
1999–2000. 5 pp. (PHS) 2004–1250.
Advance Data No. 334. Dietary intake of ten key nutrients for public health, United States: 
1999–2000. 4 pp. (PHS) 2003–1250.
National Center for Health Statistics (NCHS) Series 11 Reports
http://www.cdc.gov/nchs/products/series/series11.htm 
Hollowell JG, van Assendelft OW, Gunter EW, Lewis BG, Najjar M, Pfeiffer C. Hematological 
and iron-related analytes—Reference data for persons aged 1 year and over: United States, 1988–
1994. National Center for Health Statistics. Vital Health Stat Series No. 11(247), 2005.
Bialostosky K, Wright JD, Kennedy-Stephenson J, McDowell M, Johnson CL. Dietary intake 
of macronutrients, micronutrients, and other dietary constituents: United States 1988–1994. 
National Center for Health Statistics. Vital Health Stat Series No. 11(245), 2002.
Ervin RB, Wright JD, Kennedy-Stephenson J. Use of dietary supplements in the United States, 
1988-1994. National Center for Health Statistics. Vital Health Stat Series No. 11(244), 1999.
Wright JD, Bialostosky K, Gunter EW, Carroll MD, Najjar MF, Bowman BA, Johnson CL. Blood 
folate and vitamin B12: United States, 1988–1994. National Center for Health Statistics. Vital 
Health Stat Series No. 11(243), 1998.
467Appendices
Fulwood R, Johnson CL, Bryner JD, Gunter EW, McGrath CR. Hematological and nutritional 
biochemistry reference data for persons 6 months–74 years of age: United States, 1976–1980. 
National Center for Health Statistics. Vital Health Stat Series No. 11(232), 1982.
National Center for Health Statistics (NCHS) Series 2 Reports
http://www.cdc.gov/nchs/products/series/series02.htm 
Looker AC, Gunter EW, Cook JD, Green R, Harris JW. Comparing serum ferritin values from 
different population surveys. National Center for Health Statistics. Vital Health Stat Series No. 
2(111), 1991.
Life Sciences Research Office (LSRO) Reports
Pilch SM. Assessment of the vitamin A nutritional status of the U.S. population based on data 
collected in the Health and Nutrition Examination Surveys. Bethesda (MD): Federation of 
American Societies for Experimental Biology; 1985.
Senti FR, Pilch SM. Analysis of the folate nutritional status of the U.S. population based on 
data collected in the Second National Health and Nutrition Examination Survey, 1976–1980. 
Bethesda (MD): Federation of American Societies for Experimental Biology; 1984.
Pilch SM, Senti FR. Assessment of iron nutritional status of the U.S. population based on 
data collected in the Second National Health and Nutrition Examination Survey, 1976–1980. 
Bethesda (MD): Federation of American Societies for Experimental Biology; 1984.
Pilch SM, Senti FR. Assessment of zinc nutritional status of the U.S. population based on 
data collected in the Second National Health and Nutrition Examination Survey, 1976–1980. 
Bethesda (MD): Federation of American Societies for Experimental Biology; 1984.
Life Sciences Research Office. 1989. An update report on nutrition monitoring in the United 
States. Prepared for the U.S. Department of Agriculture and the U.S. Department of Health and 
Human Services. DHHS Publication No. (PHS) 89–1255. Available from U.S. Government 
Printing Office, Washington, D.C.
Life Sciences Research Office. 1994. Assessment of folate methodology used in the Third National 
Health and Nutrition Survey (NHANES 1988-1994). Prepared for the Center for Food Safety 
and Applied Nutrition, Food and Drug Administration, Department of Health and Human 
Services. Washington, D.C.
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Appendix C 
Cutoff Points used to Generate Prevalence Estimates
The table below presents the cutoff values used to calculate prevalence estimates of low or high 
concentrations of biochemical indicators for various population groups and the years for which 
NHANES data were available. The clinical interpretation of the cutoff values is described in the 
text that accompanies each chapter.
Indicator Units Cutoff value Population described NHANES years available
Water-Soluble Vitamins  
Serum folate ng/mL < 2 ≥ 3 years 1999–2002
   ≥ 1 years 2003–2006
Red blood cell folate ng/mL < 95 ≥ 3 years 1999–2002
   ≥ 1 years 2003–2006
Serum pyridoxal-5’-phosphate nmol/L < 20 ≥ 1 years 2005–2006
Serum vitamin B12 pg/mL < 200 ≥ 3 years 1999–2002
   ≥ 1 years 2003–2006
Plasma homocysteine µmol/L > 13 ≥ 3 years 1999–2004
   ≥ 20 years 2005–2006
Plasma methylmalonic acid nmol/L > 271 ≥ 3 years 1999–2004
Serum vitamin C µmol/L < 11.4 ≥ 6 years 2003–2006
Fat-Soluble Vitamins  
Serum vitamin A µg/dL < 20 ≥ 6 years 1999–2002; 2005–2006 
 µg/dL > 100 ≥ 6 years 1999–2002; 2005–2006
Serum vitamin E µg/dL < 500 ≥ 6 years 1999–2002; 2005–2006
 µg/dL > 20,000 ≥ 6 years 1999–2002; 2005–2006
Serum 25-hydroxyvitamin D nmol/L < 30 ≥ 6 years or ≥ 1 year* 2001–2006
 nmol/L 30–< 50 ≥ 6 years or ≥ 1 year* 2001–2006
nmol/L < 40 ≥ 6 years or ≥ 1 year* 2001–2006
 nmol/L > 125 ≥ 6 years or ≥ 1 year* 2001–2006
Iron-Status Indicators  
Serum ferritin ng/mL < 12 1-5 years 1999–2006
 ng/mL < 15 Females 12-49 years 1999–2006
ng/mL < 15 Males ≥ 6 years 1999–2002
 ng/mL > 150 Females 12-49 years 1999–2006
 ng/mL > 200 Males ≥ 12 years 1999–2002
Serum soluble transferrin receptor mg/L > 4.4 Females 12-49 years 2003–2006
Body iron mg/kg < 0 1-5 years 2003–2006
 mg/kg < 0 Females 12-49 years 2003–2006
*2001–2002: ≥ 6 years; 2003–2006: ≥ 1 year
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Appendix D
References for Analytical Methods for Biochemical 
Indicators
Detailed Laboratory Procedure Manuals for Each Analytical Method:
•	 NHANES 2003–2004: http://www.cdc.gov/nchs/nhanes/nhanes2003-2004/lab_
methods_03_04.htm.
•	 NHANES 2005–2006: http://www.cdc.gov/nchs/nhanes/nhanes2005-2006/lab_
methods_05_06.htm.
Additional Useful Analytical Method References:
Water-Soluble Vitamins
Gunter EW, Bowman BA, Caudill SP, Twite DB, Adams MJ, Sampson EJ. Results of an international round robin 
for serum folate and whole-blood folate. Clin Chem. 1996;42:1689–1694.
Life Sciences Research Office. Assessment of folate methodology used in the Third National Health and Nutrition 
Survey (NHANES 1988-1994). Washington, D.C.: Center for Food Safety and Applied Nutrition, Food and Drug 
Administration, Department of Health and Human Services; 1994.
McCoy LF, Bowen MB, Xu M, Chen H, Schleicher RL. Improved HPLC assay for measuring serum vitamin C 
with 1-methyluric acid used as an electrochemically active internal standard. Clin Chem. 2005;51:1062–1064.
Pfeiffer CM, Twite D, Shih J, Holets-McCormack SR, Gunter EW. Method comparison for total plasma 
homocysteine between the Abbott IMx analyzer and an HPLC assay with internal standardization. Clin Chem. 
1999;45(1):152–153.
Pfeiffer CM, Huff DL, Smith SJ, Miller DT, Gunter EW. Comparison of plasma total homocysteine measurements 
in 14 laboratories: an international study. Clin Chem. 1999;45(8):1261–1268.
Pfeiffer CM, Smith SJ, Miller DT, Gunter EW. Comparison of serum and plasma methylmalonic acid 
measurements in 13 laboratories: an international study. Clin Chem. 1999;45:2236–2242.
Pfeiffer CM, Caudill SP, Gunter EW, Bowman BA, Jacques PF, Selhub J, et al. Discussion of critical issues related 
to the comparison of homocysteine values between the Third National Health and Nutrition Examination Survey 
(NHANES) and NHANES 1999+. J Nutr. 2000;130:2850–2854.
Rybak ME, Pfeiffer CM. Clinical analysis of vitamin B6: Determination of pyridoxal 5’-phosphate and 4-pyridoxic 
acid in human serum by reversed-phase high-performance liquid chromatography with chlorite postcolumn 
derivatization. Anal Biochem. 2004;333:336–344.
Rybak ME, Jain RB, Pfeiffer CM. Clinical vitamin B6 analysis: an inter-laboratory comparison of pyridoxal 
5’-phosphate measurements in serum. Clin Chem. 2005;51:1223–1231.
Rybak ME, Pfeiffer CM. A simplified protein precipitation and filtration procedure for determining serum vitamin 
B6 by high-performance liquid chromatography. Anal Biochem. 2009;388:175–177.
Fat-Soluble Vitamins and Nutrients
Sowell AL, Huff DL, Yeager PR, Caudill SP, Gunter EW. Retinol, alpha-tocopherol, lutein/zeaxanthin, beta-
cryptoxanthin, lycopene, alpha-carotene, trans-beta-carotene, and four retinyl esters in serum determined 
simultaneously by reversed-phase HPLC with multi-wavelength detection. Clin Chem. 1994;40:411–416.
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Trace Elements
Looker AC, Gunter EW, Johnson CL. Methods to assess iron status in various NHANES surveys. Nutr Rev. 
1995;53:246–254.
Pfeiffer CM, Cook JD, Mei Z, Cogswell ME, Looker AC, Lacher DA. Evaluation of an automated soluble 
transferrin receptor (sTfR) assay on the Roche Hitachi analyzer and its comparison to two ELISA assays. Clin 
Chim Acta 2007;382:112–116.
Caldwell KL, Maxwell CB, Makhmudov A, Pino S, Braverman LE, Jones RL, et al. Use of inductively coupled 
plasma mass spectrometry to measure urinary iodine in NHANES 2000: comparison with previous method. Clin 
Chem. 2003;49:1019–1021.
Isoflavones and Lignans 
Valentin-Blasini L, Blount BC, Rogers HS, Needham LL. HPLC-MS/MS method for the measurement of seven 
phytoestrogens in human serum and urine. J Expo Anal Environ Epidemiol. 2000;10:799–807.
Kuklenyik Z, Ye X, Reich JA, Needham LL, Calafat AM. Automated on-line and off-line solid phase extraction 
methods for measuring isoflavones and lignans in urine. J Chromatogr Sci. 2004;42:495–500.
Rybak ME, Parker DL, Pfeiffer CM. Determination of urinary phytoestrogens by HPLC-MS/MS: a comparison 
of atmospheric pressure chemical ionization (APCI) and electrospray ionization (ESI). J Chromatogr B. 
2008;861:145–150.
Parker DL, Rybak ME, Pfeiffer CM. Phytoestrogen biomonitoring: an extractionless LC-MS/MS method for 
measuring urinary isoflavones and lignans using atmospheric pressure photoionization (APPI). Anal Bioanal Chem. 
2012;402:1123-1136.
Acrylamide Hemoglobin Adducts
Vesper HW, Ospina M, Meyers T, Ingham L, Smith A, Gray JG, Myers GL. Automated method for measuring 




Confidence Interval Estimation for Percentiles
A large body of literature describes various methods to estimate percentiles and to derive the 
variance and confidence intervals for complex survey data. Highlighted in the literature are the 
following methods: Woodruff method (Woodruff 1952), “test inversion” method (Francisco and 
Fuller 1991), the Normal transformation method (Korn and Graubard 1999), and Replication 
methods (Kovar 1988, Rogers 2003).
Confidence intervals for percentiles in this report were calculated with the Woodruff method. 
This method uses the standard error of the empirical distribution function at the selected 
percentile and constructs a 95% confidence interval, followed by back transformation using the 
inverse of the empirical distribution. The previous National Report on Biochemical Indicators 
of Diet and Nutrition in the U.S. Population, 1999–2002 used a variation of the Woodruff 
method by combining it with the method of Clopper and Pearson proposed by Korn and 
Graubard (1999) for complex surveys. This approach was used previously because large-sample 
normal approximations used to calculate confidence intervals for proportions close to zero or 
1 can lead to confidence intervals with poor coverage properties. However, a paper by Sitter 
and Wu (2001) concluded that despite the fact that confidence intervals around the empirical 
distribution function at tail regions perform poorly, the Woodruff confidence intervals obtained 
by inverting these poorly behaved intervals perform very well for percentiles. Therefore, the 
confidence intervals presented in this report are based on the Woodruff approach with no further 
modifications, as described in the steps below.
Background
Define an arbitrary percentile Xp, such that F(X) = P(X ≤ Xp) = p. This is pictured in Figure 
1, where the y-axis displays the empirical distribution function (cdf ) over a set of hypothetical 
values. In this example, p = 0.5 and so X0.5 is the median. Both SAS (version 9.2) and SUDAAN 
(version 10.0) find Xp through linear interpolation. Let F̂  (xj) be an estimate of the empirical distribution function at x and assume data x1, x2, … xn are a rank ordered listing of the sampled 
values, such that x1 is the minimum value and xn is the maximum value; then the estimated 
percentile by use of linear interpolation is calculated as:
To find the percentiles and confidence intervals in this report, we used results derived from 
SUDAAN’s PROC DESCRIPT (DESIGN=WR) PERCENTILE statement and results from the 
Histogram output group.


















Use SUDAAN (DESIGN=WR) to estimate the percentiles, the empirical distribution, and the 
standard error of the empirical distribution function at each point. SUDAAN uses a Horowitz-
Thompson estimator of the empirical distribution function at each value. The estimated 
empirical distribution function can be outputted into a dataset using the HISTPCT statement in 
conjunction with an OUTPUT statement in PROC DESCRIPT. By default, SUDAAN estimates 
the empirical distribution function by using a maximum of 100 equally spaced percentages to 
divide the population into bins. We used the option /NPCT in the HISTPCT statement to 
change this default to allow a jump in the empirical distribution function at every unique data 
value, up to 2950 unique values. An output file is generated by SUDAAN to contain: the upper 
endpoint of the current bin in the histogram, the cumulative percent less than or equal to the 
upper endpoint of the current bin and the respective estimated standard error of the cumulative 
percent. This file is used to obtain 95% confidence intervals of the empirical distribution function 
at the selected percentile. In some rare cases, using the values of the upper endpoint available in 
this file may differ slightly from a rank order list of the weighted sampled values if there are more 
than 2950 distinct values. This difference may lead to very small differences when comparing the 
confidence limits to other software which uses Woodruff confidence limits based on the weighted 
sample values. Sample SUDAAN code for serum folate (FOL) is as follows: 
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PROC DESCRIPT DATA=NHANES03_06 FILETYPE=SAS DESIGN=WR  ;
 NEST SDMVSTRA SDMVPSU/MISSUNIT;
 WEIGHT WTMEC4YR;
 VAR  LBXFOL;
 PERCENTILES 5 10 90 95 /MEDIAN ;
 HISPCT /NPCT=2950;
 OUTPUT QTILE /FILENAME=PCTILES   
FILETYPE=SAS REPLACE ;
OUTPUT UPPEREND CUMPCT SECUMPCT   /FILENAME=HIST FILETYPE=SAS 
REPLACE;
If you change the first OUTPUT statement in the above program to
OUTPUT QTILE LOWQTILE UPQTILE /FILENAME=PCTILES FILETYPE=SAS 
REPLACE ;
SUDAAN will provide the upper and lower confidence limits based on the “test inversion” 
method of Francisco and Fuller. However, as mentioned earlier, this report does not use 
SUDAAN’s default method to generate confidence intervals for percentiles.
Step 2
Using SAS DATA steps to manipulate the output files from Step 1, find the value of the estimated 
cumulative distribution function that is less than or equal to p using the values of the cumulative 
percent produced by SUDAAN in the output file HIST: 
Save F̂  (xj) and the corresponding standard error (SE) estimate at F̂  (xj) and proceed to step 3.
Step 3
Using p (the desired percentile) and the standard error of the estimate of F̂  (xj), compute the 
95% confidence interval for p: (pL, pU) as p+t0.025,DFSE, where the degrees of freedom (DF) are 
the number of primary sampling units minus the number of strata and SE is the standard error 
from step 2. To get the appropriate degrees of freedom for each subgroup use the ATLEVEL1 and 
ATLEVEL2 options in SUDAAN’s PROC DESCRIPT to count up the number of strata and 
PSUs with valid data. This must be done in a separate call to PROC DESCRIPT than the one 
that calculates the percentiles because the HISTPCT statement is not available with ATLEVEL. 
Note: SAS (version 9.2) uses the empirical point estimate at the desired percentile, p̂   = F̂  (xj), in 
order to calculate the 95% confidence interval as p̂  +t0.025,DFSE.
)x(F̂p)x(F̂ 1jj   
Figure 1: Definition of a percentile
Step 1
Use SUDAAN (DESIGN=WR) to estimate the percentiles, the empirical distribution, and the 
standard error of the empirical distribution function at each point. SUDAAN uses a Horowitz-
Thompson estimator of the empirical distribution function at each value. The estimated 
empirical distribution function can be outputted into a dataset using the HISTPCT statement in 
conjunction with an OUTPUT statement in PROC DESCRIPT. By default, SUDAAN estimates 
the empirical distribution function by using a maximum of 100 equally spaced percentages to 
divide the population into bins. We used the option /NPCT in the HISTPCT statement to 
change this default to allow a jump in the empirical distribution function at every unique data 
value, up to 2950 unique values. An output file is generated by SUDAAN to contain: the upper 
endpoint of the current bin in the histogram, the cumulative percent less than or equal to the 
upper endpoint of the current bin and the respective estimated standard error of the cumulative 
percent. This file is used to obtain 95% confidence intervals of the empirical distribution function 
at the selected percentile. In some rare cases, using the values of the upper endpoint available in 
this file may differ slightly from a rank order list of the weighted sampled values if there are more 
than 2950 distinct values. This difference may lead to very small differences when comparing the 
confidence limits to other software which uses Woodruff confidence limits based on the weighted 
sample values. Sample SUDAAN code for serum folate (FOL) is as follows:
X
p
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Step 4
Map the lower (pL) and upper (pU) confidence intervals of the empirical distribution function at 
the desired percentile using the inverse of the empirical distribution function (see Figure 2) and 
linear interpolation to get the confidence interval for the percentile of interest.
Let L̂  p be the lower confidence limit of the estimated percentile and Û  p  be the upper confidence 
limit of the estimated percentile.  x1, x2, … xn are a rank ordered listing of the values as produced 
by SUDAAN using HISTPCT, such that x1 is the minimum value and xn is the maximum value; 




























































































PROC DESRIPT in SUDAAN (version 8.0 and higher) calculates confidence limits for the 
percentiles using the “test-inversion” method by Fransisco and Fuller, as noted in Step 1. 
PROC SURVEYMEANS (SAS version 9.1 and higher) can be used to obtain Woodruff like 
confidence intervals for percentiles. However, the SURVEYMEANS method differs slightly from 
the traditional Woodruff method as noted in Step 3.
References
Francisco CA, Fuller WA. Quantile estimation with a complex survey design. Annals Statist. 1991;19:454–469.
Korn EL, Graubard BI. Analysis of Health Surveys. Wiley: New York, 1999.
Kovar JG, Rao JNK, Wu CFL. Bootstrap and other methods to measure errors in survey estimated. Can J Statist. 
1988;16S:25–45.
Research Triangle Institute (2008). SUDAAN Language Manual, Release 10.0 Research Triangle Park, NC: Research 
Triangle Institute. 
Rogers JW. Estimating the variance of percentiles using replicate weights. Proceedings of the Section on Survey 
Research Methods. 2003.
Sitter RR, Wu C. A note on Woodruff confidence intervals for quantiles. Statist Probabil Letters. 2001;52:353–358.
Woodruff RS. Confidence intervals for medians and other position measures. J Am Statist Assoc. 1952;57:622–627. 
U.S. Centers for Disease Control and Prevention. NHANES Analytic guidelines, the Third National Health and 
Nutrition Examination Survey, NHANES III (1988–94). Hyattsville (MD): National Center for Health Statistics; 
October 1996 [cited 2008]. Available from: http://www.cdc.gov/nchs/data/nhanes/nhanes3/nh3gui.pdf.
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Appendix F 
Limit of Detection Table
The table below presents the analytical limit of detection (LOD) for each indicator. The LOD is the level at 
which the measurement has a 95 percent probability of being greater than zero (Taylor 1987). For the same 
indicator, LOD values may change over time as a result of changes to analytical methods. This was the case 
for serum ferritin and urinary phytoestrogens. We used the highest LOD value when multi-year data were 
combined. The information provided in parentheses specifies what proportion of results was below the LOD 
for each indicator and survey cycle.
Indicator Units 1999-2000 2001-2002 2003-2004 2005-2006
Water-Soluble Vitamins
B Vitamins and Related Biochemical Compounds
Serum folate ng/mL 0.1 (0%) 0.1 (0%) 0.1 (0%) 0.1 (0%)
Red blood cell folate ng/mL 20 (0%) 20 (0%) 20 (< 1%) 20 (0%)
Serum pyridoxal-5’-phosphate nmol/L no data no data no data 0.3 (0%)
Serum 4-pyridoxic acid nmol/L no data no data no data 0.3 (0%)
Serum vitamin B12 pg/mL 20 (0%) 20 (0%) 20 (0%) 20 (0%)
Plasma homocysteine µmol/L 0.35 (0%) 0.35 (0%) 0.35 (0%) 0.35 (0%)
Plasma methylmalonic acid nmol/L 50 (1%) 50 (1%) 50 (< 1%) no data
Serum vitamin C µmol/L no data no data 0.68 (< 1%) 0.68 (< 1%)
Fat-Soluble Vitamins and Nutrients
Vitamins A and E and Carotenoids
Serum vitamin A (retinol) µg/dL 1.03 (0%) 1.03 (0%) no data 1.03 (< 1%)
Serum vitamin E (alpha-tocopherol) µg/dL 40.7 (0%) 40.7 (0%) no data 40.7 (0%)
Serum gamma-tocopherol µg/dL 10.7 (< 1%) 10.7 (< 1%) no data 10.7 (0%)
Serum alpha-carotene µg/dL no data 0.7 (9%) no data 0.7 (7%)
Serum trans-beta-carotene µg/dL no data 0.8 (< 1%) no data 0.8 (< 1%)
Serum cis-beta-carotene µg/dL no data 0.7 (52%) no data 0.7 (51%)
Serum beta-cryptoxanthin µg/dL no data 0.9 (< 1%) no data 0.9 (< 1%)
Serum lutein and zeaxanthin µg/dL no data 2.4 (< 1%) no data 2.4 (< 1%)
Serum trans-lycopene µg/dL no data 0.8 (< 1%) no data 0.8 (< 1%)
Serum total lycopene µg/dL no data no data no data 1.0 (< 1%)
Serum retinyl palmitate µg/dL 0.2 (16%) 0.2 (2%) no data 1.3 (22%)
Serum retinyl stearate µg/dL 0.5 (86%) 0.5 (87%) no data 0.7 (88%)
Serum 25-hydroxyvitamin D nmol/L no data 3.7 (0%) 3.7 (0%) 3.7 (0%)
Fatty Acids - Saturated
Plasma myristic acid (14:0) µmol/L no data no data 1.6 (0%) no data
Plasma palmitic acid (16:0) µmol/L no data no data 8.2 (0%) no data
Plasma stearic acid (18:0) µmol/L no data no data 23.7 (0%) no data
Plasma arachidic acid (20:0) µmol/L no data no data 0.6 (0%) no data
Plasma docosanoic acid (22:0) µmol/L no data no data 0.2 (0%) no data
Plasma lignoceric acid (24:0) µmol/L no data no data 0.1 (0%) no data
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Indicator Units 1999-2000 2001-2002 2003-2004 2005-2006
Fatty Acids - Monounsaturated
Plasma myristoleic acid (14:1n-5) µmol/L no data no data 0.1 (0%) no data
Plasma palmitoleic acid (16:1n-7) µmol/L no data no data 0.6 (0%) no data
Plasma cis-vaccenic acid (18:1n-7) µmol/L no data no data 0.3 (0%) no data
Plasm oleic acid (18:1n-9) µmol/L no data no data 5.2 (0%) no data
Plasma eicosenoic acid (20:1n-9) µmol/L no data no data 0.2 (0%) no data
Plasma docosenoic acid (22:1n-9) µmol/L no data no data 0.3 (3%) no data
Plasma nervonic acid (24:1n-9) µmol/L no data no data 0.4 (0%) no data
Fatty Acids - Polyunsaturated
Plasma linoleic acid (18:2n-6) µmol/L no data no data 2.2 (0%) no data
Plasma alpha-linolenic acid (18:3n-3) µmol/L no data no data 0.2 (0%) no data
Plasma  gamma-linolenic acid (18:3n-6) µmol/L no data no data 0.1 (0%) no data
Plasma eicosadienoic acid (20:2n-6) µmol/L no data no data 0.1 (0%) no data
Plasma homo-gamma-linolenic acid (20:3n-6) µmol/L no data no data 0.2 (0%) no data
Plasma arachidonic acid (20:4n-6) µmol/L no data no data 0.3 (0%) no data
Plasma eicosapentaenoic acid (20:5n-3) µmol/L no data no data 0.1 (0%) no data
Plasma docosatetraenoic acid (22:4n-6) µmol/L no data no data 0.2 (0%) no data
Plasma docosapentaenoic acid (22:5n-3) µmol/L no data no data 0.2 (0%) no data
Plasma docosapentaenoic acid (22:5n-6) µmol/L no data no data 0.1 (0%) no data
Plasma docosahexaenoic acid (22:6n-3) µmol/L no data no data 0.1 (0%) no data
Trace Elements
Iron-Status Indicators
Serum ferritin ng/mL 1.1 (0%) 1.1 (0%) 3 (1%) 3 (1%)
Serum soluble transferrin receptor mg/L no data no data 0.5 (0%) 0.5 (0%)
Urinary iodine ng/mL no data 1.0 (0%) 1.0 (0%) 1.0 (0%)
Isoflavones and Lignans
Urinary genistein µg/L 0.3 (6%) 0.8 (< 1%) 0.3 (< 1%) 1.0 (< 1%)
Urinary daidzein µg/L 0.5 (1%) 1.6 (7%) 0.3 (< 1%) 0.4 (< 1%)
Urinary equol µg/L 3 (28%) 3.3 (30%) 0.3 (< 1%) 0.06 (< 1%)
Urinary O-desmethylangolensin µg/L 0.2 (25%) 0.4 (27%) 0.2 (7%) 0.2 (4%)
Urinary enterodiol µg/L 0.8 (8%) 1.5 (4%) 0.3 (1%) 0.04 (< 1%)
Urinary enterolactone µg/L 0.6 (2%) 1.9 (1%) 0.3 (< 1%) 0.1 (0%)
Acrylamide Hemoglobin Adducts
Acrylamide hemoglobin adduct pmol/g Hb no data no data 3 (< 1%) no data
Glycidamide hemoglobin adduct pmol/g Hb no data no data 4 (2%) no data
Reference
Taylor JK. Quality assurance of chemical measurements. Chelsea (MI): Lewis Publishing; 1987.
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Appendix G 
Selected References of Descriptive NHANES Papers on 
Diet-and-Nutrition Biochemical Indicators
Water-Soluble Vitamins
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relation to folic acid intake from diet and supplements in a nationally representative sample of adults aged >=60 y 
in the United States. Am J Clin Nutr. 2010;92:383–389.
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Bailey RL, Dodd KW, Gahche JJ, Dwyer JT, McDowell MA, Yetley EA, et al. Total folate and folic acid intake 
from foods and dietary supplements in the United States: 2003–2006. Am J Clin Nutr. 2010;91:231–237.
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race/ethnicity after folic acid fortification. Am J Public Health. 2006;96:2040–2047.
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United States 1999–2000, 2001–2002, and 2003–2004. Morb Mortal Wkl Rep. 2007;55(51):1377–1380.
Dietrich M, Brown CJP, Block G. The effect of folate fortification of cereal-grain products on blood folate status, 
dietary folate intake and dietary folate sources among adult non-supplement users in the United States. J Am Coll 
Nutr. 2005;24:266–274.
Ganji V, Kafai MR. Hemoglobin and hematocrit values are higher and prevalence of anemia is lower in the 
post-folic acid fortification period than in the pre-folic acid fortification period in US adults. Am J Clin Nutr. 
2009;89:363–371.
Ganji V, Kafai MR. Demographic, lifestyle, and health characteristics and serum B vitamin status are determinants 
of plasma total homocysteine concentrations in the post-folic acid fortification period, 1999–2004. J Nutr. 
2009;139:345–352.
Ganji V, Kafai MR. Trends in serum folate, RBC folate, and circulating total homocysteine concentrations in the 
United States: analysis of data from National Health and Nutrition Examination Surveys, 1988–1994, 1999–2000, 
and 2001–2002. J Nutr. 2006;136:153–158.
Ganji V, Kafai MR. Population reference values for plasma total homocysteine concentrations in US adults after 
the fortification of cereals with folic acid. Am J Clin Nutr. 2006;84:989–994.
Ganji V, Kafai MR. Population references for plasma total homocysteine concentrations for US children and 
adolescents in the post-folic acid fortification era. J Nutr. 2005;135:2253–2256.
Ganji V, Kafai MR. Serum total homocysteine concentration determinants in non-Hispanic white, non-Hispanic 
black, and Mexican-American populations of the United States. Ethn Dis. 2004;14:476–482.
Ganji V, Kafai MR. Demographic, health, lifestyle, and blood vitamin determinants of serum total homocysteine 
concentrations in the Third National Health and Nutrition Examination Survey, 1988–1994. Am J Clin Nutr. 
2003;77:826–833.
Hamner HC, Mulinare J, Cogswell ME, Flores AL, Boyle CA, Prue CE, et al. Predicted contribution of folic acid 
fortification of corn masa flour to the usual folic acid intake for the US population: National Health and Nutrition 
Examination Survey, 2001–2004. Am J Clin Nutr. 2009;89:305–315.
McDowell MA, Lacher DA, Pfeiffer CM, Mulinare J, Picciano MF, Rader JI, et al. Blood folate levels: The latest 
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